Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABCA7	ABCX	ENSG00000064687	"ATP binding cassette subfamily A member 7"	Q8IZY2	19	1039997-1065572	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Phagocytosis, Transport"	Translocase	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.4;pituitary gland: 28.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Bipolar cells: 70.6;Cone photoreceptor cells: 175.2;Extravillous trophoblasts: 303.3;Rod photoreceptor cells: 149.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 20.4;HMC-1: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA041564	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Golgi apparatus, Plasma membrane"	"Cell Junctions"	"HPA041564: AB_2677550"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (7.26e-4)"	"prognostic favorable (1.12e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.68e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.08e-2)"	"unprognostic (3.66e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.85e-2)"	4.4	3.0	3.4	5.5	3.9	27.4	3.3	4.0	6.1	3.2	11.5	3.8	2.3	1.2	0.2	7.6	2.1	2.1	3.1	3.6	3.7	6.4	4.2	9.5	8.5	5.8	4.5	0.5	7.7	2.7	28.7	1.2	5.3	5.3	1.2	25.5	8.6	1.1	3.8	5.9	10.1	0.5	3.0	26.6	3.8	1.7	4.1	10.0	5.7	0.3	3.2	2.3	2.8	3.2	4.7	6.4	0.5	4.4	7.2	2.2	7.3	0.8	1.0	0.4	0.6	5.2	2.8	13.9	5.6	1.3	0.6	8.0	1.3	6.2	0.4	10.2	2.5	6.7	20.4	5.6	1.8	3.9	40.3	3.8	1.8	0.9	1.2	4.4	1.4	7.7	10.2	6.9	1.3	2.2	4.3	2.2	0.9	3.3	2.5	3.1	0.8	11.6	3.8	6.0	0.3	1.3	8.2	1.9	1.2	1.1	4.6	7.1	2.2	0.4	1.6	3.7	0.8	9.9	6.6	5.7	2.1	7.4	2.0	2.8	1.4	5.9	1.8	1.2	1.1	0.6	0.9	1.2	2.1	0.9	0.8	1.5	3.3	1.1	1.3	7.3	0.4	1.3	3.4	3.9	4.0	6.1	3.6	3.7	5.8	4.5	5.3	3.0	4.1	3.2	4.1	73.7	21.9	8.5	13.2	3.3	0.8	10.7	5.2	70.6	4.8	2.2	6.0	4.3	14.0	5.5	175.2	4.6	9.1	14.7	1.9	2.7	7.3	8.9	1.4	2.9	3.5	13.3	12.9	2.5	303.3	1.5	5.6	6.9	10.1	2.0	2.5	4.9	7.9	15.2	11.5	4.7	16.2	12.6	7.5	4.8	0.0	12.7	0.0	4.7	19.6	13.1	9.2	1.5	2.4	7.0	9.6	0.0	12.0	1.5	1.7	1.3	17.5	149.1	0.0	2.7	2.7	0.7	2.0	6.6	3.4	25.7	12.6	1.0	5.3	1.9
ABCC4	"EST170205, MOAT-B, MOATB, MRP4"	ENSG00000125257	"ATP binding cassette subfamily C member 4"	O15439	13	95019835-95301475	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 41.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 51.3;granulocytes: 53.9;Microglial cells: 203.3"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 90.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"HEL: 245.7;HMC-1: 256.3;RPTEC TERT1: 69.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002476	Enhanced		Supported	"Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Nucleoli, Golgi apparatus"	"HPA002476: AB_1844434"	"unprognostic (8.77e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.40e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.55e-2)"	"prognostic favorable (2.25e-10)"	"unprognostic (7.44e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.35e-2)"	2.2	1.3	2.5	6.1	2.3	4.1	6.9	2.5	2.5	4.9	7.2	9.2	4.9	3.4	18.8	2.0	10.2	6.1	2.0	2.3	5.4	18.0	1.3	7.6	3.9	4.3	3.7	3.7	3.3	22.5	1.4	2.1	4.6	41.1	8.5	0.9	1.5	5.5	5.3	2.9	5.4	6.3	4.9	4.1	5.2	4.7	3.2	3.9	7.7	1.7	6.3	15.4	1.8	5.1	18.5	31.7	5.3	9.4	9.5	12.3	1.3	14.4	14.3	12.6	10.9	43.8	13.2	10.2	9.3	19.5	9.0	24.0	7.9	7.1	15.8	30.7	12.1	245.7	8.8	8.8	19.2	28.6	256.3	9.4	3.2	9.1	18.5	17.9	16.4	11.3	25.8	0.4	17.1	5.9	5.4	4.6	6.2	22.3	7.9	7.7	14.3	26.9	69.3	40.4	12.5	9.3	4.8	1.2	10.1	5.9	0.0	15.1	27.0	13.3	8.6	11.2	17.3	0.1	0.0	4.0	25.4	16.0	6.6	0.2	0.5	0.2	1.3	0.6	1.1	1.4	1.0	1.5	1.8	1.6	0.6	1.5	0.3	1.9	2.3	0.3	1.5	1.3	2.5	2.3	2.5	2.5	2.3	5.4	4.3	3.7	4.6	4.9	3.2	5.1	4.6	9.6	32.7	28.4	5.8	4.2	7.0	7.3	4.0	0.1	0.6	0.6	4.5	8.6	9.1	23.9	22.9	0.1	2.0	2.7	0.0	6.9	3.8	4.2	11.3	19.8	0.0	51.3	13.6	3.1	0.4	5.7	6.1	6.0	53.9	9.5	2.9	0.6	4.5	0.0	10.3	4.0	0.0	2.5	8.1	2.0	6.8	10.7	1.8	203.3	13.5	0.5	4.1	16.1	2.5	2.9	8.3	1.9	8.3	27.1	0.5	26.4	4.7	0.8	0.0	8.2	3.1	0.9	8.3	3.4	7.5	0.3	6.4	17.3	9.2	4.5
ABHD6		ENSG00000163686	"Abhydrolase domain containing 6, acylglycerol lipase"	Q9BV23	3	58237532-58295693	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 60.6;Oligodendrocytes: 88.6;Proximal enterocytes: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017283, HPA073225"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 45: Intestine - Brush border"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	Nucleoplasm	"HPA017283: AB_1844452, HPA073225: AB_2686583"	"unprognostic (4.20e-2)"	"unprognostic (7.92e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.11e-11)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.31e-2)"	12.2	12.9	24.0	6.4	33.9	0.9	8.9	34.1	32.4	4.4	19.4	12.7	39.5	6.1	14.7	6.4	9.1	5.8	5.7	31.6	26.9	35.6	64.9	8.5	8.0	31.7	32.3	5.0	2.7	8.9	16.6	6.4	31.7	5.5	11.1	9.2	4.0	14.3	4.6	25.5	52.3	9.2	28.8	35.0	12.9	3.9	35.5	5.5	9.1	5.4	7.6	5.8	5.9	49.8	3.5	12.0	1.8	8.5	23.2	4.2	21.2	8.9	8.1	9.2	12.5	6.9	4.8	6.6	0.8	4.7	28.5	9.9	8.3	3.9	8.4	11.3	4.2	5.7	8.1	9.7	7.8	1.7	28.1	3.9	18.4	8.8	3.8	10.6	5.0	10.6	6.8	15.0	7.2	2.6	11.7	0.7	6.1	28.5	27.3	4.2	3.8	14.8	14.5	4.8	10.8	4.4	9.9	5.1	19.0	3.7	3.6	4.5	5.8	6.6	7.0	16.6	10.8	4.2	13.5	0.3	17.1	16.9	9.3	0.0	2.2	1.7	1.6	7.4	1.5	3.6	0.9	1.9	3.7	2.5	0.9	1.1	0.0	0.7	5.2	5.4	1.2	1.0	24.0	33.9	34.1	32.4	31.6	26.9	31.7	32.3	31.7	28.8	35.5	49.8	27.1	0.0	1.8	11.4	13.6	8.7	3.0	2.7	6.2	13.3	2.1	1.5	5.6	5.7	4.9	3.7	4.2	2.0	7.7	11.2	1.9	3.0	1.0	9.8	7.9	14.1	0.0	5.7	33.6	1.9	0.9	2.9	7.7	1.5	11.4	10.1	21.4	60.6	8.9	15.2	34.3	4.0	0.0	16.7	20.0	0.7	6.8	12.1	3.6	11.2	11.5	11.2	6.2	37.7	88.6	1.9	1.4	8.2	2.0	1.8	55.1	17.4	13.8	3.3	0.0	2.9	3.9	0.5	2.2	6.9	24.6	0.5	5.1	16.0	5.8	2.0
AC008687.1		ENSG00000267335	"Novel protein"		19	49022953-49036895	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	6	"pituitary gland: 17.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.6;HMC-1: 4.4;U-138 MG: 1.6;U-251 MG: 6.0"									HPA038925	Uncertain		Approved	Cytosol	"Secreted - unknown location"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"		Cytosol		"HPA038925: AB_2676272"																		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.0	17.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.6	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.6	0.0	0.2	0.0	0.0	1.6	1.3	0.3	6.0	0.3	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
AC018755.2		ENSG00000268500	"Novel transcript, sense intronic to AC018755.18"		19	51612091-51646889	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 26.1;lymphoid tissue: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 5.0"	"Immune cell enhanced"	"Detected in many"		"neutrophil: 180.3"	"Group enriched"	"Detected in many"	5	"granulocytes: 180.3;monocytes: 70.1"	"Group enriched"	"Detected in some"	10	"HMC-1: 78.0;U-937: 33.2"									HPA009085	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"			"HPA009085: AB_1079965"																		1.4	0.4	0.1	7.2	0.2	26.1	0.1	0.3	5.0	0.3	0.3	0.3	0.8	0.1	0.0	1.0	0.2	1.0	0.3	0.1	0.4	0.1	0.2	1.3	2.9	0.7	0.4	0.0	0.2	0.1	0.0	0.5	1.6	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.5	0.5	0.4	4.0	0.4	0.1	0.7	0.6	0.0	0.1	0.5	1.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	1.6	78.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	33.2	0.1	11.2	32.4	1.0	0.1	32.3	0.0	2.0	0.0	0.0	22.8	2.7	0.0	0.0	180.3	0.8	70.1	4.9	0.0	17.3	0.1	0.2	0.3	5.0	0.1	0.4	0.7	0.4	1.6	0.4	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC093155.3		ENSG00000267561	"Novel protein"		1	86993009-87169204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"adipose tissue: 19.3"	"Cell type enriched"	"Detected in single"	6	"granulocytes: 5.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.7"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.4;HEL: 14.7;HMC-1: 17.9;THP-1: 12.7"									"HPA043069, HPA043603"	Approved		Uncertain	Mitochondria		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Mitochondria		"HPA043069: AB_10964127, HPA043603: AB_10963432"	"unprognostic (4.41e-1)"				"unprognostic (3.13e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.19e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.14e-1)"			"unprognostic (2.54e-1)"	19.3	1.8	2.6	3.1	3.2	0.3	7.0	1.5	5.0	4.4	1.8	3.7	2.4	2.6	2.2	3.2	1.5	4.8	8.4	2.7	1.8	1.9	1.7	5.5	2.2	1.7	1.9	6.8	1.1	0.8	0.0	5.9	1.7	0.8	3.3	0.3	2.9	2.4	1.3	0.4	3.1	4.5	1.8	2.7	1.2	3.8	1.8	1.1	1.9	3.6	1.0	4.6	0.0	2.1	0.0	0.1	0.9	2.2	2.5	9.4	0.3	0.0	0.1	0.0	0.4	0.7	0.9	0.1	0.2	0.0	0.2	0.2	0.3	0.2	0.4	0.1	0.5	14.7	0.4	0.1	0.1	0.3	17.9	1.6	0.3	0.2	0.0	0.0	0.1	0.2	0.2	0.4	0.2	0.0	0.2	0.2	0.4	1.2	0.0	0.2	0.3	0.0	0.4	0.4	0.2	0.4	0.3	0.0	0.5	0.9	0.2	12.7	0.0	0.3	0.7	0.1	1.5	1.0	4.0	0.0	0.7	0.1	0.4	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	2.6	3.2	1.5	5.0	2.7	1.8	1.7	1.9	1.7	1.8	1.8	2.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0
AC213203.2		ENSG00000277475			Unmapped	31698-32528	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"pancreas: 5.5;testis: 12.7"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	32	"eosinophil: 7.9"	"Lineage enriched"	"Detected in single"	32	"granulocytes: 7.9"	"Cell line enhanced"	"Detected in some"		"A549: 6.9;HeLa: 2.1;HMC-1: 5.3;SCLC-21H: 4.3"															NA	NA			"Cluster 45: Eosinophils - Innate immune response"		"Cluster 3: HMC-1 - Innate immune response"																						0.3	0.8	1.1	0.1	0.4	0.0	0.0	4.4	0.5	0.0	0.3	0.1	1.2	0.3	0.0	0.7	0.6	0.3	0.6	0.7	2.7	0.9	0.2	1.4	0.3	1.4	2.0	0.8	5.5	0.0		0.1	1.0	0.3	0.0	2.3	1.4	0.0	0.2	0.2	1.2	0.0	0.0	0.5	1.7	12.7	2.4	0.0	0.0	0.0	0.0	0.1		0.3	1.4	6.9	0.8	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.8	0.4	2.1	0.0	0.0	0.0	5.3	0.1	0.0	0.1	0.0	1.4	0.5	1.1	0.6	0.0	0.0	0.0	0.0	0.1	0.8	0.7	0.0	0.7	0.0	0.0	0.0	0.0	4.3	0.0	0.7	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.4	0.1	0.1	0.0	0.0	0.0	0.0	7.9	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	4.4	0.5	0.7	2.7	1.4	2.0	1.0	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACADS	"ACAD3, SCAD"	ENSG00000122971	"Acyl-CoA dehydrogenase short chain"	P16219	12	120725774-120740008	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 245.5;skeletal muscle: 158.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 303.1;Hepatocytes: 203.3;Paneth cells: 185.7;Proximal enterocytes: 435.0;Undifferentiated cells: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004799, CAB019284, HPA022271"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"	Mitochondria		"CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472"	"unprognostic (7.14e-2)"	"unprognostic (3.03e-3)"	"unprognostic (8.15e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.11e-3)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.04e-2)"	"prognostic favorable (3.33e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.34e-5)"	50.3	52.7	13.3	11.1	15.4	14.3	40.9	13.6	16.6	11.2	13.7	74.0	84.8	10.2	0.9	14.1	10.2	8.5	90.5	12.3	13.8	51.9	245.5	13.4	6.4	14.6	14.2	8.6	33.1	4.7	9.2	7.5	13.1	13.9	21.3	0.9	19.2	7.2	158.2	13.7	73.2	5.8	14.0	31.6	34.5	20.3	16.0	6.6	21.9	79.7	3.4	18.0	12.7	14.8	3.2	11.4	0.6	9.7	12.9	5.1	11.1	4.7	4.6	6.0	4.5	8.9	8.0	0.3	11.9	3.9	2.7	5.2	6.6	2.1	0.8	16.7	8.2	8.2	3.6	19.3	9.3	0.7	36.0	15.4	3.1	2.6	0.2	1.8	6.1	20.6	6.9	0.1	2.7	6.8	11.7	19.2	2.0	10.6	4.6	8.6	4.2	2.2	11.3	18.2	1.1	6.0	9.7	0.0	15.8	0.9	7.7	13.1	6.9	0.2	4.7	4.5	0.9	15.3	9.3	4.1	10.2	7.0	4.1	8.3	15.3	7.5	13.7	16.3	9.3	6.3	12.2	14.2	13.2	8.9	15.3	14.4	1.4	19.9	10.2	11.0	14.7	12.8	13.3	15.4	13.6	16.6	12.3	13.8	14.6	14.2	13.1	14.0	16.0	14.8	18.8	12.8	13.7	10.1	6.7	6.6	9.5	21.1	4.0	1.0	25.0	14.9	44.0	27.1	13.0	18.4	0.0	78.8	9.8	303.1	50.9	35.2	23.5	12.8	8.2	13.4	45.6	38.5	2.3	32.6	31.3	18.1	28.5	10.8	19.1	12.8	19.2	203.3	55.1	1.7	2.8	105.3	20.3	21.0	8.9	36.5	21.5	15.3	17.8	0.0	26.1	13.6	18.6	3.0	3.6	26.7	185.7	18.0	7.9	8.3	435.0	94.8	7.3	0.6	6.6	13.2	12.7	41.5	8.1	9.4	4.5	75.5	11.9	140.6	185.9	12.7
ACSL4	"ACS4, FACL4, LACS4, MRX63, MRX68"	ENSG00000068366	"Acyl-CoA synthetase long chain family member 4"	O60488	X	109624244-109733403	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase	"Alport syndrome, Deafness, Disease variant, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 184.3;Glandular and luminal cells: 208.8;granulocytes: 633.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 360.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000286, HPA005552"	Supported		Approved	"Golgi apparatus,Mitochondria"		NA	NA		16000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Golgi apparatus"	Mitochondria	"HPA000286: AB_2665966, HPA005552: AB_1078774"	"unprognostic (9.13e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.94e-2)"	"unprognostic (5.32e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.29e-2)"	"prognostic favorable (5.73e-4)"	44.2	40.6	11.9	38.8	14.1	16.2	19.8	13.2	14.8	48.2	5.6	12.7	15.4	19.2	17.7	15.8	13.4	29.2	29.4	16.5	23.7	46.4	13.9	39.0	24.6	17.6	20.8	14.9	11.9	19.8	9.2	21.4	21.3	13.4	13.6	24.7	10.6	15.2	42.6	9.9	13.4	22.0	13.7	22.2	19.3	26.8	14.6	20.3	18.6	16.9	18.5	68.0	10.6	18.9	67.3	21.3	24.2	28.3	97.8	61.6	20.3	94.0	107.6	91.0	97.4	21.1	45.0	46.2	35.4	71.7	100.9	19.4	22.4	92.0	143.0	15.7	23.3	181.4	26.6	223.3	44.8	44.8	360.0	51.4	36.7	103.6	74.0	50.2	71.8	25.5	5.6	54.2	100.7	4.7	40.7	60.7	31.6	15.2	37.2	26.4	45.4	39.6	136.3	20.9	15.2	12.3	109.3	0.4	63.2	49.0	1.9	45.8	128.5	81.1	22.6	129.3	85.9	28.1	31.7	41.2	139.7	97.8	52.2	32.5	10.9	35.0	4.2	15.5	3.2	3.3	3.9	3.5	10.6	3.1	3.0	3.8	29.6	4.0	19.4	4.0	6.7	6.5	11.9	14.1	13.2	14.8	16.5	23.7	17.6	20.8	21.3	13.7	14.6	18.9	27.9	76.9	184.3	29.0	19.5	22.3	25.7	20.0	81.4	44.2	7.3	8.1	37.2	15.7	40.1	73.5	2.1	7.3	18.3	0.8	50.9	27.7	1.4	79.5	27.0	29.8	7.7	26.1	76.7	25.4	36.9	46.0	7.1	208.8	633.8	151.6	18.2	44.2	23.9	6.7	78.3	5.7	2.0	64.9	59.1	4.9	5.6	67.8	16.0	57.1	70.4	10.9	8.2	71.4	116.4	32.3	3.0	10.1	36.1	19.4	0.7	12.4	12.2	16.7	0.0	20.0	27.9	3.7	5.3	10.1	8.1	31.6	25.2	34.9	2.7	18.4
ACSM3	"SA, SAH"	ENSG00000005187	"Acyl-CoA synthetase medium chain family member 3"	Q53FZ2	16	20610243-20797581	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 85.1;liver: 178.5"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 446.7;Hepatic stellate cells: 100.6;Proximal tubular cells: 136.0;Theca cells: 208.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 23.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 95.1;HMC-1: 381.7;K-562: 285.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041013	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA041013: AB_10671693"	"unprognostic (1.62e-4)"	"unprognostic (1.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.14e-3)"	"prognostic favorable (1.97e-4)"	"unprognostic (3.56e-2)"	"unprognostic (1.95e-3)"	"prognostic favorable (9.88e-6)"	"unprognostic (1.27e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-2)"	4.5	3.2	1.7	2.4	1.6	15.3	60.2	2.1	3.1	10.3	1.9	26.4	7.7	19.9	5.7	3.2	26.8	10.4	8.6	1.7	0.8	85.1	178.5	8.1	3.1	3.1	2.7	74.8	30.4	15.2	0.9	2.5	2.5	22.0	25.6	1.0	4.8	6.9	0.8	4.3	8.2	5.1	1.0	1.9	28.1	5.9	2.2	2.8	2.8	1.0	2.9	4.9	5.2	5.3	1.0	12.4	2.3	0.7	3.9	2.3	1.5	0.2	1.3	0.3	1.0	1.0	18.2	1.6	20.1	0.4	0.7	1.6	0.2	2.1	1.6	4.5	6.6	95.1	0.2	7.7	1.3	10.9	381.7	3.7	2.2	0.5	1.4	1.9	0.2	0.7	285.1	15.3	0.1	1.5	0.7	3.5	0.7	14.5	3.8	3.1	0.1	20.3	18.3	1.1	0.8	0.7	0.4	5.4	0.3	0.8	6.1	0.9	1.3	1.2	1.2	0.9	0.7	21.9	18.6	1.2	1.2	7.5	0.5	2.6	2.0	23.5	3.6	1.2	4.2	1.6	4.5	3.3	0.2	2.8	6.9	8.2	0.5	2.3	4.0	2.3	5.6	2.9	1.7	1.6	2.1	3.1	1.7	0.8	3.1	2.7	2.5	1.0	2.2	5.3	0.3	3.2	31.3	1.0	16.5	2.8	34.6	1.5	8.0	0.0	6.3	6.1	3.2	20.0	1.7	12.9	0.0	19.1	1.5	7.0	84.1	84.8	25.0	14.0	4.3	3.4	2.4	25.4	0.3	12.5	2.1	23.7	8.6	32.8	0.0	446.7	100.6	38.2	3.2	0.0	0.3	11.8	0.0	5.4	1.7	12.3	27.7	3.4	0.0	0.0	3.1	0.0	4.1	0.0	0.1	8.9	20.3	12.8	1.0	14.5	4.7	136.0	1.5	0.0	0.0	0.4	52.7	6.9	2.2	3.8	1.8	19.2	4.3	208.3	23.0	11.3
ACTR2	ARP2	ENSG00000138071	"Actin related protein 2"	P61160	2	65227788-65271253	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005083, HPA015050"	Approved		Approved	Cytosol		NA	NA		35000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB005083: AB_2221848, HPA015050: AB_1844556"	"unprognostic (2.23e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (3.88e-2)"	"unprognostic (3.16e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.18e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.03e-2)"	113.0	70.7	39.9	216.2	48.3	160.5	77.0	42.2	54.7	81.4	38.3	142.4	104.8	70.1	64.5	111.0	53.7	90.9	64.9	51.4	47.2	85.6	108.9	115.9	246.4	43.6	41.4	43.9	61.7	61.9	25.0	109.6	42.9	71.7	139.1	70.2	64.9	64.1	60.4	69.4	118.2	104.4	48.0	172.0	107.3	46.2	45.5	182.2	73.1	64.9	256.3	128.6	46.0	61.1	267.3	221.2	205.5	224.5	218.8	296.1	213.2	367.3	284.1	280.0	193.6	249.3	214.2	590.6	181.8	406.9	174.3	196.8	179.8	258.3	459.4	337.2	150.8	652.1	147.6	235.9	248.0	619.8	731.6	256.5	201.6	312.2	297.7	228.6	356.6	202.0	282.1	209.2	480.0	198.2	325.4	330.6	173.2	245.7	157.5	347.9	266.0	248.6	328.7	341.7	105.2	171.6	239.0	273.5	262.0	186.9	167.6	417.4	467.9	306.5	184.8	202.8	408.9	158.0	155.2	824.1	264.4	598.7	353.9	325.4	182.4	220.6	104.3	241.4	111.8	97.1	91.1	98.6	213.1	80.4	70.3	99.2	258.2	104.1	273.3	79.3	113.9	344.5	39.9	48.3	42.2	54.7	51.4	47.2	43.6	41.4	42.9	48.0	45.5	61.1	187.1	86.6	112.7	32.3	202.4	74.7	88.0	93.0	70.0	81.8	75.8	57.1	76.3	51.5	93.2	97.5	66.7	81.8	257.9	280.5	50.9	100.5	37.5	114.5	131.4	131.0	110.8	89.8	152.6	129.0	138.6	96.0	105.0	163.2	191.1	77.8	113.6	102.9	277.7	104.3	106.0	166.5	85.5	450.1	311.8	92.5	65.3	352.0	88.9	97.4	378.9	87.9	207.0	38.7	68.9	164.4	195.3	74.4	119.7	114.9	131.1	89.0	127.7	82.4	124.9	63.3	122.8	31.4	41.8	102.5	90.6	124.4	203.2	74.2	172.8	181.7
ACTR3	ARP3	ENSG00000115091	"Actin related protein 3"	P61158	2	113890063-113962596	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005085, HPA047016, HPA051683"	Approved					NA	NA		25000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"			"CAB005085: AB_2289106, HPA047016: AB_2679903, HPA051683: AB_2681573"	"unprognostic (7.28e-2)"	"prognostic unfavorable (6.52e-5)"	"unprognostic (2.03e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (7.76e-5)"	"unprognostic (9.27e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.44e-2)"	"unprognostic (4.44e-1)"	97.5	125.3	29.9	229.7	36.4	216.5	64.5	37.6	41.0	62.7	52.4	129.3	107.4	78.1	47.2	167.1	58.1	84.4	71.7	48.0	41.9	79.4	89.9	97.9	291.2	46.4	38.2	46.4	64.3	54.7	23.1	101.4	41.7	71.3	125.1	31.7	64.3	83.6	47.8	77.7	119.0	137.0	36.2	155.8	113.1	84.8	39.0	185.8	67.3	49.8	331.3	153.6	67.1	46.7	377.8	179.1	249.4	170.6	178.0	251.7	259.9	518.7	395.0	369.7	349.1	379.9	233.6	538.7	590.6	487.9	497.1	200.0	262.3	286.5	486.7	806.2	135.6	502.7	210.2	296.2	314.8	474.0	879.1	227.1	220.8	484.9	316.5	216.1	348.6	207.1	273.9	393.8	493.1	153.2	429.7	204.5	187.2	254.8	297.5	328.8	246.8	273.4	381.0	348.9	124.0	124.1	263.0	269.7	330.6	188.7	112.7	387.7	514.6	440.9	288.3	205.6	451.5	208.5	446.5	635.4	385.5	304.2	417.7	753.0	478.9	1048.4	464.4	728.1	381.6	455.9	424.6	460.6	634.4	385.0	371.4	437.9	777.1	479.9	887.7	191.4	587.0	1265.4	29.9	36.4	37.6	41.0	48.0	41.9	46.4	38.2	41.7	36.2	39.0	46.7	113.7	89.8	64.1	26.4	254.0	331.9	369.7	139.1	93.9	32.0	57.5	48.9	68.5	57.2	125.4	68.0	8.4	144.6	196.5	164.4	129.1	220.8	113.6	109.2	100.8	138.9	85.3	154.8	40.1	154.8	316.6	101.4	122.9	171.0	267.5	88.4	81.0	72.9	339.2	38.7	40.4	120.2	105.8	201.4	413.7	108.3	45.4	288.1	112.1	69.3	316.5	46.7	286.3	58.3	67.6	177.0	168.1	73.0	158.7	181.7	103.3	132.4	117.7	19.5	65.7	58.5	194.1	207.1	74.7	173.4	353.8	205.6	264.4	242.2	120.3	314.1
ADAMTS7	"ADAM-TS7, DKFZp434H204"	ENSG00000136378	"ADAM metallopeptidase with thrombospondin type 1 motif 7"	Q9UKP4	15	78759206-78811464	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"heart muscle: 30.6"	"Cell type enriched"	"Detected in some"	4	"Theca cells: 44.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"HMC-1: 259.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA045284, HPA048453"	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA045284: AB_2679285, HPA048453: AB_2680399"	"unprognostic (5.94e-3)"	"unprognostic (9.94e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.88e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.89e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (9.53e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.86e-2)"	6.6	5.3	0.5	1.8	0.4	0.1	3.8	0.3	0.5	6.0	0.6	4.2	1.1	7.2	0.1	0.9	2.2	2.3	30.6	0.4	0.5	2.2	1.1	6.3	0.9	0.5	0.5	6.1	0.5	0.4	0.8	2.1	0.4	1.8	0.2	0.5	1.3	0.4	1.1	1.8	2.6	1.4	0.2	5.2	2.2	4.1	0.7	0.1	2.1	0.5	0.2	3.0	2.5	0.6	0.0	1.1	16.5	7.5	6.9	8.2	20.9	3.7	1.3	1.0	0.6	0.0	0.1	0.0	4.8	0.4	1.0	0.4	0.4	2.0	0.0	0.3	0.6	2.1	0.5	0.1	6.9	0.0	259.9	3.3	2.0	1.9	1.0	5.3	24.0	0.0	0.3	0.7	5.6	0.0	0.1	4.9	4.7	0.0	1.4	17.3	7.7	0.3	0.5	0.9	0.3	23.9	4.8	0.0	0.6	4.0	3.2	0.4	29.8	9.4	1.0	3.3	0.0	0.1	0.0	0.0	1.6	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.3	0.5	0.4	0.5	0.5	0.5	0.4	0.2	0.7	0.6	7.5	0.0	0.0	3.6	0.3	0.4	0.2	0.7	0.0	0.3	0.1	0.5	9.8	0.0	0.3	0.0	0.0	0.3	0.2	0.1	0.0	0.1	4.9	0.8	7.5	10.5	0.0	0.0	0.1	0.0	0.3	10.1	0.5	0.9	3.8	7.2	2.9	0.3	0.7	0.0	0.2	0.0	2.0	0.0	0.8	2.7	1.5	0.1	1.8	1.0	0.1	1.3	0.0	9.5	1.4	0.3	0.0	1.9	0.0	0.3	0.0	0.1	0.3	0.1	0.0	3.7	5.0	2.6	2.0	0.2	0.1	0.3	0.5	44.9	0.1	0.3
ADCY7	"AC7, KIAA0037"	ENSG00000121281	"Adenylate cyclase 7"	P51828	16	50246137-50318135	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 42.8;granulocytes: 50.6;Kupffer cells: 65.1;Langerhans cells: 48.0;Macrophages: 45.4;Microglial cells: 52.5;monocytes: 42.4;NK-cells: 76.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 81.0;HMC-1: 194.6;RPMI-8226: 100.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041218, HPA048241"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA041218: AB_2677365, HPA048241: AB_2680326"	"unprognostic (1.98e-1)"	"prognostic unfavorable (5.31e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.59e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.18e-1)"	"unprognostic (9.52e-4)"	8.1	3.9	6.8	23.9	7.3	24.7	5.6	7.8	8.8	3.9	6.9	8.2	4.1	3.7	2.3	14.3	7.6	12.4	5.5	6.2	10.6	1.6	3.8	23.3	27.1	14.4	11.4	19.4	2.0	1.6	2.0	14.5	12.8	2.7	8.8	0.8	4.0	2.1	2.2	13.7	8.6	7.8	10.9	29.7	7.8	1.9	12.9	19.3	2.4	3.5	24.5	7.6	4.7	19.1	16.3	18.5	0.7	2.6	1.9	24.0	1.7	9.7	4.5	8.1	7.0	23.4	28.4	4.2	25.4	41.0	0.5	50.5	22.3	10.0	8.9	50.7	6.9	81.0	18.4	5.8	20.6	10.6	194.6	12.0	8.5	5.7	8.3	4.4	2.3	17.7	30.4	7.9	10.5	9.2	5.8	34.9	3.5	8.4	31.1	5.7	7.1	100.6	5.0	1.1	4.0	9.8	5.4	2.0	4.8	4.4	0.1	38.7	17.6	0.9	25.5	2.9	3.6	0.3	0.6	8.5	9.3	32.6	3.4	9.2	7.6	2.8	6.9	10.7	5.1	2.8	2.9	5.2	12.2	3.3	2.5	3.6	4.1	9.5	18.1	6.8	4.4	5.6	6.8	7.3	7.8	8.8	6.2	10.6	14.4	11.4	12.8	10.9	12.9	19.1	1.4	19.2	35.9	2.0	15.4	3.7	0.4	0.6	1.2	1.2	1.3	2.8	1.0	0.0	7.9	0.0	6.2	11.6	42.8	3.3	0.0	1.9	1.5	6.7	6.5	1.9	0.0	12.4	6.4	0.2	1.8	9.2	3.6	13.6	50.6	4.7	1.4	0.5	35.2	0.0	3.8	0.7	0.0	65.1	48.0	1.3	0.6	45.4	5.4	52.5	42.4	0.5	76.2	3.5	0.7	4.2	10.4	1.2	15.6	0.5	0.1	0.2	1.0	0.8	6.6	28.3	2.2	0.0	1.5	7.2	4.0	4.0	26.6	16.0	2.3	1.3
ADGRD1	"DKFZp434B1272, GPR133, PGR25"	ENSG00000111452	"Adhesion G protein-coupled receptor D1"	Q6QNK2	12	130953907-131141469	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 62.4"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 22.4;Alveolar cells type 2: 30.5;Cardiomyocytes: 47.0;Early spermatids: 16.2;Endometrial stromal cells: 50.2;Fibroblasts: 32.7;Late spermatids: 21.4;Leydig cells: 13.7;Microglial cells: 25.3;Peritubular cells: 15.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.0;intermediate monocyte: 2.3;myeloid DC: 1.1;non-classical monocyte: 1.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.1;monocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"BJ: 4.1;fHDF/TERT166: 4.7;HeLa: 7.6;HHSteC: 4.9;HMC-1: 13.0;U-2 OS: 6.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 5.1"	"Low region specificity"	"Detected in all"			"HPA042395, HPA076279"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Plasma membrane"		"HPA042395: AB_10796906, HPA076279: "	"unprognostic (3.21e-1)"	"unprognostic (1.49e-4)"	"unprognostic (1.32e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (2.55e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.79e-5)"	"unprognostic (1.31e-3)"	"unprognostic (4.58e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.77e-3)"	26.4	1.9	1.9	1.3	2.0	0.3	10.3	1.2	2.5	20.6	1.0	10.6	1.9	15.4	7.3	6.9	17.7	12.9	62.4	1.4	3.2	3.4	10.3	35.6	0.4	2.0	2.6	17.9	12.0	0.3	6.3	25.7	2.2	15.3	1.8	0.8	2.9	1.0	7.3	7.0	12.1	7.1	2.0	2.3	20.7	7.5	3.6	0.4	11.2	8.5	1.0	40.3	16.3	1.7	0.0	0.7	0.0	2.0	0.0	0.0	0.1	4.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.6	0.0	4.9	0.0	13.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.8	0.0	0.1	0.2	2.1	0.5	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.2	0.0	0.3	0.0	0.4	6.1	1.5	0.1	0.1	1.7	0.8	0.1	0.0	0.0	0.0	2.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.8	1.9	2.0	1.2	2.5	1.4	3.2	2.0	2.6	2.2	2.0	3.6	1.7	2.0	22.4	30.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	47.0	0.0	5.0	1.8	0.0	1.3	0.0	0.0	0.0	0.0	16.2	1.3	50.2	3.4	0.0	0.0	1.1	0.4	0.6	32.7	0.5	1.0	1.3	0.3	1.8	3.6	2.3	0.0	1.4	0.0	0.0	1.5	0.0	21.4	13.7	1.5	0.0	25.3	3.5	0.0	0.0	0.0	0.1	0.3	0.0	15.8	0.0	0.0	0.0	0.1	2.2	0.7	6.6	2.2	3.5	4.3	6.5	0.1	0.0	1.0	0.6	0.2	0.1	0.3
ADGRE2	"CD312, EMR2"	ENSG00000127507	"Adhesion G protein-coupled receptor E2"	Q9UHX3	19	14732392-14778560	"CD markers, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Cell adhesion, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 19.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 47.9;Kupffer cells: 69.4;Macrophages: 73.2;monocytes: 49.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 70.0;eosinophil: 74.7;intermediate monocyte: 46.9;neutrophil: 55.7;non-classical monocyte: 89.9"	"Group enriched"	"Detected in many"	9	"granulocytes: 74.7;monocytes: 89.9"	"Cell line enhanced"	"Detected in many"		"HEL: 11.8;HMC-1: 18.3;NB-4: 11.5;RPMI-8226: 8.4;U-937: 14.9"					"Low region specificity"	"Detected in many"			HPA055200			Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	Cytosol	"HPA055200: "	"unprognostic (2.46e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.35e-6)"	"unprognostic (1.46e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.01e-1)"	4.9	1.5	1.0	19.4	1.3	6.9	1.8	1.2	2.1	0.9	1.3	1.4	1.9	0.7	0.7	0.9	0.9	2.5	0.5	1.0	1.5	2.1	2.0	4.2	3.0	2.5	1.6	0.1	0.8	1.1	0.5	1.6	2.2	1.1	1.9	0.6	1.0	2.8	0.6	2.0	2.3	1.6	1.1	15.6	1.5	0.4	1.8	2.4	0.6	0.9	2.2	5.4	0.9	2.4	0.3	1.2	0.1	0.2	0.0	0.3	1.2	0.9	1.3	0.0	0.0	0.2	0.2	0.1	0.1	0.7	2.3	1.9	0.3	0.1	0.0	0.2	0.2	11.8	3.8	0.2	0.5	4.3	18.3	0.9	1.6	4.1	0.6	0.1	0.1	1.0	2.7	0.4	1.3	0.5	1.5	11.5	0.4	0.8	0.2	0.1	1.5	8.4	0.0	0.3	0.0	0.2	2.4	2.0	0.4	0.2	0.3	5.4	0.3	0.3	0.2	0.2	0.1	0.2	0.1	0.2	1.1	14.9	0.6	70.0	13.9	74.7	0.2	46.9	0.2	0.2	0.2	0.1	9.3	0.3	0.1	0.2	55.7	3.3	89.9	1.9	0.1	7.3	1.0	1.3	1.2	2.1	1.0	1.5	2.5	1.6	2.2	1.1	1.8	2.4	0.6	3.2	7.7	0.7	1.9	0.0	4.8	0.0	0.6	0.8	1.6	1.5	0.8	0.0	2.5	0.0	0.0	0.2	12.8	0.0	0.0	0.0	2.0	0.7	3.5	1.8	1.2	3.8	0.9	0.0	0.5	1.9	1.1	0.9	47.9	0.1	0.7	0.5	12.8	0.0	1.2	0.1	0.0	69.4	0.0	2.5	0.0	73.2	0.0	0.0	49.2	0.0	2.1	0.5	12.0	0.0	0.2	0.4	2.1	2.4	0.1	0.1	2.2	0.9	0.0	2.0	1.5	0.3	0.5	0.6	0.0	0.4	3.0	0.1	0.1	3.0
ADGRE3	EMR3	ENSG00000131355	"Adhesion G protein-coupled receptor E3"	Q9BY15	19	14619117-14690027	"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.1;lymphoid tissue: 6.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.4;Astrocytes: 2.0;Excitatory neurons: 1.9;granulocytes: 2.5;Inhibitory neurons: 2.4;Macrophages: 8.0;Microglial cells: 3.7;monocytes: 3.2;Oligodendrocytes: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basophil: 281.6;eosinophil: 509.0;neutrophil: 489.4"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 509.0"	"Cell line enriched"	"Detected in some"	36	"HMC-1: 43.3"					"Not detected"	"Not detected"			HPA015638	Uncertain				"Secreted to blood"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA015638: AB_1848039"	"unprognostic (2.11e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.69e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.07e-2)"	"unprognostic (9.61e-2)"	"unprognostic (9.11e-4)"	"unprognostic (4.68e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	1.2	0.1	0.0	6.1	0.0	3.1	0.0	0.0	0.5	0.2	0.0	0.4	1.6	0.1	0.0	0.3	0.3	1.0	0.1	0.0	0.0	0.1	0.6	2.5	0.3	0.1	0.0	0.0	0.4	0.0	0.0	0.5	0.2	0.2	0.5	0.0	1.8	0.0	0.0	0.0	2.3	0.7	0.0	5.9	0.5	0.1	0.1	0.4	0.1	1.0	2.3	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	281.6	21.8	509.0	0.0	52.9	0.1	0.6	0.2	0.0	5.3	0.1	0.1	0.1	489.4	0.0	61.3	0.3	0.1	7.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	2.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.5	0.0	2.5	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.6	0.0	0.0	0.0	8.0	0.0	3.7	3.2	0.0	0.0	1.5	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
ADGRG5	"GPR114, PGR27"	ENSG00000159618	"Adhesion G protein-coupled receptor G5"	Q8IZF4	16	57542643-57591681	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 3.9;lymphoid tissue: 10.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 32.0;Microglial cells: 11.2;NK-cells: 43.3;Plasma cells: 16.4;T-cells: 7.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 125.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 39.4;OE19: 13.2;RPMI-8226: 6.2;THP-1: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007133	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear membrane, Vesicles"	Nucleoplasm	"HPA007133: AB_1849253"	"unprognostic (6.11e-3)"	"prognostic favorable (4.25e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.09e-4)"	"unprognostic (3.80e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.37e-3)"	"unprognostic (7.69e-3)"	"unprognostic (4.52e-1)"	"unprognostic (1.62e-3)"	"unprognostic (6.32e-3)"	0.3	0.3	0.3	5.0	0.2	1.4	0.7	0.2	0.2	0.2	0.1	1.7	3.7	0.3	0.1	0.6	0.5	0.1	0.0	0.3	0.4	0.0	0.2	0.9	10.5	0.8	0.4	0.0	0.0	0.1	0.2	0.0	0.6	0.3	1.3	0.0	1.3	0.3	0.1	0.1	3.9	0.3	0.6	5.8	0.4	0.4	0.4	1.6	0.3	0.0	10.5	1.4	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	39.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	3.6	3.6	13.2	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	0.1	125.9	33.3	0.1	16.9	12.0	4.8	19.1	2.4	8.6	1.2	11.2	0.5	29.9	0.1	68.8	0.2	9.0	0.3	0.2	0.2	0.2	0.3	0.4	0.8	0.4	0.6	0.6	0.4	0.3	0.3	0.0	1.3	0.3	5.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.8	0.0	0.0	0.0	0.0	0.2	32.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.0	0.6	0.0	0.3	0.0	3.2	0.0	11.2	1.7	0.0	43.3	0.0	0.3	0.0	0.0	0.0	16.4	0.1	2.9	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	7.1	0.0	0.7	0.0
ADORA3	AD026	ENSG00000282608	"Adenosine A3 receptor"	P0DMS8	1	111499429-111503633	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.8"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 17.9;Kupffer cells: 79.2;Late spermatids: 18.2;Macrophages: 26.3"					"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	40	"eosinophil: 601.6"	"Lineage enriched"	"Detected in many"	40	"granulocytes: 601.6"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 108.1"	"Low region specificity"	"Detected in many"													NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"																					4.5	15.0	8.9	4.3	9.2	0.2	5.5	10.6	14.6	4.4	8.8	6.6	4.5	1.9	0.2	2.5	3.6	5.8	3.4	8.8	12.3	1.6	3.3	3.5	6.4	16.1	11.1	1.8	1.8	3.1	2.6	2.8	14.9	2.4	5.1	1.0	2.8	2.4	0.5	0.9	9.4	4.8	13.5	4.3	3.0	1.2	16.9	3.5	1.4	1.0	2.7	4.3	1.7	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.0	0.0	0.0	0.0	108.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.0	8.1	601.6	0.0	5.6	0.1	0.2	0.0	0.0	15.0	0.1	0.1	0.1	2.0	0.1	2.1	3.0	0.0	2.5	8.9	9.2	10.6	14.6	8.8	12.3	16.1	11.1	14.9	13.5	16.9	21.8	0.2	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.1	0.1	0.6	0.4	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.0	7.3	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.0	0.0	1.8	0.2	17.9	0.0	0.0	0.0	0.0	79.2	4.4	18.2	0.3	26.3	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.2	0.2	0.4	0.3	0.1	0.4	0.0	1.6	0.0	0.0	0.1
AIF1	"AIF-1, Em:AF129756.17, IBA1, IRT-1"	ENSG00000204472	"Allograft inflammatory factor 1"	P55008	6	31615217-31617021	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 235.0;lymphoid tissue: 346.6"	"Group enriched"	"Detected in many"	22	"Hofbauer cells: 1777.1;Kupffer cells: 2140.2;Langerhans cells: 1359.1;Macrophages: 1494.0;monocytes: 1022.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	26	"classical monocyte: 3823.3;intermediate monocyte: 6550.1;myeloid DC: 2043.3;neutrophil: 2943.0;non-classical monocyte: 7744.5"	"Group enriched"	"Detected in all"	74	"dendritic cells: 2043.3;granulocytes: 2943.0;monocytes: 7744.5"	"Group enriched"	"Detected in some"	4	"HEL: 204.6;HMC-1: 329.6;NB-4: 264.7;THP-1: 184.2;U-937: 114.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049234, HPA062949"	Enhanced		Uncertain	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"HPA049234: AB_2680685, HPA062949: AB_2732694"	"unprognostic (3.20e-2)"	"unprognostic (7.21e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.98e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.89e-2)"	79.6	46.6	24.9	182.3	25.5	235.0	47.2	26.6	33.0	29.3	32.2	48.3	36.4	17.1	12.1	18.7	19.7	61.3	21.1	25.0	31.3	74.3	81.2	99.3	116.8	45.1	36.4	14.4	12.4	12.9	17.3	109.5	36.8	22.3	57.2	3.9	20.3	24.0	6.1	11.7	44.5	74.7	34.3	346.6	22.2	8.7	32.1	69.1	13.8	16.6	57.1	95.3	13.5	42.7	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	204.6	0.0	0.0	0.0	30.0	329.6	0.0	0.0	0.0	0.0	0.0	0.0	51.6	0.9	0.2	0.0	0.0	2.3	264.7	0.4	0.0	0.0	35.9	0.4	8.9	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	184.2	0.1	0.0	0.2	0.1	0.3	0.2	0.0	1.3	0.2	114.6	0.0	33.1	3823.3	177.9	10.2	6550.1	12.7	57.5	10.8	9.3	2043.3	6.3	33.1	26.2	2943.0	14.5	7744.5	144.2	10.7	4449.8	24.9	25.5	26.6	33.0	25.0	31.3	45.1	36.4	36.8	34.3	32.1	42.7	12.0	25.6	59.6	0.0	39.2	32.5	0.7	0.0	0.6	0.1	5.3	24.3	7.5	18.6	19.2	42.3	0.0	11.1	31.2	1.0	0.0	0.3	1.9	0.6	0.7	28.7	1.2	65.0	0.0	0.4	15.4	20.6	0.5	0.4	68.3	0.4	35.3	13.4	1777.1	0.0	0.0	0.1	0.0	2140.2	1359.1	4.9	7.5	1494.0	39.2	10.3	1022.6	0.0	32.0	0.5	0.1	0.2	11.1	0.7	7.2	0.4	0.3	4.2	10.2	0.1	52.6	4.7	6.5	0.5	1.5	2.1	28.3	22.7	46.1	1.9	0.6	0.3
AIFM3	"AIFL, FLJ30473"	ENSG00000183773	"Apoptosis inducing factor mitochondria associated 3"	Q96NN9	22	20965108-20981360	"Predicted intracellular proteins"	"Apoptosis, Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 70.4;choroid plexus: 136.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 92.1;Distal enterocytes: 76.5;Intestinal goblet cells: 31.3;Muller glia cells: 25.3;Paneth cells: 27.5;Undifferentiated cells: 37.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 7.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"classical monocyte: 1.1;intermediate monocyte: 3.0;myeloid DC: 1.9;non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	24	"dendritic cells: 1.9;monocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"Hep G2: 7.6;HMC-1: 10.8;T-47d: 5.3;THP-1: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001271			Supported	Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA001271: AB_1078114"	"unprognostic (1.39e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.49e-2)"	"unprognostic (9.99e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.13e-3)"	"unprognostic (5.13e-2)"	"unprognostic (7.99e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.37e-1)"	"prognostic favorable (7.13e-5)"	0.5	0.4	41.5	3.1	36.8	3.7	0.4	39.6	52.9	0.3	136.0	24.8	2.5	0.4	0.0	0.4	0.5	0.6	0.3	29.9	31.4	0.8	0.3	1.1	0.6	46.2	43.7	0.3	0.4	0.5	4.4	0.4	43.2	1.0	8.4	1.8	1.0	0.7	0.1	0.1	1.9	0.8	38.0	2.1	0.5	0.6	70.4	0.1	0.3	0.0	0.0	1.2	0.3	24.9	1.0	1.7	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.2	0.0	1.9	0.0	7.6	0.2	0.0	10.8	0.5	0.6	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	1.3	0.0	1.3	1.4	0.9	0.8	0.1	0.0	0.1	5.3	7.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	3.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.5	41.5	36.8	39.6	52.9	29.9	31.4	46.2	43.7	43.2	38.0	70.4	24.9	1.0	0.0	1.5	92.1	1.0	0.6	1.9	1.7	0.6	14.5	3.1	2.4	2.9	0.0	1.4	1.8	6.2	1.0	0.0	76.5	11.7	0.7	0.0	1.7	0.4	0.5	10.3	0.0	12.5	0.6	0.7	0.6	1.5	1.4	1.3	0.5	1.4	2.4	3.6	0.0	8.1	31.3	2.0	3.2	1.9	0.1	0.0	2.5	0.0	4.7	3.2	25.3	0.0	2.5	1.6	0.5	27.5	0.0	0.3	2.2	4.8	8.1	1.9	3.7	0.0	0.2	1.2	0.4	1.9	0.7	0.9	0.8	0.2	0.3	37.9	2.8
AKAP13	"AKAP-Lbc, ARHGEF13, BRX, c-lbc, HA-3, Ht31, LBC, PROTO-LB"	ENSG00000170776	"A-kinase anchoring protein 13"	Q12802	15	85380571-85749358	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 161.8"	"Low region specificity"	"Detected in all"							HPA019773	Approved		Supported	Cytosol		NA	NA		14000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA019773: AB_1844686"	"unprognostic (4.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.69e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.81e-3)"	37.7	18.9	10.0	38.7	9.2	56.1	32.1	1.7	9.3	28.5	66.1	25.9	16.7	83.0	20.7	25.6	22.7	44.6	66.6	11.0	17.7	14.4	22.2	54.1	47.6	16.7	17.6	26.7	54.5	11.8	18.5	26.0	13.9	20.3	21.3	8.3	23.9	23.5	83.9	24.7	32.5	40.3	9.7	38.3	34.4	20.0	15.0	46.3	32.7	60.3	46.5	32.9	26.7	16.3	13.2	29.0	20.8	7.8	31.3	34.6	11.2	10.6	23.5	9.4	9.0	11.3	11.0	62.0	14.6	19.2	23.8	26.5	23.9	9.9	9.0	45.2	11.0	83.8	20.0	8.6	17.3	17.2	161.8	25.6	25.5	11.6	39.8	10.6	25.2	22.4	5.5	29.6	14.7	6.3	24.7	12.8	13.5	22.8	11.5	16.7	20.6	23.5	15.3	27.0	13.1	23.4	27.9	8.3	14.5	22.7	6.0	14.3	30.2	11.4	7.8	6.7	10.7	46.1	30.1	48.9	6.8	55.2	9.0	282.9	66.0	181.4	122.2	54.9	68.3	74.9	81.6	93.3	38.8	68.8	68.2	75.5	104.3	108.2	77.5	100.6	73.2	48.0	10.0	9.2	1.7	9.3	11.0	17.7	16.7	17.6	13.9	9.7	15.0	16.3	110.5	125.0	431.2	88.2	186.8	75.7	105.2	29.1	57.5	18.6	50.2	39.9	215.2	91.5	71.6	40.5	41.7	36.7	336.8	143.3	5.9	83.4	258.9	155.6	327.0	121.5	63.5	37.0	51.2	69.6	27.6	119.6	170.2	323.6	279.5	65.6	75.7	53.7	79.2	13.5	13.0	57.8	36.7	147.1	276.3	166.3	77.6	257.9	99.6	290.4	197.3	45.8	252.4	123.6	13.2	101.2	118.7	63.6	205.8	77.0	68.6	10.5	60.1	17.9	85.5	139.6	117.4	23.3	37.2	77.6	79.0	23.4	269.7	30.5	61.7	179.6
AL049634.2		ENSG00000260861	"Novel protein, SIRPB1-SIRPD readthrough"		20	1540144-1620009	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 2.7;lymphoid tissue: 2.6;testis: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 78.3;neutrophil: 127.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 127.7;monocytes: 43.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 3.5;HMC-1: 6.7;NB-4: 2.6;THP-1: 4.0;U-937: 2.1"															NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"																					0.4	0.8	0.1	2.6	0.1	2.7	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.4	0.3	0.2	0.1	0.2	0.0	0.1	0.3	0.1	0.5	0.7	0.8	0.1	0.2	0.1	0.3	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.2	0.3	0.2	0.1	0.6	0.6	0.2	0.8	0.1	3.3	0.5	0.2	0.0	0.0	0.4	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.5	6.7	0.0	0.1	0.2	0.0	1.4	0.0	0.1	0.0	0.0	0.1	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.0	1.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	2.1	0.1	0.6	35.3	78.3	0.6	27.5	0.3	0.1	0.0	0.4	12.9	0.0	0.1	0.1	127.7	0.2	43.6	10.4	0.2	26.0	0.1	0.1	0.0	0.3	0.1	0.3	0.1	0.2	0.2	0.2	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL357075.4		ENSG00000288520	"Novel protein"	G9CGD6	6	154159828-154510114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.4;HMC-1: 1.0"									"HPA028708, HPA028710, HPA049651"	Uncertain		Approved	"Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies"		NA	NA					"Cluster 3: HMC-1 - Innate immune response"		"Nuclear speckles, Plasma membrane"	"Nucleoli, Cytoplasmic bodies"	"HPA028708: AB_10601916, HPA028710: AB_2732442, HPA049651: AB_2680841"																		0.2	0.1	0.0	0.1	0.2	0.1	0.3	0.3	0.4	0.5	0.5	0.3	0.5	0.7	0.1	1.0	0.4	0.3	0.2	0.0	0.2	0.8	0.6	0.2	0.0	0.3	0.2	0.5	1.4	0.0		0.5	0.3	0.4	0.3	0.1	0.0	0.3	0.0	0.0	0.6	0.6	0.3	0.5	0.3	0.6	0.2	0.0	0.2	0.0	0.4	0.5		0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.1	0.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.2	0.3	0.2	0.3	0.3	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALDH16A1	MGC10204	ENSG00000161618	"Aldehyde dehydrogenase 16 family member A1"	Q8IZ83	19	49453225-49471050	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059488	Approved					NA	NA		600000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA059488: AB_2684037"	"unprognostic (2.39e-1)"	"unprognostic (3.95e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.91e-3)"	"unprognostic (2.94e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.23e-3)"	18.5	14.1	3.0	9.7	3.4	10.0	14.5	3.5	3.8	17.7	3.6	13.9	13.9	15.9	0.8	15.5	12.9	3.5	8.5	2.9	3.3	14.1	17.1	11.7	10.4	4.5	3.8	11.3	18.6	3.8	7.5	5.0	3.6	10.3	2.3	1.0	10.8	4.9	7.0	16.2	19.1	3.2	3.9	28.3	14.1	5.2	4.2	4.9	12.4	1.8	4.9	12.9	13.8	4.0	24.6	32.7	7.8	18.4	3.5	2.3	26.3	15.5	4.9	11.8	12.1	17.1	9.3	36.8	24.9	2.1	2.8	16.7	3.1	8.9	1.5	23.3	19.0	28.7	13.1	24.6	5.1	17.6	61.3	4.3	5.0	5.7	4.6	2.4	7.7	12.5	20.7	37.3	3.1	24.8	12.8	51.9	17.1	10.6	0.0	21.8	11.1	28.1	5.7	28.7	14.1	16.1	13.9	15.4	13.4	1.9	14.0	20.3	17.4	17.4	11.3	8.0	17.4	31.4	38.2	10.7	4.3	24.9	12.6	11.2	10.9	18.6	9.3	26.0	9.8	17.1	9.1	10.1	16.4	17.1	8.4	8.8	1.8	8.6	29.8	17.4	7.9	8.1	3.0	3.4	3.5	3.8	2.9	3.3	4.5	3.8	3.6	3.9	4.2	4.0	22.3	6.4	11.5	1.0	27.2	9.9	28.6	19.2	21.1	9.2	10.8	8.6	4.0	12.8	15.5	11.0	8.4	33.7	19.5	27.6	5.9	22.0	1.5	6.3	6.3	16.9	13.1	20.0	1.3	24.5	28.7	16.3	21.4	8.0	17.2	12.9	15.4	17.4	46.2	1.7	1.2	16.6	20.3	29.9	14.7	2.9	28.0	20.2	16.0	3.7	31.4	6.4	15.5	1.5	4.2	14.0	26.0	8.2	17.6	9.1	43.8	22.9	24.3	7.0	19.7	7.2	15.8	3.6	13.1	19.7	10.5	40.4	13.8	27.6	23.7	28.3
ALG11	"CDG1P, KIAA0266"	ENSG00000253710	"ALG11 alpha-1,2-mannosyltransferase"	Q2TAA5	13	52012391-52079232	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047214	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"			"HPA047214: AB_10961640"	"unprognostic (9.21e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.97e-3)"	"unprognostic (8.89e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.03e-2)"	"unprognostic (9.71e-3)"	10.1	9.5	7.4	8.3	8.4	4.1	12.1	9.5	9.7	12.1	1.9	11.0	10.1	11.0	9.4	7.5	10.8	8.9	10.4	7.5	4.8	14.6	19.2	9.1	8.1	4.8	4.0	11.6	8.6	17.2	2.4	12.7	4.6	12.1	11.8	9.0	10.9	10.9	6.5	7.2	9.7	11.4	2.9	10.1	11.6	6.2	4.7	9.5	16.8	8.8	8.6	8.7	2.5	9.6	6.7	10.5	17.8	15.2	18.6	13.3	14.2	17.7	16.3	12.9	10.3	8.5	14.5	16.2	4.2	18.4	15.8	15.3	18.2	12.0	17.0	16.7	12.9	31.0	8.8	11.4	14.1	28.3	31.0	12.9	17.8	10.1	18.4	14.1	11.5	18.5	17.8	10.4	19.4	5.7	14.7	9.7	19.2	28.8	7.5	15.2	11.9	8.9	16.7	10.8	6.9	15.2	11.9	17.1	11.9	15.0	11.9	20.8	17.8	10.4	11.5	13.6	11.8	9.1	13.5	17.7	6.4	11.7	18.0	13.2	5.4	7.2	7.7	4.5	7.6	5.1	7.0	6.6	6.9	7.1	8.9	8.9	2.2	7.3	12.0	9.8	7.2	4.9	7.4	8.4	9.5	9.7	7.5	4.8	4.8	4.0	4.6	2.9	4.7	9.6	5.3	19.2	8.2	5.5	7.1	2.4	3.2	7.8	8.0	6.8	4.2	3.2	7.5	5.7	9.3	3.7	6.2	3.4	6.2	2.1	1.9	2.9	0.9	5.1	7.3	5.2	3.0	12.6	9.3	2.2	3.9	8.2	9.7	5.4	3.8	6.5	6.1	4.0	2.5	5.0	8.1	2.7	6.1	2.2	3.1	0.5	3.4	3.5	1.8	5.6	2.6	2.8	11.3	13.0	8.9	2.7	1.7	1.2	14.0	2.6	3.5	1.7	13.5	7.5	0.0	4.2	6.4	4.8	3.5	7.8	2.4	4.8	7.2	3.7	2.1	4.0
ALOX5AP	FLAP	ENSG00000132965	"Arachidonate 5-lipoxygenase activating protein"	P20292	13	30713478-30764426	"Disease related genes, Predicted membrane proteins"	"Leukotriene biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 487.2;lung: 183.3;lymphoid tissue: 138.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 691.3;granulocytes: 609.1;Hofbauer cells: 492.2;Langerhans cells: 335.4;Macrophages: 637.0;NK-cells: 280.2;T-cells: 368.6"	"Cancer enhanced"	"Detected in all"		"glioma: 49.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 9703.9;eosinophil: 4033.4;neutrophil: 4968.7;plasmacytoid DC: 3555.3"	"Group enriched"	"Detected in all"	8	"dendritic cells: 3555.3;granulocytes: 9703.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 658.4;HL-60: 352.3;HMC-1: 1072.9;THP-1: 434.2;U-937: 321.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026592	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA026592: AB_10601115"	"unprognostic (1.17e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.18e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (7.83e-2)"	"unprognostic (6.63e-2)"	"prognostic unfavorable (5.68e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.59e-1)"	51.6	36.1	10.8	100.6	11.6	487.2	25.7	12.5	18.1	18.8	13.4	22.8	21.6	17.4	7.1	21.8	24.5	40.0	12.4	10.2	15.7	13.3	19.7	183.3	77.2	21.0	15.6	10.6	14.1	9.6	6.1	37.2	21.1	13.2	21.4	3.7	19.9	15.5	3.8	7.4	28.3	42.6	16.6	138.5	20.0	4.3	17.7	93.2	9.1	24.7	108.2	65.6	11.9	31.3	0.6	0.8	1.2	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.0	1.3	7.1	156.3	2.2	0.0	5.2	1.2	0.0	4.6	0.1	658.4	0.0	18.7	0.3	1.0	0.7	352.3	1072.9	0.8	0.2	0.1	37.9	8.1	1.4	33.3	0.1	3.2	1.9	0.1	19.8	12.7	0.0	0.0	0.2	3.2	3.9	12.4	1.4	0.3	10.2	0.1	0.2	0.3	0.9	2.3	0.0	434.2	1.1	0.0	3.2	0.3	2.6	66.2	0.5	103.8	1.0	321.1	1.4	9703.9	322.4	4033.4	546.0	17.2	808.3	477.9	536.4	449.0	198.5	489.2	271.6	260.7	4968.7	98.0	12.4	3555.3	843.9	775.2	10.8	11.6	12.5	18.1	10.2	15.7	21.0	15.6	21.1	16.6	17.7	31.3	3.5	41.7	102.0	0.0	117.6	23.7	2.6	1.8	1.2	0.0	3.3	9.1	4.1	10.0	23.7	0.0	0.0	3.1	691.3	4.0	15.6	2.3	5.6	14.3	0.7	17.2	26.4	27.1	0.4	1.0	4.0	11.2	21.4	0.7	609.1	1.9	7.1	1.8	492.2	0.0	0.4	2.0	4.1	144.3	335.4	4.5	4.7	637.0	42.7	13.1	217.1	0.1	280.2	0.5	0.3	6.4	3.1	4.1	31.1	1.5	7.3	2.0	11.1	0.1	32.9	4.4	4.0	0.4	1.1	1.7	24.7	4.9	368.6	0.0	2.0	1.4
ALS2	ALS2CR6	ENSG00000003393	"Alsin Rho guanine nucleotide exchange factor ALS2"	Q96Q42	2	201700267-201782112	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 91.8;granulocytes: 46.9;Inhibitory neurons: 66.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"cerebellum: 26.4"	"Group enriched"	"Detected in many"	5	"basophil: 23.0;eosinophil: 6.8"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 23.0"	"Cell line enhanced"	"Detected in all"		"HMC-1: 50.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 87.8"	HPA046588	Enhanced		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Intermediate filaments, Cytosol"		"HPA046588: AB_2679709"	"unprognostic (3.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.72e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.04e-3)"	"unprognostic (9.17e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.84e-1)"	7.3	5.5	2.6	2.6	3.1	5.6	6.8	26.4	4.2	6.4	4.5	6.6	3.2	6.6	7.8	4.8	6.4	3.8	13.7	3.4	1.6	8.0	14.5	6.7	2.8	0.9	1.0	6.0	5.7	4.3	10.0	3.5	1.7	6.1	3.4	5.4	5.4	1.6	13.5	7.1	6.6	4.8	0.3	5.3	6.8	5.3	1.4	2.4	6.3	5.9	2.8	6.2	5.7	2.6	6.5	6.7	7.1	5.6	7.0	5.1	7.2	8.6	10.4	14.0	13.2	5.8	8.4	1.2	3.8	11.7	6.1	3.7	4.6	10.6	18.0	3.5	4.8	15.3	6.2	5.2	8.1	16.4	50.4	9.8	4.1	11.5	14.0	5.7	10.0	8.6	9.8	5.7	9.6	7.5	6.7	20.3	9.2	4.6	5.3	5.4	7.7	4.2	9.8	8.8	3.4	7.8	6.4	7.1	9.2	14.3	5.4	7.2	7.9	11.6	7.2	3.5	6.2	7.1	9.2	4.5	8.5	3.4	7.2	23.0	0.9	6.8	1.6	1.7	1.9	1.2	1.3	1.3	1.4	1.0	1.5	1.5	0.9	3.0	1.2	0.8	2.1	0.8	2.6	3.1	26.4	4.2	3.4	1.6	0.9	1.0	1.7	0.3	1.4	2.6	7.6	12.8	16.7	28.7	2.8	5.4	3.8	4.4	3.4	15.1	5.4	4.3	32.3	8.6	4.3	9.2	29.2	5.7	3.7	3.6	0.0	6.9	16.5	14.0	6.8	10.4	4.8	12.0	91.8	3.3	3.2	6.9	9.7	6.8	46.9	10.1	13.2	20.3	5.9	8.4	66.6	6.9	2.0	3.2	3.0	6.5	7.8	4.8	0.0	27.2	3.1	5.9	4.1	36.2	44.0	6.1	3.9	8.2	2.3	4.4	7.8	6.1	17.5	15.4	0.0	9.3	8.4	7.3	5.6	4.6	6.0	6.7	3.9	5.2	4.7	3.7
AMDHD1	MGC35366	ENSG00000139344	"Amidohydrolase domain containing 1"	Q96NU7	12	95943331-95968720	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Histidine metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 60.7;skeletal muscle: 27.3"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 132.5"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 23.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 46.6;HMC-1: 47.7;Karpas-707: 61.2;SiHa: 40.5;SK-BR-3: 46.1;U-266/70: 49.1;U-266/84: 62.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039720, HPA040149"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	NA		1400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039720: AB_10672967, HPA040149: "	"unprognostic (4.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-1)"	1.8	11.7	8.2	6.5	11.2	6.1	0.4	5.5	11.8	0.3	6.9	1.4	5.1	3.0	0.4	2.6	0.7	1.7	1.7	7.6	6.9	5.8	60.7	2.3	4.4	15.5	8.6	1.4	3.3	0.7	0.5	2.0	9.5	2.8	0.2	1.8	2.0	0.2	27.3	5.8	5.0	0.6	2.7	5.9	4.8	13.1	8.0	0.6	0.9	0.9	0.4	0.3	0.2	15.4	46.6	9.5	0.8	5.8	0.0	0.0	10.0	1.5	0.5	0.7	1.4	3.9	5.8	4.0	4.2	0.0	2.6	8.2	0.3	0.0	0.3	16.0	1.7	4.2	7.9	9.4	0.0	5.9	47.7	0.0	0.4	0.8	0.1	0.2	0.3	3.9	2.7	61.2	0.0	6.8	3.7	10.8	4.4	1.8	2.2	7.8	0.3	5.3	0.0	4.3	4.9	6.9	40.5	46.1	5.2	0.2	4.6	8.4	0.0	5.8	19.1	8.0	5.4	49.1	62.8	6.3	3.8	12.2	6.9	0.2	0.6	1.7	0.5	0.6	0.4	0.6	0.2	0.6	0.5	0.3	0.3	0.4	0.4	2.3	1.8	0.2	0.1	0.5	8.2	11.2	5.5	11.8	7.6	6.9	15.5	8.6	9.5	2.7	8.0	15.4	1.1	0.0	0.5	0.3	2.0	0.4	0.2	0.0	0.0	0.1	1.1	1.0	0.6	1.5	0.6	3.7	0.0	0.9	1.7	0.0	3.9	0.2	0.9	0.1	0.0	0.8	1.8	8.0	0.7	1.1	0.1	0.1	0.0	0.0	0.0	0.2	8.6	132.5	4.4	1.7	0.3	0.1	0.0	5.7	1.3	0.1	0.3	1.8	3.6	0.0	0.7	1.8	2.1	4.0	2.0	0.2	0.0	0.0	0.7	0.0	0.4	31.0	0.0	0.0	0.0	0.8	0.0	1.5	1.9	0.0	0.3	0.3	1.4	0.3	0.4	0.1
AMPD3		ENSG00000133805	"Adenosine monophosphate deaminase 3"	Q01432	11	10308313-10507579	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 62.9;skeletal muscle: 73.3"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 111.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 44.2;CAPAN-2: 34.6;HMC-1: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038662, HPA047408"	Uncertain		Approved	"Nuclear membrane"		NA	NA		77000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear membrane"		"HPA038662: AB_2676136, HPA047408: AB_2680034"	"unprognostic (2.24e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.44e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.12e-2)"	4.2	19.6	10.8	20.7	22.5	62.9	3.0	19.1	15.3	6.0	10.8	4.9	6.5	4.2	4.0	7.6	11.1	6.4	2.9	10.4	15.9	7.8	1.8	6.9	17.6	21.1	20.5	2.6	3.3	24.1	18.2	4.1	20.5	7.4	6.6	7.5	6.4	3.5	73.3	15.6	7.8	4.4	14.0	12.1	6.7	1.8	21.4	13.9	3.6	9.3	20.3	9.7	7.9	30.2	14.1	2.0	0.5	0.2	7.1	5.0	0.8	12.4	44.2	3.0	3.1	6.9	34.6	5.1	1.2	5.7	11.9	8.6	0.2	11.8	8.8	12.7	0.5	12.5	1.8	1.0	2.4	17.2	36.0	18.5	17.9	6.0	7.7	7.5	1.4	8.3	19.4	5.3	10.1	0.5	10.2	22.3	1.6	1.1	12.2	3.7	15.9	18.2	0.6	11.5	5.1	2.6	2.7	0.4	0.8	1.0	0.4	5.8	3.4	13.7	0.2	9.6	0.5	4.8	2.9	5.5	15.7	16.9	0.3	9.5	6.4	19.4	2.2	3.9	5.4	7.7	3.3	2.6	4.2	5.3	3.6	2.5	8.4	3.8	1.7	2.7	2.1	2.8	10.8	22.5	19.1	15.3	10.4	15.9	21.1	20.5	20.5	14.0	21.4	30.2	0.5	0.0	3.9	5.2	14.3	12.5	10.6	8.1	4.0	23.6	1.6	1.8	6.3	5.7	9.8	14.7	2.1	0.9	1.6	1.9	17.6	2.9	7.3	14.0	1.7	1.6	10.2	20.2	11.9	1.6	1.5	8.1	3.1	2.9	12.0	0.9	1.1	0.7	14.5	0.0	7.0	3.9	20.3	15.2	7.6	20.6	0.9	18.3	3.6	28.1	14.0	6.5	1.0	5.0	111.8	6.3	3.0	0.0	1.7	26.5	4.9	0.8	24.2	1.3	0.0	12.3	1.9	0.4	0.6	2.2	12.5	1.2	6.6	0.3	2.2	16.8
ANGPTL6	"AGF, ARP5"	ENSG00000130812	"Angiopoietin like 6"	Q8NI99	19	10092338-10102796	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 30.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 4.1;Hepatic stellate cells: 5.7;Hepatocytes: 8.2;Smooth muscle cells: 15.8;Spermatogonia: 6.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HMC-1: 58.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"								"Secreted to blood"	NA	NA	450000	23000000	"Cluster 24: B-cells - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (1.28e-1)"	"unprognostic (2.18e-6)"	"unprognostic (1.42e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.77e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.26e-10)"	"unprognostic (8.96e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.32e-1)"	0.3	0.3	0.8	2.1	0.7	2.8	0.3	0.8	1.1	0.2	0.4	0.6	0.7	0.1	0.2	0.3	0.7	0.4	0.2	0.7	0.8	0.5	30.2	0.5	3.3	1.7	1.1	0.3	1.1	0.1	0.4	2.2	1.3	0.2	0.4	0.1	0.2	0.0	0.0	0.3	3.5	0.2	1.2	3.4	1.6	1.6	1.0	0.8	0.3	0.0	3.3	0.5	0.2	1.7	0.3	0.0	0.0	0.1	0.1	0.0	0.4	0.2	0.1	0.0	0.2	0.0	0.1	7.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	2.0	0.2	0.2	0.0	0.5	58.9	0.0	0.2	0.1	0.1	0.3	0.0	0.6	0.4	0.3	0.0	0.0	1.3	4.7	0.2	0.4	1.1	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.3	0.0	0.5	0.0	0.0	5.0	0.0	0.1	0.1	0.0	0.0	5.1	1.4	2.9	0.2	0.7	0.7	0.0	0.3	0.0	0.6	0.4	0.4	0.7	0.4	0.4	0.1	0.9	0.2	0.4	0.0	0.4	0.2	0.1	0.5	0.2	0.8	0.7	0.8	1.1	0.7	0.8	1.7	1.1	1.3	1.2	1.0	1.7	0.3	0.0	0.0	0.0	4.1	0.3	0.1	0.4	0.0	0.1	0.4	0.3	0.4	2.8	0.3	0.0	0.0	0.2	1.7	0.1	1.9	0.3	0.3	0.0	0.3	0.2	0.0	0.4	0.9	0.0	0.2	2.5	0.5	0.1	0.0	0.1	5.7	8.2	2.3	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	2.1	0.0	0.2	0.5	0.2	0.2	0.0	0.1	15.8	0.5	6.3	0.0	0.0	0.3	1.0	0.9	0.1	0.1
ANKRD55	FLJ11795	ENSG00000164512	"Ankyrin repeat domain 55"	Q3KP44	5	56099680-56233330	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 8.3;liver: 3.1;lymphoid tissue: 3.6;testis: 9.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 161.3;Hepatic stellate cells: 41.7;Inhibitory neurons: 103.5;Late spermatids: 29.1;Spermatocytes: 59.3"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 22.9;eosinophil: 20.7;naive CD4 T-cell: 19.8"	"Group enriched"	"Detected in many"	74	"granulocytes: 22.9;T-cells: 19.8"	"Group enriched"	"Detected in some"	6	"HEL: 34.4;HMC-1: 17.1;NB-4: 22.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051049, HPA061649"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA051049: AB_2681326, HPA061649: "	"unprognostic (1.00e-4)"	"unprognostic (1.58e-4)"	"unprognostic (2.63e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.78e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.19e-6)"	"unprognostic (2.56e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.01e-1)"	0.4	0.1	2.2	0.7	3.0	0.7	0.1	0.0	2.4	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.3	0.1	0.9	8.3	0.4	3.1	0.3	3.6	4.1	4.6	0.1	0.0	0.0	0.2	0.6	5.2	0.0	0.2	0.4	1.0	0.0	0.0	0.4	1.3	0.1	3.3	1.6	0.3	9.8	7.8	3.2	0.2	0.0	2.0	0.3	0.1	0.9	0.2	0.3	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	34.4	0.2	1.3	0.0	1.6	17.1	0.0	0.1	0.0	0.0	0.1	4.2	0.1	2.9	1.1	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	1.7	0.0	2.3	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	2.0	0.4	22.9	0.2	20.7	0.1	0.1	0.0	0.0	4.3	0.0	0.1	0.0	19.8	0.8	2.0	0.0	0.1	0.0	1.0	2.8	2.2	3.0	0.0	2.4	0.9	8.3	4.1	4.6	5.2	3.3	7.8	0.9	0.3	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.5	1.5	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	161.3	0.4	0.8	2.2	0.0	0.0	1.3	0.2	0.3	0.6	0.5	7.5	2.5	0.1	41.7	0.6	0.7	0.0	103.5	0.0	0.0	3.2	1.9	29.1	0.6	1.4	1.8	1.0	0.9	0.9	3.1	18.6	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	59.3	0.6	0.0	0.0	1.2	3.9	0.5	0.0	0.2
AP000781.2		ENSG00000254979	"Novel protein"		11	57387365-57424059	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"bone marrow: 13.3;liver: 7.2;placenta: 7.1"	"Cell type enriched"	"Detected in single"	10	"granulocytes: 6.3"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"basophil: 3.5"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.5"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 186.9"									HPA038515	Supported					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"HPA038515: AB_10675800"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.55e-4)"	"unprognostic (2.16e-1)"	"unprognostic (4.01e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.51e-10)"	"unprognostic (4.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.59e-2)"	"unprognostic (3.10e-1)"	6.1	0.2	0.0	0.6	0.0	13.3	2.6	0.0	0.3	0.6	0.0	0.5	0.7	0.4	0.0	1.1	0.2	1.1	0.6	0.0	0.0	0.5	7.2	1.0	1.0	0.0	0.0	0.3	2.9	0.0	0.2	7.1	0.0	0.3	0.4	0.0	1.4	0.0	1.0	5.4	0.5	0.3	0.0	0.5	0.3	0.1	0.0	0.4	1.2	0.1	0.9	1.0	0.6	0.0	0.7	0.0	0.1	0.0	0.0	0.9	0.8	0.0	0.3	0.2	0.6	0.0	0.2	0.8	0.0	0.1	0.0	1.3	0.0	0.0	0.6	0.0	0.0	4.2	0.0	0.0	0.8	28.6	186.9	1.7	0.0	0.6	0.0	0.0	0.4	0.7	0.4	1.6	0.0	0.0	1.1	9.1	0.3	0.0	0.0	4.0	0.0	8.7	0.2	0.0	1.0	0.3	0.2	0.4	2.9	0.0	0.0	0.9	0.1	0.2	0.5	3.3	0.0	0.3	0.0	1.0	0.9	1.1	1.3	3.5	0.2	0.2	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APEH	"D3F15S2, D3S48E, DNF15S2"	ENSG00000164062	"Acylaminoacyl-peptide hydrolase"	P13798	3	49674014-49683971	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029700, HPA029701, HPA029702, HPA029703"	Enhanced		Enhanced	Cytosol		No	No		2300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA029700: AB_10599278, HPA029701: AB_10600333, HPA029702: AB_10602411, HPA029703: AB_10601348"	"unprognostic (4.93e-2)"	"unprognostic (5.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (9.32e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.03e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.32e-10)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.34e-2)"	"unprognostic (7.67e-2)"	21.7	43.6	18.0	30.7	18.0	42.3	26.8	17.9	22.8	24.8	27.7	48.5	48.6	19.7	24.7	40.2	33.7	22.3	40.6	17.7	19.9	65.8	63.3	26.8	35.2	19.2	21.3	24.6	34.8	63.0	38.3	31.9	24.3	31.0	51.7	12.9	34.0	29.5	103.8	32.8	35.1	28.1	16.8	27.2	35.5	18.7	20.0	37.3	48.6	103.9	43.4	35.0	21.2	16.7	101.2	79.2	84.2	110.8	71.3	48.3	113.6	64.2	79.3	87.4	91.2	130.1	101.7	127.1	70.0	71.7	78.9	89.8	95.1	143.4	64.2	61.9	41.0	138.8	123.4	105.1	72.0	145.5	204.7	55.0	106.5	49.2	101.4	85.5	78.7	86.4	86.6	59.8	86.0	90.8	105.3	76.6	50.4	140.5	75.3	38.4	72.8	165.1	169.9	226.7	40.4	71.2	72.4	166.7	78.9	61.0	112.1	77.2	36.1	53.8	93.0	83.6	86.8	69.8	54.5	77.7	91.7	104.1	78.7	57.9	43.0	52.8	44.8	47.6	34.8	33.3	36.3	41.9	43.6	27.6	37.9	37.4	13.6	39.0	47.6	35.1	50.4	51.9	18.0	18.0	17.9	22.8	17.7	19.9	19.2	21.3	24.3	16.8	20.0	16.7	5.4	41.7	25.3	7.5	20.1	8.7	23.3	50.2	11.4	6.8	20.8	15.9	46.8	30.0	39.4	27.6	12.5	83.7	16.5	83.2	43.0	44.4	6.4	16.6	13.8	9.0	26.5	43.8	4.8	34.7	64.8	16.4	41.8	20.5	23.5	20.0	13.2	74.7	51.1	8.4	4.7	47.1	63.1	35.9	11.9	10.9	15.2	23.2	21.4	2.8	26.8	30.4	27.8	3.0	2.0	39.0	35.8	13.5	39.4	18.0	85.4	80.7	19.4	11.1	13.1	10.6	25.2	33.2	28.5	30.6	9.2	62.1	23.9	28.5	74.0	23.7
APOBR	"APOB100R, APOB48R"	ENSG00000184730	"Apolipoprotein B receptor"	Q0VD83	16	28494643-28498970	"Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Receptor	Atherosclerosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 34.9;intestine: 26.3;lung: 11.6;lymphoid tissue: 36.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 149.9;granulocytes: 39.3;Intestinal goblet cells: 47.5;NK-cells: 65.9;Paneth cells: 84.8;Undifferentiated cells: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 41.6;HMC-1: 124.8;NB-4: 35.7;THP-1: 25.8;U-937: 30.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041667, HPA042093"	Enhanced					NA	NA		700000	"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA041667: AB_10793972, HPA042093: AB_10795393"	"unprognostic (3.16e-1)"	"unprognostic (8.01e-3)"	"unprognostic (6.19e-3)"	"prognostic favorable (3.26e-4)"	"unprognostic (5.48e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.65e-2)"	"unprognostic (7.60e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.25e-2)"	3.3	2.0	0.9	20.0	0.9	34.9	1.6	1.1	2.0	1.3	0.9	26.3	6.1	1.1	1.4	1.6	2.4	2.8	1.3	0.9	1.7	1.1	2.7	11.6	6.7	2.3	1.3	0.4	1.3	0.6	0.7	2.7	1.8	1.8	16.1	0.1	2.1	3.5	1.1	3.1	9.4	2.7	1.5	36.6	4.1	1.3	2.6	3.7	1.2	1.1	3.8	4.8	1.1	2.2	0.1	0.1	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.1	0.2	2.2	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	41.6	0.3	0.5	0.0	15.4	124.8	0.0	0.1	0.0	0.0	0.1	0.0	0.4	1.3	0.7	0.0	1.2	1.5	35.7	0.0	0.0	0.0	0.9	0.1	0.0	0.0	1.9	0.0	0.0	0.1	1.1	0.1	0.1	1.4	25.8	0.1	0.0	0.0	0.1	0.0	0.7	0.3	1.5	0.1	30.8	0.1	10.5	5.8	16.5	2.4	2.9	2.3	0.0	1.3	2.4	5.0	0.1	0.3	1.2	17.1	7.3	2.6	0.9	0.4	2.3	0.9	0.9	1.1	2.0	0.9	1.7	2.3	1.3	1.8	1.5	2.6	2.2	0.3	3.2	7.7	0.0	2.2	0.8	0.2	0.1	0.0	0.0	2.2	0.6	0.6	0.0	2.7	3.7	0.0	2.1	21.9	149.9	0.0	0.0	0.1	0.2	0.2	0.7	9.1	6.5	0.0	0.2	14.6	1.0	1.1	0.2	39.3	0.1	0.7	0.6	32.3	0.0	0.0	47.5	0.0	30.1	32.5	0.4	0.3	33.9	1.8	1.9	34.8	0.0	65.9	0.0	0.1	0.0	84.8	0.0	5.7	0.1	6.5	0.1	0.8	0.0	6.6	0.0	0.4	0.4	0.3	0.0	0.3	5.9	16.0	0.0	49.3	0.4
ARHGAP18	"bA307O14.2, MacGAP"	ENSG00000146376	"Rho GTPase activating protein 18"	Q8N392	6	129576132-129710177	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 253.6;Respiratory ciliated cells: 265.3;Syncytiotrophoblasts: 212.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 395.8;LHCN-M2: 113.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031595	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA		1900000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Nuclear speckles, Plasma membrane"	"HPA031595: AB_10959905"	"unprognostic (6.39e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (4.08e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.05e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.08e-1)"	20.5	37.2	3.4	13.0	2.5	4.3	13.4	2.4	2.8	14.9	15.1	14.8	24.8	6.7	20.2	6.0	28.3	15.4	6.0	2.9	4.1	28.4	6.3	28.7	9.4	4.7	5.7	6.0	33.2	14.2	6.7	20.8	4.3	9.9	15.0	2.6	14.6	8.4	10.6	4.0	27.3	10.6	3.5	9.0	27.9	8.3	6.4	6.1	23.0	13.0	7.9	12.6	4.1	3.7	8.6	18.8	1.9	2.6	17.8	25.0	15.1	64.0	48.8	27.7	18.5	10.0	14.1	7.1	30.6	43.2	8.8	11.0	13.4	20.9	51.3	7.0	5.7	46.7	13.8	57.3	25.4	6.9	395.8	15.9	3.2	50.4	44.7	57.8	79.8	0.0	25.3	17.4	113.1	2.3	0.1	6.8	2.0	16.0	4.5	0.3	8.5	13.7	84.6	4.8	0.0	0.1	5.3	8.8	32.3	9.3	9.7	8.1	61.6	28.8	4.1	2.3	51.8	7.8	6.0	4.8	9.7	12.7	40.9	12.0	5.1	13.5	4.9	5.8	3.1	2.9	2.5	5.5	4.8	1.7	0.4	2.6	3.9	2.5	3.2	11.8	2.8	6.0	3.4	2.5	2.4	2.8	2.9	4.1	4.7	5.7	4.3	3.5	6.4	3.7	139.5	57.7	33.3	1.6	13.0	13.0	17.7	15.7	10.8	0.7	53.4	14.7	4.1	17.2	39.5	38.6	2.1	92.7	31.0	19.0	150.6	48.2	20.7	176.1	5.8	89.2	13.1	10.9	16.8	120.5	24.9	45.3	63.2	35.7	253.6	34.7	11.0	5.0	110.4	0.0	23.1	22.1	63.1	48.4	112.4	21.2	3.7	163.9	7.2	43.1	23.9	16.4	28.8	12.5	2.2	102.4	25.0	1.2	26.4	18.5	69.8	31.7	265.3	0.9	26.3	38.9	32.5	10.6	1.1	11.2	12.9	212.3	35.9	69.1	31.3	19.1
ARHGAP25	KIAA0053	ENSG00000163219	"Rho GTPase activating protein 25"	P42331	2	68679601-68826833	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 72.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 88.7;granulocytes: 210.8;Microglial cells: 88.1;NK-cells: 103.0;T-cells: 53.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 657.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 66.7;HMC-1: 256.1;NB-4: 47.3;U-266/70: 50.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035346, HPA061395"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Vesicles"		"HPA035346: AB_10601116, HPA061395: AB_2684501"	"unprognostic (1.13e-3)"	"prognostic favorable (7.72e-4)"	"unprognostic (2.45e-2)"	"unprognostic (4.44e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (3.10e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.49e-2)"	11.1	5.2	5.2	38.8	5.4	37.4	8.0	5.6	7.9	6.0	5.1	7.2	6.2	6.7	22.7	4.3	4.7	11.7	6.7	5.2	5.6	7.1	10.1	21.3	71.4	7.6	6.0	16.7	2.1	2.3	3.5	10.7	6.7	5.0	9.6	0.6	5.1	3.8	3.2	6.2	23.3	8.3	7.1	72.8	8.8	2.5	7.0	27.3	5.1	8.4	67.3	11.9	4.7	8.4	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	20.8	0.5	0.0	0.1	2.5	0.0	20.5	0.0	2.3	0.0	66.7	0.0	0.0	1.0	14.8	256.1	0.2	2.4	0.4	8.1	0.0	0.0	22.2	0.4	23.6	0.0	0.0	17.2	47.3	1.2	0.2	0.0	18.7	4.3	0.8	0.0	5.4	4.1	0.6	0.2	0.0	1.4	1.4	0.0	12.3	3.5	0.1	0.9	0.1	0.5	50.8	29.0	16.8	0.2	33.3	0.3	234.8	60.8	528.7	171.3	75.9	107.0	156.4	76.2	150.0	37.4	100.8	54.2	95.2	657.3	170.6	94.8	52.3	102.0	132.0	5.2	5.4	5.6	7.9	5.2	5.6	7.6	6.0	6.7	7.1	7.0	8.4	14.1	3.2	15.0	0.3	88.7	5.6	12.4	2.9	5.7	0.8	0.7	6.1	1.4	1.5	2.0	0.0	0.0	0.5	35.1	0.1	1.9	0.1	1.8	0.7	0.6	16.6	3.0	11.6	15.5	0.2	0.4	3.5	2.0	0.4	210.8	0.1	15.4	1.0	48.6	0.0	0.9	0.5	2.0	27.3	12.8	3.6	1.5	22.6	1.8	88.1	40.9	0.5	103.0	0.5	0.9	0.0	0.1	2.6	34.7	1.2	0.0	0.2	5.2	0.2	6.6	0.8	2.1	0.6	1.3	2.5	1.4	0.3	53.7	1.8	0.2	2.5
ARHGAP33	"FLJ39019, SNX26, TCGAP"	ENSG00000004777	"Rho GTPase activating protein 33"	O14559	19	35774532-35788822	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 27.4;Cone photoreceptor cells: 25.0;Horizontal cells: 20.2;Oligodendrocytes: 22.7;Rod photoreceptor cells: 33.7;Spermatocytes: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 58.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030117, HPA030118"	Supported		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Actin filaments, Cytosol"	"HPA030117: AB_10599306, HPA030118: AB_10601238"	"unprognostic (1.44e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.61e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (3.09e-8)"	"unprognostic (5.70e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-2)"	7.7	8.7	24.3	4.2	28.8	20.5	10.9	14.3	39.1	20.4	8.2	11.2	4.0	13.9	1.3	8.1	17.1	2.8	6.9	30.0	21.0	10.1	5.6	6.8	5.8	19.9	16.5	26.9	11.9	4.2	33.6	1.6	18.0	12.5	1.3	9.9	7.4	3.3	3.4	9.8	9.2	2.0	15.2	11.1	10.4	39.6	19.5	11.7	18.0	1.3	2.2	9.4	13.7	22.1	9.0	5.6	15.5	11.7	0.6	1.5	1.2	7.2	0.9	2.7	1.9	2.3	6.6	5.2	2.6	2.1	2.3	2.4	1.9	2.0	1.0	16.4	3.6	7.6	8.6	2.1	0.7	2.7	58.1	2.2	0.4	2.1	0.8	2.2	1.6	20.4	3.7	22.1	2.4	6.8	18.8	7.4	3.5	3.4	2.5	25.4	2.5	2.5	1.2	1.4	15.4	9.4	3.2	5.7	1.1	1.9	8.3	7.5	3.1	11.0	10.6	5.8	8.5	19.5	4.0	5.2	4.0	8.9	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	28.8	14.3	39.1	30.0	21.0	19.9	16.5	18.0	15.2	19.5	22.1	2.7	0.0	1.1	7.8	1.0	1.7	1.0	1.0	4.6	27.4	4.8	4.7	2.3	2.8	2.7	1.8	25.0	0.7	5.1	1.4	0.0	0.4	11.4	6.1	4.8	1.6	3.5	6.5	12.1	0.7	1.0	3.5	3.6	2.5	5.1	7.3	1.1	1.5	1.2	20.2	11.3	2.3	2.0	0.8	1.9	8.9	4.1	0.7	0.0	1.9	0.2	7.3	0.0	19.1	22.7	0.7	0.6	3.0	2.2	0.6	0.3	0.2	4.2	33.7	0.0	4.6	3.1	22.2	6.2	4.2	1.7	0.4	3.6	7.2	2.8	0.6
ARHGAP9	"10C, MGC1295"	ENSG00000123329	"Rho GTPase activating protein 9"	Q9BRR9	12	57472264-57488814	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 119.7;lymphoid tissue: 100.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 171.0;Early spermatids: 96.8;NK-cells: 123.6;Spermatocytes: 89.0;T-cells: 108.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 388.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 27.6;HMC-1: 116.2;MOLT-4: 22.5;NB-4: 22.1;THP-1: 34.9;U-937: 27.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA078822			Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Cell Junctions"	"HPA078822: "	"unprognostic (1.02e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.91e-2)"	"prognostic favorable (6.61e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.79e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.90e-9)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"	10.8	4.2	4.2	34.3	6.1	119.7	4.1	8.1	11.1	2.6	4.7	7.7	8.2	3.4	1.6	4.6	7.4	10.5	3.9	4.4	5.3	5.1	7.5	22.0	56.9	7.8	5.8	1.6	3.5	0.6	2.2	5.2	8.8	4.3	10.7	0.5	4.7	1.8	1.3	2.2	37.6	5.9	5.6	100.7	8.8	19.3	6.1	34.9	4.5	6.4	60.7	9.5	3.6	6.4	0.2	0.0	0.2	0.5	0.0	0.0	0.1	0.4	0.5	0.1	0.2	0.1	0.0	14.3	0.3	0.3	0.0	0.2	0.4	0.0	0.0	0.7	0.0	27.6	0.1	0.0	1.1	16.4	116.2	0.7	0.0	0.0	0.3	0.2	0.0	14.3	0.5	7.9	0.0	0.0	22.5	22.1	1.0	0.0	0.0	9.1	10.2	4.6	0.0	0.1	3.9	3.0	0.0	0.0	0.4	0.5	0.0	34.9	0.9	0.2	0.3	0.1	0.1	9.2	7.2	13.3	0.3	27.3	0.5	51.9	86.1	243.4	43.3	89.2	30.0	35.9	47.3	39.6	72.1	44.0	61.9	46.0	388.9	68.2	71.0	97.4	63.6	70.8	4.2	6.1	8.1	11.1	4.4	5.3	7.8	5.8	8.8	5.6	6.1	6.4	2.2	0.0	14.2	1.0	49.1	1.5	0.2	0.0	1.8	0.2	1.6	2.9	2.1	1.5	1.3	0.0	2.1	0.4	171.0	0.6	0.0	0.2	96.8	0.6	0.8	1.5	0.0	11.6	3.7	0.0	0.6	2.4	4.6	0.8	12.0	0.0	3.6	1.2	43.5	0.0	1.9	0.5	0.0	39.0	19.7	44.8	1.8	35.1	0.0	8.4	34.8	0.0	123.6	0.0	0.2	0.2	0.1	0.0	50.8	0.2	0.0	0.3	2.2	0.7	0.0	0.6	1.2	89.0	17.5	0.4	1.4	0.3	108.2	0.3	0.4	0.1
ARHGEF6	"alpha-PIX, alphaPIX, αPix, Cool-2, Cool2, KIAA0006, MRX46"	ENSG00000129675	"Rac/Cdc42 guanine nucleotide exchange factor 6"	Q15052	X	136665547-136780932	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 193.9;Granulosa cells: 128.2;Microglial cells: 77.8"	"Cancer enhanced"	"Detected in all"		"glioma: 24.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 117.6;HL-60: 153.7;HMC-1: 532.0;JURKAT: 152.7;U-937: 158.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003578	Approved		Approved	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA003578: AB_1078203"	"unprognostic (9.64e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.06e-3)"	"unprognostic (9.08e-2)"	"unprognostic (7.87e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.69e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.28e-3)"	44.0	16.2	23.4	30.5	24.4	31.4	23.5	25.0	19.5	10.7	11.6	13.2	7.5	12.9	5.3	7.6	7.0	17.3	32.9	25.2	26.9	6.7	8.5	25.6	41.8	26.8	29.2	16.5	3.9	10.3	6.2	46.9	27.8	7.8	11.1	4.6	8.7	8.8	68.7	6.2	14.4	16.6	29.0	39.4	12.3	3.8	26.5	51.4	5.6	54.7	39.6	14.3	8.7	30.1	1.1	0.0	5.1	0.0	11.2	28.5	0.1	1.6	9.5	1.5	8.2	0.0	0.0	5.5	2.3	8.0	7.8	0.8	6.1	0.0	1.5	28.1	2.0	117.6	0.1	0.0	4.2	153.7	532.0	30.9	0.1	5.4	0.1	10.1	3.0	152.7	0.5	22.1	20.4	0.2	70.6	88.4	4.9	0.0	2.3	26.6	37.2	0.1	1.6	29.5	0.3	6.7	0.2	1.2	4.0	2.6	3.5	61.2	0.5	7.6	1.2	9.3	7.2	3.6	0.1	57.3	35.1	158.2	10.1	57.2	16.4	71.3	13.8	18.9	16.0	6.2	15.4	11.3	19.1	5.4	13.7	12.3	9.1	12.4	16.1	6.0	21.5	15.3	23.4	24.4	25.0	19.5	25.2	26.9	26.8	29.2	27.8	29.0	26.5	30.1	18.1	6.4	8.9	57.1	22.4	1.1	0.9	0.8	1.2	0.8	16.1	10.8	60.0	0.0	2.4	1.8	0.0	0.3	23.6	0.1	1.9	0.6	12.0	0.9	2.4	13.2	0.0	11.3	20.6	1.8	0.4	10.7	5.6	1.6	193.9	128.2	12.5	2.5	15.2	13.5	21.6	0.4	0.0	46.5	25.1	35.8	14.9	40.3	3.6	77.8	36.1	4.7	36.0	48.2	4.3	0.7	0.0	14.7	12.8	0.4	0.0	0.2	2.2	0.3	13.1	33.5	18.5	0.7	0.7	0.6	1.7	0.4	40.5	30.1	0.1	0.7
ARMC8	"DKFZP434A043, GID5, HSPC056, VID28"	ENSG00000114098	"Armadillo repeat containing 8"	Q8IUR7	3	138187248-138298384	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 128.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036996, HPA044869"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA036996: AB_10672786, HPA044869: AB_2679123"	"unprognostic (2.04e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (3.51e-2)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (8.90e-5)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.48e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (3.27e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.18e-1)"	20.8	14.3	14.6	18.0	16.6	60.6	16.4	41.2	18.5	14.7	25.6	16.8	12.0	17.6	12.2	21.0	15.7	15.3	17.4	13.3	16.9	18.9	16.9	16.3	21.2	16.0	15.8	16.0	14.2	21.3	12.3	19.8	17.5	16.5	18.3	26.2	12.5	17.5	38.7	12.8	13.5	24.4	15.9	15.9	15.4	18.4	16.7	22.2	21.3	34.8	22.9	22.2	13.4	19.4	46.2	22.0	28.5	23.2	35.2	30.7	37.9	34.8	33.4	46.7	45.3	34.3	23.7	43.2	35.0	30.2	54.6	23.5	37.1	33.9	57.4	29.3	25.7	77.2	14.3	23.9	44.3	60.6	82.5	46.2	21.2	30.0	42.9	25.4	37.0	37.0	29.3	23.8	58.6	40.5	42.7	28.6	39.2	34.8	19.1	33.0	45.7	34.6	30.7	42.3	33.0	24.0	50.0	17.2	29.1	36.8	33.8	31.6	40.4	24.8	20.2	33.1	25.9	45.0	37.5	65.2	22.4	28.4	25.2	79.7	39.7	74.8	38.6	43.5	44.6	48.8	35.2	41.1	45.9	43.3	41.1	40.6	27.9	48.8	46.0	20.3	50.4	37.4	14.6	16.6	41.2	18.5	13.3	16.9	16.0	15.8	17.5	15.9	16.7	19.4	25.0	28.9	14.1	56.2	38.2	31.0	31.9	29.0	25.0	34.9	17.7	14.9	23.1	24.3	27.2	12.9	33.3	29.9	35.6	25.1	11.7	20.2	7.3	16.2	22.3	23.4	23.4	59.6	101.9	14.6	27.6	23.4	31.1	19.5	35.4	24.1	24.3	24.6	22.5	43.7	93.6	16.9	30.5	32.7	39.2	7.3	30.4	35.2	19.6	70.3	27.2	25.0	39.1	128.2	120.8	14.8	17.2	22.2	26.8	28.1	17.0	26.1	17.4	47.0	13.1	30.2	31.5	43.4	32.2	22.3	28.4	34.1	30.9	19.6	17.4	28.3
ARMH3	"C10orf76, FLJ13114"	ENSG00000120029	"Armadillo like helical domain containing 3"	Q5T2E6	10	101845599-102056193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 11.2;dendritic cells: 10.5;Extravillous trophoblasts: 14.8;Granulosa cells: 11.5;Hofbauer cells: 12.6;Syncytiotrophoblasts: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050913, HPA053580"	Approved		Approved	Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA050913: AB_2681270, HPA053580: AB_2682198"	"unprognostic (5.88e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.41e-2)"	"unprognostic (9.55e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.03e-3)"	"unprognostic (1.40e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.85e-1)"	"unprognostic (4.87e-2)"	10.4	9.1	5.9	12.0	7.6	21.8	9.9	10.2	7.3	11.2	8.0	12.5	12.8	10.5	9.4	14.3	10.5	9.2	16.6	5.7	7.3	10.0	12.0	11.8	12.7	7.1	8.2	11.2	10.1	16.4	7.9	11.0	6.1	10.8	13.2	16.3	9.5	10.5	19.7	12.2	12.2	12.9	6.0	13.6	10.3	8.9	6.7	13.1	10.0	19.8	13.3	10.8	10.1	7.9	23.2	17.7	15.5	19.1	12.9	17.3	13.9	20.3	24.0	20.0	16.9	12.2	18.6	17.0	13.5	22.9	14.5	17.7	20.4	22.4	18.3	17.9	18.9	30.3	15.9	14.6	15.2	21.3	26.4	16.0	17.7	22.6	19.9	23.4	15.3	15.3	0.9	15.9	16.6	14.4	16.5	13.8	8.5	18.8	11.6	16.0	28.1	11.0	16.4	18.6	7.3	12.1	15.8	10.9	21.0	15.8	28.8	12.4	15.1	10.5	17.1	9.8	14.7	15.4	17.0	17.1	16.9	23.7	7.9	19.4	7.3	7.4	5.9	8.7	5.5	6.1	6.2	4.5	7.7	7.0	4.8	4.9	1.9	5.2	10.7	7.4	6.0	4.7	5.9	7.6	10.2	7.3	5.7	7.3	7.1	8.2	6.1	6.0	6.7	7.9	8.8	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	7.4	6.0	0.0	0.0	0.0	0.0	0.0	11.2	10.5	0.0	1.9	7.8	0.0	6.9	6.8	1.9	0.0	0.0	0.0	9.7	14.8	2.7	0.0	7.7	0.0	11.5	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	9.9	0.0	0.0	2.2	0.0	0.0	7.6	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	16.3	3.9	5.7	0.0	0.0
ARRB2	"ARR2, BARR2, DKFZp686L0365"	ENSG00000141480	"Arrestin beta 2"	P32121	17	4710596-4721499	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 263.6;lymphoid tissue: 168.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 262.0;Kupffer cells: 242.5;Langerhans cells: 164.2;Macrophages: 226.4;monocytes: 311.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 195.8;HMC-1: 315.9;NB-4: 199.2;U-937: 279.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075177			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA075177: "	"unprognostic (1.12e-1)"	"prognostic favorable (2.93e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.43e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.32e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.88e-1)"	48.6	39.7	54.4	110.0	53.8	263.6	26.1	48.2	62.2	19.3	49.1	29.5	50.5	17.4	10.8	15.1	29.0	31.4	25.0	63.8	67.7	25.2	35.6	94.8	59.4	61.6	58.3	17.5	19.4	16.4	24.9	35.5	59.5	19.5	27.6	16.9	20.9	11.7	12.7	14.6	51.1	29.6	55.4	168.3	35.0	7.2	59.5	45.2	15.8	18.1	38.0	41.6	17.6	66.5	17.3	88.7	34.7	32.9	6.8	9.5	18.6	13.7	18.0	38.4	48.0	31.0	14.2	49.1	12.2	10.3	18.3	28.5	58.0	18.4	39.4	116.6	85.0	195.8	46.8	55.6	10.2	89.2	315.9	8.8	23.5	47.9	18.7	24.9	29.6	89.1	13.5	46.4	8.9	30.5	87.9	199.2	18.9	44.9	18.4	104.3	31.0	53.8	13.2	9.2	36.0	49.2	30.8	50.8	23.6	14.2	24.6	40.0	26.1	14.3	29.1	25.1	51.5	19.8	28.6	27.6	37.9	279.4	21.6	116.2	145.5	269.7	49.1	151.1	35.1	10.1	31.1	51.3	84.9	9.0	29.3	38.7	250.6	29.9	168.6	20.7	28.8	93.5	54.4	53.8	48.2	62.2	63.8	67.7	61.6	58.3	59.5	55.4	59.5	66.5	7.7	22.4	32.3	5.5	26.4	11.5	7.7	16.6	3.4	20.5	9.6	12.3	8.3	14.3	47.9	3.7	2.1	7.5	83.8	7.4	15.6	11.2	0.6	1.5	3.6	10.1	8.4	33.9	20.4	7.3	12.0	8.7	19.4	1.8	94.9	7.8	19.2	12.4	262.0	21.9	18.2	17.0	50.8	242.5	164.2	3.5	5.0	226.4	10.6	42.2	311.3	5.8	89.6	7.1	8.4	6.3	22.0	4.9	23.4	4.4	35.5	17.5	24.4	8.7	19.7	10.9	8.5	1.1	13.1	6.8	8.4	6.0	77.2	3.5	11.4	11.7
ASCC2	"ASC1p100, DKFZp586O0223, FLJ21588"	ENSG00000100325	"Activating signal cointegrator 1 complex subunit 2"	Q9H1I8	22	29788609-29838304	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 155.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001439, HPA052879"	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA001439: AB_1078229, HPA052879: AB_2732577"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.01e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.97e-3)"	"unprognostic (5.19e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.05e-3)"	26.6	31.3	11.4	22.7	12.7	53.7	24.9	12.6	13.7	23.7	16.7	24.5	23.7	21.0	16.1	42.0	19.9	17.1	22.8	11.6	11.9	19.8	35.8	22.1	24.5	13.5	12.9	19.9	23.5	21.8	26.7	21.8	13.2	27.1	24.6	8.4	29.8	18.0	43.5	30.1	23.1	19.2	12.9	29.4	37.0	24.5	12.5	29.6	28.3	32.3	34.0	26.8	27.5	13.3	46.9	26.8	28.4	38.7	41.6	36.7	40.7	47.6	36.3	48.4	48.1	31.5	24.7	46.5	33.4	46.2	30.7	55.5	36.8	54.0	40.5	59.8	64.3	39.9	33.0	38.0	52.1	72.3	115.6	39.6	48.2	55.0	50.0	28.4	42.9	30.7	41.8	43.7	44.3	57.8	44.5	37.9	20.7	65.6	36.0	53.0	34.9	48.6	29.6	76.1	43.8	38.5	44.3	48.2	35.4	28.8	34.3	37.4	42.8	67.1	11.3	41.2	47.9	51.9	42.8	54.4	39.2	39.9	49.5	44.7	29.8	53.6	32.1	49.2	28.4	18.8	23.6	26.9	37.7	15.0	24.1	24.6	9.2	33.7	43.9	21.7	30.3	20.0	11.4	12.7	12.6	13.7	11.6	11.9	13.5	12.9	13.2	12.9	12.5	13.3	27.7	19.2	14.7	18.6	35.8	30.0	25.2	38.1	13.1	9.4	23.3	12.3	19.1	31.5	33.3	40.5	4.2	46.3	40.5	38.8	11.7	25.4	110.2	14.0	28.1	20.7	15.5	116.0	13.5	24.9	63.3	22.9	69.8	20.0	34.9	24.3	22.9	25.7	30.6	5.0	13.8	23.2	44.7	29.2	37.3	155.2	31.1	29.1	28.4	11.2	27.9	12.2	56.7	15.6	16.3	27.7	34.0	24.8	32.4	16.2	46.8	18.2	24.4	13.6	19.7	19.6	19.7	48.4	22.5	35.0	39.2	44.3	34.9	27.8	23.9	34.2
ASMTL		ENSG00000169093	"Acetylserotonin O-methyltransferase like"	O95671	X	1403139-1453762	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 92.5;monocytes: 106.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 131.0"					"Low region specificity"	"Detected in all"			"HPA003630, HPA021865"	Supported		Enhanced	Cytosol		NA	NA		17000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA003630: AB_1078230, HPA021865: AB_1845099"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.87e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.05e-2)"	"unprognostic (8.17e-2)"	"unprognostic (5.23e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.91e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.26e-3)"	"unprognostic (9.70e-2)"	"unprognostic (8.38e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.20e-1)"	28.1	21.8	15.6	15.7	15.1	17.4	26.8	15.1	20.3	29.1	23.0	30.8	11.7	29.4	14.3	15.1	28.6	13.6	34.5	15.7	16.5	23.1	32.1	18.3	21.4	20.4	18.4	33.9	23.6	22.4	31.0	11.2	18.3	26.8	7.8	9.4	24.8	23.4	23.8	27.7	20.6	12.2	15.9	24.1	23.1	13.0	16.6	20.0	29.5	15.3	12.4	25.1	22.9	18.0	14.0	24.0	28.0	21.4	16.5	25.5	38.9	16.3	21.3	18.2	23.2	22.0	16.5	24.6	9.0	21.5	19.7	5.1	7.4	7.9	11.4	36.7	23.9	21.4	17.0	26.6	37.5	10.1	131.0	33.9	13.4	13.9	13.4	20.3	21.7	18.7	11.0	19.3	14.6	52.4	43.5	39.6	33.9	12.9	15.0	35.2	26.7	60.0	12.8	7.6	1.1	13.2	21.9	27.8	20.7	18.9	6.4	13.4	28.6	15.2	16.5	29.0	6.1	24.8	8.0	62.9	19.3	14.5	4.6	45.7	25.5	65.9	28.8	30.9	25.6	24.2	26.1	26.9	22.0	37.7	22.5	17.7	37.2	52.9	22.5	42.1	31.4	23.2	15.6	15.1	15.1	20.3	15.7	16.5	20.4	18.4	18.3	15.9	16.6	18.0	20.6	12.8	9.4	5.2	19.3	18.4	25.3	17.2	23.3	17.7	16.4	17.4	21.3	10.0	9.9	14.7	4.2	33.4	28.8	16.1	27.4	15.2	0.9	8.8	14.3	19.5	14.4	7.4	8.3	17.1	24.1	23.8	14.8	10.4	54.6	27.0	17.9	30.8	20.3	92.5	6.7	17.9	8.2	12.3	31.0	2.8	26.1	18.8	12.4	9.4	106.2	17.1	26.8	5.0	7.1	10.9	18.3	43.2	21.8	22.1	19.9	34.2	11.1	12.6	32.9	21.4	23.2	2.5	8.2	22.3	15.6	66.4	20.4	21.9	20.4	18.4
ATG16L2	"ATG16B, FLJ00012, WDR80"	ENSG00000168010	"Autophagy related 16 like 2"	Q8NAA4	11	72814406-72843674	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 136.8;lymphoid tissue: 129.0"	"Cell type enhanced"	"Detected in many"		"Paneth cells: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 45.4;neutrophil: 59.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 58.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045444, HPA050312"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA045444: AB_2679324, HPA050312: AB_2681082"	"unprognostic (7.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.61e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (7.06e-4)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.83e-2)"	20.2	18.1	18.1	33.0	19.2	136.8	14.9	20.2	24.1	21.6	16.2	20.4	10.8	14.6	7.5	26.1	22.1	18.9	20.8	18.0	16.0	20.1	18.5	41.2	34.3	18.9	17.7	23.4	15.1	6.3	13.7	10.2	18.0	14.4	17.0	2.9	13.6	8.2	7.7	72.9	34.0	15.0	15.3	129.0	17.7	6.5	21.1	9.7	15.9	7.4	25.2	18.9	22.2	20.9	2.7	2.5	7.5	5.9	8.7	7.2	4.6	6.1	5.9	2.9	4.4	3.1	6.4	18.3	4.0	7.7	5.3	5.2	0.9	20.1	5.0	14.2	3.0	14.5	14.4	5.1	6.4	18.8	58.2	6.9	2.7	6.6	8.0	32.2	9.0	32.7	1.9	24.1	3.4	9.1	22.5	32.0	1.1	12.0	2.9	10.6	5.5	8.6	9.7	9.2	5.5	4.4	2.6	13.2	5.8	5.9	6.6	25.5	12.6	7.9	2.9	14.4	5.0	11.0	2.9	8.1	3.5	16.4	4.5	5.9	16.3	45.4	2.7	9.3	2.7	2.6	3.9	5.4	10.9	4.6	2.2	2.6	59.6	5.2	11.8	1.7	4.0	4.0	18.1	19.2	20.2	24.1	18.0	16.0	18.9	17.7	18.0	15.3	21.1	20.9	19.5	6.4	14.4	11.4	37.6	16.7	5.1	6.1	10.2	3.6	8.7	9.0	5.0	4.3	6.2	5.5	2.1	9.6	29.0	13.0	0.0	5.0	0.8	8.9	12.0	12.7	13.1	9.9	14.0	1.0	3.7	7.1	17.9	7.9	22.9	10.6	18.9	3.8	16.2	5.0	11.1	9.1	8.2	48.5	18.1	2.1	10.2	45.7	3.6	23.4	39.2	4.4	30.9	18.1	9.7	2.7	59.1	7.9	17.3	2.5	8.3	2.5	8.1	3.5	0.0	8.8	11.4	4.9	13.4	15.7	17.3	12.3	21.3	7.2	14.0	6.0
ATP2A3	SERCA3	ENSG00000074370	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3"	Q93084	17	3923870-3964464	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 101.5;salivary gland: 185.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 82.5;Distal enterocytes: 120.7;Enteroendocrine cells: 97.8;Gastric mucus-secreting cells: 153.4;Intestinal goblet cells: 128.4;Plasma cells: 96.0;Undifferentiated cells: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 186.8;HMC-1: 266.1;JURKAT: 152.1;MOLT-4: 253.2;SK-BR-3: 195.2"	"Region enriched"	"Detected in all"	15	"cerebellum: 67.2"	"Low region specificity"	"Detected in all"			"HPA007180, CAB010882"	Approved					NA	NA		5400000	"Cluster 52: Eosinophils - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB010882: AB_258368, HPA007180: AB_1845177"	"unprognostic (4.14e-2)"	"prognostic favorable (4.69e-5)"	"unprognostic (1.21e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.02e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (8.83e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.29e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-3)"	6.8	13.7	6.8	62.2	8.7	98.3	7.7	20.0	6.1	6.0	15.3	55.0	30.7	9.1	1.6	9.7	6.1	13.7	8.0	3.0	4.5	11.4	4.6	22.4	101.5	2.3	12.8	3.1	64.0	2.1	2.5	2.8	3.9	20.3	33.0	0.2	185.3	19.6	3.3	28.2	75.3	6.3	2.0	98.2	92.8	2.1	11.6	97.5	11.7	3.3	58.7	17.0	7.2	2.3	0.3	7.6	0.3	6.8	0.0	0.0	0.3	0.4	0.9	0.2	0.6	2.5	1.7	186.8	11.0	0.6	0.1	0.8	3.1	0.0	0.0	23.5	2.1	98.0	6.0	0.1	1.7	108.0	266.1	0.2	0.0	0.7	0.0	0.1	0.3	152.1	20.1	117.1	0.1	116.8	253.2	115.5	1.2	53.1	1.6	27.5	0.2	43.3	0.0	3.3	11.5	3.4	1.5	195.2	0.2	1.1	12.2	26.3	0.5	0.0	2.1	0.4	0.1	43.4	14.2	66.0	2.5	75.6	0.1	16.0	1.4	33.7	10.8	0.9	8.3	9.8	6.7	10.3	1.6	11.4	4.8	6.0	13.1	3.8	0.5	15.8	6.4	6.7	6.8	8.7	20.0	6.1	3.0	4.5	2.3	12.8	3.9	2.0	11.6	2.3	7.1	0.0	1.9	0.7	82.5	0.9	0.4	0.7	1.2	0.0	4.7	1.7	3.8	2.8	2.7	23.9	0.0	0.2	59.2	120.7	0.0	1.3	0.1	0.3	0.4	7.8	97.8	22.5	0.5	12.1	0.3	1.9	153.4	0.3	33.0	0.2	8.9	1.0	2.8	0.0	0.6	128.4	36.7	3.1	2.5	0.2	0.0	17.8	12.4	5.6	5.0	0.2	28.8	0.0	0.3	25.2	50.3	0.7	96.0	4.2	14.0	0.4	2.7	0.2	0.0	1.0	3.4	0.0	1.5	0.4	0.3	0.0	38.4	0.4	65.6	4.6
ATP6V0A2	"a2, ATP6a2, ATP6N1D, J6B7, Stv1, TJ6, TJ6M, TJ6s, Vph1"	ENSG00000185344	"ATPase H+ transporting V0 subunit a2"	Q9Y487	12	123712353-123761755	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 13.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 51.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044279	Approved		Supported	"Vesicles,Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"	"Vesicles, Focal adhesion sites"	"HPA044279: AB_10961274"	"unprognostic (2.60e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.58e-1)"	6.6	4.4	5.6	7.0	6.2	10.4	5.7	7.4	6.5	4.7	6.9	5.5	8.7	6.0	3.9	4.3	4.8	3.8	4.7	6.0	6.0	3.8	4.2	6.3	8.3	6.6	5.8	4.1	5.7	3.7	4.9	3.7	6.5	4.7	5.8	6.7	7.6	4.0	6.5	9.4	7.0	5.1	5.6	6.6	8.8	4.9	6.2	7.5	4.8	3.5	8.2	5.3	4.5	7.9	4.8	10.3	12.0	17.8	9.2	7.0	6.7	6.2	6.2	5.4	5.8	6.9	2.7	18.0	4.2	7.6	5.5	9.0	16.1	6.2	4.5	11.4	10.2	27.9	9.2	5.4	10.2	16.8	51.0	6.7	4.4	5.9	7.4	9.0	5.0	15.0	14.5	3.4	8.1	8.4	15.4	24.8	11.5	6.6	6.5	15.7	9.9	6.4	8.3	10.4	7.2	13.6	9.3	6.9	9.4	6.6	5.9	14.4	8.3	8.0	3.1	10.8	9.1	10.8	12.8	14.9	9.4	12.1	6.5	6.3	0.7	13.7	1.7	0.9	1.0	0.9	1.7	1.5	0.8	3.7	1.6	1.8	2.0	1.7	1.5	2.8	1.0	0.8	5.6	6.2	7.4	6.5	6.0	6.0	6.6	5.8	6.5	5.6	6.2	7.9	13.0	6.4	11.0	3.9	20.4	10.1	10.8	4.6	11.4	20.5	7.9	5.3	8.8	12.8	8.3	9.2	12.5	5.2	27.9	17.9	0.0	8.1	10.2	11.0	11.9	10.6	13.2	50.3	21.2	10.9	5.7	11.3	18.3	12.3	75.3	8.7	18.2	11.4	8.4	11.8	19.3	9.8	2.0	9.4	17.2	4.5	8.7	11.3	1.8	7.5	13.2	9.0	25.7	10.6	17.1	9.2	9.0	9.4	19.7	15.7	11.1	4.0	13.5	28.8	6.6	12.4	10.9	23.6	12.6	9.6	14.2	6.8	21.8	5.7	11.4	11.4
ATP6V0D1	"ATP6D, ATP6DV, P39, VATX, Vma6, VPATPD"	ENSG00000159720	"ATPase H+ transporting V0 subunit d1"	P61421	16	67438014-67481181	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 380.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016938	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA016938: AB_1845191"	"unprognostic (1.12e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.79e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.20e-5)"	"unprognostic (5.72e-3)"	"prognostic favorable (1.76e-8)"	"unprognostic (2.72e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.33e-3)"	51.3	112.9	103.1	66.9	107.1	82.3	50.3	84.1	118.4	65.2	82.4	89.8	69.0	69.2	56.6	88.6	57.8	55.9	71.5	119.9	145.1	86.2	73.0	78.7	66.9	112.6	107.4	35.1	59.2	116.3	107.7	55.8	136.0	60.5	72.7	41.4	62.8	55.0	127.6	85.9	79.9	79.6	82.6	96.1	69.4	69.5	99.4	64.7	75.1	84.7	64.0	66.8	62.2	98.5	78.9	111.6	67.3	87.5	167.2	91.2	64.3	92.7	149.1	187.0	224.3	116.5	82.6	33.0	74.2	134.7	125.3	91.9	99.0	117.7	108.8	40.3	90.5	60.5	58.4	97.6	159.4	60.5	243.3	139.8	115.1	187.4	44.5	68.2	117.9	38.0	69.7	41.9	151.9	193.7	45.7	134.9	65.2	70.6	77.9	80.2	78.5	92.1	113.3	129.3	130.4	60.4	244.0	65.8	103.1	52.3	104.8	91.1	114.4	93.4	38.6	113.9	49.8	69.5	106.8	94.9	130.1	63.8	56.3	312.7	732.5	542.4	130.1	511.7	89.9	189.4	96.3	120.3	469.2	174.5	73.1	91.3	936.5	155.5	485.5	168.4	128.0	742.7	103.1	107.1	84.1	118.4	119.9	145.1	112.6	107.4	136.0	82.6	99.4	98.5	46.0	16.0	47.2	11.1	80.1	73.8	61.5	138.2	45.5	73.3	65.7	50.5	38.8	54.3	78.0	68.0	73.0	112.1	74.7	258.8	181.9	127.7	109.6	93.3	46.4	42.6	121.9	68.8	22.7	111.0	73.1	61.5	68.3	74.5	50.1	44.2	42.5	50.2	380.4	82.4	25.7	160.2	154.6	149.4	186.7	50.1	58.7	183.1	124.5	7.5	260.9	70.6	77.2	13.6	23.1	102.0	179.5	53.0	57.0	38.8	203.1	173.6	92.7	52.9	118.3	26.6	53.2	125.7	64.0	55.0	87.5	283.6	54.7	91.3	101.6	63.2
ATP8A2	"ATPIB, ML-1"	ENSG00000132932	"ATPase phospholipid transporting 8A2"	Q9NTI2	13	25371974-26025851	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 21.6;pituitary gland: 15.2;retina: 17.2"	"Group enriched"	"Detected in many"	6	"Excitatory neurons: 518.7;Inhibitory neurons: 727.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 19.9;JURKAT: 9.8;MOLT-4: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039926, HPA040033"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Nucleoplasm	"HPA039926: AB_10794205, HPA040033: AB_2676809"	"unprognostic (3.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.95e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.96e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.20e-5)"	"unprognostic (9.10e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.22e-2)"	0.1	2.1	5.5	0.3	6.7	0.0	0.6	8.0	21.6	0.2	0.0	0.4	0.3	0.6	1.8	0.0	0.0	0.1	0.1	8.7	19.3	0.3	0.0	0.8	0.6	12.8	4.6	0.2	0.6	0.0	15.2	0.2	12.1	0.1	0.2	17.2	0.1	0.0	0.3	0.1	0.3	0.1	0.2	0.3	0.6	2.9	6.6	1.0	0.1	0.1	0.2	0.2	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	19.9	0.1	0.0	0.0	0.0	0.6	0.5	9.8	0.0	0.0	1.7	0.1	3.9	0.0	2.0	0.0	0.7	0.0	2.7	0.9	0.2	0.0	3.2	0.0	0.2	0.2	0.1	0.2	0.0	0.4	0.2	0.0	1.0	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.2	0.1	5.5	6.7	8.0	21.6	8.7	19.3	12.8	4.6	12.1	0.2	6.6	6.8	0.7	0.0	12.2	9.4	0.8	1.0	0.2	0.3	0.0	21.5	1.5	0.3	2.5	1.5	0.4	0.0	95.9	1.5	0.4	0.0	0.0	0.3	39.0	1.2	23.6	2.6	0.0	0.8	518.7	0.0	0.4	1.7	1.1	0.9	5.1	3.7	0.0	0.0	3.2	21.9	727.7	0.0	0.0	0.0	0.7	30.3	0.9	0.3	0.0	9.4	0.0	7.2	1.0	88.4	24.7	0.0	0.0	1.2	0.1	0.2	0.0	1.3	0.3	91.6	13.1	0.3	0.8	19.8	12.5	0.0	0.4	1.1	1.8	10.1	0.1	0.1
B3GNT8	"B3GALT7, beta3Gn-T8, BGALT15"	ENSG00000177191	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8"	Q7Z7M8	19	41425359-41428730	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.5;vagina: 19.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 37.2;Distal enterocytes: 58.1;Ionocytes: 44.7;Paneth cells: 45.0;Proximal enterocytes: 68.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"basophil: 95.0;eosinophil: 117.5;neutrophil: 159.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 159.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 6.5;HUVEC TERT2: 3.5;K-562: 3.1;THP-1: 3.4;U-937: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043669	Enhanced				"Intracellular and membrane"	NA	NA		57000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA043669: AB_2678608"	"unprognostic (6.89e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (6.44e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.84e-2)"	"unprognostic (9.92e-3)"	"unprognostic (7.30e-2)"	"unprognostic (2.56e-2)"	"prognostic favorable (9.31e-6)"	"unprognostic (5.04e-2)"	"unprognostic (2.62e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.46e-1)"	2.3	1.2	0.2	1.6	0.4	3.9	2.0	1.1	0.4	11.1	0.2	10.5	15.5	2.4	0.3	44.5	1.8	0.5	6.4	0.1	0.2	3.9	0.5	9.0	0.7	0.5	0.2	0.8	1.5	0.5	1.9	0.5	0.6	3.3	2.7	0.1	6.3	2.6	0.8	5.3	15.3	0.8	0.0	8.6	2.0	0.2	0.3	0.3	1.2	0.9	1.6	2.7	19.5	0.7	0.2	0.0	0.2	0.0	0.3	1.4	0.3	0.4	0.1	0.0	0.0	2.1	0.0	0.1	0.5	1.0	0.0	1.4	0.0	0.3	0.0	0.1	0.2	0.0	0.1	1.1	0.5	0.5	6.5	1.7	1.2	0.0	0.0	0.0	3.5	0.1	3.1	0.2	0.0	0.5	0.0	2.0	0.5	0.0	0.0	0.1	0.4	0.0	0.1	0.7	0.9	0.6	0.0	0.1	0.0	0.2	0.0	3.4	1.3	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.1	5.5	0.0	95.0	16.3	117.5	2.4	12.3	28.4	0.0	1.2	5.2	6.0	0.0	0.1	0.6	159.0	1.5	26.5	0.5	0.6	7.1	0.2	0.4	1.1	0.4	0.1	0.2	0.5	0.2	0.6	0.0	0.3	0.7	0.9	6.4	37.2	0.0	0.0	1.8	5.2	16.3	2.2	0.4	1.4	2.2	0.5	0.0	10.6	23.9	0.0	0.9	0.3	58.1	3.9	5.8	0.0	0.8	0.5	1.7	15.0	1.3	0.1	0.6	2.1	3.0	0.5	1.8	5.1	0.1	2.5	0.0	11.2	0.0	0.1	23.8	44.7	8.8	0.6	0.0	1.5	5.6	0.0	0.0	3.8	0.1	1.0	0.0	0.1	2.9	45.0	0.7	0.1	7.4	68.7	0.3	3.5	0.4	0.0	0.6	2.7	0.0	0.1	20.5	1.7	2.3	1.2	0.0	18.5	13.4
BARX1		ENSG00000131668	"BARX homeobox 1"	Q9HBU1	9	93951627-93955355	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"stomach 1: 166.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.0;Early spermatids: 2.6;Fibroblasts: 2.9;Smooth muscle cells: 1.2"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 19.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AN3-CA: 29.5;HMC-1: 69.8;NTERA-2: 20.7;THP-1: 28.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055858			Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Vesicles	"HPA055858: AB_2682947"	"unprognostic (6.19e-4)"	"unprognostic (4.81e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (8.16e-6)"	"unprognostic (4.96e-3)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (1.46e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.23e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (9.68e-13)"	"unprognostic (7.02e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.16e-2)"	17.1	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	2.9	0.0	0.3	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.6	15.1	1.5	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	166.5	3.9	0.0	0.0	1.0	0.5	0.4	0.0	0.0	0.0	0.0	2.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.6	0.0	4.3	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	69.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.4	20.7	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.3	5.8	0.0	28.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	2.9	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BIN2	BRAP-1	ENSG00000110934	"Bridging integrator 2"	Q9UBW5	12	51281038-51324668	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 101.3;lymphoid tissue: 48.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 213.6;Extravillous trophoblasts: 172.1;NK-cells: 598.3;Syncytiotrophoblasts: 158.6;T-cells: 165.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 82.6;HMC-1: 134.9;Karpas-707: 59.1;NB-4: 140.8;RPMI-8226: 55.4;THP-1: 117.4;U-937: 76.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038666, HPA038667"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		19000000	"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA038666: AB_2676139, HPA038667: AB_2676140"	"unprognostic (8.44e-3)"	"prognostic favorable (1.33e-4)"	"unprognostic (2.48e-1)"	"prognostic favorable (6.34e-4)"	"unprognostic (4.63e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.65e-3)"	"unprognostic (4.03e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-1)"	7.1	3.7	3.6	32.5	3.5	101.3	3.3	3.6	4.8	3.6	4.2	8.9	6.2	2.1	1.0	3.2	3.1	9.2	2.3	3.2	3.8	3.0	7.3	16.4	41.9	5.9	4.7	1.7	1.3	1.0	1.1	19.5	5.1	2.1	9.2	0.4	3.4	2.0	1.5	1.3	10.7	6.4	4.4	48.7	7.4	7.9	6.4	48.6	2.2	4.3	36.4	10.1	2.0	6.2	0.1	0.1	0.0	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	38.3	0.1	82.6	0.0	0.0	0.0	34.7	134.9	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.1	59.1	0.0	0.5	24.2	140.8	0.1	0.1	0.0	0.0	0.0	55.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.2	117.4	0.1	0.0	0.1	0.1	0.1	31.5	0.1	8.0	0.1	76.8	0.0	663.7	199.8	245.9	281.0	311.8	227.7	49.2	188.9	237.2	107.2	74.0	145.4	193.5	380.1	235.6	411.7	39.7	267.1	479.5	3.6	3.5	3.6	4.8	3.2	3.8	5.9	4.7	5.1	4.4	6.4	6.2	1.5	3.2	17.6	1.3	54.0	0.6	0.1	0.0	0.0	0.1	1.3	1.5	0.6	1.5	2.6	1.8	0.0	103.9	213.6	4.5	17.6	0.1	26.5	0.1	0.2	3.5	1.2	16.2	0.7	0.0	172.1	2.7	3.1	0.2	56.3	0.1	8.2	1.2	56.9	0.0	0.6	8.5	0.0	73.0	22.3	25.7	0.6	111.2	1.8	44.0	77.6	0.0	598.3	2.0	0.6	0.0	4.6	0.4	51.3	0.1	0.1	1.6	3.7	0.1	0.0	1.0	0.9	39.6	11.3	0.4	0.6	158.6	165.7	0.1	5.4	0.1
BMP2K	"BIKe, DKFZp434K0614"	ENSG00000138756	"BMP2 inducible kinase"	Q9NSY1	4	78776342-78916365	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 242.9;granulocytes: 129.2;Hofbauer cells: 140.4;Microglial cells: 351.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 50.1;HEL: 73.6;HMC-1: 80.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026436, HPA026451, HPA026501"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nuclear speckles"		"HPA026436: AB_10600102, HPA026451: AB_10600228, HPA026501: AB_10601341"	"unprognostic (7.96e-2)"	"unprognostic (3.68e-1)"	"prognostic favorable (1.74e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.18e-2)"	6.0	4.2	8.5	13.5	8.2	11.9	7.4	7.3	7.2	6.5	3.8	9.5	5.6	4.4	5.4	7.4	6.0	7.4	8.0	7.2	18.6	4.9	6.7	7.7	16.5	12.1	11.2	3.1	3.5	4.3	0.6	9.2	13.5	3.3	11.9	6.5	3.5	3.5	2.2	9.9	6.9	6.6	10.9	12.2	4.7	10.2	9.8	10.9	7.7	4.5	16.3	7.1	1.4	16.5	11.4	3.2	6.0	7.5	12.0	11.1	4.8	10.8	14.4	10.3	13.7	6.4	6.4	13.2	5.6	50.1	9.9	2.9	6.7	8.5	19.4	3.5	2.3	73.6	5.0	3.5	13.2	15.9	80.6	15.9	11.0	16.4	15.6	7.3	14.4	10.0	19.8	36.5	12.1	2.4	9.5	7.4	2.9	8.8	2.1	13.5	10.3	3.7	13.3	5.2	8.4	5.2	14.2	7.8	10.4	7.9	2.7	10.0	14.7	10.6	4.2	18.4	11.9	7.7	3.2	4.8	9.9	21.4	7.7	0.1	0.5	0.3	0.0	0.2	0.0	0.6	0.0	0.0	0.4	0.6	0.1	0.0	0.9	0.1	0.8	0.3	0.0	0.1	8.5	8.2	7.3	7.2	7.2	18.6	12.1	11.2	13.5	10.9	9.8	16.5	10.7	28.9	16.2	242.9	31.5	25.0	4.3	5.4	10.2	10.9	27.4	15.2	6.5	2.8	7.7	7.3	4.2	5.0	6.1	24.6	0.0	7.5	15.9	18.6	12.7	17.6	6.7	105.4	53.2	8.8	14.2	13.7	6.6	25.0	129.2	32.1	22.1	19.7	140.4	10.1	59.0	48.2	6.1	65.9	68.2	11.1	8.1	65.4	28.4	351.3	34.6	37.0	1.0	49.3	59.1	14.6	43.0	6.8	7.6	6.3	19.9	18.0	12.3	8.4	6.6	22.3	11.7	26.1	11.2	17.1	31.4	3.4	7.6	5.4	24.0	3.2
BMPR1A	"ACVRLK3, ALK3, CD292"	ENSG00000107779	"Bone morphogenetic protein receptor type 1A"	P36894	10	86756601-86932825	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 142.7;Inhibitory neurons: 79.9;Oligodendrocyte precursor cells: 122.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB019398	Approved		Approved	Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"CAB019398: "	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.05e-3)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (8.93e-4)"	"unprognostic (3.64e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.07e-1)"	9.1	6.4	4.3	4.5	5.2	0.0	10.3	5.4	5.5	8.1	4.9	9.9	5.4	12.9	11.9	7.8	7.4	9.6	7.8	4.7	6.1	7.0	4.3	7.3	2.9	6.8	5.8	11.6	5.8	9.9	2.6	6.5	6.3	12.5	8.2	4.8	12.1	13.0	7.9	9.3	8.6	12.5	6.2	2.9	7.3	5.2	4.6	2.9	19.1	4.8	3.0	7.9	4.1	6.5	14.6	7.8	27.6	26.8	15.0	10.6	5.5	14.5	18.3	9.4	11.3	11.0	13.1	4.7	6.1	19.2	5.9	15.0	15.8	14.3	14.1	5.5	8.2	5.9	6.9	19.0	10.2	7.4	37.7	10.7	8.5	11.2	9.5	13.9	0.0	8.1	7.6	2.7	12.3	7.0	6.7	7.8	17.6	5.2	4.2	0.0	12.3	0.1	18.9	12.1	3.7	12.8	17.8	8.4	12.6	34.1	15.0	4.1	6.2	7.0	9.8	12.7	13.3	0.3	12.3	5.3	6.5	5.6	6.0	0.3	0.0	0.0	0.3	0.0	0.2	0.3	0.2	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.0	4.3	5.2	5.4	5.5	4.7	6.1	6.8	5.8	6.3	6.2	4.6	6.5	3.5	35.3	22.4	142.7	3.5	12.1	7.1	9.9	17.6	7.5	10.2	10.2	22.6	18.6	10.5	11.0	20.9	14.1	2.3	10.7	1.9	10.6	0.7	10.7	19.7	4.5	18.0	0.0	63.8	9.5	1.0	20.6	19.4	13.9	15.2	22.9	9.3	7.2	3.4	11.8	79.9	13.9	8.2	4.8	6.1	4.1	33.5	2.3	8.8	34.7	0.8	12.9	2.1	122.2	64.3	8.9	4.9	31.2	3.2	13.7	10.6	5.5	16.5	20.4	6.6	20.3	19.2	2.1	6.6	11.5	9.8	5.1	4.3	11.9	11.1	6.7
BPIFB3	"C20orf185, dJ726C3.4, LPLUNC3, RYA3"	ENSG00000186190	"BPI fold containing family B member 3"	P59826	20	33055424-33073628	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.9;Late spermatids: 1.8"	"Cancer enriched"	"Detected in single"	7	"ovarian cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"HEL: 3.7;HMC-1: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045741	Uncertain				"Secreted in other tissues"	NA	NA					"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA045741: AB_2679439"										"unprognostic (4.33e-2)"					"unprognostic (1.06e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BTK	"AGMX1, ATK, IMD1, PSCTK1, XLA"	ENSG00000010671	"Bruton tyrosine kinase"	Q06187	X	101349447-101390796	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.6;lymphoid tissue: 78.0"	"Cell type enhanced"	"Detected in some"		"B-cells: 84.7;granulocytes: 211.4;Hofbauer cells: 56.6;Kupffer cells: 63.5;Macrophages: 61.1;monocytes: 71.1;Plasma cells: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 557.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 557.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 206.7;HEL: 287.4;HMC-1: 990.3;U-937: 149.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001198, HPA002028, CAB016689"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		2300000	"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"		"CAB016689: AB_1611894, HPA001198: AB_1078305, HPA002028: AB_1078306"	"unprognostic (3.19e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.76e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.14e-2)"	6.3	2.9	2.3	30.7	2.6	32.6	4.4	2.8	3.4	3.9	3.1	6.6	4.8	2.5	1.5	3.6	1.9	7.6	1.6	2.3	3.1	1.3	5.4	19.6	55.5	4.7	3.6	0.8	1.2	0.9	0.9	7.0	4.7	1.9	9.1	0.3	2.8	2.3	0.6	2.9	14.7	7.1	3.8	38.4	7.0	1.4	3.9	9.3	1.3	2.0	78.0	9.3	1.5	6.5	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	206.7	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.3	287.4	0.0	0.0	0.0	116.7	990.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	61.9	2.3	0.0	0.0	0.6	81.5	1.6	0.0	0.0	87.2	0.1	13.2	0.0	0.0	0.2	0.0	0.3	0.1	0.5	1.0	0.0	68.5	0.4	0.0	0.3	0.2	0.1	2.6	1.4	98.3	0.5	149.8	0.3	557.5	62.2	110.5	0.2	99.9	0.2	72.4	0.2	0.1	72.7	73.0	0.4	0.1	24.7	0.2	123.9	33.1	0.1	38.4	2.3	2.6	2.8	3.4	2.3	3.1	4.7	3.6	4.7	3.8	3.9	6.5	1.5	3.2	8.9	0.3	84.7	1.0	0.2	0.0	0.6	0.0	0.9	1.4	0.6	0.0	0.6	0.0	0.0	1.4	30.1	0.1	0.0	0.0	0.2	1.3	0.3	0.8	0.0	27.1	0.5	0.0	0.5	0.9	1.1	2.3	211.4	0.0	0.7	0.3	56.6	0.0	0.3	0.3	0.0	63.5	31.0	0.1	0.3	61.1	3.6	10.3	71.1	0.0	2.1	0.0	0.1	0.1	0.5	0.0	43.8	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.5	0.7	1.7	0.5	0.3	1.9	5.7	0.2	0.1	0.1
C15orf39	"DKFZP434H132, FLJ46337"	ENSG00000167173	"Chromosome 15 open reading frame 39"	Q6ZRI6	15	75195643-75212169	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 61.9;testis: 73.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.9;Late spermatids: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 8.0;granulocytes: 23.5;monocytes: 16.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039961, HPA041907"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA039961: AB_10673024, HPA041907: AB_2677736"	"unprognostic (3.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.46e-2)"	"prognostic favorable (7.94e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.74e-1)"	"unprognostic (8.47e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.14e-1)"	14.9	15.5	4.4	12.7	4.6	61.9	13.7	2.4	8.3	13.7	4.6	10.8	11.5	14.4	1.9	20.4	16.1	7.9	14.4	3.3	5.7	8.6	4.3	15.3	10.9	6.3	5.4	18.2	14.5	15.7	8.9	15.2	4.6	8.8	5.3	1.8	14.4	6.8	4.1	15.3	10.2	7.2	5.0	25.5	9.6	73.7	7.7	8.7	11.1	3.8	6.7	15.0	14.4	4.2	20.5	41.2	8.8	10.3	11.7	7.6	26.4	5.8	11.7	6.7	7.2	51.2	27.8	45.9	19.1	8.6	24.0	27.0	37.6	17.5	1.9	45.0	42.7	91.0	19.6	35.4	13.3	26.4	90.1	10.0	13.7	14.2	6.6	8.3	17.2	17.1	39.7	66.4	2.2	12.3	25.5	32.2	27.4	13.6	16.3	23.0	6.6	49.3	4.1	15.9	25.4	8.1	13.4	30.6	21.2	8.8	10.5	33.2	14.7	11.6	17.3	20.6	17.0	47.8	32.9	26.3	11.4	50.3	11.5	8.5	6.4	18.6	1.7	11.7	1.3	1.1	1.0	1.2	3.9	0.7	0.7	1.1	23.5	3.4	16.2	8.0	1.4	4.1	4.4	4.6	2.4	8.3	3.3	5.7	6.3	5.4	4.6	5.0	7.7	4.2	13.0	25.6	5.5	0.7	7.8	14.9	7.0	5.5	19.9	0.3	8.1	5.8	2.3	7.2	9.6	3.7	0.0	12.6	17.7	13.5	0.0	15.8	50.9	17.2	10.0	10.4	7.7	5.9	0.4	14.6	16.8	7.8	8.6	30.0	17.7	14.3	10.8	2.8	12.4	0.0	1.0	6.1	6.1	23.6	10.5	68.8	11.8	24.0	7.2	1.9	31.6	0.7	12.3	1.0	0.1	18.1	26.1	10.9	19.9	5.2	3.4	1.6	8.1	2.2	13.1	6.5	10.0	37.2	5.6	15.5	14.2	20.9	7.3	3.7	8.6	17.8
C17orf107		ENSG00000205710	"Chromosome 17 open reading frame 107"	Q6ZR85	17	4899418-4902934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 16.6;pituitary gland: 27.0"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 288.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 9.0"	"Immune cell enriched"	"Detected in single"	7	"neutrophil: 2.9"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.9"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 2.6;HMC-1: 3.2;hTCEpi: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069713	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA069713: AB_2686181"	"prognostic favorable (5.06e-5)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.61e-2)"	"unprognostic (5.03e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.17e-1)"	"prognostic favorable (2.68e-4)"	"unprognostic (9.29e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.12e-1)"	2.2	1.8	1.3	1.1	0.9	2.1	2.0	9.0	3.6	2.1	0.0	0.9	1.0	1.5	3.4	1.1	1.8	1.5	16.6	1.7	3.5	2.9	5.6	2.0	0.5	1.3	0.2	4.2	5.0	3.6	27.0	0.6	0.7	3.4	0.4	1.7	13.2	1.9	0.5	3.5	1.0	0.4	0.0	2.0	3.3	4.6	1.6	0.3	1.3	0.0	0.6	1.0	1.6	1.0	0.3	0.4	0.5	0.1	1.0	0.8	0.7	1.9	0.2	0.1	0.3	0.3	0.3	0.2	0.3	2.6	0.0	0.7	0.0	0.2	0.1	0.0	0.4	0.8	0.4	0.4	1.4	0.0	3.2	0.8	3.3	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.9	0.4	0.1	0.1	1.4	0.1	0.1	0.0	0.2	0.2	1.0	0.1	0.2	0.3	0.5	0.2	0.1	0.3	0.2	0.2	0.2	0.3	0.0	0.2	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	2.9	0.0	0.0	0.0	0.0	0.1	1.3	0.9	9.0	3.6	1.7	3.5	1.3	0.2	0.7	0.0	1.6	1.0	1.7	0.0	1.3	1.6	9.7	1.8	2.8	0.4	6.8	1.2	3.5	1.7	14.4	0.0	1.1	0.0	0.0	0.4	4.5	0.1	1.9	0.4	53.3	0.8	0.4	1.5	0.0	0.0	0.7	1.3	2.3	2.3	2.0	1.2	11.4	0.9	0.4	3.1	1.0	5.0	0.8	1.5	2.0	1.9	10.7	288.4	1.5	6.3	1.8	0.0	0.1	0.0	0.0	0.0	0.2	0.7	0.0	1.2	8.1	2.3	0.2	1.9	0.6	0.8	0.0	0.5	2.0	1.5	1.2	1.2	1.3	5.2	4.0	1.1	0.2	1.1
C17orf99	"GLPG464, UNQ464"	ENSG00000187997	"Chromosome 17 open reading frame 99"	Q6UX52	17	78146353-78166177	"Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"bone marrow: 9.0"	"Cell type enriched"	"Detected in some"	29	"Erythroid cells: 52.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"HaCaT: 3.5;HMC-1: 7.1;K-562: 4.2"	"Not detected"	"Not detected"							HPA029655	Uncertain				"Secreted to blood"	NA	NA				"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA029655: AB_10601691"	"unprognostic (3.55e-5)"	"unprognostic (1.87e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.86e-1)"	"unprognostic (9.77e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.38e-4)"	"unprognostic (6.58e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.78e-3)"	0.0	0.0	0.0	0.1	0.0	9.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	1.8	0.4	0.6	1.1	0.1	0.3	0.5	0.0	0.7	1.8	0.0	0.2	0.1	0.6	0.0	0.1	0.0	0.1	0.2	0.5	0.0	52.6	0.3	0.4	0.4	0.4	0.0	0.3	0.0	0.1	0.4	0.2	0.5	0.0	0.3	0.7	0.0	0.0	0.7	0.1	0.6	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.7	0.2	0.1	0.2	0.1	0.0	1.1	0.6	0.1	0.1	0.6	0.9	0.3	0.2	0.9	0.4	0.8
C20orf203	FLJ33706	ENSG00000198547	"Chromosome 20 open reading frame 203"	Q8NBC4	20	32631625-32673941	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.1;Excitatory neurons: 4.8;Horizontal cells: 15.2;Inhibitory neurons: 5.0;Oligodendrocyte precursor cells: 2.5;Rod photoreceptor cells: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	6	"basophil: 1.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"HEL: 3.3;HMC-1: 3.3;U-2 OS: 2.0"															NA	NA			"Cluster 34: Basophils - Unknown function"		"Cluster 3: HMC-1 - Innate immune response"	"Cluster 62: Horizontal cells - Visual perception"				"unprognostic (6.24e-2)"	"unprognostic (3.39e-3)"	"unprognostic (8.39e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.70e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.25e-10)"	"unprognostic (3.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.46e-5)"	0.1	0.2	0.4	0.1	0.8	0.1	0.5	0.5	1.3	0.3	0.0	0.1	0.0	0.6	0.9	0.2	0.5	0.2	0.2	0.3	0.2	0.1	0.3	0.1	0.3	0.4	0.2	0.8	0.1	0.2		0.2	0.5	0.3	0.3	1.4	0.1	0.5	0.0	0.6	0.1	0.3	0.0	0.3	0.1	0.3	0.5	0.5	0.5	0.3	0.5	0.1		1.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.2	0.1	0.0	0.2	3.3	0.0	0.0	0.3	0.0	3.3	0.4	0.2	0.3	0.1	0.2	0.2	0.2	0.2	0.2	0.9	0.0	0.3	0.8	0.2	0.0	0.0	0.3	0.1	0.3	0.5	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	2.0	0.0	0.0	0.8	0.2	0.2	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.5	1.3	0.3	0.2	0.4	0.2	0.5	0.0	0.5	1.0	0.1	0.0	0.0	1.6	0.0	0.3	0.1	0.0	0.0	4.1	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	4.8	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.1	15.2	5.0	0.0	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.0	0.0	1.5	0.0	2.5	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0
C2CD2L	"KIAA0285, TMEM24"	ENSG00000172375	"C2CD2 like"	O14523	11	119102198-119118544	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 37.5;Distal enterocytes: 40.6;Proximal enterocytes: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HMC-1: 50.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011044, HPA075369"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA011044: AB_2668414, HPA075369: "	"unprognostic (3.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.03e-3)"	"prognostic favorable (4.92e-4)"	"unprognostic (3.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.37e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.99e-3)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (8.02e-2)"	"unprognostic (8.32e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.60e-1)"	6.6	8.2	26.9	6.5	27.6	13.6	5.8	15.5	28.9	6.4	15.3	11.1	16.1	6.2	4.8	10.8	8.8	5.3	10.2	26.8	19.6	11.6	13.1	10.3	8.1	18.0	18.4	6.0	11.0	5.7	23.9	3.9	18.4	7.1	7.3	14.1	9.6	5.3	15.3	15.3	17.1	5.1	15.2	14.9	8.1	4.3	21.4	8.5	6.7	7.3	5.7	7.0	6.6	23.7	6.1	4.5	6.0	12.5	7.7	3.2	3.9	9.0	7.8	8.7	7.2	7.3	6.3	9.1	23.1	6.3	9.1	13.4	7.6	3.9	3.4	14.3	6.2	35.7	5.9	5.3	10.2	10.5	50.5	3.7	7.9	16.4	6.1	9.8	5.4	13.5	15.1	16.1	8.3	16.2	11.9	24.9	2.2	15.0	11.8	7.4	5.3	10.5	8.7	3.8	18.7	10.5	3.8	20.1	5.9	2.3	35.3	13.9	6.7	8.1	2.8	9.9	16.1	6.8	4.5	3.5	4.9	17.6	9.1	0.5	1.3	2.7	0.2	1.4	0.4	0.1	0.6	0.6	0.5	0.0	0.6	0.3	0.4	0.8	2.0	0.3	0.6	0.5	26.9	27.6	15.5	28.9	26.8	19.6	18.0	18.4	18.4	15.2	21.4	23.7	5.1	6.4	4.2	9.4	3.7	10.7	1.6	2.3	10.2	15.6	6.8	5.0	2.4	2.8	4.3	1.8	37.5	0.9	7.4	40.6	3.9	3.4	5.4	12.1	2.6	5.7	1.2	7.0	15.1	2.8	1.7	2.5	3.6	4.6	2.5	2.2	11.4	5.4	9.4	21.9	15.0	8.0	0.0	13.9	16.1	1.3	2.1	11.4	7.2	5.6	15.3	5.9	7.2	4.5	8.4	5.1	10.4	1.5	7.2	3.2	33.0	4.0	21.9	29.9	6.6	2.1	3.6	3.7	2.0	10.3	10.9	1.1	8.6	3.6	5.5	1.9
C3AR1	"AZ3B, C3AR"	ENSG00000171860	"Complement C3a receptor 1"	Q16581	12	8056844-8066359	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.1"	"Cell type enhanced"	"Detected in some"		"granulocytes: 36.8;Hofbauer cells: 161.5;Kupffer cells: 139.7;Macrophages: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 898.6;eosinophil: 450.8;intermediate monocyte: 273.6;non-classical monocyte: 371.3"	"Group enriched"	"Detected in many"	20	"granulocytes: 898.6;monocytes: 371.3"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 148.0"	"Low region specificity"	"Detected in many"							CAB009405	Enhanced					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB009405: AB_2066739"	"unprognostic (1.11e-2)"	"unprognostic (5.67e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.10e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.22e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.09e-2)"	"unprognostic (8.16e-2)"	18.0	10.6	3.8	40.1	4.0	22.9	6.7	4.7	5.7	6.8	4.4	7.4	6.6	3.8	1.5	3.9	5.9	16.2	4.4	3.9	6.9	3.1	10.8	18.6	12.4	10.1	6.3	3.7	6.0	3.3	2.5	22.0	9.0	3.3	6.8	0.8	5.6	4.3	1.4	2.0	9.7	15.6	8.3	21.4	5.3	2.1	7.8	4.9	2.4	2.6	5.1	15.2	2.7	15.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.9	0.5	3.8	0.0	0.0	1.6	0.0	0.0	2.2	0.1	0.0	0.0	0.1	0.0	0.0	12.0	0.0	0.0	1.4	15.6	148.0	0.7	0.0	0.2	0.4	0.3	0.7	1.2	4.0	8.2	0.7	0.0	0.7	5.2	0.1	0.0	0.0	0.1	3.1	15.1	0.7	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	6.6	0.6	0.5	0.4	0.1	0.3	0.3	0.0	0.4	8.5	6.4	0.4	898.6	105.0	450.8	21.8	273.6	26.9	0.2	10.6	14.5	31.1	0.3	2.0	7.8	14.0	4.1	371.3	2.8	11.0	76.0	3.8	4.0	4.7	5.7	3.9	6.9	10.1	6.3	9.0	8.3	7.8	15.6	0.7	0.0	3.0	0.3	1.1	0.5	0.1	0.1	0.0	0.1	0.3	0.9	0.6	1.5	2.5	0.0	2.1	0.7	5.9	0.0	0.0	0.0	3.0	0.0	0.1	6.6	0.0	0.8	0.4	0.2	1.0	0.6	0.0	0.0	36.8	0.0	1.8	0.8	161.5	0.0	0.3	0.0	0.0	139.7	19.8	4.2	1.2	105.7	0.0	8.4	16.2	0.0	8.2	0.0	0.2	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.7	0.4	19.7	0.7	1.0	0.0	0.2	0.0	0.6	1.5	8.6	0.1	0.0	0.0
C3orf80		ENSG00000180044	"Chromosome 3 open reading frame 80"	F5H4A9	3	160225422-160228213	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 5.5;esophagus: 4.6;intestine: 8.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 5.6;Excitatory neurons: 23.6;Hepatic stellate cells: 6.1;Horizontal cells: 6.7;Inhibitory neurons: 6.3;Oligodendrocytes: 5.9;Spermatocytes: 7.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HMC-1: 140.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA047439	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA047439: AB_10965171"	"unprognostic (5.34e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.92e-3)"	"unprognostic (6.70e-3)"	"unprognostic (4.28e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.09e-10)"	"unprognostic (1.32e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.11e-3)"	"unprognostic (5.00e-2)"	0.9	0.1	2.8	0.6	4.2	0.6	0.4	1.2	5.5	0.4	0.0	8.0	0.7	0.4	0.1	4.6	0.2	0.5	0.4	4.9	0.0	0.3	0.6	0.8	0.0	0.0	0.1	0.1	0.2	0.3	0.6	0.0	0.0	0.6	1.3	0.1	0.4	0.2	0.0	0.1	0.5	0.7	0.0	1.2	1.1	0.9	0.0	0.0	0.2	0.1	0.1	1.0	1.4	2.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.2	0.0	0.0	0.0	0.8	0.1	0.1	0.3	0.0	0.2	2.9	1.7	12.2	3.3	0.1	0.0	2.4	140.5	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.0	2.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	7.0	0.1	1.3	0.0	0.0	0.1	0.4	29.8	0.0	0.1	0.5	0.0	3.7	0.3	0.0	0.0	1.0	21.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4.2	1.2	5.5	4.9	0.0	0.0	0.1	0.0	0.0	0.0	2.6	1.2	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.2	0.0	1.3	4.2	3.0	23.6	0.4	0.0	0.4	0.0	0.1	0.0	0.0	6.1	0.3	0.1	6.7	6.3	0.0	0.0	0.0	0.4	1.8	0.3	0.0	0.0	1.9	0.0	0.0	0.0	1.5	5.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	2.3	7.1	1.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0
C8G		ENSG00000176919	"Complement C8 gamma chain"	P07360	9	136945185-136946975	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"liver: 564.4"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 1134.7"	"Cancer enriched"	"Detected in all"	58	"liver cancer: 260.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"HMC-1: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA046269	Approved				"Secreted to blood"	NA	NA		2800000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA046269: AB_2679606"	"unprognostic (5.00e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (3.94e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.16e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.05e-2)"	0.3	1.5	0.1	0.0	0.1	0.0	0.3	0.1	0.3	0.3	0.0	1.2	31.2	0.4	0.9	0.5	0.4	2.5	1.3	0.1	0.1	2.3	564.4	0.3	0.1	0.1	0.1	0.1	0.3	0.0	0.6	0.0	0.2	0.4	0.3	0.0	0.4	0.1	3.1	0.3	17.8	0.0	0.1	2.1	1.3	2.3	0.1	0.2	0.7	0.0	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.4	0.0	0.0	41.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	1.0	0.0	0.0	0.3	2.3	0.4	0.2	0.4	0.0	0.0	0.4	0.9	0.7	28.6	0.3	0.0	2.1	0.4	1.1	25.0	0.0	0.2	0.9	0.1	0.1	0.7	1.8	8.0	0.2	0.8	1.0	0.1	0.0	0.3	8.9	1.2	17.5	1134.7	0.3	0.0	0.2	5.0	0.0	25.3	0.2	1.5	0.0	0.2	0.0	0.0	0.0	1.1	4.1	0.5	0.1	0.5	4.7	0.7	0.0	0.4	122.3	6.7	0.1	0.5	0.0	0.3	0.3	0.7	0.6	0.5	0.4	3.4	1.8	0.2	2.0	0.2
CABP4	CSNB2B	ENSG00000175544	"Calcium binding protein 4"	P57796	11	67452406-67461752	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"retina: 68.2"	"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 141.8;Rod photoreceptor cells: 254.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 12.1"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 19.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"				"unprognostic (2.24e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.32e-3)"	"unprognostic (2.57e-1)"	"unprognostic (7.10e-4)"	"unprognostic (5.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.44e-3)"	1.2	0.6	1.2	0.5	1.4	0.7	1.4	2.2	1.7	1.4	1.5	0.7	0.6	0.5	1.7	0.3	0.4	0.8	0.5	1.3	1.2	0.8	0.7	1.7	1.0	1.6	1.2	0.2	0.8	0.1	0.1	1.4	1.6	1.4	0.4	68.2	0.9	0.6	0.9	0.7	1.2	0.3	1.1	7.2	1.4	0.2	1.5	0.2	0.5	0.2	0.4	0.6	0.3	2.4	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	4.5	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.1	0.2	0.1	4.1	0.1	0.0	0.1	19.4	0.0	0.0	0.1	0.0	0.1	0.6	0.1	0.0	0.6	1.0	0.3	0.0	0.5	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	1.9	0.1	0.1	0.3	0.1	0.2	0.0	0.6	0.1	0.2	0.1	4.0	3.3	0.8	0.7	1.7	0.5	0.6	0.6	0.5	2.5	1.1	0.6	0.7	2.7	1.3	12.1	0.9	0.4	3.5	1.2	1.4	2.2	1.7	1.3	1.2	1.6	1.2	1.6	1.1	1.5	2.4	2.2	0.0	0.5	0.3	1.9	0.9	1.2	0.0	0.6	17.0	2.2	2.0	2.0	2.8	0.0	5.5	141.8	0.1	0.9	0.4	0.0	1.6	0.4	3.8	0.6	3.6	0.0	0.0	0.2	1.5	0.2	0.7	2.6	2.8	0.0	0.1	3.9	0.2	3.9	13.5	0.3	0.7	0.0	9.5	1.9	0.2	0.3	1.9	1.8	2.8	0.3	28.9	5.2	0.0	0.4	1.7	0.1	0.0	1.5	1.5	0.1	1.2	0.7	254.4	0.0	4.8	0.6	0.0	0.3	0.2	0.3	0.8	1.4	0.0	0.2	1.0
CACNA2D4		ENSG00000151062	"Calcium voltage-gated channel auxiliary subunit alpha2delta 4"	Q7Z3S7	12	1791963-1918666	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	39	"retina: 20.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 56.3;Cone photoreceptor cells: 156.4;Early spermatids: 56.3;Late spermatids: 117.6;Rod photoreceptor cells: 98.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 2.9;monocytes: 4.4;T-cells: 4.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 4.7;HL-60: 2.8;HMC-1: 14.0;NB-4: 6.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA031952	Uncertain					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 79: Retina - Phototransduction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA031952: AB_10600798"	"unprognostic (5.04e-2)"	"unprognostic (2.82e-2)"	"unprognostic (5.32e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.18e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.13e-1)"	0.3	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.0	20.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.3	0.2	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	4.7	0.2	2.8	14.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	4.4	0.0	2.1	1.7	4.2	0.0	1.0	1.5	2.9	0.0	0.5	0.3	0.1	0.4	0.5	0.1	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	1.7	0.0	1.9	0.7	2.4	0.9	0.4	0.1	1.2	56.3	0.7	1.0	0.9	2.8	0.8	0.0	156.4	0.1	5.5	2.4	0.0	0.8	56.3	0.2	1.2	1.5	1.2	0.4	0.8	0.4	0.2	1.8	1.1	0.2	15.2	0.8	1.4	1.2	23.7	0.0	0.4	2.1	0.0	29.2	5.7	117.6	0.9	23.2	3.6	0.0	17.3	6.9	18.6	0.0	1.8	0.3	3.4	0.4	0.8	0.2	12.2	1.3	1.1	98.5	0.0	0.3	2.3	9.0	4.9	0.4	0.6	0.1	8.6	0.6	3.4	0.3
CACNB4	EJM4	ENSG00000182389	"Calcium voltage-gated channel auxiliary subunit beta 4"	O00305	2	151832771-152099167	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 16.4;skin 1: 7.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 495.6;Inhibitory neurons: 470.7;Microglial cells: 136.8;Oligodendrocyte precursor cells: 155.3"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 4.1;HMC-1: 20.2;U-937: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015601	Approved					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 6: Brain - Smell perception"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA015601: AB_1845873"	"unprognostic (2.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (9.42e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (7.26e-3)"	"unprognostic (3.93e-2)"	"unprognostic (9.55e-3)"	"unprognostic (2.45e-1)"	0.7	0.7	4.6	0.4	12.0	0.7	1.5	15.2	16.4	0.4	1.3	0.3	0.4	0.4	0.6	1.4	0.3	0.9	0.3	6.2	2.3	1.4	0.1	2.0	0.3	0.2	5.6	0.3	0.4	0.4	1.8	0.9	0.3	2.0	0.5	1.8	1.7	1.9	0.1	7.3	0.3	0.5	0.3	0.4	0.6	2.3	6.8	1.1	1.4	0.2	1.0	2.0	0.5	6.8	0.0	0.0	0.7	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.9	0.0	1.9	0.0	0.1	0.3	3.2	0.0	0.2	4.1	0.0	0.2	20.2	0.2	0.1	0.4	0.0	1.7	0.0	0.8	0.0	0.5	0.1	0.0	0.2	0.3	0.5	0.1	0.6	2.0	0.2	0.6	1.1	0.5	1.3	0.7	0.0	0.0	0.0	0.1	3.3	0.8	0.0	1.8	2.0	0.6	0.4	0.3	0.0	0.0	0.4	5.9	0.1	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	3.4	0.0	0.0	0.6	0.0	0.1	4.6	12.0	15.2	16.4	6.2	2.3	0.2	5.6	0.3	0.3	6.8	6.8	1.1	12.8	53.3	80.6	0.8	12.4	16.3	3.5	30.7	9.9	6.8	7.2	1.3	0.0	3.8	3.7	4.2	0.1	0.3	0.3	3.9	0.5	0.9	3.0	3.0	1.3	0.0	0.0	495.6	1.5	0.0	7.9	1.1	5.4	0.0	84.1	0.7	0.0	3.4	20.2	470.7	0.0	0.0	1.2	7.5	2.1	3.4	2.4	1.8	136.8	1.2	2.3	1.0	155.3	31.2	1.0	0.1	4.5	2.0	29.0	0.1	0.9	1.2	3.4	0.0	0.6	1.2	0.7	4.1	3.2	8.2	0.0	1.1	6.6	0.1	16.3
CACNG8		ENSG00000142408	"Calcium voltage-gated channel auxiliary subunit gamma 8"	Q8WXS5	19	53962937-53990215	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	37	"brain: 33.9"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 61.9;Horizontal cells: 50.5;Inhibitory neurons: 66.0;Oligodendrocyte precursor cells: 29.7"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	9	"basophil: 5.5"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 5.5"	"Group enriched"	"Detected in some"	5	"AF22: 7.2;HMC-1: 23.7;hTERT-RPE1: 8.4;TIME: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041351	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA041351: AB_10796666"	"unprognostic (7.01e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.29e-4)"	"unprognostic (9.66e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.40e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.82e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	0.0	0.0	9.6	0.1	9.3	0.2	0.0	0.0	33.9	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	32.6	3.7	0.0	0.0	0.0	0.1	0.7	1.2	0.0	0.0	0.3	0.6	0.0	0.4	0.1	0.0	0.9	0.1	0.0	0.4	0.2	0.1	0.1	1.8	0.1	0.2	0.6	6.4	0.0	0.1	0.2	0.0	0.0	0.0	9.4	0.0	2.4	7.2	0.2	0.0	0.1	0.1	0.1	0.4	0.0	0.1	0.5	0.4	0.0	0.2	0.0	0.3	0.2	0.0	0.1	0.0	0.0	1.0	2.7	0.7	0.1	1.1	0.0	23.7	0.3	0.0	0.1	0.3	8.4	2.4	0.1	0.1	0.2	0.0	0.1	0.0	0.0	1.5	0.3	3.0	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.1	0.1	0.0	0.2	0.2	0.0	14.9	0.1	1.3	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.1	5.5	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	9.6	9.3	0.0	33.9	32.6	3.7	0.7	1.2	0.4	1.8	6.4	9.4	3.6	0.0	0.0	5.9	0.4	1.7	1.5	0.0	0.0	6.9	0.1	1.5	3.3	0.0	0.7	1.8	0.0	0.0	0.0	0.4	0.0	1.9	2.3	0.7	1.0	6.4	0.0	2.7	61.9	0.0	0.0	0.6	0.0	1.0	0.0	0.0	5.7	0.0	0.1	50.5	66.0	0.3	0.0	0.8	2.1	1.7	0.0	0.5	0.0	0.0	0.3	1.1	1.0	29.7	4.3	0.2	0.1	0.4	0.0	1.5	0.1	0.2	2.6	1.7	0.0	3.8	1.0	6.2	7.1	0.0	1.1	0.1	0.6	0.5	0.9	1.3
CALB2	CAL2	ENSG00000172137	"Calbindin 2"	P22676	16	71358713-71390436	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 100.5;brain: 131.9;breast: 53.5"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 97.8;granulocytes: 251.5;Granulosa cells: 44.1;Theca cells: 70.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"hypothalamus: 76.3;medulla oblongata: 89.5;midbrain: 42.2;pons: 86.7;thalamus: 131.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 21.5;HEL: 63.9;HMC-1: 133.0;U-2 OS: 38.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"thalamus: 449.0"	"CAB000106, HPA007305, HPA007306"	Enhanced	Supported	Enhanced	Cytosol		NA	NA		9600		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Cytosol		"CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.78e-5)"	"unprognostic (1.75e-3)"	"unprognostic (5.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.55e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.54e-4)"	"unprognostic (1.97e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.04e-2)"	100.5	36.6	19.9	4.1	15.4	0.0	53.5	16.5	20.0	3.5	4.1	13.8	0.7	0.7	0.5	7.7	7.7	1.1	7.7	12.8	76.3	0.3	0.2	3.6	0.1	89.5	42.2	11.4	0.7	0.0	14.3	0.0	86.7	0.9	4.7	23.6	11.1	0.4	0.5	4.9	6.2	1.7	16.0	0.1	1.0	13.0	131.9	0.1	0.2	0.2	0.9	2.0	2.7	8.4	19.1	2.0	17.0	0.0	0.6	0.1	3.3	0.6	0.3	0.5	0.1	0.1	21.5	0.0	0.3	0.2	2.7	3.7	0.0	0.0	0.2	0.1	0.1	63.9	0.0	0.6	0.1	0.0	133.0	0.0	0.0	1.3	0.2	0.3	0.0	1.6	0.0	0.5	0.1	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.1	0.1	0.2	0.1	0.6	0.0	0.1	0.0	3.1	38.0	0.3	3.8	0.0	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	15.4	16.5	20.0	12.8	76.3	89.5	42.2	86.7	16.0	131.9	8.4	0.5	9.6	7.2	0.3	0.0	0.3	0.1	0.2	0.0	12.5	10.3	2.3	0.4	1.5	0.0	0.0	6.2	0.0	0.0	0.0	0.0	1.8	2.6	0.3	10.8	0.7	0.0	0.0	0.4	97.8	0.1	29.6	0.0	0.1	251.5	44.1	0.0	0.1	0.1	30.3	17.4	0.0	0.0	0.0	0.4	2.4	6.2	1.2	5.4	1.0	0.0	2.5	0.0	0.0	0.6	16.5	0.0	0.0	0.1	0.1	0.0	0.0	1.5	10.3	0.0	0.2	1.9	1.8	5.0	0.0	0.0	0.1	3.5	70.2	0.0	0.2
CAMK1	"CaMKI, CaMKI-alpha"	ENSG00000134072	"Calcium/calmodulin dependent protein kinase I"	Q14012	3	9757347-9769992	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Differentiation, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 58.3;Hofbauer cells: 76.2;Macrophages: 71.2;Sertoli cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"eosinophil: 280.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 280.5"	"Cell line enriched"	"Detected in many"	4	"HMC-1: 403.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031904, HPA051409"	Approved		Approved	Cytosol		NA	NA		110000	"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB031904: AB_630964, HPA051409: AB_2681473"	"unprognostic (4.43e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.53e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.01e-1)"	52.4	99.7	50.1	17.2	48.9	5.1	37.2	39.9	61.0	27.0	31.8	33.6	9.2	31.8	13.7	8.0	37.0	11.1	20.5	61.2	46.3	24.9	36.4	23.9	11.1	37.8	41.7	41.2	8.4	14.4	21.6	6.7	38.8	31.1	10.6	5.9	9.8	19.7	7.1	7.9	16.5	26.0	36.8	16.7	21.7	29.8	46.9	4.3	19.5	7.8	15.0	28.4	18.3	46.1	0.5	16.4	12.6	0.0	64.7	24.3	32.6	38.4	21.1	43.1	40.4	24.1	3.0	1.1	9.0	26.0	6.2	2.7	0.0	5.0	27.0	0.4	95.4	53.5	32.1	34.1	35.9	4.5	403.3	25.3	4.1	60.6	6.7	35.4	36.8	0.9	7.2	1.2	16.3	10.3	0.3	38.8	9.0	0.4	25.7	0.3	0.4	1.1	25.9	2.8	4.2	16.7	6.6	0.7	4.0	5.3	4.1	67.2	19.6	19.8	24.4	28.0	48.7	0.4	0.3	1.0	41.5	14.7	3.0	17.8	21.3	280.5	0.3	42.2	0.1	0.1	0.4	0.2	14.1	0.2	0.3	0.1	1.0	3.6	43.0	0.4	2.0	4.7	50.1	48.9	39.9	61.0	61.2	46.3	37.8	41.7	38.8	36.8	46.9	46.1	58.3	0.0	3.1	17.9	2.8	5.0	19.2	3.4	5.7	9.9	5.2	4.6	0.1	12.8	2.1	11.0	2.1	0.4	3.0	2.6	9.8	14.4	1.8	1.8	14.9	22.8	6.0	4.8	25.6	4.0	1.2	23.3	5.6	3.1	30.5	16.7	30.4	23.5	76.2	0.0	14.5	2.3	0.0	46.4	40.2	7.2	36.1	71.2	5.4	8.4	36.7	39.4	3.1	6.6	2.7	5.5	2.9	45.1	0.2	17.5	3.6	47.4	1.3	7.7	59.2	12.2	42.7	1.5	3.7	1.5	3.8	0.8	7.1	6.6	7.6	11.0
CAPG	"AFCP, MCP"	ENSG00000042493	"Capping actin protein, gelsolin like"	P40121	2	85394753-85418432	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 548.8;Hofbauer cells: 1107.4;Macrophages: 432.1;monocytes: 432.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 1136.5;classical monocyte: 1139.3;eosinophil: 712.7;intermediate monocyte: 431.6;memory B-cell: 575.6;myeloid DC: 1363.2;naive B-cell: 516.8;NK-cell: 605.5;plasmacytoid DC: 959.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 563.6;HMC-1: 972.7;SK-MEL-30: 722.2;THP-1: 513.5;U-937: 569.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018843, HPA019080, HPA019092"	Enhanced		Enhanced	Nucleoplasm		Yes	No		5400000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA018843: AB_2669948, HPA019080: AB_1845979, HPA019092: AB_1845980"	"unprognostic (2.82e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (8.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.96e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.30e-3)"	"unprognostic (7.89e-3)"	92.4	26.3	42.8	82.4	44.2	159.3	94.9	46.3	79.6	119.1	37.5	56.9	30.3	50.0	46.2	289.5	48.7	44.4	19.2	41.7	51.1	201.1	8.9	175.7	117.9	60.2	46.3	19.7	44.9	151.7	27.2	26.1	57.2	76.5	42.9	4.2	111.8	38.0	16.5	219.9	54.2	24.5	57.5	46.2	94.4	26.0	66.1	58.0	162.3	5.8	109.5	97.1	174.8	79.4	165.5	75.9	0.7	6.9	50.2	102.8	83.7	59.6	6.1	51.2	49.8	9.4	563.6	28.1	96.6	116.0	64.0	181.1	0.2	113.7	23.0	142.0	4.4	74.3	128.0	29.3	40.6	44.8	972.7	93.8	80.5	53.8	70.3	3.6	37.5	143.8	8.2	60.1	38.1	150.1	101.3	414.8	23.2	166.5	112.8	87.3	13.3	11.8	220.6	77.7	0.8	1.4	86.9	128.4	722.2	44.2	40.0	513.5	148.7	111.6	26.8	4.6	2.4	1.4	6.2	10.3	259.5	569.5	1.5	1136.5	1139.3	712.7	12.2	431.6	39.2	575.6	107.8	41.1	1363.2	516.8	30.5	13.9	162.9	605.5	131.3	959.7	122.1	977.9	42.8	44.2	46.3	79.6	41.7	51.1	60.2	46.3	57.2	57.5	66.1	79.4	6.6	19.2	24.5	3.3	84.7	121.2	167.5	265.0	60.9	0.8	86.8	70.4	1.3	51.5	119.6	316.3	0.0	34.3	91.5	211.0	211.3	113.8	4.1	33.0	10.3	16.2	28.8	16.0	0.2	91.5	324.0	34.7	124.9	63.9	548.8	1.2	3.6	1.1	1107.4	1.7	0.2	55.9	50.8	141.6	337.2	15.2	46.9	432.1	147.7	1.0	432.4	43.6	11.3	0.5	0.1	405.8	205.4	22.6	17.2	106.0	74.1	168.5	48.8	1.7	13.1	2.0	54.0	9.6	33.1	167.4	169.5	35.7	101.9	0.9	83.9	253.1
CAPN12		ENSG00000182472	"Calpain 12"	Q6ZSI9	19	38730187-38769904	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"gallbladder: 22.8;liver: 24.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 41.4;Cholangiocytes: 41.5;NK-cells: 39.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	9	"basophil: 59.3;NK-cell: 25.5"	"Group enriched"	"Detected in many"	9	"granulocytes: 59.3;NK-cells: 25.5"	"Cell line enriched"	"Detected in some"	14	"HMC-1: 35.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 3.0"	HPA053322			Approved	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Focal adhesion sites"	Nucleoplasm	"HPA053322: AB_2682111"	"unprognostic (1.81e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-3)"	"unprognostic (7.20e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (5.90e-6)"	"unprognostic (7.04e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.59e-2)"	0.5	0.2	0.4	1.3	0.4	0.5	0.6	0.3	0.7	5.3	0.3	1.1	2.6	1.1	0.7	1.0	2.9	22.8	1.1	0.3	0.7	3.5	24.8	2.5	2.2	0.5	0.4	0.3	1.9	0.5	0.3	0.2	0.7	0.4	1.0	0.0	5.3	1.2	0.4	4.0	1.0	0.8	0.3	1.9	2.0	0.5	0.7	1.3	0.3	0.0	2.8	0.5	0.9	0.4	0.2	1.4	0.0	0.0	0.2	0.1	2.0	0.0	0.0	0.0	0.1	2.4	0.1	0.6	0.0	0.0	0.3	1.0	0.0	0.6	0.0	0.1	0.0	0.2	0.7	0.7	0.0	0.0	35.1	0.6	2.0	0.2	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.2	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.1	1.4	0.0	0.1	0.0	0.1	0.3	0.0	0.3	0.1	1.1	0.0	0.0	0.0	0.0	0.4	0.7	0.6	0.0	0.1	0.0	0.5	59.3	0.1	3.6	4.4	0.0	4.4	2.6	1.3	2.4	0.1	3.8	0.0	1.1	0.7	25.5	0.0	0.0	1.0	1.2	0.4	0.4	0.3	0.7	0.3	0.7	0.5	0.4	0.7	0.3	0.7	0.4	2.5	12.8	41.4	0.7	14.8	9.4	9.2	16.5	4.0	1.6	3.3	4.6	0.9	41.5	8.5	5.5	0.0	1.7	17.7	4.3	0.0	11.6	0.8	7.8	2.8	2.6	3.6	1.3	0.5	7.2	9.4	1.1	8.6	21.2	5.1	0.9	2.5	16.1	1.0	0.0	0.2	21.4	10.2	1.3	3.3	0.6	0.6	1.4	3.6	1.0	1.0	1.4	39.1	0.0	0.3	5.4	6.0	0.4	9.8	5.4	9.7	21.7	10.0	0.6	0.0	2.3	3.0	0.3	2.4	3.4	9.5	2.9	19.1	2.2	15.7	4.8
CAPZB		ENSG00000077549	"Capping actin protein of muscle Z-line subunit beta"	P47756	1	19338775-19485539	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1188.8;Late spermatids: 3669.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031531	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		No	No		6600000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	Vesicles	"HPA031531: AB_10603556"	"unprognostic (7.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (4.55e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.78e-1)"	210.2	193.0	126.1	196.7	126.9	154.3	189.1	128.8	133.4	233.9	129.0	294.5	149.1	254.5	145.8	265.1	199.9	144.2	207.5	139.9	129.8	161.3	127.7	217.9	223.8	133.7	128.6	205.1	94.2	128.6	121.5	178.7	132.5	200.9	214.2	123.8	152.5	177.9	301.8	195.1	220.6	241.4	126.3	215.9	192.6	216.2	135.8	237.1	155.2	214.2	271.8	230.3	222.2	143.8	263.9	146.4	260.0	179.3	355.6	467.0	187.9	435.9	430.0	364.0	377.5	189.6	338.1	179.7	186.4	533.5	218.7	212.0	224.0	297.9	424.3	280.0	160.5	340.1	170.6	298.3	355.0	236.5	533.6	424.0	243.4	314.9	292.6	300.5	338.6	204.5	132.1	229.7	393.9	185.1	270.5	307.0	200.5	343.8	155.3	223.4	184.6	225.2	507.6	133.0	158.0	123.4	255.2	200.6	299.3	229.5	222.2	199.6	351.5	237.9	207.0	409.4	208.7	156.0	188.8	217.4	314.1	306.8	261.5	456.1	358.2	1077.5	304.0	542.3	265.0	266.1	318.5	329.4	362.3	203.7	263.5	293.7	576.3	196.7	703.0	199.1	404.2	597.6	126.1	126.9	128.8	133.4	139.9	129.8	133.7	128.6	132.5	126.3	135.8	143.8	197.7	99.3	68.9	52.9	160.3	156.3	282.8	263.0	103.6	93.9	106.9	117.7	87.6	112.9	143.5	101.2	41.7	338.0	247.5	301.7	297.4	322.1	1188.8	86.7	122.2	182.4	141.2	89.4	49.8	256.5	396.4	178.9	101.9	96.8	147.5	164.6	156.0	98.7	800.9	77.4	67.5	278.7	215.7	302.6	276.7	3669.8	232.7	311.2	144.1	124.6	561.5	151.1	338.8	42.7	64.9	349.6	295.2	302.4	103.4	206.8	235.6	251.2	122.6	93.2	243.3	97.8	262.6	119.0	81.5	150.3	182.7	342.2	268.2	197.9	193.8	280.5
CARD9		ENSG00000187796	"Caspase recruitment domain family member 9"	Q9H257	9	136361903-136373681	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.0;lymphoid tissue: 9.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 14.1;Hofbauer cells: 21.2;Horizontal cells: 15.2;Kupffer cells: 18.8;Langerhans cells: 12.9;Macrophages: 22.3;monocytes: 16.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 57.6;non-classical monocyte: 50.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 22.5;HMC-1: 69.7;NB-4: 50.0;THP-1: 63.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059502	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA059502: AB_2684042"	"unprognostic (7.03e-2)"	"unprognostic (5.61e-2)"	"unprognostic (8.62e-3)"	"unprognostic (2.06e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.89e-3)"	"unprognostic (6.36e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.55e-2)"	"unprognostic (7.68e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.02e-6)"	"unprognostic (2.52e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.06e-1)"	1.2	1.3	0.5	4.7	0.5	13.0	1.2	2.5	1.0	2.0	0.3	1.0	1.3	0.8	0.4	1.0	1.8	1.0	0.5	0.5	0.7	1.0	0.9	3.4	1.2	1.9	0.9	0.3	0.5	0.1	0.8	0.9	1.3	1.8	0.4	0.2	1.1	1.0	0.2	2.7	1.8	1.1	1.4	9.9	0.6	0.4	1.1	0.4	0.4	0.0	1.5	1.2	1.1	1.7	0.1	0.0	0.3	0.0	0.0	0.0	4.6	9.5	0.3	0.2	0.0	0.7	0.0	0.0	0.1	3.5	0.0	0.0	0.3	0.0	0.1	0.0	0.2	22.5	0.1	6.8	4.9	12.2	69.7	0.0	0.1	0.2	0.2	0.0	0.1	0.0	5.3	0.0	0.0	0.2	0.0	50.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	12.3	0.0	16.0	0.1	0.0	4.1	63.7	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	16.0	0.0	6.9	34.5	11.5	0.0	57.6	0.9	0.0	0.0	0.0	26.0	0.0	0.0	0.0	2.3	0.7	50.5	0.1	0.5	14.1	0.5	0.5	2.5	1.0	0.5	0.7	1.9	0.9	1.3	1.4	1.1	1.7	0.8	0.0	4.6	4.6	1.1	1.8	0.6	0.3	3.4	0.2	4.2	4.3	2.6	0.0	4.9	3.7	0.0	0.4	2.2	0.4	1.9	0.1	1.0	1.2	14.1	1.1	0.0	2.5	2.1	0.0	0.4	2.1	1.5	1.4	10.8	0.4	0.7	0.1	21.2	15.2	1.1	0.0	0.0	18.8	12.9	6.9	0.3	22.3	1.8	6.5	16.3	4.6	3.1	0.0	0.2	0.0	0.1	0.0	1.4	0.1	0.0	0.3	0.6	0.9	0.0	0.3	1.5	1.0	1.5	0.9	1.7	0.4	1.4	0.2	0.2	0.6
CASS4	"C20orf32, HEFL, HEPL"	ENSG00000087589	"Cas scaffold protein family member 4"	Q9NQ75	20	56412112-56460387	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 12.2;lymphoid tissue: 9.6"	"Cell type enhanced"	"Detected in some"		"granulocytes: 14.0;Kupffer cells: 8.2;Langerhans cells: 7.1;Macrophages: 12.1;Microglial cells: 29.0;T-cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"eosinophil: 23.1;neutrophil: 68.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 68.9"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 7.5;HEL: 13.7;HMC-1: 38.9;K-562: 16.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB034217	Approved					NA	NA		680000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB034217: AB_2071598"	"unprognostic (9.55e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.10e-2)"	"unprognostic (5.28e-2)"	"unprognostic (6.19e-2)"	"unprognostic (7.27e-4)"	"unprognostic (5.33e-2)"	"unprognostic (3.65e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.16e-2)"	1.7	0.9	1.9	9.6	1.9	2.8	0.9	1.6	1.9	1.0	1.7	1.0	1.4	0.5	0.2	0.9	0.6	2.3	0.6	1.6	2.0	0.7	1.7	12.2	3.9	2.6	1.9	1.4	0.4	0.4	0.3	4.5	2.0	0.5	1.0	0.4	0.6	0.4	0.3	0.7	2.1	1.3	1.7	5.6	1.0	0.3	2.0	1.9	0.3	0.5	2.4	2.0	0.4	1.8	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.7	0.2	0.1	0.3	0.2	2.5	0.2	0.1	7.5	0.2	0.2	0.1	0.0	0.5	0.2	0.2	13.7	0.1	0.9	0.2	0.5	38.9	0.8	0.3	0.2	0.0	0.4	0.0	0.2	16.1	0.2	0.5	0.2	0.3	5.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.1	0.1	0.1	0.1	0.2	0.0	1.7	0.3	0.1	0.2	0.2	0.0	0.3	0.3	0.2	0.1	1.5	0.2	0.7	4.0	23.1	1.3	0.9	2.0	0.1	2.2	2.4	6.9	0.1	4.2	3.8	68.9	2.8	0.1	2.4	1.4	2.6	1.9	1.9	1.6	1.9	1.6	2.0	2.6	1.9	2.0	1.7	2.0	1.8	0.4	0.0	1.1	1.6	0.9	0.1	0.0	0.0	0.6	0.0	0.3	0.3	0.5	0.0	1.8	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.4	1.8	0.0	0.0	1.8	1.5	0.0	14.0	0.0	0.4	1.1	2.2	0.0	1.4	0.0	0.0	8.2	7.1	0.1	0.0	12.1	0.0	29.0	6.5	0.0	5.2	1.5	1.0	0.0	0.0	0.0	4.3	0.1	0.0	0.5	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.1	0.1	0.3	13.1	0.1	0.0	0.0
CATSPER1	CATSPER	ENSG00000175294	"Cation channel sperm associated 1"	Q8NEC5	11	66016752-66026479	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	34	"testis: 17.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 44.0;granulocytes: 99.6;Hofbauer cells: 19.9;monocytes: 27.3;NK-cells: 42.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 16.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.4;EFO-21: 4.0;HEL: 2.8;HMC-1: 5.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"				"unprognostic (2.21e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.44e-3)"	"unprognostic (5.99e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.12e-8)"	"unprognostic (8.79e-3)"	"unprognostic (9.02e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.51e-1)"	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.4	0.3	0.0	4.4	0.0	4.0	0.8	1.4	0.0	0.0	0.8	0.4	0.0	0.0	2.8	0.1	0.0	0.0	0.0	5.1	0.0	0.0	0.3	0.5	0.9	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.3	0.0	1.5	0.1	1.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.2	1.1	2.2	0.1	0.2	0.0	0.0	0.0	0.8	0.3	0.6	16.9	5.8	0.1	0.2	0.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.6	3.7	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.2	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.3	9.6	0.0	0.0	0.4	44.0	0.1	0.1	0.4	0.0	0.8	0.1	0.7	6.0	0.2	0.0	0.0	99.6	0.0	1.4	0.1	19.9	0.0	0.2	0.0	0.0	17.0	12.2	4.3	0.9	15.4	1.8	0.0	27.3	0.0	42.2	0.5	0.0	3.7	0.0	0.4	1.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	1.9	1.2	0.0	0.3	0.4	4.5	0.0	0.0	0.3
CATSPERG	"C19orf15, DKFZp434A1022, FLJ46353"	ENSG00000099338	"Cation channel sperm associated auxiliary subunit gamma"	Q6ZRH7	19	38335775-38370943	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 31.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.4;Gastric mucus-secreting cells: 27.0;Late spermatids: 49.2;Proximal enterocytes: 20.7;Spermatocytes: 28.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.4;HMC-1: 1.8;MCF7: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052777			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in male reproductive system"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA052777: "	"unprognostic (8.50e-5)"	"unprognostic (5.12e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.37e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.07e-3)"	0.2	0.1	0.5	0.1	0.8	0.3	0.4	0.8	0.9	0.4	0.2	0.2	0.4	0.2	0.7	0.2	0.5	0.1	0.1	0.4	0.5	0.2	0.2	0.3	0.3	0.7	2.8	0.4	0.2	0.2	0.2	0.1	0.7	0.4	0.2	0.2	0.3	0.2	0.2	1.0	0.3	0.1	0.4	0.2	0.2	31.3	0.8	0.2	0.5	0.0	0.2	0.1	0.2	1.1	0.0	0.1	0.0	0.6	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.0	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.5	0.0	1.5	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.7	0.0	0.1	0.2	0.1	0.3	0.0	0.2	0.1	0.0	0.1	0.0	0.3	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.5	0.0	0.7	0.1	0.1	0.0	0.5	0.8	0.8	0.9	0.4	0.5	0.7	2.8	0.7	0.4	0.8	1.1	4.9	0.0	2.7	2.6	3.6	2.5	2.4	1.0	4.6	1.3	4.8	8.0	3.0	1.5	0.6	1.8	0.0	1.7	5.1	10.1	0.0	1.0	29.4	4.9	4.4	2.7	1.8	3.2	4.3	0.7	0.3	3.0	27.0	8.8	1.3	2.0	2.5	0.3	3.2	1.7	3.8	3.9	2.0	1.2	3.1	49.2	1.8	3.3	0.0	1.9	3.9	1.9	10.3	3.0	17.0	0.4	5.6	2.2	2.2	1.9	20.7	0.9	1.3	1.4	0.0	5.3	3.7	28.9	3.7	4.9	1.8	1.4	3.4	1.9	3.5	1.8
CCDC30	"FLJ20972, LOC728621, PFD6L"	ENSG00000186409	"Coiled-coil domain containing 30"	Q5VVM6	1	42463221-42657190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 13.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 81.9;Endometrial ciliated cells: 62.9;Excitatory neurons: 109.2;Inhibitory neurons: 70.3;Respiratory ciliated cells: 109.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036344, HPA036345"	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA036344: AB_10795572, HPA036345: AB_10796213"	"unprognostic (3.21e-2)"	"unprognostic (8.48e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.72e-3)"	"unprognostic (6.77e-3)"	"unprognostic (7.68e-3)"	"unprognostic (4.61e-3)"	"unprognostic (1.41e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.70e-3)"	"unprognostic (6.95e-3)"	0.8	1.5	3.9	0.7	3.5	1.6	2.3	4.5	4.0	2.4	13.0	0.7	0.6	1.8	5.1	0.7	6.1	1.3	0.7	3.6	5.3	4.7	0.7	1.8	1.0	6.2	5.4	2.2	1.5	3.3	1.6	0.9	2.6	1.5	1.0	3.1	1.4	1.9	1.6	1.7	1.1	1.1	2.6	1.2	0.8	3.9	5.4	1.0	4.9	0.5	0.8	0.8	0.2	3.6	1.4	0.9	2.1	2.2	1.0	1.2	0.7	0.7	0.3	1.1	1.0	0.8	2.5	1.6	1.0	0.2	1.2	0.9	1.0	1.2	1.5	1.3	1.4	1.0	2.0	0.7	1.0	1.3	8.8	0.6	2.3	1.9	0.8	2.0	0.8	1.0	0.9	0.9	0.5	0.8	0.8	1.6	1.3	0.7	0.6	0.7	0.8	0.9	2.7	0.7	2.6	2.1	0.8	1.7	1.5	1.9	1.2	3.2	0.3	1.0	1.0	1.3	1.1	1.1	1.0	0.7	1.9	2.4	1.0	5.8	1.0	2.4	1.0	0.6	1.1	1.0	0.6	0.9	0.7	1.4	1.0	0.8	4.6	1.3	1.7	1.8	1.0	0.4	3.9	3.5	4.5	4.0	3.6	5.3	6.2	5.4	2.6	2.6	5.4	3.6	2.8	6.4	12.9	43.1	2.0	1.3	2.8	2.5	2.2	5.8	5.5	4.2	2.7	5.7	21.1	7.3	8.4	1.6	6.3	3.1	1.9	5.9	81.9	62.9	5.5	3.8	3.0	4.0	109.2	2.4	1.0	5.2	2.0	4.2	8.9	11.8	2.5	0.9	1.2	6.7	70.3	2.0	2.0	2.5	1.7	37.7	5.9	3.0	1.8	33.7	4.5	5.3	5.2	40.2	41.6	1.3	2.9	7.2	1.3	2.3	3.0	9.1	109.1	9.3	6.6	9.0	5.3	42.4	6.6	1.0	1.0	1.8	3.9	7.1	1.3	1.9
CCDC88B	"BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3"	ENSG00000168071	"Coiled-coil domain containing 88B"	A6NC98	11	64340204-64357534	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.6;lymphoid tissue: 86.1"	"Cell type enhanced"	"Detected in many"		"NK-cells: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 21.7;HMC-1: 83.3;Karpas-707: 22.0;THP-1: 34.5;U-937: 25.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA026652	Approved		Supported	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Centrosome, Cytosol"	Nucleoplasm	"HPA026652: AB_1846168"	"unprognostic (1.18e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (1.48e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.55e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (7.65e-5)"	"unprognostic (3.77e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.83e-2)"	8.5	6.7	14.9	15.1	15.1	47.6	5.3	20.1	21.6	5.6	15.3	17.8	4.0	3.5	0.3	12.9	6.5	8.5	5.5	15.3	15.0	6.5	7.3	21.1	28.6	17.2	15.5	3.1	4.1	0.9	4.5	1.7	17.5	7.8	3.6	1.4	14.4	2.5	1.2	4.5	34.1	1.2	15.4	86.1	8.9	17.4	15.4	17.4	5.4	0.8	13.8	8.3	7.7	15.9	0.3	1.3	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.0	0.0	3.4	19.7	2.9	1.1	0.5	1.6	0.1	0.6	0.0	21.7	0.0	15.0	4.6	1.1	0.8	9.4	83.3	0.0	0.0	0.2	0.0	1.3	0.5	6.3	0.5	22.0	0.7	0.9	12.7	7.7	0.7	3.7	0.5	11.9	0.3	18.5	0.3	0.3	4.8	0.0	0.0	0.5	1.1	0.1	2.6	34.5	0.0	0.0	0.7	0.1	0.2	4.7	1.5	15.8	1.0	25.3	0.4	2.9	4.6	6.7	3.5	3.6	1.0	1.6	2.0	2.9	1.6	2.0	1.8	2.2	9.2	6.5	2.5	2.7	0.6	1.3	14.9	15.1	20.1	21.6	15.3	15.0	17.2	15.5	17.5	15.4	15.4	15.9	3.3	0.0	10.7	5.2	30.3	2.7	4.5	10.5	0.6	45.2	5.7	4.8	13.5	4.3	9.9	9.2	0.0	2.9	34.9	46.0	0.0	12.8	11.1	8.7	2.6	4.4	18.0	7.0	2.6	28.9	5.8	3.1	51.0	6.8	26.6	2.2	6.1	10.4	14.5	0.0	2.0	24.4	8.2	26.0	26.6	15.8	1.5	27.3	5.4	12.2	35.0	15.4	64.9	2.0	0.6	35.0	33.2	0.7	24.9	2.9	36.1	3.2	22.7	4.7	0.0	2.8	2.8	13.7	8.7	2.0	1.6	1.4	31.7	10.0	32.4	15.7
CCL1	"I-309, P500, SCYA1, SISe, TCA3"	ENSG00000108702	"C-C motif chemokine ligand 1"	P22362	17	34360328-34363233	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 2.2;lymphoid tissue: 1.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.2;granulocytes: 8.9;Late spermatids: 1.6;T-cells: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	38	"HMC-1: 702.6"									HPA049861	Uncertain				"Secreted to blood"	NA	NA	84400		"Cluster 25: Monocytes - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA049861: AB_2680919"		"unprognostic (6.52e-2)"				"unprognostic (4.81e-3)"		"unprognostic (5.84e-2)"	"unprognostic (5.01e-1)"	"unprognostic (6.04e-1)"				"unprognostic (2.71e-1)"	"unprognostic (1.37e-1)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	702.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.4	0.8	0.5	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0
CCL2	"GDCF-2, HC11, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF"	ENSG00000108691	"C-C motif chemokine ligand 2"	P13500	17	34255218-34257203	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 756.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 1152.5;Ductal cells: 3382.2;Exocrine glandular cells: 919.2;Prostatic glandular cells: 889.0;Skeletal myocytes: 994.7;Smooth muscle cells: 1507.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 7.5;eosinophil: 3.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.0;monocytes: 7.5"	"Group enriched"	"Detected in many"	4	"BJ hTERT+: 1902.2;HMC-1: 2427.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"midbrain: 9.9;spinal cord: 39.4"	"CAB013676, HPA019163"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	323000		"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"	Vesicles	"CAB013676: , HPA019163: AB_1846179"	"unprognostic (6.43e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.78e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.37e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.33e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.92e-2)"	390.9	129.8	15.6	167.2	15.1	96.5	76.8	14.7	26.8	20.4	24.4	169.5	41.2	30.2	15.0	47.1	85.6	256.5	305.8	16.0	21.1	229.5	161.1	405.1	78.4	32.7	16.5	19.3	141.6	34.6	70.5	39.1	21.9	153.1	103.5	11.5	47.0	45.4	19.6	40.3	80.3	150.7	21.4	73.2	121.2	12.1	43.3	142.7	84.4	47.0	16.6	756.1	36.3	25.3	0.1	15.3	40.4	0.0	110.7	94.5	0.3	116.6	1902.2	243.3	516.8	7.1	0.2	0.3	90.4	27.6	3.8	64.0	4.3	0.1	122.9	0.6	0.9	0.2	13.5	0.0	3.5	0.4	2427.9	105.9	0.0	50.6	2.9	162.6	112.4	0.0	6.5	20.2	0.0	0.0	0.7	19.6	5.8	0.0	0.4	0.6	3.3	20.9	354.7	0.0	0.1	8.1	0.3	6.0	3.3	108.4	4.6	2.5	6.4	129.0	5.7	3.6	0.7	1.2	0.5	0.1	75.7	37.6	84.3	0.0	7.5	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	1.6	15.6	15.1	14.7	26.8	16.0	21.1	32.7	16.5	21.9	21.4	43.3	25.3	218.3	182.7	126.5	2.0	3.6	568.6	866.2	595.3	1152.5	0.1	23.5	50.9	29.5	92.9	120.7	138.0	0.0	2.7	2.2	0.0	0.0	3382.2	0.0	8.4	37.8	577.2	0.0	0.0	0.7	919.2	3.6	840.5	5.6	11.4	353.0	0.1	50.3	0.4	439.1	0.0	0.1	0.0	6.1	8.9	408.5	0.4	12.2	593.1	213.5	8.4	37.8	13.8	0.0	0.0	0.1	781.2	0.0	1.5	2.9	889.0	0.0	67.7	27.7	0.7	131.5	994.7	1507.0	0.4	0.3	13.0	222.8	4.5	44.3	1.7	0.1	40.6
CCNA1	CT146	ENSG00000133101	"Cyclin A1"	P78396	13	36431520-36442870	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 22.2;testis: 81.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 162.4;Endometrial ciliated cells: 119.1;Late spermatids: 91.1;Spermatocytes: 285.7"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 20.7;head and neck cancer: 6.2;ovarian cancer: 18.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	103	"basophil: 49.2"	"Lineage enriched"	"Detected in single"	301	"granulocytes: 49.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 350.9;NB-4: 71.4;THP-1: 71.5;U-937: 90.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA060646, HPA077614"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA060646: AB_2684336, HPA077614: "	"unprognostic (1.92e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.89e-3)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (1.70e-4)"		"unprognostic (1.51e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.01e-3)"	"unprognostic (1.64e-1)"	"unprognostic (4.04e-6)"	"unprognostic (7.04e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-2)"	0.4	0.9	5.9	0.4	5.9	2.1	0.7	2.3	7.8	5.8	4.1	0.6	0.4	3.7	7.0	0.4	18.0	0.7	0.3	5.5	7.3	0.5	0.1	1.4	0.3	5.3	5.4	0.5	0.1	22.2	8.2	0.0	10.7	0.5	0.1	1.0	0.6	0.1	1.2	0.3	0.3	8.2	4.9	0.6	0.4	81.3	6.1	0.4	0.6	0.4	0.6	0.6	1.1	4.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	15.2	0.1	15.5	1.2	12.9	1.4	0.1	0.0	0.7	0.0	0.4	0.0	0.6	8.0	350.9	0.3	34.1	0.7	2.8	5.5	0.9	1.7	0.0	0.5	0.2	4.4	0.4	71.4	2.5	0.0	8.8	0.0	8.3	0.0	2.3	0.0	2.5	5.8	0.0	8.4	0.2	1.8	0.0	71.5	4.5	0.0	0.0	0.1	2.9	0.8	0.0	0.0	0.3	90.3	0.6	49.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	5.9	5.9	2.3	7.8	5.5	7.3	5.3	5.4	10.7	4.9	6.1	4.0	0.1	0.0	0.6	0.3	0.3	0.6	0.6	19.1	0.0	0.4	0.5	1.4	0.4	0.0	10.3	0.0	0.0	0.1	0.0	0.1	0.0	0.2	162.4	119.1	1.8	0.4	0.0	0.0	3.5	0.0	0.8	1.1	0.0	31.9	5.1	2.2	0.0	0.0	0.2	0.0	3.0	0.0	6.1	0.0	1.8	91.1	3.1	1.1	0.0	0.0	0.0	1.4	0.0	0.5	0.4	0.0	0.0	2.6	0.0	0.7	0.0	0.1	29.3	0.8	6.6	0.5	1.5	285.7	2.4	0.0	0.4	0.3	0.9	0.0	0.1	1.1
CD101	"IGSF2, V7"	ENSG00000134256	"CD101 molecule"	Q93033	1	117001750-117036476	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.6;intestine: 6.1;lung: 6.5"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 6.7;Macrophages: 9.0;monocytes: 6.0;Oligodendrocyte precursor cells: 4.5;Sertoli cells: 6.6;Skeletal myocytes: 4.8;T-cells: 5.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 92.7"	"Group enriched"	"Detected in many"	18	"dendritic cells: 32.6;granulocytes: 92.7;monocytes: 51.5"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 27.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA049527, HPA057763"	Approved		Uncertain	Mitochondria		NA	NA		630000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Mitochondria		"HPA049527: , HPA057763: AB_2683519"	"unprognostic (1.25e-1)"	"unprognostic (7.95e-3)"	"unprognostic (5.40e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.03e-2)"	"unprognostic (3.58e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.15e-1)"	"unprognostic (4.54e-2)"	"unprognostic (7.15e-6)"	"unprognostic (7.00e-2)"	"unprognostic (8.07e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.28e-2)"	0.4	0.7	0.2	3.2	0.2	4.6	0.6	0.0	0.3	0.4	0.1	1.8	3.4	0.6	0.4	0.9	0.5	1.1	0.4	0.2	0.0	0.2	0.6	6.5	1.9	0.2	0.1	0.3	0.9	0.0	0.1	0.2	0.1	0.6	2.3	0.1	1.4	0.4	0.1	0.9	6.1	1.3	0.2	3.0	1.4	0.4	0.1	1.2	0.3	0.0	1.4	1.2	0.6	0.2	0.5	0.0	0.9	3.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	1.4	2.1	0.1	0.0	0.0	1.2	0.1	1.0	0.0	0.0	0.2	27.3	0.3	1.4	0.0	0.1	0.2	0.2	0.5	0.1	0.7	0.1	1.8	0.0	3.3	0.9	0.0	0.0	0.0	0.5	0.0	0.7	0.7	0.4	0.7	0.5	0.6	0.3	0.6	1.0	0.7	0.5	0.1	0.4	0.5	0.2	0.2	0.1	0.0	0.8	2.1	1.7	0.1	20.3	92.7	0.3	26.3	1.8	0.3	0.6	3.2	32.6	0.0	0.9	3.0	0.8	0.0	51.5	0.1	3.0	7.4	0.2	0.2	0.0	0.3	0.2	0.0	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.0	1.1	2.0	0.6	1.3	0.2	0.1	0.6	0.0	1.0	0.6	0.9	0.0	0.1	0.0	0.0	0.0	0.5	0.2	0.0	0.3	2.1	0.1	0.3	0.1	1.8	0.0	1.8	0.6	0.0	0.7	1.1	0.9	1.3	0.8	0.0	0.5	0.6	0.0	1.1	0.0	2.0	6.7	3.9	2.4	0.3	9.0	0.0	1.0	6.0	0.0	0.0	4.5	0.3	0.2	0.1	1.2	0.5	0.3	0.1	0.0	0.8	0.0	6.6	4.8	0.5	0.0	0.1	0.4	1.6	0.0	5.1	1.1	0.2	0.1
CD164	"DFNA66, MGC-24, MUC-24"	ENSG00000135535	"CD164 molecule"	Q04900	6	109366514-109382467	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Myogenesis"		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010636	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA010636: AB_1078447"	"unprognostic (1.23e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.51e-1)"	260.9	123.6	43.6	119.1	53.6	213.9	211.2	57.4	69.5	151.0	68.9	264.8	252.0	117.0	161.9	95.0	124.8	159.3	91.8	40.6	57.7	298.1	256.8	121.9	137.8	65.3	56.1	126.4	124.1	219.2	89.5	190.1	64.1	146.1	270.5	36.4	303.8	112.7	96.0	89.2	277.6	116.1	52.3	121.0	272.8	113.6	50.7	132.0	360.4	91.7	122.9	154.2	76.0	70.7	130.0	73.0	34.6	242.9	503.0	496.6	235.7	230.8	304.0	213.7	308.0	148.1	194.9	105.7	218.0	261.5	198.0	125.4	136.9	152.7	315.4	220.1	144.5	177.8	72.0	173.9	294.9	209.5	399.0	384.6	279.7	211.3	186.5	270.3	196.9	86.9	178.9	279.9	287.8	141.1	191.5	251.2	52.9	273.1	119.6	126.3	109.0	135.1	292.2	180.5	40.2	80.9	144.6	184.0	348.6	168.0	167.7	265.0	205.6	138.8	99.1	199.5	188.6	96.3	147.4	121.2	244.0	242.8	147.2	349.0	192.3	167.0	166.8	198.6	175.0	126.2	135.2	155.1	189.7	111.0	138.0	150.1	128.5	255.2	197.5	214.1	192.9	413.8	43.6	53.6	57.4	69.5	40.6	57.7	65.3	56.1	64.1	52.3	50.7	70.7	76.5	163.5	78.9	22.5	168.1	200.1	180.2	149.6	128.7	33.8	251.1	123.3	70.9	174.5	153.5	281.4	25.0	244.9	372.7	600.0	93.9	178.8	103.8	111.9	109.2	89.2	166.5	92.8	22.1	136.8	407.2	176.3	175.8	151.2	128.6	76.7	98.2	177.4	311.9	33.7	16.4	427.3	215.7	360.4	223.9	97.3	158.8	237.3	247.3	38.4	147.1	113.3	266.8	15.6	83.1	177.6	430.0	182.1	173.6	230.3	425.5	348.0	351.2	44.4	124.9	110.0	138.1	160.5	184.4	143.0	231.0	674.5	165.9	87.7	285.0	334.7
CD244	"2B4, NAIL, NKR2B4, Nmrk, SLAMF4"	ENSG00000122223	"CD244 molecule"	Q9BZW8	1	160830160-160862887	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.0;lymphoid tissue: 16.8"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 28.4;Kupffer cells: 17.7;NK-cells: 66.9;T-cells: 21.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	4	"basophil: 472.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 472.1"	"Cell line enhanced"	"Detected in some"		"HEL: 20.6;HMC-1: 69.4;NB-4: 14.4;U-937: 28.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA		280000	"Cluster 46: Basophils - DNA binding"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (6.11e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.95e-6)"	"unprognostic (5.79e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.93e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.40e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.79e-1)"	2.1	0.4	0.3	3.7	0.4	10.0	0.4	0.3	0.5	0.3	0.3	1.1	3.0	0.3	0.3	0.4	0.5	1.0	0.6	0.4	0.3	0.3	4.2	3.3	3.4	0.4	0.3	1.0	0.1	0.1	0.1	0.4	0.3	0.4	1.4	0.0	1.1	0.4	0.3	0.3	2.8	1.1	0.3	16.8	1.0	2.7	0.3	2.8	0.2	0.2	2.0	1.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.4	6.8	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	2.1	14.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	2.6	1.1	0.1	0.0	28.7	0.0	472.1	43.3	107.9	71.3	59.1	35.2	0.3	3.7	39.7	41.0	0.2	5.3	36.0	3.1	78.5	73.6	2.4	0.2	70.7	0.3	0.4	0.3	0.5	0.4	0.3	0.4	0.3	0.3	0.3	0.3	0.4	0.1	3.2	6.1	0.3	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	5.2	0.0	0.1	0.2	0.0	2.1	0.7	1.7	0.0	0.3	0.5	0.1	3.8	0.0	0.7	0.2	0.6	0.0	0.1	0.0	0.0	17.7	3.1	2.4	1.8	8.3	0.0	0.0	8.5	0.0	66.9	0.0	0.2	0.0	0.0	2.2	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.2	0.1	0.0	0.1	0.0	21.9	0.5	0.0	0.0
CD300A	"CMRF-35-H9, CMRF35H, IGSF12, IRC1, IRC2, Irp60"	ENSG00000167851	"CD300a molecule"	Q9UGN4	17	74466399-74484794	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 95.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 103.5;granulocytes: 59.5;Hofbauer cells: 114.0;Kupffer cells: 97.6;Macrophages: 90.9;NK-cells: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HMC-1: 104.4;NB-4: 45.9;RPMI-8226: 88.7"									"HPA010971, HPA011645"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010971: , HPA011645: AB_1846988"	"unprognostic (1.99e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.17e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (5.97e-2)"	"unprognostic (5.45e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	10.6	7.5	6.7	31.1	7.1	24.4	4.6	7.1	31.1	2.8	7.5	9.2	11.3	3.5	1.8	3.5	3.1	14.2	4.7	6.9	7.8	3.5	14.6	18.1	27.0	11.4	8.6	1.5	3.2	1.4	3.6	13.9	13.2	4.0	8.6	1.0	4.0	2.5	1.6	4.5	13.5	11.7	9.2	95.2	4.9	1.2	12.1	14.1	2.3	2.7	11.7	9.5	2.6	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	5.5	104.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	1.5	45.9	0.0	0.0	0.0	0.2	0.0	88.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	17.1	0.0	845.6	170.3	481.9	226.4	374.2	48.3	18.9	45.5	67.5	159.2	6.4	16.7	52.5	560.5	456.5	387.6	149.7	3.1	197.0	6.7	7.1	7.1	31.1	6.9	7.8	11.4	8.6	13.2	9.2	12.1	12.5	1.0	0.0	7.4	0.3	7.8	0.9	0.1	0.2	0.0	0.0	0.6	1.8	0.6	1.5	0.7	0.0	0.0	0.7	103.5	0.1	0.0	0.1	0.0	0.6	0.2	2.5	0.0	5.7	0.1	0.0	1.2	0.8	0.5	0.7	59.5	0.0	2.2	1.3	114.0	0.0	0.3	0.2	0.0	97.6	24.0	0.4	0.0	90.9	3.6	5.6	36.6	0.0	225.6	1.0	0.0	0.0	0.1	0.0	14.5	0.1	0.0	0.4	0.6	0.1	6.6	0.6	0.5	0.0	0.4	0.2	0.6	1.5	33.2	0.0	0.2	0.2
CD300C	"CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR"	ENSG00000167850	"CD300c molecule"	Q08708	17	74541073-74546115	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.7;lung: 8.4;lymphoid tissue: 7.3"	"Group enriched"	"Detected in some"	5	"granulocytes: 15.2;Hofbauer cells: 32.1;Kupffer cells: 26.3;Langerhans cells: 15.3;Macrophages: 36.1;monocytes: 19.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 228.3;non-classical monocyte: 242.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 7.1;HMC-1: 33.1;THP-1: 6.5;U-937: 16.2"					"Low region specificity"	"Detected in some"			"HPA014523, HPA060349"	Approved		Uncertain	"Golgi apparatus,Vesicles,Mitochondria"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus"	"Vesicles, Mitochondria"	"HPA014523: AB_1846293, HPA060349: "	"unprognostic (1.55e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.99e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.47e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.51e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.37e-3)"	"unprognostic (6.27e-2)"	"prognostic unfavorable (8.53e-5)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	4.0	1.3	0.7	6.8	1.1	9.7	0.8	0.8	5.5	0.6	1.1	1.3	1.1	0.6	0.1	0.6	0.7	2.0	0.9	0.7	1.4	0.7	1.5	8.4	2.1	1.7	1.8	0.3	0.6	0.4	0.4	2.9	2.1	0.5	1.3	0.0	0.7	0.5	0.3	0.4	1.2	3.1	1.4	7.3	0.7	0.3	2.7	1.0	1.0	0.2	1.1	3.8	0.4	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	3.3	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.6	0.0	0.0	0.2	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.5	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.9	16.2	0.0	51.8	142.1	7.0	0.7	228.3	0.4	2.7	0.3	0.3	158.8	2.4	0.2	0.2	5.2	43.9	242.7	10.5	0.2	64.6	0.7	1.1	0.8	5.5	0.7	1.4	1.7	1.8	2.1	1.4	2.7	2.2	0.1	0.0	1.3	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.7	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.0	0.2	0.3	0.1	0.0	0.0	15.2	0.0	0.0	0.2	32.1	0.0	0.0	0.0	0.0	26.3	15.3	0.1	0.0	36.1	1.8	1.0	19.6	0.0	1.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.3	1.3	0.0	0.0	0.0
CD300LD	"CD300D, CMRF35A4"	ENSG00000204345	"CD300 molecule like family member d"	Q6UXZ3	17	74579365-74592283	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 4.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.9"	"Cell line enhanced"	"Detected in single"		"HMC-1: 1.0"									HPA027756	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"		"Cluster 3: HMC-1 - Innate immune response"				"HPA027756: AB_10601097"			"unprognostic (8.03e-2)"											"unprognostic (3.30e-1)"				0.0	0.1	0.0	0.6	0.2	0.9	0.0	0.5	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.4	0.0	0.1	0.4	0.3	0.1	0.0	0.3	0.0	0.2	0.2	0.1	0.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.2	1.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.4	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.2	0.2	0.4	0.1	0.1	0.1	0.1	0.4	0.2	0.2	0.2	4.9	0.4	0.2	0.3	0.8	0.1	0.0	0.2	0.5	0.5	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CD37	TSPAN26	ENSG00000104894	"CD37 molecule"	P11049	19	49335171-49343335	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 155.2;intestine: 116.3;lymphoid tissue: 235.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 1643.9;dendritic cells: 489.6;Hofbauer cells: 345.3;Langerhans cells: 358.4;Macrophages: 319.7;monocytes: 365.0;NK-cells: 394.4;T-cells: 390.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 306.4;HMC-1: 290.0;RPMI-8226: 110.7;THP-1: 109.0;U-698: 69.4;U-937: 81.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002492, HPA032120, HPA032121"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus"	"Plasma membrane"	"CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163"	"unprognostic (4.30e-3)"	"unprognostic (2.39e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.46e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (7.71e-2)"	16.6	7.0	7.5	100.2	7.4	155.2	6.5	9.4	13.7	4.2	5.9	13.9	8.2	3.7	0.7	7.3	5.8	13.9	5.2	6.3	11.4	7.6	6.4	46.9	215.0	17.0	12.0	1.7	3.2	1.8	3.4	15.1	16.5	6.9	3.8	0.3	11.5	2.8	1.9	4.1	116.3	3.9	16.7	235.7	14.8	7.4	15.6	57.5	8.3	2.4	88.0	19.1	5.2	28.7	0.2	0.6	1.5	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	306.4	0.1	0.0	0.0	0.6	0.0	0.0	0.0	49.5	0.2	53.1	0.0	0.5	0.0	9.4	290.0	0.0	0.0	0.0	0.0	0.2	0.0	18.5	2.6	16.3	0.0	0.0	0.4	5.8	0.2	0.0	0.0	2.9	0.3	110.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	109.0	0.8	0.3	1.0	0.2	0.0	0.3	0.1	69.4	0.2	81.4	0.1	550.2	658.2	829.6	353.2	601.6	357.4	1511.6	426.3	376.2	449.7	1722.2	435.3	368.6	903.8	321.8	747.8	586.3	467.1	816.2	7.5	7.4	9.4	13.7	6.3	11.4	17.0	12.0	16.5	16.7	15.6	28.7	7.1	9.6	14.3	0.3	1643.9	11.7	1.3	0.1	4.6	12.1	4.6	12.1	1.6	2.8	2.5	1.8	6.2	1.9	489.6	2.2	0.0	0.5	94.2	1.2	1.9	9.7	1.2	67.7	0.1	0.0	2.3	6.9	11.7	1.5	264.6	0.3	11.4	4.1	345.3	0.0	0.2	1.7	0.0	272.0	358.4	221.3	2.8	319.7	28.4	21.5	365.0	1.1	394.4	0.0	0.1	0.0	8.0	0.7	119.8	1.1	0.6	2.9	0.9	6.3	0.0	3.2	5.7	1.1	1.3	2.6	11.8	2.9	390.3	0.9	1.9	1.1
CD47	"IAP, MER6, OA3"	ENSG00000196776	"CD47 molecule"	Q08722	3	108043091-108091862	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 589.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016055, HPA044659"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA		49000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	Vesicles	"CAB016055: AB_627086, HPA044659: AB_2679040"	"unprognostic (3.54e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.05e-3)"	"unprognostic (8.77e-3)"	"unprognostic (7.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (7.37e-2)"	"unprognostic (3.78e-1)"	"prognostic favorable (7.29e-5)"	"unprognostic (1.83e-1)"	51.8	64.9	39.2	116.4	47.9	232.2	89.3	64.4	63.5	57.4	30.4	89.0	74.6	53.0	92.4	93.9	100.5	86.7	59.5	47.2	41.9	44.4	71.4	154.6	137.9	53.1	40.5	46.1	41.5	27.2	34.6	80.1	48.5	122.2	99.3	285.7	105.3	55.7	57.9	59.8	79.3	55.4	50.9	100.1	104.2	59.0	49.2	79.1	91.2	22.8	161.7	110.1	52.4	76.4	303.3	49.9	108.0	62.1	130.3	122.6	147.9	106.0	139.4	70.8	126.0	2.1	159.1	129.6	180.0	90.7	216.5	201.0	52.2	98.7	91.7	81.5	35.8	311.6	45.9	3.9	73.8	227.4	467.6	85.7	58.1	71.6	53.6	118.5	73.4	132.6	85.1	323.6	108.5	148.1	268.5	77.0	46.7	298.4	133.6	154.2	69.3	187.8	185.3	115.8	69.7	37.9	63.6	111.7	124.4	56.5	227.4	85.8	76.5	210.9	40.9	120.7	79.4	124.2	100.8	208.0	131.5	119.8	65.6	185.2	119.2	232.8	178.1	244.2	155.6	191.6	209.7	192.0	181.6	188.7	149.2	169.0	145.4	232.6	339.2	133.3	334.5	296.9	39.2	47.9	64.4	63.5	47.2	41.9	53.1	40.5	48.5	50.9	49.2	76.4	72.3	368.6	157.4	98.6	192.9	165.3	311.7	504.4	101.3	102.9	119.0	93.1	51.9	110.1	205.7	93.8	95.9	169.9	218.6	36.5	15.6	589.6	81.5	157.2	17.0	76.5	63.8	112.6	219.2	412.5	85.5	119.1	36.2	120.4	57.7	250.0	83.6	34.2	186.4	122.8	129.3	70.8	148.5	79.6	200.7	52.2	34.2	121.5	117.4	39.4	100.5	51.7	219.4	107.1	150.4	344.7	92.6	48.5	143.8	439.0	53.7	16.3	162.2	229.7	65.7	47.1	85.4	111.5	19.6	97.1	140.1	121.2	160.8	80.6	94.3	321.3
CD82	"IA4, KAI1, R2, ST6, TSPAN27"	ENSG00000085117	"CD82 molecule"	P27701	11	44564427-44620358	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 280.3;Proximal enterocytes: 220.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 536.4"	"Group enriched"	"Detected in all"	6	"B-cells: 310.1;granulocytes: 536.4;T-cells: 173.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 463.8;U-87 MG: 323.3"	"Region enhanced"	"Detected in all"		"white matter: 210.9"	"Low region specificity"	"Detected in all"			"CAB002508, HPA028900, HPA061418"	Supported		Approved	Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"CAB002508: AB_563640, HPA028900: AB_10603558, HPA061418: AB_2684510"	"unprognostic (5.31e-2)"	"unprognostic (4.62e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.29e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.88e-2)"	"unprognostic (6.30e-2)"	39.2	9.1	47.7	57.3	80.5	140.9	36.6	45.2	48.8	38.8	48.5	24.7	74.1	9.1	31.9	130.9	54.0	39.6	25.6	41.9	51.7	26.1	36.9	87.3	68.5	58.5	74.3	14.9	31.3	7.8	7.5	41.0	49.8	27.5	17.2	4.2	81.1	72.1	23.1	84.2	81.6	16.6	39.6	47.3	62.8	4.5	79.0	45.0	22.4	20.0	82.6	47.6	66.1	67.2	30.0	5.2	35.1	7.2	24.0	98.4	1.2	16.9	132.9	29.4	78.5	2.0	19.6	30.9	20.8	8.1	61.1	118.8	4.6	88.4	59.6	145.4	2.7	220.9	9.3	0.6	21.3	58.8	463.8	142.1	99.2	128.3	62.1	68.4	49.7	26.9	1.6	9.4	247.3	25.0	46.7	97.7	1.1	103.2	2.4	1.5	190.0	43.9	16.8	36.1	1.2	2.0	13.0	162.6	23.0	4.2	161.2	51.3	33.9	94.4	12.5	1.8	179.0	3.6	0.4	0.9	323.3	32.5	56.0	369.9	59.3	110.7	29.9	33.0	51.4	310.1	150.7	70.3	14.9	211.9	51.1	23.1	536.4	50.1	25.0	44.5	173.1	65.9	47.7	80.5	45.2	48.8	41.9	51.7	58.5	74.3	49.8	39.6	79.0	67.2	43.6	48.1	38.8	9.4	112.8	55.1	108.1	149.0	107.6	2.4	68.1	54.7	7.7	58.6	143.8	158.2	2.1	1.3	14.9	17.4	11.7	79.7	2.0	23.1	5.0	41.0	13.2	92.9	0.3	66.7	1.1	29.1	58.6	25.2	280.3	0.7	59.6	32.5	64.3	1.7	0.6	36.8	63.1	26.6	18.2	2.0	40.4	52.3	64.0	3.7	11.0	35.7	0.0	54.3	22.4	86.7	50.3	8.2	16.0	59.1	220.6	2.5	73.0	2.7	13.1	109.0	46.0	2.1	5.9	161.3	67.2	1.4	46.3	0.6	43.1	142.8
CD84	"hCD84, mCD84, SLAMF5"	ENSG00000066294	"CD84 molecule"	Q9UIB8	1	160541095-160579516	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Autophagy, Cell adhesion, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.2"	"Cell type enhanced"	"Detected in many"		"granulocytes: 187.1;Hofbauer cells: 91.1;Kupffer cells: 177.0;Macrophages: 90.6;monocytes: 76.4;T-cells: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 23.8;HEL: 45.3;HL-60: 13.1;HMC-1: 49.7;MOLT-4: 12.9;U-698: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063316, HPA068020, HPA070502"	Enhanced		Enhanced	"Vesicles,Plasma membrane"		NA	NA		35000000	"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	Vesicles	"HPA063316: , HPA068020: , HPA070502: AB_2686274"	"unprognostic (4.38e-2)"	"unprognostic (6.16e-3)"	"unprognostic (1.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.54e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-1)"	3.3	2.4	1.9	19.4	2.1	7.9	2.7	2.3	2.4	2.8	1.9	3.2	2.4	1.4	0.9	2.2	1.1	6.2	1.4	1.7	1.9	0.8	5.2	7.8	24.2	5.2	3.1	1.5	2.0	0.9	0.4	7.1	4.5	1.1	4.5	0.2	1.4	3.4	0.4	1.3	4.6	4.0	3.8	15.2	3.6	1.9	5.2	9.9	1.1	0.7	13.2	4.7	0.8	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	45.3	0.1	0.0	0.0	13.1	49.7	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.9	0.1	0.0	0.0	12.9	9.7	0.0	0.0	0.0	0.4	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	30.8	0.0	2.9	0.0	32.7	9.6	15.0	8.2	8.0	6.5	6.3	7.0	10.1	7.1	6.0	4.0	7.4	1.2	1.4	3.2	4.1	10.5	8.8	1.9	2.1	2.3	2.4	1.7	1.9	5.2	3.1	4.5	3.8	5.2	7.2	1.3	0.0	6.4	0.0	27.4	2.4	0.7	0.0	0.6	0.2	0.6	1.5	1.2	2.8	1.3	0.0	0.0	0.5	20.5	0.2	0.0	0.1	0.9	0.5	0.2	4.2	0.0	21.5	0.1	0.2	0.5	1.2	2.6	0.2	187.1	0.1	3.3	1.1	91.1	0.0	0.2	0.1	0.0	177.0	42.2	1.5	0.6	90.6	5.4	34.7	76.4	0.0	4.1	0.0	0.1	0.0	0.0	0.0	10.8	0.9	0.3	0.3	0.7	0.2	0.0	1.6	1.5	0.1	0.4	0.5	2.4	1.0	46.8	2.9	0.2	0.6
CDC40	"EHB3, FLJ10564, PRP17, PRPF17"	ENSG00000168438	"Cell division cycle 40"	O60508	6	110180141-110254275	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 257.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046620			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA046620: AB_2679722"	"unprognostic (4.19e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.68e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.09e-1)"	11.1	14.7	6.9	13.3	10.3	38.2	13.6	6.5	10.9	11.3	7.3	11.1	11.1	11.7	10.4	10.7	11.0	10.4	10.5	10.2	6.1	16.3	16.9	11.0	19.6	4.7	5.0	16.1	12.4	14.0	9.4	9.9	5.0	12.5	12.1	14.8	11.0	9.4	11.6	10.6	11.0	10.1	5.2	16.0	11.4	11.8	5.2	18.6	15.9	11.6	18.6	12.6	8.5	9.2	11.3	10.4	18.2	31.8	18.3	18.8	14.8	21.5	26.4	21.3	26.9	22.8	11.3	37.8	23.7	19.2	22.7	15.8	28.2	17.5	30.1	30.5	21.3	31.0	14.4	12.4	24.2	40.2	39.8	17.1	16.4	22.5	18.1	15.9	21.6	24.3	31.5	22.0	21.3	11.0	29.9	14.9	18.1	15.1	11.2	26.0	21.4	13.1	15.5	23.6	19.4	19.1	15.8	13.8	15.9	16.6	12.8	38.1	24.5	11.5	11.4	27.3	24.1	11.0	15.9	33.8	18.6	33.2	17.4	28.6	18.7	20.4	13.8	20.3	13.7	29.5	13.7	14.3	15.9	28.3	16.2	14.1	20.8	16.5	23.4	24.9	16.8	10.2	6.9	10.3	6.5	10.9	10.2	6.1	4.7	5.0	5.0	5.2	5.2	9.2	38.9	32.1	37.6	18.3	85.7	26.4	26.2	43.1	36.5	94.4	32.2	32.8	21.5	30.0	37.5	27.6	43.8	32.9	79.2	20.9	56.7	35.8	257.8	34.6	48.4	35.5	26.4	44.2	65.4	37.3	30.9	35.8	35.2	30.4	49.4	43.0	38.9	56.6	37.8	94.2	25.6	29.8	22.4	44.9	28.6	84.6	67.4	49.6	10.6	24.4	76.0	46.1	57.7	27.2	43.6	28.5	28.9	45.1	27.8	23.4	29.1	74.0	31.0	84.0	78.9	38.2	39.3	20.9	22.5	37.6	27.1	28.7	59.0	70.6	35.5	22.4
CDK11A	"CDC2L2, CDC2L3, CDK11-p110, CDK11-p46, CDK11-p58, p58GTA, PITSLRE"	ENSG00000008128	"Cyclin dependent kinase 11A"	Q9UQ88	1	1702379-1724357	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 85.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB010467, HPA025061, HPA073626"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear speckles"	Cytosol	"CAB010467: AB_631212, HPA025061: AB_1846407, HPA073626: AB_2686619"	"unprognostic (6.25e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.32e-3)"	"unprognostic (3.54e-2)"	"unprognostic (2.25e-3)"	"unprognostic (7.97e-2)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.58e-3)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (1.15e-6)"	"unprognostic (1.97e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	17.7	17.0	14.9	24.8	15.3	41.7	17.7	18.7	16.2	22.2	14.9	25.0	29.3	19.4	8.8	15.7	20.6	9.4	13.5	14.3	15.8	15.5	18.6	27.4	23.3	15.9	14.6	20.3	17.2	9.3	18.5	12.5	15.4	20.3	14.7	13.1	16.8	7.8	26.0	19.8	36.7	8.8	12.9	36.7	20.3	21.6	15.1	17.0	20.0	7.6	13.8	17.8	19.1	16.4	26.6	16.3	18.7	16.9	20.5	14.5	13.4	25.4	14.3	18.7	20.1	21.9	30.1	31.8	15.2	10.0	19.8	27.1	14.3	15.0	14.3	25.4	19.4	28.8	42.6	20.4	13.3	29.6	45.9	17.1	10.7	13.5	12.2	20.3	22.2	21.4	35.7	27.4	11.1	15.5	19.0	33.4	18.1	18.4	16.0	27.7	19.0	18.9	12.3	13.0	17.7	22.6	25.0	36.3	37.9	7.6	20.4	19.4	22.7	24.3	18.5	10.9	17.2	38.0	31.1	35.3	9.8	33.1	7.2	64.1	16.7	22.0	14.5	9.0	12.1	19.3	12.4	10.7	5.6	19.5	12.0	9.9	85.3	12.0	11.6	33.3	10.9	3.5	14.9	15.3	18.7	16.2	14.3	15.8	15.9	14.6	15.4	12.9	15.1	16.4	27.7	51.3	59.0	5.9	33.9	14.0	16.0	12.5	22.2	33.0	11.3	10.4	1.0	14.3	38.3	14.7	27.1	16.2	54.1	28.8	9.8	19.7	37.6	18.0	24.2	26.4	9.1	29.0	5.3	15.3	22.6	16.6	52.5	21.8	84.6	18.9	18.5	15.6	12.2	40.4	5.0	29.1	12.2	12.2	26.9	16.3	35.4	28.5	10.6	2.8	25.6	16.1	44.3	4.5	8.7	25.9	51.0	21.4	42.7	16.3	62.0	11.7	34.5	42.4	13.1	21.3	19.1	124.0	93.7	15.3	14.6	30.5	48.1	16.5	23.0	14.3
CDK15	"ALS2CR7, PFTAIRE2, PFTK2"	ENSG00000138395	"Cyclin dependent kinase 15"	Q96Q40	2	201790461-201895550	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 15.2;ovary: 6.1"	"Group enriched"	"Detected in some"	13	"Early spermatids: 27.1;granulocytes: 79.1;Late spermatids: 40.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 2.4"	"Group enriched"	"Detected in some"	28	"basophil: 1.8;eosinophil: 3.7"	"Lineage enriched"	"Detected in single"	37	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 22.6;BJ hTERT+ SV40 Large T+ RasG12V: 20.7;HBF TERT88: 30.9;HMC-1: 58.4;LHCN-M2: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015786	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Golgi apparatus"	"HPA015786: AB_1844780"	"unprognostic (2.51e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.38e-2)"	"unprognostic (9.99e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.05e-2)"	0.7	0.3	0.0	0.2	0.0	0.0	0.8	2.4	0.4	0.8	0.0	0.5	0.3	0.6	15.2	0.6	0.5	1.9	0.2	0.5	0.0	0.3	0.0	1.0	0.1	0.4	0.1	6.1	0.1	0.2	0.3	0.0	0.4	0.7	0.7	0.0	0.3	0.3	0.9	0.6	0.8	0.4	0.1	0.0	0.7	1.9	0.1	0.2	0.1	0.7	0.1	0.8	0.5	0.3	0.3	0.0	0.0	0.0	1.6	2.8	0.0	5.9	22.6	10.2	20.7	0.0	3.0	0.0	0.0	2.3	0.5	0.0	0.0	0.0	30.9	0.0	0.1	1.9	0.0	0.0	0.3	0.1	58.4	3.4	0.0	2.7	1.5	0.4	0.0	0.0	0.0	0.1	19.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.5	2.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.5	0.0	0.4	0.1	0.4	0.1	0.1	0.3	0.1	0.0	1.3	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.8	0.0	0.0	79.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	40.3	0.3	0.1	3.6	1.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.5	0.2	0.0	0.1	0.0	0.9	0.1	0.0	0.0
CEACAM21	"FLJ13540, R29124_1"	ENSG00000007129	"CEA cell adhesion molecule 21"	Q3KPI0	19	41549518-41586844	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.5;lymphoid tissue: 10.2"	"Cell type enriched"	"Detected in some"	10	"Granulosa cells: 150.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HMC-1: 8.6;Karpas-707: 6.1;THP-1: 3.3;U-266/70: 5.8;U-937: 5.8"									HPA043411	Uncertain					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA043411: AB_10794886"	"unprognostic (2.55e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.73e-2)"	"prognostic favorable (1.89e-5)"	"unprognostic (2.57e-1)"	"unprognostic (8.02e-4)"	"unprognostic (3.04e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.37e-6)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.37e-1)"	1.3	0.7	1.4	2.2	0.8	17.5	0.8	0.8	1.3	2.2	0.6	0.8	0.6	2.6	0.3	0.4	0.7	0.5	0.5	0.8	2.8	0.7	1.2	3.8	5.3	1.9	2.7	0.4	0.2	0.1	0.4	1.5	2.2	0.6	0.6	0.0	0.5	3.6	0.1	0.2	2.6	0.5	1.8	10.2	0.9	1.1	3.9	2.2	0.6	0.1	3.5	0.8	0.3	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	6.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	5.8	1.0	1.0	0.0	5.8	0.0	0.1	6.0	27.3	29.7	11.7	20.1	10.8	25.6	20.8	6.9	15.1	21.3	21.0	30.2	19.2	7.0	12.4	26.6	17.9	1.4	0.8	0.8	1.3	0.8	2.8	1.9	2.7	2.2	1.8	3.9	1.2	1.5	0.0	0.0	0.3	5.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.6	1.8	0.0	0.1	7.2	0.0	0.0	0.0	5.4	7.3	0.1	2.0	0.0	5.7	0.1	0.0	0.1	0.3	0.0	2.2	4.5	150.8	10.0	0.3	9.4	0.0	0.7	0.0	0.0	9.0	0.6	10.3	0.0	6.2	1.8	15.0	1.0	0.0	9.2	0.0	0.1	0.0	0.0	0.4	10.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.6	0.6	0.0	0.0	0.3	8.8	0.0	0.0	0.0
CEL	"BSSL, MODY8"	ENSG00000170835	"Carboxyl ester lipase"	P19835	9	133061981-133071861	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	548	"pancreas: 110578.0"	"Group enriched"	"Detected in many"	10	"Breast glandular cells: 390.7;Exocrine glandular cells: 943.6"	"Cancer enriched"	"Detected in many"	29	"pancreatic cancer: 469.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008023, HPA052701"	Enhanced				"Secreted to digestive system"	NA	NA		110000		"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA008023: AB_1846509, HPA052701: AB_2681921"	"prognostic unfavorable (4.14e-4)"	"unprognostic (2.30e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.98e-1)"	"unprognostic (4.41e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.02e-1)"	10.0	3.0	3.1	2.2	3.2	0.9	10.4	4.8	4.5	6.4	13.5	2.9	21.6	3.2	200.8	7.1	11.1	0.4	22.0	4.1	2.7	7.5	6.4	2.1	4.1	2.9	2.8	57.2	110578.0	0.3	201.7	7.1	3.0	5.1	1.3	1.1	19.9	3.3	2.2	5.5	9.2	0.5	2.5	3.4	18.5	2.5	3.0	1.9	2.5	0.4	0.6	3.4	3.4	3.0	0.3	0.8	3.1	1.9	1.0	0.7	3.1	0.6	0.3	0.4	0.6	0.9	0.6	0.9	1.5	0.6	0.5	2.2	0.7	5.9	0.2	1.9	1.2	1.6	0.5	2.1	0.4	0.7	5.9	1.5	3.8	0.5	0.3	1.3	0.6	7.5	1.0	0.8	0.5	1.3	0.9	3.2	5.2	0.7	1.0	1.8	0.9	0.7	0.4	2.7	5.3	1.3	0.7	0.7	0.3	4.5	1.0	2.9	0.4	1.5	2.0	1.7	0.4	0.4	3.4	0.7	0.0	1.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.2	4.8	4.5	4.1	2.7	2.9	2.8	3.0	2.5	3.0	3.0	1.5	0.0	0.0	1.0	0.7	0.0	1.7	0.8	1.2	1.0	390.7	4.4	2.1	1.5	0.5	0.0	0.0	0.1	1.8	2.5	3.9	1.7	0.5	62.4	0.8	0.9	0.0	0.0	2.0	943.6	0.1	0.4	0.0	1.3	0.0	4.7	0.0	0.1	0.0	0.0	1.4	0.8	26.4	0.0	0.3	3.6	0.3	1.0	0.0	0.0	6.7	0.9	0.0	1.0	0.7	27.7	0.1	0.0	0.0	0.4	10.6	0.1	2.3	0.8	0.0	0.2	1.4	0.2	0.1	2.0	0.3	0.4	0.5	6.0	5.1	3.0
CELA2A	ELA2A	ENSG00000142615	"Chymotrypsin like elastase 2A"	P08217	1	15456728-15472091	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2325	"pancreas: 162732.5"	"Cell type enriched"	"Detected in some"	34	"Exocrine glandular cells: 7828.2"	"Cancer enriched"	"Detected in single"	3818	"pancreatic cancer: 463.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.2"														"Secreted to digestive system"	NA	NA		2700000		"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 1: Pancreatic cells - Digestion"				"unprognostic (9.78e-2)"	"unprognostic (3.33e-2)"		"unprognostic (5.60e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.63e-3)"		"unprognostic (2.35e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.94e-9)"	"unprognostic (4.10e-2)"		"unprognostic (3.42e-1)"	"unprognostic (3.55e-2)"	7.9	5.5	0.0	2.6	0.0	1.1	4.4	0.2	0.1	3.9	0.0	2.0	18.5	2.1	0.0	2.3	1.1	0.0	26.9	0.0	0.0	1.6	5.8	1.2	4.3	0.0	0.0	70.0	162732.5	0.0	1.3	10.2	0.0	2.7	0.0	0.0	28.0	0.0	1.6	2.2	8.7	0.0	0.0	2.2	15.4	2.0	0.0	0.0	1.1	0.0	0.0	0.9	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.8	0.1	0.3	0.3	0.3	0.0	0.0	1.1	7828.2	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	20.7	0.0	0.0	0.0	0.1	227.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.1
CELF2	"BRUNOL3, CUGBP2, Etr-3, NAPOR-2"	ENSG00000048740	"CUGBP Elav-like family member 2"	O95319	10	10798397-11336675	"Predicted intracellular proteins"	"mRNA processing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 558.0;Excitatory neurons: 1676.4;Inhibitory neurons: 576.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 200.2;HMC-1: 186.2;REH: 86.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016395, HPA035813"	Enhanced		Supported	"Nucleoplasm,Vesicles,Midbody ring"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Vesicles, Midbody ring"	"CAB016395: AB_2086271, HPA035813: AB_2674797"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.55e-2)"	"unprognostic (9.00e-2)"	"prognostic favorable (7.61e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.77e-2)"	"unprognostic (4.20e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.45e-1)"	39.6	5.7	33.7	30.7	42.7	78.9	17.7	0.2	42.0	14.2	0.0	16.5	9.2	15.0	5.0	21.4	13.3	17.2	37.5	42.5	7.2	3.0	4.3	28.2	42.4	0.9	13.9	46.8	4.4	3.5	6.5	8.6	0.4	14.1	17.9	35.4	9.6	12.2	17.6	8.6	23.4	23.2	8.6	31.1	10.3	7.6	23.7	60.7	8.5	15.0	29.4	16.2	8.0	21.0	0.1	0.0	47.6	0.0	7.4	2.7	5.3	7.0	0.2	1.1	0.2	0.1	0.0	0.1	5.3	6.1	0.0	0.1	6.8	0.2	0.4	40.4	11.9	200.2	0.7	0.0	1.7	58.0	186.2	3.0	0.3	0.4	0.0	0.7	6.7	70.6	9.3	80.7	59.6	0.0	71.9	42.0	19.3	0.0	0.0	86.7	50.8	18.0	3.4	0.0	7.1	0.5	0.1	0.2	51.1	15.2	0.0	39.0	0.1	8.9	2.5	29.9	0.1	30.7	30.1	9.3	2.9	68.8	21.6	68.0	43.2	90.8	54.8	57.5	69.2	48.1	54.1	60.5	53.4	51.0	56.1	52.7	115.1	73.5	67.8	37.9	60.9	63.5	33.7	42.7	0.2	42.0	42.5	7.2	0.9	13.9	0.4	8.6	23.7	21.0	20.4	160.3	147.3	558.0	165.6	19.9	3.4	5.8	12.5	68.2	18.8	13.7	122.7	5.7	22.4	12.9	102.2	1.1	233.5	11.8	15.6	1.6	135.9	5.3	11.3	34.7	59.3	45.2	1676.4	2.1	0.9	106.0	11.2	17.0	128.5	0.7	13.2	5.1	90.0	134.6	576.9	37.5	24.4	261.4	134.3	110.3	111.6	192.9	115.6	376.6	263.6	90.5	256.4	324.7	21.6	1.5	16.9	89.5	124.3	10.1	2.4	1.0	5.8	99.2	52.6	117.6	33.7	4.1	11.5	5.7	14.5	1.9	232.5	8.5	23.8	2.4
CGB1		ENSG00000267631	"Chorionic gonadotropin subunit beta 1"	A6NKQ9	19	49035569-49036895	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"pancreas: 2.7;pituitary gland: 4.3"	"Cell type enriched"	"Detected in single"	77	"Syncytiotrophoblasts: 69.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 17.7"									"HPA038925, HPA038934"	Uncertain		Approved	Cytosol	"Secreted to blood"	NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	3.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	69.9	0.0	0.0	0.0	0.0
CGB2		ENSG00000104818	"Chorionic gonadotropin subunit beta 2"	Q6NT52	19	49031890-49033238	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.6"	"Cell type enriched"	"Detected in some"	6	"Syncytiotrophoblasts: 40.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HMC-1: 29.9;U-266/70: 12.1;U-266/84: 15.6"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"										"unprognostic (3.05e-2)"								0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.8	0.7	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	4.1	0.0	0.5	0.0	0.1	0.3	0.0	29.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.3	0.8	0.0	3.9	12.1	15.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.2	0.2	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	1.5	1.8	0.0	0.0	40.0	0.0	0.0	0.0	0.0
CHN2	"ARHGAP3, RhoGAP3"	ENSG00000106069	"Chimerin 2"	P52757	7	29146569-29514328	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 101.0;intestine: 70.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 307.9;Early spermatids: 130.6;Excitatory neurons: 139.5;Late spermatids: 118.1;Microglial cells: 145.2;Oligodendrocytes: 496.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 37.4;HMC-1: 68.3"									"HPA018989, HPA019026"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies"	"HPA018989: AB_1846681, HPA019026: "	"unprognostic (3.88e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.71e-2)"	"unprognostic (7.54e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.58e-3)"	4.6	6.3	19.0	5.3	33.0	2.2	3.4	101.0	37.5	10.2	12.4	8.5	70.1	4.1	2.3	2.6	8.0	7.0	11.7	22.2	27.1	13.1	37.9	5.6	3.1	30.4	26.5	20.2	25.1	0.5	3.4	10.8	33.2	8.0	9.8	51.5	2.7	4.1	4.7	1.9	57.9	4.3	24.2	8.2	6.6	2.5	25.4	3.8	7.8	1.4	2.5	6.3	3.2	59.6	0.3	0.8	3.0	0.0	0.0	0.0	19.0	0.0	0.0	0.7	0.0	10.4	2.9	0.9	6.0	0.2	1.2	5.2	10.1	0.1	0.0	18.1	3.8	37.4	1.7	18.4	0.2	0.0	68.3	0.0	6.4	0.0	0.7	0.0	3.5	5.9	1.5	0.5	0.0	0.4	11.2	0.4	1.2	6.8	3.4	0.8	0.0	2.0	18.2	12.0	18.3	1.4	3.9	5.8	10.2	10.7	0.7	2.0	0.4	1.0	0.3	0.1	0.4	3.6	15.2	0.0	0.3	2.2	1.2	4.4	11.6	0.1	2.8	12.7	1.9	0.3	0.4	2.1	10.1	0.1	0.4	1.1	0.5	9.6	7.3	1.1	0.0	3.6	19.0	33.0	101.0	37.5	22.2	27.1	30.4	26.5	33.2	24.2	25.4	59.6	3.3	6.4	3.6	5.5	2.0	2.7	0.8	0.2	0.6	307.9	0.3	0.3	14.1	5.7	2.0	3.7	43.8	24.6	6.1	15.3	0.0	0.5	130.6	8.8	0.3	8.5	39.4	9.5	139.5	2.1	33.5	3.8	12.2	2.7	23.5	2.2	3.9	84.4	18.5	6.7	28.8	24.0	2.0	29.0	33.1	118.1	5.0	20.5	17.8	145.2	29.3	11.7	22.6	10.1	496.8	0.2	14.3	4.9	1.3	1.0	107.8	2.3	7.6	15.9	0.0	5.4	1.1	2.6	6.2	0.2	0.6	16.4	14.4	0.7	23.6	1.1
CHRM5		ENSG00000184984	"Cholinergic receptor muscarinic 5"	P08912	15	33968497-34067458	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 18.8"	"Cell type enriched"	"Detected in some"	9	"Oligodendrocytes: 178.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.6;HMC-1: 10.4;NB-4: 1.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 13.2"	"Low region specificity"	"Detected in many"			HPA013172	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA013172: AB_1854212"	"unprognostic (8.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.67e-2)"	"unprognostic (4.32e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.61e-4)"	"unprognostic (7.95e-2)"	"unprognostic (1.33e-6)"	"unprognostic (1.42e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.07e-2)"	0.1	0.1	2.4	0.3	5.8	0.4	0.3	4.2	4.8	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.1	0.0	1.8	8.4	0.2	0.6	0.1	0.3	9.5	8.3	0.1	0.3	0.0	0.2	1.5	9.0	0.1	0.0	1.3	0.1	0.0	0.2	0.4	0.5	0.0	3.1	0.2	0.1	1.5	18.8	0.0	0.6	0.0	0.0	0.0	0.1	13.8	0.1	0.1	0.5	0.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.6	0.2	0.2	0.0	0.4	10.4	0.3	0.0	0.1	0.0	0.1	0.0	0.3	0.5	1.0	0.0	0.1	0.2	1.9	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.2	0.2	0.6	0.2	0.1	0.1	1.0	0.1	0.1	0.2	0.2	0.1	0.7	0.2	0.3	0.0	0.2	0.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.0	2.4	5.8	4.2	4.8	1.8	8.4	9.5	8.3	9.0	3.1	18.8	13.8	0.1	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	3.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	1.5	0.2	0.0	1.9	0.0	5.9	0.2	0.1	0.0	0.0	0.0	8.7	0.0	18.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	12.6	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	2.8	0.1	0.2	1.0	2.5	178.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.8	0.0	0.1	0.0	0.4	0.9	0.0	0.0	0.8	0.0	0.2	0.0	0.0
CHRNE	ACHRE	ENSG00000108556	"Cholinergic receptor nicotinic epsilon subunit"	Q04844	17	4897771-4934438	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 55.3;pituitary gland: 27.6"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 161.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"HEL: 5.0;HMC-1: 11.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	14	"basal ganglia: 6.3"							NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (2.00e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.35e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.80e-4)"	"unprognostic (7.75e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.39e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.70e-2)"	0.7	0.4	0.1	0.4	0.1	0.7	0.7	0.6	0.4	0.7	0.0	0.3	0.3	0.4	1.3	0.4	0.6	1.0	55.3	0.2	0.1	1.0	3.5	0.8	0.5	0.3	0.0	0.8	1.7	0.2	27.6	0.6	0.1	0.6	0.0	5.1	0.8	0.2	1.8	2.2	0.8	0.2	0.0	1.8	0.5	0.7	0.1	0.1	0.4	2.1	0.2	0.3	0.5	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	5.0	0.0	0.8	0.4	0.0	11.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.2	1.3	2.5	0.4	0.0	0.0	0.1	0.8	0.2	0.4	0.1	0.7	1.1	0.8	0.6	0.1	0.0	0.7	0.1	0.1	0.6	0.4	0.2	0.1	0.3	0.0	0.1	0.0	0.1	0.2	4.9	0.0	0.0	0.3	4.2	1.7	1.4	0.8	1.2	5.0	1.6	2.0	6.5	1.5	0.6	1.8	4.2	0.6	10.2	0.0	1.9	0.3	27.8	0.6	1.1	3.3	0.0	0.0	0.5	0.9	7.3	2.3	1.1	0.8	8.2	1.4	2.9	7.4	3.4	3.3	0.4	0.1	2.0	1.3	13.0	161.5	0.9	9.9	0.0	2.8	5.3	1.1	8.2	0.5	0.7	0.7	0.0	0.4	3.5	1.1	0.0	2.9	0.6	10.0	0.0	0.9	1.1	5.6	8.4	0.2	1.1	11.1	3.5	6.2	0.2	0.7
CIB3	KIP3	ENSG00000141977	"Calcium and integrin binding family member 3"	Q96Q77	19	16161368-16173525	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"bone marrow: 1.2"	"Group enriched"	"Detected in some"	8	"Cardiomyocytes: 30.2;Late spermatids: 9.5"	"Cancer enriched"	"Detected in single"	7	"breast cancer: 0.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"HMC-1: 4.5;MCF7: 2.2;NB-4: 1.4;THP-1: 1.3;U-937: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043553, HPA043995"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane, Cytosol"		"HPA043553: AB_10964566, HPA043995: "	"unprognostic (8.43e-2)"	"unprognostic (7.26e-5)"		"unprognostic (3.18e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.25e-1)"		"unprognostic (3.14e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.05e-1)"		"unprognostic (5.68e-2)"	"unprognostic (3.42e-1)"		"unprognostic (1.54e-2)"	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	1.4	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.7	0.0	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.3	30.2	0.0	0.1	0.0	0.0	0.2	0.1	1.8	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLC	"Gal-10, LGALS10, MGC149659"	ENSG00000105205	"Charcot-Leyden crystal galectin"	Q05315	19	39731255-39738029	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"bone marrow: 451.9"	"Cell type enriched"	"Detected in some"	15	"Erythroid cells: 127.8"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	312	"basophil: 28756.2;eosinophil: 21481.0"	"Lineage enriched"	"Detected in all"	2254	"granulocytes: 28756.2"	"Cell line enriched"	"Detected in some"	12	"HMC-1: 7553.4"					"Not detected"	"Not detected"			HPA041751	Enhanced					NA	NA		400000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA041751: AB_10793973"		"unprognostic (4.53e-2)"	"unprognostic (3.04e-2)"		"unprognostic (4.09e-2)"	"unprognostic (1.45e-1)"		"unprognostic (2.72e-1)"		"unprognostic (1.34e-2)"	"unprognostic (6.60e-2)"		"unprognostic (2.21e-1)"	"unprognostic (4.28e-2)"	"unprognostic (5.74e-2)"		"unprognostic (1.24e-1)"	2.0	0.1	0.0	30.0	0.0	451.9	0.3	0.2	0.4	0.3	0.0	10.2	25.4	0.3	0.1	0.9	1.7	16.6	0.5	0.0	0.5	0.3	4.8	6.2	1.8	0.1	0.1	0.0	0.4	0.2	0.4	1.4	0.1	0.1	8.1	0.0	0.9	0.2	0.1	1.5	41.6	24.5	0.1	11.3	15.6	0.6	0.8	7.3	0.3	0.2	0.2	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	4.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	619.0	7553.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	3.5	0.7	0.9	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	2.3	0.0	0.0	3.8	0.0	2.4	28756.2	5.0	21481.0	2.5	11.1	6.0	4.8	6.9	1.7	5.3	6.2	3.1	9.2	80.3	2.5	12.7	7.8	4.0	100.3	0.0	0.0	0.2	0.4	0.0	0.5	0.1	0.1	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	127.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.3	0.2	0.0	0.0	0.0
CLN8	"C8orf61, EPMR, FLJ39417, TLCD6"	ENSG00000182372	"CLN8 transmembrane ER and ERGIC protein"	Q9UBY8	8	1755778-1801711	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 136.8;Syncytiotrophoblasts: 131.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"plasmacytoid DC: 76.7"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 76.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"				"unprognostic (5.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.05e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.03e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.36e-8)"	"unprognostic (1.36e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.24e-2)"	"unprognostic (8.38e-2)"	5.4	5.2	11.4	3.7	15.7	9.1	4.3	14.6	12.4	4.7	6.6	4.9	5.0	3.2	11.2	9.8	3.3	7.5	6.2	10.6	11.3	6.2	8.9	8.9	6.5	18.2	15.2	2.5	10.1	8.0	3.5	6.0	18.5	3.8	4.4	3.8	5.1	3.6	5.9	13.2	6.3	4.0	16.9	7.9	6.8	5.9	15.1	3.2	5.1	3.3	7.2	4.4	5.8	24.3	3.6	8.5	6.2	6.5	8.3	8.4	14.8	8.3	5.1	4.2	5.2	8.6	10.0	4.4	2.3	8.2	5.6	13.7	4.9	15.6	8.6	3.3	3.6	4.4	3.2	4.9	4.7	3.7	19.1	8.4	12.2	5.8	4.1	10.1	9.2	3.2	6.0	2.6	13.1	9.0	6.0	3.2	6.1	14.0	7.3	4.2	4.3	3.4	7.8	15.4	3.2	3.9	3.5	8.1	4.6	12.7	16.2	4.2	17.3	11.3	3.2	0.9	5.2	1.5	5.4	5.0	11.4	7.3	16.9	7.4	10.6	4.7	6.4	13.6	7.1	10.3	6.9	4.5	10.6	14.0	6.7	4.4	3.7	5.1	12.5	76.7	8.0	6.4	11.4	15.7	14.6	12.4	10.6	11.3	18.2	15.2	18.5	16.9	15.1	24.3	18.3	9.6	17.5	6.2	30.1	54.7	71.6	38.6	26.7	27.6	23.4	13.2	7.7	20.0	37.2	31.3	31.3	38.0	115.3	28.5	15.6	27.2	5.4	20.5	6.9	34.7	19.7	40.8	7.4	19.0	18.0	32.7	13.7	37.2	27.3	17.1	27.8	28.5	44.1	40.4	7.6	17.5	50.8	54.6	136.8	5.9	8.1	69.8	21.4	8.4	22.3	13.9	23.7	10.1	27.1	19.3	20.7	12.0	9.1	76.5	19.5	10.6	27.1	26.1	13.1	22.5	16.8	34.4	23.5	20.1	63.5	131.6	22.0	16.1	15.4	61.2
CLTCL1	"CHC22, CLH22, CLTCL, CLTD"	ENSG00000070371	"Clathrin heavy chain like 1"	P53675	22	19179473-19291719	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 187.4;testis: 47.2;tongue: 61.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 11.3;Cone photoreceptor cells: 14.6;Early spermatids: 19.3;Late spermatids: 17.0;Oligodendrocyte precursor cells: 12.5;Oligodendrocytes: 12.5;Spermatocytes: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 2.1;neutrophil: 5.2"	"Group enriched"	"Detected in many"	20	"granulocytes: 5.2;monocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 64.8;K-562: 31.8"									"HPA075327, HPA075795"	Enhanced		Approved	Vesicles		NA	NA		2300000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA075327: , HPA075795: AB_2686764"	"unprognostic (1.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.16e-3)"	"unprognostic (8.20e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.71e-4)"	"unprognostic (1.61e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.06e-1)"	6.8	16.0	5.4	0.8	6.1	15.6	4.8	6.2	6.5	5.0	5.0	2.4	0.5	3.1	1.6	3.6	3.8	1.2	14.8	5.2	7.8	3.2	6.5	3.0	0.7	7.4	8.6	3.6	2.5	2.1	13.4	1.5	8.5	5.2	1.0	2.0	3.9	0.8	187.4	4.1	1.8	1.7	5.7	3.5	2.8	47.2	9.1	3.9	8.0	61.3	0.5	2.8	3.7	6.9	4.5	4.6	3.0	4.9	10.8	5.9	1.4	3.1	3.3	4.2	6.3	1.7	1.4	1.9	0.4	7.0	3.3	1.5	4.7	8.5	3.5	0.3	4.6	0.2	4.4	5.3	5.5	6.5	64.8	25.0	7.0	7.8	10.9	12.5	2.7	2.4	31.8	1.7	10.0	3.6	0.6	22.4	3.8	18.1	2.8	2.4	24.2	0.1	3.4	1.8	6.9	1.2	6.6	4.1	0.4	3.6	8.9	27.1	0.8	7.6	15.5	4.2	5.2	3.1	8.4	0.8	4.5	17.4	1.6	0.0	2.1	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	5.2	0.0	0.0	0.0	0.0	0.4	5.4	6.1	6.2	6.5	5.2	7.8	7.4	8.6	8.5	5.7	9.1	6.9	1.4	3.2	0.5	9.4	0.1	0.6	0.5	1.0	1.2	2.4	0.7	0.3	11.3	1.5	1.8	0.0	14.6	0.4	0.2	1.2	0.0	0.8	19.3	1.2	1.9	0.9	0.0	0.8	4.5	0.0	0.2	1.4	1.5	1.4	0.0	3.5	1.1	2.4	0.3	0.0	8.9	1.3	6.1	1.0	0.7	17.0	2.5	0.5	0.0	4.7	1.3	1.5	0.0	12.5	12.5	1.2	0.8	4.1	0.1	1.3	0.2	1.3	1.0	2.0	0.0	2.6	4.5	14.5	4.7	1.0	0.9	1.1	0.1	6.2	0.9	0.0
CMIP		ENSG00000153815	"C-Maf inducing protein"	Q8IY22	16	81444808-81711762	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.0;neutrophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HMC-1: 180.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054424, HPA066710"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		83000	"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"		"HPA054424: AB_2682484, HPA066710: AB_2685708"	"unprognostic (6.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.89e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.02e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (9.47e-7)"	"unprognostic (1.60e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.42e-2)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.59e-1)"	27.9	22.1	45.2	32.1	46.2	26.1	23.2	12.6	50.1	30.7	0.0	26.5	40.4	18.8	6.1	35.8	23.0	25.6	13.0	48.8	51.1	20.7	13.5	26.3	22.2	29.9	34.8	22.8	19.3	7.8	55.6	28.4	46.1	17.7	23.1	10.8	20.1	15.0	4.7	34.3	49.9	22.5	19.9	22.5	33.3	17.2	52.7	20.1	15.6	5.3	18.2	31.2	32.8	34.4	40.9	133.5	25.9	13.3	13.4	10.7	52.7	28.9	19.5	17.9	7.9	45.5	81.5	18.2	24.2	24.1	23.9	40.6	16.9	96.2	17.0	11.6	12.3	87.4	24.4	80.0	13.3	27.2	180.8	10.5	39.9	33.1	42.5	27.1	50.0	31.7	77.6	15.3	11.1	40.9	47.7	33.8	20.6	39.5	28.1	84.9	8.5	17.8	22.6	39.7	135.0	27.1	67.4	24.7	8.6	25.9	19.1	35.7	34.6	28.5	30.6	27.7	26.8	19.2	15.9	78.0	33.6	31.5	11.7	3.0	0.7	1.0	0.4	0.5	0.2	0.0	0.1	0.1	0.2	0.3	0.0	0.2	2.4	0.2	0.1	0.2	0.1	0.4	45.2	46.2	12.6	50.1	48.8	51.1	29.9	34.8	46.1	19.9	52.7	34.4	81.5	12.8	16.6	59.4	31.7	107.3	66.6	43.8	48.9	15.6	21.5	21.1	7.8	47.1	27.7	14.7	0.0	46.5	71.2	58.0	7.9	22.3	70.0	51.1	9.2	77.3	72.1	17.9	119.1	23.8	106.6	25.7	35.7	45.4	45.1	29.8	70.6	31.6	32.0	25.2	95.2	128.0	40.7	69.4	115.9	100.8	47.5	95.5	12.4	100.2	68.2	8.0	37.0	69.9	52.9	65.5	30.9	143.3	35.2	69.6	47.3	49.6	57.6	3.4	13.1	8.0	24.1	5.0	15.4	51.8	143.5	88.7	42.8	6.4	39.1	111.7
CMTR2	"AFT, FLJ11171, FTSJD1, MTr2"	ENSG00000180917	"Cap methyltransferase 2"	Q8IYT2	16	71281389-71289715	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 95.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041700, HPA048265"	Uncertain		Approved	"Nuclear speckles,Cell Junctions"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Cell Junctions"	"Nuclear speckles"	"HPA041700: AB_2677623, HPA048265: AB_2680334"	"unprognostic (1.27e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.93e-3)"	"unprognostic (2.86e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.39e-2)"	"prognostic favorable (4.97e-5)"	"unprognostic (9.55e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.34e-2)"	6.7	8.8	4.0	10.3	4.6	7.2	15.9	4.6	4.2	7.6	8.0	10.1	14.9	8.5	12.2	14.3	9.0	9.4	7.0	3.2	4.7	12.5	14.3	11.4	14.4	5.1	4.4	11.2	8.1	10.7	7.8	10.6	4.8	10.8	10.4	7.3	13.3	8.0	5.7	10.3	14.2	9.0	5.2	13.6	10.0	13.8	4.9	10.7	14.1	5.7	17.9	9.7	7.6	6.6	17.8	11.6	23.2	19.5	18.9	15.3	10.6	14.9	18.2	17.4	18.4	10.6	26.5	10.0	18.4	13.7	18.9	19.4	11.1	14.2	24.9	10.5	7.9	22.3	13.1	8.3	20.3	16.8	37.7	12.7	24.7	15.4	17.9	12.8	18.5	22.2	11.6	6.6	31.1	15.9	18.8	23.1	11.0	14.2	6.7	28.5	10.2	24.5	16.3	19.5	12.0	12.8	15.1	12.2	15.4	10.3	18.0	10.4	18.7	21.1	15.1	15.5	11.4	13.3	17.6	21.3	14.7	14.6	16.8	22.6	9.6	9.2	10.8	10.3	13.2	13.1	10.6	11.7	13.7	12.0	11.4	11.1	0.7	16.6	6.9	3.9	9.8	11.4	4.0	4.6	4.6	4.2	3.2	4.7	5.1	4.4	4.8	5.2	4.9	6.6	11.4	3.2	11.8	13.7	28.1	14.1	14.5	10.7	15.9	20.3	23.9	13.7	8.6	20.0	9.4	16.5	31.3	24.2	30.2	25.8	7.9	12.2	95.6	12.6	15.1	14.6	18.6	17.0	9.9	9.7	12.7	11.5	15.8	11.5	8.2	26.1	18.9	32.7	16.1	15.2	10.3	20.5	18.3	18.0	11.4	30.9	16.8	13.6	1.8	21.5	17.8	12.1	51.5	17.6	21.5	12.9	15.2	12.4	17.9	13.5	46.3	17.7	6.5	25.5	6.6	11.1	10.1	26.1	13.8	22.0	24.3	26.4	20.0	21.8	17.9	18.2
CNR2	CB2	ENSG00000188822	"Cannabinoid receptor 2"	P34972	1	23870515-23913362	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.4;lymphoid tissue: 8.8"	"Cell type enriched"	"Detected in some"	5	"B-cells: 27.8"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 2.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"basophil: 49.3;eosinophil: 35.1;memory B-cell: 29.6;naive B-cell: 27.9;NK-cell: 19.4"	"Group enriched"	"Detected in many"	9	"B-cells: 29.6;granulocytes: 49.3;NK-cells: 19.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.3;HEL: 4.4;HMC-1: 19.7;U-698: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB009719	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"CAB009719: AB_2082784"	"unprognostic (9.45e-4)"	"unprognostic (5.40e-3)"	"unprognostic (8.50e-3)"	"unprognostic (8.19e-3)"	"unprognostic (3.55e-3)"	"unprognostic (9.34e-6)"	"unprognostic (5.58e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.75e-2)"	"unprognostic (4.91e-2)"	0.1	0.0	0.2	2.4	0.1	1.5	0.0	0.5	0.2	0.0	0.2	0.3	0.2	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	7.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	1.6	0.2	3.4	0.1	0.0	8.8	0.4	0.1	0.2	1.0	0.2	0.0	7.5	0.4	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.2	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	13.4	0.0	0.1	0.0	49.3	0.1	35.1	3.2	0.1	3.8	29.6	0.1	3.0	0.4	27.9	0.2	1.8	1.2	19.4	0.2	1.7	0.2	2.0	0.2	0.1	0.5	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.1	3.2	3.9	0.3	27.8	0.6	0.8	0.0	0.0	0.8	0.2	0.0	0.3	0.0	1.8	0.0	0.0	0.1	2.1	0.5	0.0	0.0	0.2	0.1	0.3	0.3	0.0	3.2	0.4	0.0	0.0	0.9	0.0	0.2	3.8	0.1	0.4	0.3	0.2	0.0	0.4	0.0	0.0	0.6	0.9	0.0	0.0	0.8	0.0	0.0	0.5	0.2	5.2	0.0	0.5	0.1	2.0	0.0	0.5	0.5	0.0	0.1	0.7	0.7	0.0	0.9	0.4	0.3	0.2	0.0	0.3	0.3	2.4	0.2	0.0	0.8
COL9A2	"EDM2, MED"	ENSG00000049089	"Collagen type IX alpha 2 chain"	Q14055	1	40300489-40317813	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Deafness, Disease variant, Dwarfism, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 86.2;pituitary gland: 108.1"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 295.4;Oligodendrocyte precursor cells: 62.4;Oligodendrocytes: 128.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 68.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 3.2;myeloid DC: 1.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.2;granulocytes: 3.2"	"Group enriched"	"Detected in many"	4	"HDLM-2: 98.6;Hep G2: 27.6;HMC-1: 90.3;THP-1: 105.0"	"Low region specificity"	"Detected in all"							"HPA056316, HPA075286"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA		510000	"Cluster 52: Eosinophils - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	Nucleoplasm	"HPA056316: AB_2683099, HPA075286: AB_2732288"	"unprognostic (1.42e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.94e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.06e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.71e-2)"	2.2	3.4	42.6	3.7	71.5	10.9	5.9	58.9	51.1	12.1	21.6	6.5	5.8	5.0	1.7	1.6	11.4	8.5	2.2	38.2	49.7	24.6	0.9	4.3	5.9	65.9	74.1	1.3	2.3	21.0	108.1	1.1	66.2	13.7	3.1	23.1	16.3	24.2	0.2	4.6	10.4	1.4	52.0	9.8	16.5	2.6	58.6	1.8	12.2	0.3	3.1	12.1	2.0	86.2	12.0	0.3	1.8	0.8	2.6	1.3	7.8	0.0	0.0	0.6	1.3	0.4	6.8	3.4	10.0	0.3	0.0	2.0	0.1	0.0	0.3	98.6	1.4	2.0	0.8	27.6	1.5	0.9	90.3	4.8	0.0	0.1	0.0	0.7	0.0	1.5	0.1	19.8	0.0	2.7	1.2	2.1	2.2	0.0	1.2	2.3	0.0	6.9	0.0	14.3	1.4	2.3	0.1	11.8	1.3	6.6	15.0	105.0	0.1	0.0	11.6	0.2	0.4	1.4	0.2	3.4	1.0	12.3	0.6	0.0	0.1	3.2	0.0	0.2	0.0	0.2	0.1	0.0	1.2	0.2	0.0	0.0	0.5	0.2	0.3	0.1	0.1	0.0	42.6	71.5	58.9	51.1	38.2	49.7	65.9	74.1	66.2	52.0	58.6	86.2	0.5	0.0	3.3	26.1	10.8	1.0	3.0	8.5	0.0	2.0	7.1	9.7	1.0	7.2	10.0	25.8	0.0	3.2	2.5	7.2	0.0	11.7	0.2	13.6	0.9	0.6	12.7	0.4	0.3	0.8	0.6	2.1	26.0	20.0	26.1	1.6	1.1	0.0	3.4	0.0	0.3	6.6	2.0	0.3	22.4	0.9	2.1	6.4	1.8	3.7	22.1	295.4	1.0	62.4	128.1	4.9	9.6	0.0	4.0	6.1	5.0	0.3	12.9	10.9	0.0	1.3	1.8	3.4	6.2	0.2	0.6	1.4	2.7	1.8	13.4	13.4
COPS4	CSN4	ENSG00000138663	"COP9 signalosome subunit 4"	Q9BT78	4	83034447-83075818	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036894, HPA042828"	Approved		Supported	"Nuclear speckles"		NA	NA		100000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA036894: AB_10670929, HPA042828: AB_2678191"	"unprognostic (1.82e-3)"	"unprognostic (1.01e-2)"	"prognostic favorable (4.14e-4)"	"unprognostic (7.97e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.21e-2)"	"prognostic favorable (5.21e-6)"	"unprognostic (5.84e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.80e-1)"	25.6	38.6	28.4	22.0	30.7	41.0	32.0	26.9	33.5	31.7	26.0	27.4	23.1	30.8	28.8	30.5	26.0	22.5	59.7	30.6	35.0	38.8	29.2	22.2	29.9	28.4	29.9	31.9	24.6	43.7	39.2	30.2	32.0	30.3	25.1	45.6	23.7	30.5	104.8	26.7	22.0	33.3	28.7	22.5	22.4	45.0	30.8	36.2	38.4	84.1	32.7	31.8	23.5	28.9	51.7	30.4	64.1	59.0	56.0	71.7	34.8	67.2	85.7	74.8	66.0	43.7	51.8	86.9	57.3	140.5	41.3	37.7	80.6	68.9	101.1	55.6	56.9	50.4	43.5	42.1	46.3	86.8	135.6	54.4	47.0	55.8	47.8	56.2	101.1	53.5	65.2	48.0	91.9	43.4	105.0	63.6	35.3	81.1	40.6	74.0	48.8	48.1	59.8	47.2	67.7	39.6	45.0	69.4	43.5	43.8	52.7	46.4	66.7	52.2	55.1	39.7	48.6	49.8	32.7	96.8	50.3	55.2	52.8	91.4	37.0	55.2	43.0	50.4	53.9	39.7	47.1	49.7	45.3	38.9	44.7	48.1	8.2	54.6	59.8	29.0	47.6	52.3	28.4	30.7	26.9	33.5	30.6	35.0	28.4	29.9	32.0	28.7	30.8	28.9	25.6	12.8	20.1	21.9	34.1	42.8	42.2	94.5	23.3	38.7	20.1	23.4	81.3	20.0	51.5	20.2	31.3	82.5	36.5	14.5	90.1	42.4	130.6	24.9	27.6	31.9	31.2	26.5	34.7	33.2	62.7	39.9	15.3	21.3	34.2	38.2	20.0	22.4	49.0	26.9	32.9	22.0	67.1	29.2	29.2	38.3	30.7	27.2	33.8	18.7	37.8	62.5	37.0	28.6	32.9	28.2	22.1	42.9	28.6	20.5	22.6	75.7	37.9	44.6	32.9	34.1	42.5	121.2	50.2	29.7	35.2	95.0	32.8	53.3	26.3	34.3
COQ2	"CL640, FLJ26072"	ENSG00000173085	"Coenzyme Q2, polyprenyltransferase"	Q96H96	4	83261536-83284914	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Disease variant, Neurodegeneration, Parkinsonism, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 37.5"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 50.7;Kupffer cells: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056599, HPA068727"	Approved		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA056599: AB_2683184, HPA068727: AB_2686022"	"unprognostic (8.26e-2)"	"unprognostic (7.40e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.09e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.46e-1)"	6.0	17.0	2.8	8.0	3.2	11.8	5.8	3.5	3.3	7.9	3.6	14.2	9.5	6.3	7.5	10.4	4.4	4.3	15.0	3.0	3.5	5.6	13.6	7.9	6.4	3.6	3.5	6.5	6.5	6.0	4.0	8.4	3.8	6.6	14.2	4.0	7.8	5.0	29.1	10.8	9.1	6.9	4.1	10.1	5.5	3.5	3.9	3.6	5.7	37.5	7.1	7.9	6.5	4.9	26.1	14.7	14.1	27.4	10.5	11.9	9.7	16.1	27.0	29.7	34.4	10.5	38.7	17.2	11.7	28.4	24.6	18.6	23.9	26.0	38.7	17.2	14.8	15.3	22.3	15.4	11.7	31.3	73.5	15.9	16.3	14.2	24.8	8.9	30.7	9.7	10.0	21.4	29.3	27.4	8.6	21.7	10.9	30.6	19.9	14.1	11.4	22.1	45.4	13.8	10.3	6.3	19.0	24.5	9.2	6.7	15.4	18.8	21.0	14.6	14.6	11.1	23.4	5.7	5.2	10.2	29.5	36.8	20.2	2.1	28.8	4.0	2.7	26.8	1.9	6.2	3.0	2.5	21.1	6.9	2.1	3.2	9.8	6.7	33.5	11.2	4.1	13.6	2.8	3.2	3.5	3.3	3.0	3.5	3.6	3.5	3.8	4.1	3.9	4.9	5.4	0.0	4.2	15.7	11.5	6.6	12.4	9.8	4.6	5.9	6.3	5.6	19.5	2.8	10.7	9.2	0.0	25.4	7.1	14.0	31.3	6.7	0.8	7.6	19.5	6.1	4.8	14.1	12.8	10.8	30.0	9.0	6.6	9.2	0.0	17.2	9.3	15.0	50.7	1.7	20.1	15.3	8.2	53.2	7.9	0.8	3.7	25.2	7.2	33.7	21.8	12.6	6.2	25.6	15.6	5.4	15.4	4.9	4.3	12.6	11.0	9.9	6.2	4.8	0.0	7.3	9.7	18.1	19.7	16.7	12.6	12.4	9.6	35.5	26.7	12.9
CORO1A	"coronin-1, HCORO1, p57"	ENSG00000102879	"Coronin 1A"	P31146	16	30182827-30189076	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 568.8;lymphoid tissue: 583.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 523.9;dendritic cells: 588.7;Hofbauer cells: 494.4;Kupffer cells: 395.8;Macrophages: 342.7;monocytes: 583.7;NK-cells: 968.1;T-cells: 663.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 924.0;HL-60: 645.7;HMC-1: 1086.7;JURKAT: 603.0;MOLT-4: 632.5;NB-4: 771.8;RPMI-8226: 980.9;U-698: 618.2;U-937: 829.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046473, HPA051132"	Enhanced		Approved	Cytosol		NA	NA		45000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB046473: AB_10602363, HPA051132: AB_2681355"	"unprognostic (4.17e-3)"	"unprognostic (3.64e-3)"	"unprognostic (3.86e-2)"	"prognostic favorable (6.91e-4)"	"unprognostic (2.41e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (1.99e-2)"	"unprognostic (8.27e-3)"	"unprognostic (8.26e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (5.74e-7)"	"unprognostic (2.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	29.1	20.8	34.4	306.4	37.1	568.8	11.2	24.9	52.0	10.6	23.6	26.8	44.3	10.0	3.1	22.5	17.9	45.0	11.3	36.9	31.9	11.5	13.1	49.5	583.8	37.6	32.0	6.4	8.4	4.3	9.3	18.4	32.2	11.4	15.3	0.9	32.9	7.3	6.7	17.6	111.0	22.2	35.8	321.4	49.0	4.8	33.9	257.6	12.7	8.8	309.1	57.6	10.4	50.0	3.1	3.6	10.9	21.5	0.1	0.1	6.1	2.6	0.7	5.4	3.0	0.7	6.9	924.0	6.1	0.9	1.5	4.4	5.2	10.8	1.3	302.3	2.5	97.9	0.5	15.0	1.7	645.7	1086.7	2.8	0.0	4.3	0.5	0.4	2.0	603.0	1.5	467.6	3.4	80.7	632.5	771.8	4.0	3.1	6.4	340.0	17.5	980.9	1.3	5.1	17.3	13.0	2.2	110.7	2.0	0.2	1.9	373.0	1.6	4.0	9.0	2.7	3.1	348.5	497.7	618.2	3.0	829.6	6.3	797.2	773.6	2671.1	637.5	859.7	597.8	505.5	567.3	625.6	843.2	512.0	537.1	566.2	1318.9	531.0	898.0	482.1	858.7	1647.2	34.4	37.1	24.9	52.0	36.9	31.9	37.6	32.0	32.2	35.8	33.9	50.0	6.3	22.4	32.5	0.3	523.9	11.3	1.2	3.2	2.2	1.2	4.7	5.5	1.5	17.2	6.0	1.8	0.0	4.6	588.7	2.3	0.0	3.5	0.5	1.1	2.0	12.3	6.0	60.2	3.3	0.9	17.4	9.5	18.8	1.3	83.7	0.6	21.8	4.8	494.4	0.0	1.7	2.2	6.1	395.8	197.9	1.2	0.6	342.7	32.0	4.7	583.7	0.8	968.1	1.5	0.4	11.1	47.5	0.0	201.4	0.8	1.0	4.8	3.5	0.9	6.6	2.9	5.1	0.1	0.9	2.4	9.1	4.9	663.0	2.7	3.3	0.9
CR1	"CD35, KN"	ENSG00000203710	"Complement C3b/C4b receptor 1 (Knops blood group)"	P17927	1	207496147-207641765	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 13.2;lymphoid tissue: 27.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 32.6;Erythroid cells: 20.4;Kupffer cells: 59.1;Macrophages: 24.9;monocytes: 13.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 53.7;eosinophil: 17.2;neutrophil: 15.6"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 53.7"	"Group enriched"	"Detected in some"	9	"HL-60: 9.9;HMC-1: 21.8;NB-4: 9.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB002491, CAB016271, HPA042455, HPA043579, HPA049348"	Enhanced					NA	NA		33000000	"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"CAB002491: AB_563553, CAB016271: AB_627040, HPA042455: AB_2678006, HPA043579: AB_2678564, HPA049348: AB_2680723"	"unprognostic (1.74e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.29e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.50e-3)"	13.2	0.8	0.1	27.2	0.5	10.5	0.6	0.1	2.9	1.2	1.3	1.5	1.3	0.5	0.2	0.9	1.4	2.1	0.6	0.2	0.2	2.5	2.6	3.2	20.1	0.7	0.5	0.2	0.3	0.1	0.2	9.1	1.6	0.2	1.5	0.0	0.4	0.4	0.2	0.1	4.4	6.3	0.1	24.4	1.7	0.6	2.1	1.6	0.3	1.0	17.9	6.7	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	9.9	21.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	53.7	4.2	17.2	0.0	2.4	0.7	4.5	0.9	0.4	0.3	2.2	0.2	0.1	15.6	0.0	2.3	0.0	0.0	1.3	0.1	0.5	0.1	2.9	0.2	0.2	0.7	0.5	1.6	0.1	2.1	1.8	0.3	0.0	4.2	0.3	32.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.2	0.2	0.0	20.4	0.3	0.0	0.1	0.6	0.0	0.2	1.3	0.3	0.0	0.4	9.7	0.0	0.4	0.0	0.0	59.1	1.4	0.0	0.0	24.9	0.0	1.9	13.3	0.0	0.0	1.5	4.4	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.3	1.3	0.5	0.0	0.0
CR1L		ENSG00000197721	"Complement C3b/C4b receptor 1 like"	Q2VPA4	1	207645113-207738416	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"bone marrow: 1.5"	"Cell type enriched"	"Detected in some"	18	"Erythroid cells: 128.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEL: 1.3;HMC-1: 2.9;K-562: 1.6"									HPA049348	Approved				"Secreted in other tissues"	NA	NA				"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA049348: AB_2680723"	"unprognostic (2.35e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.45e-2)"	"unprognostic (5.27e-2)"	"unprognostic (8.21e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.02e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.31e-2)"	"unprognostic (9.68e-2)"	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.5	0.5	0.0	0.3	1.8	0.0	0.1	0.0	0.0	5.9	0.4	0.2	6.9	0.2	1.8	0.0	128.6	0.4	0.0	0.1	0.2	0.0	1.0	0.0	0.0	3.6	0.2	1.2	0.0	0.4	0.0	2.0	0.3	0.3	0.4	0.0	0.5	0.0	1.0	1.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.4	0.0	0.2	3.3	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.3	0.3	0.1	0.1	0.0	0.2
CREB3L2	"BBF2H7, TCAG_1951439"	ENSG00000182158	"CAMP responsive element binding protein 3 like 2"	Q70SY1	7	137874979-138002086	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 141.1;Syncytiotrophoblasts: 144.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015068, HPA015534"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Endoplasmic reticulum"		"HPA015068: AB_1847224, HPA015534: AB_2669210"	"unprognostic (8.50e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.88e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.50e-1)"	"unprognostic (4.77e-1)"	"unprognostic (8.93e-2)"	"unprognostic (9.48e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.32e-2)"	20.7	29.7	8.3	18.5	13.9	23.8	22.8	8.3	12.2	30.3	46.5	22.4	22.3	33.9	26.8	15.0	22.6	15.0	25.9	8.1	9.6	19.6	12.5	19.3	12.8	13.2	10.8	29.0	30.1	59.5	25.1	39.4	12.1	21.6	17.6	5.0	28.7	23.2	6.1	8.7	22.9	29.2	9.6	13.0	17.4	9.0	16.1	10.0	65.3	9.4	20.4	19.5	19.9	17.3	13.1	19.9	37.6	0.6	62.9	61.7	28.1	65.1	104.0	44.4	44.7	27.5	11.7	2.6	16.8	71.1	24.1	6.9	21.9	47.1	86.9	19.1	10.8	83.4	26.7	67.6	41.4	25.3	115.5	25.4	29.2	56.0	65.3	45.5	59.7	6.5	43.8	37.4	52.9	23.5	8.0	31.6	13.6	17.9	13.7	17.5	19.8	22.1	35.3	13.2	9.4	22.3	21.1	54.0	29.1	21.7	7.9	18.9	63.1	59.5	8.7	72.3	24.2	43.9	16.2	16.9	70.9	71.3	135.0	10.4	5.5	6.0	7.3	3.0	9.8	3.9	5.4	8.2	5.7	3.9	2.0	3.4	2.0	7.2	1.6	11.9	12.5	3.2	8.3	13.9	8.3	12.2	8.1	9.6	13.2	10.8	12.1	9.6	16.1	17.3	30.6	6.4	25.9	18.6	27.3	12.2	9.7	18.9	8.0	12.0	32.0	25.4	17.5	21.5	34.9	23.9	10.4	62.6	39.5	24.7	13.7	10.2	56.3	18.1	86.6	31.6	15.7	12.0	7.5	17.6	93.0	49.6	16.3	42.4	49.4	27.8	29.6	24.3	56.3	15.2	10.6	21.0	20.3	34.9	25.6	18.7	61.8	30.7	26.6	63.7	21.4	5.4	40.2	55.8	48.0	14.4	18.2	103.0	141.1	35.1	66.2	7.9	22.4	12.3	39.5	62.3	50.2	3.4	7.4	9.5	7.1	144.5	26.6	11.1	17.0	44.0
CRLF2	"CRL2, TSLPR"	ENSG00000205755	"Cytokine receptor like factor 2"	Q9HC73	X	1187549-1212723	"Cancer-related genes, Human disease related genes, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.8;gallbladder: 1.3;lymphoid tissue: 1.5"	"Cell type enriched"	"Detected in some"	4	"monocytes: 100.2"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	13	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 1.2"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"				"unprognostic (7.84e-2)"	"unprognostic (7.99e-4)"	"unprognostic (6.02e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.15e-3)"	"unprognostic (2.31e-6)"	"unprognostic (1.72e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.88e-5)"	"unprognostic (7.09e-3)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.62e-1)"	0.2	0.0	0.0	1.5	0.0	1.8	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.1	0.5	0.6	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.5	0.8	0.1	0.3	2.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.6	0.9	3.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.3	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	1.8	0.0	1.0	100.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1
CSAG2	"CSAG3B, CT24.2, TRAG3"	ENSG00000268902	"CSAG family member 2"		X	152708261-152714549	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 15.3;SK-BR-3: 6.3;U-266/70: 5.1;U-266/84: 7.1"															NA	NA					"Cluster 3: HMC-1 - Innate immune response"						"unprognostic (5.87e-2)"				"unprognostic (3.82e-2)"		"unprognostic (1.44e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.81e-2)"				"unprognostic (3.35e-2)"	"unprognostic (1.55e-1)"		"unprognostic (1.50e-2)"	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.4	0.0	0.8	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.2	0.0	0.0	0.0	0.0	0.3	2.0	1.9	0.0	0.0	2.3	0.0	0.0	1.2	2.7	0.0	6.3	2.9	0.0	0.0	0.3	0.1	0.1	2.2	0.5	0.1	5.1	7.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.6	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CSF2RB	"betaGMR, CD131, IL3RB, IL5RB"	ENSG00000100368	"Colony stimulating factor 2 receptor subunit beta"	P32927	22	36913628-36940439	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 54.5;lymphoid tissue: 65.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 44.8;Extravillous trophoblasts: 37.9;granulocytes: 91.2;Langerhans cells: 68.3;Late spermatids: 41.2;Macrophages: 34.7;monocytes: 42.3;Plasma cells: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"basophil: 238.1;neutrophil: 76.0"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 238.1"	"Group enriched"	"Detected in some"	5	"HEL: 107.3;HMC-1: 321.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA078677			Approved	"Golgi apparatus"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus"		"HPA078677: AB_2732389"	"unprognostic (1.67e-2)"	"unprognostic (9.44e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (7.47e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.38e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (5.76e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.52e-2)"	10.1	2.0	1.0	65.5	1.1	54.5	5.4	1.2	5.2	2.5	1.3	9.9	10.3	2.0	0.7	6.6	2.6	9.8	2.3	0.9	1.6	1.8	2.6	15.1	40.1	2.6	2.1	0.5	2.1	0.9	0.7	31.3	3.1	1.6	8.5	0.0	4.9	1.5	1.0	5.4	11.0	7.0	2.3	22.8	9.3	2.1	3.0	9.8	2.7	4.0	62.5	18.3	2.5	2.9	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.0	0.0	0.0	0.0	26.8	0.1	0.0	0.0	0.3	0.0	0.0	0.1	16.1	0.0	107.3	0.0	0.0	0.1	1.7	321.1	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.1	12.6	0.0	0.0	0.1	11.2	0.0	0.0	0.0	10.7	0.0	40.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.1	0.1	9.6	0.3	1.0	0.1	0.3	0.0	1.6	1.1	6.8	0.2	15.6	0.1	238.1	9.1	23.5	0.0	7.7	0.0	1.6	0.2	0.0	4.8	1.1	0.0	0.0	76.0	0.0	7.0	14.4	2.3	10.3	1.0	1.1	1.2	5.2	0.9	1.6	2.6	2.1	3.1	2.3	3.0	2.9	4.3	0.0	9.1	1.6	9.1	7.1	0.0	0.0	0.0	0.0	0.2	0.3	1.2	2.8	1.8	0.0	0.0	3.4	44.8	0.0	0.0	0.0	13.4	0.0	0.2	22.0	0.0	32.0	0.1	0.2	37.9	2.8	0.0	0.0	91.2	0.0	4.6	0.0	20.1	0.0	0.1	0.0	0.0	31.9	68.3	41.2	0.0	34.7	12.4	5.6	42.3	0.0	2.1	0.0	0.0	0.0	0.0	0.4	49.5	0.1	0.0	0.1	2.9	0.0	0.0	0.3	0.5	0.0	0.0	0.1	6.3	16.6	2.9	0.1	0.0	0.2
CSK		ENSG00000103653	"C-terminal Src kinase"	P41240	15	74782057-74803198	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 169.3"	"Cell type enhanced"	"Detected in all"		"B-cells: 130.9;dendritic cells: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011203, HPA026488, HPA028425"	Approved	Approved	Enhanced	Vesicles,Cytosol		No	No		150000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Vesicles, Cytosol"		"CAB011203: AB_259070, HPA026488: AB_1847273, HPA028425: AB_10600899"	"unprognostic (1.05e-1)"	"prognostic favorable (5.14e-5)"	"unprognostic (2.59e-3)"	"prognostic favorable (8.22e-4)"	"unprognostic (4.15e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (1.74e-4)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.29e-2)"	21.4	19.9	23.4	89.1	26.2	50.6	19.4	26.5	26.7	26.8	18.2	33.6	36.7	22.4	8.0	98.5	20.0	22.9	29.3	22.5	23.9	21.3	48.8	32.0	169.3	31.0	29.8	19.0	17.2	15.8	21.1	17.6	31.6	24.8	19.5	6.9	31.6	14.1	14.8	36.7	59.9	18.7	29.1	127.9	30.0	19.2	28.2	68.5	19.5	15.8	106.3	33.0	32.8	28.4	62.2	85.6	41.2	68.1	38.5	29.2	35.3	40.7	38.8	75.7	53.6	78.9	56.0	275.7	52.6	37.0	70.2	62.9	87.2	82.1	21.2	134.7	107.8	233.8	29.5	80.2	53.3	123.6	285.1	41.7	39.6	54.0	48.1	37.9	58.1	127.5	68.7	93.1	45.7	104.6	89.7	72.7	51.2	55.7	60.6	98.0	35.4	201.9	34.9	135.6	68.1	47.2	52.8	109.5	72.3	26.2	75.5	179.5	50.7	91.1	47.8	72.5	71.7	49.6	108.7	283.8	47.1	232.5	63.1	88.7	68.0	176.1	74.3	146.8	63.4	95.6	63.6	73.9	76.6	113.6	48.3	57.0	130.8	58.6	169.8	44.3	106.2	79.5	23.4	26.2	26.5	26.7	22.5	23.9	31.0	29.8	31.6	29.1	28.2	28.4	21.3	3.2	9.2	8.5	130.9	9.3	8.2	7.6	13.1	16.6	16.7	17.1	11.5	12.8	9.3	9.2	6.2	7.5	99.1	40.6	1.9	9.3	15.8	10.0	15.1	15.3	9.5	29.2	5.3	14.0	13.7	11.3	27.0	15.3	26.6	19.0	12.5	34.3	50.7	28.6	10.0	23.2	6.1	91.2	44.9	3.3	9.0	85.1	8.8	23.4	86.9	6.4	90.6	3.5	4.7	21.2	18.4	8.2	56.7	13.9	27.5	8.0	9.3	5.1	6.6	6.9	18.1	5.7	12.5	49.4	9.1	5.6	90.3	21.5	27.5	14.9
CT45A1	"CT45-1, CT45.1"	ENSG00000268940	"Cancer/testis antigen family 45 member A1"	Q5HYN5	X	135713453-135723539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 7.8"	"Group enriched"	"Detected in some"	50	"Spermatocytes: 3.5;Spermatogonia: 6.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HMC-1: 246.0;Karpas-707: 112.8"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"										"unprognostic (6.58e-3)"					"unprognostic (2.14e-1)"			0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	246.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	112.8	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	21.5	0.0	0.3	1.7	33.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.6	0.2	0.3	0.3	0.4	0.4	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A8		ENSG00000278085	"Cancer/testis antigen family 45 member A8"	P0DMV1	X	135846497-135854538	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HMC-1: 115.3"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA					"Cluster 3: HMC-1 - Innate immune response"		"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A9		ENSG00000270946	"Cancer/testis antigen family 45 member A9"	P0DMV2	X	135863418-135871812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"testis: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"AN3-CA: 29.9;HMC-1: 111.3;U-266/84: 49.2"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"		"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	4.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.8	49.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.2	0.1	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTNNBL1	"C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L"	ENSG00000132792	"Catenin beta like 1"	Q8WYA6	20	37693955-37872129	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 372.9;granulocytes: 263.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 308.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004742, HPA027906, HPA027907"	Approved		Enhanced	Nucleoplasm,Centrosome,Cytosol		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Centrosome, Cytosol"	"HPA004742: AB_1847323, HPA027906: , HPA027907: AB_10601362"	"unprognostic (2.81e-1)"	"unprognostic (3.42e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.31e-2)"	26.9	16.8	20.9	27.3	22.8	41.8	23.8	21.6	24.8	23.7	23.4	31.8	21.7	27.7	31.1	23.4	25.3	19.8	32.3	22.0	22.4	22.9	46.8	25.3	39.3	22.8	22.3	27.1	17.3	19.7	18.2	22.1	21.7	23.4	23.1	18.8	18.5	30.6	33.3	25.3	25.1	30.6	21.6	54.0	34.8	43.3	22.1	40.1	17.1	20.9	41.2	25.8	20.4	23.6	66.7	60.3	56.7	44.6	40.3	32.8	89.2	41.9	43.7	98.0	86.0	224.8	52.4	73.9	59.6	42.7	94.4	69.8	77.1	98.6	105.3	36.1	38.0	243.0	33.2	110.2	41.8	77.4	308.0	35.1	58.9	55.6	54.8	34.1	59.8	103.8	66.8	29.6	53.5	54.9	127.0	101.4	51.4	74.9	85.8	87.9	109.1	56.3	42.9	55.0	45.1	53.6	72.5	102.3	75.4	52.3	50.6	61.1	44.5	97.4	58.0	64.9	68.8	34.1	46.6	85.5	68.5	48.6	52.7	267.9	77.7	103.3	51.0	103.0	49.1	88.9	49.9	53.8	110.3	83.4	49.8	53.6	16.9	79.9	109.6	86.9	66.2	71.3	20.9	22.8	21.6	24.8	22.0	22.4	22.8	22.3	21.7	21.6	22.1	23.6	28.6	28.9	26.4	21.2	40.0	22.8	32.9	40.7	13.1	26.1	13.0	13.2	39.8	17.2	34.1	18.4	18.8	147.8	40.4	21.1	37.2	34.8	372.9	24.2	24.9	32.5	20.9	43.7	31.6	34.7	69.4	28.7	48.4	21.6	263.6	34.4	44.3	45.2	49.3	18.5	35.6	27.3	42.7	36.0	35.5	131.2	34.2	44.5	26.6	14.0	89.8	32.1	40.2	30.7	39.8	31.9	21.5	33.4	21.6	22.3	34.7	43.1	26.1	25.8	19.7	25.4	48.0	79.4	45.2	10.7	22.4	52.9	38.8	23.7	24.2	20.6
CTTNBP2	"C7orf8, CORTBP2, KIAA1758, Orf4"	ENSG00000077063	"Cortactin binding protein 2"	Q8WZ74	7	117710651-117874139	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 128.8;granulocytes: 139.9;Inhibitory neurons: 194.9;Oligodendrocyte precursor cells: 428.8;Oligodendrocytes: 444.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"non-classical monocyte: 7.7"	"Lineage enriched"	"Detected in single"	26	"monocytes: 7.7"	"Group enriched"	"Detected in some"	6	"HEL: 57.6;HMC-1: 74.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009151, HPA044654"	Enhanced		Approved	"Midbody ring,Cytosol"		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Midbody ring, Cytosol"		"CAB009151: AB_2088281, HPA044654: AB_2679037"	"unprognostic (6.28e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.28e-4)"	"unprognostic (3.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.71e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.45e-3)"	6.9	1.8	11.4	0.7	16.7	0.0	3.8	13.0	14.7	5.7	6.8	2.4	1.6	10.6	4.8	12.1	6.0	3.5	1.8	12.7	14.8	6.4	1.8	1.8	0.2	15.7	14.7	3.1	7.8	9.3	2.9	1.7	16.3	3.4	2.4	7.9	3.4	1.8	0.5	1.8	2.4	5.2	11.9	2.2	1.3	1.0	15.1	0.7	5.5	0.9	0.9	4.2	4.2	26.1	0.0	0.9	1.6	0.0	0.0	0.0	1.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.1	8.3	0.0	0.0	0.0	2.5	57.6	0.5	0.0	0.2	0.0	74.1	0.3	0.4	0.0	0.0	1.0	1.6	0.0	0.0	0.1	1.1	0.0	0.0	0.0	10.6	0.0	0.3	0.0	0.0	0.2	10.6	0.0	6.1	0.0	0.0	0.0	0.2	4.6	0.0	0.0	0.0	2.6	1.0	0.1	0.0	0.7	0.0	0.2	5.0	0.0	1.3	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	11.4	16.7	13.0	14.7	12.7	14.8	15.7	14.7	16.3	11.9	15.1	26.1	15.6	3.2	4.8	10.1	0.0	1.9	3.4	3.7	15.9	33.6	1.9	6.7	3.6	10.0	5.6	7.3	56.3	2.8	0.3	1.8	1.9	6.3	1.8	5.1	32.5	10.2	1.8	0.0	128.8	4.2	2.1	9.1	1.1	7.4	139.9	3.8	20.0	1.1	9.2	74.0	194.9	1.1	24.4	10.1	12.3	3.3	0.9	8.0	7.2	75.9	1.3	97.2	0.0	428.8	444.2	0.6	2.1	1.2	0.3	2.1	0.3	24.3	1.4	6.6	0.0	3.3	9.6	0.6	2.1	38.8	0.3	1.1	2.7	0.2	6.8	1.4
CXCR1	"CD181, CDw128a, CKR-1, CMKAR1, IL8RA"	ENSG00000163464	"C-X-C motif chemokine receptor 1"	P25024	2	218162841-218166962	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 5.1;dendritic cells: 5.2;granulocytes: 2.5;NK-cells: 11.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	14	"neutrophil: 1472.7"	"Lineage enriched"	"Detected in many"	62	"granulocytes: 1472.7"	"Cell line enriched"	"Detected in single"	26	"HMC-1: 5.8"	"Not detected"	"Not detected"							HPA031991	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA031991: AB_2674103"	"unprognostic (2.80e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.53e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.85e-2)"	13.2	0.5	0.3	25.1	0.5	9.5	0.4	0.3	1.7	0.7	0.5	0.4	0.2	0.2	0.0	1.6	2.9	4.1	1.8	0.3	0.3	0.5	2.0	9.7	0.3	0.4	0.4	0.1	1.5	0.3	0.2	2.6	1.2	0.3	0.2	0.0	0.5	0.1	0.4	0.3	0.6	1.8	0.3	40.5	0.9	0.2	0.5	1.8	0.4	12.0	0.6	5.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.2	2.3	2.9	23.7	0.8	0.3	0.2	2.1	6.1	0.7	0.1	0.4	8.7	1472.7	1.5	3.2	0.9	0.3	8.3	0.3	0.5	0.3	1.7	0.3	0.3	0.4	0.4	1.2	0.3	0.5	0.3	0.0	0.0	5.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	2.5	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.7	0.0	0.0	0.2	0.0	11.3	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0
CXCR2	"CD182, CMKAR2, IL8RB"	ENSG00000180871	"C-X-C motif chemokine receptor 2"	P25025	2	218125289-218137251	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 27.2;lymphoid tissue: 40.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 10.5;dendritic cells: 12.9;granulocytes: 6.3;NK-cells: 40.2;Squamous epithelial cells: 11.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	52	"neutrophil: 3273.9"	"Lineage enriched"	"Detected in many"	111	"granulocytes: 3273.9"	"Group enriched"	"Detected in some"	11	"BEWO: 14.5;HL-60: 8.2;HMC-1: 16.5;THP-1: 15.3;U-937: 15.1"					"Low region specificity"	"Detected in all"			"CAB016268, HPA031999, HPA032017"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle"		Yes	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Microtubules, Mitotic spindle"	"CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112"	"unprognostic (4.89e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.48e-2)"	13.8	1.5	0.3	40.0	0.6	7.3	0.8	0.2	2.6	4.5	0.1	0.9	0.2	0.4	1.3	27.2	2.9	7.8	1.0	0.3	0.1	0.4	2.4	6.5	0.7	0.6	0.5	0.4	2.9	0.4	0.2	4.6	1.4	0.6	0.7	0.0	3.0	3.8	0.5	4.8	1.2	2.4	0.3	27.3	0.7	0.2	0.5	2.8	0.6	11.6	3.0	7.8	7.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.2	16.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	1.3	0.2	0.0	0.0	0.4	0.0	1.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.5	0.0	15.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	15.1	0.0	63.5	29.5	50.3	28.8	7.4	0.4	0.2	1.3	7.3	13.5	0.2	1.1	9.9	3273.9	6.8	3.6	25.0	0.5	17.4	0.3	0.6	0.2	2.6	0.3	0.1	0.6	0.5	1.4	0.3	0.5	0.4	0.0	0.0	10.5	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.4	0.2	0.0	1.9	0.0	0.0	0.7	12.9	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	6.3	3.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.2	1.6	0.0	0.0	2.8	0.0	1.0	3.7	0.0	40.2	0.0	0.1	0.0	2.2	0.0	1.4	0.1	0.0	0.1	0.3	0.0	0.0	0.4	0.4	0.0	0.0	11.6	0.1	0.3	4.1	0.1	0.1	1.9
CYP17A1	"CPT7, CYP17, P450C17, S17AH"	ENSG00000148795	"Cytochrome P450 family 17 subfamily A member 1"	P05093	10	102830531-102837472	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Steroidogenesis	"Lyase, Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	84	"adrenal gland: 8229.5"	"Cell type enriched"	"Detected in some"	17	"Theca cells: 1871.0"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 22.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 3.0;SCLC-21H: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048533	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA048533: AB_2680432"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.39e-4)"	"unprognostic (8.26e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.43e-7)"	"unprognostic (1.07e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.94e-4)"	0.4	8229.5	0.0	2.1	0.0	0.0	0.4	0.1	0.1	1.1	0.0	0.5	0.0	0.8	0.1	0.9	1.0	0.4	1.0	0.0	0.0	52.9	6.7	1.4	0.0	0.0	0.1	16.6	1.7	10.5	0.7	0.0	0.0	0.7	0.0	0.2	3.4	0.0	1.0	0.7	0.6	0.0	0.0	0.9	1.3	98.3	0.0	0.0	2.9	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	2.2	0.1	0.4	0.1	0.0	0.5	0.0	0.1	0.7	0.0	0.0	1.8	0.0	0.4	0.1	0.1	21.5	0.0	41.6	0.1	0.0	0.7	0.0	2.7	0.1	0.2	0.0	1.3	0.0	0.1	0.0	0.1	0.4	6.1	0.1	1.7	0.1	0.0	0.0	0.6	0.7	10.6	1.8	0.9	0.0	0.0	0.1	0.2	3.1	0.5	0.1	0.7	0.0	0.0	0.0	0.3	0.0	104.3	0.0	1.2	0.0	1.2	0.6	0.3	0.1	0.0	0.0	0.3	0.4	1871.0	0.0	0.1
CYP2F1	CYP2F	ENSG00000197446	"Cytochrome P450 family 2 subfamily F member 1"	P24903	19	41114432-41128381	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 1.4;salivary gland: 1.0;testis: 2.1"	"Cell type enriched"	"Detected in some"	4	"Club cells: 67.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"HMC-1: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (2.04e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.63e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.29e-3)"		"unprognostic (6.23e-3)"		"unprognostic (2.87e-2)"	"unprognostic (3.91e-2)"		"unprognostic (1.58e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.50e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.5	0.0	67.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	16.5	0.0	0.0	0.0	1.6	8.0	5.3	1.5	0.0	0.0	0.6	0.0	0.0	0.1
CYTH4	"CYT4, cytohesin-4, PSCD4"	ENSG00000100055	"Cytohesin 4"	Q9UIA0	22	37282027-37315341	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 58.3;lymphoid tissue: 67.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 117.5;granulocytes: 57.0;Hofbauer cells: 76.8;Kupffer cells: 71.5;Langerhans cells: 87.5;Macrophages: 55.0;NK-cells: 120.5;T-cells: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 34.1;HMC-1: 141.1;THP-1: 95.2;U-266/70: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004065, HPA071573"	Approved		Supported	"Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Cytokinetic bridge, Centriolar satellite, Cytosol"	"HPA004065: , HPA071573: AB_2686418"	"unprognostic (4.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.28e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.42e-2)"	"prognostic unfavorable (2.41e-8)"	"unprognostic (3.70e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.07e-1)"	21.5	8.8	4.9	67.3	4.5	58.3	5.1	4.4	8.5	5.3	6.0	10.7	8.5	4.4	1.6	6.1	4.8	16.4	5.6	4.7	5.6	4.1	5.7	18.9	57.0	8.8	7.4	3.4	2.5	2.1	2.9	28.0	7.8	3.6	10.0	0.3	7.3	4.3	2.2	2.2	15.2	12.9	6.7	59.2	11.5	2.7	9.7	25.6	3.0	5.1	40.3	23.2	2.5	9.1	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.8	9.3	0.3	0.0	2.5	0.1	0.0	0.6	0.0	5.3	0.0	9.8	0.0	0.0	0.0	34.1	141.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	23.2	0.0	0.0	0.5	13.5	0.0	0.1	1.0	1.3	0.2	19.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	95.2	0.3	0.0	0.1	0.1	0.0	28.4	4.0	4.5	18.5	11.5	0.2	15.8	62.6	87.5	55.4	102.5	39.0	30.3	30.5	44.8	47.5	31.8	30.0	38.3	199.1	45.0	129.4	113.8	30.7	76.2	4.9	4.5	4.4	8.5	4.7	5.6	8.8	7.4	7.8	6.7	9.7	9.1	1.1	3.2	8.4	0.0	37.0	2.4	0.8	0.0	0.6	0.1	0.7	1.5	2.0	0.0	1.8	0.0	0.0	0.5	117.5	0.1	0.0	0.0	0.4	0.1	0.2	2.5	0.0	2.5	0.2	0.2	0.6	1.9	2.0	0.1	57.0	0.0	2.2	1.1	76.8	0.0	0.2	0.2	0.0	71.5	87.5	0.9	0.6	55.0	7.2	24.4	42.7	0.0	120.5	0.5	0.0	0.8	0.0	0.0	25.1	0.3	0.0	0.8	0.0	0.1	0.0	0.9	1.0	0.0	0.2	0.3	2.3	1.0	43.9	0.0	0.2	0.5
DAPK1	"DAPK, ROCO3"	ENSG00000196730	"Death associated protein kinase 1"	P53355	9	87497228-87708634	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Apoptosis, Translation regulation"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 139.1;Excitatory neurons: 120.2;Inhibitory neurons: 155.9;Kupffer cells: 85.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.7;eosinophil: 8.7;intermediate monocyte: 14.0;myeloid DC: 4.8;non-classical monocyte: 15.2;plasmacytoid DC: 6.2"	"Group enriched"	"Detected in many"	56	"dendritic cells: 6.2;granulocytes: 8.7;monocytes: 15.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 97.6;HUVEC TERT2: 56.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037302, HPA040472, HPA048436"	Approved		Approved	Centrosome		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Centrosome		"CAB037302: AB_1078622, HPA040472: AB_2677001, HPA048436: AB_2680390"	"unprognostic (2.55e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (8.31e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.09e-3)"	22.9	5.9	12.1	11.8	16.4	5.4	5.9	2.2	20.5	9.6	12.6	27.1	10.1	7.9	18.8	5.5	15.2	28.0	5.2	22.8	7.6	22.0	27.6	37.5	12.5	7.6	7.6	46.0	29.2	6.7	23.4	27.3	13.8	5.2	9.2	11.5	13.7	8.5	1.8	5.0	14.4	9.4	7.8	22.8	19.5	8.1	8.6	41.8	9.8	2.3	6.8	14.5	3.8	7.5	0.0	47.5	22.5	15.8	0.7	0.3	35.4	3.1	4.4	18.3	20.4	6.8	0.3	0.4	4.7	1.0	0.2	43.9	13.9	1.0	7.9	0.4	11.4	23.4	6.6	23.7	19.5	0.0	97.6	1.4	7.5	3.5	1.4	28.5	56.3	6.5	17.8	9.6	15.4	1.5	7.0	0.0	25.4	44.4	0.0	2.0	19.8	0.1	50.6	47.6	10.2	11.3	0.0	4.6	20.1	32.7	0.0	15.2	0.4	0.1	0.3	0.1	0.1	36.9	8.1	0.0	0.2	6.4	3.0	1.7	6.7	8.7	0.0	14.0	0.0	0.1	0.0	0.0	4.8	0.0	0.0	0.1	2.0	0.1	15.2	6.2	0.0	3.0	12.1	16.4	2.2	20.5	22.8	7.6	7.6	7.6	13.8	7.8	8.6	7.5	8.8	51.3	72.2	139.1	2.7	3.6	0.8	1.2	0.6	19.4	1.3	2.3	2.4	31.5	24.3	22.0	2.1	6.8	9.5	1.1	1.9	33.8	1.8	30.2	7.9	17.3	0.0	12.8	120.2	23.0	19.0	12.3	26.5	58.6	24.1	22.1	68.9	20.8	22.7	18.5	155.9	9.3	0.0	85.7	18.3	3.1	14.9	57.1	12.4	18.7	41.2	14.6	2.1	6.6	4.7	35.8	1.9	13.5	6.2	3.2	9.6	7.0	10.2	2.9	0.0	1.5	3.9	3.4	7.2	1.6	3.1	14.2	2.8	3.4	3.7	14.9
DAPK2	"DRP-1, MGC119312"	ENSG00000035664	"Death associated protein kinase 2"	Q9UIK4	15	63907036-64072033	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 50.2;thyroid gland: 41.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 86.6;Late spermatids: 112.5;Oligodendrocytes: 99.9;Proximal enterocytes: 64.0"	"Cancer enriched"	"Detected in many"	15	"thyroid cancer: 30.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"basophil: 94.3;eosinophil: 213.0;neutrophil: 65.9"	"Lineage enriched"	"Detected in many"	25	"granulocytes: 213.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 10.6;HaCaT: 9.2;HMC-1: 18.3;MCF7: 9.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071581			Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"		"HPA071581: AB_2686421"	"unprognostic (3.20e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.77e-7)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.07e-2)"	12.5	2.2	5.9	2.7	7.6	15.9	8.8	5.9	8.1	6.7	4.3	9.8	20.6	1.6	0.2	3.3	1.7	1.5	28.0	5.5	6.7	4.5	2.0	20.0	3.1	6.2	6.8	0.9	2.7	0.9	1.6	0.4	6.6	5.1	6.6	0.4	7.5	3.6	50.2	8.1	21.3	1.7	6.0	7.8	9.9	3.1	6.6	1.5	41.9	19.6	2.6	2.4	9.5	9.5	3.1	2.3	6.1	1.5	10.6	0.5	0.0	2.1	6.7	1.1	1.2	1.0	1.6	0.2	0.7	6.7	3.7	9.2	3.8	0.1	0.6	0.2	0.2	1.3	4.5	0.1	0.1	0.1	18.3	1.1	7.9	0.4	0.2	7.0	0.7	0.1	0.4	0.1	0.7	9.7	0.0	0.4	0.7	3.1	2.2	2.9	0.0	0.3	0.0	3.2	0.4	0.3	0.4	1.2	0.0	1.5	5.2	0.4	0.4	0.9	1.0	1.4	1.8	0.6	0.2	0.0	0.0	3.0	0.3	94.3	0.2	213.0	2.1	0.1	0.9	1.3	0.6	2.2	0.2	0.4	0.0	1.4	65.9	2.7	0.1	8.6	0.1	1.3	5.9	7.6	5.9	8.1	5.5	6.7	6.2	6.8	6.6	6.0	6.6	9.5	24.9	86.6	22.3	5.2	4.8	11.6	7.0	8.7	0.6	0.1	9.4	7.4	46.2	1.5	14.6	0.0	0.0	0.1	22.6	45.2	1.9	9.1	25.3	3.0	1.6	6.4	8.4	0.8	15.9	35.6	0.2	8.7	16.3	7.8	15.2	1.3	5.7	1.3	0.4	5.0	2.1	17.0	6.1	1.3	0.8	112.5	3.1	3.2	0.0	15.0	0.3	2.1	2.1	11.1	99.9	9.4	30.6	5.7	0.4	12.0	64.0	0.3	2.8	0.3	13.1	7.6	4.5	2.6	4.9	0.5	4.1	0.1	14.9	1.9	19.6	14.0
DAZAP2	KIAA0058	ENSG00000183283	"DAZ associated protein 2"	Q15038	12	51238724-51271362	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045940			Supported	"Nuclear speckles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA045940: AB_2679506"	"unprognostic (1.00e-2)"	"unprognostic (3.13e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.75e-3)"	"unprognostic (8.43e-2)"	"unprognostic (4.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (3.94e-9)"	"unprognostic (1.79e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.84e-3)"	136.4	115.7	112.2	187.5	125.3	613.5	154.0	136.6	124.4	150.5	109.8	206.2	194.9	131.6	122.5	129.9	180.5	168.0	202.1	105.1	125.9	251.4	198.4	193.2	220.6	132.7	119.8	114.1	116.5	227.3	30.7	79.5	134.4	152.8	215.5	75.2	140.7	171.8	113.5	121.4	200.5	148.4	129.8	224.3	174.3	52.7	116.5	213.2	209.8	106.7	241.5	190.3	76.3	151.5	159.8	209.0	95.4	92.2	201.1	171.5	57.6	104.6	208.9	187.7	162.8	155.9	239.0	153.2	262.2	209.9	130.0	147.8	134.2	178.4	189.2	167.3	160.2	227.1	129.7	91.0	216.4	265.5	350.2	220.5	252.1	175.3	147.2	207.2	234.8	118.8	141.6	303.1	155.4	252.6	219.8	145.6	19.6	109.2	58.7	123.2	144.7	165.3	244.9	260.2	103.3	101.0	159.3	137.9	121.3	56.7	190.5	382.7	195.7	111.1	102.4	136.9	132.6	231.5	237.5	158.6	161.2	175.0	66.9	2018.1	2144.1	3354.3	1055.9	1770.0	979.3	1090.7	962.8	1037.9	1354.1	1068.7	1063.1	918.3	3499.5	1045.4	1727.1	875.9	1420.3	4885.3	112.2	125.3	136.6	124.4	105.1	125.9	132.7	119.8	134.4	129.8	116.5	151.5	116.7	144.2	205.1	19.6	271.9	113.8	201.2	144.6	167.9	50.6	127.7	88.5	114.3	165.8	127.9	235.4	58.4	55.8	167.4	337.2	266.1	158.6	28.1	115.1	87.2	138.3	126.3	155.6	16.8	194.7	53.5	108.0	171.8	142.1	182.2	72.2	157.1	177.1	209.4	67.3	16.8	230.6	140.4	444.4	214.2	85.6	117.4	282.0	135.2	19.7	324.4	88.7	221.4	15.6	43.9	198.0	275.8	95.5	169.5	179.9	233.3	292.7	155.9	55.2	46.0	63.2	130.4	39.4	35.4	153.5	133.3	124.9	249.6	72.8	182.4	268.7
DBI	"ACBD1, ACBP"	ENSG00000155368	"Diazepam binding inhibitor, acyl-CoA binding protein"	P07108	2	119366921-119372560	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 2215.1;Proximal tubular cells: 2834.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 2479.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051428	Approved					NA	NA		9100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA051428: AB_2681482"	"unprognostic (1.24e-1)"	"prognostic favorable (5.77e-5)"	"unprognostic (4.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.70e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.45e-1)"	358.3	153.9	486.0	158.7	470.8	121.9	717.3	495.6	726.7	218.6	452.3	322.8	312.8	73.5	653.7	667.7	85.8	129.7	515.4	493.0	498.5	536.2	971.1	236.0	182.9	499.4	495.1	86.0	143.8	866.9	76.9	116.3	510.0	451.5	297.3	116.3	369.9	215.1	273.0	451.0	229.6	97.2	512.7	115.5	185.1	201.3	487.6	173.3	133.7	460.5	324.5	136.5	327.7	516.4	543.0	276.9	557.1	257.2	1339.7	1131.9	350.7	281.3	708.7	387.0	746.1	580.6	427.8	747.3	312.1	440.6	938.5	277.9	397.0	588.3	345.9	498.2	262.1	641.4	279.9	775.8	335.6	206.1	2479.2	648.2	376.5	596.2	222.1	255.4	464.3	358.8	77.0	679.2	558.8	559.1	436.5	585.9	370.2	349.7	429.7	157.4	541.4	658.5	948.1	816.5	263.2	210.1	235.3	548.5	634.9	388.8	338.0	952.8	332.5	259.3	329.8	288.8	346.3	220.9	170.5	610.0	365.7	364.8	315.3	1180.7	439.9	1077.9	472.9	489.1	347.3	461.4	367.8	465.2	748.8	505.3	279.1	419.2	285.8	450.7	402.5	791.0	615.7	792.2	486.0	470.8	495.6	726.7	493.0	498.5	499.4	495.1	510.0	512.7	487.6	516.4	505.2	150.6	613.0	46.0	256.7	289.2	249.4	724.2	190.1	37.9	806.5	1025.9	1079.6	663.4	390.0	310.8	14.6	796.5	395.6	737.5	1197.4	466.9	844.4	154.8	194.7	206.2	371.3	108.8	5.2	670.3	643.2	258.2	243.1	185.6	433.4	219.4	167.8	2215.1	1069.4	30.3	3.9	495.0	524.9	305.0	785.7	325.7	152.2	476.1	1058.3	15.0	871.5	928.6	552.0	33.2	25.0	372.7	612.0	127.5	192.0	355.0	753.6	2834.8	340.5	59.1	151.2	267.2	289.9	462.0	30.1	972.6	684.9	516.3	260.8	456.0	673.2	361.0
DENND1C	"FAM31C, FLJ22757"	ENSG00000205744	"DENN domain containing 1C"	Q8IV53	19	6467207-6482557	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 21.2;intestine: 14.4;lymphoid tissue: 35.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 27.5;dendritic cells: 30.1;granulocytes: 15.9;Hofbauer cells: 14.6;NK-cells: 35.0;T-cells: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 22.5;HEL: 15.1;HMC-1: 44.7;MOLT-4: 14.7;THP-1: 13.8;U-937: 31.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042758, HPA042839"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Nucleoplasm, Centrosome"	"HPA042758: AB_10962357, HPA042839: AB_10959898"	"unprognostic (5.94e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.91e-2)"	"prognostic favorable (1.23e-4)"	"unprognostic (7.76e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (8.95e-4)"	"prognostic favorable (7.51e-14)"	"unprognostic (1.37e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.53e-2)"	"prognostic favorable (5.62e-4)"	2.2	1.0	1.4	21.4	1.3	21.2	1.0	1.5	1.7	0.9	1.5	3.0	4.9	0.9	0.0	1.9	1.3	2.8	1.1	1.4	1.5	1.6	2.1	5.8	32.1	2.4	1.8	0.3	1.3	0.1	0.8	1.8	2.2	1.6	1.2	0.0	3.0	0.5	0.8	1.4	14.4	1.2	1.8	35.1	5.2	0.4	2.8	20.5	1.7	0.3	14.9	3.0	1.3	2.6	0.2	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.0	22.5	0.1	0.0	0.1	0.2	0.1	0.3	0.0	0.0	0.0	15.1	0.0	1.6	0.0	7.5	44.7	0.0	0.0	0.1	0.0	0.0	0.0	7.4	0.3	9.4	0.1	0.0	14.7	11.5	0.0	0.5	0.0	1.7	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	13.8	0.1	0.0	0.0	0.0	0.0	0.4	2.0	10.6	0.1	31.3	0.0	18.3	19.9	32.8	40.1	32.4	35.0	23.8	28.6	35.0	19.5	18.7	35.7	32.1	27.8	23.8	35.0	11.2	35.6	37.1	1.4	1.3	1.5	1.7	1.4	1.5	2.4	1.8	2.2	1.8	2.8	2.6	0.3	3.2	3.0	0.0	27.5	0.4	0.1	0.0	1.2	0.0	0.6	0.6	1.3	2.8	0.0	1.8	0.0	0.2	30.1	0.5	1.9	0.4	0.7	1.5	0.2	0.4	0.0	5.7	0.4	0.0	0.2	0.7	1.5	0.3	15.9	0.5	1.1	0.7	14.6	0.0	0.5	0.9	0.0	11.6	9.2	0.6	0.0	13.8	3.6	2.8	10.9	0.0	35.0	0.0	0.5	0.3	0.4	0.0	13.5	0.2	2.9	6.2	1.6	0.0	0.0	0.0	0.3	0.3	1.2	1.6	0.1	0.3	34.5	0.7	1.0	0.1
DENND4B	KIAA0476	ENSG00000198837	"DENN domain containing 4B"	O75064	1	153929501-153946718	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040188, HPA071133"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Golgi apparatus"		"HPA040188: AB_10671168, HPA071133: AB_2732173"	"unprognostic (1.75e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-3)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (9.27e-9)"	"unprognostic (4.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.56e-3)"	18.2	13.4	10.9	24.3	11.1	37.1	15.7	2.3	19.1	17.1	0.0	15.6	9.5	16.3	3.4	10.2	16.2	10.0	21.3	10.2	6.5	13.8	11.4	24.2	30.1	12.0	7.8	19.6	15.5	7.7	13.1	10.3	13.0	13.0	6.0	9.5	11.7	7.0	49.2	11.0	22.0	8.9	3.1	41.0	12.9	7.6	9.8	14.6	15.2	29.5	17.3	15.1	12.9	10.0	12.0	22.7	17.1	17.3	10.0	9.7	17.8	11.5	12.4	17.8	16.6	13.8	13.4	29.9	19.1	7.8	13.5	20.9	15.5	10.6	8.0	27.5	14.0	26.5	26.1	13.3	13.9	28.0	51.5	8.8	18.3	16.6	17.8	14.8	12.8	32.3	28.7	16.4	10.3	24.6	34.2	25.7	23.8	14.1	21.8	36.2	11.5	17.3	8.5	17.6	20.3	24.9	12.1	28.4	16.7	17.0	20.6	68.0	13.5	19.2	18.5	16.1	18.7	49.3	37.7	39.5	13.2	21.7	23.5	1.5	1.6	0.4	1.1	2.4	1.4	1.0	0.9	0.7	1.4	0.9	0.4	1.0	1.5	0.7	1.9	1.9	0.7	1.5	10.9	11.1	2.3	19.1	10.2	6.5	12.0	7.8	13.0	3.1	9.8	10.0	14.7	9.6	10.3	18.6	20.3	4.7	3.7	4.6	1.2	22.3	7.1	6.9	22.9	8.6	5.7	7.3	6.2	4.6	31.9	4.8	5.9	5.2	1.2	4.0	8.0	11.8	4.9	9.5	21.8	6.5	4.7	7.2	13.7	7.4	17.2	12.5	10.8	9.2	18.0	35.3	23.6	4.6	2.0	30.2	11.7	1.9	7.5	31.1	5.4	18.7	22.5	5.8	30.9	19.1	27.9	6.1	4.8	7.9	7.1	6.8	7.6	2.7	4.4	17.8	6.6	7.9	6.0	6.4	8.1	5.7	3.4	3.4	17.0	9.2	7.1	5.2
DEPDC5	"DEP.5, KIAA0645"	ENSG00000100150	"DEP domain containing 5, GATOR1 subcomplex subunit"	O75140	22	31753867-31908033	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 31.9;Inhibitory neurons: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 34.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 34.8"	"Cell line enhanced"	"Detected in all"		"U-698: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054969, HPA055619"	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"			"HPA054969: AB_2682655, HPA055619: AB_2682864"	"unprognostic (5.68e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.98e-3)"	"unprognostic (8.83e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.87e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.59e-3)"	"unprognostic (6.64e-2)"	"prognostic favorable (2.46e-5)"	"unprognostic (5.66e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (4.86e-5)"	6.3	7.7	6.4	5.1	6.5	4.4	5.6	8.7	10.8	8.7	5.8	7.4	3.0	6.0	3.4	7.2	6.6	3.5	4.8	6.5	6.3	5.5	9.9	5.3	6.3	6.0	5.8	11.3	4.2	4.9	6.2	3.6	6.2	5.5	5.2	4.0	6.0	3.0	5.9	6.4	8.5	3.7	5.3	9.4	6.2	7.4	6.5	4.9	5.7	3.8	9.7	6.6	7.1	8.6	5.7	5.0	9.1	5.7	4.5	4.7	7.4	3.9	6.4	5.1	6.8	6.8	3.4	13.0	1.5	5.5	4.1	5.8	6.3	6.3	9.1	6.7	5.8	6.1	6.1	6.7	4.4	20.6	19.0	5.2	3.2	9.6	4.8	4.3	9.3	4.8	4.3	3.9	7.3	5.5	5.8	5.8	4.6	9.9	2.1	11.2	10.0	7.4	6.0	12.0	6.0	6.7	7.8	4.2	5.2	6.6	4.4	11.5	8.0	5.0	6.0	5.2	3.8	5.8	5.7	31.5	5.5	6.0	5.1	34.8	2.9	15.2	2.6	3.4	3.0	6.8	1.9	1.5	2.5	4.2	3.0	3.8	1.8	4.2	3.7	1.8	2.3	1.3	6.4	6.5	8.7	10.8	6.5	6.3	6.0	5.8	6.2	5.3	6.5	8.6	4.7	0.0	3.9	20.5	12.0	2.7	1.8	3.0	5.2	4.9	4.5	2.9	4.3	2.8	5.5	7.3	2.1	3.8	4.5	10.4	3.9	5.1	1.3	4.2	6.1	5.1	13.2	2.1	31.9	4.9	3.1	4.3	6.6	6.5	5.7	18.2	4.2	4.9	3.5	16.8	29.6	6.2	6.1	3.1	2.2	2.2	1.8	6.9	3.6	24.4	3.9	4.2	5.2	23.1	24.3	4.7	5.6	2.6	4.4	1.6	4.7	2.8	5.2	5.6	6.6	3.1	3.1	4.8	5.2	4.3	2.3	2.3	5.3	11.4	5.0	1.8
DIAPH1	"DFNA1, hDIA1, LFHL1"	ENSG00000131504	"Diaphanous related formin 1"	O60610	5	141515016-141619055	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Hearing	Actin-binding	"Cancer-related genes, Deafness, Disease variant, Epilepsy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 172.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 564.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004916, HPA076913"	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA		2000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA004916: AB_1847668, HPA076913: "	"unprognostic (6.79e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.73e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.54e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (7.81e-5)"	"unprognostic (2.88e-3)"	"prognostic favorable (1.29e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.65e-1)"	27.9	20.3	21.0	42.1	22.5	90.2	24.2	18.3	20.9	24.4	40.0	31.0	40.6	18.5	44.3	58.0	25.2	30.0	34.9	21.5	25.7	38.1	91.7	51.3	67.0	18.8	19.9	12.9	37.3	44.6	24.5	25.1	20.1	14.7	31.1	28.4	36.1	19.3	172.0	47.3	36.5	18.7	18.0	36.3	45.1	19.9	27.4	68.5	33.1	55.7	66.4	47.1	30.4	18.6	147.8	92.6	53.2	68.4	40.4	54.5	71.3	59.5	62.2	67.7	70.2	318.1	131.6	156.5	88.1	85.5	103.0	157.9	116.9	191.5	84.8	88.9	66.6	282.6	121.4	103.6	37.7	198.9	564.7	34.4	102.1	94.5	95.5	30.5	87.0	234.8	101.2	106.9	67.7	141.5	217.2	256.8	51.6	75.2	61.6	240.1	87.1	87.6	129.8	158.5	69.4	37.3	146.2	184.6	59.5	47.5	77.5	92.1	52.8	93.9	49.9	52.1	119.9	54.2	94.4	111.7	50.2	153.7	57.8	23.6	12.8	29.8	32.6	14.0	21.2	9.3	20.3	25.3	12.6	9.1	14.8	23.9	13.7	13.7	15.1	10.0	18.7	15.4	21.0	22.5	18.3	20.9	21.5	25.7	18.8	19.9	20.1	18.0	27.4	18.6	33.9	48.1	46.8	11.8	40.0	52.6	60.8	22.4	21.6	17.3	35.1	23.1	18.6	22.8	48.0	44.1	54.2	20.9	96.9	60.5	5.9	62.7	27.9	42.3	18.9	39.0	5.4	52.6	44.1	98.0	31.9	25.9	76.0	83.0	46.9	14.5	16.8	91.6	17.1	6.7	33.6	23.1	12.2	38.4	60.6	9.0	11.8	78.5	19.6	24.4	54.6	12.1	115.4	25.6	9.1	122.9	35.7	10.9	54.1	77.3	35.2	13.9	30.4	69.0	13.1	15.4	26.4	18.3	26.1	38.7	59.7	52.1	92.8	18.3	30.1	91.2
DIRAS1	"Di-Ras1, GBTS1, RIG"	ENSG00000176490	"DIRAS family GTPase 1"	O95057	19	2714567-2721372	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.8;heart muscle: 105.0;tongue: 51.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 18.0;Distal tubular cells: 31.3;Excitatory neurons: 20.4;Horizontal cells: 89.2;Inhibitory neurons: 25.9"	"Cancer enhanced"	"Detected in many"		"glioma: 17.4;melanoma: 13.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 43.4;REH: 49.2;SH-SY5Y: 27.8;THP-1: 34.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050164			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA050164: "	"unprognostic (7.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.19e-3)"	"unprognostic (8.01e-3)"	"unprognostic (2.68e-1)"	"unprognostic (5.62e-2)"	"unprognostic (3.60e-2)"	"prognostic favorable (4.78e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.79e-3)"	"unprognostic (5.47e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.91e-4)"	1.8	2.5	10.5	1.2	20.7	0.7	1.9	16.1	84.8	7.0	0.0	1.4	1.2	12.7	2.5	5.4	6.6	0.7	105.0	19.8	16.9	4.8	0.1	0.6	0.6	17.1	17.4	2.7	6.7	17.0	22.4	0.3	14.5	3.3	1.1	11.5	6.7	1.8	2.7	1.9	2.2	7.4	0.0	4.2	3.5	6.0	45.2	0.1	0.5	51.8	0.7	4.0	2.4	34.8	0.1	2.2	7.0	24.1	0.9	3.1	0.1	8.2	2.8	0.4	0.1	1.4	0.4	0.0	1.0	21.9	12.2	0.1	10.1	0.0	0.0	0.0	15.6	0.5	0.8	0.9	1.0	0.0	43.4	1.4	5.1	0.1	0.1	4.6	0.0	0.2	15.0	7.2	2.8	3.6	0.2	0.4	15.2	0.0	3.3	49.2	0.0	11.7	0.0	0.0	3.1	27.8	0.3	1.1	15.6	1.2	1.1	34.2	0.0	5.3	6.6	0.2	2.6	16.4	12.4	8.9	11.8	0.5	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	20.7	16.1	84.8	19.8	16.9	17.1	17.4	14.5	0.0	45.2	34.8	0.0	0.0	0.0	1.6	6.9	1.1	0.8	0.2	2.2	7.9	2.6	2.8	18.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	31.3	1.4	0.4	0.1	2.2	0.3	0.0	1.3	20.4	2.0	0.5	0.9	0.0	0.3	0.0	2.3	0.0	0.0	5.7	89.2	25.9	0.0	0.0	0.0	3.6	1.1	1.2	0.5	3.6	4.7	0.1	4.6	0.0	2.0	3.4	1.5	0.0	0.0	0.6	0.9	0.0	0.1	0.0	6.1	0.0	0.7	2.1	0.7	0.4	0.3	0.4	0.3	0.1	0.0	0.0	0.2
DNAH8	hdhc9	ENSG00000124721	"Dynein axonemal heavy chain 8"	Q96JB1	6	38715311-39030792	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 2.6;prostate: 2.1;testis: 7.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 35.4;Late spermatids: 13.2;Spermatocytes: 33.3"	"Cancer enriched"	"Detected in single"	7	"prostate cancer: 2.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	8	"basophil: 2.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.5"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 47.1"	"Not detected"	"Not detected"							HPA028447	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA028447: AB_10599600"	"unprognostic (2.83e-1)"	"unprognostic (4.46e-4)"	"unprognostic (1.27e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.17e-9)"	"unprognostic (1.46e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-3)"	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	2.1	0.0	0.0	0.0	0.1	0.0	1.6	0.1	0.0	0.0	0.9	0.1	7.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	47.1	0.0	0.0	0.0	0.0	0.0	5.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	35.4	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.1	0.2	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	13.2	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	33.3	5.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0
DNAI2	"CILD9, DIC2"	ENSG00000171595	"Dynein axonemal intermediate chain 2"	Q9GZS0	17	74274234-74314884	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"	"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 30.4;testis: 19.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 21.7;Endometrial ciliated cells: 51.3;Late spermatids: 16.4;Respiratory ciliated cells: 68.1;Spermatocytes: 41.7"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 2.2;lung cancer: 0.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	7	"NK-cell: 3.8"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 3.8"	"Cell line enriched"	"Detected in single"	4	"HMC-1: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB006245, HPA050565"	Enhanced					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"CAB006245: AB_426059, HPA050565: AB_2681177"	"unprognostic (6.99e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.59e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.39e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.62e-3)"	0.0	0.0	0.6	0.1	0.4	0.0	0.0	0.2	0.1	1.8	6.5	0.0	0.0	0.3	0.0	0.0	30.4	0.0	0.0	0.9	0.9	0.0	0.0	3.0	0.0	3.0	4.3	0.0	0.0	0.0	0.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.9	0.0	19.3	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.3	0.0	0.6	0.4	0.2	0.1	0.9	0.9	3.0	4.3	2.1	2.3	0.8	0.7	0.0	0.0	0.0	0.7	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.7	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	21.7	51.3	0.4	0.4	0.0	0.0	0.6	0.0	0.0	0.3	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	2.0	0.0	4.4	16.4	0.6	0.3	0.0	1.0	0.6	0.0	1.0	1.0	0.9	0.0	0.0	0.4	0.0	0.1	0.0	0.1	68.1	0.0	0.0	0.0	0.9	41.7	0.5	0.0	0.0	0.0	0.4	0.6	0.2	0.0
DNM3	KIAA0820	ENSG00000197959	"Dynamin 3"	Q9UQ16	1	171841498-172418466	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 66.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 365.7;Inhibitory neurons: 631.8;Oligodendrocyte precursor cells: 976.1;Oligodendrocytes: 1970.9"	"Cancer enhanced"	"Detected in many"		"glioma: 2.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 22.9;HMC-1: 10.2;RPTEC TERT1: 19.0;U-251 MG: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064121			Approved	"Golgi apparatus"		NA	NA		70000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"HPA064121: AB_2685193"	"unprognostic (8.21e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.84e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.52e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.10e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.70e-3)"	4.2	11.9	15.3	1.0	29.9	1.3	4.0	59.4	24.3	5.8	0.0	2.4	0.6	3.2	1.3	1.3	3.2	2.7	2.1	12.2	36.0	4.1	0.4	4.4	1.1	42.8	29.5	2.6	1.1	1.2	6.2	0.4	47.8	2.6	1.1	13.4	2.1	1.6	1.2	2.4	1.4	3.1	10.6	1.8	2.7	3.2	32.3	1.8	3.3	1.3	0.8	2.2	5.1	66.9	0.8	2.5	2.0	0.4	1.5	1.0	0.0	0.5	1.2	1.0	1.3	0.0	3.7	0.0	7.5	1.1	1.2	0.3	1.5	2.9	0.9	1.0	2.9	22.9	3.7	0.0	0.1	0.5	10.2	0.7	0.5	1.2	0.7	1.1	0.5	2.0	0.0	0.3	0.4	0.0	1.5	0.1	5.8	9.5	1.7	1.5	9.9	0.0	19.0	0.1	3.9	0.8	2.7	0.7	0.2	0.7	0.0	0.9	0.3	2.8	3.8	2.3	14.3	3.8	0.7	0.2	2.7	1.2	1.0	0.0	0.1	0.0	0.2	0.0	0.3	0.2	0.3	0.1	0.2	0.0	0.3	0.5	0.3	0.3	0.1	0.0	1.4	1.2	15.3	29.9	59.4	24.3	12.2	36.0	42.8	29.5	47.8	10.6	32.3	66.9	21.8	0.0	6.8	207.3	1.5	2.4	1.5	0.7	3.4	25.1	1.4	1.3	2.4	0.0	0.4	0.0	29.2	0.1	0.7	0.2	3.9	0.3	8.2	7.3	1.3	19.5	0.0	0.8	365.7	0.4	0.1	3.2	7.1	1.0	1.3	0.8	8.2	0.2	0.7	8.4	631.8	0.7	0.0	0.6	3.1	3.9	1.8	13.4	0.0	178.0	0.3	5.9	0.0	976.1	1970.9	2.5	0.1	2.6	0.3	0.7	0.0	0.8	2.2	29.0	0.0	4.5	2.2	5.3	0.4	1.1	1.7	0.3	0.9	10.3	0.8	0.7
DOCK11	"ACG, FLJ32122, FLJ43653, ZIZ2"	ENSG00000147251	"Dedicator of cytokinesis 11"	Q5JSL3	X	118495815-118686163	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 54.3"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 100.4;Kupffer cells: 47.5;Macrophages: 45.7;Microglial cells: 67.5;NK-cells: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 63.3;HMC-1: 92.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059695	Uncertain					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA059695: AB_2684104"	"unprognostic (4.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.50e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.37e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.11e-2)"	"unprognostic (8.16e-3)"	54.3	8.2	5.7	15.4	11.2	33.6	34.9	4.1	6.8	17.1	4.7	26.0	3.1	12.6	9.7	6.1	13.7	8.5	6.9	5.6	9.9	10.8	3.5	25.8	23.7	6.3	6.8	4.2	2.3	4.4	28.3	12.8	7.1	6.7	5.7	1.2	7.0	3.1	3.8	8.2	19.9	8.9	5.8	34.1	12.3	2.6	5.6	21.0	18.3	4.8	17.8	16.6	14.3	7.7	0.1	5.9	4.8	4.5	63.3	26.8	12.7	6.7	14.5	5.5	14.2	0.7	0.1	18.2	0.6	24.3	6.5	0.2	8.5	0.0	4.8	22.7	7.4	39.8	6.2	0.2	20.4	24.3	92.3	18.9	0.4	5.8	6.4	3.8	0.2	15.6	12.3	32.0	3.5	4.1	14.6	32.2	5.0	5.3	9.2	9.7	12.3	0.6	0.1	1.3	1.7	11.3	20.3	18.7	6.6	3.7	2.2	20.3	0.3	4.4	1.4	25.5	3.0	9.8	15.7	16.6	9.5	38.1	2.3	5.7	3.3	6.2	6.4	4.9	4.1	3.7	5.4	5.2	3.6	3.8	4.8	6.1	10.1	5.9	6.2	2.8	9.1	1.8	5.7	11.2	4.1	6.8	5.6	9.9	6.3	6.8	7.1	5.8	5.6	7.7	10.9	28.9	3.7	6.8	38.3	2.9	0.1	0.4	0.6	0.5	0.7	0.9	2.7	0.0	7.7	7.3	0.0	3.0	34.5	0.3	0.0	0.2	0.5	0.4	5.4	7.4	4.2	14.7	4.4	0.0	3.2	18.7	5.1	0.3	44.4	0.2	2.9	1.1	20.6	0.0	100.4	3.2	2.0	47.5	24.9	0.6	12.2	45.7	8.8	67.5	38.6	0.3	52.5	20.6	14.8	0.7	1.5	4.9	22.7	0.4	3.0	6.3	1.2	0.4	26.3	4.3	14.0	3.8	3.3	0.6	1.8	6.8	36.6	0.2	1.3	0.4
DOCK2	KIAA0209	ENSG00000134516	"Dedicator of cytokinesis 2"	Q92608	5	169637268-170083382	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 61.6;lung: 16.4;lymphoid tissue: 51.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 53.3;dendritic cells: 78.1;Kupffer cells: 93.2;Macrophages: 78.0;Microglial cells: 173.3;monocytes: 72.5;T-cells: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 123.4;HDLM-2: 172.7;HL-60: 132.7;HMC-1: 135.8;MOLT-4: 94.5;U-698: 112.4;U-937: 85.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036469	Enhanced					NA	NA		46000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA036469: AB_2675140"	"unprognostic (3.45e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.92e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.95e-2)"	"unprognostic (7.24e-2)"	7.7	3.6	1.4	34.4	2.4	61.6	3.6	1.9	2.6	3.1	2.8	7.6	5.0	2.3	1.3	3.3	2.4	9.6	1.6	1.8	2.5	1.2	5.5	16.4	42.5	6.4	3.7	1.6	1.9	1.5	0.8	7.3	4.6	1.8	7.8	0.2	2.6	1.9	0.9	1.2	9.6	7.0	4.6	36.5	8.1	1.7	6.3	51.4	1.5	1.4	46.9	9.9	1.1	8.4	0.4	0.3	0.0	0.0	0.0	0.4	0.0	3.3	0.0	8.2	14.3	0.0	0.0	123.4	4.5	13.0	3.9	0.1	0.1	0.6	19.5	172.7	0.3	71.0	3.4	0.0	0.2	132.7	135.8	0.4	0.0	6.3	0.0	5.5	0.5	65.1	1.4	60.3	8.7	0.0	94.5	27.0	0.2	0.0	0.0	59.9	4.8	49.3	3.0	0.0	0.4	0.0	0.5	0.1	0.0	0.0	0.1	64.8	0.4	5.9	6.8	4.1	9.1	18.6	40.9	112.4	7.3	85.1	0.2	19.7	28.6	22.0	12.3	48.6	12.6	13.2	11.3	12.6	29.8	9.7	7.8	9.5	29.4	13.5	72.1	10.9	11.7	24.0	1.4	2.4	1.9	2.6	1.8	2.5	6.4	3.7	4.6	4.6	6.3	8.4	1.4	0.0	3.9	2.0	53.3	0.9	0.2	0.0	0.0	0.0	0.7	2.3	1.7	0.0	2.5	0.0	0.0	0.3	78.1	0.2	0.0	0.0	5.9	0.3	0.3	1.5	0.0	15.1	9.6	0.0	0.3	1.3	1.5	0.3	33.6	0.8	1.8	1.3	42.6	0.0	4.9	0.0	0.0	93.2	31.1	5.6	0.3	78.0	5.4	173.3	72.5	0.0	47.4	4.0	21.7	0.2	0.1	0.0	39.6	0.1	0.0	0.2	0.7	0.1	6.6	0.7	0.6	2.8	1.4	0.2	2.0	0.8	50.8	0.3	0.1	0.1
DOK2	"Dok-2, p56dok-2"	ENSG00000147443	"Docking protein 2"	O60496	8	21908873-21913690	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 25.6;lymphoid tissue: 40.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 130.6;Hofbauer cells: 131.8;Kupffer cells: 171.8;Langerhans cells: 288.4;Macrophages: 181.5;NK-cells: 344.0;T-cells: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1565.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 25.3;HEL: 54.3;HMC-1: 119.8;JURKAT: 22.3;THP-1: 43.1;U-937: 42.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004379, HPA005507, HPA066571"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		220000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Nucleoplasm, Nuclear bodies, Golgi apparatus"	"CAB004379: AB_627449, HPA005507: , HPA066571: AB_2732749"	"unprognostic (5.39e-2)"	"unprognostic (8.84e-3)"	"unprognostic (8.72e-3)"	"unprognostic (1.74e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.22e-2)"	"prognostic favorable (4.31e-4)"	"unprognostic (2.22e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.80e-1)"	9.5	5.0	1.1	26.5	1.2	19.5	5.0	1.2	2.3	1.9	2.5	5.5	7.0	2.2	0.5	2.3	3.5	6.5	3.5	1.3	1.3	3.0	6.1	25.6	26.3	1.4	1.5	1.4	1.9	0.5	1.1	7.9	1.5	2.3	3.6	0.0	3.4	1.5	2.0	2.3	9.5	6.9	1.2	40.9	6.8	1.6	4.5	16.4	2.4	1.6	7.8	8.4	2.3	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	54.3	0.0	0.1	0.0	0.4	119.8	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.8	5.0	0.0	0.0	0.9	8.7	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.1	0.3	0.0	0.1	0.2	0.1	0.2	0.1	0.3	1.4	42.0	0.2	577.6	484.3	1565.6	398.3	624.0	184.5	14.5	274.3	304.8	421.9	6.6	151.0	185.9	37.2	307.6	580.7	7.6	597.2	810.3	1.1	1.2	1.2	2.3	1.3	1.3	1.4	1.5	1.5	1.2	4.5	1.5	2.0	3.2	18.1	0.0	13.2	11.5	0.6	0.0	0.0	0.0	1.2	1.8	2.1	0.0	1.3	3.7	0.0	0.7	130.6	0.3	0.0	0.1	0.2	0.2	0.5	2.8	0.0	10.5	0.1	0.0	1.0	2.6	3.1	0.4	36.3	0.1	5.7	1.1	131.8	0.0	0.0	0.2	0.0	171.8	288.4	0.6	0.3	181.5	19.6	0.0	74.8	0.0	344.0	0.0	0.0	0.0	0.0	0.0	15.4	0.2	0.0	0.7	1.5	0.0	0.0	0.6	2.5	0.2	4.3	0.7	8.5	1.0	147.4	0.0	0.2	0.8
DOK3	FLJ22570	ENSG00000146094	"Docking protein 3"	Q7L591	5	177501904-177511274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 93.6;lymphoid tissue: 118.4"	"Group enriched"	"Detected in many"	5	"B-cells: 31.6;granulocytes: 18.3;Hofbauer cells: 55.7;Kupffer cells: 51.1;Macrophages: 38.3;monocytes: 45.4;Plasma cells: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 133.6"	"Group enriched"	"Detected in many"	6	"B-cells: 37.2;granulocytes: 133.6;monocytes: 77.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 124.0;HMC-1: 87.5;REH: 148.6;U-698: 122.1;U-937: 88.0"	"Low region specificity"	"Detected in many"							HPA077312	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"		Yes	NA		240000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Nucleoplasm, Cytokinetic bridge, Cytosol"	"HPA077312: AB_2732339"	"unprognostic (2.21e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (3.82e-11)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	11.0	6.1	5.2	30.2	6.2	93.6	4.4	6.5	7.9	3.2	6.3	8.2	6.5	3.4	1.7	5.5	7.8	4.3	4.1	6.0	7.0	5.0	6.5	27.1	31.5	11.3	6.8	2.1	4.5	0.8	3.4	7.0	10.5	5.5	3.5	2.1	6.6	2.0	3.6	2.6	28.9	4.5	6.7	118.4	5.9	8.9	9.9	4.3	4.4	4.1	32.3	7.1	4.0	8.1	5.2	7.8	5.4	6.3	3.2	0.4	13.0	4.4	1.1	14.0	12.9	11.0	2.2	124.0	3.2	4.0	6.8	8.9	12.2	7.6	6.9	26.1	14.6	21.3	21.4	2.5	1.0	46.1	87.5	1.6	4.5	16.2	1.6	1.5	1.9	11.4	14.8	50.2	5.1	12.9	2.7	52.5	12.2	1.5	12.9	148.6	9.3	1.2	4.4	5.2	7.4	4.9	2.0	2.1	6.2	4.8	11.7	63.4	2.7	12.3	11.3	6.5	5.4	11.1	15.0	122.1	2.7	88.0	2.2	16.8	62.4	57.0	0.3	61.3	0.6	37.2	0.1	0.3	14.5	19.6	0.1	0.1	133.6	0.5	77.6	1.2	0.0	28.7	5.2	6.2	6.5	7.9	6.0	7.0	11.3	6.8	10.5	6.7	9.9	8.1	1.4	0.0	5.6	1.6	31.6	0.3	0.1	0.4	1.8	0.8	1.0	0.9	0.4	0.0	0.2	0.0	0.0	0.5	0.3	0.2	0.0	0.2	0.0	0.4	0.4	1.9	0.0	6.3	4.1	0.2	0.7	1.2	0.5	0.8	18.3	0.2	7.1	0.8	55.7	0.0	3.5	0.3	0.0	51.1	2.3	0.4	0.6	38.3	1.8	3.7	45.4	0.3	2.1	0.5	0.5	0.0	0.7	1.2	38.3	0.2	0.2	0.1	0.1	0.6	0.0	1.8	0.4	3.0	1.9	0.7	0.3	1.0	2.2	0.3	0.8	0.1
DPEP2		ENSG00000167261	"Dipeptidase 2"	Q9H4A9	16	67987394-68000586	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.3;lymphoid tissue: 28.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 29.9;Kupffer cells: 55.0;Macrophages: 34.6;monocytes: 28.6;NK-cells: 25.7;Syncytiotrophoblasts: 54.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 410.0;eosinophil: 841.1;neutrophil: 358.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 841.1"	"Cell line enhanced"	"Detected in some"		"HEL: 4.1;HMC-1: 18.1;NB-4: 4.1;U-937: 6.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 12.3"	HPA035644	Approved					NA	NA		330000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA035644: AB_10670164"	"unprognostic (8.81e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.91e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (7.78e-3)"	"unprognostic (3.91e-2)"	6.0	0.9	4.3	12.6	4.4	23.3	2.8	4.3	9.3	2.3	4.1	4.1	3.3	1.4	0.6	1.8	2.8	6.2	2.4	4.1	4.8	1.8	3.8	18.5	18.8	6.3	4.9	0.6	1.0	0.9	0.7	13.4	5.1	1.5	4.1	0.2	1.7	1.2	1.4	1.2	11.9	4.0	5.1	28.6	3.2	2.8	5.6	9.0	2.5	3.3	18.3	8.1	1.3	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.2	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	4.1	0.0	0.1	0.0	0.1	18.1	0.0	0.1	0.0	0.0	0.1	0.1	1.3	0.3	0.1	0.0	0.0	0.1	4.1	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.5	0.0	0.0	0.0	0.0	1.0	0.5	0.3	0.0	6.3	0.0	410.0	82.6	841.1	17.0	101.9	19.8	30.3	29.5	13.7	33.0	35.9	34.7	17.8	358.8	44.7	126.7	5.3	31.8	48.9	4.3	4.4	4.3	9.3	4.1	4.8	6.3	4.9	5.1	5.1	5.6	6.6	0.9	0.0	7.9	0.0	20.4	2.0	0.0	0.3	1.2	0.0	0.2	0.3	1.8	0.0	1.7	0.0	0.0	10.0	8.7	0.1	0.0	0.1	0.2	0.1	0.1	4.8	0.0	2.1	0.1	0.0	0.7	1.0	0.5	0.1	2.5	0.0	18.9	0.1	29.9	0.0	0.2	0.0	2.0	55.0	21.0	1.1	0.0	34.6	3.6	10.3	28.6	0.0	25.7	0.0	0.1	0.0	0.0	0.4	3.4	0.0	0.0	0.3	8.6	0.0	0.0	0.3	0.8	12.0	9.4	0.1	1.3	54.0	13.1	0.0	0.0	0.1
DUSP19	"DUSP17, SKRP1"	ENSG00000162999	"Dual specificity phosphatase 19"	Q8WTR2	2	183078559-183100008	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.2;Endometrial ciliated cells: 17.7;Respiratory ciliated cells: 15.7;Spermatocytes: 15.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"amygdala: 1.3;basal ganglia: 2.4;cerebral cortex: 2.7;hippocampal formation: 3.8"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021501	Approved		Approved	Nucleoplasm		Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA021501: AB_1847892"	"unprognostic (1.24e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.53e-2)"	"unprognostic (5.80e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.75e-2)"	1.1	1.4	1.3	0.8	2.4	0.3	1.1	0.0	2.7	1.2	0.1	1.4	1.4	1.4	3.5	1.4	3.2	1.3	3.1	3.8	0.1	1.8	1.1	1.3	1.0	0.1	0.0	1.6	0.9	1.6	1.2	1.0	0.0	1.5	1.0	1.2	0.9	1.9	1.6	1.3	1.1	1.9	0.0	1.6	3.9	3.7	0.0	1.2	1.7	1.7	0.7	1.1	0.6	0.4	0.1	1.6	1.8	0.9	2.5	1.4	0.0	0.7	1.1	2.9	1.0	1.5	1.9	0.6	3.8	0.8	2.1	0.2	3.8	0.5	2.3	3.9	1.8	7.1	1.1	1.0	1.0	1.8	4.2	1.1	0.3	1.3	0.7	1.8	1.5	0.0	2.2	1.0	1.8	0.6	3.4	1.6	1.5	0.6	1.2	3.3	2.9	0.2	0.6	0.7	2.3	0.9	2.6	1.1	2.0	0.1	0.5	0.6	1.3	1.6	1.3	1.1	0.6	1.3	1.6	0.0	2.0	0.3	2.4	0.7	0.1	0.6	0.6	0.2	0.6	1.1	0.5	0.8	0.1	0.5	0.7	0.7	0.3	0.7	0.1	0.4	1.0	0.3	1.3	2.4	0.0	2.7	3.8	0.1	0.1	0.0	0.0	0.0	0.0	0.4	2.5	0.0	3.2	0.7	1.6	1.0	1.3	1.1	3.4	1.8	2.1	2.7	8.3	1.5	1.8	1.8	2.1	2.0	0.8	1.5	5.9	0.9	15.2	17.7	2.3	3.3	2.4	0.0	9.9	0.7	1.5	1.7	3.6	1.5	1.3	3.0	2.9	1.9	0.6	1.7	7.8	1.9	0.0	0.8	0.3	6.0	1.8	2.2	0.0	1.0	1.1	4.8	2.1	4.0	3.1	0.6	3.4	2.6	0.3	0.7	2.2	2.9	15.7	1.5	0.0	1.9	4.4	15.5	3.8	2.3	1.6	0.7	1.2	3.6	1.8	1.1
EAF2	"BM040, TRAITS, U19"	ENSG00000145088	"ELL associated factor 2"	Q96CJ1	3	121835183-121886526	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 71.8;lymphoid tissue: 53.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 73.7;Plasma cells: 144.1;Proximal tubular cells: 128.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"memory B-cell: 104.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 73.5;HL-60: 114.9;THP-1: 59.9;U-698: 93.5;U-937: 64.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA008411	Enhanced					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA008411: AB_1847950"	"unprognostic (3.43e-1)"	"prognostic favorable (2.25e-9)"	"unprognostic (1.48e-1)"	"prognostic favorable (2.66e-4)"	"unprognostic (1.00e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.89e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.04e-2)"	"unprognostic (8.34e-2)"	4.3	2.6	2.3	19.5	2.0	71.8	10.0	2.1	3.1	5.5	1.5	10.3	8.9	2.0	4.9	2.7	1.4	5.0	1.7	2.7	2.4	30.2	3.5	4.3	53.6	2.1	2.4	1.0	4.2	3.1	3.3	2.9	2.2	21.0	11.6	1.7	7.6	8.4	0.8	1.0	7.7	3.5	1.4	16.9	8.2	4.6	3.0	7.7	1.7	1.3	43.4	7.8	1.4	2.0	3.5	3.0	2.0	2.5	0.7	2.1	6.0	1.3	0.8	2.4	4.4	5.8	2.0	73.5	1.5	0.3	7.7	5.7	5.0	3.0	6.0	35.8	2.9	42.4	3.0	11.1	1.0	114.9	44.7	1.0	6.9	2.8	2.6	0.0	2.3	10.0	5.0	14.2	1.1	1.0	16.3	15.1	2.9	13.8	2.5	17.1	6.4	11.2	2.4	4.3	2.5	0.6	2.1	2.0	5.7	5.5	1.8	59.9	0.7	1.5	2.4	1.4	3.4	25.4	12.2	93.5	2.8	64.0	4.7	11.9	18.8	42.8	1.4	41.2	2.8	104.4	2.2	1.5	22.5	97.4	2.9	1.6	3.5	1.8	54.7	30.5	2.7	13.1	2.3	2.0	2.1	3.1	2.7	2.4	2.1	2.4	2.2	1.4	3.0	2.0	4.5	3.2	4.2	48.0	73.7	2.4	6.9	25.0	6.2	1.3	5.9	6.6	4.3	0.0	16.5	1.8	4.2	15.5	15.3	2.9	17.6	4.4	36.4	4.3	2.0	2.5	1.2	10.3	17.3	17.6	2.2	4.9	7.7	7.7	10.1	2.5	3.9	1.6	16.5	0.0	28.6	5.7	16.2	32.4	15.7	4.6	5.0	29.8	16.0	8.4	29.5	9.4	6.2	12.1	7.7	4.2	4.7	3.0	144.1	11.1	2.4	128.0	9.1	5.3	0.0	4.5	4.6	37.6	18.1	2.3	2.4	7.7	11.1	2.2	3.5	5.9
EDEM2	"bA4204.1, C20orf31, C20orf49, FLJ10783"	ENSG00000088298	"ER degradation enhancing alpha-mannosidase like protein 2"	Q9BV94	20	35115364-35147336	"Predicted intracellular proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 137.9;Plasma cells: 89.0;Syncytiotrophoblasts: 94.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037238, HPA048353"	Approved				"Intracellular and membrane"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB037238: AB_1840826, HPA048353: AB_2680369"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.09e-2)"	"prognostic unfavorable (4.76e-6)"	"unprognostic (4.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.29e-2)"	21.1	26.9	10.3	16.2	11.4	27.7	17.9	16.0	12.8	18.5	13.6	19.5	20.0	11.6	44.9	14.5	16.2	14.7	15.0	9.8	10.7	19.1	38.9	26.7	20.1	13.4	11.4	10.4	32.4	13.2	24.5	28.1	12.9	16.0	21.8	10.7	19.1	15.5	7.5	13.9	19.4	15.4	11.0	32.5	16.4	6.6	14.8	16.8	15.3	5.9	21.7	16.4	12.2	12.5	18.6	54.4	8.6	34.0	98.0	33.9	49.2	20.8	70.5	24.4	34.4	61.3	47.7	16.0	61.3	40.9	77.0	37.6	31.5	43.3	19.6	12.3	8.8	31.6	11.8	58.7	54.1	23.2	117.6	41.3	59.4	23.5	58.2	60.2	91.9	30.3	14.9	66.5	33.9	20.6	18.6	28.9	9.7	52.8	35.0	15.5	29.5	33.6	54.6	16.0	7.1	11.1	21.8	55.8	53.9	36.3	26.2	38.5	41.0	36.9	22.0	21.9	25.6	34.5	23.2	9.7	64.7	29.2	31.4	35.9	96.9	75.3	39.9	72.4	78.4	42.3	36.4	39.6	101.4	42.0	26.0	32.9	67.2	42.9	72.9	59.1	47.7	79.9	10.3	11.4	16.0	12.8	9.8	10.7	13.4	11.4	12.9	11.0	14.8	12.5	16.7	16.0	17.4	6.8	27.5	4.0	14.6	34.7	6.2	3.7	12.0	9.3	4.6	24.3	18.9	12.9	2.1	72.9	27.4	14.7	11.7	35.5	2.5	11.4	13.8	16.4	4.8	13.3	5.2	29.1	137.9	14.1	7.7	16.6	55.1	13.6	13.9	23.3	72.2	0.0	6.5	13.8	32.6	21.3	7.9	1.2	7.8	28.3	12.4	9.4	26.8	7.9	14.4	1.5	6.9	28.9	16.1	5.3	89.0	12.8	43.6	18.9	15.3	6.5	13.1	7.9	19.0	8.7	11.2	8.9	4.7	94.7	18.7	15.7	17.3	12.7
EEF2K	"CaMKIII, eEF-2K"	ENSG00000103319	"Eukaryotic elongation factor 2 kinase"	O00418	16	22206278-22288738	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 49.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 69.1;Late spermatids: 76.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.5;HL-60: 1.6;HMC-1: 1.8;NB-4: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007818, HPA056061"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"CAB007818: AB_598150, HPA056061: AB_2683021"	"unprognostic (4.79e-2)"	"unprognostic (6.10e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	19.8	7.1	1.0	0.4	0.9	0.7	15.9	1.5	2.2	17.2	0.7	20.1	0.3	14.3	0.7	9.1	13.1	0.3	9.2	0.9	1.2	3.6	7.8	9.0	0.5	1.1	0.9	8.2	12.9	0.0	5.2	0.4	1.2	19.6	0.2	0.3	15.0	0.2	24.9	49.0	8.1	0.3	0.9	8.0	9.8	2.3	1.4	0.0	6.3	0.0	0.2	18.8	15.4	1.1	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	1.5	0.2	0.0	0.0	0.1	0.0	0.6	0.2	1.0	0.0	1.6	1.8	0.0	0.4	0.1	0.1	0.3	0.1	0.1	0.2	1.3	0.0	0.0	0.1	1.6	0.1	0.4	0.0	0.4	1.0	0.2	0.4	0.0	0.3	0.6	0.0	0.0	0.2	0.1	0.2	0.5	0.5	0.7	0.3	1.4	0.0	0.3	0.1	0.3	1.0	1.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.4	0.1	0.0	1.0	0.9	1.5	2.2	0.9	1.2	1.1	0.9	1.2	0.9	1.4	1.1	43.7	22.4	13.3	22.5	7.3	12.6	9.6	3.9	31.3	69.1	15.4	9.3	17.3	12.8	9.8	9.2	14.6	16.3	12.7	24.2	0.0	4.9	42.9	42.4	12.6	18.4	3.0	7.6	21.2	13.4	11.7	19.2	26.0	34.9	29.2	12.0	22.5	17.7	18.7	1.7	37.4	12.3	4.1	15.3	16.2	76.6	14.3	8.7	8.8	15.9	7.9	6.1	6.2	31.7	8.6	10.2	26.3	15.8	19.6	6.6	12.5	4.0	14.9	21.6	6.6	43.5	10.0	1.3	4.2	16.9	23.0	7.8	7.8	5.7	8.1	6.7
EFCAB2	"CFAP200, DRC8, MGC12458"	ENSG00000203666	"EF-hand calcium binding domain 2"	Q5VUJ9	1	244969705-245127164	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 112.3;Endometrial ciliated cells: 103.1;Late spermatids: 132.5;Respiratory ciliated cells: 177.2;Spermatocytes: 115.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 8.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 77.1;THP-1: 70.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031206, HPA031207"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA031206: AB_10599710, HPA031207: AB_10599946"	"unprognostic (1.36e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.02e-1)"	"unprognostic (4.34e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (4.88e-2)"	13.0	10.6	11.5	6.7	13.8	14.4	16.0	14.4	21.9	8.7	26.7	6.8	3.3	21.2	17.5	10.5	36.1	14.7	15.0	11.4	14.4	11.1	5.6	12.6	9.6	18.1	16.9	11.3	9.0	15.4	8.5	16.8	13.9	8.9	12.4	17.7	8.8	13.1	19.7	6.9	7.4	11.4	14.9	7.5	12.4	28.0	12.9	7.4	26.8	7.5	10.7	8.2	4.9	16.3	7.3	9.1	20.3	5.2	7.2	16.7	24.7	9.2	9.7	11.5	10.6	23.5	19.5	25.3	19.2	11.6	12.2	5.7	8.2	5.3	7.1	2.7	5.0	12.4	41.3	10.7	15.2	12.8	77.1	14.6	11.0	15.5	14.4	13.7	18.0	0.7	48.0	20.1	10.0	7.6	2.6	34.6	26.0	10.4	6.9	48.4	3.1	6.8	29.0	12.3	15.9	21.4	16.0	6.1	13.6	22.7	5.9	70.5	2.8	14.1	5.3	7.9	33.7	6.9	12.4	17.2	11.2	35.9	11.7	0.9	1.3	2.3	0.4	1.4	0.5	3.1	0.5	0.3	4.3	3.3	0.4	0.4	3.8	2.3	1.1	8.7	0.6	1.0	11.5	13.8	14.4	21.9	11.4	14.4	18.1	16.9	13.9	14.9	12.9	16.3	13.3	3.2	14.5	76.0	11.5	5.1	11.8	17.2	10.2	12.6	11.6	11.0	58.6	8.6	23.0	23.9	14.6	16.3	9.3	5.4	50.9	8.2	112.3	103.1	18.5	11.7	18.8	17.2	54.6	10.8	46.3	15.5	11.2	11.1	0.0	13.6	12.5	7.3	11.2	5.0	90.3	6.5	22.4	21.3	6.5	132.5	9.0	13.2	7.2	42.2	6.6	19.2	1.0	74.9	75.9	5.6	6.6	6.4	12.0	7.1	2.7	35.6	177.2	19.1	6.6	15.5	15.8	115.9	30.6	5.4	3.0	34.2	7.5	8.3	6.9	10.6
EFHC2	"FLJ22843, MRX74"	ENSG00000183690	"EF-hand domain containing 2"	Q5JST6	X	44147872-44343672	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 17.1;fallopian tube: 14.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.0;Early spermatids: 78.6;Endometrial ciliated cells: 55.3;Respiratory ciliated cells: 79.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 16.4;NK-cell: 5.8"	"Group enriched"	"Detected in many"	7	"granulocytes: 16.4;NK-cells: 5.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.7;HEL: 3.7;HMC-1: 12.0;NB-4: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034492	Approved	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli fibrillar center"	"Plasma membrane"	"HPA034492: AB_10671227"	"unprognostic (1.93e-1)"	"unprognostic (7.80e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.83e-3)"	"unprognostic (5.07e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.13e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.97e-2)"	0.4	0.3	1.5	0.3	1.9	1.4	0.7	1.0	1.4	2.7	17.1	1.1	0.3	3.7	3.4	1.8	14.7	1.4	3.7	1.5	2.1	1.8	0.0	2.0	0.2	5.2	3.9	1.7	0.1	0.2	3.1	0.8	2.8	1.9	0.3	2.0	8.2	3.6	0.0	3.5	0.5	1.6	2.7	0.3	0.9	6.7	2.5	0.5	2.3	0.1	0.4	0.5	0.9	2.6	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	3.7	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.1	0.0	0.1	3.7	0.0	0.0	0.0	0.0	12.0	0.2	0.2	0.1	0.0	0.1	0.0	0.6	1.1	0.0	0.0	0.0	0.0	1.9	0.4	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	16.4	0.0	0.0	1.5	0.0	0.6	0.1	0.6	0.1	0.3	0.1	0.5	0.7	1.5	5.8	0.0	0.0	0.0	0.9	1.5	1.9	1.0	1.4	1.5	2.1	5.2	3.9	2.8	2.7	2.5	2.6	0.1	0.0	3.9	32.0	0.0	3.1	6.0	9.6	1.2	0.2	0.4	0.5	10.8	4.3	5.1	0.0	2.1	0.0	1.6	1.2	1.9	0.9	78.6	55.3	6.0	0.3	0.0	1.7	7.2	5.9	0.1	0.8	0.0	17.1	16.4	3.8	0.4	0.0	0.3	0.0	1.7	1.5	4.1	0.0	0.4	19.0	6.8	4.9	0.0	0.0	0.4	5.3	3.1	1.5	0.2	1.0	0.0	7.2	0.2	1.0	3.8	0.7	79.6	0.1	6.6	0.1	3.7	11.3	10.5	7.3	2.8	0.3	1.6	0.4	5.2	6.0
EGR4	"NGFI-C, PAT133"	ENSG00000135625	"Early growth response 4"	Q05215	2	73290929-73293701	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 54.0"	"Cell type enriched"	"Detected in many"	6	"Enteroendocrine cells: 99.5"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"cerebellum: 31.4;cerebral cortex: 54.0;hippocampal formation: 22.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"HMC-1: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028983	Enhanced					NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA028983: AB_10603665"	"unprognostic (7.75e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.39e-4)"	"unprognostic (2.43e-3)"	"unprognostic (2.68e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.07e-3)"	0.2	0.1	2.6	0.1	5.5	0.1	0.0	31.4	54.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	22.1	1.6	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	3.4	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	5.5	31.4	54.0	22.1	1.6	0.0	2.4	2.4	0.0	1.5	2.6	1.3	0.0	0.0	0.0	2.6	2.7	13.2	0.6	0.6	3.0	6.8	7.2	1.2	0.0	0.2	0.0	0.0	0.1	5.0	0.4	0.0	0.2	0.0	2.9	7.0	1.0	99.5	0.0	3.8	1.0	0.3	0.7	5.1	15.9	8.9	16.1	0.0	0.0	0.2	0.0	0.5	0.6	2.0	0.6	5.3	0.6	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	1.1	0.0	1.0	10.8	0.0	0.0	0.1	0.8	0.0	0.2	5.7	0.2	13.2	1.7	2.3	0.8	1.5	3.4	0.8	0.2
ELF1		ENSG00000120690	"E74 like ETS transcription factor 1"	P32519	13	40931924-41061440	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 200.9"	"Cell type enhanced"	"Detected in all"		"T-cells: 365.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 271.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001755, CAB005172"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB005172: AB_631428, HPA001755: AB_1078732"	"unprognostic (1.21e-1)"	"unprognostic (8.73e-3)"	"unprognostic (4.20e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.72e-2)"	64.2	22.5	8.8	64.3	14.5	200.9	45.3	13.8	9.9	45.8	11.1	45.6	53.4	35.3	28.9	52.6	41.1	59.6	29.1	8.9	12.4	31.9	50.4	47.3	95.3	19.7	14.1	34.6	56.1	39.8	9.7	48.6	19.5	35.2	48.3	4.2	35.3	33.9	21.3	38.5	57.8	43.9	13.7	68.3	49.7	15.1	14.9	134.5	54.9	25.9	96.9	61.3	36.5	21.0	35.5	20.5	15.3	15.3	68.6	72.6	57.2	35.9	84.9	48.7	55.1	51.2	90.9	199.7	22.1	60.4	36.5	78.7	2.9	45.4	30.8	44.9	23.7	179.6	16.3	36.5	50.9	103.3	271.2	75.1	78.5	32.9	62.0	32.8	69.2	93.1	45.0	51.7	32.4	32.5	136.6	63.1	12.1	117.7	15.8	179.2	25.1	58.7	49.9	54.8	6.1	21.3	31.0	31.0	62.9	21.2	22.0	132.8	63.8	21.5	12.4	17.7	13.0	23.7	14.8	131.2	29.0	65.0	45.9	265.9	60.4	134.2	70.0	66.1	73.8	63.0	79.3	77.9	58.6	65.1	84.8	75.9	97.4	73.0	98.4	38.9	86.8	80.1	8.8	14.5	13.8	9.9	8.9	12.4	19.7	14.1	19.5	13.7	14.9	21.0	156.8	76.9	68.0	51.6	326.8	108.8	188.2	86.0	90.0	2.8	71.5	37.7	41.3	52.9	86.1	57.0	10.4	35.7	292.0	62.9	19.6	70.2	47.7	121.6	69.5	122.0	58.1	78.8	8.2	69.4	55.8	79.0	64.2	126.0	323.1	8.1	91.4	25.2	97.5	3.3	8.6	57.0	95.6	115.4	206.3	21.9	42.9	244.1	120.9	125.5	123.5	8.1	133.9	52.8	138.7	65.9	54.4	43.2	211.5	150.4	58.7	28.3	84.6	3.7	39.5	52.7	52.8	7.7	11.2	95.6	114.8	53.5	365.3	26.9	56.0	221.9
ELK4	SAP1	ENSG00000158711	"ETS transcription factor ELK4"	P28324	1	205597556-205632011	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 104.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 6.6"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028863	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA028863: AB_10602492"	"unprognostic (2.08e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (4.65e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (2.94e-6)"	"unprognostic (2.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.58e-3)"	9.0	4.9	7.4	11.5	11.0	11.7	8.1	12.2	7.5	8.2	7.0	6.9	6.1	7.7	7.2	8.0	6.7	9.2	7.0	6.0	6.4	7.8	13.2	9.7	17.5	8.5	8.8	6.7	8.1	7.8	5.5	7.9	9.9	26.0	6.8	9.3	8.2	5.7	10.6	13.5	9.6	6.1	9.1	15.8	7.7	7.3	8.5	14.1	6.9	8.7	16.8	9.6	9.3	14.1	14.9	13.2	5.1	13.3	11.9	15.2	12.9	9.8	10.1	7.6	8.9	5.7	14.6	31.3	9.0	12.2	5.7	18.0	10.9	12.0	13.1	35.9	7.7	13.6	22.0	12.2	16.1	25.7	51.8	13.4	14.5	12.0	24.4	14.7	32.3	14.8	12.7	25.6	10.7	20.1	21.3	9.5	8.5	3.4	7.8	15.7	31.2	25.4	10.2	32.0	5.9	7.0	25.2	13.7	17.3	8.9	12.7	8.5	23.5	15.3	17.8	13.7	18.8	19.1	18.9	21.1	13.3	10.3	18.2	6.6	0.4	0.7	0.8	0.5	1.1	0.7	0.9	1.1	0.6	1.1	1.1	1.6	0.2	0.6	0.3	0.8	1.0	0.4	7.4	11.0	12.2	7.5	6.0	6.4	8.5	8.8	9.9	9.1	8.5	14.1	50.7	9.6	16.2	7.2	39.3	39.4	35.3	19.0	9.6	104.8	15.1	11.9	20.8	34.3	17.8	31.3	12.5	15.6	34.0	13.8	3.9	14.7	17.4	37.7	37.4	40.1	13.1	21.4	22.8	17.8	6.2	23.2	18.3	82.5	28.5	12.8	36.4	30.2	10.0	25.2	11.7	18.3	14.2	23.5	39.1	19.5	25.4	22.3	30.2	27.2	22.3	11.2	39.1	17.6	28.0	17.5	9.0	15.4	18.6	71.3	14.4	17.5	24.9	26.9	26.3	28.5	21.4	24.6	11.6	19.2	48.6	18.3	32.6	16.7	17.5	103.1
ELSPBP1	"E12, EDDM12, HE12"	ENSG00000169393	"Epididymal sperm binding protein 1"	Q96BH3	19	47994632-48025154	"Predicted intracellular proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"epididymis: 2828.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 22.0;Cone photoreceptor cells: 16.7;Early spermatids: 32.0;Horizontal cells: 18.5;Late spermatids: 28.8;Muller glia cells: 20.4;Rod photoreceptor cells: 120.5"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HMC-1: 10.1;NB-4: 5.5"					"Not detected"	"Not detected"			"HPA044256, HPA050341"	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA044256: AB_2678879, HPA050341: AB_2681097"					"unprognostic (1.51e-1)"				"unprognostic (1.11e-1)"						"unprognostic (1.87e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2828.6	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	32.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	18.5	0.1	0.0	0.0	0.0	0.0	28.8	0.6	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	120.5	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EMILIN2	"FLJ33200, FOAP-10"	ENSG00000132205	"Elastin microfibril interfacer 2"	Q9BXX0	18	2847006-2916003	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 76.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 98.0;Hofbauer cells: 61.1;Kupffer cells: 52.9;Langerhans cells: 99.7;Macrophages: 97.5;monocytes: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 48.2;BEWO: 37.8;HL-60: 37.8;HMC-1: 60.6;HSkMC: 26.1;SuSa: 25.7;THP-1: 36.7;U-2197: 46.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 25.7"	HPA064576	Supported				"Secreted to extracellular matrix"	NA	NA		840000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA064576: AB_2732717"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.91e-3)"	"prognostic unfavorable (6.30e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.96e-1)"	13.0	1.3	1.2	17.2	2.2	11.3	5.1	4.8	1.7	5.3	2.2	2.8	1.6	6.4	0.8	2.4	4.7	5.9	6.8	0.7	1.2	1.1	1.5	11.9	2.4	8.1	4.4	5.9	1.4	76.0	0.4	21.9	5.8	1.0	3.3	0.1	2.3	1.2	0.8	2.7	2.2	8.4	6.6	3.9	1.6	1.8	7.4	2.9	1.6	2.4	2.0	8.0	4.0	10.6	0.2	0.4	2.9	0.0	48.2	19.9	37.8	7.9	0.0	1.4	2.4	5.6	0.1	0.0	0.6	19.3	0.5	0.1	1.0	0.0	2.6	0.0	2.6	0.5	0.2	0.4	1.6	37.8	60.6	26.1	0.0	1.5	0.0	0.0	0.2	0.6	0.1	0.1	0.0	0.0	0.1	10.4	4.9	0.4	0.1	0.1	2.5	0.0	0.1	0.2	0.4	0.2	0.2	0.3	1.4	25.7	0.0	36.7	0.4	0.0	5.2	46.7	0.4	0.0	0.0	0.0	3.1	9.1	1.0	5.5	1.1	0.3	0.4	0.8	0.3	0.2	0.4	0.3	1.1	0.3	0.2	0.4	1.1	1.5	0.7	0.7	0.3	0.4	1.2	2.2	4.8	1.7	0.7	1.2	8.1	4.4	5.8	6.6	7.4	10.6	6.8	3.2	6.7	0.0	13.7	5.7	3.3	0.5	0.6	0.1	2.8	3.0	15.7	1.5	5.3	3.7	0.0	4.7	14.5	2.8	1.9	2.7	2.3	19.3	98.0	8.8	3.0	6.7	0.5	1.1	11.9	31.4	5.6	46.0	46.3	5.7	2.9	0.5	61.1	0.0	1.2	4.9	0.0	52.9	99.7	2.3	15.2	97.5	5.4	2.8	51.0	0.0	7.2	11.1	9.1	2.4	7.9	1.2	2.7	3.5	1.5	1.7	4.0	0.2	0.0	2.3	8.7	4.9	5.5	0.4	4.0	2.9	9.6	14.7	5.1	2.8
ESYT1	"FAM62A, KIAA0747, MBC2"	ENSG00000139641	"Extended synaptotagmin 1"	Q9BSJ8	12	56118250-56144674	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016858, HPA076926"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		720000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum"		"HPA016858: AB_1848404, HPA076926: AB_2686819"	"unprognostic (5.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.28e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.29e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (3.04e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.98e-2)"	107.9	39.3	15.2	38.5	14.4	18.7	72.7	18.5	18.9	36.6	19.8	45.9	17.2	53.4	22.2	29.2	47.1	27.8	24.5	13.5	23.0	26.8	46.7	45.0	45.9	34.2	21.7	38.8	39.5	40.7	11.7	38.7	36.2	30.5	36.2	8.9	28.0	47.2	54.2	26.1	30.7	74.4	22.5	37.2	29.3	12.1	23.6	36.6	27.8	33.3	49.8	44.7	32.3	24.0	107.0	78.1	62.2	158.2	90.8	67.3	53.4	117.4	129.3	136.2	94.4	72.4	114.3	40.8	92.2	201.3	50.7	118.7	73.7	120.4	121.6	58.8	54.2	244.7	56.0	58.5	125.9	193.2	371.6	76.7	125.5	147.1	81.3	145.3	117.8	39.2	153.6	263.9	124.4	81.2	70.4	116.4	78.9	44.6	102.5	105.4	85.0	107.3	113.7	89.0	52.4	54.8	174.1	52.9	80.5	71.3	111.1	128.4	154.5	104.8	94.7	59.7	85.7	62.3	99.0	58.7	97.3	79.6	111.7	423.2	37.4	423.0	127.2	69.4	157.2	62.4	129.4	129.5	87.2	48.2	102.3	120.2	9.3	84.2	85.6	29.7	139.6	177.8	15.2	14.4	18.5	18.9	13.5	23.0	34.2	21.7	36.2	22.5	23.6	24.0	44.4	9.6	9.3	4.6	25.9	16.3	19.8	23.5	14.2	5.5	20.5	21.3	8.2	14.3	12.9	31.3	10.4	31.9	22.3	6.1	0.0	36.8	2.0	20.5	15.1	28.2	25.2	17.9	10.2	26.8	18.1	17.6	9.2	19.3	62.7	24.7	27.1	37.8	46.4	0.0	7.1	12.0	22.4	21.3	24.8	2.1	17.4	22.9	35.6	6.5	50.6	5.7	60.8	2.0	4.1	26.2	3.5	25.2	18.5	19.9	2.2	4.4	10.7	5.9	52.6	14.3	22.0	3.9	2.9	18.0	11.9	37.9	40.3	12.5	10.8	12.7
EVI2B	"CD361, D17S376, EVDB"	ENSG00000185862	"Ecotropic viral integration site 2B"	P34910	17	31303770-31314105	"CD markers, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 189.0;lymphoid tissue: 169.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 233.2;Kupffer cells: 522.3;Langerhans cells: 169.8;Macrophages: 271.9;monocytes: 426.4;T-cells: 170.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1366.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 1366.0;monocytes: 381.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 87.9;HL-60: 99.9;HMC-1: 133.3;Karpas-707: 96.4;NB-4: 79.4;RPMI-8226: 147.7;THP-1: 124.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007346, HPA053383"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"		"HPA007346: , HPA053383: "	"unprognostic (1.07e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.56e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.73e-2)"	24.6	11.0	6.4	100.9	7.3	189.0	13.8	7.3	11.6	13.1	8.7	27.9	23.7	7.4	4.3	11.8	7.8	30.5	6.7	6.3	8.4	5.1	24.9	61.1	159.5	13.3	10.3	5.5	3.0	3.8	1.8	15.4	10.8	7.4	30.5	1.2	11.8	6.1	2.0	5.1	39.2	17.0	7.7	158.8	33.7	3.7	8.5	76.4	5.3	12.2	169.8	38.5	4.1	11.1	0.6	0.7	0.0	0.0	6.5	8.3	0.1	0.8	5.8	6.7	12.4	0.0	3.4	87.9	0.1	5.5	26.4	0.6	0.0	1.2	7.5	0.1	0.0	2.1	0.0	0.0	66.0	99.9	133.3	15.3	0.0	3.9	5.3	2.2	6.9	7.3	1.4	96.4	19.8	0.0	29.4	79.4	0.1	0.0	0.0	51.0	0.4	147.7	0.3	0.2	0.0	0.1	0.4	0.2	0.5	0.0	0.0	124.8	7.2	1.9	0.2	0.7	7.0	18.4	0.9	18.9	8.6	34.0	2.2	1005.3	328.9	798.7	79.2	240.1	76.8	183.6	120.8	102.8	149.9	146.2	91.9	87.5	1366.0	44.2	381.9	86.3	173.6	251.4	6.4	7.3	7.3	11.6	6.3	8.4	13.3	10.3	10.8	7.7	8.5	11.1	2.1	0.0	14.8	0.7	233.2	5.4	0.7	0.7	1.8	0.2	1.5	1.7	1.0	2.8	6.7	1.8	0.0	0.6	129.0	1.3	0.0	0.3	8.3	0.1	0.3	5.6	0.0	6.5	2.7	0.0	0.8	4.0	1.5	0.4	82.2	0.0	7.5	2.3	89.1	0.0	3.1	0.1	2.0	522.3	169.8	9.0	0.0	271.9	37.4	11.2	426.4	0.0	117.4	4.0	31.7	1.0	0.0	0.4	110.4	0.4	0.1	1.1	2.4	0.8	19.7	1.2	1.9	0.4	0.4	0.4	3.7	0.3	170.9	0.0	1.3	1.1
EXD3	"FLJ20433, LOC54932, mut-7, Nbr"	ENSG00000187609	"Exonuclease 3'-5' domain containing 3"	Q8N9H8	9	137306896-137423211	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 73.2;Paneth cells: 178.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 29.4"					"Low region specificity"	"Detected in all"			HPA047395	Approved		Approved	"Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 72: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Focal adhesion sites"	"Actin filaments"	"HPA047395: AB_10962864"	"unprognostic (2.91e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.75e-3)"	"prognostic favorable (4.30e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.72e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.99e-3)"	"unprognostic (2.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (5.05e-2)"	9.4	10.1	6.2	3.5	6.8	3.5	10.8	5.9	11.0	11.5	6.6	16.0	9.4	9.9	1.5	11.6	12.3	4.2	11.2	6.5	5.8	12.2	8.1	10.2	3.8	7.2	6.1	10.7	9.8	3.7	13.5	3.4	6.4	14.5	3.6	0.8	10.1	3.7	9.5	10.2	11.3	1.4	5.5	14.8	12.3	4.8	6.1	1.1	11.4	2.6	2.3	10.9	11.2	6.3	8.3	7.0	3.3	9.5	2.8	4.0	7.8	4.0	4.5	3.5	5.3	4.8	17.5	3.5	9.1	3.1	8.7	14.5	1.0	4.4	1.1	8.2	8.1	2.6	13.0	7.9	8.5	1.9	29.4	4.8	6.0	3.1	2.8	10.2	11.9	0.0	7.0	6.4	3.0	22.3	0.1	6.9	3.8	18.1	4.7	6.3	2.6	25.3	7.1	4.7	4.5	7.7	4.0	8.4	3.8	3.8	13.6	9.3	15.0	4.8	4.4	7.5	6.2	8.1	4.1	3.0	8.7	6.4	7.4	10.7	3.4	7.8	2.2	4.5	2.7	2.6	4.0	2.1	3.9	2.4	3.1	2.5	0.8	4.1	4.4	2.5	6.1	2.3	6.2	6.8	5.9	11.0	6.5	5.8	7.2	6.1	6.4	5.5	6.1	6.3	17.6	0.0	6.3	24.2	5.3	5.9	10.0	8.9	13.6	14.6	13.5	17.0	5.2	10.0	11.2	7.3	14.6	9.9	8.1	46.4	9.8	6.8	17.9	11.5	6.5	14.1	7.3	5.0	21.6	11.3	3.3	7.3	19.4	13.1	61.7	10.5	17.2	7.2	9.2	21.9	24.1	27.6	16.2	5.4	7.3	73.2	5.9	6.9	3.6	13.1	6.2	10.0	12.3	26.2	14.6	6.4	178.2	7.9	6.6	10.0	31.3	11.9	9.3	10.4	13.1	5.5	9.9	2.3	8.9	9.9	8.9	4.0	6.4	19.5	39.0	9.2
FAM102A	"bA203J24.7, C9orf132, Eeig1, SYM-3A"	ENSG00000167106	"Family with sequence similarity 102 member A"	Q5T9C2	9	127940582-127980989	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 131.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036030			Approved	Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA036030: AB_10670675"	"unprognostic (3.27e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.06e-3)"	"unprognostic (4.69e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.97e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.28e-3)"	"unprognostic (6.98e-2)"	11.4	40.6	63.9	35.4	86.8	13.9	19.7	64.4	77.2	52.5	20.3	38.9	55.6	33.5	19.4	61.1	47.5	46.7	14.1	59.0	58.0	37.4	39.0	16.1	59.3	76.5	79.4	20.6	35.1	22.4	51.2	9.0	70.7	23.7	17.5	14.5	44.0	20.1	4.0	45.2	65.7	27.2	60.4	27.3	105.5	32.6	91.2	40.1	23.3	3.9	44.7	37.1	47.0	144.1	26.5	56.7	11.9	9.6	25.1	30.0	45.1	10.1	27.4	6.6	4.1	33.1	46.0	29.8	6.6	19.4	14.2	28.4	6.3	5.1	2.5	14.4	6.3	8.9	14.5	30.1	15.6	4.4	66.3	12.2	26.0	18.9	8.0	13.3	9.2	18.0	7.4	36.7	7.7	68.6	17.8	9.5	14.8	52.0	27.4	9.2	8.8	10.7	19.1	44.3	18.7	9.2	16.7	36.9	23.9	12.8	69.3	5.7	9.8	10.3	11.1	55.1	15.5	49.1	72.7	20.7	44.7	5.9	24.9	0.7	0.1	2.5	1.9	0.0	6.1	4.8	9.7	5.7	0.1	1.1	8.9	6.3	0.1	0.4	0.1	0.0	13.4	3.9	63.9	86.8	64.4	77.2	59.0	58.0	76.5	79.4	70.7	60.4	91.2	144.1	3.3	6.4	9.0	37.5	37.2	21.9	29.4	11.5	24.5	15.6	44.9	26.9	11.4	41.5	14.9	64.4	10.4	6.3	10.7	91.2	7.9	61.5	7.0	51.0	35.8	8.6	28.1	8.0	13.8	100.5	5.9	12.4	99.4	46.0	18.4	22.3	54.7	49.1	3.3	26.9	12.2	42.1	40.7	6.9	8.8	7.4	34.2	3.8	23.2	5.6	4.4	69.0	1.0	26.2	103.5	59.3	51.9	43.2	22.6	69.9	131.9	12.9	33.2	14.3	0.0	6.0	7.4	9.8	10.2	38.6	47.9	5.3	40.3	13.1	28.7	122.4
FAM104A	FLJ14775	ENSG00000133193	"Family with sequence similarity 104 member A"	Q969W3	17	73207353-73236753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 44.8;testis: 153.0"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1305.1;Late spermatids: 1771.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA021459, HPA079514"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA021459: AB_1848361, HPA079514: "	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (5.19e-2)"	"unprognostic (2.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.26e-10)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	16.6	11.7	13.1	14.1	13.0	44.8	15.3	16.9	14.0	14.4	11.1	14.7	12.6	11.7	12.5	17.8	11.1	10.4	12.4	12.9	11.3	10.8	13.9	12.8	17.8	12.0	11.5	12.2	15.0	12.2	16.0	17.8	11.5	14.1	12.4	14.0	12.3	11.1	17.1	21.6	12.8	11.2	11.4	17.0	21.7	153.0	12.6	20.9	11.8	12.0	16.9	13.4	14.8	13.7	41.8	33.5	16.7	31.0	24.7	23.1	54.1	33.4	34.7	35.9	36.9	28.3	26.3	24.3	26.7	32.2	35.0	26.0	21.4	24.3	38.7	28.6	28.7	35.4	29.1	43.5	32.9	31.1	58.1	24.6	31.6	31.9	23.2	23.7	42.6	28.8	28.0	39.6	43.6	28.5	55.7	21.5	22.9	30.7	42.5	30.1	46.3	23.5	27.6	33.7	27.3	36.1	19.6	28.2	36.7	31.0	39.4	31.8	29.8	42.3	49.1	29.1	39.4	38.5	41.5	29.8	37.9	33.7	31.9	72.4	49.4	87.7	57.1	44.6	55.5	53.5	69.6	65.7	48.8	55.8	50.1	60.9	81.9	68.9	49.8	31.7	128.5	82.5	13.1	13.0	16.9	14.0	12.9	11.3	12.0	11.5	11.5	11.4	12.6	13.7	37.1	9.6	10.2	7.5	24.2	57.0	20.7	42.3	17.6	17.7	22.5	21.1	5.6	22.8	26.9	22.0	6.2	122.3	23.0	20.8	31.3	32.7	1305.1	21.9	16.0	23.9	19.8	103.6	14.2	25.3	70.1	19.4	28.5	24.6	29.2	20.4	18.2	18.5	35.6	26.9	14.1	22.9	26.4	21.8	34.2	1771.9	35.1	25.5	24.9	10.3	32.2	20.2	33.0	10.6	11.3	32.1	20.1	24.0	30.4	32.8	26.4	18.9	27.4	19.7	6.6	14.8	43.7	277.3	60.7	29.9	65.8	324.9	32.7	21.3	20.7	51.8
FAM209A	"C20orf106, dJ1153D9.3"	ENSG00000124103	"Family with sequence similarity 209 member A"	Q5JX71	20	56517187-56526152	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 104.2"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 2173.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.5;Karpas-707: 1.0;U-266/84: 1.5"									HPA079442			Uncertain	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Cell Junctions"		"HPA079442: "	"unprognostic (1.03e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.10e-1)"	"unprognostic (9.83e-2)"	"unprognostic (5.56e-3)"	"unprognostic (7.68e-2)"	"unprognostic (1.86e-9)"	"unprognostic (2.98e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-2)"	0.6	0.2	0.1	0.9	0.1	16.6	0.5	0.1	0.3	0.4	0.0	0.5	0.3	0.3	0.4	0.3	0.4	0.5	0.2	0.1	0.1	0.3	0.6	0.8	1.5	0.1	0.1	0.2	1.0	0.0	0.7	0.0	0.1	0.6	0.4	0.1	0.5	0.3	0.2	1.2	1.1	0.2	0.0	2.3	0.5	104.2	0.1	0.2	0.3	0.0	1.3	0.3	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.3	0.0	0.3	0.0	0.4	2.5	0.0	0.7	0.0	0.1	0.1	0.1	0.5	0.0	1.0	0.0	0.4	0.1	0.7	0.0	0.0	0.1	0.2	0.3	0.2	0.0	0.4	0.1	0.0	0.0	0.8	0.1	0.0	0.1	0.5	0.0	0.0	0.1	0.2	0.1	0.5	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	2.3	0.0	0.4	0.1	0.2	0.1	0.0	0.0	0.2	0.3	0.7	0.0	0.7	0.0	0.0	0.1	2.0	0.4	0.0	0.0	2173.4	0.2	0.2	1.1	1.2	0.4	0.0	0.0	0.2	0.2	0.0	0.5	1.3	0.1	1.1	0.2	0.1	0.0	0.0	0.2	0.0	0.6	0.0	266.1	8.7	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	6.4	0.0	0.1	0.2	0.0	0.8	0.0	0.0	0.3	0.2	10.4	5.9	0.1	0.0	0.3	0.5	0.1	0.1	0.2
FBXO33	Fbx33	ENSG00000165355	"F-box protein 33"	Q7Z6M2	14	39397669-39432500	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 52.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046657	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA046657: AB_10960398"	"unprognostic (8.84e-3)"	"unprognostic (6.72e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.19e-1)"	"prognostic favorable (4.94e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"prognostic favorable (4.58e-4)"	"unprognostic (9.61e-2)"	"unprognostic (4.54e-1)"	"unprognostic (4.41e-2)"	"unprognostic (8.58e-3)"	7.0	9.6	12.2	8.1	12.6	52.6	6.5	10.8	16.2	8.0	16.7	5.9	7.2	6.5	10.1	5.2	6.0	7.3	5.3	14.9	12.9	7.3	6.9	7.9	9.4	12.4	10.8	6.1	5.9	13.2	10.8	7.8	12.5	7.5	5.7	8.4	6.7	7.4	3.0	5.7	5.6	6.6	9.8	7.8	6.0	12.1	11.6	11.8	11.6	6.7	9.8	7.2	4.9	12.5	12.8	7.8	7.0	10.8	24.7	11.5	11.6	12.6	16.9	6.9	8.0	4.7	11.1	14.3	15.2	19.7	6.9	6.4	18.3	12.4	12.3	13.7	11.8	5.7	10.5	12.2	7.0	21.7	20.9	10.7	13.2	11.8	3.8	11.9	5.8	14.0	5.0	12.6	13.6	13.7	19.4	13.5	7.2	11.5	11.6	16.6	11.4	13.0	13.2	16.1	12.1	5.5	11.3	11.8	14.0	10.4	8.7	13.7	7.5	11.6	10.4	17.4	10.1	17.0	21.6	22.6	9.0	10.1	8.8	0.9	0.9	1.8	1.6	1.1	1.4	1.2	1.6	1.7	0.8	1.1	2.2	2.1	3.9	2.8	1.1	0.7	1.7	0.6	12.2	12.6	10.8	16.2	14.9	12.9	12.4	10.8	12.5	9.8	11.6	12.5	14.7	9.6	20.1	21.9	25.7	34.5	13.6	6.4	27.9	24.0	19.1	16.4	8.9	4.3	8.1	9.2	43.8	8.4	40.8	18.0	7.9	8.1	42.1	25.7	14.3	14.7	23.9	16.2	82.6	9.3	9.5	14.8	12.8	39.8	10.2	10.1	13.9	10.6	10.5	28.6	46.7	14.2	2.0	19.2	23.3	10.7	8.4	22.6	19.6	23.4	14.8	12.4	10.3	34.7	36.7	14.0	10.1	5.3	32.7	21.5	13.9	4.0	8.4	17.9	0.0	18.8	17.8	28.5	12.2	24.0	56.4	21.2	31.4	8.0	13.7	24.7
FCER1G		ENSG00000158869	"Fc fragment of IgE receptor Ig"	P30273	1	161215234-161220699	"FDA approved drug targets, Predicted membrane proteins"	"Immunity, Innate immunity"	"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 441.6;lymphoid tissue: 470.1"	"Group enriched"	"Detected in many"	9	"dendritic cells: 726.6;granulocytes: 705.6;Hofbauer cells: 2318.6;Kupffer cells: 1950.8;Langerhans cells: 1526.3;Macrophages: 1971.3;monocytes: 808.9;NK-cells: 1037.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	11	"basophil: 1987.3;classical monocyte: 3240.2;intermediate monocyte: 5333.6;myeloid DC: 2386.3;neutrophil: 1831.0;NK-cell: 1750.9;non-classical monocyte: 6984.5;plasmacytoid DC: 3315.6"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"HEL: 77.8;HMC-1: 301.7;THP-1: 276.1;U-266/84: 90.1;U-937: 87.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022108, HPA026872"	Supported					NA	NA		270000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB022108: , HPA026872: AB_1848473"	"unprognostic (3.71e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.46e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.67e-2)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (1.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.87e-2)"	251.7	86.5	34.0	275.6	33.8	441.6	62.9	35.5	66.0	52.5	47.5	82.7	44.9	30.7	38.7	30.6	72.0	101.5	53.1	33.7	42.0	40.3	177.3	286.6	160.9	53.4	48.7	19.9	22.3	26.8	26.9	211.0	50.1	31.0	113.2	8.3	42.9	38.8	11.9	21.0	60.6	160.3	41.5	470.1	39.4	14.5	49.9	62.7	25.5	34.6	82.5	254.6	21.7	65.4	0.2	0.0	0.7	1.3	1.8	0.7	0.4	0.5	0.2	0.5	0.8	2.2	0.1	0.5	0.7	0.0	0.3	0.2	0.5	0.0	0.4	0.3	1.5	77.8	0.6	14.0	0.3	16.1	301.7	6.0	3.3	2.3	0.2	0.7	0.4	1.8	0.1	7.3	2.4	0.5	1.4	37.9	1.6	0.0	0.0	0.1	6.7	0.2	0.5	0.4	0.3	1.0	0.6	0.1	2.7	1.4	0.2	276.1	0.4	1.8	0.4	0.9	1.1	3.0	90.1	0.9	1.7	87.1	0.5	1987.3	3240.2	307.3	13.6	5333.6	15.9	28.2	10.6	10.6	2386.3	9.0	17.3	45.0	1831.0	1750.9	6984.5	3315.6	21.8	4265.5	34.0	33.8	35.5	66.0	33.7	42.0	53.4	48.7	50.1	41.5	49.9	65.4	12.8	86.6	147.7	0.7	35.9	39.6	1.5	0.2	1.8	0.1	5.2	22.1	6.8	15.7	27.3	18.4	0.0	14.5	726.6	1.0	0.0	1.9	3.0	1.0	0.9	38.6	1.8	79.3	0.1	1.0	18.8	18.3	1.1	1.0	705.6	0.5	41.0	13.6	2318.6	0.0	0.2	0.5	0.0	1950.8	1526.3	9.4	5.3	1971.3	80.0	12.2	808.9	0.2	1037.1	0.0	0.1	1.0	1.4	1.2	10.1	1.3	0.4	5.4	15.3	2.3	72.3	3.8	11.2	1.0	2.5	1.4	35.9	23.7	133.3	0.4	0.6	1.8
FCGR2A	"CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2"	ENSG00000143226	"Fc fragment of IgG receptor IIa"	P12318	1	161505430-161524013	"CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 101.7;placenta: 107.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 178.2;Kupffer cells: 159.1;Langerhans cells: 336.6;Macrophages: 305.0;monocytes: 97.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 2322.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 2322.4"	"Cell line enhanced"	"Detected in some"		"HEL: 29.4;HMC-1: 56.2;K-562: 17.9;NB-4: 15.8;THP-1: 61.9;U-937: 26.7"									"HPA010718, HPA010776, HPA014730"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA		46000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Golgi apparatus"	"HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074"	"unprognostic (2.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (6.49e-7)"	"unprognostic (8.85e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-2)"	68.0	24.8	7.3	101.7	6.6	48.6	13.3	8.0	12.1	18.1	13.9	16.0	8.1	7.3	4.3	11.7	14.6	36.8	11.5	6.5	11.5	12.7	12.3	77.5	16.1	15.1	11.4	7.2	12.7	8.5	7.6	107.3	13.3	6.1	21.0	2.3	9.9	9.6	2.6	3.5	10.8	40.9	11.9	61.8	10.1	4.4	13.8	9.8	6.4	10.2	7.7	68.3	5.2	21.8	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.0	0.0	2.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	29.4	0.3	0.0	0.7	8.6	56.2	0.5	0.0	0.0	0.0	0.7	0.1	0.0	17.9	0.5	0.0	0.0	0.4	15.8	0.0	0.0	1.1	0.2	1.2	8.1	0.0	0.0	0.1	0.0	0.0	0.0	4.6	0.0	0.0	61.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.4	26.7	6.6	2.4	358.3	421.8	0.7	268.4	1.0	3.2	0.5	0.4	89.9	1.7	0.4	0.7	2322.4	0.4	232.7	3.8	0.9	170.3	7.3	6.6	8.0	12.1	6.5	11.5	15.1	11.4	13.3	11.9	13.8	21.8	2.3	22.4	49.1	0.0	8.6	8.7	0.9	0.3	1.2	0.4	1.1	3.8	1.8	2.8	12.1	0.0	0.0	1.0	3.4	0.1	9.8	0.2	38.2	0.1	0.8	15.6	0.0	3.0	0.1	0.6	1.6	8.9	1.1	0.1	30.4	0.1	3.9	2.1	178.2	0.0	0.1	0.0	0.0	159.1	336.6	66.5	1.5	305.0	17.8	12.2	97.3	0.5	7.2	1.0	0.6	0.5	0.0	0.0	4.6	0.3	0.0	9.6	3.7	0.2	6.6	1.5	6.0	0.4	0.6	0.8	7.7	1.6	4.8	0.2	0.1	0.4
FCGR2B	"CD32, CD32B, FCG2, FCGR2"	ENSG00000072694	"Fc fragment of IgG receptor IIb"	P31994	1	161663147-161678654	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Host-virus interaction"	"IgG-binding protein, Receptor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"placenta: 398.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 75.0;Hepatic stellate cells: 333.8;Langerhans cells: 244.0;Macrophages: 145.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 327.2;memory B-cell: 202.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 24.9;HMC-1: 31.2;NB-4: 7.3;RPMI-8226: 11.7"									"CAB007796, HPA014730"	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB007796: AB_562288, HPA014730: AB_2669074"	"unprognostic (1.58e-1)"	"unprognostic (5.14e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.12e-2)"	"unprognostic (6.79e-3)"	"unprognostic (4.05e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.65e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (3.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.37e-1)"	30.4	7.5	0.9	12.2	1.3	1.7	15.4	1.3	3.3	9.7	4.2	10.3	3.0	2.6	2.8	11.4	4.4	13.0	7.9	0.7	1.1	4.2	42.4	21.7	15.8	4.5	1.1	4.8	4.7	2.8	1.4	398.2	2.2	1.8	11.0	1.1	7.0	2.8	2.2	4.8	16.0	16.6	2.2	25.5	4.9	2.5	1.4	7.4	4.2	13.7	29.6	18.7	3.1	5.8	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	7.3	0.1	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.1	0.1	0.0	0.0	2.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	2.8	0.0	327.2	8.5	26.4	1.4	9.7	0.6	202.8	0.7	1.1	72.4	160.4	0.1	1.4	53.6	0.7	9.5	0.1	0.1	13.0	0.9	1.3	1.3	3.3	0.7	1.1	4.5	1.1	2.2	2.2	1.4	5.8	2.2	0.0	3.9	0.0	75.0	5.4	0.1	0.0	0.0	0.0	0.3	0.9	2.1	2.8	1.3	0.0	0.0	0.2	5.6	0.0	0.0	0.0	4.8	0.0	0.0	49.8	0.0	3.2	0.0	0.0	0.2	1.7	1.1	0.0	2.5	0.2	333.8	8.2	7.6	0.0	0.0	0.0	0.0	47.4	244.0	4.2	0.6	145.5	23.2	0.0	9.5	0.0	5.2	0.0	0.1	0.0	0.0	0.0	45.4	0.0	0.0	0.3	0.0	0.0	0.0	1.7	2.5	0.3	0.2	0.7	3.1	0.4	5.8	0.1	0.1	0.0
FERMT3	"KIND3, MGC10966, MIG-2, MIG2B, UNC112C, URP2"	ENSG00000149781	"Fermitin family member 3"	Q86UX7	11	64206678-64223891	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 180.6;lymphoid tissue: 130.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 118.3;granulocytes: 96.4;Hofbauer cells: 193.1;Kupffer cells: 95.8;Langerhans cells: 88.0;Macrophages: 232.9;monocytes: 142.9;NK-cells: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 306.9;HL-60: 135.9;HMC-1: 314.2;Karpas-707: 127.6;MOLT-4: 121.8;NB-4: 174.1;U-937: 138.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA065231			Approved	Vesicles		NA	NA		160000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"HPA065231: AB_2685439"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.38e-3)"	"prognostic favorable (9.89e-4)"	"unprognostic (8.77e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.20e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (3.08e-3)"	"unprognostic (5.25e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.75e-1)"	25.1	14.5	9.4	63.3	11.6	180.6	13.0	11.2	18.1	8.5	12.2	17.3	22.0	8.4	0.7	6.4	13.6	15.6	12.0	9.8	11.6	11.1	12.5	46.2	89.2	17.9	12.2	5.1	7.0	1.3	5.9	15.0	13.2	8.2	8.1	0.6	10.7	4.4	6.0	7.1	34.1	9.4	13.3	130.1	29.6	4.5	17.1	48.7	10.0	4.6	41.8	19.8	7.3	15.3	1.2	1.6	0.5	0.9	0.3	0.8	2.0	1.4	0.2	0.4	0.3	2.6	2.3	32.6	3.2	6.3	0.7	2.4	1.0	0.5	0.5	83.9	0.6	306.9	1.6	0.1	10.8	135.9	314.2	1.2	1.1	5.2	0.0	0.5	81.2	77.0	7.3	127.6	8.6	3.5	121.8	174.1	1.2	1.0	2.3	72.4	8.8	0.7	0.3	0.7	1.9	0.5	0.7	4.5	1.7	0.7	2.0	92.6	7.8	1.1	2.5	1.9	0.9	1.5	3.3	59.4	19.5	138.9	86.6	204.1	207.0	236.5	120.0	192.6	114.9	54.5	94.1	112.0	162.0	53.1	60.9	80.6	184.6	102.4	151.2	195.7	120.9	292.6	9.4	11.6	11.2	18.1	9.8	11.6	17.9	12.2	13.2	13.3	17.1	15.3	3.8	9.6	14.7	0.7	52.1	4.7	0.9	0.3	3.4	0.5	3.3	5.2	2.4	4.3	3.9	0.0	0.0	1.2	118.3	6.1	0.0	0.8	0.4	4.3	5.6	7.9	0.0	62.5	1.2	2.4	1.4	5.4	19.9	7.3	96.4	0.4	19.6	1.4	193.1	0.0	1.5	32.1	0.0	95.8	88.0	0.9	0.9	232.9	17.8	5.6	142.9	0.3	93.7	1.0	1.5	4.3	10.9	2.6	35.2	0.9	8.2	0.4	1.0	0.3	6.6	13.7	6.6	1.2	0.8	1.9	4.5	2.6	78.5	1.4	15.0	0.7
FES	FPS	ENSG00000182511	"FES proto-oncogene, tyrosine kinase"	P07332	15	90883695-90895776	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 83.4;lymphoid tissue: 110.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 46.8;Hofbauer cells: 48.7;Kupffer cells: 92.3;Macrophages: 51.9;monocytes: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 315.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 162.6;granulocytes: 315.8;monocytes: 151.7"	"Cell line enhanced"	"Detected in many"		"HEL: 63.5;HL-60: 56.9;HMC-1: 116.6;NB-4: 76.1;THP-1: 110.8;U-937: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001376	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	Vesicles	"HPA001376: AB_1078847"	"unprognostic (1.07e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.05e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-1)"	30.8	8.0	9.4	20.2	8.8	83.4	21.3	9.6	10.8	18.1	9.6	12.5	5.8	15.7	2.4	5.9	19.0	14.0	19.6	8.3	8.7	18.9	25.2	30.9	13.8	11.1	9.2	13.5	7.8	2.3	5.6	16.3	10.1	17.9	4.6	1.5	58.3	8.0	6.1	8.0	12.5	10.7	10.4	110.9	9.6	4.5	10.9	4.2	16.0	7.0	5.7	15.1	13.5	9.8	0.4	0.8	0.8	10.3	3.1	8.8	17.9	2.9	0.1	5.1	2.9	2.6	0.1	6.8	0.5	6.0	0.2	1.5	1.7	0.3	1.6	3.3	1.1	63.5	0.0	11.9	6.8	56.9	116.6	8.8	0.1	7.6	0.0	0.0	31.2	9.4	1.8	0.2	0.0	21.3	1.8	76.1	3.2	2.5	0.0	8.6	0.1	0.1	0.0	0.2	0.4	0.1	0.0	2.8	2.3	2.9	0.1	110.8	24.9	0.2	10.4	0.2	0.2	0.1	8.0	2.5	0.3	48.0	2.4	64.4	151.7	315.8	0.5	88.6	0.4	5.2	0.3	0.4	162.6	4.1	0.2	0.3	100.5	51.4	39.8	65.0	0.2	81.5	9.4	8.8	9.6	10.8	8.3	8.7	11.1	9.2	10.1	10.4	10.9	9.8	46.8	3.2	5.8	3.6	5.0	3.8	5.4	0.5	0.6	0.2	4.1	3.8	3.4	8.6	0.5	1.8	0.0	5.3	25.6	0.6	3.9	7.3	1.7	2.0	4.2	29.1	3.0	8.0	2.8	4.3	4.2	9.0	2.0	4.2	29.2	10.7	20.0	15.0	48.7	0.0	0.2	2.0	2.0	92.3	27.9	8.4	9.0	51.9	7.2	5.6	57.8	2.5	26.8	2.0	0.3	2.1	2.0	10.1	4.0	3.1	0.7	1.5	0.2	1.9	13.1	4.6	12.9	4.4	15.9	1.0	2.8	4.5	6.7	3.3	3.7	5.2
FFAR2	"FFA2R, GPR43"	ENSG00000126262	"Free fatty acid receptor 2"	O15552	19	35443907-35451767	"G-protein coupled receptors, Predicted membrane proteins"	"Immunity, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.3;lymphoid tissue: 22.2"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 24.1;Intestinal goblet cells: 8.9;Kupffer cells: 11.9;Macrophages: 15.4;Prostatic glandular cells: 7.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	25	"eosinophil: 85.0;neutrophil: 249.7"	"Lineage enriched"	"Detected in many"	38	"granulocytes: 249.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.9;OE19: 1.8;SK-BR-3: 1.1;THP-1: 1.2;U-937: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023985	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA023985: AB_1849302"	"unprognostic (7.75e-3)"	"unprognostic (5.65e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.55e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.60e-2)"	"unprognostic (5.17e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.03e-2)"	4.9	0.3	0.2	17.8	0.4	20.3	2.3	0.2	0.4	0.2	0.6	0.8	3.3	0.1	0.0	1.3	1.0	1.4	1.0	0.2	0.2	0.3	1.5	7.5	0.1	0.4	0.4	0.0	0.6	0.3	0.1	1.6	0.5	1.1	0.7	0.1	0.7	0.0	0.2	1.1	4.6	1.3	0.2	22.2	1.2	0.0	0.4	0.7	0.4	3.7	0.7	6.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.6	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	1.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	3.1	2.1	85.0	0.0	5.6	0.0	0.1	0.0	0.0	0.9	0.2	0.0	0.0	249.7	0.0	6.5	0.1	0.0	0.7	0.2	0.4	0.2	0.4	0.2	0.2	0.4	0.4	0.5	0.2	0.4	0.8	5.6	0.0	3.2	0.0	0.6	0.1	0.4	0.3	0.0	0.0	0.2	0.3	0.4	0.0	2.7	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.2	0.0	0.1	0.8	24.1	0.0	0.0	0.0	0.1	1.4	0.0	0.0	5.1	0.0	0.4	0.0	5.0	0.0	0.0	8.9	2.0	11.9	2.6	0.1	0.0	15.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	7.7	1.1	0.0	2.2	0.0	0.0	0.4	2.4	0.1	0.2	0.0	0.6	0.1	1.3	0.1	0.6	1.5
FHAD1	KIAA1937	ENSG00000142621	"Forkhead associated phosphopeptide binding domain 1"	B1AJZ9	1	15247272-15400283	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 13.8;fallopian tube: 15.2;testis: 13.4"	"Group enriched"	"Detected in many"	7	"Early spermatids: 234.4;Endometrial ciliated cells: 179.0;Late spermatids: 244.9;Respiratory ciliated cells: 265.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 29.5;HMC-1: 80.4;K-562: 18.5;U-87 MG: 42.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054284	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA054284: AB_2682436"	"unprognostic (3.18e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.36e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.04e-3)"	0.4	0.2	1.0	0.7	1.1	0.0	1.0	0.2	0.9	2.1	13.8	0.3	0.9	0.5	1.8	0.1	15.2	0.5	0.1	1.9	2.0	0.6	0.3	3.5	0.2	3.8	8.1	0.3	0.7	0.9	0.6	0.4	3.4	0.3	0.3	0.1	0.5	0.5	0.0	0.2	1.0	0.3	2.2	0.1	2.2	13.4	1.5	0.1	1.2	0.0	0.2	0.8	0.2	1.5	2.1	0.5	1.7	1.4	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.2	1.1	5.6	0.8	0.3	0.2	0.5	0.2	0.0	0.3	29.5	0.2	0.1	0.0	0.0	0.5	2.5	80.4	0.8	0.0	0.3	0.0	0.1	0.0	0.0	18.5	0.0	0.0	0.3	0.3	0.3	0.1	0.3	0.9	0.0	0.5	0.0	0.1	0.1	0.7	0.6	0.0	0.1	0.5	0.1	0.1	0.5	0.0	7.1	0.2	8.3	0.1	0.0	10.0	0.0	42.9	0.1	0.3	0.0	0.4	0.0	0.9	0.2	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.4	0.0	0.3	0.3	0.0	0.0	0.1	1.0	1.1	0.2	0.9	1.9	2.0	3.8	8.1	3.4	2.2	1.5	1.5	0.4	0.0	2.2	2.6	0.1	0.1	0.8	4.4	0.0	0.4	0.3	0.6	1.9	4.3	29.0	0.0	0.0	0.0	0.3	0.4	0.0	2.0	234.4	179.0	2.1	1.5	1.8	0.0	4.7	1.4	0.0	2.4	7.7	13.5	0.0	0.5	0.0	0.0	2.6	3.3	2.4	1.2	6.1	1.3	1.7	244.9	2.1	2.6	0.0	1.9	0.1	0.2	0.0	1.0	1.3	0.8	1.1	0.0	0.0	0.4	0.7	0.6	265.6	0.0	13.1	0.2	2.6	14.9	9.5	0.0	0.0	0.1	0.3	0.3	0.6	1.7
FHOD1	FHOS	ENSG00000135723	"Formin homology 2 domain containing 1"	Q9Y613	16	67229387-67247481	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 88.1;skeletal muscle: 127.0"	"Cell type enhanced"	"Detected in many"		"granulocytes: 40.6;Theca cells: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HMC-1: 112.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA024468	Approved		Supported	Cytosol		NA	NA		1300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA024468: AB_1848568"	"unprognostic (6.53e-3)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-2)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (1.90e-8)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-3)"	"unprognostic (4.70e-2)"	16.9	16.9	3.6	9.6	3.5	6.2	13.2	3.5	4.0	9.6	4.6	9.3	5.9	8.5	1.6	4.5	7.9	5.5	10.4	3.4	3.3	10.5	3.3	26.6	8.5	4.1	4.0	14.7	7.7	3.7	5.4	8.9	3.9	8.8	4.2	0.3	8.4	3.9	127.0	6.2	9.7	5.8	4.0	88.1	7.2	5.0	4.8	4.1	16.8	29.8	5.9	7.4	6.7	3.8	12.0	31.6	11.8	9.8	46.1	27.9	39.2	24.9	19.8	27.2	26.3	22.3	15.7	14.1	17.5	18.0	8.8	14.7	13.5	20.0	13.5	11.3	21.7	63.1	13.9	24.5	12.2	26.3	112.1	34.8	2.6	42.2	4.1	24.3	43.0	19.9	32.9	9.3	17.6	41.0	18.1	48.3	17.6	11.0	10.0	20.3	25.9	33.8	8.7	4.9	3.7	19.2	38.2	22.4	22.5	11.7	23.8	21.1	51.6	37.4	22.0	24.0	20.3	29.9	32.0	20.7	76.1	24.7	34.7	0.3	0.7	0.1	0.2	0.2	0.3	0.0	0.3	0.2	0.4	0.1	0.1	0.1	0.5	0.3	0.2	0.2	0.3	0.6	3.6	3.5	3.5	4.0	3.4	3.3	4.1	4.0	3.9	4.0	4.8	3.8	18.0	12.8	21.6	4.6	7.2	5.7	1.8	2.0	3.4	1.8	11.5	8.0	13.8	10.0	5.9	5.5	8.4	8.7	11.4	16.9	0.0	3.6	1.1	3.5	8.1	22.3	9.1	8.6	2.5	5.9	4.7	10.9	5.6	4.7	40.6	12.0	25.0	0.8	17.1	1.7	2.2	13.1	2.0	20.3	19.7	1.1	10.5	19.8	3.6	17.8	18.9	2.9	10.3	2.0	0.6	7.4	6.1	10.9	7.1	3.1	6.3	1.4	3.9	1.2	26.3	4.2	15.7	19.0	12.3	5.6	3.7	1.9	13.3	40.3	13.8	1.7
FLT1	"FLT, VEGFR1"	ENSG00000102755	"Fms related receptor tyrosine kinase 1"	P17948	13	28300346-28495145	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"placenta: 432.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 411.6;Endothelial cells: 263.1;Extravillous trophoblasts: 815.4;Hepatic stellate cells: 234.9;Microglial cells: 433.8;Syncytiotrophoblasts: 1127.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 28.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 71.8;BJ hTERT+: 57.2;HMC-1: 349.2;HUVEC TERT2: 64.9;WM-115: 127.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011740, HPA014290, CAB068189, CAB068190"	Enhanced		Supported	"Plasma membrane,Actin filaments"	"Secreted to blood"	NA	NA	876000	87000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"	"Actin filaments"	"CAB068189: AB_2665636, CAB068190: AB_2665637, HPA011740: AB_1858737, HPA014290: AB_1858738"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.13e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.03e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.91e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (4.20e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	47.6	9.6	37.6	9.1	36.2	1.1	31.2	37.0	43.0	16.4	24.6	9.4	7.5	17.2	3.7	5.9	11.7	16.6	46.0	33.3	39.8	34.9	18.2	25.8	5.3	44.6	40.0	4.4	12.7	30.5	9.0	432.4	50.1	13.9	6.1	52.5	7.0	11.0	19.9	5.9	9.3	17.4	33.4	18.6	10.9	17.4	59.6	3.6	48.9	38.8	5.7	14.0	9.5	38.7	0.1	0.0	0.0	0.6	0.6	0.9	0.3	71.8	57.2	25.8	14.9	0.0	0.2	0.1	0.1	9.6	0.0	0.3	6.7	0.0	45.4	0.0	2.0	0.2	0.1	0.0	0.1	0.0	349.2	0.6	0.0	0.1	1.0	0.1	64.9	6.1	1.7	0.3	0.0	0.3	4.5	3.7	37.5	0.0	0.1	2.9	0.0	0.1	0.1	0.1	8.1	0.6	0.0	0.1	0.2	44.4	0.3	0.2	6.3	0.2	1.2	0.1	0.1	2.1	1.0	0.2	0.4	0.3	127.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	37.6	36.2	37.0	43.0	33.3	39.8	44.6	40.0	50.1	33.4	59.6	38.7	411.6	0.0	6.0	2.0	4.7	4.1	0.7	0.2	3.4	17.8	1.2	1.5	26.5	2.8	2.9	0.0	4.2	197.2	1.4	0.1	1.9	0.6	157.2	0.5	1.5	263.1	0.0	0.0	0.9	0.0	815.4	32.1	0.5	2.1	1.3	0.1	234.9	6.9	30.8	1.7	14.5	0.0	0.0	12.5	23.6	173.8	18.6	15.3	0.0	433.8	0.0	153.2	0.0	9.5	2.0	0.0	0.0	48.5	4.1	1.3	0.0	0.1	1.8	9.7	92.1	11.4	30.1	14.6	4.6	1.0	4.8	1127.1	2.8	1.5	0.0	1.1
FNDC10	C1orf233	ENSG00000228594	"Fibronectin type III domain containing 10"	F2Z333	1	1598012-1600135	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 25.4;brain: 24.4"	"Group enriched"	"Detected in some"	6	"Granulosa cells: 57.0;Theca cells: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HMC-1: 27.8"	"Low region specificity"	"Detected in all"													NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (9.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.32e-3)"	"unprognostic (4.33e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (1.11e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.76e-2)"	1.5	25.4	11.0	1.5	11.4	2.6	1.4	11.2	24.4	2.3	6.2	1.5	2.1	1.1	0.0	9.5	0.8	2.2	3.0	12.6	22.0	3.7	0.5	2.3	1.0	20.6	17.8	1.8	0.9	7.4	10.9	1.0	19.0	0.9	0.5	0.6	2.2	0.4	0.3	10.0	1.6	0.6	10.0	3.1	2.9	8.3	14.3	0.3	5.2	0.3	0.8	1.2	3.7	12.9	0.0	4.1	3.9	12.1	7.9	1.8	5.5	9.6	1.9	15.1	0.8	3.7	17.2	0.0	11.2	4.7	0.1	2.5	0.9	2.1	1.3	0.0	3.5	0.2	4.1	9.1	1.8	3.0	27.8	2.6	9.5	0.7	0.1	1.8	1.0	11.0	8.0	0.0	1.8	18.7	2.3	9.1	16.6	5.8	5.9	0.0	0.0	9.7	5.4	0.9	17.9	14.8	10.2	15.1	10.6	2.5	0.0	9.3	1.6	0.0	2.9	6.5	0.0	2.9	0.3	0.2	0.0	6.2	4.3	0.0	0.7	1.6	0.1	0.5	0.1	0.0	0.3	0.3	0.7	0.0	0.3	0.2	0.0	0.0	0.7	0.0	0.3	0.2	11.0	11.4	11.2	24.4	12.6	22.0	20.6	17.8	19.0	10.0	14.3	12.9	0.3	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.9	8.5	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	3.9	1.3	0.0	2.4	3.0	0.5	0.0	0.0	0.0	0.9	2.5	2.4	0.0	4.7	0.0	57.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.6	46.3	0.0	0.0
FOSB	"AP-1, DKFZp686C0818, G0S3, GOS3, GOSB, MGC42291"	ENSG00000125740	"FosB proto-oncogene, AP-1 transcription factor subunit"	P53539	19	45467995-45475179	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 1627.1;Skeletal myocytes: 2234.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 45.6"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 11.4;HMC-1: 13.3;hTCEpi: 8.1;Karpas-707: 6.8;SK-BR-3: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010267, HPA054663"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"CAB010267: AB_640583, HPA054663: AB_2682562"	"unprognostic (7.22e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-2)"	"unprognostic (4.99e-3)"	"unprognostic (8.72e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.04e-2)"	394.7	121.6	2.1	118.4	5.5	433.8	91.7	35.7	45.6	150.3	4.8	37.6	24.8	46.6	3.9	187.7	404.1	347.1	48.9	11.1	7.8	34.7	85.5	113.5	67.7	1.5	1.6	274.4	126.3	46.2	27.3	57.8	1.5	118.5	78.4	10.7	76.8	29.6	3.3	267.8	63.1	353.7	0.8	21.8	104.4	8.8	1.2	152.2	316.0	81.3	1.6	213.9	11.0	3.8	0.4	0.6	0.1	0.3	1.2	0.3	1.8	2.3	1.0	0.7	0.7	0.5	1.0	2.0	0.4	1.5	11.4	0.8	0.5	1.6	0.5	0.3	0.7	0.6	0.8	0.4	0.8	1.1	13.3	0.5	8.1	1.7	1.9	0.4	0.9	2.3	0.8	6.8	0.2	0.2	0.2	1.2	0.4	1.0	0.4	0.5	0.1	1.4	0.6	1.3	3.1	0.4	1.4	9.6	1.2	1.9	0.5	0.8	0.1	0.5	0.6	1.1	0.7	5.1	0.8	0.5	1.1	0.8	1.3	0.9	1.2	1.0	0.2	0.1	0.4	0.0	0.2	0.1	1.0	0.1	0.0	0.0	4.5	0.1	0.0	0.0	0.1	0.1	2.1	5.5	35.7	45.6	11.1	7.8	1.5	1.6	1.5	0.8	1.2	3.8	1048.7	685.9	761.3	2.6	445.7	380.5	533.4	162.4	865.6	50.6	1627.1	1523.2	177.8	370.3	174.4	11.0	135.5	237.5	359.6	551.1	1.9	145.5	10.1	667.9	1204.4	442.6	877.0	68.6	1.3	74.2	301.9	788.2	911.3	1541.3	830.4	239.3	393.7	77.9	210.3	8.4	0.3	898.4	42.7	345.2	353.4	11.3	240.2	797.3	172.5	1.0	16.3	186.1	1.0	0.0	0.3	111.6	457.3	59.5	503.4	307.3	417.8	2.7	111.5	217.6	302.4	2234.0	608.8	3.3	4.5	476.3	380.9	396.9	481.8	174.2	616.5	208.5
FOXJ2	FHX	ENSG00000065970	"Forkhead box J2"	Q9P0K8	12	8032716-8055517	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Meiosis, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008723	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA008723: AB_1078903"	"unprognostic (1.68e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (9.01e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.02e-2)"	13.8	8.3	6.6	8.7	6.7	15.5	12.3	14.3	11.9	15.5	4.6	14.8	7.3	17.7	8.0	8.8	14.4	8.1	14.7	6.7	6.6	7.3	5.9	12.1	8.3	6.3	6.2	16.8	10.0	15.4	8.5	11.0	6.1	10.6	7.7	9.3	9.5	12.8	25.2	17.5	10.1	14.7	5.1	10.8	11.3	5.8	6.2	10.7	9.9	20.6	9.1	13.5	12.3	7.0	12.4	10.3	11.1	14.0	12.6	13.8	24.3	17.5	17.8	16.7	12.4	14.8	13.3	0.2	3.2	21.3	15.4	13.2	10.0	11.7	17.8	21.6	6.8	16.4	11.8	5.1	15.8	7.4	43.9	12.2	17.2	21.7	31.5	17.4	12.1	13.0	12.2	8.0	13.7	9.6	10.5	6.6	12.6	18.4	6.8	11.2	17.2	6.0	7.0	8.2	4.6	6.3	22.0	15.1	7.6	23.1	3.5	8.8	11.0	20.3	24.8	14.5	10.7	6.4	6.8	8.1	13.1	5.9	12.3	2.5	1.4	2.2	1.5	1.1	1.9	0.8	1.5	1.7	1.8	1.5	1.7	1.5	2.7	2.8	1.5	1.7	1.2	1.2	6.6	6.7	14.3	11.9	6.7	6.6	6.3	6.2	6.1	5.1	6.2	7.0	14.1	16.0	13.1	6.2	9.1	18.9	4.5	5.5	14.8	10.7	10.4	9.1	19.9	12.8	4.0	0.0	8.4	5.5	7.7	7.1	0.0	5.9	0.4	4.0	14.0	12.8	4.9	13.7	6.1	7.5	3.1	12.0	7.7	7.2	3.8	16.1	18.9	9.5	10.1	8.4	6.4	8.4	4.1	13.2	23.0	0.9	10.5	13.9	7.2	6.5	14.2	4.0	11.3	3.0	5.7	10.3	4.4	17.0	6.7	9.8	5.0	2.4	2.9	7.5	19.7	9.9	8.4	1.4	6.4	14.2	21.5	6.2	12.3	8.1	7.4	5.3
FOXN2	HTLF	ENSG00000170802	"Forkhead box N2"	P32314	2	48314637-48379295	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 54.0;brain: 53.3"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 152.3;Oligodendrocytes: 282.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003485	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Vesicles	"HPA003485: AB_1078905"	"unprognostic (5.38e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.65e-3)"	"prognostic favorable (3.85e-4)"	"unprognostic (4.00e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (2.81e-5)"	"unprognostic (2.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.12e-2)"	17.9	5.5	13.3	15.4	30.3	54.0	8.0	25.3	19.0	7.7	4.2	7.7	8.3	6.7	4.2	9.3	5.5	9.7	8.6	13.9	16.3	6.6	19.8	9.5	19.4	24.1	21.0	5.9	8.9	9.5	3.0	13.4	21.9	5.0	8.0	3.4	5.5	4.2	4.8	3.6	10.3	9.8	20.0	18.1	7.9	6.3	19.2	14.9	6.9	6.4	17.1	10.6	3.9	53.3	13.1	19.5	22.2	19.6	17.2	12.7	24.3	14.4	15.8	11.9	13.2	17.3	15.9	28.4	18.7	17.0	14.5	16.2	13.7	16.5	17.2	22.3	11.7	56.1	13.3	17.4	30.0	30.9	42.1	11.4	6.9	12.9	22.3	9.6	12.8	11.6	26.6	32.7	19.5	10.1	34.4	20.3	16.8	9.8	10.2	17.0	46.5	23.2	10.2	16.5	12.4	12.6	6.9	13.2	24.9	7.5	5.7	18.0	15.0	16.0	16.1	15.2	15.2	17.8	14.2	40.5	13.9	27.5	22.2	120.9	32.4	129.6	24.0	26.2	27.4	21.2	23.1	22.4	33.6	20.6	17.2	17.7	40.8	25.7	36.4	20.8	28.8	17.2	13.3	30.3	25.3	19.0	13.9	16.3	24.1	21.0	21.9	20.0	19.2	53.3	22.1	0.0	7.4	66.6	31.3	15.6	27.5	10.0	15.4	6.7	5.4	5.6	11.1	14.3	6.1	1.8	0.0	6.7	28.3	7.0	5.9	6.0	4.8	8.9	17.2	21.8	2.4	22.5	28.1	5.4	32.1	13.3	14.3	13.3	22.8	1.2	20.7	19.7	17.9	13.5	25.2	8.0	8.2	39.5	47.3	4.7	12.2	44.4	12.4	35.6	44.1	7.8	26.8	152.3	282.0	11.0	7.1	11.3	31.0	35.2	11.3	4.8	3.3	3.6	6.6	17.8	27.4	22.7	13.1	11.9	21.2	16.6	38.3	2.8	8.9	35.9
FUNDC1	MGC51029	ENSG00000069509	"FUN14 domain containing 1"	Q8IVP5	X	44523639-44542859	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038773	Uncertain					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA038773: AB_10670789"	"unprognostic (1.04e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.88e-3)"	"unprognostic (6.40e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.63e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-1)"	"unprognostic (2.49e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (6.67e-3)"	"prognostic favorable (2.58e-4)"	11.5	18.4	30.5	9.5	31.3	11.3	20.4	35.9	37.8	14.4	30.3	12.7	12.5	13.4	22.4	13.1	15.3	15.8	37.6	30.5	34.2	25.2	13.0	10.5	17.8	36.0	31.7	19.0	10.2	28.2	14.8	11.5	34.5	16.3	13.5	34.2	49.2	11.5	17.9	16.2	8.0	12.4	32.0	12.8	29.7	14.4	33.3	20.0	16.8	24.9	16.3	15.5	12.0	32.1	39.4	33.1	36.5	22.4	15.8	21.8	20.8	19.4	29.4	38.2	41.7	41.3	32.2	29.0	19.1	26.6	83.5	21.0	60.4	36.7	46.2	32.2	67.6	32.5	41.5	32.3	23.4	35.3	103.3	22.1	35.3	55.1	27.4	36.6	23.8	30.9	34.9	18.0	45.8	41.6	32.9	42.6	43.3	33.6	38.4	20.3	37.1	21.5	39.1	28.0	20.0	31.6	59.3	32.5	37.7	66.0	65.4	0.1	14.0	23.5	34.1	28.0	21.6	14.0	25.2	34.6	31.1	13.8	31.3	7.5	6.3	10.9	7.3	6.3	9.8	10.8	10.1	11.5	11.6	6.6	11.5	9.0	6.8	11.5	4.6	23.8	10.7	5.5	30.5	31.3	35.9	37.8	30.5	34.2	36.0	31.7	34.5	32.0	33.3	32.1	15.2	19.2	10.8	5.2	12.5	14.8	20.1	67.3	18.2	21.9	18.6	21.2	41.6	27.1	34.1	25.8	6.2	35.3	13.0	14.0	115.4	33.6	1.7	27.1	20.9	15.8	10.2	12.0	5.3	36.8	29.4	20.2	16.8	23.1	7.6	36.4	20.3	14.8	37.5	21.9	6.4	13.8	42.7	14.5	7.2	5.7	23.0	13.6	14.2	6.5	13.1	62.9	17.5	6.6	6.8	34.6	26.0	21.8	14.3	17.5	14.5	50.7	26.4	16.1	13.1	12.9	19.8	19.9	45.4	20.7	16.3	26.5	12.7	35.5	17.1	26.0
FUT1	"H, HSC"	ENSG00000174951	"Fucosyltransferase 1 (H blood group)"	P19526	19	48748011-48755390	"Blood group antigen proteins, Enzymes, Metabolic proteins, Predicted membrane proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 27.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 13.8;Endothelial cells: 8.5;Langerhans cells: 41.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 9.3;HEL: 11.5;RT4: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA		15000	"Cluster 11: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (2.90e-2)"	"unprognostic (3.09e-2)"	"unprognostic (8.05e-3)"	"unprognostic (4.65e-3)"	"unprognostic (2.92e-3)"	"unprognostic (8.73e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (3.99e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.67e-3)"	"unprognostic (3.98e-2)"	3.8	1.6	2.3	0.6	3.5	2.9	3.1	5.2	3.3	1.2	1.0	0.7	1.9	0.9	0.9	2.8	2.0	1.0	3.8	3.1	1.5	4.1	1.0	10.6	0.7	1.6	1.6	0.3	27.5	3.3	2.7	4.2	1.7	1.4	0.5	0.3	1.4	1.0	1.7	1.6	0.6	0.9	1.3	5.4	13.6	1.6	2.0	0.7	1.9	2.9	1.4	1.3	1.4	1.8	3.8	0.1	0.2	0.2	0.0	0.0	1.8	0.2	0.1	0.2	0.2	9.3	5.4	0.4	0.4	0.3	0.8	6.2	1.9	5.8	0.2	0.1	0.9	11.5	0.4	0.2	2.6	0.4	4.9	0.0	9.1	0.4	4.1	0.1	4.1	2.0	0.6	1.8	0.0	4.4	0.2	7.3	1.1	7.5	0.5	0.3	0.0	1.9	0.3	11.2	8.5	0.5	0.5	8.0	0.2	0.4	5.2	0.3	4.0	0.4	2.6	0.2	0.4	1.5	4.3	1.1	0.1	0.3	0.4	1.3	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.5	0.3	0.0	0.2	0.0	0.0	2.3	3.5	5.2	3.3	3.1	1.5	1.6	1.6	1.7	1.3	2.0	1.8	13.8	3.2	1.7	0.0	0.0	2.5	0.7	4.1	1.2	0.4	1.2	0.9	1.1	2.8	2.3	0.0	2.1	0.4	0.0	0.1	1.9	1.7	0.0	1.3	0.3	8.5	1.2	6.5	1.3	2.4	0.3	0.8	4.1	3.4	1.3	0.0	6.8	0.0	0.3	0.0	0.4	1.2	2.0	0.8	41.9	0.1	0.9	1.9	5.4	1.0	0.0	0.0	0.0	0.0	0.1	3.6	0.0	0.0	0.1	0.9	0.1	0.0	0.9	0.2	0.0	0.6	0.9	0.1	0.1	2.4	1.7	0.4	0.3	0.0	0.1	0.6
FXYD7		ENSG00000221946	"FXYD domain containing ion transport regulator 7"	P58549	19	35143250-35154302	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 273.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 14.0;Excitatory neurons: 42.0;Inhibitory neurons: 12.9;Microglial cells: 9.4;T-cells: 19.2"	"Cancer enhanced"	"Detected in some"		"glioma: 4.2;ovarian cancer: 3.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 52.1"	"Group enriched"	"Detected in many"	23	"B-cells: 19.0;NK-cells: 52.1;T-cells: 23.7"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.8;HMC-1: 5.3;Karpas-707: 2.0;NTERA-2: 1.5;WM-115: 3.1"									HPA026916	Approved					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA026916: AB_1849217"	"unprognostic (1.25e-3)"	"unprognostic (8.73e-3)"	"unprognostic (4.64e-2)"	"unprognostic (6.95e-4)"	"unprognostic (8.47e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.08e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.90e-5)"	"unprognostic (1.51e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.37e-1)"	2.1	0.4	119.1	1.7	140.3	0.6	1.1	45.1	273.1	5.8	37.8	2.7	0.6	1.9	0.0	0.4	0.9	0.4	0.7	153.8	75.1	0.4	1.1	1.1	2.8	124.3	83.1	1.0	0.2	0.0	2.1	0.1	129.5	1.0	0.2	1.6	0.5	0.3	2.7	1.3	2.0	0.2	70.1	2.8	1.0	1.3	101.6	0.2	0.5	0.1	1.5	0.8	3.1	185.5	0.6	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.1	0.0	0.0	0.2	1.8	0.0	0.2	0.3	0.1	0.2	0.6	0.0	0.1	0.0	5.3	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.5	2.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.2	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.4	0.1	3.1	0.0	0.0	0.0	15.0	0.0	9.5	19.0	23.7	17.2	0.1	14.6	7.5	13.8	0.6	52.1	0.1	1.3	7.5	4.9	119.1	140.3	45.1	273.1	153.8	75.1	124.3	83.1	129.5	70.1	101.6	185.5	1.1	0.0	1.3	7.2	8.0	2.0	0.1	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	1.8	0.0	0.0	14.0	0.0	0.0	0.0	0.1	0.0	1.0	0.9	0.0	0.4	42.0	0.2	0.1	1.1	0.0	0.0	1.3	0.1	0.7	0.2	0.1	1.7	12.9	0.0	0.0	0.0	4.4	0.2	1.2	0.7	3.6	9.4	0.2	1.5	0.0	3.5	6.2	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	6.6	0.7	1.1	3.1	5.0	0.1	1.1	0.3	19.2	0.0	0.0	0.0
GAB3		ENSG00000160219	"GRB2 associated binding protein 3"	Q8WWW8	X	154675249-154751583	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 20.4;dendritic cells: 32.0;Erythroid cells: 20.4;granulocytes: 20.8;Kupffer cells: 24.7;Microglial cells: 30.9;NK-cells: 39.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 21.3;HMC-1: 23.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA010090	Approved		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"	"Nucleoplasm, Cytosol"	"HPA010090: AB_1849362"	"unprognostic (2.67e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.19e-1)"	3.7	2.1	1.8	7.0	3.5	12.5	2.3	2.6	3.4	1.8	2.2	2.6	3.4	2.0	3.8	1.7	1.9	3.7	7.4	2.0	2.6	1.0	1.9	6.0	7.6	4.7	2.2	1.3	1.0	2.7	0.4	3.7	5.0	1.3	3.4	1.2	2.1	1.9	1.3	3.6	4.2	3.5	2.1	13.9	2.6	4.9	3.6	5.2	3.6	1.6	6.6	3.1	1.1	8.6	0.8	0.0	0.7	1.0	0.9	2.3	0.5	0.3	0.6	0.2	0.3	0.0	0.5	2.5	0.7	0.0	1.5	0.4	0.6	0.4	0.0	2.9	1.0	21.3	2.9	2.4	1.6	6.5	23.3	0.9	0.2	2.0	0.8	0.8	5.2	2.0	4.8	7.3	1.0	0.3	2.4	6.6	0.2	0.0	0.1	3.5	0.0	0.3	1.3	0.0	3.0	0.4	0.3	0.3	0.4	0.5	0.9	3.7	4.8	1.2	1.9	0.8	0.6	8.0	7.0	2.5	2.0	8.4	0.6	26.4	5.9	8.7	13.3	5.7	10.2	1.0	3.5	9.7	5.8	1.3	1.2	6.8	9.0	2.5	3.6	3.3	0.8	5.0	1.8	3.5	2.6	3.4	2.0	2.6	4.7	2.2	5.0	2.1	3.6	8.6	9.9	0.0	6.7	0.7	6.0	0.6	0.0	0.3	0.0	0.1	0.2	0.6	20.4	0.0	1.3	0.0	0.0	0.1	32.0	0.0	0.0	0.8	0.3	0.5	1.2	8.3	0.0	20.4	0.3	0.5	0.6	2.3	0.0	0.1	20.8	2.2	6.1	0.3	13.8	0.0	0.3	0.0	0.0	24.7	5.8	1.7	1.8	18.8	0.0	30.9	16.1	2.6	39.1	8.5	0.3	0.4	0.0	4.5	7.5	0.1	0.0	0.2	1.7	0.4	6.6	0.7	6.6	0.1	1.0	0.2	1.0	0.1	18.6	0.5	0.0	0.1
GAL3ST2	GP3ST	ENSG00000154252	"Galactose-3-O-sulfotransferase 2"	Q9H3Q3	2	241776822-241804287	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"intestine: 9.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Oligodendrocyte precursor cells: 1.0"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 6.7;ovarian cancer: 4.9;stomach cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Hep G2: 3.7;HMC-1: 10.5"	"Not detected"	"Not detected"							HPA071809	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA071809: AB_2686450"	"unprognostic (5.22e-3)"	"unprognostic (6.52e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.04e-3)"	"unprognostic (3.04e-4)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.87e-11)"	"unprognostic (4.32e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.99e-3)"	"unprognostic (3.49e-1)"	0.5	0.3	0.4	0.8	0.3	0.2	0.0	0.0	0.6	0.5	0.0	9.4	0.0	0.1	0.0	0.0	0.5	0.4	0.1	0.2	0.3	0.3	0.5	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	3.7	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	3.7	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.6	0.2	0.3	0.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0
GALC		ENSG00000054983	Galactosylceramidase	P54803	14	87837820-87993665	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism, Sphingolipid metabolism"	"Glycosidase, Hydrolase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 68.4;Kupffer cells: 72.1;Late spermatids: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 84.3;HMC-1: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022196	Approved				"Intracellular and membrane"	NA	NA		53000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB022196: "	"unprognostic (1.27e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.44e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-2)"	15.0	17.2	20.0	14.9	23.3	23.2	13.3	22.1	26.1	12.0	20.8	15.1	33.3	11.1	12.2	6.6	20.7	18.4	13.5	18.5	21.6	21.3	12.1	23.9	11.7	23.0	22.6	15.8	10.8	9.4	9.8	16.8	23.9	14.3	17.3	18.4	8.1	9.3	8.0	9.1	34.4	9.6	22.3	15.4	16.4	24.0	20.8	9.7	24.5	12.9	7.9	13.6	7.5	30.6	0.0	19.5	7.2	0.0	23.8	21.3	0.0	9.1	17.9	8.3	9.9	10.8	84.3	5.3	26.4	8.7	0.0	1.3	0.0	1.0	10.2	2.7	0.6	29.8	0.7	0.0	19.5	0.1	78.4	20.7	6.6	5.6	0.0	3.4	22.6	0.0	10.0	3.9	14.4	1.9	0.0	4.5	6.5	35.4	2.2	0.0	0.5	0.3	13.4	7.8	6.7	15.6	24.6	4.0	0.2	17.2	20.4	20.5	19.7	0.0	12.9	5.6	0.2	4.2	8.0	0.0	2.3	6.8	19.2	25.3	15.2	34.2	11.1	16.6	24.0	2.5	8.3	10.8	8.9	1.2	6.0	7.0	11.9	16.3	13.4	1.6	5.3	11.7	20.0	23.3	22.1	26.1	18.5	21.6	23.0	22.6	23.9	22.3	20.8	30.6	11.3	25.6	19.0	26.8	8.0	8.4	5.6	9.4	3.4	10.1	9.1	5.2	9.2	10.0	8.9	14.7	12.5	6.2	27.6	15.3	3.9	9.8	51.6	17.3	10.9	11.4	6.1	13.7	17.8	11.4	12.7	15.2	7.7	5.8	68.4	15.9	18.2	6.1	26.6	3.3	21.2	10.2	4.1	72.1	11.8	77.9	16.1	25.0	10.6	8.4	26.7	7.3	40.2	33.2	42.6	14.1	20.0	10.1	9.3	6.1	15.9	6.7	22.1	10.4	0.0	9.8	10.6	14.9	10.0	3.5	11.5	6.6	21.2	12.9	16.7	7.9
GBGT1	"A3GALNT, FS, MGC44848, UDP-GalNAc"	ENSG00000148288	"Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group)"	Q8N5D6	9	133152948-133163933	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 16.4;Hofbauer cells: 21.3;Kupffer cells: 31.9;Macrophages: 22.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 64.1;HMC-1: 57.1;HUVEC TERT2: 24.0;NB-4: 29.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051298	Approved				"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA051298: AB_2681428"	"unprognostic (4.63e-3)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (6.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.38e-1)"	"unprognostic (2.97e-2)"	"unprognostic (7.43e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.27e-3)"	"unprognostic (2.35e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (3.46e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.35e-2)"	9.9	10.5	6.3	11.0	5.9	9.9	6.5	11.8	7.0	5.4	11.8	5.3	3.3	6.7	2.7	3.6	7.4	7.5	6.7	5.9	8.2	5.6	1.3	9.7	9.7	13.5	11.2	12.5	3.4	4.8	4.2	12.8	13.8	6.1	3.2	1.0	4.8	4.2	2.2	3.5	6.7	6.7	7.7	8.9	22.2	1.3	11.5	2.7	6.7	2.9	8.1	6.0	6.3	8.5	0.1	1.6	1.5	0.0	1.0	1.1	0.5	4.7	3.8	2.6	0.1	0.0	0.9	1.2	15.5	4.7	1.7	17.3	10.5	1.0	0.1	0.0	0.5	64.1	1.1	0.0	12.4	2.4	57.1	5.3	1.7	0.6	0.1	10.5	24.0	0.8	18.7	0.2	1.0	0.3	0.2	29.0	4.9	0.5	0.4	4.5	0.4	1.7	1.6	0.2	0.4	1.8	0.0	2.6	0.1	2.0	0.1	14.0	14.8	0.0	2.0	1.9	0.1	0.0	0.0	0.1	0.3	10.2	0.8	6.2	10.7	5.2	0.2	7.2	0.4	1.8	0.3	0.0	3.0	2.7	0.1	0.1	1.7	0.2	6.4	2.2	0.2	2.5	6.3	5.9	11.8	7.0	5.9	8.2	13.5	11.2	13.8	7.7	11.5	8.5	1.6	0.0	1.7	4.9	4.9	0.8	2.2	0.6	2.8	0.3	4.1	2.7	2.6	1.5	0.7	1.8	0.0	2.4	0.0	0.6	0.0	3.2	0.0	0.5	1.8	1.8	0.0	16.4	2.4	0.6	1.1	7.3	2.6	0.3	11.4	3.6	0.7	0.0	21.3	0.0	1.9	0.3	0.0	31.9	3.1	0.0	7.5	22.0	0.0	5.6	11.1	2.4	0.0	1.5	0.0	0.8	12.1	1.9	0.7	1.5	0.1	1.6	0.0	0.2	0.0	3.9	6.2	0.1	0.1	1.4	1.1	3.6	2.0	0.5	1.2	1.7
GBX1		ENSG00000164900	"Gastrulation brain homeobox 1"	Q14549	7	151148589-151174745	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 12.9;testis: 5.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"cervical cancer: 1.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.3"	"Low region specificity"	"Detected in single"			HPA055783	Approved					NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA055783: AB_2682919"		"unprognostic (4.24e-2)"			"unprognostic (3.87e-2)"			"unprognostic (3.58e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.95e-1)"				"unprognostic (1.87e-1)"	"unprognostic (1.91e-1)"		"unprognostic (3.14e-1)"	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	1.4	0.0	0.0	5.2	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.7	0.2	0.9	1.1	0.0	0.0	1.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GCSAML	"C1orf150, FLJ44728"	ENSG00000169224	"Germinal center associated signaling and motility like"	Q5JQS6	1	247507058-247577690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.4;prostate: 5.5"	"Cell type enriched"	"Detected in some"	24	"granulocytes: 223.3"	"Cancer enriched"	"Detected in single"	13	"prostate cancer: 1.9"	"Region enriched"	"Detected in some"	5	"cerebellum: 6.4"	"Immune cell enriched"	"Detected in single"	661	"basophil: 227.7"	"Lineage enriched"	"Detected in single"	661	"granulocytes: 227.7"	"Group enriched"	"Detected in some"	71	"HEL: 151.8;HMC-1: 564.8"					"Low region specificity"	"Detected in all"			"HPA027507, HPA027510"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Cytosol		"HPA027507: AB_10600756, HPA027510: AB_2672309"	"unprognostic (5.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.76e-4)"	"unprognostic (3.21e-1)"	"unprognostic (6.14e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-2)"	0.5	0.2	0.4	0.8	0.4	1.8	1.0	6.4	0.7	0.7	0.4	1.2	1.5	0.8	0.5	1.1	0.3	1.4	0.2	0.3	0.4	0.1	0.2	2.1	0.3	0.4	0.3	0.1	0.4	0.1	0.0	0.3	1.2	5.5	1.5	1.2	0.3	0.4	0.2	0.7	1.4	0.6	0.1	0.4	0.9	3.4	0.4	0.7	0.3	0.7	0.2	0.7	0.3	1.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.8	0.8	0.2	0.1	0.0	0.1	151.8	0.2	0.0	0.0	0.3	564.8	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.3	0.3	5.0	0.2	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.4	0.0	0.0	0.3	0.2	0.0	2.3	0.1	0.4	227.7	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.2	0.5	0.4	0.4	6.4	0.7	0.3	0.4	0.4	0.3	1.2	0.1	0.4	1.2	0.0	0.0	4.4	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	1.9	0.0	9.1	0.0	0.1	0.6	0.0	5.0	0.4	0.0	0.0	0.3	0.0	0.0	223.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.7	7.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	8.3	1.7	0.0	0.6	0.0	1.4	0.1	0.0	0.2
GDF11	"BMP-11, BMP11"	ENSG00000135414	"Growth differentiation factor 11"	O95390	12	55743122-55757264	"Predicted secreted proteins"		"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 76.6;Cone photoreceptor cells: 77.2;Horizontal cells: 57.2;Rod photoreceptor cells: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HMC-1: 127.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060985, HPA069609"	Approved		Approved	Vesicles	"Secreted to blood"	No	No	46400	340000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA060985: AB_2684403, HPA069609: AB_2686159"	"unprognostic (5.21e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.48e-2)"	3.6	4.0	22.5	3.7	17.5	1.8	2.3	16.4	17.8	6.8	15.9	5.4	1.6	7.6	2.0	2.4	5.0	4.6	7.5	18.1	18.5	3.0	1.3	3.6	2.8	22.0	26.6	5.7	2.9	2.9	4.7	2.0	20.9	6.0	1.6	21.6	4.8	9.4	1.8	1.5	3.7	4.6	18.3	5.6	2.7	1.1	22.3	4.6	3.6	2.0	1.8	5.9	3.4	17.7	4.9	7.6	32.8	18.6	24.4	17.8	8.2	10.1	9.5	12.5	10.7	26.0	2.1	9.5	13.0	10.5	5.9	4.6	25.0	18.0	4.3	18.2	22.7	11.7	12.3	4.1	4.9	9.8	127.7	17.2	1.0	18.3	5.2	14.0	16.4	12.7	13.2	30.1	16.0	9.2	16.0	8.5	26.4	0.3	18.9	25.1	8.9	5.9	7.7	6.6	22.2	13.6	6.2	2.8	2.6	13.3	10.7	10.7	10.1	15.0	22.9	11.9	7.4	8.1	2.6	4.9	8.0	9.7	10.8	0.2	0.2	0.5	1.2	0.1	1.0	0.7	0.7	0.7	0.2	0.7	0.6	0.8	0.3	0.2	0.4	0.7	0.5	0.1	22.5	17.5	16.4	17.8	18.1	18.5	22.0	26.6	20.9	18.3	22.3	17.7	8.4	0.0	1.1	19.2	10.9	0.5	9.8	0.6	4.0	76.6	6.3	6.6	25.6	1.5	0.9	0.0	77.2	3.6	16.6	1.5	0.0	5.0	0.6	9.9	35.2	8.0	10.7	11.1	4.3	1.4	5.3	13.3	3.1	18.0	5.7	7.6	6.4	0.2	1.6	57.2	10.8	1.9	0.0	1.9	0.7	0.8	9.0	4.4	3.6	1.9	4.1	30.6	22.6	17.1	3.2	3.3	4.1	5.7	4.1	9.8	3.4	0.5	0.1	53.1	13.1	31.1	18.1	2.9	4.1	3.0	0.9	4.7	18.9	7.2	2.2	6.2
GFI1B	ZNF163B	ENSG00000165702	"Growth factor independent 1B transcriptional repressor"	Q5VTD9	9	132944000-132991687	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"bone marrow: 39.0"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 99.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	20	"basophil: 195.6;eosinophil: 395.8"	"Lineage enriched"	"Detected in many"	26	"granulocytes: 395.8"	"Group enriched"	"Detected in some"	5	"HEL: 168.9;HMC-1: 104.6;K-562: 53.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004420, HPA006291"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Plasma membrane"		"CAB004420: AB_2110132, HPA006291: "	"unprognostic (1.79e-2)"	"unprognostic (2.90e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.54e-2)"		"unprognostic (2.53e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.41e-1)"	0.0	0.0	0.0	0.3	0.1	39.0	0.0	0.2	0.2	0.0	0.2	0.5	0.9	0.0	0.1	0.1	0.0	0.3	0.2	0.1	0.0	0.0	0.2	1.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.3	0.0	0.1	0.1	0.4	0.5	1.0	0.1	0.1	1.8	0.3	2.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	1.9	0.3	23.8	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	168.9	0.2	0.1	0.0	0.1	104.6	0.0	1.4	0.0	0.2	0.0	0.0	0.0	53.0	0.2	0.0	0.0	0.1	17.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	1.5	0.0	0.0	0.0	195.6	0.3	395.8	0.1	1.9	0.1	0.1	0.1	0.0	1.9	0.2	0.5	0.1	3.9	0.5	15.1	1.0	0.0	12.5	0.0	0.1	0.2	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.4	0.2	0.0	0.6	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.2	0.0	1.3	0.0	1.8	0.0	0.0	0.1	0.1	0.8	0.0	0.1	3.8	0.0	0.3	0.4	1.2	99.1	0.4	0.0	0.2	0.3	0.0	0.1	14.5	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.0	12.9	0.0	15.8	0.0	0.0	0.6	0.0	0.0	0.5	0.2	0.0	24.2	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.4	0.0	0.0	0.3	0.2	1.0	0.6	0.1
GFOD1	"ADG-90, C6orf114, FLJ20330"	ENSG00000145990	"Glucose-fructose oxidoreductase domain containing 1"	Q9NXC2	6	13357830-13487662	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 100.9;Cardiomyocytes: 108.2;Excitatory neurons: 133.2;Inhibitory neurons: 106.2;NK-cells: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 15.5;NK-cell: 13.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 15.5;NK-cells: 13.1"	"Cell line enhanced"	"Detected in many"		"HEL: 30.5;HMC-1: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029096	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted - unknown location"	No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029096: AB_10602320"	"unprognostic (5.00e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (8.49e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (6.72e-5)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.66e-3)"	10.5	2.0	14.3	2.8	21.6	12.7	9.6	11.2	26.1	5.0	0.0	6.2	1.8	3.6	0.8	8.6	4.4	4.3	16.7	24.5	3.7	2.3	7.2	9.7	4.3	3.0	1.5	1.5	1.5	1.7	3.5	3.9	2.3	4.0	2.8	2.1	3.6	1.4	12.0	5.5	6.5	4.9	0.6	8.8	7.9	0.6	2.5	3.0	2.7	9.7	4.2	6.2	5.8	16.9	12.5	1.3	1.0	2.1	1.7	1.8	1.3	1.0	0.5	0.7	0.4	0.4	0.9	16.8	16.6	1.2	1.0	10.9	3.4	5.4	0.7	1.2	6.0	30.5	7.2	6.6	2.4	9.0	46.3	0.9	4.1	1.6	4.5	2.6	9.5	4.5	0.9	1.5	1.3	4.1	2.0	5.2	1.8	4.3	3.3	6.9	2.1	8.8	0.6	2.4	5.5	1.0	4.0	0.7	4.0	2.1	0.9	0.9	12.2	1.6	3.2	3.5	5.6	13.4	8.3	19.8	1.4	5.3	0.4	0.2	0.4	15.5	1.5	0.9	0.2	2.7	0.2	0.7	0.2	1.9	0.1	0.5	0.3	13.1	0.9	0.1	0.1	1.0	14.3	21.6	11.2	26.1	24.5	3.7	3.0	1.5	2.3	0.6	2.5	16.9	100.9	0.0	1.8	33.0	14.3	20.3	4.9	14.5	19.9	43.8	7.4	3.7	108.2	10.0	14.4	0.0	0.0	1.5	46.1	18.2	0.0	5.3	0.1	3.8	1.0	49.0	8.4	31.2	133.2	3.1	34.7	9.1	2.0	8.0	4.5	0.2	51.4	19.5	2.5	1.7	106.2	11.2	8.2	15.7	31.3	0.3	2.5	21.4	12.4	42.2	4.7	2.1	142.2	58.8	56.6	30.5	31.7	1.2	14.5	3.1	10.6	0.3	13.6	2.7	13.1	19.9	17.5	0.0	3.3	34.6	22.4	0.7	23.4	1.0	4.4	4.7
GFRA2	"GDNFRB, NTNRA, RETL2, TRNR2"	ENSG00000168546	"GDNF family receptor alpha 2"	O00451	8	21690398-21812357	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 9.4;thyroid gland: 8.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 91.9;Horizontal cells: 220.4;Late spermatids: 238.1"	"Cancer enriched"	"Detected in some"	5	"thyroid cancer: 6.2"	"Region enhanced"	"Detected in many"		"cerebral cortex: 5.0"	"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 9.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.5;monocytes: 9.2"	"Cell line enhanced"	"Detected in some"		"HEL: 9.1;HMC-1: 21.4;WM-115: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024704, CAB032791"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA		9000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"CAB032791: AB_2110428, HPA024704: AB_1849629"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.48e-4)"	"unprognostic (2.87e-1)"	"unprognostic (6.11e-2)"	"unprognostic (4.40e-3)"	"unprognostic (2.11e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.50e-4)"	"unprognostic (8.45e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.68e-2)"	"unprognostic (9.63e-3)"	2.4	1.8	1.2	2.0	1.0	0.6	0.6	0.0	5.0	2.6	0.0	2.1	1.9	0.5	0.2	1.5	1.3	0.6	1.0	1.5	2.2	0.2	0.9	1.2	1.6	0.0	0.8	0.3	0.3	0.1	0.4	7.1	0.0	0.4	1.1	2.6	0.9	1.5	0.1	0.5	1.8	2.0	0.0	7.5	1.0	9.4	1.8	1.1	8.7	0.6	0.8	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.9	0.8	0.0	9.2	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.4	0.0	1.3	0.0	0.0	0.9	1.2	1.0	0.0	5.0	1.5	2.2	0.0	0.8	0.0	0.0	1.8	0.0	0.3	0.0	1.8	1.3	0.1	1.8	0.2	0.0	0.0	4.3	0.1	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	91.9	0.0	1.2	0.3	0.0	0.0	39.5	0.0	0.1	1.8	0.0	0.1	1.3	0.0	0.7	0.2	0.6	220.4	6.5	0.0	0.0	30.6	25.2	238.1	0.6	11.8	0.0	3.7	0.5	1.9	0.0	2.5	1.1	0.0	0.0	1.9	0.1	0.1	0.0	0.0	0.0	2.1	6.6	0.7	1.8	1.2	7.0	0.0	0.9	0.3	0.2	0.1	0.0	0.1
GHDC	LGP1	ENSG00000167925	"GH3 domain containing"	Q8N2G8	17	42188799-42194532	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031650	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA031650: AB_10601014"	"unprognostic (2.30e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (3.21e-4)"	"prognostic unfavorable (6.81e-5)"	"unprognostic (5.13e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (6.69e-3)"	"unprognostic (5.18e-2)"	"prognostic favorable (2.00e-6)"	"unprognostic (2.08e-1)"	"unprognostic (7.93e-2)"	"unprognostic (9.66e-2)"	"unprognostic (4.02e-2)"	15.7	32.9	14.3	10.1	15.2	11.8	15.8	15.1	16.2	18.6	15.2	15.3	15.8	15.1	11.0	8.8	15.9	10.6	12.3	13.9	15.8	24.5	18.6	15.9	13.2	18.3	15.7	22.2	26.4	12.8	16.7	9.3	16.7	20.7	5.3	3.8	24.1	14.2	7.8	9.8	19.4	5.3	15.0	32.2	19.5	5.9	15.5	7.4	26.8	5.7	6.5	15.5	13.3	16.3	7.5	26.1	1.8	20.5	6.8	6.0	16.1	9.9	7.7	5.0	6.5	8.4	35.4	11.4	34.9	9.2	6.1	0.6	5.8	0.2	1.2	18.8	21.1	17.3	11.9	18.0	17.7	13.9	70.4	9.1	5.3	13.7	4.2	6.1	7.8	6.9	16.8	50.0	2.6	9.2	9.0	27.1	4.4	28.1	0.0	8.7	9.5	49.8	13.8	6.0	4.0	13.9	0.3	46.1	34.4	0.4	31.8	22.0	6.7	23.3	9.2	20.4	4.7	37.3	31.3	7.7	19.7	17.3	9.6	0.8	3.2	1.8	2.3	3.0	1.0	2.5	1.5	2.3	2.7	4.1	1.5	1.8	1.6	1.1	4.1	2.4	1.4	2.6	14.3	15.2	15.1	16.2	13.9	15.8	18.3	15.7	16.7	15.0	15.5	16.3	16.2	0.0	9.6	4.9	9.9	2.9	9.3	8.8	2.2	7.6	8.8	7.1	2.1	14.3	6.7	16.5	6.2	13.1	8.7	5.1	3.9	12.9	1.0	5.6	8.5	12.6	13.8	4.6	2.6	19.3	11.6	10.0	6.1	8.9	13.3	6.5	28.5	15.3	27.9	8.4	4.3	10.7	8.2	25.5	5.4	1.3	11.5	12.6	8.8	2.8	9.3	16.2	13.4	1.0	3.5	10.3	4.8	13.9	4.7	6.5	25.6	16.5	7.8	5.5	0.0	12.8	6.3	2.8	0.5	2.2	1.8	7.3	9.5	15.9	9.4	5.4
GIPR		ENSG00000010310	"Gastric inhibitory polypeptide receptor"	P48546	19	45668221-45683722	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 22.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 29.9;Gastric mucus-secreting cells: 28.1;Respiratory ciliated cells: 44.5;Rod photoreceptor cells: 17.4"	"Cancer enriched"	"Detected in many"	5	"pancreatic cancer: 4.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.8;HMC-1: 20.6;SCLC-21H: 13.9;U-266/70: 16.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB022710, HPA068054"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"CAB022710: , HPA068054: "	"unprognostic (2.40e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.70e-4)"	"unprognostic (1.82e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.59e-2)"	10.0	0.3	1.8	3.1	2.6	2.0	9.0	2.3	3.3	2.5	2.7	6.9	3.7	0.3	0.7	2.5	10.2	1.4	15.2	1.8	2.7	3.8	0.7	5.6	2.7	4.1	4.7	0.1	10.8	5.6	0.4	0.2	4.5	7.1	4.9	13.1	7.8	0.4	0.3	4.2	4.2	0.3	1.7	4.0	22.7	0.2	4.4	0.6	2.5	0.0	2.4	2.6	3.4	4.4	0.7	0.4	1.3	0.7	0.6	0.0	0.1	1.0	0.8	0.0	0.7	0.4	3.9	1.9	0.6	0.8	0.7	2.0	0.3	0.2	0.1	9.8	0.3	1.6	1.0	0.3	0.1	0.6	20.6	0.0	0.3	0.1	0.0	1.8	0.0	2.1	4.5	2.2	0.0	0.2	0.1	1.1	0.0	2.9	0.7	0.5	0.4	4.4	0.5	0.9	13.9	1.2	0.0	0.8	0.2	0.5	2.0	3.1	0.4	0.0	0.5	0.3	0.2	16.7	0.2	0.4	0.6	1.5	0.3	1.1	0.1	0.5	0.5	0.2	0.1	0.2	0.2	0.3	0.2	0.3	0.2	0.3	0.5	0.9	0.0	0.2	0.4	0.2	1.8	2.6	2.3	3.3	1.8	2.7	4.1	4.7	4.5	1.7	4.4	4.4	1.4	3.2	6.3	0.0	1.0	0.9	3.4	2.9	0.0	0.3	2.0	0.5	4.0	5.7	9.8	5.5	0.0	0.0	3.7	13.2	0.0	2.2	0.4	7.1	0.1	0.5	29.9	0.0	0.2	3.6	0.1	0.5	28.1	0.7	1.3	0.1	0.0	0.0	0.1	0.0	0.4	6.8	4.1	0.0	7.8	0.2	0.0	1.4	0.0	0.0	0.5	0.2	1.0	0.0	5.0	5.6	11.3	0.0	4.0	1.5	0.3	0.1	44.5	17.4	13.1	0.3	3.5	0.2	0.3	1.5	0.4	0.1	2.1	0.1	1.9	2.8
GKN1	"AMP18, BRICD1, CA11"	ENSG00000169605	"Gastrokine 1"	Q9NS71	2	68974573-68980980	"Plasma proteins, Predicted secreted proteins"		Mitogen		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1840	"stomach 1: 37425.0"	"Cell type enriched"	"Detected in some"	28	"Gastric mucus-secreting cells: 9780.9"	"Cancer enriched"	"Detected in some"	116	"stomach cancer: 255.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 6.5;HMC-1: 17.2;MOLT-4: 12.4;NTERA-2: 16.0;REH: 7.2;U-2 OS: 10.1;U-266/70: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047684	Enhanced				"Secreted to digestive system"	NA	NA		18000000		"Cluster 4: Stomach - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA047684: AB_2680120"						"unprognostic (5.40e-2)"					"prognostic unfavorable (1.54e-4)"			"unprognostic (4.54e-1)"			"prognostic favorable (4.53e-4)"	3.0	1.8	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.4	0.0	1.4	0.0	0.3	0.0	3.6	0.4	0.0	1.0	0.0	0.0	1.8	0.8	3.5	0.0	0.0	0.0	0.4	4.8	0.0	0.3	20.3	0.0	0.7	0.3	0.0	0.4	0.1	1.0	0.5	0.4	0.0	0.0	10.4	37425.0	0.4	0.0	1.1	0.2	0.2	0.1	1.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	6.5	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.4	0.0	16.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	10.1	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.3	3.3	9780.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	346.5	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.5	0.0	0.0
GLA	GALA	ENSG00000102393	"Galactosidase alpha"	P06280	X	101393273-101408012	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 229.9;Plasma cells: 171.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 328.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000237, HPA000966"	Enhanced				"Intracellular and membrane"	NA	NA		1300000	"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA000237: AB_1078968, HPA000966: AB_1078969"	"unprognostic (7.27e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (5.62e-5)"	"unprognostic (2.53e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.73e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (1.13e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.21e-1)"	15.6	21.5	5.2	12.7	5.4	25.1	26.7	6.6	6.9	13.8	6.2	13.0	22.4	10.9	17.5	9.3	15.2	11.8	9.9	5.6	6.2	15.6	12.7	17.2	13.2	7.0	7.3	9.2	6.7	31.7	9.9	22.1	7.3	7.9	15.3	6.9	10.0	39.3	6.2	9.2	13.5	15.4	6.5	13.2	9.3	3.8	6.9	12.0	7.9	6.5	15.6	14.7	9.1	8.1	30.5	117.9	30.8	31.9	68.9	26.8	13.8	34.1	51.9	63.5	176.3	64.7	45.9	33.6	70.0	35.3	151.8	70.3	65.9	38.3	53.8	19.3	47.1	18.3	87.9	78.4	19.2	26.7	328.1	24.3	11.3	72.9	21.6	17.4	50.9	18.2	28.6	71.2	60.8	52.3	24.4	53.7	48.2	72.5	46.4	18.2	39.5	81.5	95.1	61.9	11.5	19.4	78.6	34.6	30.9	54.4	15.2	51.2	29.9	20.7	23.8	52.6	27.0	23.0	26.3	25.4	36.9	39.9	23.1	22.5	37.3	11.9	6.9	38.5	9.0	8.8	5.6	8.8	29.8	9.0	5.6	6.9	21.6	5.6	40.6	10.9	7.3	20.4	5.2	5.4	6.6	6.9	5.6	6.2	7.0	7.3	7.3	6.5	6.9	8.1	31.5	16.0	10.2	3.3	65.8	30.2	32.6	23.7	45.5	4.0	34.0	23.2	7.7	4.3	19.3	11.0	6.2	38.4	25.5	26.5	17.6	22.5	3.9	57.6	19.5	30.8	33.9	12.6	3.2	18.7	26.3	66.1	39.8	97.6	31.0	9.6	8.9	7.1	93.0	8.4	3.9	15.9	20.3	28.5	229.9	0.9	11.1	115.7	88.9	4.7	30.3	17.5	14.4	3.0	3.9	14.4	25.3	18.0	171.4	20.5	30.9	9.5	29.9	5.3	6.6	22.6	70.8	6.4	5.8	31.0	23.7	75.5	33.2	19.8	19.2	27.9
GLO1	GLOD1	ENSG00000124767	"Glyoxalase I"	Q04760	6	38675925-38703145	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HMC-1: 2571.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB040541, CAB040542, HPA059791"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1500000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB040541: , CAB040542: , HPA059791: AB_2684126"	"unprognostic (4.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.21e-2)"	55.4	62.3	69.4	38.9	74.1	31.6	74.2	74.6	83.4	55.9	77.2	51.8	116.3	57.8	110.9	60.0	72.3	41.4	88.9	72.6	76.2	87.2	157.7	66.6	48.4	73.7	72.8	82.8	42.1	106.1	23.2	64.1	75.1	171.4	52.3	100.3	43.2	62.1	154.2	66.6	67.7	61.8	77.9	48.2	48.5	27.9	72.9	50.0	54.8	128.8	60.3	52.4	51.6	77.1	201.6	92.0	257.4	256.7	119.2	213.9	227.0	171.1	161.4	235.4	243.0	224.4	75.3	222.5	132.2	137.5	280.1	129.5	222.5	221.1	295.8	203.8	343.0	329.4	105.7	211.3	178.5	126.7	2571.5	183.9	133.5	223.7	159.0	153.2	258.5	154.9	264.7	143.6	223.3	170.6	199.5	160.5	185.5	179.2	176.7	171.0	311.1	145.8	217.8	149.9	199.3	201.3	120.6	165.4	329.8	175.9	192.4	628.3	107.6	182.0	167.1	159.8	275.9	112.7	227.0	608.6	66.1	322.7	299.6	23.7	20.7	15.3	35.5	33.4	48.0	51.9	35.3	36.7	39.0	51.4	32.7	34.9	2.7	23.5	26.9	60.4	34.1	33.3	69.4	74.1	74.6	83.4	72.6	76.2	73.7	72.8	75.1	77.9	72.9	77.1	69.2	131.4	174.4	26.1	86.3	64.6	112.6	88.2	37.0	56.1	67.7	55.8	133.2	58.6	84.5	90.1	20.9	102.7	68.3	34.1	248.4	132.1	4.5	76.2	58.8	74.3	36.5	83.5	23.9	73.3	323.0	86.0	53.0	67.5	71.4	78.7	161.0	114.0	78.8	69.0	21.9	39.3	99.7	125.7	72.8	6.5	83.9	70.0	104.9	17.8	92.6	190.3	49.4	25.1	24.8	77.3	36.0	109.9	86.4	178.8	103.2	132.2	80.7	65.5	46.0	62.0	70.9	15.0	16.1	77.2	88.2	73.2	62.4	123.7	63.4	130.2
GMCL1	"BTBD13, FLJ13057, GCL1, SPATA29"	ENSG00000087338	"Germ cell-less 1, spermatogenesis associated"	Q96IK5	2	69829660-69881384	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 264.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 93.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039579	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA039579: AB_10805480"	"unprognostic (1.89e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.27e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	9.4	6.5	4.4	8.1	4.8	13.6	10.6	5.3	6.7	8.6	11.6	10.7	15.9	7.7	8.8	8.2	7.9	8.5	4.8	5.2	4.4	11.5	10.7	7.7	12.0	4.4	4.7	8.5	9.1	19.1	6.5	9.3	4.3	11.1	12.2	6.1	9.4	8.7	4.1	8.8	13.1	6.4	4.6	9.1	8.6	16.3	4.5	18.5	9.2	5.4	12.2	8.3	6.3	5.3	14.7	10.3	17.2	18.4	15.0	13.1	18.4	12.1	8.0	8.1	13.7	9.9	13.5	30.7	9.7	8.0	9.5	14.2	20.3	10.5	14.1	14.2	21.2	48.0	11.3	22.8	9.9	36.1	32.4	7.2	11.3	6.4	14.9	10.5	14.5	23.2	19.5	21.8	12.9	12.6	37.1	33.7	18.4	24.9	9.6	26.1	22.6	23.6	11.9	22.2	27.0	22.5	13.2	19.1	14.8	13.4	12.6	22.2	9.0	12.4	15.5	19.4	14.7	22.1	28.6	18.9	12.8	29.5	13.0	93.5	8.0	40.1	11.1	6.3	19.1	8.8	10.9	13.7	7.5	8.3	15.6	15.5	26.8	26.8	10.3	7.9	15.5	9.4	4.4	4.8	5.3	6.7	5.2	4.4	4.4	4.7	4.3	4.6	4.5	5.3	17.9	28.9	27.4	22.9	25.9	26.8	21.4	19.5	27.3	22.5	28.3	20.4	7.6	74.4	22.0	18.4	27.1	38.3	42.5	40.0	41.1	36.1	264.8	26.7	21.8	19.5	23.4	29.0	68.1	17.5	51.9	19.4	16.3	18.4	22.2	24.2	26.4	25.4	15.9	21.9	63.8	37.0	44.7	23.8	13.1	50.8	15.8	15.0	16.0	11.2	22.8	44.2	50.4	42.7	45.6	15.2	21.7	22.6	28.2	33.0	42.1	23.2	38.4	37.0	13.1	26.0	21.1	44.2	45.1	38.4	27.7	81.5	36.7	17.5	30.6	25.7
GMIP	ARHGAP46	ENSG00000089639	"GEM interacting protein"	Q9P107	19	19629476-19643657	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 50.9;lymphoid tissue: 54.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 26.6;Gastric mucus-secreting cells: 24.5;Hofbauer cells: 22.7;Kupffer cells: 33.3;Macrophages: 26.7;monocytes: 27.6;T-cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 92.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042484, HPA045481"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042484: AB_2678018, HPA045481: AB_2679343"	"unprognostic (7.54e-2)"	"unprognostic (5.35e-3)"	"unprognostic (3.10e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.75e-3)"	"prognostic unfavorable (3.97e-5)"	"prognostic favorable (3.03e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (5.15e-4)"	7.5	3.3	2.9	32.0	2.4	50.9	5.4	2.5	6.1	3.7	2.5	9.6	10.4	3.3	1.4	8.6	5.4	6.0	2.9	3.8	4.0	4.3	4.7	16.9	29.4	6.5	4.4	2.6	6.0	8.9	3.6	4.6	5.7	5.4	6.5	0.4	6.9	2.8	1.1	6.9	22.6	4.3	4.5	54.3	16.7	2.9	6.6	19.1	8.5	1.9	22.9	8.3	5.3	7.4	9.9	4.5	5.9	6.5	6.4	3.3	23.5	6.1	5.2	3.6	3.4	3.6	13.0	24.1	12.1	4.3	4.7	11.5	3.9	6.7	2.3	8.3	6.1	7.6	7.1	4.0	1.9	21.7	92.0	4.2	4.5	3.9	2.0	4.2	8.2	21.1	5.3	8.5	3.9	14.6	13.7	35.8	3.5	12.7	8.1	23.3	2.6	14.0	6.9	23.3	5.1	15.2	8.4	8.7	3.7	4.5	8.0	30.7	15.0	6.6	3.8	7.6	4.6	4.3	1.9	19.8	4.2	28.0	4.6	7.0	19.5	51.9	13.2	23.7	12.3	12.6	8.4	11.9	15.1	12.8	8.9	9.7	71.8	9.7	33.1	13.5	10.0	12.5	2.9	2.4	2.5	6.1	3.8	4.0	6.5	4.4	5.7	4.5	6.6	7.4	1.7	0.0	10.2	0.3	26.6	1.1	1.7	2.5	1.2	0.0	1.9	1.3	0.9	2.8	3.1	0.0	0.0	0.6	14.9	21.2	0.0	4.1	0.1	1.4	0.9	1.8	0.0	1.3	2.1	4.7	5.3	0.9	24.5	4.0	7.0	3.5	2.5	1.6	22.7	0.0	2.1	6.6	0.0	33.3	6.6	0.4	0.6	26.7	1.8	6.5	27.6	0.4	20.6	0.5	0.2	12.9	20.2	0.7	13.9	2.0	9.3	0.7	1.5	0.1	0.0	0.4	1.6	0.6	1.3	3.5	1.1	0.8	25.8	0.9	6.0	4.1
GMPR		ENSG00000137198	"Guanosine monophosphate reductase"	P36959	6	16238587-16295549	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 358.6;tongue: 205.0"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 86.1;Endometrial ciliated cells: 118.2;Erythroid cells: 367.1;Melanocytes: 92.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 95.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 14.9"	"Group enriched"	"Detected in all"	6	"granulocytes: 14.9;monocytes: 5.0;NK-cells: 9.6"	"Cell line enhanced"	"Detected in many"		"HEL: 193.1;HMC-1: 314.7;SK-MEL-30: 74.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA021476"	Uncertain					NA	NA		950000	"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA000904: AB_1078998, HPA021476: AB_1849858"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.06e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (4.12e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (2.94e-5)"	"unprognostic (3.01e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.17e-1)"	10.0	23.3	28.5	2.8	31.9	29.7	6.5	32.4	21.6	6.6	35.7	15.5	2.7	13.3	16.5	5.3	56.9	3.7	101.7	19.6	38.2	25.5	5.9	9.1	2.5	36.8	45.6	38.0	18.3	14.2	24.9	7.8	35.0	63.1	3.4	2.2	21.5	9.0	358.6	12.4	6.0	9.9	39.7	12.5	36.5	52.3	41.3	6.5	4.4	205.0	1.6	5.2	3.7	33.2	0.0	0.0	0.3	0.0	2.7	2.1	0.1	3.9	15.7	27.2	55.2	1.6	0.4	0.0	8.8	6.0	19.1	0.1	6.7	0.8	4.5	0.0	5.0	193.1	0.1	0.0	11.8	0.8	314.7	3.7	2.8	8.5	0.0	22.2	49.5	0.7	43.9	0.3	4.8	3.8	0.2	4.1	2.0	0.2	7.5	0.0	41.9	0.0	36.1	5.4	9.4	1.2	1.9	3.2	74.4	12.1	3.0	1.4	12.5	0.4	0.2	1.3	7.5	2.3	0.0	0.0	0.9	20.3	21.8	14.9	3.3	0.4	0.7	5.0	1.2	0.2	0.1	0.5	1.5	1.5	0.0	0.2	3.3	9.6	1.7	1.5	0.0	16.0	28.5	31.9	32.4	21.6	19.6	38.2	36.8	45.6	35.0	39.7	41.3	33.2	4.6	0.0	0.0	8.8	1.3	5.1	30.2	0.7	0.6	0.7	5.3	3.8	52.8	35.8	2.7	20.2	0.0	25.3	0.6	1.4	86.1	12.4	16.0	118.2	8.7	6.8	7.8	367.1	3.8	4.9	2.8	10.2	9.2	78.9	55.3	38.9	17.9	5.0	8.9	0.0	11.5	3.2	4.1	6.4	2.1	16.3	34.5	47.4	92.5	2.8	9.2	9.8	2.1	3.0	1.7	3.0	1.2	80.9	1.4	69.9	2.2	15.5	6.4	0.8	0.0	12.6	7.4	6.5	17.2	1.3	1.8	6.8	3.5	19.4	3.8	8.3
GNS		ENSG00000135677	"Glucosamine (N-acetyl)-6-sulfatase"	P15586	12	64713445-64759431	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 198.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 228.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013695, CAB026011, HPA048508"	Enhanced				"Intracellular and membrane"	NA	NA		510000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"CAB026011: , HPA013695: AB_1849741, HPA048508: AB_2680423"	"unprognostic (8.07e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (7.76e-4)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.04e-1)"	106.1	174.7	18.0	56.4	19.9	25.4	51.9	20.4	21.3	58.9	80.7	35.3	34.6	49.5	38.5	26.2	43.8	63.7	52.9	17.2	26.4	132.0	56.2	71.5	41.0	30.0	23.3	64.3	24.1	76.8	23.0	80.2	25.5	38.5	36.9	25.1	32.9	47.7	30.1	26.3	41.4	69.2	22.5	51.2	34.6	31.8	27.3	20.5	72.8	29.0	26.9	63.7	27.6	31.2	41.0	61.3	50.7	81.4	240.0	145.2	108.8	92.0	213.5	108.4	117.1	55.9	53.3	17.4	117.0	117.8	133.3	33.1	49.1	52.6	119.5	51.4	36.6	41.4	45.4	36.4	109.3	30.6	346.2	139.6	62.9	111.5	49.3	342.0	200.1	24.7	28.8	117.2	156.8	32.6	8.1	17.9	19.4	102.8	53.2	23.8	77.3	53.7	91.5	116.2	33.7	37.3	119.6	56.6	82.4	65.8	102.2	40.4	185.1	104.5	54.8	101.8	54.4	112.1	143.4	14.9	151.1	58.4	72.1	51.7	136.9	27.5	29.3	158.4	21.9	13.0	15.9	22.6	78.2	10.0	16.4	16.4	56.6	18.4	228.5	19.3	13.0	101.9	18.0	19.9	20.4	21.3	17.2	26.4	30.0	23.3	25.5	22.5	27.3	31.2	52.6	48.1	31.7	19.2	11.0	16.6	8.4	14.8	11.4	10.5	28.4	17.0	59.9	22.8	24.2	103.0	18.8	24.3	18.8	24.2	1.9	36.2	24.4	26.5	25.5	50.6	41.9	15.4	25.0	15.1	19.7	40.2	12.2	32.9	48.1	36.3	58.5	57.9	81.0	16.8	31.3	16.6	18.3	198.8	46.5	24.5	34.8	107.8	16.0	27.2	79.0	20.1	13.4	15.1	19.9	20.0	15.7	37.2	16.0	17.2	60.9	64.3	42.8	7.5	6.6	23.1	24.9	11.3	7.8	10.5	12.9	29.1	13.2	30.0	18.2	19.2
GPR141	PGR13	ENSG00000187037	"G protein-coupled receptor 141"	Q7Z602	7	37683796-37833788	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"bone marrow: 27.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 8.9;granulocytes: 23.4;Langerhans cells: 8.2;monocytes: 7.5;NK-cells: 13.4;Oligodendrocytes: 14.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 13.0;eosinophil: 9.7;gdT-cell: 5.2;memory CD8 T-cell: 5.1;myeloid DC: 6.6;naive CD8 T-cell: 3.4;neutrophil: 12.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 13.2;HMC-1: 49.7;NB-4: 8.0;NTERA-2: 27.1;THP-1: 8.2;U-937: 21.9"	"Not detected"	"Not detected"													NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (4.91e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.26e-4)"	"unprognostic (4.70e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.39e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.60e-1)"	1.4	0.4	0.6	4.1	1.5	27.9	0.6	1.2	0.7	1.3	0.9	1.2	0.8	0.7	0.4	1.5	0.5	2.2	0.3	0.3	1.3	0.3	0.7	1.8	1.9	3.2	1.2	0.1	0.2	0.3	0.1	2.4	1.9	0.4	1.7	0.0	0.3	0.3	0.2	0.9	1.2	1.5	1.5	3.0	0.8	0.8	1.8	1.4	0.3	0.6	1.8	3.7	0.2	3.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	13.2	1.0	0.0	0.0	0.3	49.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	8.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	21.9	0.0	0.0	13.0	9.7	5.2	0.9	0.0	0.0	1.2	5.1	6.6	0.0	0.5	3.4	12.3	0.8	0.1	0.2	0.0	4.3	0.6	1.5	1.2	0.7	0.3	1.3	3.2	1.2	1.9	1.5	1.8	3.0	0.0	3.2	3.0	0.3	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.0	8.9	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.1	0.0	0.1	23.4	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	5.4	8.2	1.3	0.0	5.7	0.0	1.9	7.5	0.0	13.4	1.0	14.4	0.0	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.6	0.0	0.1	0.3	2.3	0.0	0.0	0.0
GPR34		ENSG00000171659	"G protein-coupled receptor 34"	Q9UPC5	X	41688973-41697275	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 251.4;Kupffer cells: 173.3;Macrophages: 100.6;Microglial cells: 54.4"	"Cancer enhanced"	"Detected in all"		"glioma: 26.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"basophil: 339.6;eosinophil: 117.9"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 339.6"	"Cell line enhanced"	"Detected in single"		"HMC-1: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010668, CAB025490"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB025490: , HPA010668: AB_1849294"	"unprognostic (1.26e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.81e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-3)"	"unprognostic (3.18e-2)"	28.2	17.1	5.2	15.1	5.2	0.9	21.5	6.1	5.8	14.0	5.6	12.0	6.5	6.7	2.7	8.2	7.8	17.0	8.3	5.0	7.6	5.0	8.5	10.9	20.0	10.6	7.9	7.3	5.4	5.3	1.4	42.7	11.4	3.2	13.1	0.6	3.6	8.8	0.8	1.0	14.6	16.3	9.9	15.6	7.8	2.7	9.7	6.9	3.7	4.6	16.7	13.3	1.7	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	339.6	9.7	117.9	0.0	12.9	0.4	1.5	0.4	0.1	2.0	1.2	0.1	0.3	1.1	14.3	7.0	0.3	0.6	2.8	5.2	5.2	6.1	5.8	5.0	7.6	10.6	7.9	11.4	9.9	9.7	18.8	0.9	0.0	2.8	1.0	2.0	0.6	0.2	0.0	0.0	0.0	0.5	2.3	1.2	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.6	0.1	0.1	5.0	1.2	0.4	0.7	0.0	1.6	1.0	0.5	0.0	37.3	0.0	2.9	0.8	251.4	0.0	0.9	0.0	0.0	173.3	13.6	1.9	0.9	100.6	1.8	54.4	7.1	0.1	1.0	3.5	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.1	0.0	0.8	19.7	0.6	0.3	0.0	0.2	0.4	1.0	2.5	7.2	0.1	0.1	0.0
GPR65	"hTDAG8, TDAG8"	ENSG00000140030	"G protein-coupled receptor 65"	Q8IYL9	14	88005135-88014811	"G-protein coupled receptors, Predicted membrane proteins"	Apoptosis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.6;lymphoid tissue: 9.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 256.1;granulocytes: 317.8;Kupffer cells: 112.5;monocytes: 90.9;NK-cells: 319.3;T-cells: 192.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 5.7;HEL: 6.2;HL-60: 7.5;HMC-1: 9.0;RH-30: 11.5"	"Not detected"	"Not detected"							"HPA072624, HPA077397"	Enhanced		Approved	Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Nucleoli, Cytosol"	"HPA072624: , HPA077397: "	"unprognostic (8.56e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.98e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.10e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (3.79e-1)"	"unprognostic (4.46e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.80e-1)"	2.0	1.1	0.5	9.1	0.6	12.6	0.9	0.5	0.8	1.1	0.6	1.2	1.6	0.7	0.4	0.9	0.7	2.8	0.6	0.4	1.0	0.8	2.7	4.3	8.8	1.9	1.0	0.3	0.4	0.4	0.4	1.7	1.6	0.8	1.5	0.1	0.7	0.5	0.2	0.3	2.4	2.3	1.0	9.6	1.6	0.6	1.2	4.2	0.4	0.5	6.6	3.4	0.5	2.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.2	0.0	0.0	0.2	7.5	9.0	0.3	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.2	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	39.0	19.8	43.6	33.8	28.4	62.4	9.3	16.9	26.2	13.0	8.1	8.6	19.4	15.2	49.1	32.1	5.9	9.0	24.5	0.5	0.6	0.5	0.8	0.4	1.0	1.9	1.0	1.6	1.0	1.2	2.3	2.9	3.2	21.6	0.3	77.8	4.2	0.5	0.0	0.0	0.2	1.9	3.2	0.4	7.2	1.3	0.0	0.0	0.2	256.1	0.5	0.0	0.0	9.1	0.2	0.4	2.1	0.0	6.6	0.0	0.0	0.3	2.3	6.6	0.5	317.8	0.0	3.9	1.4	62.8	0.0	0.0	0.6	0.0	112.5	73.1	1.4	0.6	88.6	3.6	4.7	90.9	0.0	319.3	0.0	0.1	0.0	0.0	0.0	25.6	0.2	0.1	0.3	0.7	0.2	0.0	0.9	2.0	0.1	0.1	0.7	5.3	0.4	192.8	0.9	0.4	0.2
GPR82		ENSG00000171657	"G protein-coupled receptor 82"	Q96P67	X	41724181-41730130	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 2.7;lymphoid tissue: 6.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 16.5;Cone photoreceptor cells: 20.9;Kupffer cells: 37.0;Rod photoreceptor cells: 17.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	10	"eosinophil: 40.2;NK-cell: 10.9"	"Group enriched"	"Detected in many"	10	"granulocytes: 40.2;NK-cells: 10.9"	"Cell line enriched"	"Detected in single"	30	"HMC-1: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA035914	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA035914: AB_10670671"	"unprognostic (5.62e-3)"	"unprognostic (1.81e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.62e-4)"	"unprognostic (1.41e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.00e-3)"	"unprognostic (1.18e-1)"	0.1	0.9	0.7	2.3	0.5	0.1	0.6	0.8	0.7	0.3	0.4	1.1	1.7	0.3	0.1	0.4	0.3	0.6	0.1	0.5	1.0	0.3	0.7	0.2	3.2	1.4	0.7	0.2	0.1	0.2	0.1	0.0	0.7	0.2	1.1	0.0	0.4	0.4	0.0	0.4	2.7	0.3	0.6	1.1	0.9	0.0	1.3	0.5	0.3	0.0	6.9	0.8	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	40.2	0.0	2.5	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.3	10.9	2.4	0.0	0.0	0.2	0.7	0.5	0.8	0.7	0.5	1.0	1.4	0.7	0.7	0.6	1.3	0.8	0.7	0.0	7.2	2.0	5.5	4.7	5.2	2.8	0.6	16.5	1.2	0.3	0.4	4.3	5.9	1.8	20.9	0.9	3.7	3.1	0.0	2.0	0.2	1.0	3.4	3.1	1.2	0.8	1.7	1.1	0.2	2.9	1.5	1.4	0.0	1.4	3.3	1.3	1.3	13.5	2.2	2.0	2.0	37.0	7.7	0.2	4.1	13.9	3.6	0.0	3.4	1.7	12.3	10.6	1.1	2.8	5.1	3.0	1.3	3.6	6.9	0.3	1.1	17.2	0.0	3.4	2.3	1.6	1.1	0.3	2.7	0.7	12.6	3.9	3.4	3.8
GPRC5C	RAIG-3	ENSG00000170412	"G protein-coupled receptor class C group 5 member C"	Q9NQ84	17	74424851-74451653	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 192.7;stomach 1: 230.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 211.3;Gastric mucus-secreting cells: 143.2;Hepatocytes: 183.6;Paneth cells: 153.8;Sertoli cells: 144.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 7.9"	"Group enriched"	"Detected in many"	9	"dendritic cells: 7.9;monocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 82.4;HMC-1: 146.7;PC-3: 80.8;RPTEC TERT1: 172.1;RT4: 89.9;T-47d: 108.0"	"Region enriched"	"Detected in all"	9	"cerebellum: 42.5"	"Low region specificity"	"Detected in all"			HPA029776	Enhanced		Uncertain	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	Yes		15000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA029776: AB_10602324"	"unprognostic (1.48e-1)"	"unprognostic (3.35e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.58e-5)"	"unprognostic (7.58e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.54e-3)"	16.1	19.3	17.4	3.1	18.4	0.4	20.1	48.9	18.1	42.0	28.0	38.7	25.0	17.1	10.2	12.2	30.0	21.3	33.7	14.8	16.9	135.7	192.7	23.0	2.1	18.1	18.7	38.2	136.1	28.2	14.8	11.9	18.6	45.6	14.6	1.5	37.4	24.3	110.1	43.9	30.3	4.0	16.6	22.3	230.3	4.0	17.0	4.4	74.8	33.9	3.0	30.8	20.9	15.7	17.3	61.6	3.8	5.5	0.0	0.0	0.2	0.3	0.0	0.0	0.0	66.4	73.0	0.0	45.0	0.3	18.5	52.9	7.7	1.0	0.1	0.2	10.7	0.0	4.0	82.4	15.8	0.0	146.7	1.3	26.7	0.0	0.0	69.2	0.0	0.1	4.8	1.2	0.0	18.0	0.7	17.2	9.2	79.5	80.8	0.2	0.1	2.8	172.1	89.9	27.5	2.5	3.7	5.9	0.1	33.1	108.0	4.6	0.0	0.0	5.5	0.1	0.1	0.1	0.4	0.2	6.5	2.5	0.4	0.0	1.1	0.1	0.0	2.5	0.0	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	3.7	7.9	0.0	0.3	17.4	18.4	48.9	18.1	14.8	16.9	18.1	18.7	18.6	16.6	17.0	15.7	11.2	3.2	57.7	13.4	1.4	13.6	39.2	79.6	26.7	0.8	27.3	19.4	211.3	67.2	76.2	136.1	0.0	0.8	11.8	74.9	29.4	65.5	0.1	62.5	6.6	20.9	45.5	5.3	0.1	68.1	20.3	11.3	143.2	74.9	10.2	0.1	48.2	183.6	12.3	5.0	0.5	50.8	69.2	16.3	4.6	1.7	18.0	6.3	3.6	2.8	4.1	15.9	0.0	5.0	0.2	41.2	153.8	22.2	1.2	44.6	61.0	73.5	45.4	1.5	144.7	4.7	64.0	0.5	5.0	14.8	11.2	25.3	2.4	1.5	48.5	63.1
GPSM3	"AGS4, C6orf9, G18, G18.1a, G18.1b, G18.2, NG1"	ENSG00000213654	"G protein signaling modulator 3"	Q9Y4H4	6	32190766-32195523	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 160.8;lymphoid tissue: 229.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 261.0;dendritic cells: 238.9;Hofbauer cells: 278.3;Kupffer cells: 397.2;Langerhans cells: 209.3;Macrophages: 268.2;monocytes: 375.1;NK-cells: 352.2;T-cells: 256.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 226.9;NB-4: 115.8;THP-1: 107.1;U-937: 76.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		73000	"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (2.93e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.02e-2)"	"prognostic favorable (5.98e-4)"	"unprognostic (3.55e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.61e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (6.92e-9)"	"unprognostic (2.01e-2)"	"unprognostic (1.69e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.87e-2)"	28.7	11.8	11.1	96.8	10.3	160.8	15.5	10.8	14.1	8.9	10.5	17.9	14.4	6.8	9.1	9.4	13.9	24.8	14.9	10.5	13.4	15.9	14.5	62.9	139.9	15.6	13.6	5.3	6.1	1.8	7.6	22.2	13.9	13.8	15.8	0.3	11.8	5.5	3.7	9.1	67.7	10.0	12.3	229.3	17.5	5.6	14.6	83.0	11.6	5.6	100.8	32.8	9.1	14.4	1.0	0.0	1.6	0.6	0.1	0.2	1.5	1.3	17.0	5.6	8.8	0.2	5.2	41.1	7.8	6.7	0.5	0.9	0.1	7.2	3.1	53.8	0.1	59.5	0.0	1.2	9.6	0.0	226.9	2.0	0.0	1.9	5.9	1.2	25.8	25.7	11.4	47.9	1.6	0.0	23.6	115.8	0.0	0.0	0.5	24.5	0.0	38.4	1.4	0.0	0.6	0.1	0.0	0.6	8.7	2.1	1.1	107.1	22.6	3.0	3.1	0.0	1.5	1.1	0.9	25.9	0.9	76.3	15.5	44.1	55.8	194.3	35.5	73.3	35.7	52.8	45.5	44.7	57.9	41.9	38.5	42.7	244.9	27.1	71.5	24.3	34.7	53.2	11.1	10.3	10.8	14.1	10.5	13.4	15.6	13.6	13.9	12.3	14.6	14.4	12.8	0.0	2.2	1.0	261.0	11.2	12.9	11.5	4.0	0.2	7.7	9.1	0.5	2.8	7.3	3.7	0.0	3.4	238.9	2.2	0.0	7.9	6.5	1.1	1.0	19.5	1.2	46.3	0.1	5.2	5.1	7.1	8.6	0.9	57.8	0.5	28.2	4.4	278.3	0.0	0.3	6.5	30.5	397.2	209.3	12.1	1.2	268.2	44.4	4.7	375.1	0.5	352.2	0.0	0.3	20.5	34.2	0.0	76.4	5.8	0.5	2.4	5.5	0.5	6.6	1.3	9.4	0.8	3.9	1.4	8.5	6.3	256.1	7.8	3.7	24.6
GRAMD4	"DIP, KIAA0767"	ENSG00000075240	"GRAM domain containing 4"	Q6IC98	22	46576012-46679790	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 168.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 45.1;Distal enterocytes: 56.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 96.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"				"unprognostic (8.67e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.19e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.04e-4)"	"unprognostic (1.08e-1)"	"unprognostic (7.07e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.38e-2)"	"unprognostic (8.69e-2)"	15.1	52.1	15.1	17.4	15.9	22.6	11.9	9.3	20.2	11.5	11.9	40.6	34.6	7.5	9.9	24.2	16.1	20.5	45.0	15.6	11.9	18.6	168.2	19.6	17.6	11.6	11.6	10.8	17.6	10.0	24.1	10.5	12.0	14.1	26.6	9.1	17.8	7.1	23.8	45.3	36.0	9.1	11.2	16.0	28.0	7.4	11.8	23.5	20.3	11.9	26.6	9.4	13.2	13.8	12.6	14.2	16.3	20.9	21.4	12.5	16.8	9.5	5.9	3.8	4.8	5.1	19.6	45.9	15.9	10.7	11.1	26.2	10.0	5.2	5.8	12.2	11.3	15.4	10.9	12.2	17.4	96.9	60.0	8.4	12.2	3.0	6.8	13.4	5.3	34.6	29.4	30.3	5.4	22.0	56.4	51.0	8.9	28.2	6.6	25.3	2.5	30.2	7.4	14.6	11.6	32.3	10.2	20.3	37.1	18.7	19.8	33.8	8.3	4.9	9.7	6.6	6.3	6.2	21.5	24.3	10.9	37.4	43.1	1.2	1.4	1.0	0.6	0.9	0.3	1.0	0.5	0.4	2.0	0.3	0.4	0.2	0.5	3.9	0.4	2.4	1.9	0.8	15.1	15.9	9.3	20.2	15.6	11.9	11.6	11.6	12.0	11.2	11.8	13.8	17.7	16.0	18.4	45.1	5.9	8.2	3.6	7.6	6.8	5.0	7.1	10.8	19.3	8.6	4.1	3.7	0.0	3.7	9.5	56.1	0.0	4.7	0.3	13.4	7.2	7.5	20.8	3.8	21.6	6.7	2.2	4.7	8.2	10.6	7.0	5.4	2.5	23.0	14.0	3.3	18.2	20.7	6.1	10.1	14.7	1.1	4.7	12.0	7.2	11.2	10.9	12.2	3.1	13.6	5.9	7.9	18.9	5.7	8.6	5.0	34.5	3.0	5.1	1.7	0.0	3.4	5.3	1.2	3.8	8.2	10.4	3.4	7.0	5.9	22.8	3.7
GRB2	NCKAP2	ENSG00000177885	"Growth factor receptor bound protein 2"	P62993	17	75318076-75405709	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 340.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002589, HPA030749, HPA030750"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA		400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Nucleoli	"CAB002589: AB_10693935, HPA030749: AB_2673590, HPA030750: AB_2673591"	"unprognostic (4.83e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (6.04e-7)"	"unprognostic (1.01e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.58e-1)"	55.7	58.0	66.1	98.3	64.8	127.1	40.3	56.6	66.1	35.9	49.9	54.7	57.3	46.4	31.5	51.0	39.5	43.2	53.3	71.0	68.7	50.5	54.0	65.5	116.9	64.1	64.8	39.3	35.0	39.8	42.6	64.5	61.5	41.8	52.6	24.1	40.6	45.8	48.8	36.3	60.6	58.9	67.5	92.2	44.6	18.5	68.5	83.1	37.6	39.1	107.3	67.5	36.1	72.3	98.6	87.7	58.9	71.1	64.1	54.5	129.5	91.2	70.5	89.3	87.3	75.8	66.7	128.9	57.9	97.0	77.5	58.5	84.0	76.1	89.8	63.4	76.5	137.2	55.7	111.8	57.3	162.8	259.0	55.2	78.0	112.9	55.8	62.3	128.3	125.3	95.5	88.8	64.9	127.4	160.3	160.5	40.5	98.9	81.3	113.7	123.8	94.9	82.7	75.0	66.6	101.1	83.7	85.4	114.7	102.8	94.4	264.9	83.4	100.0	71.0	81.8	104.9	161.1	127.3	205.5	79.1	125.8	75.3	134.5	136.1	164.9	52.3	160.9	45.0	94.5	48.0	52.2	101.2	96.5	46.8	47.8	273.8	51.5	185.1	71.9	56.5	102.9	66.1	64.8	56.6	66.1	71.0	68.7	64.1	64.8	61.5	67.5	68.5	72.3	73.5	60.9	62.2	18.3	210.5	47.0	45.7	31.0	67.7	35.7	45.6	37.5	59.7	41.5	46.9	16.5	31.3	71.9	137.6	74.4	52.8	64.8	3.0	52.9	56.4	60.9	41.9	55.5	41.5	63.4	340.9	47.2	47.9	57.6	124.4	30.0	41.7	42.3	260.3	35.3	41.1	46.4	22.4	182.0	243.8	5.6	25.1	259.9	46.2	81.5	237.0	47.1	73.2	31.7	41.5	77.2	69.6	41.8	236.3	63.3	60.1	69.9	55.1	46.4	6.6	34.6	50.5	27.4	49.9	76.3	44.8	87.2	109.0	59.7	44.9	92.7
GRIN2D	"EB11, GluN2D, NMDAR2D, NR2D"	ENSG00000105464	"Glutamate ionotropic receptor NMDA type subunit 2D"	O15399	19	48393668-48444931	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 8.4"	"Group enriched"	"Detected in some"	5	"Inhibitory neurons: 36.5;Oligodendrocyte precursor cells: 15.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 17.3;EFO-21: 11.5;HMC-1: 28.4;NB-4: 17.6;SK-BR-3: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB009006	Approved					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB009006: AB_2279191"	"unprognostic (9.96e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (4.17e-1)"	"unprognostic (1.43e-4)"	"unprognostic (7.84e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.23e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.66e-13)"	"unprognostic (2.15e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.14e-1)"	0.6	0.3	3.0	0.3	1.4	0.1	0.3	3.0	2.8	0.1	0.0	0.2	0.5	0.1	0.0	0.1	0.4	0.3	0.3	1.2	4.8	0.1	0.1	0.2	0.1	4.7	5.8	0.2	0.1	0.9	0.2	0.9	4.8	0.3	0.0	0.8	0.2	0.0	0.1	0.6	0.7	0.1	2.4	0.2	0.2	1.1	8.4	0.0	0.7	0.0	0.0	0.1	0.3	0.6	1.5	17.3	0.4	0.0	1.2	3.5	9.8	2.1	0.0	0.5	0.1	1.3	10.0	0.5	11.5	1.1	0.1	0.1	0.1	0.2	0.3	2.3	0.4	5.4	0.6	2.2	1.8	0.4	28.4	1.3	0.0	1.0	0.0	0.1	0.4	0.1	9.9	0.5	0.1	3.2	0.0	17.6	0.5	8.6	0.3	0.1	0.0	0.3	0.3	0.0	1.8	1.7	0.8	15.0	0.1	0.2	0.0	6.6	5.8	0.0	0.1	0.0	0.0	5.8	3.5	0.0	0.0	2.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.4	3.0	2.8	1.2	4.8	4.7	5.8	4.8	2.4	8.4	0.6	0.3	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.3	2.6	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.9	0.2	0.3	0.4	0.0	0.0	2.3	0.2	4.6	0.9	0.0	0.1	0.0	0.1	1.8	0.2	1.3	0.0	36.5	0.0	0.0	0.3	0.2	1.5	0.6	0.6	0.0	1.0	0.2	0.7	0.0	15.6	1.3	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.2	0.4	0.0	0.0	1.8	0.2	0.2	0.1	0.0
GSG1L	"KTSR5831, MGC18079, PRO19651"	ENSG00000169181	"GSG1 like"	Q6UXU4	16	27787528-28063714	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 22.5;heart muscle: 23.0"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 26.0;Oligodendrocyte precursor cells: 89.5"	"Cancer enriched"	"Detected in some"	7	"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HMC-1: 8.3;THP-1: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014479	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA014479: AB_2247974"	"unprognostic (1.85e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.06e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.10e-1)"		"unprognostic (2.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.35e-2)"	"unprognostic (9.77e-2)"	0.2	0.2	15.6	0.1	19.4	0.2	0.1	9.4	19.5	0.2	4.4	0.4	0.3	0.3	0.3	0.1	1.5	0.0	23.0	17.9	11.0	0.3	0.4	0.4	0.1	21.8	20.0	0.1	0.1	0.0	0.5	0.9	19.0	0.2	0.1	2.4	0.2	0.1	0.3	0.8	0.4	0.0	12.5	0.3	1.1	1.6	22.5	0.0	0.3	0.0	0.0	0.4	0.1	11.8	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.2	0.2	0.1	0.0	0.0	8.3	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.3	0.5	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.2	0.0	3.2	0.7	0.0	0.5	0.0	0.1	0.6	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	15.6	19.4	9.4	19.5	17.9	11.0	21.8	20.0	19.0	12.5	22.5	11.8	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.1	8.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.8	7.4	0.1	0.0	0.0	26.0	0.0	0.0	1.8	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.7	7.4	0.4	0.0	0.0	0.0	3.6	0.0	0.1	0.0	4.7	0.0	0.2	0.0	89.5	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.0	3.7	0.3	0.5	1.4	0.0	0.0	0.0	0.1	0.4	0.0	0.0
GZMB	"CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT"	ENSG00000100453	"Granzyme B"	P10144	14	24630954-24634267	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 68.2;lymphoid tissue: 37.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2050.2;NK-cells: 1704.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"plasmacytoid DC: 6765.2"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 6765.2"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 22.0"									"CAB000376, HPA003418"	Enhanced				"Secreted to blood"	NA	NA	2170		"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB000376: AB_323716, HPA003418: AB_1079020"	"prognostic favorable (7.27e-4)"	"unprognostic (2.82e-3)"	"unprognostic (8.54e-2)"	"prognostic favorable (1.58e-5)"	"unprognostic (2.07e-3)"	"unprognostic (1.48e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.25e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.10e-7)"	"unprognostic (1.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-3)"	8.2	1.7	1.2	17.8	1.3	68.2	2.1	1.2	3.9	1.2	1.4	2.5	2.3	7.1	1.6	3.8	1.5	6.5	1.8	1.2	7.9	1.5	4.1	15.3	37.1	1.5	1.5	0.3	1.0	0.7	0.7	3.3	1.6	1.4	2.2	0.0	2.3	1.4	2.0	0.4	4.4	4.3	1.4	28.9	3.5	0.5	1.8	9.7	1.9	1.5	34.6	18.5	1.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.7	2.8	9.9	3.0	5.3	1338.5	4.0	16.0	7.0	95.2	641.6	6.3	3.1	29.1	607.5	43.1	507.8	6.0	6765.2	2.7	1607.1	1.2	1.3	1.2	3.9	1.2	7.9	1.5	1.5	1.6	1.4	1.8	1.3	4.3	6.4	36.0	0.0	15.9	2.8	0.3	0.0	0.0	0.0	0.9	0.8	1.1	4.3	7.4	0.0	0.0	0.4	2050.2	0.6	0.0	1.6	0.0	0.4	0.5	2.7	0.0	11.8	0.0	0.0	0.1	5.1	9.2	0.5	17.7	0.0	4.2	1.2	0.2	0.0	0.0	0.6	0.0	4.8	9.0	0.2	0.0	27.1	42.7	1.0	11.6	0.0	1704.4	0.0	0.1	0.1	2.3	0.0	86.8	0.2	0.6	3.1	4.4	0.0	0.0	1.3	1.3	0.0	0.1	0.4	4.1	0.3	373.8	0.0	0.6	0.1
HCLS1	"CTTNL, HS1"	ENSG00000180353	"Hematopoietic cell-specific Lyn substrate 1"	P14317	3	121631399-121660927	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 153.6;lymphoid tissue: 300.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 175.7;Kupffer cells: 666.3;Macrophages: 269.0;monocytes: 245.7;NK-cells: 216.3;T-cells: 181.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 265.6;HMC-1: 362.3;RPMI-8226: 256.5;THP-1: 262.8;U-266/70: 361.6;U-698: 371.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019143	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		870000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA019143: AB_1850532"	"unprognostic (2.27e-2)"	"unprognostic (1.79e-3)"	"unprognostic (5.38e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.93e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	67.0	32.9	14.6	147.2	14.7	153.6	25.5	15.4	18.7	20.7	15.8	29.2	21.2	13.7	6.4	15.7	21.5	37.8	18.4	14.3	17.0	21.5	39.1	52.7	207.6	21.6	17.5	9.4	11.9	7.7	14.6	51.4	20.8	15.8	31.4	2.3	16.0	11.1	7.3	11.1	68.7	34.6	18.5	300.3	27.1	4.5	18.2	140.3	15.4	18.8	242.8	53.0	13.7	23.0	0.8	0.0	0.2	0.1	20.9	11.5	5.7	4.1	4.0	0.8	1.6	0.1	0.0	265.6	124.6	0.0	0.2	0.3	6.9	9.9	1.1	120.6	0.0	172.6	0.0	0.0	11.6	192.4	362.3	2.2	0.5	0.0	1.5	0.0	153.4	106.2	35.1	235.9	0.0	0.0	137.9	162.9	0.3	0.2	4.5	137.1	0.2	256.5	0.0	68.0	0.3	0.2	0.2	0.4	0.6	0.6	0.1	262.8	203.5	0.0	2.0	0.3	0.9	361.6	118.1	371.5	1.9	181.5	0.2	357.3	713.1	1180.9	405.3	870.4	333.0	345.7	334.2	376.8	636.2	313.1	279.3	326.2	1619.2	280.0	997.1	197.4	494.2	1427.9	14.6	14.7	15.4	18.7	14.3	17.0	21.6	17.5	20.8	18.5	18.2	23.0	23.0	9.6	31.8	1.0	175.7	3.2	1.0	7.8	0.6	0.5	2.7	5.1	2.3	4.3	13.1	0.0	0.0	122.4	139.5	0.8	0.0	0.3	1.1	8.8	1.6	23.3	0.0	50.5	1.4	0.2	60.0	7.0	8.6	3.1	73.4	0.7	27.8	7.7	126.9	0.0	0.7	0.4	4.1	666.3	105.8	1.5	3.4	269.0	19.6	26.2	245.7	0.4	216.3	0.5	0.3	0.2	0.2	1.2	148.6	0.4	0.1	0.9	24.7	0.8	13.1	3.7	6.7	0.6	0.6	1.3	4.4	145.4	181.4	2.4	0.5	2.2
HDC		ENSG00000140287	"Histidine decarboxylase"	P19113	15	50241947-50265965	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 102.9;epididymis: 46.1"	"Cell type enriched"	"Detected in some"	12	"granulocytes: 596.0"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.9;testis cancer: 2.7"	"Region enriched"	"Detected in many"	6	"hypothalamus: 102.9"	"Immune cell enriched"	"Detected in single"	2140	"basophil: 686.2"	"Lineage enriched"	"Detected in single"	2140	"granulocytes: 686.2"	"Group enriched"	"Detected in some"	4	"HEL: 460.8;HMC-1: 1051.3"	"Region enriched"	"Detected in many"	5	"hypothalamus: 43.9"	"Group enriched"	"Detected in some"	10	"hypothalamus: 16.5;midbrain: 4.2"	HPA038891	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nuclear bodies"		"HPA038891: AB_10673231"	"unprognostic (4.97e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.93e-7)"	"unprognostic (4.18e-5)"	"unprognostic (8.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	2.3	0.4	0.0	3.5	5.6	4.7	1.4	0.0	0.2	2.3	0.7	3.8	4.1	2.5	46.1	4.8	0.8	11.2	0.7	0.2	102.9	0.4	0.5	6.9	0.9	0.0	13.7	0.1	1.2	0.5	0.4	0.4	0.0	1.7	3.6	0.8	1.3	0.9	0.3	2.3	4.6	2.5	0.0	0.5	12.9	1.3	17.8	0.9	0.1	0.8	1.0	3.8	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	460.8	0.2	0.0	0.0	1.2	1051.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.5	181.8	0.3	0.0	0.0	0.2	0.4	0.4	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.5	0.2	0.4	686.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	1.6	0.0	5.6	0.0	0.2	0.2	102.9	0.0	13.7	0.0	0.0	17.8	0.1	0.0	12.8	47.5	0.3	0.0	0.8	0.0	0.0	0.0	2.6	0.0	0.0	0.5	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	10.9	0.3	0.0	0.0	2.3	9.2	0.0	596.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.8	0.4	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	3.5	0.0	0.1	0.1
HEATR3	FLJ20718	ENSG00000155393	"HEAT repeat containing 3"	Q7Z4Q2	16	50065970-50107272	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041990, HPA058579"	Uncertain		Enhanced	Nucleoplasm,Cytosol		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Cytosol	"HPA041990: AB_10793940, HPA058579: AB_2683762"	"unprognostic (7.36e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.80e-3)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (7.68e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.17e-2)"	7.1	8.2	3.8	9.0	3.7	5.6	5.3	4.6	4.2	5.1	4.3	7.0	4.9	5.0	4.5	8.0	4.8	4.2	6.4	3.7	3.6	6.7	10.2	6.3	6.6	4.2	3.2	3.3	8.0	4.8	6.5	5.8	3.4	4.9	6.3	4.8	6.0	3.4	12.0	6.3	7.0	5.3	3.2	12.6	6.6	5.8	3.8	4.6	3.7	6.2	6.2	5.1	5.1	3.9	13.0	12.8	11.8	18.6	7.0	9.6	12.6	15.5	10.1	15.0	6.0	15.9	9.4	24.4	10.9	14.7	5.6	15.1	14.1	11.3	17.2	6.1	15.4	12.1	9.0	20.4	10.2	21.1	23.5	7.5	7.8	10.4	6.2	6.6	12.2	12.6	15.5	3.9	14.9	7.8	16.2	26.4	13.8	15.5	13.1	17.6	15.8	19.8	8.4	10.4	15.1	8.0	14.8	18.9	10.0	8.8	8.5	15.4	16.1	12.0	8.0	9.1	11.8	9.8	8.0	21.3	11.7	20.9	12.0	0.5	2.4	0.5	0.9	2.8	1.0	0.6	0.5	1.0	1.7	0.8	0.8	0.9	0.5	0.7	2.6	1.5	0.9	1.0	3.8	3.7	4.6	4.2	3.7	3.6	4.2	3.2	3.4	3.2	3.8	3.9	4.2	3.2	5.8	7.8	4.6	3.2	1.4	1.5	3.4	7.8	3.1	2.0	6.0	2.8	1.8	1.8	16.7	3.5	7.1	3.3	7.9	2.4	10.7	3.7	6.8	4.6	3.5	3.8	21.2	3.1	3.6	4.7	7.7	3.8	1.3	6.5	1.8	9.6	9.4	1.7	16.7	3.2	4.1	22.2	4.7	18.3	3.4	13.9	1.8	7.5	13.3	2.4	3.1	20.1	12.8	2.9	2.5	2.2	7.2	1.9	4.7	4.1	2.8	8.1	0.0	2.5	4.2	5.3	4.8	7.6	1.7	1.0	5.8	6.7	5.8	1.5
HELQ	Hel308	ENSG00000163312	"Helicase, POLQ like"	Q8TDG4	4	83407343-83455855	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036852, HPA036853"	Approved		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"	Nucleoplasm	"HPA036852: AB_2675349, HPA036853: AB_10672102"	"unprognostic (4.58e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.13e-3)"	"unprognostic (7.14e-2)"	"unprognostic (8.62e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-1)"	4.8	9.1	2.2	5.0	2.6	4.6	5.5	4.0	2.8	5.4	4.6	4.0	3.1	4.9	4.5	3.4	4.6	3.8	5.1	2.1	2.4	5.4	5.5	4.0	9.3	2.2	2.3	8.1	3.7	5.6	4.4	3.2	2.5	3.9	3.9	5.5	4.6	4.0	7.2	3.9	4.5	4.3	2.4	6.2	3.7	6.0	2.4	8.0	5.8	8.1	7.5	4.4	4.0	3.0	4.0	2.9	6.0	4.0	7.5	7.2	3.1	5.5	7.9	7.2	6.9	2.9	4.1	11.2	4.3	5.1	4.9	4.0	6.9	3.9	7.7	6.5	3.3	6.3	4.8	3.9	4.5	8.4	15.9	6.1	5.5	5.9	5.8	6.1	5.3	7.2	8.8	9.4	7.0	4.3	7.5	5.9	2.7	6.0	2.2	5.9	7.1	3.9	6.2	2.3	4.7	4.2	5.6	6.2	6.6	5.9	3.8	8.3	4.6	5.4	4.8	6.7	4.4	8.7	3.8	9.2	4.7	6.1	6.1	3.4	1.7	3.6	3.1	2.2	3.2	3.4	3.3	3.2	2.6	5.1	5.6	4.7	1.3	3.6	3.1	2.5	4.5	1.6	2.2	2.6	4.0	2.8	2.1	2.4	2.2	2.3	2.5	2.4	2.4	3.0	14.1	3.2	14.0	14.4	23.1	4.2	8.6	6.6	12.0	10.2	6.7	9.0	12.3	5.7	7.7	5.5	8.4	10.9	11.4	4.5	11.7	6.7	28.3	7.3	10.2	10.2	0.0	7.8	17.0	5.4	10.3	11.1	4.1	7.7	7.6	9.8	10.0	4.1	10.2	6.7	21.3	5.5	4.1	7.2	5.4	8.9	13.1	9.9	7.2	20.6	10.7	7.8	17.5	10.6	15.7	4.4	8.3	7.9	15.8	5.4	7.6	11.8	15.9	13.8	0.0	11.2	11.9	24.3	12.7	7.0	3.8	11.5	18.2	17.4	5.5	6.1
HIGD1B	"CLST11240, CLST11240-15"	ENSG00000131097	"HIG1 hypoxia inducible domain family member 1B"	Q9P298	17	44846353-44850476	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 114.6;choroid plexus: 65.0;placenta: 105.2"	"Group enriched"	"Detected in some"	5	"Sertoli cells: 762.6;Smooth muscle cells: 209.3"	"Cancer enhanced"	"Detected in all"		"glioma: 9.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA079501			Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA079501: "	"unprognostic (6.85e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.07e-1)"	"unprognostic (8.46e-2)"	"unprognostic (2.37e-2)"	"unprognostic (4.98e-3)"	"unprognostic (3.61e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.98e-1)"	"unprognostic (6.19e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.23e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.52e-2)"	11.7	0.5	71.0	0.7	71.0	0.5	8.8	70.3	114.6	8.3	65.0	3.7	2.1	9.9	11.6	5.0	5.3	11.3	46.4	68.8	71.4	11.5	0.6	38.6	2.6	71.4	70.9	2.9	3.1	8.0	1.4	105.2	72.4	9.5	1.1	2.3	1.4	6.4	14.5	2.0	4.3	11.3	68.9	0.1	3.7	1.5	73.0	1.8	5.0	30.8	1.4	4.3	4.4	69.1	0.2	0.6	0.0	0.7	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.3	0.2	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.7	0.1	0.8	0.5	0.0	0.9	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.7	0.5	0.0	0.3	0.7	0.7	0.4	0.3	0.3	0.8	0.4	1.0	0.0	0.5	0.7	0.3	0.2	0.0	0.1	0.0	0.3	0.3	0.0	0.6	0.2	0.4	0.5	0.4	1.2	0.6	0.5	1.1	0.7	1.7	0.6	0.2	1.2	1.0	0.4	0.2	0.7	0.9	1.2	0.3	0.9	0.7	0.0	0.7	0.1	0.3	0.8	0.5	71.0	71.0	70.3	114.6	68.8	71.4	71.4	70.9	72.4	68.9	73.0	69.1	88.9	0.0	0.5	0.0	0.3	3.4	0.6	0.3	0.0	0.5	1.2	2.8	11.0	0.0	1.3	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.2	0.2	0.7	70.2	0.0	0.0	0.7	0.0	0.2	4.4	0.0	0.3	0.0	0.0	0.7	0.1	0.8	1.7	0.6	0.0	0.0	0.0	3.9	0.6	0.3	1.6	0.0	2.8	0.0	1.0	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.9	762.6	9.5	209.3	0.0	0.3	0.7	2.4	0.3	0.8	32.3	0.0	0.7
HOXB2	"HOX2, HOX2H"	ENSG00000173917	"Homeobox B2"	P14652	17	48540894-48545109	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 156.5;Endometrial ciliated cells: 69.2;NK-cells: 58.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"medulla oblongata: 14.9;pons: 10.9;spinal cord: 12.1;white matter: 10.7"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 54.5;EFO-21: 52.2;HEK 293: 59.1;HMC-1: 116.8;WM-115: 52.6"	"Region enriched"	"Detected in single"	34	"pons and medulla: 4.4"	"Group enriched"	"Detected in some"	4	"medulla oblongata: 4.9;spinal cord: 7.0"	HPA047857			Supported	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA047857: AB_2680184"	"unprognostic (8.58e-3)"	"unprognostic (4.39e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (7.72e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.12e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.89e-1)"	26.7	29.0	0.2	6.6	0.2	3.6	21.7	0.4	0.3	20.8	0.3	44.5	3.5	17.4	42.7	24.0	33.6	5.2	11.7	0.2	0.2	47.5	5.0	15.6	7.2	14.9	0.9	3.4	3.7	19.6	0.4	2.4	10.9	13.7	2.4	0.0	0.8	12.0	9.9	8.9	17.3	5.3	12.1	16.4	16.5	3.4	0.3	4.2	6.7	7.8	2.0	11.1	18.7	10.7	0.3	1.9	54.5	0.1	12.1	14.0	0.2	5.1	0.0	0.1	0.0	0.7	0.4	0.0	52.2	15.3	0.0	0.0	8.2	0.0	0.1	0.2	59.1	21.4	2.7	0.0	21.3	0.0	116.8	8.9	0.0	23.3	9.2	0.5	8.6	0.2	42.3	0.1	31.9	0.1	0.1	0.1	0.0	1.3	0.2	0.0	26.9	0.1	38.9	4.9	0.0	0.0	4.0	0.0	34.3	3.8	28.9	0.0	0.3	0.0	3.5	0.6	0.1	0.0	0.1	0.1	20.8	0.0	52.6	3.9	0.3	0.0	3.0	0.4	1.0	0.2	4.6	3.4	1.5	0.5	6.8	2.9	0.0	1.8	0.3	4.8	6.1	1.0	0.2	0.2	0.4	0.3	0.2	0.2	14.9	0.9	10.9	12.1	0.3	10.7	27.9	3.2	1.1	0.0	4.9	7.0	7.3	0.5	53.5	0.0	18.5	18.7	2.5	0.0	2.0	53.3	0.0	15.9	26.9	1.0	156.5	1.4	0.5	69.2	9.9	21.4	2.4	21.9	0.0	0.2	30.2	19.4	0.0	42.4	21.0	0.0	31.1	0.3	7.6	0.0	0.0	1.6	24.4	10.4	21.2	1.7	0.0	11.4	12.4	2.8	7.5	0.0	58.7	0.0	0.1	0.1	1.7	0.0	3.7	8.8	0.1	26.1	0.9	0.0	0.0	9.6	31.6	7.4	6.6	36.6	5.7	24.9	28.6	0.1	0.9	28.0
HS6ST1	HS6ST	ENSG00000136720	"Heparan sulfate 6-O-sulfotransferase 1"	O60243	2	128236716-128318868	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Transferase	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 75.4;Granulosa cells: 285.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"EFO-21: 131.2;HMC-1: 206.6;SCLC-21H: 112.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044586			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		72000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA044586: AB_10963057"	"unprognostic (9.94e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.94e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.66e-2)"	16.2	63.4	36.2	8.8	33.8	5.1	16.1	24.4	45.5	15.5	10.9	15.4	8.7	12.3	6.1	34.1	17.5	21.0	19.0	35.4	26.5	71.4	46.8	17.0	8.4	32.1	34.7	26.4	30.8	8.8	15.2	12.0	33.6	28.2	6.9	26.4	26.0	22.8	36.2	26.5	15.1	6.4	31.2	32.1	12.7	25.0	39.9	14.5	14.2	18.7	7.4	19.4	23.1	28.9	12.5	17.4	46.0	26.5	17.5	32.5	24.7	15.1	19.1	14.8	8.1	9.0	8.0	11.9	131.2	19.4	6.9	32.5	17.5	29.1	5.5	19.9	18.1	10.5	6.4	87.9	21.1	18.4	206.6	43.9	33.9	11.9	3.6	4.9	8.0	31.8	6.7	12.1	5.4	25.7	49.6	81.0	55.3	4.7	10.7	16.1	12.6	61.9	13.4	36.3	112.9	28.4	12.1	30.1	6.7	30.6	12.2	6.9	9.6	13.1	28.9	49.1	12.3	7.2	7.6	2.7	7.9	13.0	9.7	3.0	0.7	0.6	1.0	0.4	0.1	0.7	0.4	0.6	0.5	0.7	0.4	0.4	0.2	0.2	1.5	2.3	0.2	0.6	36.2	33.8	24.4	45.5	35.4	26.5	32.1	34.7	33.6	31.2	39.9	28.9	9.5	25.6	8.9	20.9	4.9	16.2	11.2	16.1	14.8	9.4	15.1	12.8	7.3	10.0	10.3	75.4	31.3	9.7	7.3	22.3	5.9	15.4	0.9	22.9	11.5	12.6	3.0	6.9	24.2	5.8	36.9	12.6	4.1	39.7	57.0	285.6	30.0	23.8	10.7	21.9	20.3	6.5	8.2	14.2	9.2	3.3	11.8	9.1	7.2	5.6	6.7	8.2	1.0	6.6	10.4	6.6	12.0	17.0	3.2	9.7	6.9	3.3	8.7	32.8	6.6	7.6	9.4	1.1	3.1	18.3	17.0	23.3	3.5	27.1	3.7	8.9
HTT	"HD, IT15"	ENSG00000197386	Huntingtin	P42858	4	3041363-3243960	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 181.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002756, HPA026114"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		36000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"CAB002756: , HPA026114: AB_1851330"	"unprognostic (2.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.52e-2)"	"unprognostic (8.33e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.04e-2)"	"prognostic favorable (2.41e-12)"	"unprognostic (9.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.84e-2)"	8.3	9.3	10.5	8.2	11.7	8.1	7.6	7.8	14.2	6.1	8.2	8.1	6.0	7.1	8.3	10.4	6.7	5.1	7.1	15.7	3.5	7.9	8.9	10.1	11.5	8.7	5.2	7.2	21.3	12.3	9.0	6.9	7.8	7.0	6.5	10.3	7.2	5.8	15.3	15.1	9.7	5.8	3.0	11.5	8.9	10.1	6.8	11.3	9.1	12.4	8.8	7.3	7.0	11.0	19.5	14.2	17.6	10.3	30.9	20.2	17.7	9.0	10.4	13.0	12.6	17.3	12.2	28.6	8.9	20.9	21.6	10.7	20.6	15.3	12.0	7.8	15.4	27.4	18.0	18.8	7.5	17.7	37.9	11.1	9.5	25.4	10.7	9.3	14.3	13.0	17.7	9.9	11.4	17.9	22.4	17.1	21.2	9.7	20.7	17.7	16.9	5.7	14.2	18.1	18.5	13.9	15.0	5.7	14.6	12.9	16.1	10.8	20.6	16.8	11.1	12.4	19.0	7.6	8.8	22.9	13.4	16.4	13.3	0.0	0.7	0.9	1.0	1.1	0.7	0.8	0.8	1.3	1.1	0.6	0.4	0.7	0.1	0.9	1.5	0.7	1.2	0.7	10.5	11.7	7.8	14.2	15.7	3.5	8.7	5.2	7.8	3.0	6.8	11.0	15.8	25.6	14.8	41.1	20.7	13.8	8.0	12.4	9.1	48.1	20.4	15.4	10.4	17.2	14.6	14.7	181.4	11.8	26.1	22.4	5.9	12.0	9.4	23.1	20.8	17.2	18.5	18.5	88.8	17.5	11.7	13.9	20.9	25.3	11.4	54.9	22.1	17.1	26.7	45.4	75.1	13.3	4.1	23.4	15.4	10.3	16.1	25.4	8.8	40.3	18.2	20.8	24.7	59.8	52.4	20.0	21.2	11.7	15.3	15.7	20.9	12.2	12.0	50.7	13.1	19.2	13.6	13.0	21.3	21.9	20.0	8.3	19.5	16.8	20.9	11.6
HYAL3	"LUCA-3, LUCA14, Minna14"	ENSG00000186792	"Hyaluronidase 3"	O43820	3	50292831-50299405	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.4"	"Group enriched"	"Detected in many"	17	"Early spermatids: 79.7;Late spermatids: 268.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 33.2;eosinophil: 54.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 54.6"	"Cell line enhanced"	"Detected in all"		"HEL: 58.8;HMC-1: 101.1;THP-1: 107.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA049402	Uncertain				"Secreted to blood"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA049402: AB_2680746"	"unprognostic (1.21e-3)"	"unprognostic (2.55e-2)"	"unprognostic (5.45e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.65e-2)"	"unprognostic (7.98e-3)"	"unprognostic (7.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.61e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.12e-5)"	2.1	2.8	5.1	1.3	5.4	36.4	1.8	6.7	8.3	2.0	2.9	1.9	1.7	1.6	1.1	3.9	1.6	1.8	1.8	5.1	4.0	2.6	5.1	2.1	1.2	7.4	4.0	1.5	1.9	0.9	1.9	1.5	7.3	3.2	1.0	1.1	3.5	2.4	1.0	2.1	1.8	2.2	3.9	1.7	4.5	13.9	5.4	1.6	1.7	0.9	1.6	1.8	2.7	5.8	6.0	6.9	3.8	4.3	7.6	3.9	2.3	6.5	5.8	8.0	6.1	9.3	6.2	5.2	3.1	7.5	12.4	6.5	7.0	15.2	3.0	12.3	3.6	58.8	18.8	7.6	5.5	6.4	101.1	8.1	11.5	8.1	5.2	5.8	8.4	5.8	4.6	6.3	3.8	3.6	2.4	37.4	2.9	7.0	17.2	2.6	5.1	9.5	9.5	2.6	4.7	5.4	9.6	7.5	5.1	4.4	4.9	107.2	11.1	6.8	4.9	22.2	3.8	3.0	7.0	4.4	6.0	22.5	5.8	33.2	4.1	54.6	1.3	2.3	2.2	1.6	4.1	1.9	8.2	2.9	1.1	1.5	1.4	2.1	1.4	2.0	2.6	2.4	5.1	5.4	6.7	8.3	5.1	4.0	7.4	4.0	7.3	3.9	5.4	5.8	2.5	3.2	1.1	0.3	0.8	3.1	2.8	8.1	2.8	1.5	2.2	2.8	0.4	1.5	5.0	3.7	4.2	2.8	0.2	0.8	9.8	5.6	79.7	2.0	1.6	3.5	4.2	9.2	2.4	0.7	5.3	1.2	4.1	2.1	7.0	1.1	7.1	2.1	2.1	5.0	1.6	1.9	6.1	1.9	4.4	268.2	1.8	2.0	3.6	1.0	5.9	1.5	0.0	0.5	0.3	3.6	0.4	2.6	1.9	2.2	0.5	2.7	1.8	0.8	6.6	1.2	1.8	4.3	4.6	3.7	3.7	3.0	2.2	1.6	1.8	3.5
IGFBP2	IBP2	ENSG00000115457	"Insulin like growth factor binding protein 2"	P18065	2	216632828-216664436	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Growth regulation"	"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 956.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1379.1;Granulosa cells: 1649.7;Hepatocytes: 658.6;Theca cells: 2199.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 2139.8;HMC-1: 5110.0;NB-4: 1106.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077723			Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	303000000	810000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Endoplasmic reticulum"		"HPA077723: AB_2686853"	"unprognostic (2.58e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.32e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-3)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (2.22e-5)"	"unprognostic (5.04e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.22e-1)"	219.5	58.8	15.9	28.3	14.8	21.4	90.5	15.6	30.2	86.9	123.3	85.5	76.8	232.5	59.9	145.6	157.0	26.9	169.2	15.6	16.3	187.3	607.7	71.0	8.8	15.3	21.7	281.7	956.0	12.4	66.9	81.0	19.3	217.3	35.0	2.4	76.4	196.2	23.3	30.8	44.6	49.7	13.2	398.9	492.2	58.0	16.0	33.6	57.8	21.9	14.5	132.6	97.4	13.2	0.1	52.3	402.1	396.3	2139.8	652.9	8.5	125.2	61.9	6.1	0.6	1.2	1.5	0.1	171.7	0.8	15.2	11.5	145.4	156.9	0.6	0.8	84.9	91.3	0.2	26.3	53.3	38.6	5110.0	219.3	15.8	2.5	7.1	12.5	0.2	184.7	3.9	11.7	2.8	103.1	162.8	1106.5	437.4	98.2	4.8	139.2	9.1	2.0	2.0	117.1	84.1	443.4	0.3	3.4	2.6	362.2	332.4	67.3	0.5	1.6	2.4	1.6	6.2	6.2	0.9	9.7	6.0	177.4	478.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	15.9	14.8	15.6	30.2	15.6	16.3	15.3	21.7	19.3	13.2	16.0	13.2	354.3	3.2	0.6	2.0	3.3	13.8	534.0	238.2	19.4	0.2	79.0	498.0	12.5	11.5	40.1	264.8	2.1	1.8	5.4	86.4	29.4	3.0	1.0	153.2	1379.1	149.2	321.0	31.1	4.5	128.4	7.7	296.7	411.8	176.0	4.5	1649.7	92.1	658.6	5.3	0.0	0.8	191.6	54.9	24.1	5.0	4.9	5.6	21.8	3.6	13.1	1.3	3.6	3.1	1.0	1.0	60.7	51.3	79.4	0.4	255.7	4.2	1.2	195.9	1.7	105.2	17.9	435.7	6.0	35.8	103.3	5.5	2.2	16.0	2199.1	133.8	304.0
IGHD3-16	IGHD316	ENSG00000211917	"Immunoglobulin heavy diversity 3-16"		14	105895634-105895670	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	4	"bone marrow: 4.0;intestine: 2.6;lymphoid tissue: 4.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	7	"naive B-cell: 27.0"	"Lineage enriched"	"Detected in many"	12	"B-cells: 27.0"	"Group enriched"	"Detected in some"	16	"HEL: 2.4;HMC-1: 1.3;NB-4: 1.0"															NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"																						0.0	0.0	0.0	1.7	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.8	0.0	0.0	0.0	2.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	27.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL10	"CSIF, IL-10, IL10A, TGIF"	ENSG00000136634	"Interleukin 10"	P22301	1	206767602-206774541	"Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 6.7;lymphoid tissue: 7.7"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 28.3;Kupffer cells: 44.4;Langerhans cells: 35.5;Macrophages: 99.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"thalamus: 3.5"	"Immune cell enhanced"	"Detected in some"		"classical monocyte: 2.1;intermediate monocyte: 1.8"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.1"	"Group enriched"	"Detected in some"	11	"HMC-1: 14.6;U-266/70: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013120, HPA071391"	Approved				"Secreted to blood"	NA	NA	5670		"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"CAB013120: , HPA071391: "	"unprognostic (3.65e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	"unprognostic (4.26e-1)"	"unprognostic (8.01e-2)"	"unprognostic (4.00e-1)"	"unprognostic (4.66e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.96e-2)"	6.7	2.1	0.1	7.7	0.1	3.2	0.7	0.2	0.7	0.8	0.9	1.0	0.8	0.3	0.1	1.5	1.4	3.5	1.1	0.2	0.5	0.2	1.6	1.5	5.7	0.7	0.4	0.4	0.1	0.2	0.4	1.9	0.6	0.4	1.3	0.0	0.2	0.7	0.0	0.1	1.1	3.1	0.5	4.9	0.8	0.8	3.5	2.9	0.2	1.2	2.0	2.9	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.2	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.4	0.1	0.1	0.2	0.7	0.2	0.5	0.7	0.4	0.6	0.5	3.5	1.2	0.5	0.0	1.9	0.0	5.6	1.0	0.4	0.0	0.0	0.2	0.2	0.3	0.3	0.0	1.3	0.0	0.0	0.1	1.3	0.0	0.0	0.0	6.9	0.1	0.2	1.9	0.0	0.4	0.0	0.0	0.1	0.8	1.1	0.2	1.3	0.0	0.7	0.5	28.3	0.0	0.0	0.0	0.0	44.4	35.5	2.9	0.0	99.5	1.8	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.4	0.9	0.3	0.0	0.0	0.0	0.4	0.0	0.9	0.8	0.0	0.2	0.7	1.1	0.1	12.9	0.0	0.0	0.4
IL16	"FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16"	ENSG00000172349	"Interleukin 16"	Q14005	15	81159575-81314058	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Host-virus interaction, Transcription, Transcription regulation"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 135.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 135.3;dendritic cells: 78.1;Kupffer cells: 59.2;Langerhans cells: 94.4;NK-cells: 121.5;Plasma cells: 55.6;T-cells: 76.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 57.3"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 27.7;HEL: 29.4;HMC-1: 50.6;RPMI-8226: 51.0;U-266/70: 60.3;U-698: 25.8;U-937: 35.1"	"Group enriched"	"Detected in all"	11	"cerebellum: 54.5;hippocampal formation: 27.0"	"Region enriched"	"Detected in many"	12	"cerebellum: 48.8"	"CAB005247, HPA018467, HPA048861"	Enhanced		Supported	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	208000	7300	"Cluster 5: Granulocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: "	"unprognostic (8.23e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.61e-4)"	"unprognostic (2.01e-1)"	"unprognostic (5.26e-4)"	"unprognostic (2.63e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.29e-1)"	18.9	6.3	3.5	63.3	3.0	62.1	15.5	57.3	4.1	9.6	13.8	14.4	11.3	9.9	7.7	7.4	17.8	16.2	5.9	2.9	5.7	3.2	9.7	23.7	132.6	5.9	5.7	6.1	2.6	2.3	2.1	9.0	10.5	5.8	16.8	0.5	11.2	4.5	3.3	12.0	39.9	9.8	5.8	86.2	15.6	4.2	5.2	130.4	6.9	8.5	135.3	18.9	10.4	7.6	0.0	0.0	0.0	0.1	17.5	7.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	27.7	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.4	0.0	29.4	0.0	0.0	0.9	21.0	50.6	0.9	0.0	0.1	0.6	0.0	0.4	3.5	3.2	10.7	0.1	0.0	1.7	22.2	0.0	0.1	0.0	0.1	0.1	51.0	0.0	0.2	0.1	0.1	0.1	0.0	9.9	0.0	0.0	4.6	0.2	0.3	0.2	1.0	0.0	60.3	5.5	25.8	1.8	35.1	1.5	252.8	116.2	321.3	164.5	142.7	185.9	166.0	170.6	180.6	150.9	157.2	224.9	185.6	282.5	213.2	149.1	113.7	197.0	338.0	3.5	3.0	57.3	4.1	2.9	5.7	5.9	5.7	10.5	5.8	5.2	7.6	9.4	3.2	6.6	0.0	135.3	8.2	0.2	0.8	1.2	0.2	0.8	1.4	2.7	8.6	1.9	1.8	0.0	0.3	78.1	0.3	0.0	0.1	1.4	3.1	6.6	7.5	0.0	20.2	3.4	0.2	0.3	15.9	1.1	0.7	27.1	0.0	26.7	9.2	19.0	0.0	4.9	0.3	0.0	59.2	94.4	1.4	10.8	33.1	28.4	18.7	30.2	0.3	121.5	0.0	0.3	0.0	1.2	18.0	55.6	0.1	0.1	0.4	7.7	0.7	6.6	1.1	3.2	2.1	7.5	1.2	3.7	0.4	76.3	0.2	0.7	0.2
IL1RL1	"DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1"	ENSG00000115602	"Interleukin 1 receptor like 1"	Q01638	2	102311502-102352037	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 126.4;lung: 162.0;placenta: 199.8"	"Cell type enriched"	"Detected in many"	9	"granulocytes: 501.5"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	64	"basophil: 38.3;eosinophil: 29.3"	"Lineage enriched"	"Detected in single"	72	"granulocytes: 38.3"	"Group enriched"	"Detected in some"	6	"HHSteC: 245.1;HMC-1: 373.7;HUVEC TERT2: 185.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007406, HPA007917"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"	"Secreted to blood"	NA	NA	19100000	3100000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA007406: AB_1079128, HPA007917: AB_1079129"	"unprognostic (7.25e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.60e-3)"	22.3	30.3	7.5	3.1	9.8	0.7	14.7	7.8	11.0	3.6	12.2	5.2	1.7	2.5	0.6	4.4	2.6	14.7	24.7	7.2	8.2	126.4	16.0	162.0	0.7	7.6	7.7	1.1	4.8	0.8	5.7	199.8	7.7	4.9	3.4	2.8	1.8	4.6	2.5	4.3	8.0	3.7	8.0	1.4	25.1	0.5	9.6	1.3	4.1	0.7	0.8	6.5	3.9	8.9	0.9	0.2	0.7	0.1	15.1	0.6	0.3	0.5	0.7	0.4	0.6	0.3	0.5	0.5	0.7	0.2	0.2	1.4	0.2	6.3	0.4	0.2	0.1	45.7	0.8	0.8	245.1	1.9	373.7	5.1	1.5	6.2	40.0	0.6	185.5	0.2	0.9	0.8	0.7	0.4	0.6	8.7	0.3	0.4	0.7	0.3	0.2	0.2	1.0	0.3	0.6	0.4	0.5	0.3	0.2	0.4	0.3	0.1	15.4	0.5	0.5	3.5	0.5	0.1	0.3	0.4	0.7	0.6	0.5	38.3	0.0	29.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	7.5	9.8	7.8	11.0	7.2	8.2	7.6	7.7	7.7	8.0	9.6	8.9	22.6	9.6	13.1	0.0	0.1	8.5	20.3	0.4	0.0	0.0	0.3	0.1	2.7	0.0	7.7	1.8	0.0	0.0	3.3	0.1	0.0	3.2	0.4	1.1	14.8	49.7	0.0	1.3	0.2	0.5	0.1	54.5	0.0	2.5	501.5	0.0	26.4	0.7	0.0	0.0	0.2	0.0	0.0	0.3	19.1	1.3	0.9	3.0	3.6	0.0	0.0	0.0	0.0	0.5	0.1	37.2	0.0	0.0	3.2	15.7	0.0	0.0	6.6	0.3	39.5	1.5	37.7	0.0	0.0	0.0	5.1	0.0	31.5	0.0	0.0	16.4
IL3	"IL-3, MCGF, MGC79398, MGC79399, MULTI-CSF"	ENSG00000164399	"Interleukin 3"	P08700	5	132060655-132063204	"Predicted secreted proteins"		"Cytokine, Growth factor"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"HMC-1: 2.8"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA	17800				"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"																		"unprognostic (9.74e-2)"			0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IL5RA	"CD125, CDw125, IL5R"	ENSG00000091181	"Interleukin 5 receptor subunit alpha"	Q01344	3	3066324-3126613	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 9.0;fallopian tube: 10.7"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 28.0;granulocytes: 19.0;Plasma cells: 9.9;Respiratory ciliated cells: 13.9"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	192	"basophil: 178.4;eosinophil: 355.1"	"Lineage enriched"	"Detected in many"	255	"granulocytes: 355.1"	"Cell line enriched"	"Detected in some"	28	"HMC-1: 71.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	NA	NA		910000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (1.38e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.84e-4)"	"unprognostic (4.32e-3)"	"unprognostic (3.08e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.49e-2)"	"unprognostic (4.93e-2)"	0.2	0.2	0.8	0.6	0.7	0.6	1.0	0.6	0.3	1.0	9.0	0.7	1.7	0.4	0.2	0.5	10.7	0.7	1.0	0.8	1.2	0.4	0.1	2.7	0.4	5.0	4.6	0.1	0.4	0.0	1.5	0.1	3.2	1.8	1.1	0.0	0.7	0.1	0.4	0.1	1.6	0.3	4.5	1.8	1.1	1.1	1.2	0.5	0.2	0.0	1.5	1.7	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	2.5	71.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	178.4	0.1	355.1	0.9	0.1	0.1	0.4	1.0	0.7	0.1	1.3	0.3	0.7	1.0	0.0	0.1	0.1	0.1	0.7	0.8	0.7	0.6	0.3	0.8	1.2	5.0	4.6	3.2	4.5	1.2	0.9	0.2	0.0	2.5	0.0	4.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	2.3	1.5	1.4	0.0	0.0	0.1	2.8	0.0	0.0	0.0	2.4	28.0	0.3	0.1	0.0	0.8	0.7	0.0	0.0	0.2	0.0	0.5	19.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.3	5.7	0.0	0.1	5.4	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	9.9	0.8	0.0	0.1	13.9	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.1
IL7	IL-7	ENSG00000104432	"Interleukin 7"	P13232	8	78675743-78805523	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 108.8;Late spermatids: 145.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 9.7;naive B-cell: 8.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 7.6;HDLM-2: 15.4;HEL: 18.2;HMC-1: 25.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA019590	Approved				"Secreted to blood"	NA	NA	60700		"Cluster 19: B-cells - Humoral immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA019590: AB_10794621"	"unprognostic (3.19e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.57e-3)"	"unprognostic (5.45e-2)"	"unprognostic (9.37e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.11e-4)"	2.3	1.2	0.2	4.1	0.3	2.1	1.5	0.4	0.2	2.3	0.3	5.1	6.7	1.1	0.3	3.5	4.8	3.1	0.6	0.3	0.5	1.4	4.2	3.3	8.7	0.6	0.4	0.9	1.0	0.0	0.5	0.3	0.5	1.8	4.4	0.7	1.1	0.9	0.1	8.8	8.7	1.1	0.4	3.5	3.8	1.7	1.2	0.8	1.3	0.1	4.2	2.8	1.5	0.2	0.3	0.0	0.1	0.0	0.4	0.4	0.0	1.4	1.4	1.3	1.9	0.0	7.6	0.1	0.0	4.4	4.5	4.2	0.1	0.0	0.0	15.4	0.0	18.2	0.6	2.1	0.1	0.1	25.4	1.3	0.0	0.2	0.6	4.9	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.1	0.0	5.4	3.2	0.0	2.4	2.6	0.3	0.2	0.0	0.1	0.0	0.2	0.8	0.9	0.0	2.0	0.3	0.0	0.0	3.4	0.0	1.9	5.2	0.3	0.0	0.4	0.2	0.0	9.7	1.0	1.0	2.2	8.7	0.2	0.3	0.0	0.5	0.8	0.3	7.3	0.6	0.2	0.3	0.4	0.2	0.3	0.5	0.6	0.4	0.5	0.4	1.2	0.2	0.6	0.0	3.6	5.9	12.2	6.0	3.2	1.2	10.8	0.1	1.3	0.9	0.7	5.7	2.4	1.8	0.0	0.0	1.3	7.8	9.8	1.2	108.8	22.9	0.8	4.9	3.0	10.5	16.0	5.1	0.0	2.5	11.2	0.6	0.0	0.1	1.8	2.4	0.9	0.0	11.0	6.2	2.0	1.0	3.3	145.5	0.6	1.9	0.0	1.0	3.4	2.0	0.0	20.1	6.0	2.6	11.5	1.2	1.0	1.2	12.4	9.5	24.2	0.4	0.0	2.2	0.5	2.3	0.9	5.2	6.5	0.0	1.6	0.1	4.6	1.7
IL9R	CD129	ENSG00000124334	"Interleukin 9 receptor"	Q01113	X	155997581-156010817	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.4;urinary bladder: 4.4"	"Group enriched"	"Detected in some"	5	"granulocytes: 4.5;T-cells: 2.7"	"Group enriched"	"Detected in some"	4	"cervical cancer: 0.7;urothelial cancer: 1.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.4"	"Group enriched"	"Detected in many"	23	"B-cells: 1.8;granulocytes: 3.4;T-cells: 1.4"	"Cell line enriched"	"Detected in some"	10	"HMC-1: 247.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA063240, HPA064557"	Approved				"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA063240: AB_2732700, HPA064557: AB_2732716"	"unprognostic (1.07e-2)"	"unprognostic (3.27e-3)"	"unprognostic (9.52e-3)"	"unprognostic (4.13e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.26e-4)"	"unprognostic (8.94e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.98e-8)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.07e-1)"	"prognostic favorable (1.90e-7)"	0.1	0.0	0.2	1.0	0.2	0.5	0.2	0.0	0.2	0.2	0.0	0.5	0.6	0.2	0.1	0.5	0.3	0.8	0.0	0.1	0.1	0.1	0.2	1.0	2.4	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.9	0.1	0.4	0.1	0.1	0.4	1.7	0.1	0.1	1.7	0.7	0.0	0.1	3.4	0.3	0.0	2.2	4.4	0.2	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.5	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.3	23.8	0.0	0.0	0.0	0.5	247.8	0.0	0.2	0.0	0.0	0.0	0.0	5.6	3.7	0.8	0.0	1.1	9.5	4.9	0.0	0.1	0.0	0.6	0.1	0.0	0.0	19.2	0.2	0.1	0.0	0.4	0.2	0.0	0.3	0.4	0.0	0.1	0.6	0.1	0.1	1.2	0.6	0.9	0.2	0.3	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.8	0.3	0.6	0.0	1.8	0.0	0.0	0.9	0.0	0.0	0.0	1.4	0.2	0.2	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.5	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1
INPP5B		ENSG00000204084	"Inositol polyphosphate-5-phosphatase B"	P32019	1	37860697-37947057	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 47.5;Inhibitory neurons: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028803	Approved		Supported	Cytosol		NA	NA		8400	"Cluster 46: Basophils - DNA binding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA028803: AB_10612121"	"unprognostic (2.28e-2)"	"unprognostic (8.91e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (5.33e-4)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (6.11e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.28e-1)"	13.3	9.3	9.5	10.3	10.7	20.7	11.9	14.7	11.8	16.1	11.5	18.7	6.9	13.9	9.9	7.2	15.7	8.4	12.8	9.2	9.3	10.8	16.2	14.7	18.5	11.5	10.2	23.9	10.5	8.9	11.9	10.4	11.4	10.9	10.0	12.5	8.4	11.1	9.1	10.8	13.4	11.9	9.0	17.3	13.7	7.0	10.5	13.4	12.2	6.0	18.7	16.8	11.7	15.3	6.8	4.6	10.7	15.7	12.3	15.8	18.5	7.5	12.5	9.6	13.2	7.2	9.4	23.2	3.6	12.9	5.0	9.1	14.3	6.0	12.8	16.2	6.3	35.8	15.4	4.9	17.7	19.0	47.4	17.8	3.7	10.2	6.6	9.4	11.0	16.4	11.7	25.6	12.4	5.3	16.7	21.4	15.5	9.5	3.9	18.7	21.3	10.9	5.5	6.2	4.3	6.8	8.8	4.2	18.9	15.7	5.2	15.8	10.6	8.8	7.9	8.5	7.1	20.8	11.8	18.3	10.1	15.8	8.1	27.3	2.9	16.5	7.0	2.3	9.9	7.1	4.8	6.7	6.1	7.6	6.1	5.8	3.7	6.2	6.0	5.4	6.8	4.9	9.5	10.7	14.7	11.8	9.2	9.3	11.5	10.2	11.4	9.0	10.5	15.3	5.7	28.9	26.3	35.3	11.8	2.2	5.8	2.1	4.0	14.7	2.2	2.3	3.2	1.5	6.4	1.8	25.0	4.1	7.9	3.9	0.0	2.4	10.7	2.3	8.4	5.9	3.5	6.5	47.5	4.4	15.4	6.3	16.8	3.3	8.2	6.9	5.3	7.8	5.2	23.5	48.5	5.0	6.1	8.1	5.4	15.9	8.4	8.3	7.2	35.6	11.3	4.6	28.8	20.1	39.4	3.0	4.7	9.1	8.5	4.5	3.5	2.6	5.8	18.9	6.6	7.7	7.1	4.6	8.1	3.4	3.3	4.7	11.2	7.7	4.7	4.1
INPP5D	"hp51CN, SHIP, SHIP1"	ENSG00000168918	"Inositol polyphosphate-5-phosphatase D"	Q92835	2	233059967-233207903	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 50.8;lymphoid tissue: 99.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 94.5;dendritic cells: 95.8;Kupffer cells: 65.6;Microglial cells: 181.8;NK-cells: 193.6;T-cells: 60.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 44.7;HEL: 94.6;HMC-1: 94.8;hTCEpi: 87.1;NB-4: 89.4;THP-1: 62.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016300, HPA070455"	Enhanced		Supported	Cytosol		No	No		4400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB016300: AB_628250, HPA070455: AB_2686267"	"unprognostic (5.29e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.99e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (6.54e-2)"	15.5	5.8	6.7	19.8	7.3	32.7	11.4	7.6	6.5	9.2	6.7	9.5	3.7	6.3	2.8	7.5	9.2	6.0	8.2	6.0	8.5	9.5	6.5	25.2	34.1	10.8	9.4	3.2	3.1	1.2	6.9	8.4	11.2	11.8	4.7	0.3	26.3	2.9	3.9	7.9	50.8	3.5	9.3	99.4	6.3	3.5	10.4	14.5	7.8	1.7	31.9	9.8	8.4	10.3	0.1	0.1	0.6	0.0	0.0	0.2	4.8	0.1	0.2	0.1	0.0	0.0	1.2	17.9	0.0	0.0	0.0	0.1	0.0	44.7	0.1	15.4	0.2	94.6	0.1	9.0	0.7	28.7	94.8	1.6	87.1	0.3	9.6	0.3	12.7	2.6	0.4	8.0	0.4	0.0	13.2	89.4	2.9	0.0	0.1	27.5	0.1	6.5	0.1	5.5	0.1	0.1	0.0	1.7	0.0	11.1	0.0	62.9	10.7	0.0	1.5	0.0	0.0	0.2	5.2	26.7	0.1	36.5	0.2	13.2	10.8	11.4	16.0	15.8	10.9	14.0	7.1	12.0	12.3	12.6	5.8	8.4	10.3	12.5	20.0	6.1	10.5	17.9	6.7	7.3	7.6	6.5	6.0	8.5	10.8	9.4	11.2	9.3	10.4	10.3	18.1	3.2	15.5	3.3	94.5	1.7	1.6	5.4	9.1	0.5	3.2	5.8	3.6	4.3	5.2	3.7	0.0	0.6	95.8	1.1	0.0	0.5	13.0	0.8	0.3	20.8	0.0	35.7	2.6	0.5	0.8	1.7	2.0	0.5	15.2	0.1	15.0	2.2	29.2	0.0	1.1	0.2	0.0	65.6	17.1	13.4	0.0	51.5	0.0	181.8	51.4	0.0	193.6	4.0	1.8	0.4	2.5	1.2	34.0	0.6	0.1	0.4	5.7	0.0	0.0	2.0	1.7	0.5	1.0	3.1	1.1	1.1	60.6	0.1	0.5	1.5
IPCEF1	"KIAA0403, PIP3-E"	ENSG00000074706	"Interaction protein for cytohesin exchange factors 1"	Q8WWN9	6	154154496-154356792	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 17.7;brain: 13.6;lymphoid tissue: 13.5;thyroid gland: 39.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 46.1;Excitatory neurons: 120.0;Microglial cells: 252.9;T-cells: 65.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.3"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 71.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"HMC-1: 19.8;THP-1: 10.5;U-937: 11.0"	"Low region specificity"	"Detected in all"							"HPA028708, HPA028710"	Supported		Approved	"Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles, Plasma membrane"	"Nucleoli, Cytoplasmic bodies"	"HPA028708: AB_10601916, HPA028710: AB_2732442"	"unprognostic (1.23e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.51e-4)"	0.7	0.2	8.4	7.9	5.4	17.7	1.5	4.1	13.6	2.7	0.0	1.3	0.7	1.1	1.4	1.4	2.1	2.9	0.6	5.4	3.2	2.8	2.0	1.5	13.5	0.0	7.4	0.6	0.7	0.1	0.6	1.6	0.0	0.8	1.2	0.2	1.2	0.4	0.2	0.5	2.3	0.9	0.0	6.8	2.4	0.9	12.2	10.6	39.1	0.2	12.8	2.1	0.5	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	19.8	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	3.1	1.2	0.8	0.0	0.5	0.1	0.1	0.3	0.7	2.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.0	0.0	3.2	14.5	71.6	13.0	6.5	27.6	0.0	16.3	12.5	16.2	0.1	27.9	16.8	42.7	14.3	8.5	0.4	22.6	12.6	8.4	5.4	4.1	13.6	5.4	3.2	0.0	7.4	0.0	0.0	12.2	5.4	1.1	0.0	1.7	7.8	3.5	0.6	0.5	0.4	12.0	0.6	1.8	1.0	1.1	1.5	1.7	1.8	0.0	1.7	46.1	0.0	7.9	2.1	1.3	2.0	1.2	2.3	0.0	3.2	120.0	0.0	0.1	1.0	3.1	2.5	0.0	0.1	3.3	1.1	2.8	3.3	9.8	0.5	2.0	23.4	15.2	0.3	0.3	15.2	0.0	252.9	17.9	0.2	27.8	9.0	14.6	0.0	0.1	0.4	20.7	0.6	0.1	2.0	1.3	0.2	0.0	3.4	0.4	0.2	1.1	4.0	0.6	2.7	65.5	2.0	0.3	1.3
IQGAP2		ENSG00000145703	"IQ motif containing GTPase activating protein 2"	Q13576	5	76403285-76708132	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 113.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 1011.9;Late spermatids: 351.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 21.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 74.2;Hep G2: 61.7;HMC-1: 211.8;RPMI-8226: 81.6;U-937: 57.0"	"Region enhanced"	"Detected in many"		"hippocampal formation: 30.5"	"Low region specificity"	"Detected in all"			"CAB004241, HPA037403, HPA037404"	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA		3700000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Vesicles, Plasma membrane"		"CAB004241: AB_2125909, HPA037403: AB_2675459, HPA037404: AB_2675460"	"unprognostic (9.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.03e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (9.44e-12)"	"unprognostic (3.29e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.27e-2)"	7.9	12.2	0.8	11.7	0.6	25.0	27.1	0.5	0.7	19.6	2.4	25.7	56.5	3.3	9.5	2.8	3.4	18.6	2.9	0.4	0.9	35.2	113.1	9.9	14.4	2.2	2.5	8.9	25.7	44.3	1.1	30.7	1.9	15.2	23.0	23.9	34.6	15.4	0.3	2.7	31.4	4.3	1.4	13.2	39.1	51.1	2.4	7.3	28.6	1.3	8.2	6.5	1.5	2.4	0.0	9.6	31.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	74.2	0.1	0.7	2.7	0.0	2.7	0.2	12.1	0.0	0.1	8.6	12.0	27.6	6.8	61.7	0.2	15.7	211.8	0.0	0.0	0.0	0.0	0.0	1.2	14.9	24.6	21.4	0.0	0.0	13.5	42.4	14.8	25.4	0.3	4.9	0.1	81.6	0.0	0.1	0.6	3.2	17.3	0.9	0.1	31.4	0.0	9.3	0.4	0.0	0.5	0.0	0.3	19.8	0.0	18.7	0.1	57.0	3.0	21.3	3.1	1.9	4.5	2.5	3.7	0.5	4.7	3.9	2.9	0.2	1.8	3.3	6.0	4.3	3.4	7.7	6.2	1.4	0.8	0.6	0.5	0.7	0.4	0.9	2.2	2.5	1.9	1.4	2.4	2.4	9.1	12.8	12.2	0.7	27.3	4.7	21.5	2.4	0.0	6.7	68.9	34.5	3.5	107.2	9.1	35.0	108.4	14.2	230.3	96.2	7.9	44.5	1011.9	43.8	3.3	7.7	9.1	76.3	2.3	66.7	1.2	22.0	99.4	37.5	94.9	8.7	18.5	235.7	65.9	1.7	19.0	52.9	61.1	132.6	63.3	351.0	7.5	141.3	16.0	47.8	63.4	14.0	114.4	0.5	1.1	18.7	37.5	5.3	148.3	21.5	87.1	65.2	16.1	121.8	0.0	3.9	3.5	25.5	11.4	1.2	3.8	7.3	112.1	82.7	43.7	6.5
ITGA2B	"CD41, CD41B, GP2B, PPP1R93"	ENSG00000005961	"Integrin subunit alpha 2b"	P08514	17	44372180-44389649	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.6;epididymis: 10.7;lymphoid tissue: 11.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 16.1;Erythroid cells: 43.5;granulocytes: 17.8;Late spermatids: 24.8;Macrophages: 23.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	14	"basophil: 64.5"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 64.5"	"Group enriched"	"Detected in some"	14	"HEL: 404.6;HMC-1: 631.7"	"Not detected"	"Not detected"							"CAB018611, HPA031168, HPA031169, HPA031170, HPA031171"	Enhanced		Approved	"Plasma membrane"		NA	NA		90000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"		"CAB018611: AB_2265153, HPA031168: AB_10664706, HPA031169: AB_10669671, HPA031170: AB_10696214, HPA031171: AB_10669773"	"unprognostic (6.11e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.98e-3)"	"unprognostic (4.23e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.83e-9)"	"unprognostic (7.82e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.25e-1)"	0.8	0.2	3.7	0.2	3.6	16.6	0.4	4.0	4.8	1.5	3.8	0.3	0.0	0.9	10.7	0.3	1.5	0.8	1.4	3.5	3.6	1.0	0.5	5.1	0.2	3.6	3.5	1.5	0.1	1.3	1.9	1.1	3.6	0.6	0.1	1.6	0.1	0.8	0.6	0.1	0.3	0.2	3.3	11.2	0.3	2.9	3.5	0.1	3.1	1.1	0.1	0.2	0.7	3.7	0.5	0.7	2.2	0.3	0.1	0.3	18.4	0.3	0.1	0.8	0.6	0.0	0.2	0.0	0.3	0.0	0.2	0.6	1.8	0.0	0.4	0.4	1.1	404.6	0.3	1.3	0.0	0.2	631.7	0.4	0.0	0.2	0.0	0.0	0.0	0.3	0.7	1.1	0.0	0.7	0.5	36.4	0.8	0.0	0.7	0.7	0.2	0.0	0.0	0.1	0.4	1.0	0.5	0.5	0.1	1.5	4.5	0.9	0.3	0.2	0.7	0.0	0.0	0.4	0.2	0.3	0.4	0.3	0.8	64.5	0.3	4.0	0.1	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	4.5	0.0	0.0	0.8	0.0	19.3	3.7	3.6	4.0	4.8	3.5	3.6	3.6	3.5	3.6	3.3	3.5	3.7	0.3	0.0	1.5	1.0	0.4	0.3	0.4	0.1	1.8	5.1	0.2	1.1	1.5	1.5	1.3	5.5	8.4	1.3	0.1	0.6	0.0	0.0	16.1	1.0	0.7	2.1	0.0	43.5	4.1	0.0	1.4	1.1	0.0	3.2	17.8	0.1	3.6	0.0	0.2	3.3	2.8	0.0	0.0	3.1	0.7	24.8	1.8	23.0	0.0	1.0	2.9	1.3	0.0	9.5	4.6	0.1	0.0	1.9	0.1	0.3	0.0	0.0	0.0	3.0	0.0	1.8	0.7	3.4	7.4	0.5	0.0	0.7	0.6	0.1	0.3	0.3
ITGA8		ENSG00000077943	"Integrin subunit alpha 8"	P53708	10	15513954-15719922	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein, Integrin, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 37.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 82.8;Inhibitory neurons: 56.1;Microglial cells: 34.7;Oligodendrocyte precursor cells: 64.8;Plasma cells: 25.5;Sertoli cells: 52.6;Smooth muscle cells: 57.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 8.4;HMC-1: 19.8;HSkMC: 8.7;U-266/84: 9.7"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"basal ganglia: 14.1"	HPA003432	Approved		Approved	"Plasma membrane"		NA	NA		200000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA003432: AB_1851825"	"unprognostic (2.15e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.13e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.03e-2)"	8.6	10.5	1.6	2.1	2.1	0.1	2.7	1.9	5.0	23.8	8.0	6.1	6.7	9.7	5.5	9.8	8.8	6.7	7.7	7.0	0.9	10.0	0.7	20.8	3.2	1.5	2.8	5.7	0.8	4.7	3.2	0.2	1.1	37.4	6.1	1.6	1.8	30.8	2.9	3.3	6.8	9.1	1.5	19.9	19.3	0.6	1.5	1.0	5.6	6.9	4.4	15.7	9.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	8.4	2.5	0.0	0.0	0.0	0.0	19.8	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	9.7	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.1	1.9	5.0	7.0	0.9	1.5	2.8	1.1	1.5	1.5	2.2	1.2	0.0	1.3	0.7	2.4	1.0	1.9	0.0	0.6	6.3	0.1	0.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	4.0	11.4	0.0	0.0	82.8	0.0	0.0	10.1	0.0	0.2	0.0	0.0	4.2	0.0	0.1	0.0	56.1	0.0	0.0	0.0	1.8	0.1	0.9	0.5	1.8	34.7	0.0	13.6	0.0	64.8	4.0	0.0	0.0	0.0	25.5	1.5	0.0	0.0	0.0	0.3	52.6	11.3	57.6	0.0	0.2	0.4	1.1	0.0	1.2	0.1	0.1	1.4
ITGAL	"CD11A, LFA-1"	ENSG00000005844	"Integrin subunit alpha L"	P20701	16	30472658-30523567	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction, Phagocytosis"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.8;lymphoid tissue: 64.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 118.6;monocytes: 36.8;NK-cells: 152.4;Plasma cells: 46.6;T-cells: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 121.7"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"HMC-1: 608.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025011	Enhanced					NA	NA		1600000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB025011: "	"unprognostic (1.10e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.72e-3)"	"prognostic favorable (5.63e-5)"	"unprognostic (2.88e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (1.63e-1)"	"unprognostic (5.69e-3)"	"prognostic favorable (5.57e-4)"	"unprognostic (3.37e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (2.89e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-2)"	4.2	1.4	0.3	36.7	0.5	36.8	2.3	0.3	1.0	2.4	0.5	5.5	6.0	2.3	1.0	2.5	3.0	7.0	1.4	0.3	0.4	2.6	10.6	22.0	62.4	1.6	1.1	1.3	1.0	0.5	1.2	3.0	1.4	2.4	8.6	0.0	5.3	1.4	0.9	1.4	19.7	3.6	0.7	64.9	8.6	1.0	1.6	55.2	3.5	0.9	46.4	6.9	2.3	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.1	0.0	1.1	608.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	134.3	0.0	0.0	43.3	3.5	0.0	0.0	0.0	0.1	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	26.0	0.0	0.0	0.0	0.0	0.0	36.6	12.5	0.0	0.1	3.8	0.0	5.3	24.4	17.0	56.6	48.0	27.7	4.8	21.4	42.7	22.3	1.7	9.4	29.7	14.3	24.2	121.7	6.0	15.6	43.6	0.3	0.5	0.3	1.0	0.3	0.4	1.6	1.1	1.4	0.7	1.6	2.1	1.2	6.4	10.5	0.7	19.1	0.8	0.3	0.0	0.0	0.4	1.2	1.0	1.9	0.0	1.9	1.8	0.0	0.2	118.6	0.3	0.0	0.1	0.5	4.1	0.6	2.3	0.0	4.8	3.6	0.0	0.6	1.4	1.1	0.9	5.1	0.1	5.3	4.9	19.3	0.0	2.8	0.2	0.0	30.0	3.4	0.7	0.0	31.5	1.8	15.9	36.8	0.1	152.4	0.5	1.6	0.0	0.0	0.0	46.6	0.1	0.9	0.3	6.7	0.9	0.0	1.2	0.7	0.2	0.2	0.1	0.3	0.7	84.9	0.1	0.0	0.2
ITGAM	"CD11B, CR3A, MAC-1"	ENSG00000169896	"Integrin subunit alpha M"	P11215	16	31259967-31332892	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity, Innate immunity"	"Integrin, Receptor"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"bone marrow: 182.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 45.4;granulocytes: 35.5;Hofbauer cells: 47.2;Kupffer cells: 117.7;Langerhans cells: 45.5;Macrophages: 83.2;Microglial cells: 41.2;monocytes: 87.4;NK-cells: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HMC-1: 50.0;NB-4: 19.9;U-937: 22.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002274, CAB025091, CAB072870"	Enhanced					NA	NA		1000000	"Cluster 46: Basophils - DNA binding"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"CAB025091: , CAB072870: AB_2665722, HPA002274: AB_1078435"	"unprognostic (1.82e-2)"	"unprognostic (1.70e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.40e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (9.89e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (3.99e-2)"	"unprognostic (5.03e-2)"	13.4	4.7	3.4	24.7	3.5	182.8	3.0	4.5	4.2	3.3	4.8	3.0	2.2	2.0	0.7	2.6	2.3	5.9	2.9	3.6	5.1	1.0	3.5	16.4	7.4	6.7	5.7	1.6	2.3	1.3	0.1	7.7	7.3	1.5	3.4	0.3	2.4	2.2	1.4	1.7	3.5	11.2	6.5	13.1	3.1	1.4	8.6	5.2	1.0	3.1	10.4	8.0	0.2	10.8	0.8	1.8	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.5	0.8	1.3	0.9	0.0	0.4	0.1	0.0	0.4	0.0	7.6	0.0	1.0	0.0	0.0	0.0	1.8	50.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.3	0.1	1.0	0.0	2.2	0.0	0.0	0.0	0.5	0.4	0.0	0.2	4.3	0.1	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	22.6	0.1	93.3	55.7	70.2	31.1	20.9	1.9	4.8	3.3	9.5	9.5	1.0	0.9	7.7	58.4	54.4	3.2	0.6	1.2	27.0	3.4	3.5	4.5	4.2	3.6	5.1	6.7	5.7	7.3	6.5	8.6	10.8	1.4	3.2	9.8	0.7	9.3	1.1	0.3	1.5	0.0	0.0	1.8	3.8	2.3	4.3	1.8	0.0	0.0	0.3	45.4	0.0	0.0	1.2	0.5	0.3	0.4	1.6	3.6	9.4	1.0	0.0	0.7	1.1	1.1	0.5	35.5	0.5	2.2	1.2	47.2	0.0	1.0	0.1	0.0	117.7	45.5	1.8	0.3	83.2	0.0	41.2	87.4	0.0	75.2	3.0	0.3	0.9	0.0	0.0	4.5	0.5	0.0	0.2	0.9	0.0	13.1	1.2	0.5	0.7	0.9	0.5	1.0	0.8	14.9	0.0	0.3	0.2
ITGAX	CD11C	ENSG00000140678	"Integrin subunit alpha X"	P20702	16	31355134-31382999	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 48.1;brain: 33.7;lung: 58.1;lymphoid tissue: 67.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 51.1;granulocytes: 74.0;Hofbauer cells: 45.1;Kupffer cells: 51.5;Langerhans cells: 77.3;Macrophages: 141.7;Microglial cells: 56.2;NK-cells: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 87.5"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 106.1"	"Not detected"	"Not detected"							"CAB004458, HPA004723, CAB072871"	Enhanced					NA	NA		50000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"CAB004458: AB_626859, CAB072871: AB_2665723, HPA004723: AB_1846231"	"unprognostic (9.75e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.59e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.20e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.95e-2)"	12.9	2.3	6.0	42.7	8.1	48.1	4.3	8.8	33.7	2.2	8.4	2.9	2.3	2.8	0.8	2.0	5.9	10.8	3.5	6.2	9.3	2.9	6.3	58.1	23.2	14.6	11.8	1.0	2.9	1.4	2.9	4.6	14.3	3.2	4.3	0.6	4.5	1.5	1.3	2.1	5.5	4.7	13.0	67.5	4.8	0.6	18.4	4.0	2.8	3.2	12.3	9.2	2.1	24.8	0.1	0.6	0.1	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.4	0.0	9.0	0.0	0.3	0.1	0.0	0.3	0.1	18.6	0.1	0.1	0.3	0.4	0.0	1.1	106.1	0.1	0.1	1.7	0.2	0.7	1.0	0.0	0.1	0.4	0.0	0.0	0.1	8.8	0.4	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	2.7	0.1	0.0	3.3	0.8	0.0	1.6	0.0	0.1	0.1	0.0	0.2	4.9	1.8	0.3	12.8	29.1	27.1	4.8	50.3	0.4	2.1	0.1	0.7	34.7	1.0	0.1	0.7	87.5	41.4	61.0	0.6	0.1	11.5	6.0	8.1	8.8	33.7	6.2	9.3	14.6	11.8	14.3	13.0	18.4	24.8	0.8	12.8	51.1	0.0	9.8	2.8	0.3	0.0	0.0	0.1	0.6	1.3	1.5	0.0	10.5	0.0	0.0	0.4	33.6	0.0	0.0	0.3	0.0	0.4	0.5	4.8	0.0	3.4	0.2	0.0	0.6	4.4	0.0	0.5	74.0	0.0	1.1	0.1	45.1	0.0	0.3	0.0	0.0	51.5	77.3	0.0	0.0	141.7	1.8	56.2	35.3	0.1	68.0	0.5	0.3	0.2	0.0	0.0	5.5	0.2	0.0	0.3	1.5	0.1	0.0	0.6	1.0	0.0	0.2	0.0	1.1	0.4	16.5	0.1	0.0	0.1
ITGB1BP2	CHORDC3	ENSG00000147166	"Integrin subunit beta 1 binding protein 2"	Q9UKP3	X	71301750-71305371	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 89.4;skeletal muscle: 46.1;tongue: 52.9"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 80.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040721			Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"HPA040721: AB_10805827"	"unprognostic (1.87e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.91e-5)"	"unprognostic (1.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.02e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.08e-11)"	"unprognostic (4.38e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.64e-1)"	0.7	0.6	0.5	1.5	0.6	1.5	0.5	1.0	0.9	2.4	0.5	6.5	1.0	16.6	3.0	4.1	3.3	2.5	89.4	0.6	0.6	0.8	1.4	1.0	0.9	0.6	0.6	1.6	0.5	0.0	0.5	0.3	0.6	6.0	1.8	1.8	1.3	10.3	46.1	0.6	2.1	16.3	0.5	1.1	2.0	1.3	0.6	1.0	0.7	52.9	0.6	5.5	1.5	0.7	0.5	1.4	2.1	1.8	0.1	0.1	0.4	0.7	1.0	0.5	0.5	0.9	1.1	2.1	0.2	1.1	0.5	0.9	1.9	0.6	1.1	0.7	0.9	1.3	1.5	0.4	0.2	0.4	9.3	1.1	0.7	0.2	0.3	0.4	0.8	2.2	1.0	0.5	1.1	0.4	0.8	2.3	3.1	1.4	0.9	1.4	1.6	0.8	1.0	1.3	1.0	0.3	0.5	0.1	0.6	1.4	0.5	0.3	0.0	0.9	1.8	0.1	0.4	1.8	2.8	3.1	0.2	1.6	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	1.0	0.9	0.6	0.6	0.6	0.6	0.6	0.5	0.6	0.7	0.2	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	1.7	0.3	0.3	80.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.6	0.1	0.2	0.2	0.8	0.0	0.4	0.2	0.0	0.1	2.3	0.0	0.2	0.0	0.4	1.1	0.8	0.2	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.3	0.1	1.0	0.0	0.5	0.2	0.1	8.6	0.0	0.3	0.1	0.5	0.3	1.1	0.0	0.6	2.5	0.5	0.4	0.0	0.3	0.0	0.1	0.6	0.3	0.1
JAML	"AMICA, AMICA1, Gm638"	ENSG00000160593	"Junction adhesion molecule like"	Q86YT9	11	118193725-118225094	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 43.3;lymphoid tissue: 68.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 136.9;Kupffer cells: 125.8;Macrophages: 166.6;monocytes: 204.7;T-cells: 56.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 3529.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 1017.6;granulocytes: 3529.6;monocytes: 1023.8"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 28.0"					"Region enriched"	"Detected in many"	11	"cerebellum: 58.0"	"HPA005854, HPA047919"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Nucleoplasm	"HPA005854: , HPA047919: AB_2680209"	"unprognostic (3.91e-3)"	"unprognostic (1.55e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.87e-3)"	"prognostic favorable (3.11e-4)"	"unprognostic (2.80e-1)"	"prognostic favorable (3.92e-4)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.08e-1)"	"unprognostic (6.43e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-2)"	13.9	4.5	0.9	68.7	1.0	20.9	5.6	2.4	2.1	5.6	2.3	16.8	17.8	3.5	1.5	8.5	4.3	20.4	3.2	0.7	0.9	3.4	9.8	43.3	31.1	1.3	0.9	1.8	2.9	1.0	1.6	7.8	1.0	4.4	22.7	0.3	2.9	3.6	1.2	4.6	32.1	15.3	1.0	60.0	9.4	1.5	1.0	24.3	2.9	7.8	31.6	24.9	3.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.9	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.0	2.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.3	3.1	0.4	3.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.2	0.0	137.4	1023.8	3529.6	60.1	616.5	386.5	7.1	107.4	113.7	1017.6	2.9	124.7	103.1	2121.1	24.3	310.3	765.1	191.3	844.1	0.9	1.0	2.4	2.1	0.7	0.9	1.3	0.9	1.0	1.0	1.0	1.1	1.2	6.4	34.2	0.0	6.9	0.0	0.2	0.0	0.0	0.3	0.9	1.3	0.0	2.8	5.6	1.8	0.0	0.3	136.9	0.9	0.0	0.1	1.0	0.4	0.2	1.3	0.0	5.0	0.0	0.4	0.4	1.8	2.6	0.6	15.2	0.0	5.7	2.8	31.0	0.0	0.0	0.2	0.0	125.8	0.0	1.1	0.0	166.6	0.0	0.0	204.7	0.0	9.2	0.0	0.0	0.1	0.1	0.0	6.3	0.1	0.6	0.8	2.2	0.2	0.0	0.4	0.5	2.2	5.9	0.2	0.0	0.4	56.0	0.0	0.1	0.2
KCNA7	"HAK6, Kv1.7"	ENSG00000104848	"Potassium voltage-gated channel subfamily A member 7"	Q96RP8	19	49067418-49072941	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	51	"skeletal muscle: 75.7;tongue: 19.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 16.9;Cone photoreceptor cells: 6.2;granulocytes: 3.8;Pancreatic endocrine cells: 3.8;Skeletal myocytes: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-251 MG: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 37: Myocytes - Muscle contraction"				"unprognostic (2.00e-1)"	"unprognostic (2.10e-2)"		"unprognostic (1.19e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.68e-1)"		"unprognostic (4.31e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.21e-8)"	"unprognostic (1.70e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.29e-2)"	0.0	0.0	0.2	0.1	0.2	0.3	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.4	0.0	75.7	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	19.5	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.3	0.1	0.3	0.1	0.1	1.0	0.1	0.0	0.0	0.1	0.1	0.0	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.2	0.0	0.0	0.2	0.2	0.3	0.3	0.2	0.1	0.3	0.2	0.3	0.0	0.2	0.5	0.2	6.4	16.9	0.0	0.1	0.4	1.2	0.1	0.0	0.4	0.3	0.1	3.4	0.0	3.2	0.0	6.2	0.1	0.1	0.0	0.0	0.1	0.2	0.4	0.9	0.8	0.0	0.0	0.1	0.2	0.2	1.8	0.0	0.9	3.8	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	3.8	0.0	0.0	0.0	0.7	0.0	0.2	0.9	1.4	0.0	4.7	0.6	0.2	0.6	0.0	0.3	1.1	1.5	0.0	0.0	0.5
KCNC3	"Kv3.3, SCA13"	ENSG00000131398	"Potassium voltage-gated channel subfamily C member 3"	Q14003	19	50311937-50333515	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 75.8;thyroid gland: 52.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 20.2;Endometrial ciliated cells: 23.9;Excitatory neurons: 15.6;Glandular and luminal cells: 16.3;Inhibitory neurons: 18.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 75.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.7;CAPAN-2: 7.2;HDLM-2: 7.0;HMC-1: 20.3;K-562: 7.0;SK-BR-3: 14.0;T-47d: 12.0;U-2 OS: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018041	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"HPA018041: AB_1855579"	"unprognostic (8.05e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.01e-4)"	"unprognostic (4.41e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.94e-3)"	"unprognostic (2.10e-5)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.19e-1)"	0.8	1.3	3.1	2.8	1.9	0.7	3.5	17.3	75.8	6.2	0.0	0.8	0.6	2.8	2.6	1.6	23.2	0.5	2.4	12.5	0.0	17.8	4.4	4.6	2.6	20.0	3.4	0.4	5.7	14.1	21.1	1.2	11.4	4.4	0.5	8.0	3.0	8.1	1.3	2.9	3.3	0.7	3.1	5.7	1.2	3.6	15.0	2.5	52.1	0.1	1.9	2.0	1.5	20.2	0.0	0.5	0.0	1.2	0.0	0.0	3.8	0.1	0.0	0.0	0.0	7.7	7.2	0.7	0.9	0.0	0.5	1.1	0.2	0.0	0.0	7.0	1.7	0.0	0.0	2.0	0.0	0.0	20.3	0.1	0.0	0.0	0.0	0.0	0.1	0.3	7.0	0.0	0.0	2.7	0.1	0.0	0.9	1.1	3.3	0.0	0.1	0.0	0.5	0.3	0.0	1.2	1.7	14.0	0.0	0.1	12.0	2.4	0.2	0.0	8.2	0.0	0.0	0.0	0.1	0.5	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1	1.9	17.3	75.8	12.5	0.0	20.0	3.4	11.4	3.1	15.0	20.2	0.3	0.0	0.5	3.3	2.4	0.8	1.0	0.2	0.0	8.8	4.4	2.5	2.7	1.5	2.4	20.2	8.4	2.3	0.2	0.2	0.0	1.6	0.3	23.9	1.2	0.7	4.2	0.0	15.6	1.4	0.9	0.2	0.5	16.3	0.0	0.1	1.1	2.4	2.8	1.7	18.3	0.1	4.1	7.3	1.9	0.6	0.6	6.3	0.0	3.7	3.2	0.8	0.0	2.0	1.9	0.3	0.1	0.0	0.3	1.3	0.0	3.3	1.1	6.2	0.0	0.1	1.1	1.3	1.2	0.4	0.6	2.3	0.4	0.0	0.1	0.9
KCNE5	KCNE1L	ENSG00000176076	"Potassium voltage-gated channel subfamily E regulatory subunit 5"	Q9UJ90	X	109623700-109625172	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Alport syndrome, Deafness, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.8;skeletal muscle: 4.0;tongue: 4.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.6;Erythroid cells: 3.8;monocytes: 9.4;Muller glia cells: 5.3;Peritubular cells: 3.8"	"Group enriched"	"Detected in some"	8	"glioma: 7.9;testis cancer: 2.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.5;hTEC/SVTERT24-B: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042316			Uncertain	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA042316: AB_10795397"	"unprognostic (5.33e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.62e-3)"	"unprognostic (7.83e-2)"	"unprognostic (5.64e-6)"	"unprognostic (5.10e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.37e-3)"	1.1	0.8	3.2	0.1	5.4	1.6	0.5	9.4	2.7	0.2	0.7	0.1	0.0	0.0	0.1	0.1	0.0	0.4	0.7	2.7	6.6	0.7	0.2	0.4	0.0	6.3	9.8	0.5	0.1	0.0	0.3	0.2	6.9	0.3	0.0	0.2	0.2	0.3	4.0	0.1	0.1	0.1	4.0	0.9	0.1	0.3	7.8	2.3	0.1	4.9	0.0	0.3	0.2	4.6	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.3	0.3	0.0	0.8	0.3	0.0	0.1	1.0	1.1	0.7	0.0	0.0	1.5	0.2	0.5	2.0	0.5	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.4	0.5	0.0	0.9	0.4	0.7	0.3	0.3	0.9	0.2	0.2	0.1	0.4	0.4	0.1	0.0	0.3	0.0	0.3	0.8	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	3.2	5.4	9.4	2.7	2.7	6.6	6.3	9.8	6.9	4.0	7.8	4.6	0.1	0.0	1.1	4.6	0.1	0.0	0.0	0.0	1.2	0.0	0.3	1.1	0.6	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.3	0.0	0.5	0.1	0.2	0.0	3.8	0.1	0.4	1.2	1.4	0.0	0.5	1.3	0.7	1.1	0.0	0.6	0.0	0.1	0.0	0.0	2.0	0.0	0.0	1.2	2.1	0.0	1.0	9.4	5.3	0.0	0.0	0.0	0.3	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.4	0.0	0.0	0.1	0.0	0.8	0.2	0.1	0.0	0.1
KCNG3	Kv6.3	ENSG00000171126	"Potassium voltage-gated channel modifier subfamily G member 3"	Q8TAE7	2	42442017-42493982	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"brain: 5.7"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 12.1;Excitatory neurons: 16.4;Glandular and luminal cells: 12.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.1"	"Group enriched"	"Detected in many"	8	"amygdala: 1.8;basal ganglia: 2.3;cerebral cortex: 3.7;hippocampal formation: 5.7;pons: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HAP1: 4.7;HMC-1: 16.2;NTERA-2: 10.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA041625			Approved	"Cytoplasmic bodies"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Cytoplasmic bodies"		"HPA041625: "	"unprognostic (1.56e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.67e-3)"	"unprognostic (7.95e-2)"	"unprognostic (9.14e-3)"		"unprognostic (4.83e-3)"	"unprognostic (6.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.23e-1)"	0.0	0.9	1.8	0.1	2.3	0.0	0.0	0.0	3.7	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.5	0.0	0.4	0.0	1.7	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.2	0.0	4.7	0.0	0.0	0.0	2.5	0.0	0.5	0.9	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.1	0.9	0.0	10.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.5	0.6	1.0	1.6	0.4	1.6	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.3	0.0	3.7	5.7	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.1	3.2	1.1	0.7	0.0	1.3	0.3	0.0	0.0	1.6	0.1	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.6	12.1	1.5	0.2	1.8	0.0	16.4	0.0	0.0	0.5	0.0	12.8	0.0	0.3	0.0	0.0	0.1	0.0	1.4	0.4	0.0	0.0	0.3	0.2	1.8	0.1	0.0	0.0	0.0	2.0	0.0	1.5	0.4	0.2	0.2	2.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	1.1	0.0	1.1	0.1	0.1	1.8	0.3	0.3
KCNIP2	KCHIP2	ENSG00000120049	"Potassium voltage-gated channel interacting protein 2"	Q9NS61	10	101825974-101843920	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 227.4;brain: 139.6;heart muscle: 307.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 54.3;Cardiomyocytes: 135.7;Cone photoreceptor cells: 25.0;Excitatory neurons: 23.3;Horizontal cells: 48.8;Inhibitory neurons: 41.9"	"Cancer enhanced"	"Detected in many"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 21.3;HMC-1: 12.7"	"Group enriched"	"Detected in all"	4	"amygdala: 96.8;basal ganglia: 234.9;cerebral cortex: 106.9;hippocampal formation: 142.6;olfactory bulb: 144.0"	"Low region specificity"	"Detected in all"			HPA066717			Approved	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA066717: "	"unprognostic (5.92e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.77e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.31e-3)"	"unprognostic (8.80e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.49e-9)"	"unprognostic (9.85e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.37e-4)"	227.4	6.8	74.5	3.5	139.6	0.9	67.1	48.8	84.5	7.4	40.5	5.0	1.8	4.1	4.1	2.5	4.9	3.1	307.5	98.8	50.6	2.8	2.3	2.5	8.1	47.5	51.6	11.5	2.4	1.7	19.7	2.9	48.1	5.2	4.7	52.6	9.9	3.5	8.0	5.9	5.3	2.6	50.3	5.7	2.7	8.5	57.1	2.3	3.5	5.4	8.3	4.8	4.4	60.8	1.7	2.6	2.5	3.2	1.0	1.1	0.6	1.2	1.0	0.6	0.9	3.6	3.4	1.6	0.9	0.8	0.7	1.7	0.9	0.4	0.6	2.4	2.0	21.3	3.0	1.9	0.9	1.4	12.7	2.6	1.7	1.0	1.4	3.7	1.0	4.7	6.3	1.8	1.0	1.2	0.8	4.0	0.8	0.7	0.6	1.0	0.2	1.4	1.0	1.1	7.4	1.2	0.8	0.6	2.4	1.5	2.2	0.9	2.3	1.3	2.0	0.6	1.2	1.7	1.9	1.7	1.4	5.3	0.2	0.0	0.0	0.7	0.0	0.5	0.1	0.9	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	74.5	139.6	48.8	84.5	98.8	50.6	47.5	51.6	48.1	50.3	57.1	60.8	0.4	0.0	0.0	8.5	2.3	0.4	0.1	0.3	0.0	54.3	0.3	0.5	135.7	0.0	0.1	1.8	25.0	0.2	0.0	0.8	0.0	0.2	6.6	0.0	0.2	1.6	0.0	0.0	23.3	0.0	0.2	5.8	0.0	0.0	0.0	0.8	0.4	0.1	2.2	48.8	41.9	0.4	0.0	0.6	0.8	5.2	1.8	0.3	0.0	1.0	0.5	8.3	0.0	5.5	3.7	0.3	0.2	0.7	0.3	0.1	0.5	0.1	0.2	4.7	0.0	0.1	1.3	2.5	5.5	0.5	0.0	0.3	0.1	0.5	0.3	0.1
KCNK6	"K2p6.1, TWIK-2"	ENSG00000099337	"Potassium two pore domain channel subfamily K member 6"	Q9Y257	19	38319845-38332076	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 151.3;Urothelial cells: 131.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 26.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 11.4;granulocytes: 26.2;monocytes: 7.2"	"Cell line enhanced"	"Detected in many"		"HEL: 37.6;HMC-1: 40.3;T-47d: 22.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022637, HPA040184"	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB022637: , HPA040184: AB_2676876"	"unprognostic (7.98e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.45e-6)"	"unprognostic (3.76e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.91e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (1.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.59e-3)"	3.9	2.4	2.9	7.5	2.4	3.9	5.6	3.0	3.3	29.9	2.7	15.4	4.6	24.0	1.5	30.5	15.7	4.5	6.7	2.7	2.2	3.1	3.0	9.4	5.6	2.9	2.3	9.5	12.5	0.6	1.9	7.0	2.9	6.2	9.4	0.8	14.5	2.4	1.5	19.1	6.8	14.3	2.1	15.6	9.5	2.1	2.8	2.5	1.4	0.7	7.9	13.3	18.2	3.7	9.2	3.3	0.5	0.5	5.1	3.3	0.7	7.8	3.8	2.0	2.7	2.6	9.8	0.6	3.5	11.2	2.1	11.7	4.2	17.7	1.3	0.4	0.3	37.6	1.9	0.4	4.7	2.7	40.3	0.8	15.6	2.5	4.8	10.5	5.3	5.8	0.5	2.8	5.7	20.2	2.4	2.3	0.4	19.4	2.1	3.9	0.5	2.7	7.1	0.8	0.5	0.8	0.8	0.8	0.3	1.8	22.8	10.5	5.8	0.5	4.4	4.1	0.4	1.0	0.2	1.0	0.6	13.4	0.3	26.2	6.9	15.8	1.4	6.2	1.2	1.4	2.0	1.9	11.4	1.1	1.7	1.2	5.0	0.6	7.2	3.1	2.6	2.3	2.9	2.4	3.0	3.3	2.7	2.2	2.9	2.3	2.9	2.1	2.8	3.7	8.7	0.0	10.5	0.0	16.0	43.1	50.6	20.6	20.5	3.3	61.2	32.9	12.1	17.2	15.1	7.3	6.2	2.0	18.5	62.4	0.0	19.1	2.8	32.5	58.8	28.3	12.6	17.9	1.1	47.7	4.0	19.2	28.1	84.8	22.2	72.7	151.3	4.3	39.2	0.0	1.7	64.5	2.0	75.7	61.5	1.2	25.7	47.0	5.4	2.8	62.1	1.2	11.3	0.0	0.9	67.2	39.2	20.3	45.6	41.1	37.6	0.4	7.7	5.9	26.3	3.1	9.3	14.8	3.3	48.0	67.2	2.5	14.8	1.5	26.7	131.5
KDM6A	UTX	ENSG00000147050	"Lysine demethylase 6A"	O15550	X	44873188-45112779	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 116.2;Oligodendrocyte precursor cells: 118.1;Oligodendrocytes: 264.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000568, HPA001165, HPA002111"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA000568: AB_1858705, HPA001165: AB_1080541, HPA002111: AB_1858704"	"unprognostic (1.73e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.58e-3)"	"unprognostic (8.22e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.16e-2)"	9.6	8.0	6.7	4.5	7.6	19.4	10.6	7.2	10.6	15.7	6.5	9.1	6.2	14.0	5.1	11.1	14.0	3.4	6.6	6.8	6.9	6.8	10.4	10.8	8.0	7.3	6.8	17.2	10.8	6.4	8.6	3.9	7.3	7.7	4.1	3.8	10.5	3.1	10.4	18.4	13.0	4.1	7.1	14.1	12.5	12.2	7.0	12.9	9.4	6.1	5.3	9.8	15.2	9.9	7.3	5.8	7.0	9.3	5.0	6.8	15.7	4.9	4.2	4.0	4.1	10.4	5.2	4.6	3.2	3.5	10.1	13.9	6.5	5.4	3.9	7.6	10.8	2.4	4.5	5.2	3.7	2.6	13.2	2.6	6.4	8.2	6.6	5.1	4.2	5.3	6.4	10.1	2.4	6.0	6.9	13.6	6.8	4.2	7.4	6.4	7.1	1.4	3.8	9.2	6.2	4.4	18.2	6.8	10.7	14.1	8.5	0.0	3.0	5.4	5.2	5.2	3.6	5.5	8.8	5.6	4.0	3.3	3.3	7.3	1.7	1.5	1.9	3.5	2.1	1.9	2.5	2.8	3.1	1.2	2.5	2.4	2.8	2.8	3.0	1.7	2.2	2.0	6.7	7.6	7.2	10.6	6.8	6.9	7.3	6.8	7.3	7.1	7.0	9.9	23.2	6.4	10.6	92.1	26.0	26.1	14.3	9.4	38.1	7.7	16.8	12.1	12.8	12.8	10.9	7.3	14.6	4.5	26.1	24.6	0.0	8.4	1.5	26.4	25.5	13.1	13.1	16.8	88.3	7.5	7.9	14.2	23.0	39.7	2.5	27.3	6.4	17.6	7.0	25.2	74.0	14.0	6.1	9.1	13.8	2.0	6.5	19.9	10.6	116.2	12.6	6.8	6.2	118.1	264.6	9.1	17.4	7.2	31.4	14.2	22.6	3.7	8.9	9.7	6.6	20.9	17.0	14.1	12.5	29.3	26.3	10.9	27.4	10.6	13.1	17.1
KIAA0232		ENSG00000170871	KIAA0232	Q92628	4	6781375-6884170	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 10.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036891, HPA036892, HPA061498"	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol		"HPA036891: AB_10672272, HPA036892: AB_2675366, HPA061498: AB_2684541"	"unprognostic (6.88e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-1)"	"prognostic favorable (3.91e-10)"	"unprognostic (1.21e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.18e-2)"	13.0	12.0	18.6	8.5	19.9	16.2	13.3	20.2	20.9	12.0	17.8	14.0	8.5	15.4	12.6	20.6	15.3	12.4	33.2	18.0	22.3	18.8	15.0	12.0	7.5	18.2	22.5	13.1	10.6	23.9	10.3	10.4	19.8	14.7	12.3	24.7	8.9	14.6	32.5	7.6	11.5	13.1	20.1	12.9	10.9	12.0	23.4	11.7	15.1	51.1	8.6	10.4	9.8	21.0	13.7	13.0	26.7	16.7	18.8	20.2	14.0	17.4	18.1	12.0	10.1	8.2	11.3	9.0	5.8	19.7	18.5	7.0	13.7	7.7	15.5	5.1	5.6	26.7	11.1	11.0	9.9	11.6	33.6	13.6	17.7	13.4	7.4	15.4	12.6	8.9	20.3	7.6	15.4	6.7	22.3	11.7	14.1	10.2	14.3	15.7	27.3	4.2	20.3	12.8	20.2	13.1	12.9	11.4	12.1	18.3	14.5	21.1	16.0	11.0	12.8	9.8	15.2	13.1	14.1	7.0	13.5	12.2	30.3	2.0	2.0	5.7	2.1	1.4	2.9	1.3	1.6	2.5	1.3	1.3	1.5	1.6	10.6	1.8	2.1	2.0	1.6	0.9	18.6	19.9	20.2	20.9	18.0	22.3	18.2	22.5	19.8	20.1	23.4	21.0	27.6	32.1	39.2	62.3	19.1	12.7	27.4	12.9	24.5	77.2	29.0	20.6	132.1	10.0	29.0	12.9	37.5	14.7	23.6	47.9	41.1	23.4	45.0	74.4	28.0	20.6	25.1	49.9	123.8	11.7	7.7	27.7	44.9	38.7	12.6	16.3	15.0	42.9	11.2	99.3	120.7	20.9	30.5	23.9	11.8	64.2	24.8	28.4	7.2	73.1	34.8	49.7	27.8	90.0	138.0	21.8	24.8	33.1	24.2	28.0	29.6	24.6	58.0	44.6	26.3	39.4	31.6	31.6	22.4	19.2	11.1	22.4	27.4	27.0	17.5	35.7
KIFC3		ENSG00000140859	"Kinesin family member C3"	Q9BVG8	16	57758217-57863053	"Cancer-related genes, Predicted intracellular proteins"		"Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 169.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 141.8;Early spermatids: 203.7;Late spermatids: 430.5;Rod photoreceptor cells: 165.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"A549: 215.1;HMC-1: 204.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021240	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA021240: AB_1852509"	"unprognostic (1.53e-1)"	"unprognostic (3.10e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.33e-2)"	30.5	29.0	25.4	25.9	16.6	14.5	23.8	28.2	35.9	22.7	13.4	21.0	30.7	22.2	30.1	26.2	14.8	21.1	62.7	21.2	38.5	169.2	85.6	45.4	13.5	25.7	14.2	19.0	76.6	26.1	30.9	25.6	29.9	26.3	13.4	82.3	22.1	22.3	13.7	80.0	37.4	13.0	7.3	21.2	24.5	64.9	35.0	4.1	68.1	6.6	9.6	30.3	24.4	46.4	41.5	215.1	15.2	32.8	4.9	10.4	26.8	51.1	65.1	76.4	36.3	58.2	62.6	4.4	64.5	32.8	79.3	43.2	1.8	47.1	25.6	2.1	10.2	34.6	72.9	75.8	28.8	5.0	204.7	14.2	16.6	40.3	40.5	39.1	18.4	11.9	61.7	7.4	28.6	28.2	7.4	60.9	10.3	16.2	45.6	4.6	23.1	33.0	48.9	21.3	5.3	10.7	86.8	60.7	55.8	10.5	18.2	26.0	39.9	98.4	69.3	45.3	71.5	5.9	3.7	4.3	49.9	3.3	94.7	0.1	0.2	0.2	1.5	0.0	0.1	0.7	0.6	1.5	0.1	0.5	0.3	0.4	0.5	0.1	0.7	0.1	0.0	0.6	25.4	16.6	28.2	35.9	21.2	38.5	25.7	14.2	29.9	7.3	35.0	46.4	40.0	48.1	33.3	28.4	0.5	12.6	12.3	8.1	5.7	5.7	5.0	7.4	8.4	38.6	15.3	66.2	141.8	31.8	9.2	0.1	50.9	50.6	203.7	18.5	4.8	25.3	0.0	4.8	15.8	63.6	6.4	11.8	2.0	15.6	3.8	0.9	25.4	16.6	25.7	1.7	14.8	2.1	2.0	6.6	10.2	430.5	12.2	24.7	28.4	16.9	1.1	10.6	15.5	27.2	28.9	67.1	1.2	22.6	0.8	13.8	34.7	51.4	14.9	165.5	19.7	10.3	16.5	7.7	9.9	1.0	8.2	19.4	5.8	10.5	0.9	7.9
KIRREL2	"DKFZp564A1164, FILTRIN, MGC15718, NEPH3, NLG1"	ENSG00000126259	"Kirre like nephrin family adhesion molecule 2"	Q6UWL6	19	35855861-35867136	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"pancreas: 70.0"	"Cell type enriched"	"Detected in some"	9	"Bipolar cells: 58.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.5;HMC-1: 33.0;JURKAT: 19.5;U-937: 7.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA071587, HPA074326"	Enhanced		Supported	"Centriolar satellite"	"Intracellular and membrane"	NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Centriolar satellite"		"HPA071587: AB_2732182, HPA074326: AB_2732251"	"unprognostic (1.28e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.30e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-6)"	"unprognostic (1.72e-1)"	"unprognostic (4.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.62e-2)"	0.5	0.0	0.5	0.2	1.4	0.1	0.0	0.3	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	1.1	0.0	0.0	0.8	0.4	0.4	0.0	70.0	0.0	0.9	0.1	0.4	0.0	0.1	11.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.6	0.5	0.6	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.7	1.1	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.0	1.1	0.7	0.0	0.1	0.0	3.6	0.1	2.9	0.0	0.1	21.5	0.1	0.0	0.0	0.3	0.0	0.0	33.0	0.2	0.0	0.0	0.0	0.0	0.0	19.5	0.2	0.3	0.0	0.2	0.6	0.1	0.2	0.1	0.0	5.5	0.0	0.0	0.0	0.0	4.1	1.3	0.0	0.0	0.0	0.1	0.0	5.3	0.0	0.8	1.3	0.3	0.0	0.0	0.0	0.4	0.0	7.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.3	1.0	0.8	0.1	0.4	0.4	0.4	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	1.8	0.1	0.2	0.1	0.0	0.0	0.4	6.0	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.7	5.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.7	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0
KIT	"C-Kit, CD117, PBT, SCFR"	ENSG00000157404	"KIT proto-oncogene, receptor tyrosine kinase"	P10721	4	54657918-54740715	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 114.9"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 83.1;granulocytes: 529.3;Inhibitory neurons: 111.2;Ionocytes: 101.7;Melanocytes: 211.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 28.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 20.3;eosinophil: 12.8;NK-cell: 13.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 20.3;NK-cells: 13.1"	"Group enriched"	"Detected in many"	13	"HEL: 247.2;HMC-1: 496.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003288, HPA004471, CAB068253, CAB072867, HPA073252"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA		49000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 5: Breast - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"		"CAB003288: AB_2335702, CAB068253: AB_2665717, CAB072867: AB_2665718, HPA004471: AB_1078431, HPA073252: AB_2686589"	"unprognostic (1.55e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.30e-1)"	6.6	1.8	8.2	5.3	6.3	6.4	114.9	21.4	6.5	17.6	5.1	13.5	9.2	9.6	5.9	13.0	2.9	20.3	3.4	23.9	5.1	12.4	0.8	21.8	3.4	6.8	12.3	45.0	2.6	1.7	1.9	10.0	8.8	5.6	16.0	3.2	21.4	8.7	1.1	24.5	13.4	10.1	5.9	5.0	17.4	6.2	16.7	3.1	47.1	6.9	6.2	14.5	4.9	5.1	0.0	0.0	3.9	0.0	0.7	0.3	0.0	3.3	4.6	12.6	15.8	0.0	0.0	0.0	0.0	7.3	0.6	0.3	2.6	0.0	10.8	0.0	5.9	247.2	0.0	0.0	0.0	0.0	496.2	0.0	0.0	0.0	0.0	0.0	28.4	4.3	3.5	0.5	0.0	0.0	1.4	2.5	6.9	0.0	0.0	0.8	0.0	0.0	0.0	24.2	6.0	2.1	0.0	0.0	0.0	14.1	0.0	2.6	0.3	0.5	0.0	4.9	0.1	0.4	0.0	0.0	0.5	0.9	0.6	20.3	0.0	12.8	0.1	0.0	2.3	0.0	0.4	0.9	2.3	0.0	0.0	0.0	1.0	13.1	1.4	0.1	0.0	0.2	8.2	6.3	21.4	6.5	23.9	5.1	6.8	12.3	8.8	5.9	16.7	5.1	7.3	6.4	21.9	9.8	1.0	14.3	0.9	0.4	2.2	4.5	83.1	59.2	0.7	4.3	3.6	3.7	0.0	0.1	5.2	0.4	3.9	1.0	0.0	0.2	0.7	9.2	5.4	15.5	0.9	0.0	0.1	2.8	8.6	0.7	529.3	0.5	1.8	0.0	0.3	0.0	111.2	0.5	101.7	0.3	4.2	0.4	1.2	1.6	211.7	14.0	0.2	2.4	0.0	16.1	3.7	0.0	0.1	0.0	3.2	0.5	0.0	0.8	0.1	0.2	0.0	0.7	0.8	0.1	12.3	2.2	3.8	0.3	8.8	63.7	0.6	0.3
KLHDC7B	MGC16635	ENSG00000130487	"Kelch domain containing 7B"	Q96G42	22	50545899-50551023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.2;parathyroid gland: 13.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 5.2;Collecting duct cells: 5.5;granulocytes: 5.7;Kupffer cells: 5.2;monocytes: 21.1;NK-cells: 10.3;T-cells: 5.7"	"Group enriched"	"Detected in many"	4	"cervical cancer: 42.3;head and neck cancer: 11.4;urothelial cancer: 40.7"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 97.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA000518, HPA076540"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"		"HPA000518: AB_1079213, HPA076540: "	"prognostic favorable (1.30e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.96e-2)"	"unprognostic (6.04e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	0.2	0.2	0.2	2.1	0.1	1.0	0.3	0.1	0.2	0.5	0.1	0.3	0.4	0.2	0.3	0.4	0.1	0.3	0.0	0.1	0.2	3.7	0.4	0.7	2.3	0.5	0.2	0.0	0.1	13.7	1.0	0.1	0.3	0.4	0.1	0.0	1.3	0.2	0.0	0.3	1.1	0.1	0.2	2.7	0.5	0.2	0.4	5.2	2.0	0.0	1.3	1.5	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.8	0.0	0.8	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.0	0.2	97.7	0.1	1.2	0.0	0.2	0.1	0.0	0.0	0.0	11.6	0.0	0.0	0.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.3	0.0	0.1	1.1	1.1	0.1	2.0	1.9	1.4	1.9	2.1	2.6	0.9	1.3	2.3	2.0	0.2	0.7	1.4	0.3	2.0	1.5	0.2	0.1	0.1	0.2	0.1	0.2	0.5	0.2	0.3	0.2	0.4	0.2	0.0	0.0	0.6	0.0	5.2	0.1	0.0	1.6	0.0	0.0	3.0	1.4	0.5	0.0	1.6	5.5	0.0	0.0	2.5	0.1	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.7	0.1	0.2	0.5	0.3	5.7	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	5.2	1.2	0.0	0.0	2.7	0.0	0.0	21.1	0.0	10.3	0.0	0.0	1.3	0.0	0.0	2.8	0.1	0.0	0.3	1.6	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.2
KREMEN2	"KRM2, MGC10791"	ENSG00000131650	"Kringle containing transmembrane protein 2"	Q8NCW0	16	2964216-2968383	"Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 4.1;skin 1: 7.7"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 14.1;Basal squamous epithelial cells: 23.3;Intestinal goblet cells: 14.0;Rod photoreceptor cells: 10.9;Spermatocytes: 9.7;Spermatogonia: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.2;naive B-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 29.3;MCF7: 15.0;RPMI-8226: 28.8;T-47d: 14.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA003223	Uncertain		Approved	Nucleoli	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoli		"HPA003223: AB_1079217"	"unprognostic (8.36e-2)"	"unprognostic (4.65e-1)"	"unprognostic (6.24e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.02e-3)"	"prognostic unfavorable (8.98e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.57e-2)"	"unprognostic (7.79e-12)"	"unprognostic (6.69e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.58e-3)"	0.1	0.1	0.7	0.3	0.7	0.7	0.1	0.0	0.6	1.5	0.0	0.3	0.1	0.1	0.1	2.0	0.3	0.1	0.0	1.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.3	0.0	4.1	0.4	0.0	0.3	7.7	0.6	0.0	0.0	0.2	0.2	1.7	0.0	2.1	0.0	0.0	0.8	0.0	0.5	0.1	1.8	1.1	0.4	10.2	0.0	0.0	1.5	0.6	0.0	0.0	0.0	4.2	1.5	7.8	2.1	0.0	1.1	8.6	1.3	0.7	0.0	1.1	1.2	0.5	2.9	2.6	0.0	0.6	29.3	0.2	0.0	0.0	0.1	0.9	0.0	0.8	3.3	2.9	0.0	15.0	1.8	3.5	2.9	3.0	2.2	4.7	11.8	28.8	0.1	0.3	2.9	1.8	2.0	4.7	5.2	0.4	14.9	2.8	0.2	0.9	12.2	1.0	0.7	5.3	1.3	4.7	0.4	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.7	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	1.4	14.1	0.9	0.3	23.3	0.4	1.0	0.9	0.9	0.0	0.0	0.0	6.2	0.2	0.0	1.1	0.0	0.1	0.7	0.4	0.1	0.1	0.0	0.0	0.4	2.7	1.8	0.1	0.0	0.9	4.5	0.0	0.0	0.0	0.1	0.0	0.1	14.0	0.0	0.0	0.6	0.6	0.0	0.2	3.6	0.0	0.1	0.5	0.0	0.0	0.0	0.2	1.3	0.0	0.1	2.1	0.5	0.0	0.0	10.9	0.0	0.0	0.3	9.7	18.0	1.2	5.5	0.1	0.6	0.0	0.5	0.4
KRT2	"KRT2A, KRTE"	ENSG00000172867	"Keratin 2"	P35908	12	52644558-52652211	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	57	"skin 1: 4660.3"	"Cell type enriched"	"Detected in some"	14	"Suprabasal keratinocytes: 265.4"	"Cancer enriched"	"Detected in some"	5	"melanoma: 23.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in single"		"HEL: 2.0"	"Group enriched"	"Detected in some"	6	"amygdala: 1.7;hippocampal formation: 2.7"	"Not detected"	"Not detected"			"HPA006299, CAB037321"	Enhanced		Approved	"Golgi apparatus,Intermediate filaments,Cytosol"		NA	NA		9700000000	"Cluster 32: T-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 28: Keratinocytes - Keratinization"	"Intermediate filaments, Cytosol"	"Golgi apparatus"	"CAB037321: , HPA006299: AB_1079180"	"unprognostic (1.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.69e-2)"		"unprognostic (1.84e-1)"	"unprognostic (3.59e-1)"		"unprognostic (2.12e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.56e-7)"	"unprognostic (6.43e-2)"	"unprognostic (5.98e-3)"	"unprognostic (6.69e-2)"	"unprognostic (3.46e-1)"	3.0	0.5	0.0	0.1	0.0	1.0	81.9	0.0	0.0	0.8	0.0	0.9	1.6	0.4	0.3	1.1	0.1	0.0	1.7	0.0	0.0	0.5	1.2	1.0	0.5	0.0	0.0	0.5	1.0	0.0	0.5	0.0	0.0	0.4	0.1	0.0	1.6	0.0	47.8	4660.3	0.8	0.0	0.0	0.5	0.7	1.0	0.0	6.8	0.8	0.0	6.1	0.1	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.1	0.0	0.0	0.0	0.1	0.4	1.5	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.3	9.5	0.0	0.0	0.1	8.8	0.0	0.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	265.4	0.1	1.0	0.0	0.6	0.1
KRT79	"K6L, KRT6L"	ENSG00000185640	"Keratin 79"	Q5XKE5	12	52821408-52834311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"skin 1: 68.3"	"Cell type enhanced"	"Detected in some"		"granulocytes: 4.5;Late spermatids: 1.1;Melanocytes: 3.6"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.4;cervical cancer: 2.6;head and neck cancer: 2.7;melanoma: 1.6;urothelial cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"HMC-1: 425.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059347	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA		1900000000		"Cluster 61: Skin - Cornification"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA059347: AB_2683986"	"unprognostic (5.19e-3)"	"unprognostic (1.56e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-2)"		"unprognostic (6.85e-2)"		"unprognostic (6.36e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.88e-2)"			"unprognostic (1.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.99e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	68.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	425.5	0.0	0.0	5.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	21.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0
LAPTM5		ENSG00000162511	"Lysosomal protein transmembrane 5"	Q13571	1	30732469-30757774	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1285.7;lymphoid tissue: 672.2"	"Group enriched"	"Detected in many"	4	"B-cells: 872.9;dendritic cells: 340.2;granulocytes: 639.8;Hofbauer cells: 1150.4;Kupffer cells: 942.2;Langerhans cells: 489.6;Macrophages: 925.0;monocytes: 446.1;NK-cells: 562.3;T-cells: 432.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 554.0;HEL: 1053.2;HL-60: 676.4;HMC-1: 2382.4;REH: 785.2;U-698: 898.1;U-937: 542.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051293	Approved		Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA051293: AB_2681424"	"unprognostic (3.12e-2)"	"prognostic favorable (3.40e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.89e-5)"	"unprognostic (9.47e-2)"	"unprognostic (8.18e-3)"	"unprognostic (5.98e-2)"	"unprognostic (3.94e-2)"	144.7	82.1	47.6	443.0	49.7	1285.7	60.4	49.7	90.4	53.1	55.7	82.2	68.1	27.3	16.7	49.5	46.8	137.9	31.6	45.2	62.7	30.5	98.6	284.9	672.2	82.4	67.3	16.4	30.2	21.8	22.6	145.2	75.8	31.5	90.6	5.9	38.5	30.9	9.2	24.0	155.9	93.5	69.2	491.1	72.9	10.9	81.1	298.3	38.5	20.9	636.5	161.1	22.8	114.9	1.2	0.0	1.7	0.0	0.1	0.1	0.6	0.9	0.3	0.5	0.1	0.7	1.2	554.0	56.0	1.7	1.9	2.2	0.0	0.8	0.5	62.3	0.0	1053.2	0.0	1.6	0.9	676.4	2382.4	0.6	1.2	0.6	4.1	0.3	124.2	70.7	13.8	34.0	8.8	0.0	117.5	142.2	0.7	0.0	0.0	785.2	99.6	391.6	0.8	0.1	0.6	0.4	1.3	1.3	1.1	1.0	0.5	422.2	145.3	0.6	3.0	0.6	3.4	2.7	0.7	898.1	3.1	542.8	1.8	1094.2	1522.8	1446.7	538.5	1046.1	616.3	823.6	485.5	502.8	825.7	1089.4	481.2	481.2	1709.5	327.0	1075.7	392.7	656.9	2740.4	47.6	49.7	49.7	90.4	45.2	62.7	82.4	67.3	75.8	69.2	81.1	114.9	62.9	25.6	100.4	0.0	872.9	23.8	1.1	1.3	4.0	0.0	6.2	10.4	5.5	14.3	13.9	3.7	0.0	5.8	340.2	0.8	0.0	1.2	2.0	1.4	0.9	60.2	1.2	78.2	0.2	0.7	8.4	12.3	10.2	1.1	639.8	0.2	47.2	9.4	1150.4	0.0	0.8	0.9	0.0	942.2	489.6	4.9	1.5	925.0	49.8	43.1	446.1	0.3	562.3	0.5	0.5	1.4	0.2	0.4	144.8	0.9	0.5	3.0	11.4	1.3	0.0	4.1	5.6	0.3	1.1	1.8	20.0	8.9	432.7	18.2	2.4	1.9
LAT	LAT1	ENSG00000213658	"Linker for activation of T cells"	O43561	16	28984826-28990784	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Adaptive immunity, Immunity, Mast cell degranulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 117.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 80.7;granulocytes: 78.9;Macrophages: 55.9;NK-cells: 152.4;T-cells: 151.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	19	"basophil: 307.7;gdT-cell: 303.4;MAIT T-cell: 212.5;memory CD4 T-cell: 295.1;memory CD8 T-cell: 307.2;naive CD4 T-cell: 276.0;naive CD8 T-cell: 266.9;NK-cell: 114.6;T-reg: 410.8"	"Group enriched"	"Detected in all"	142	"granulocytes: 307.7;NK-cells: 114.6;T-cells: 410.8"	"Cell line enhanced"	"Detected in many"		"HEL: 189.8;HMC-1: 765.9;MOLT-4: 279.5"	"Not detected"	"Not detected"							"CAB002223, HPA011157, CAB012978, CAB079960"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		140000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Golgi apparatus"	"CAB002223: AB_563852, CAB012978: , CAB079960: , HPA011157: AB_1079237"	"unprognostic (4.35e-3)"	"unprognostic (5.17e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.15e-5)"	"unprognostic (1.17e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.52e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.02e-8)"	"unprognostic (1.04e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.51e-4)"	8.1	4.4	9.1	23.9	9.6	17.5	6.6	9.0	11.9	15.6	8.1	31.3	9.2	19.3	5.2	8.1	11.6	9.6	3.9	9.2	8.5	15.3	10.5	14.1	65.9	9.2	8.5	7.7	5.7	2.0	14.2	3.9	9.0	21.6	5.2	3.5	7.8	9.5	4.2	10.7	22.7	5.7	8.0	32.0	13.4	4.1	9.7	117.9	17.6	1.6	29.0	24.7	13.3	8.9	1.0	2.3	1.5	2.5	3.7	2.4	4.9	5.5	1.4	1.7	2.2	2.3	3.0	0.7	7.2	2.2	0.6	2.9	2.6	1.3	0.8	1.6	3.3	189.8	5.4	3.3	1.0	5.9	765.9	2.1	3.8	1.7	0.7	2.8	0.9	62.7	2.6	21.7	0.8	5.6	279.5	38.3	3.4	0.4	2.7	3.2	0.8	24.9	1.9	1.6	5.3	1.0	0.9	1.8	2.7	1.4	2.7	31.7	3.6	3.6	18.0	3.9	1.3	7.6	7.0	3.1	45.5	2.7	2.9	307.7	1.4	0.7	303.4	1.5	212.5	1.7	295.1	307.2	1.1	1.7	276.0	266.9	14.6	114.6	1.3	1.9	410.8	196.5	9.1	9.6	9.0	11.9	9.2	8.5	9.2	8.5	9.0	8.0	9.7	8.9	5.2	0.0	13.1	4.6	6.2	7.1	2.1	1.1	2.8	11.0	3.7	4.3	1.7	7.2	3.1	9.2	6.2	2.6	80.7	1.2	1.9	1.7	0.3	1.5	2.3	4.7	0.0	16.6	4.7	0.5	0.9	3.0	7.7	2.7	78.9	4.9	8.6	2.9	14.3	6.7	5.5	1.5	0.0	7.3	9.4	0.1	1.5	55.9	10.6	5.6	9.2	3.0	152.4	3.0	3.5	1.0	0.7	0.7	17.0	2.2	1.3	1.3	1.3	9.6	0.0	3.0	3.8	1.7	2.1	1.9	5.3	2.7	151.7	1.7	1.4	1.3
LCP1	"CP64, L-PLASTIN, LC64P, PLS2"	ENSG00000136167	"Lymphocyte cytosolic protein 1"	P13796	13	46125920-46211871	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 709.0;epididymis: 402.7;lymphoid tissue: 605.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 438.4;granulocytes: 309.1;Hofbauer cells: 264.4;Kupffer cells: 401.2;Langerhans cells: 337.6;Late spermatids: 290.9;Macrophages: 466.1;monocytes: 535.7;NK-cells: 471.7;T-cells: 375.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 875.8;HDLM-2: 799.3;HL-60: 850.7;HMC-1: 861.7;JURKAT: 792.7;NB-4: 789.2;THP-1: 840.5;U-698: 1105.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019493, CAB020673"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		1800000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB020673: , HPA019493: AB_1855457"	"unprognostic (2.79e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.99e-2)"	"unprognostic (6.70e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.92e-1)"	85.9	31.1	11.3	396.9	13.1	709.0	43.9	13.9	30.9	28.5	16.8	54.7	42.4	27.4	402.7	29.5	21.5	76.4	14.5	11.3	14.2	13.1	89.0	173.8	563.5	19.7	18.9	10.0	12.2	12.6	4.3	67.2	21.3	184.5	71.2	4.9	44.4	24.3	7.1	40.6	62.3	60.4	18.6	375.2	53.2	33.2	24.8	499.8	23.6	17.8	605.1	133.0	7.7	29.9	36.1	0.2	1.9	0.0	0.0	0.0	409.8	0.1	1.2	3.9	2.9	237.4	1.4	875.8	179.5	0.0	249.1	1.7	0.1	0.6	3.9	799.3	202.9	187.6	0.4	1.1	0.9	850.7	861.7	2.3	0.1	1.4	1.2	0.3	0.0	792.7	100.4	569.7	0.0	2.8	624.8	789.2	1.0	0.4	8.2	451.6	1.6	638.2	0.0	233.8	2.8	7.5	1.9	91.8	6.4	25.0	6.4	840.5	3.1	22.0	13.6	1.5	25.5	135.3	292.5	1105.7	17.0	530.9	3.6	1007.3	1559.5	810.8	915.7	1806.2	822.0	342.3	539.6	761.2	1134.5	251.6	330.2	560.5	1908.6	650.6	1826.1	297.5	598.1	3644.2	11.3	13.1	13.9	30.9	11.3	14.2	19.7	18.9	21.3	18.6	24.8	29.9	7.4	32.1	73.2	0.3	185.2	12.0	1.2	0.0	1.8	0.4	10.3	11.7	4.2	5.7	18.0	3.7	0.0	9.8	438.4	0.2	0.0	16.9	113.1	4.7	42.8	9.6	1.2	63.9	0.5	16.3	68.3	10.9	19.9	7.0	309.1	0.7	12.5	24.0	264.4	0.0	0.5	0.5	0.0	401.2	337.6	290.9	1.2	466.1	23.2	17.8	535.7	23.7	471.7	0.5	1.5	6.8	2.4	1.9	102.4	42.0	0.1	1.5	13.8	1.2	0.0	3.1	6.2	2.7	1.6	2.2	11.8	13.5	375.3	0.5	0.4	4.0
LCP2	"SLP-76, SLP76"	ENSG00000043462	"Lymphocyte cytosolic protein 2"	Q13094	5	170246233-170297815	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 163.9;lymphoid tissue: 115.1"	"Cell type enhanced"	"Detected in many"		"granulocytes: 129.6;Kupffer cells: 154.4;Macrophages: 158.2;NK-cells: 91.6;T-cells: 104.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 147.0;HL-60: 152.5;HMC-1: 375.9;Karpas-707: 80.4;MOLT-4: 91.4;THP-1: 80.8;U-937: 99.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004574, HPA036396, HPA036397"	Enhanced					NA	NA		2900000	"Cluster 52: Eosinophils - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB004574: AB_628259, HPA036396: AB_10671840, HPA036397: AB_10670436"	"unprognostic (1.33e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.52e-3)"	"prognostic favorable (5.08e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.10e-1)"	"prognostic unfavorable (6.22e-5)"	"unprognostic (1.87e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.07e-1)"	23.0	14.1	5.0	75.7	5.7	163.9	8.4	5.9	22.9	10.3	6.3	14.6	15.8	8.2	4.9	9.6	6.8	28.6	5.7	5.1	6.9	5.6	26.3	31.5	77.5	12.2	8.4	3.7	7.7	3.3	2.2	21.9	11.6	8.0	16.4	0.8	6.6	6.5	3.2	3.9	24.4	16.6	7.9	81.1	17.6	3.9	10.2	115.1	4.7	6.2	47.3	28.2	3.7	12.7	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.4	0.0	147.0	0.0	0.0	0.0	152.5	375.9	0.0	0.0	0.0	0.0	0.0	0.1	49.7	1.1	80.4	0.0	0.0	91.4	53.2	0.5	0.0	0.0	14.0	0.0	45.5	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.3	0.0	80.8	0.1	0.0	0.1	0.2	0.1	1.4	14.6	0.2	0.3	99.9	1.7	56.8	20.4	76.6	40.5	42.5	40.2	2.7	32.4	38.6	26.6	1.0	29.8	31.0	68.9	41.7	65.8	5.3	39.8	22.9	5.0	5.7	5.9	22.9	5.1	6.9	12.2	8.4	11.6	7.9	10.2	12.7	13.4	16.0	29.2	0.7	12.2	3.2	0.2	0.1	0.0	0.2	0.9	2.8	4.8	1.5	5.6	1.8	0.0	0.5	35.2	0.1	0.0	0.2	1.6	0.4	2.4	14.2	0.0	24.0	2.8	0.0	0.8	9.5	5.1	0.7	129.6	0.0	18.9	2.4	57.9	0.0	7.9	0.7	0.0	154.4	49.4	0.9	2.5	158.2	1.8	31.9	48.2	0.0	91.6	0.5	0.5	0.0	0.0	3.0	12.6	0.4	0.0	0.3	2.9	0.0	26.3	1.3	3.1	0.0	0.2	1.0	1.8	0.8	104.6	0.5	0.0	0.3
LEO1		ENSG00000166477	"LEO1 homolog, Paf1/RNA polymerase II complex component"	Q8WVC0	15	51938025-51971778	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	7	"granulocytes: 272.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040741, HPA040941"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Nucleoli fibrillar center"	Centrosome	"HPA040741: AB_10794859, HPA040941: AB_10805832"	"unprognostic (2.76e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.08e-1)"	10.2	11.4	8.1	13.8	8.8	9.0	15.5	14.7	12.9	11.6	6.4	17.0	13.3	10.4	10.0	19.8	8.7	13.2	8.1	8.0	10.0	13.7	22.2	9.7	18.0	8.0	8.1	8.5	8.1	18.8	9.1	12.1	7.7	12.3	19.2	12.0	18.5	8.6	13.9	20.8	14.5	11.7	6.9	10.5	13.2	9.3	8.3	22.1	11.1	11.7	17.9	19.3	14.0	10.0	28.0	63.9	40.3	32.6	40.7	35.0	28.8	44.4	36.6	37.3	33.9	44.3	17.9	56.2	25.3	45.8	41.3	53.2	54.2	39.6	35.8	37.5	24.5	88.5	50.6	78.5	32.0	80.7	118.2	37.9	30.5	29.2	37.6	35.2	37.0	46.5	54.6	30.1	44.9	118.7	43.0	61.1	17.4	82.6	27.0	47.6	69.7	58.9	32.8	77.0	28.5	43.4	33.9	51.5	36.5	43.8	42.8	72.6	44.4	36.8	25.5	34.3	53.7	23.4	78.2	50.7	32.2	113.1	40.0	11.5	14.5	15.7	27.4	23.3	25.7	18.7	27.2	22.3	23.8	16.4	27.9	25.2	3.3	30.9	26.0	17.8	31.7	16.3	8.1	8.8	14.7	12.9	8.0	10.0	8.0	8.1	7.7	6.9	8.3	10.0	16.2	35.3	24.6	10.1	15.2	26.1	16.8	33.4	18.2	38.2	11.8	10.2	21.2	17.2	37.0	7.3	10.4	24.9	24.8	24.6	15.6	26.3	2.4	19.5	38.8	18.0	7.7	12.4	16.5	24.2	26.7	19.9	15.8	29.8	272.8	16.2	10.0	18.0	19.5	26.9	16.9	17.9	26.4	14.8	6.0	2.7	8.1	13.0	3.6	5.6	12.8	23.1	22.6	13.0	13.3	18.2	14.7	13.5	11.0	9.0	20.5	23.3	31.4	23.2	6.6	18.5	29.3	21.5	11.0	19.5	24.7	17.6	25.0	23.8	17.0	21.2
LGALS9	LGALS9A	ENSG00000168961	"Galectin 9"	O00182	17	27629798-27649560	"Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 99.1;stomach 1: 87.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 181.1;Gastric mucus-secreting cells: 174.8;Hofbauer cells: 298.2;Intestinal goblet cells: 183.5;Kupffer cells: 254.2;Paneth cells: 181.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 40.2;HMC-1: 124.9;MOLT-4: 44.8;REH: 48.4;THP-1: 83.2;U-937: 92.1"									"HPA046876, HPA047218"	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA	448000		"Cluster 7: Monocytes - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA046876: AB_2679852, HPA047218: AB_2679988"	"unprognostic (2.62e-2)"	"prognostic favorable (2.35e-5)"	"unprognostic (1.16e-2)"	"unprognostic (3.57e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (4.76e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.24e-3)"	20.7	6.4	12.6	46.0	13.0	68.5	9.5	13.8	20.8	25.6	14.3	99.1	46.3	12.8	3.0	14.5	28.4	38.2	8.7	12.8	13.4	2.4	11.6	34.2	60.9	21.7	15.2	5.3	5.2	2.8	1.2	16.8	16.5	3.7	89.2	1.0	21.2	7.9	3.8	4.2	41.8	19.4	17.3	50.7	87.5	3.8	17.0	29.1	4.1	4.1	38.9	39.6	1.9	20.1	2.0	0.7	0.6	0.3	0.1	0.2	1.6	0.4	1.3	8.9	29.6	0.1	12.6	1.5	14.2	1.1	1.5	4.1	0.3	0.1	0.5	9.4	0.9	14.9	0.9	0.0	1.0	40.2	124.9	0.3	0.0	0.4	0.0	0.5	16.5	13.6	0.6	0.5	0.0	0.1	44.8	15.0	0.4	28.4	0.0	48.4	0.0	3.6	5.9	1.0	0.3	0.8	0.0	4.4	0.2	0.9	0.2	83.2	3.1	0.0	0.3	0.1	0.2	0.1	0.1	0.3	0.2	92.1	0.2	32.6	116.2	78.2	5.6	214.9	2.6	32.3	15.6	5.9	165.5	41.7	9.6	4.0	41.7	22.0	217.4	28.5	40.3	75.1	12.6	13.0	13.8	20.8	12.8	13.4	21.7	15.2	16.5	17.3	17.0	20.1	32.2	9.6	6.3	2.0	42.2	3.2	7.7	32.9	18.8	0.2	10.5	13.2	1.7	20.0	40.5	7.3	0.0	2.3	19.0	181.1	3.9	124.1	1.5	11.4	11.6	43.5	40.5	64.3	0.4	126.9	3.1	7.4	174.8	12.9	31.1	11.2	26.0	2.2	298.2	0.0	0.6	183.5	26.4	254.2	85.4	2.2	4.4	154.1	1.8	25.3	150.7	0.2	41.2	3.5	0.9	146.0	181.6	3.0	3.5	4.4	20.6	1.4	15.4	0.6	19.7	1.6	6.2	0.1	0.7	8.8	1.7	3.7	19.6	86.2	126.7	31.1
LHPP	HDHD2B	ENSG00000107902	"Phospholysine phosphohistidine inorganic pyrophosphate phosphatase"	Q9H008	10	124461823-124617888	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 198.8;choroid plexus: 104.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 114.9;Late spermatids: 163.3;Proximal tubular cells: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009163, HPA009269"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA		820000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles, Cytosol"		"HPA009163: AB_1079250, HPA009269: AB_1079249"	"unprognostic (3.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.77e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.64e-1)"	12.9	32.0	135.1	8.2	173.7	10.5	13.0	159.3	190.6	18.5	104.0	27.1	23.4	20.2	13.4	24.1	10.0	10.2	17.5	129.7	156.5	28.4	60.2	9.2	11.8	179.2	165.8	9.0	15.9	9.2	14.5	8.6	170.7	14.0	8.5	7.5	18.3	12.5	10.2	15.3	21.1	10.2	151.1	14.0	20.1	24.2	156.3	9.7	29.4	4.8	15.2	14.7	16.1	198.8	24.7	12.0	4.7	12.1	18.2	14.7	12.8	8.2	18.0	5.5	10.0	2.1	22.4	24.4	19.7	13.5	6.1	26.1	1.4	4.7	5.7	5.4	16.3	17.6	4.1	11.4	18.5	3.6	27.6	11.0	20.0	5.4	13.0	16.0	8.8	21.4	8.9	9.5	6.9	24.5	12.0	11.3	8.5	10.4	6.8	12.4	5.3	31.8	12.1	3.2	2.7	14.2	6.3	22.6	8.2	6.5	17.2	0.6	4.2	8.5	12.2	7.2	2.3	7.9	2.5	7.8	7.7	6.8	2.0	8.1	28.8	25.3	16.1	24.5	20.8	41.0	18.7	17.2	35.6	43.3	22.4	16.0	4.8	7.9	29.0	13.4	32.1	24.4	135.1	173.7	159.3	190.6	129.7	156.5	179.2	165.8	170.7	151.1	156.3	198.8	5.0	3.2	14.8	22.9	29.1	7.4	9.4	22.1	13.1	6.0	19.8	19.8	15.8	12.8	19.4	7.3	0.0	54.2	6.2	17.9	33.2	5.3	114.9	17.7	12.7	4.6	9.5	19.8	29.4	2.3	24.7	11.2	19.9	8.2	10.8	23.3	6.1	61.1	26.5	11.8	27.8	21.3	24.4	16.0	8.1	163.3	5.9	12.9	17.8	8.4	15.6	9.8	8.2	15.6	76.4	3.3	30.2	10.5	19.7	6.7	80.5	93.8	24.9	6.4	13.1	5.2	9.5	33.1	11.3	30.7	5.4	24.2	12.1	12.4	23.0	16.3
LHX5		ENSG00000089116	"LIM homeobox 5"	Q9H2C1	12	113462033-113472280	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 5.0"	"Cell type enhanced"	"Detected in single"		"Basal respiratory cells: 1.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA053908			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA053908: AB_2682304"		"unprognostic (5.20e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.19e-2)"		"unprognostic (1.06e-2)"		"unprognostic (1.95e-1)"	"unprognostic (4.56e-1)"			"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.10e-2)"	"unprognostic (7.54e-3)"	0.0	0.0	0.4	0.0	0.3	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	5.0	1.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.7	0.1	0.0	1.9	5.0	1.5	1.7	1.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0
LIG3	"LIG2, LIG3alpha"	ENSG00000005156	"DNA ligase 3"	P49916	17	34980512-35009743	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006723	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA006723: AB_1847781"	"unprognostic (6.05e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.71e-2)"	4.9	6.4	3.2	7.3	3.3	7.1	8.7	3.8	4.4	7.9	4.7	8.2	5.9	12.5	6.4	8.9	11.9	5.3	7.6	3.4	1.9	6.6	6.3	5.2	7.2	2.2	2.0	11.5	8.7	13.7	6.6	8.3	1.8	11.1	9.0	7.2	10.6	9.0	10.6	8.4	6.7	10.2	1.0	7.6	6.6	21.1	2.1	13.9	10.1	9.3	8.5	8.9	7.2	3.1	16.6	32.6	38.3	33.9	7.4	9.3	29.2	15.7	11.4	20.9	20.8	15.8	8.8	27.0	12.7	20.6	20.5	15.2	43.9	20.3	26.7	12.8	29.4	28.4	14.6	23.2	11.7	44.9	48.1	7.0	17.5	15.5	24.0	10.3	25.6	40.8	45.3	30.2	15.2	18.6	56.7	14.1	36.8	20.6	13.7	30.4	35.2	28.6	10.2	17.7	31.2	22.3	23.6	19.0	15.2	55.9	34.5	22.3	12.3	13.5	16.8	16.8	25.6	27.0	31.5	35.1	9.7	20.9	26.5	0.6	3.4	4.2	4.6	5.1	6.7	3.7	3.1	4.1	8.4	3.0	4.1	3.0	0.3	9.3	2.8	4.9	2.1	3.9	3.2	3.3	3.8	4.4	3.4	1.9	2.2	2.0	1.8	1.0	2.1	3.1	7.6	3.2	10.3	1.6	8.0	5.0	10.5	3.6	12.0	18.2	10.0	7.5	10.1	10.0	9.2	12.9	16.7	14.6	11.9	7.0	9.8	6.7	41.8	18.5	11.9	8.5	6.7	8.2	5.0	6.0	17.8	7.3	16.8	15.8	9.5	16.7	3.6	8.9	7.9	16.8	5.2	7.9	8.2	5.3	2.7	80.0	7.2	6.7	3.6	2.8	6.4	7.6	16.5	4.0	5.8	3.6	7.5	7.9	15.4	11.6	6.8	6.5	5.3	17.7	6.6	11.8	7.0	32.7	13.2	11.2	5.3	21.6	8.9	10.8	9.5	10.2
LIMS1	"PINCH, PINCH1"	ENSG00000169756	"LIM zinc finger domain containing 1"	P48059	2	108534355-108687246	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 379.6;Macrophages: 405.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 402.5"									"HPA058455, HPA061230"	Approved		Approved	"Focal adhesion sites,Cytosol"		NA	NA		10000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Focal adhesion sites"	"HPA058455: AB_2683723, HPA061230: AB_2684456"	"unprognostic (1.79e-1)"	"unprognostic (8.82e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.95e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (7.51e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.11e-1)"	41.0	45.0	7.0	33.8	10.4	32.9	28.9	9.4	8.4	22.7	10.8	22.1	16.7	35.8	11.6	26.9	31.5	31.2	38.0	6.9	11.4	16.7	20.1	37.0	37.9	12.9	11.0	20.5	15.0	12.0	8.0	32.2	12.8	19.5	18.0	11.5	17.6	26.7	99.1	14.2	20.0	35.8	11.3	21.0	22.2	16.8	15.0	21.4	24.8	35.8	32.8	30.0	17.6	15.9	44.7	49.0	19.0	22.8	30.8	44.5	91.6	49.0	56.0	37.1	37.6	85.3	93.7	43.1	145.4	63.0	55.0	28.3	29.0	50.2	49.3	106.7	52.0	225.6	32.1	45.8	70.4	42.7	402.5	43.5	45.5	98.3	80.3	44.2	135.9	37.3	81.0	58.2	115.4	36.5	41.4	31.4	37.5	29.0	49.6	52.2	65.9	35.0	70.2	79.5	34.3	46.3	76.6	32.5	34.5	25.0	16.8	39.6	184.2	166.6	75.6	37.5	101.2	56.4	81.6	60.6	139.3	47.6	43.6	211.9	69.6	196.2	16.6	119.3	30.5	18.7	72.3	22.4	59.4	18.0	19.2	7.3	31.6	35.9	156.2	7.7	89.0	140.3	7.0	10.4	9.4	8.4	6.9	11.4	12.9	11.0	12.8	11.3	15.0	15.9	143.5	99.3	55.6	80.6	43.2	74.1	63.0	65.1	63.7	26.2	34.9	37.0	61.6	38.6	53.4	29.5	54.2	45.1	40.6	19.2	39.2	80.9	22.5	266.8	122.9	187.6	118.1	84.5	32.6	233.5	130.3	109.4	32.6	379.6	101.4	107.0	76.1	34.6	189.0	15.2	34.6	24.0	48.8	181.1	265.4	12.0	81.4	405.4	44.4	115.2	118.5	69.2	41.2	54.3	66.8	122.3	17.2	88.0	76.3	82.1	33.5	44.0	84.8	18.8	65.7	116.2	161.2	45.4	51.1	75.2	77.0	27.9	82.4	51.3	32.4	66.4
LIMS3		ENSG00000256977	"LIM zinc finger domain containing 3"	P0CW19	2	109898428-109924868	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 6.5;fallopian tube: 6.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.6;Distal tubular cells: 1.9;Exocrine glandular cells: 1.2;NK-cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 12.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 14.1;HMC-1: 41.3"									HPA058455	Uncertain		Approved	"Focal adhesion sites,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	"Focal adhesion sites"	"HPA058455: AB_2683723"										"unprognostic (2.23e-2)"								1.2	1.7	0.2	2.6	0.2	0.4	0.7	0.2	0.4	1.3	0.2	0.5	0.7	6.5	1.7	1.6	6.4	1.3	1.9	0.2	0.3	2.8	0.2	0.5	0.6	0.4	0.3	2.3	0.9	0.5	0.6	1.5	0.4	0.5	1.2	0.4	1.0	1.0	5.7	0.2	0.8	1.5	0.2	0.5	0.7	1.2	0.3	1.0	0.6	2.0	0.4	1.7	0.3	0.5	0.1	0.1	1.8	2.1	0.7	0.6	0.0	2.2	0.0	0.4	0.9	2.2	0.0	0.0	6.5	0.4	4.2	1.2	0.0	2.6	1.8	3.5	0.0	14.1	0.6	1.3	1.9	2.5	41.3	3.0	1.5	1.6	1.9	0.0	3.5	0.0	3.0	2.3	4.6	0.1	0.0	0.3	2.2	1.4	0.8	2.6	4.4	1.5	1.2	2.2	0.6	5.0	5.7	0.0	1.2	0.1	0.0	0.7	10.4	8.8	8.1	4.6	0.4	0.0	0.0	2.8	1.2	0.0	2.6	5.6	3.2	12.3	0.7	5.4	1.4	0.6	4.7	1.5	2.4	0.2	0.8	0.3	0.6	1.2	5.7	0.2	6.1	8.5	0.2	0.2	0.2	0.4	0.2	0.3	0.4	0.3	0.4	0.2	0.3	0.5	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.3	0.1	0.6	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1
LIN54	"CXCDC1, DKFZp686L1814, JC8.6, MIP120, TCX1"	ENSG00000189308	"Lin-54 DREAM MuvB core complex component"	Q6MZP7	4	82909973-83012926	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.2;Oligodendrocytes: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 117.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056606	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA056606: AB_2683187"	"unprognostic (2.01e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.56e-3)"	"unprognostic (6.04e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.60e-2)"	"prognostic favorable (1.06e-4)"	"unprognostic (3.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.81e-2)"	3.8	3.4	2.6	4.9	4.4	13.1	4.9	5.4	5.1	5.3	0.2	6.0	5.4	4.4	3.8	10.5	3.7	3.9	4.4	2.9	3.2	6.9	8.2	3.9	6.5	4.7	3.5	5.0	2.7	5.9	2.0	6.2	4.2	3.9	6.9	10.0	3.4	4.4	4.4	5.4	4.3	4.5	3.6	4.7	4.5	6.9	3.1	12.8	10.3	5.8	8.6	4.7	3.4	7.8	16.8	9.8	15.1	17.3	7.8	7.5	11.2	26.7	18.5	19.8	18.9	11.7	18.9	18.3	14.4	27.6	13.0	12.9	20.8	8.7	24.1	19.9	9.1	16.8	14.7	13.2	6.8	20.7	117.8	6.3	5.0	21.7	10.4	6.1	12.2	17.0	18.6	35.5	19.4	11.9	44.3	8.6	6.3	20.6	6.5	23.9	16.8	12.8	9.4	14.3	15.7	8.3	16.2	25.7	10.6	9.4	11.2	13.3	9.6	23.6	17.6	22.1	12.2	17.6	14.0	30.6	13.1	12.8	18.9	3.5	2.5	5.5	3.7	2.0	4.2	1.6	3.7	4.2	1.5	2.1	4.6	3.9	5.4	4.7	6.6	1.1	4.7	2.4	2.6	4.4	5.4	5.1	2.9	3.2	4.7	3.5	4.2	3.6	3.1	7.8	7.5	6.4	5.5	10.7	7.2	12.1	3.6	2.4	9.6	8.5	5.5	5.2	6.1	4.3	3.3	5.5	2.1	4.3	8.9	11.3	0.0	3.1	37.2	7.1	6.0	4.9	4.2	15.2	23.4	3.6	4.8	4.9	6.6	12.9	2.5	5.7	5.7	7.5	6.5	5.0	22.1	4.9	2.0	6.3	7.8	14.2	2.5	8.2	8.8	12.2	4.4	7.3	7.2	18.1	60.3	4.0	3.4	4.9	17.2	3.8	4.7	6.2	4.4	8.6	13.1	6.4	6.9	3.1	3.1	14.0	12.5	3.4	9.1	3.5	5.2	8.2
LINGO3	"LERN2, LRRN6B"	ENSG00000220008	"Leucine rich repeat and Ig domain containing 3"	P0C6S8	19	2289784-2292024	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 34.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 39.5;Oligodendrocyte precursor cells: 17.1"	"Cancer enhanced"	"Detected in some"		"glioma: 1.4"	"Region enhanced"	"Detected in all"		"basal ganglia: 34.1"	"Group enriched"	"Detected in some"	5	"basophil: 1.3;eosinophil: 4.0;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.0"	"Group enriched"	"Detected in some"	5	"HMC-1: 17.4;RPMI-8226: 4.5"	"Region enhanced"	"Detected in all"		"basal ganglia: 59.6"	"Group enriched"	"Detected in many"	8	"basal ganglia: 28.8;cerebellum: 19.6;hippocampal formation: 8.4"	"HPA043781, HPA059558"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"HPA043781: AB_2678668, HPA059558: AB_2684062"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.16e-3)"	"unprognostic (3.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.61e-3)"	"unprognostic (3.53e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.03e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.14e-2)"	0.3	0.2	4.6	1.2	34.1	1.1	0.2	9.3	14.4	0.2	0.0	0.6	0.2	0.3	0.0	0.3	0.3	0.0	0.1	4.6	1.2	0.2	0.2	0.9	1.1	5.1	1.8	0.1	0.2	0.0	0.4	0.0	4.1	0.4	0.0	0.6	0.3	0.0	0.1	0.2	5.0	0.0	2.6	6.3	0.5	0.4	7.6	0.0	0.3	0.0	0.0	0.4	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	2.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	2.4	0.2	0.0	0.1	1.7	0.0	4.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.3	0.0	4.0	0.1	0.0	0.2	0.3	0.0	0.1	0.0	0.4	0.0	0.0	1.4	0.1	0.0	0.0	0.3	0.0	4.6	34.1	9.3	14.4	4.6	1.2	5.1	1.8	4.1	2.6	7.6	2.7	0.0	0.0	0.0	1.6	3.1	0.1	0.0	0.0	0.0	39.5	0.2	0.6	0.7	0.0	0.0	0.0	4.2	0.0	2.0	0.0	0.0	0.1	0.4	0.0	0.0	0.3	0.0	0.4	5.1	0.0	0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.2	3.3	3.0	0.0	0.0	2.2	0.6	0.0	0.0	0.8	0.0	1.9	1.3	0.1	5.2	17.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.9	1.1	0.0	0.0	0.0	1.0	0.0	0.2	0.0
LIPF	"HGL, HLAL"	ENSG00000182333	"Lipase F, gastric type"	P07098	10	88664441-88678814	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	142	"stomach 1: 37213.5"	"Cell type enriched"	"Detected in some"	444	"Gastric mucus-secreting cells: 1509.7"	"Cancer enriched"	"Detected in some"	75	"stomach cancer: 278.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 4.1;MOLT-4: 3.4;NTERA-2: 3.4;REH: 2.1;RPMI-8226: 1.8;THP-1: 6.8;U-2 OS: 2.2;U-266/70: 3.1"	"Region enriched"	"Detected in single"	77	"olfactory bulb: 7.6"					HPA045930	Enhanced				"Secreted to digestive system"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA045930: AB_10959518"										"unprognostic (1.53e-1)"				"unprognostic (1.83e-1)"				6.3	2.8	0.0	0.0	0.0	0.0	4.6	0.1	0.0	3.9	0.0	13.0	262.0	1.9	0.0	117.9	5.4	0.0	3.2	0.0	0.0	11.4	4.9	7.3	0.0	0.3	0.1	2.2	4.5	0.0	7.3	0.5	0.1	6.7	0.0	0.0	2.6	0.0	1.6	2.0	1.9	0.0	0.0	2.6	37213.5	2.9	0.0	0.0	1.3	0.0	0.1	2.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	3.4	0.0	0.0	2.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	2.2	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1509.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LPAR2	"EDG-4, EDG4, LPA2"	ENSG00000064547	"Lysophosphatidic acid receptor 2"	Q9HBW0	19	19623655-19628930	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 76.0"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 73.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA019616	Approved					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA019616: AB_1847988"	"unprognostic (1.60e-2)"	"unprognostic (1.83e-3)"	"unprognostic (6.39e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.05e-3)"	"unprognostic (8.07e-2)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (1.61e-7)"	"prognostic favorable (1.43e-4)"	"unprognostic (2.40e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.29e-2)"	10.3	3.3	6.6	18.7	6.5	51.9	8.2	5.5	9.2	9.4	7.9	12.9	9.6	4.3	2.5	15.9	10.6	13.0	3.7	7.1	8.5	11.0	6.5	28.5	17.1	8.2	8.0	10.4	27.6	7.8	10.0	4.2	8.1	17.8	7.8	1.7	17.2	4.3	1.4	18.2	23.7	1.9	6.8	76.0	33.6	49.5	9.4	10.0	18.4	1.5	14.7	10.8	11.3	8.5	31.4	3.4	35.7	8.0	9.1	4.4	30.2	2.0	2.9	1.4	2.6	22.0	29.6	19.8	19.5	2.9	1.8	32.1	5.6	11.0	1.4	8.5	9.2	4.4	6.9	1.7	1.2	7.4	73.3	4.9	26.9	1.4	2.0	5.0	0.8	9.7	4.4	7.7	1.2	51.4	4.5	12.3	35.3	42.0	14.2	19.6	2.9	9.1	22.1	45.5	12.6	23.0	8.2	6.6	4.9	19.6	16.9	47.0	9.1	6.8	5.7	12.0	3.0	3.4	10.7	6.8	1.5	53.3	3.4	0.2	1.0	3.8	9.2	1.1	16.2	5.5	20.7	11.8	0.7	2.7	18.2	13.5	10.1	2.8	1.7	1.8	25.7	6.3	6.6	6.5	5.5	9.2	7.1	8.5	8.2	8.0	8.1	6.8	9.4	8.5	0.9	3.2	7.2	0.7	7.1	6.2	11.7	12.4	9.1	0.3	9.7	10.8	2.2	5.7	9.9	7.3	2.1	1.0	6.6	12.2	3.9	14.3	0.4	10.2	2.4	1.0	2.4	3.2	1.9	20.1	6.0	1.9	39.3	18.3	3.8	6.9	1.1	0.6	2.5	1.7	2.2	11.5	6.1	5.6	4.0	2.1	0.6	8.3	0.0	5.6	6.4	4.7	2.1	1.0	0.1	16.9	7.1	0.4	8.7	14.9	10.1	0.7	6.0	1.4	0.0	0.4	2.1	1.3	4.2	7.2	5.1	0.1	20.4	0.2	7.6	11.2
LPAR5	"GPR92, GPR93, KPG_010, LPA5"	ENSG00000184574	"Lysophosphatidic acid receptor 5"	Q9H1C0	12	6618835-6635960	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 20.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 26.5;Hofbauer cells: 38.0;Microglial cells: 33.7;Proximal enterocytes: 18.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 18.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 83.8;T-cells: 66.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 10.5;HEL: 19.6;HMC-1: 26.0;K-562: 14.8;OE19: 9.4;U-698: 13.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA013170	Approved					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA013170: AB_1849314"	"unprognostic (1.94e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.27e-2)"	"unprognostic (7.99e-3)"	"unprognostic (5.43e-1)"	"prognostic favorable (6.56e-5)"	"unprognostic (7.43e-2)"	1.9	2.5	6.0	5.3	6.1	1.0	1.3	6.1	5.9	5.8	3.4	8.9	9.7	0.5	2.7	20.9	1.6	1.7	4.1	5.4	6.8	0.7	1.3	1.9	8.9	10.3	8.9	0.7	0.5	0.8	1.0	5.4	9.4	1.0	8.3	0.2	5.5	1.3	0.2	6.9	8.9	1.0	10.2	9.3	7.2	1.6	11.8	2.6	1.6	0.1	12.4	2.1	9.6	14.4	5.8	0.7	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	10.5	4.3	1.3	0.0	0.1	7.0	0.0	3.2	0.0	0.0	0.0	19.6	0.6	0.4	0.0	0.0	26.0	0.0	3.5	0.1	1.5	0.0	0.0	4.0	14.8	0.0	0.0	0.5	0.6	6.1	0.1	9.4	1.0	4.8	0.0	0.0	0.0	3.3	0.1	0.1	3.0	0.0	0.0	1.1	0.0	2.2	0.1	0.0	3.9	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	10.4	0.3	0.1	66.8	3.4	51.2	83.8	11.2	40.2	17.3	82.7	10.8	24.6	0.8	4.6	6.1	1.1	18.0	20.1	6.0	6.1	6.1	5.9	5.4	6.8	10.3	8.9	9.4	10.2	11.8	14.4	0.2	0.0	0.0	0.0	26.5	1.5	0.4	3.9	1.8	0.0	0.6	0.5	2.8	1.5	4.4	1.8	0.0	0.3	2.8	16.9	0.0	0.3	4.9	0.4	0.1	1.5	1.2	0.8	0.2	0.9	0.2	0.6	3.6	0.7	16.5	0.0	1.1	0.2	38.0	0.0	0.3	11.1	2.0	15.6	7.0	14.5	0.0	13.9	0.0	33.7	4.6	0.1	17.5	0.5	0.1	9.4	16.8	0.0	2.7	0.7	18.4	0.1	0.6	0.1	0.0	0.1	0.2	0.6	1.4	10.3	1.3	0.5	6.9	0.0	13.0	2.2
LPCAT2	"AGPAT11, AYTL1, FLJ20481, LysoPAFAT"	ENSG00000087253	"Lysophosphatidylcholine acyltransferase 2"	Q7L5N7	16	55509072-55586666	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.3;thyroid gland: 86.3"	"Cell type enhanced"	"Detected in many"		"granulocytes: 173.3;Microglial cells: 224.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 23.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 151.4;eosinophil: 199.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 199.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 115.9;HaCaT: 89.2;HL-60: 103.0;HMC-1: 161.7;hTERT-RPE1: 162.9;WM-115: 117.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007891, HPA008433"	Enhanced	Supported	Supported	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Endoplasmic reticulum"	"Lipid droplets"	"HPA007891: AB_1845223, HPA008433: "	"unprognostic (1.43e-1)"	"unprognostic (2.44e-2)"	"prognostic favorable (3.43e-4)"	"prognostic favorable (8.03e-6)"	"unprognostic (2.91e-1)"	"unprognostic (9.65e-3)"	"unprognostic (8.12e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.18e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	9.8	9.0	5.6	14.4	7.7	88.3	12.2	10.6	5.2	14.0	10.7	9.0	7.4	18.5	36.7	7.8	8.8	10.5	5.7	4.8	8.5	10.9	3.9	10.4	5.0	13.7	8.5	15.8	5.4	13.6	1.0	16.0	15.9	7.0	9.3	7.7	8.4	28.6	2.2	12.0	9.1	15.0	12.7	11.8	9.0	4.1	7.9	3.5	86.3	5.8	4.0	9.5	7.5	22.4	33.5	4.2	3.5	0.3	10.8	4.1	5.6	14.1	13.5	6.8	6.9	7.5	115.9	0.0	46.6	19.9	5.5	89.2	2.2	19.4	10.9	9.1	9.6	34.2	10.2	17.3	4.1	103.0	161.7	2.1	19.2	7.5	6.3	162.9	53.5	1.8	1.5	0.4	11.6	2.1	0.0	41.8	5.1	9.5	0.4	10.4	3.8	5.1	6.8	12.9	2.2	25.3	27.1	10.8	19.9	15.8	4.6	25.8	60.3	0.3	0.1	6.9	9.6	0.6	0.2	0.2	0.5	49.4	117.8	151.4	17.5	199.2	0.0	27.4	0.0	0.0	0.0	0.0	21.0	0.1	0.0	0.0	47.0	0.0	39.1	0.7	0.0	6.5	5.6	7.7	10.6	5.2	4.8	8.5	13.7	8.5	15.9	12.7	7.9	22.4	68.6	6.4	25.7	2.9	1.1	15.4	37.2	68.3	17.1	5.5	8.8	33.9	2.2	4.3	22.3	68.0	10.4	0.7	3.3	7.0	1.9	8.3	1.7	6.4	4.8	41.0	1.2	9.7	8.1	9.7	7.5	20.7	10.2	13.9	173.3	0.4	12.1	2.0	36.5	0.0	11.7	12.2	18.3	71.9	57.7	3.1	16.4	74.4	17.8	224.9	40.6	24.0	0.0	4.5	66.5	32.8	23.0	12.8	1.0	9.0	3.4	3.5	8.1	5.3	0.0	20.0	4.2	49.6	24.0	14.2	15.3	1.9	5.6	7.0	11.6	17.6
LPIN1	KIAA0188	ENSG00000134324	"Lipin 1"	Q14693	2	11677595-11827409	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 193.5;tongue: 137.2"	"Cell type enriched"	"Detected in all"	5	"Late spermatids: 1705.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024591, HPA038021"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Plasma membrane"	"HPA024591: , HPA038021: AB_10669514"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.02e-1)"	36.2	15.0	29.0	14.9	30.6	8.6	36.7	24.2	24.9	25.1	21.9	16.7	11.9	16.6	19.0	40.5	15.6	13.0	20.1	21.0	32.1	14.9	27.0	16.1	22.3	31.8	38.2	31.5	9.9	23.1	34.2	11.7	35.3	13.7	8.5	14.8	27.3	14.1	193.5	13.4	19.7	13.0	14.1	14.8	14.9	57.4	35.0	16.1	14.6	137.2	26.3	19.9	23.1	18.8	16.2	18.0	15.9	34.9	71.4	77.9	7.8	22.2	38.7	14.0	24.3	6.9	15.4	8.2	2.9	18.6	41.6	17.3	17.4	49.2	12.8	32.9	9.8	20.3	11.5	9.7	25.1	14.1	90.1	71.1	21.7	57.9	22.6	41.7	28.0	19.6	27.4	68.3	10.4	6.4	13.5	12.0	16.2	5.5	18.9	18.1	28.6	52.0	36.9	10.0	42.8	33.6	8.0	19.7	51.9	15.0	4.9	7.9	19.5	22.1	19.9	14.4	19.0	108.0	92.0	15.2	31.3	24.7	16.6	11.2	2.9	13.4	10.3	2.3	11.2	7.3	9.9	10.1	2.7	5.1	8.6	7.2	1.1	9.5	2.3	10.3	12.2	3.7	29.0	30.6	24.2	24.9	21.0	32.1	31.8	38.2	35.3	14.1	35.0	18.8	15.6	22.4	56.8	167.8	46.1	19.1	45.1	12.6	18.8	48.6	32.8	22.9	59.6	31.5	43.9	11.0	85.5	8.7	68.0	21.2	7.9	23.0	338.4	27.8	44.4	25.8	36.2	9.7	55.7	28.0	6.0	28.8	19.4	76.5	35.4	13.1	17.5	48.7	8.9	48.8	71.7	25.2	22.4	15.7	39.4	1705.8	119.0	25.5	17.8	21.5	15.4	14.7	66.9	41.7	43.5	36.5	29.7	179.8	76.0	34.9	5.4	4.8	52.0	49.0	32.9	32.4	18.4	20.6	19.7	5.5	11.9	12.3	73.2	26.6	16.3	31.3
LPXN	LDPL	ENSG00000110031	Leupaxin	O60711	11	58526871-58578220	"Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 118.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 75.9;dendritic cells: 80.7;Langerhans cells: 154.6;Macrophages: 81.7;Plasma cells: 82.2;T-cells: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 200.7;HMC-1: 329.3;Karpas-707: 285.0;U-2197: 199.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043741, CAB046478, HPA061441"	Enhanced		Supported	"Nuclear speckles,Focal adhesion sites,Cytosol"		No	No			"Cluster 13: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Focal adhesion sites"	"Nuclear speckles, Cytosol"	"CAB046478: AB_10603113, HPA043741: AB_2678647, HPA061441: AB_2684518"	"unprognostic (1.61e-3)"	"unprognostic (6.91e-2)"	"unprognostic (6.54e-2)"	"prognostic favorable (8.81e-4)"	"unprognostic (5.16e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.87e-3)"	"unprognostic (5.18e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.41e-3)"	10.4	8.3	7.5	48.3	8.2	10.2	10.2	7.8	11.8	7.9	4.5	14.5	10.9	7.4	11.9	5.2	7.6	15.1	5.3	7.1	7.8	10.6	14.0	33.5	87.1	9.1	8.8	9.5	8.6	6.5	7.2	5.2	10.2	9.4	19.6	7.0	11.0	7.1	3.8	5.9	26.2	9.7	8.6	44.1	13.0	10.2	10.0	103.3	10.2	5.1	118.5	32.4	6.0	10.9	1.7	2.1	2.0	3.9	7.4	9.3	1.4	50.5	200.7	12.4	22.0	0.4	5.1	149.8	2.0	61.9	9.2	2.0	1.7	137.7	51.4	65.4	0.9	6.8	1.3	1.0	12.8	41.1	329.3	7.2	3.2	170.8	22.0	12.0	80.9	90.0	1.9	285.0	101.5	1.1	144.8	51.6	1.6	2.3	45.8	2.1	2.5	129.2	8.3	71.2	1.0	1.6	2.2	3.2	20.1	2.8	2.7	11.7	79.8	30.8	9.5	199.5	45.9	18.4	18.9	146.5	71.6	36.8	71.6	6.3	74.3	12.2	101.3	41.8	148.9	71.9	102.9	117.6	137.5	46.2	79.6	95.9	14.1	79.2	22.2	124.4	152.1	98.8	7.5	8.2	7.8	11.8	7.1	7.8	9.1	8.8	10.2	8.6	10.0	10.9	4.1	0.0	6.7	22.9	75.9	9.7	6.6	7.2	3.4	4.1	4.0	4.7	2.3	4.3	2.8	0.0	4.2	2.8	80.7	4.2	3.9	2.5	23.0	2.8	1.9	5.9	6.1	13.3	18.2	5.6	1.3	6.6	13.3	2.3	51.5	5.4	2.5	7.6	44.0	1.7	19.8	3.1	6.1	63.7	154.6	8.7	1.8	81.7	19.6	30.0	52.9	2.8	49.4	11.6	27.3	4.1	5.2	3.8	82.2	3.6	6.9	5.7	4.3	4.4	6.6	3.6	3.8	9.2	4.2	2.6	9.7	2.5	90.3	2.9	5.2	27.6
LRRC25	"FLJ38116, MAPA"	ENSG00000175489	"Leucine rich repeat containing 25"	Q8N386	19	18391137-18397622	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 32.4;lymphoid tissue: 61.2"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 47.0;Kupffer cells: 123.6;Macrophages: 90.0;monocytes: 74.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 320.6;eosinophil: 356.2;intermediate monocyte: 512.1;myeloid DC: 229.3;neutrophil: 573.0;non-classical monocyte: 706.7"	"Group enriched"	"Detected in all"	60	"dendritic cells: 229.3;granulocytes: 573.0;monocytes: 706.7"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.0;HMC-1: 1.8;THP-1: 1.7;U-937: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029459	Approved		Approved	"Endoplasmic reticulum,Microtubules,Cytosol"		NA	NA		630000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Endoplasmic reticulum, Microtubules, Cytosol"		"HPA029459: AB_10610005"	"unprognostic (2.72e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.77e-2)"	"unprognostic (9.15e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-3)"	"unprognostic (5.77e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (1.74e-1)"	"unprognostic (1.14e-1)"	9.4	9.4	2.4	21.8	2.5	32.4	3.1	3.3	2.9	1.8	3.2	3.3	3.7	1.6	0.7	2.3	3.9	5.3	2.5	2.3	3.1	2.4	5.9	11.5	9.9	4.6	4.0	1.5	2.0	0.7	1.2	5.4	4.2	2.0	2.8	0.3	2.6	1.2	3.7	1.0	4.8	6.7	2.8	61.2	2.3	1.2	5.4	3.0	1.2	8.7	4.0	7.0	1.3	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.3	1.0	0.8	0.4	1.8	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.7	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.2	1.5	0.1	55.4	320.6	356.2	0.9	512.1	1.9	7.3	0.6	0.7	229.3	8.4	0.5	0.6	573.0	4.6	706.7	32.1	1.3	229.2	2.4	2.5	3.3	2.9	2.3	3.1	4.6	4.0	4.2	2.8	5.4	4.7	0.7	0.0	1.3	0.0	5.0	0.0	0.1	0.1	0.0	0.1	0.3	1.0	0.3	0.0	0.7	0.0	0.0	0.1	2.9	0.1	5.9	0.1	1.9	0.2	0.1	0.9	0.0	2.1	0.1	0.0	0.4	0.5	0.0	0.4	10.2	0.0	1.8	0.5	47.0	0.0	0.1	0.0	0.0	123.6	12.5	0.5	0.0	90.0	1.8	1.0	74.9	0.0	6.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	2.4	0.2	0.0	0.2	0.0	0.1	0.4	1.1	0.2	0.1	0.1
LTC4S	MGC33147	ENSG00000213316	"Leukotriene C4 synthase"	Q16873	5	179793980-179796647	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Leukotriene biosynthesis, Lipid biosynthesis, Lipid metabolism"	"Lyase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"granulocytes: 327.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 20.2;eosinophil: 63.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 63.1"	"Cell line enriched"	"Detected in some"	11	"HMC-1: 102.0"					"Low region specificity"	"Detected in many"			HPA044688			Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Endoplasmic reticulum, Cytosol"	"HPA044688: "	"unprognostic (8.94e-2)"	"unprognostic (2.40e-2)"			"unprognostic (9.35e-3)"		"unprognostic (3.57e-2)"	"unprognostic (1.24e-2)"		"unprognostic (9.40e-2)"	"unprognostic (4.53e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.62e-1)"	8.9	6.9	1.1	0.5	0.8	2.3	5.5	1.5	1.3	4.2	0.7	3.3	0.7	5.7	0.0	3.1	11.8	0.3	12.4	1.0	1.4	7.1	1.9	7.7	0.2	2.1	1.5	5.7	2.0	0.2	3.5	0.4	1.4	4.8	0.2	0.0	4.3	0.8	1.0	3.1	3.2	0.4	2.9	6.1	3.0	1.5	2.6	0.0	5.9	0.0	0.1	4.8	4.0	4.7	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.9	8.9	0.2	0.4	0.3	0.6	102.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.1	6.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	3.2	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	1.0	0.1	20.2	0.5	63.1	0.8	0.6	3.0	0.3	2.1	1.5	8.6	0.2	0.4	1.0	0.3	4.7	0.0	0.4	0.2	0.6	1.1	0.8	1.5	1.3	1.0	1.4	2.1	1.5	1.4	2.9	2.6	4.7	32.3	0.0	3.2	2.9	2.3	9.9	9.6	11.2	14.8	0.4	26.4	38.6	0.0	14.3	6.2	14.7	0.0	10.4	5.0	0.6	1.9	5.9	0.3	4.0	1.5	49.5	3.0	2.1	0.8	2.4	1.9	8.3	3.1	5.6	327.4	0.5	72.1	0.9	41.5	0.0	0.7	1.7	0.0	20.8	46.3	0.9	16.4	53.9	1.8	28.1	2.0	0.1	2.1	1.0	1.5	1.9	0.5	47.4	10.0	3.7	2.2	54.8	5.8	0.5	0.0	0.8	1.6	0.1	0.7	5.2	7.0	3.0	10.0	1.5	3.1	10.0
LYN	JTK8	ENSG00000254087	"LYN proto-oncogene, Src family tyrosine kinase"	P07948	8	55879835-56014169	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 73.8;lymphoid tissue: 85.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 237.5;Kupffer cells: 183.7;Macrophages: 226.0;monocytes: 182.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 64.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 198.4;HMC-1: 193.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001231, CAB004492"	Enhanced		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		770000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus, Plasma membrane"	Vesicles	"CAB004492: AB_627897, HPA001231: AB_1079286"	"unprognostic (7.87e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.74e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	17.2	7.3	3.9	79.2	4.0	73.8	9.2	7.4	8.7	11.0	7.8	14.2	36.3	6.2	4.8	8.6	10.0	23.5	5.4	4.4	5.5	5.9	14.9	28.2	49.2	9.4	7.2	3.6	9.5	6.3	4.8	23.5	8.3	5.6	13.3	8.9	17.0	9.7	1.6	3.7	31.6	14.2	7.2	85.4	13.3	3.1	9.0	10.4	10.6	4.4	53.1	29.7	5.7	11.2	47.2	24.6	6.9	0.7	0.5	0.0	43.6	34.6	54.7	21.0	15.7	18.0	15.5	41.2	15.0	12.1	15.3	19.3	22.2	23.8	14.6	70.0	19.8	198.4	6.9	5.5	4.0	20.6	193.4	0.8	7.8	0.6	13.6	13.1	27.2	0.0	98.3	90.2	3.0	3.3	0.1	21.5	38.6	72.9	2.1	3.3	9.6	5.0	9.8	24.9	4.5	74.8	17.3	0.1	7.5	44.9	3.4	41.4	33.1	0.0	10.0	0.1	15.0	26.4	13.2	102.4	1.5	38.8	1.7	4.5	12.2	22.7	1.6	28.3	1.3	15.9	0.3	0.6	10.3	16.1	0.2	0.7	64.4	4.3	49.1	16.2	0.0	5.0	3.9	4.0	7.4	8.7	4.4	5.5	9.4	7.2	8.3	7.2	9.0	11.2	21.0	35.3	37.5	27.7	237.5	5.4	23.8	32.4	4.6	6.3	10.3	7.0	2.2	18.6	44.5	9.2	2.1	2.9	130.0	14.5	0.0	21.8	0.9	14.6	26.2	28.1	6.0	40.4	1.1	53.0	65.2	13.6	18.8	15.9	72.8	0.5	22.9	13.2	126.6	0.0	2.5	14.1	14.2	183.7	96.1	2.4	3.4	226.0	5.4	92.8	182.6	54.3	94.7	13.0	1.7	40.7	13.3	1.2	58.9	62.9	26.0	2.1	40.9	2.6	19.7	3.7	6.4	1.2	2.1	4.9	5.8	38.7	25.0	62.5	17.1	82.4
LYPLA1	"APT-1, LPL1"	ENSG00000120992	"Lysophospholipase 1"	O75608	8	54046367-54102017	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 787.7;Late spermatids: 796.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050941, HPA063151"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		330000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA050941: AB_2681284, HPA063151: "	"unprognostic (2.62e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.42e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.56e-3)"	25.8	30.3	8.8	31.8	7.6	43.6	45.0	10.5	12.7	23.3	14.7	42.6	44.4	19.7	16.1	55.0	22.9	25.9	40.9	7.9	10.8	63.4	83.5	25.9	49.0	9.9	9.5	11.7	23.8	40.8	8.8	50.4	9.1	35.0	42.1	45.9	35.5	15.0	54.5	41.4	42.8	24.3	9.7	30.2	35.4	65.1	10.3	28.8	28.4	70.7	52.0	63.1	27.5	10.0	124.0	69.3	85.9	78.7	31.0	49.4	109.8	71.7	41.6	65.0	61.1	53.2	116.7	214.8	83.6	47.2	70.5	80.7	122.8	119.9	89.8	78.9	70.0	148.8	37.9	80.0	50.8	91.4	196.1	44.6	103.8	50.8	114.0	55.6	171.6	91.6	154.5	63.4	91.3	32.7	141.1	69.9	129.3	206.3	31.5	85.3	45.2	99.3	100.2	163.6	45.2	77.6	50.1	93.6	113.4	81.0	137.0	81.7	83.4	39.0	56.9	68.7	67.8	89.3	143.8	194.0	52.9	97.1	78.7	93.7	80.7	111.1	44.8	79.6	44.6	73.0	42.2	43.5	92.3	64.4	42.1	41.1	49.3	69.6	108.2	59.7	75.5	98.3	8.8	7.6	10.5	12.7	7.9	10.8	9.9	9.5	9.1	9.7	10.3	10.0	60.4	28.9	53.3	19.9	83.8	61.7	94.8	96.6	82.6	34.9	103.8	64.0	70.8	57.2	71.8	62.5	52.1	199.7	74.5	70.4	303.3	82.8	787.7	86.6	34.7	69.3	57.5	50.0	30.0	89.0	318.3	36.4	74.9	96.3	49.5	31.5	81.4	120.1	121.0	18.5	43.7	77.3	99.7	108.4	83.3	796.2	28.3	82.6	74.7	25.3	102.1	36.9	69.0	20.6	9.8	127.4	63.7	23.0	104.5	171.0	91.6	194.3	62.9	70.3	46.0	24.5	43.1	92.1	239.1	118.2	81.1	334.2	57.0	94.0	90.2	229.7
MACO1	"FLJ10747, TMEM57"	ENSG00000204178	"Macoilin 1"	Q8N5G2	1	25430858-25500209	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 38.8;Exocrine glandular cells: 62.3;Pancreatic endocrine cells: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019680			Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA019680: AB_1858125"	"unprognostic (2.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (7.13e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (5.35e-3)"	8.5	15.0	11.2	5.3	10.8	28.4	8.7	19.9	14.9	8.6	12.8	8.5	6.2	7.9	12.5	16.1	6.9	7.4	8.4	10.9	11.2	11.8	26.3	8.3	7.8	10.6	9.9	16.2	24.9	9.2	8.9	6.8	11.1	12.3	7.8	11.0	16.3	7.9	30.3	9.6	9.0	7.4	10.5	8.7	11.7	14.1	10.0	11.4	12.4	15.2	9.0	7.3	9.6	12.7	8.6	3.6	9.3	18.0	16.4	10.1	4.3	9.0	11.1	9.2	8.6	2.6	11.0	20.1	10.1	11.9	5.2	8.0	8.8	9.2	10.4	9.4	7.9	26.8	5.7	7.7	9.3	10.1	15.3	10.3	13.3	12.5	8.9	9.7	11.6	12.4	15.8	7.5	9.3	5.0	19.0	13.8	13.2	10.1	7.1	12.1	11.0	15.0	15.0	3.7	15.2	15.5	7.5	19.3	10.9	7.3	7.7	14.3	13.8	9.3	6.2	12.9	6.2	12.1	7.2	10.6	10.5	13.1	7.9	0.5	0.3	1.6	0.3	0.2	0.5	0.4	0.5	0.5	0.2	0.5	0.4	0.7	0.1	0.3	0.3	1.1	0.3	0.2	11.2	10.8	19.9	14.9	10.9	11.2	10.6	9.9	11.1	10.5	10.0	12.7	31.3	19.2	23.6	0.0	9.9	0.0	0.0	0.0	0.0	0.0	27.8	17.8	0.0	0.0	11.2	7.3	0.0	13.7	27.0	0.0	5.9	38.8	0.0	19.4	23.8	12.9	0.0	0.0	0.0	62.3	22.7	9.2	0.0	32.5	10.1	26.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	7.2	0.0	0.0	0.0	0.0	48.6	0.0	0.0	9.8	0.0	0.0	19.6	13.8	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	10.4	11.0	22.7	0.0	0.0
MAN2B1	"LAMAN, MANB"	ENSG00000104774	"Mannosidase alpha class 2B member 1"	O00754	19	12646511-12666742	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 32.8;Plasma cells: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 201.8;intermediate monocyte: 178.8;myeloid DC: 158.8;non-classical monocyte: 138.4;plasmacytoid DC: 187.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 187.5;monocytes: 201.8"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041530, HPA053404"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		3200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Vesicles"		"HPA041530: AB_10795639, HPA053404: "	"unprognostic (6.63e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (4.00e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.51e-1)"	35.8	21.4	5.3	54.6	6.4	83.6	24.8	6.6	5.9	19.6	18.5	30.3	31.0	21.8	9.0	19.8	19.9	28.4	16.0	4.9	7.4	17.3	23.7	46.8	52.1	10.3	6.7	16.7	39.7	16.6	9.9	24.6	9.5	20.5	22.6	1.6	35.2	14.9	12.1	28.9	33.6	20.2	8.9	70.1	32.7	6.4	9.7	23.1	16.3	9.4	39.3	35.6	16.7	12.4	52.4	26.3	26.4	31.3	85.8	57.3	74.0	37.9	79.2	33.1	32.4	21.3	21.4	56.9	44.9	30.4	9.4	40.1	13.6	25.6	15.7	28.5	41.6	19.8	13.6	34.9	43.5	131.6	130.2	68.5	49.2	18.5	23.3	35.6	31.7	21.1	25.6	41.9	17.8	40.9	17.9	74.2	21.9	26.2	32.8	40.8	36.1	28.8	38.9	59.8	8.2	25.5	37.7	32.0	63.0	15.8	49.4	80.0	42.0	44.8	18.4	44.0	36.2	55.4	65.5	28.0	30.4	127.5	51.2	12.2	201.8	29.7	31.9	178.8	35.4	32.9	28.9	29.0	158.8	26.4	15.4	15.9	29.4	13.2	138.4	187.5	30.7	150.3	5.3	6.4	6.6	5.9	4.9	7.4	10.3	6.7	9.5	8.9	9.7	12.4	1.6	6.4	7.5	8.5	25.1	3.6	2.0	2.7	14.2	2.6	1.9	1.0	0.9	2.8	2.0	1.8	0.0	2.5	20.5	2.0	1.9	1.7	3.7	1.4	2.5	3.1	1.8	9.4	7.8	2.3	2.8	7.2	20.9	1.3	1.3	3.4	1.8	0.8	8.4	0.0	6.4	0.9	0.0	15.4	24.7	11.1	3.7	32.8	1.8	17.8	11.0	1.5	9.2	3.5	13.4	1.5	2.5	4.5	78.1	2.5	3.8	1.5	3.9	4.0	13.1	2.3	2.0	0.6	1.6	11.5	3.3	2.7	9.4	2.7	2.0	2.0
MARCHF2	"HSPC240, MARCH-II, MARCH2, RNF172"	ENSG00000099785	"Membrane associated ring-CH-type finger 2"	Q9P0N8	19	8413270-8439017	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.1;Cardiomyocytes: 42.3;Extravillous trophoblasts: 11.6;Hofbauer cells: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014063	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Endoplasmic reticulum"	Cytosol	"HPA014063: AB_1853576"	"unprognostic (1.15e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.48e-4)"	"prognostic favorable (1.05e-5)"	"unprognostic (3.00e-1)"	"prognostic favorable (8.29e-4)"	"unprognostic (3.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.32e-1)"	"prognostic favorable (6.21e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.80e-2)"	65.7	33.0	102.2	20.3	101.5	29.4	49.8	99.5	106.6	24.2	66.4	96.2	15.7	34.4	53.9	32.4	27.1	15.3	101.1	90.9	94.3	35.6	59.1	41.9	19.5	113.7	102.5	15.8	19.2	15.3	30.5	19.8	106.0	40.8	14.0	9.1	25.5	28.8	89.5	34.5	31.4	30.1	109.2	51.2	32.9	18.9	105.1	14.2	47.9	48.6	14.5	49.8	26.1	96.7	11.4	14.2	6.3	29.5	37.9	12.6	10.7	12.3	14.7	9.5	9.8	7.0	5.5	4.4	34.8	26.7	12.6	8.1	8.2	17.5	7.3	22.7	20.3	34.2	6.6	15.9	20.5	5.0	49.6	14.7	20.1	9.2	8.1	13.9	38.2	17.8	4.9	24.5	7.5	21.5	7.0	16.7	13.3	14.0	34.2	11.0	2.0	11.4	22.4	13.9	3.1	17.7	0.8	12.9	24.2	21.5	10.2	10.8	38.9	13.3	8.4	44.5	10.4	21.7	28.2	5.0	21.6	10.2	10.7	52.6	18.5	31.3	10.6	28.6	10.8	7.2	10.6	8.6	13.1	7.3	7.2	9.6	23.4	7.9	25.7	51.8	14.9	17.4	102.2	101.5	99.5	106.6	90.9	94.3	113.7	102.5	106.0	109.2	105.1	96.7	23.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.3	0.0	0.0	0.0	0.0	8.1	9.9	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	11.6	7.7	0.0	0.0	0.0	0.0	0.0	0.0	66.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	5.7	1.5	0.0	0.0	0.0
MAS1		ENSG00000130368	"MAS1 proto-oncogene, G protein-coupled receptor"	P04201	6	159890988-159917447	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"brain: 9.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;B-cells: 2.0;Cone photoreceptor cells: 2.1;Rod photoreceptor cells: 2.1;Urothelial cells: 1.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 5.1;hippocampal formation: 9.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"HMC-1: 7.5"	"Group enriched"	"Detected in many"	22	"amygdala: 38.5;basal ganglia: 26.6;cerebral cortex: 32.4;hippocampal formation: 64.6;white matter: 18.1"	"Group enriched"	"Detected in some"	4	"amygdala: 5.2;cerebral cortex: 8.0;hippocampal formation: 15.1"	HPA079325	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA079325: "	"unprognostic (3.31e-1)"	"unprognostic (2.25e-3)"		"unprognostic (2.91e-1)"	"unprognostic (2.22e-3)"	"unprognostic (8.15e-3)"		"unprognostic (7.05e-2)"		"unprognostic (1.88e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.48e-5)"	"unprognostic (1.69e-1)"	"unprognostic (7.67e-2)"	"unprognostic (6.28e-1)"		0.0	0.0	1.7	0.0	0.7	0.3	0.0	0.0	5.1	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.7	0.0	5.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	3.2	0.6	0.0	2.0	0.0	1.4	0.0	0.0	1.2	0.1	0.3	0.8	0.0	0.6	0.0	2.1	0.2	0.2	0.0	0.0	0.0	0.1	0.4	0.3	0.8	0.0	0.0	0.1	0.0	0.3	0.7	0.0	0.3	0.0	0.4	1.1	0.4	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.9	0.7	0.0	0.0	0.5	0.7	1.0	0.0	0.0	0.1	0.0	0.7	0.0	1.4	0.0	0.3	0.0	2.1	0.0	1.3	1.0	0.4	0.5	0.0	0.0	0.3	0.5	0.2	0.2	1.9
MAX	"bHLHd4, bHLHd5, bHLHd6, bHLHd7, bHLHd8"	ENSG00000125952	"MYC associated factor X"	P61244	14	65006174-65102695	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 390.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000328, HPA003474"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB000328: AB_2281783, HPA003474: AB_1079317"	"unprognostic (4.50e-3)"	"unprognostic (1.51e-3)"	"unprognostic (4.08e-2)"	"unprognostic (2.87e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.36e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.68e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (6.03e-2)"	48.1	36.3	57.4	43.5	63.2	105.1	41.2	74.6	62.9	61.0	44.8	51.1	41.3	51.1	29.2	75.8	67.2	36.2	52.8	55.0	59.4	39.5	36.8	51.6	63.7	65.5	61.8	56.2	29.3	31.3	32.5	39.8	65.0	52.2	31.8	23.6	43.5	38.7	43.8	55.3	51.7	39.5	59.4	66.3	39.4	21.5	62.1	63.7	42.7	54.0	55.1	51.3	68.7	65.3	117.1	40.4	27.8	44.6	73.4	58.0	35.4	39.9	62.3	47.5	58.4	29.1	86.7	88.1	33.1	48.8	45.0	60.4	63.4	52.7	37.3	84.5	40.5	143.4	29.9	32.0	90.9	56.2	390.3	67.6	43.5	42.7	54.9	71.9	54.9	71.8	66.8	42.4	53.1	63.9	140.1	217.6	36.3	71.3	70.6	75.2	42.7	47.3	49.2	38.8	61.8	38.2	49.6	60.6	60.4	25.1	58.0	71.6	69.7	47.8	55.8	42.0	33.6	50.7	43.6	61.7	56.9	56.1	46.0	667.6	141.9	540.8	125.7	126.4	140.1	115.7	147.5	130.5	119.9	114.9	151.1	127.9	305.1	126.9	120.3	114.6	194.0	314.2	57.4	63.2	74.6	62.9	55.0	59.4	65.5	61.8	65.0	59.4	62.1	65.3	45.8	28.9	27.4	31.0	74.5	170.2	66.0	63.3	126.3	28.2	59.8	43.1	27.4	32.9	42.0	18.4	20.9	38.4	79.1	116.3	52.8	38.8	45.5	38.1	43.6	59.9	44.3	40.4	50.7	31.4	43.4	46.7	32.6	36.0	62.8	38.2	71.0	23.8	59.9	47.1	43.3	49.7	38.7	81.8	66.7	115.6	77.9	147.2	56.9	32.8	67.1	47.3	69.0	28.1	60.4	61.6	96.7	60.2	58.0	80.3	100.6	66.4	32.9	16.9	138.1	47.4	76.3	43.2	28.4	84.8	180.6	54.0	83.9	25.4	29.7	76.2
MBOAT7	"BB1, hMBOA-7, LENG4, LPLAT"	ENSG00000125505	"Membrane bound O-acyltransferase domain containing 7"	Q96N66	19	54173412-54189882	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 108.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	9	"basophil: 157.3;eosinophil: 265.9;neutrophil: 239.1"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 265.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 216.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055967	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA055967: AB_2682990"	"unprognostic (1.89e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (5.55e-6)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (5.36e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (1.31e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.95e-1)"	"prognostic favorable (4.31e-4)"	14.9	108.4	17.6	13.4	14.8	13.1	13.7	0.0	21.4	19.0	0.0	27.8	27.0	19.0	6.6	20.6	20.1	9.2	12.8	17.6	34.4	19.2	16.0	23.6	4.8	24.9	27.8	23.0	21.0	18.9	22.8	6.9	29.2	17.3	5.3	1.0	18.6	20.2	7.9	21.1	25.3	4.4	2.7	26.6	19.9	36.3	28.7	3.2	15.9	1.1	2.3	32.5	18.1	4.8	66.8	43.2	3.8	50.8	21.0	15.4	57.1	90.5	42.6	32.9	49.2	22.1	64.3	11.3	46.5	34.4	10.9	111.9	0.3	26.1	9.0	16.1	54.6	12.8	30.0	12.6	18.9	29.0	216.2	31.0	17.9	17.3	9.8	44.1	46.0	11.0	51.6	42.2	9.2	32.2	10.9	22.7	22.0	21.1	60.1	28.4	7.3	24.9	47.0	71.1	2.3	14.3	57.3	37.0	16.3	4.2	34.5	2.8	73.1	49.4	16.0	12.1	40.8	17.4	31.0	6.4	66.1	25.8	27.9	157.3	22.5	265.9	2.2	11.8	3.3	1.8	3.2	1.7	24.8	1.5	1.1	1.7	239.1	7.8	7.0	7.0	1.9	8.6	17.6	14.8	0.0	21.4	17.6	34.4	24.9	27.8	29.2	2.7	28.7	4.8	11.8	12.8	26.4	11.4	11.3	13.9	66.4	29.2	14.8	15.4	31.1	19.8	8.4	31.5	23.2	44.1	6.2	43.5	15.2	88.8	5.9	52.2	1.1	28.7	22.1	18.5	42.5	13.9	18.7	33.1	52.2	16.3	10.7	26.4	76.8	25.3	15.0	22.7	32.2	30.3	13.6	49.6	16.2	36.8	38.1	4.3	19.3	52.5	8.8	8.4	48.9	24.6	3.1	5.5	9.3	28.6	43.0	15.4	9.3	44.5	101.1	14.5	28.5	8.5	39.5	7.7	19.6	5.1	15.0	17.9	21.6	51.6	23.0	46.3	46.6	47.2
MCTP2	"FLJ11175, FLJ33303"	ENSG00000140563	"Multiple C2 and transmembrane domain containing 2"	Q6DN12	15	94231538-94483952	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 72.8;NK-cells: 97.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 6.8"	"Immune cell enhanced"	"Detected in many"		"neutrophil: 32.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 20.8;HMC-1: 16.4;U-698: 22.4;U-87 MG: 24.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051176, HPA070541"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA051176: AB_2681373, HPA070541: AB_2686277"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.15e-4)"	"unprognostic (3.57e-2)"	"unprognostic (2.66e-3)"	"unprognostic (3.45e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (2.18e-5)"	"unprognostic (5.87e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.76e-3)"	"unprognostic (9.41e-2)"	4.1	3.8	1.0	6.6	1.8	18.0	2.9	0.0	6.8	5.4	0.8	10.6	6.9	1.8	8.6	3.9	4.1	4.5	0.6	1.1	2.8	2.3	1.5	8.7	6.1	0.0	0.3	1.6	5.7	3.5	7.3	19.3	1.0	5.4	12.2	2.6	5.9	4.1	0.1	3.6	6.4	1.6	0.0	21.1	4.7	1.0	1.3	3.0	5.5	0.4	6.2	6.6	3.7	0.6	3.6	0.0	0.1	0.0	0.0	0.0	2.5	1.9	1.1	0.3	0.1	2.4	4.4	10.3	0.5	0.1	0.1	8.0	0.1	6.6	0.0	2.1	0.8	20.8	2.9	1.2	1.4	4.4	16.4	1.1	7.8	0.1	8.2	0.0	0.0	3.6	0.8	5.9	0.0	0.0	2.0	11.4	0.8	3.6	3.7	4.7	0.1	4.0	0.5	10.7	1.9	0.4	0.2	3.4	1.3	0.8	0.0	0.3	0.2	0.1	1.7	0.0	0.0	12.0	0.3	22.4	24.1	11.1	1.2	6.6	0.8	12.1	6.1	0.2	3.0	3.5	1.7	2.8	0.0	3.6	0.7	2.7	32.1	10.9	0.9	0.3	0.1	1.9	1.0	1.8	0.0	6.8	1.1	2.8	0.0	0.3	1.0	0.0	1.3	0.6	1.1	3.2	18.6	1.0	38.9	4.2	12.9	8.6	22.8	15.6	3.8	4.3	1.1	7.2	13.2	3.7	0.0	17.0	72.8	39.4	0.0	3.4	4.0	6.5	3.4	1.8	15.6	35.7	15.6	4.7	7.3	7.8	5.6	6.6	36.2	0.3	1.4	1.4	9.6	0.0	10.3	43.8	8.2	8.7	2.1	4.8	0.3	11.1	1.8	25.3	4.7	0.1	97.9	0.0	0.7	4.2	24.6	0.0	45.8	14.2	18.1	1.9	8.7	0.6	0.0	2.5	1.6	3.4	2.5	15.0	2.3	24.5	26.6	0.5	21.5	19.6
MED18	"FLJ20045, p28b, SRB5"	ENSG00000130772	"Mediator complex subunit 18"	Q9BUE0	1	28329002-28335965	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027429	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA027429: AB_10610137"	"unprognostic (2.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.78e-3)"	"prognostic favorable (3.93e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (8.38e-5)"	"prognostic favorable (6.72e-4)"	"unprognostic (9.20e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.69e-2)"	4.9	7.7	1.8	3.9	1.8	2.8	4.9	2.0	2.3	4.0	2.5	9.4	4.2	5.7	3.6	10.0	4.8	2.2	7.0	1.8	2.0	7.6	15.3	3.9	5.6	2.0	1.9	3.3	6.7	2.4	4.6	3.1	2.0	4.8	4.3	1.8	5.8	2.8	9.2	7.2	9.4	2.9	1.8	10.2	7.8	5.8	2.1	3.8	4.1	3.1	6.0	5.6	5.2	2.2	12.6	6.1	6.0	5.2	7.9	7.6	6.7	7.4	8.7	9.4	8.1	3.5	11.6	15.6	7.5	7.6	5.7	7.7	9.7	9.1	7.3	10.6	6.9	12.0	5.4	7.7	10.9	7.3	12.3	8.1	11.0	7.4	11.2	5.6	8.2	7.6	11.6	4.0	8.9	6.1	9.3	9.2	7.1	6.9	3.4	6.7	8.7	8.3	8.3	6.2	5.8	6.1	7.4	7.5	10.9	6.3	6.3	6.9	10.0	5.7	6.4	9.4	7.8	6.9	9.8	8.5	8.4	15.2	4.1	3.6	3.4	5.1	3.2	3.3	2.4	3.7	2.5	2.7	2.9	2.7	3.1	3.2	5.0	2.5	4.2	3.9	3.7	3.4	1.8	1.8	2.0	2.3	1.8	2.0	2.0	1.9	2.0	1.8	2.1	2.2	3.3	9.6	4.8	0.7	5.1	0.8	4.0	7.9	1.8	3.1	1.8	2.4	5.9	4.3	7.6	1.8	12.5	11.9	12.0	7.9	7.9	7.9	0.4	7.1	4.8	2.7	3.5	3.2	0.8	6.0	13.5	3.0	4.6	4.6	1.3	3.4	4.2	4.3	7.9	10.1	0.8	5.9	6.1	4.1	0.9	0.7	4.7	3.5	1.8	0.0	7.0	4.5	10.3	0.0	0.7	5.7	7.2	5.3	2.6	3.1	8.0	8.6	5.9	4.6	19.7	2.5	5.4	7.5	7.7	1.9	1.3	14.8	4.6	4.8	4.6	6.0
MED23	"CRSP130, CRSP3, DRIP130, MRT18, Sur2"	ENSG00000112282	"Mediator complex subunit 23"	Q9ULK4	6	131573966-131628242	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 72.0;Inhibitory neurons: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070341			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA070341: AB_2686257"	"unprognostic (1.11e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.47e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.53e-2)"	7.7	10.5	3.4	11.5	3.7	22.0	14.3	9.8	5.0	12.0	3.7	10.6	11.4	13.3	10.6	8.5	11.0	8.9	6.5	3.5	3.6	10.3	7.9	9.9	14.8	2.4	2.8	14.2	10.7	18.3	6.0	11.0	3.1	11.7	12.4	11.5	12.7	11.6	7.4	11.5	10.6	10.4	2.7	12.8	11.6	10.5	3.5	18.0	14.4	10.1	15.3	10.1	7.8	6.4	7.2	7.8	18.2	23.0	22.1	16.8	16.7	17.6	19.8	16.0	23.0	8.2	9.8	15.9	12.5	18.2	15.4	12.6	9.9	11.4	24.7	18.1	13.8	16.6	14.9	14.0	16.0	27.8	27.1	14.9	13.3	17.7	17.8	18.6	20.1	16.9	21.7	16.2	17.0	11.0	21.3	17.4	8.7	12.3	7.8	18.9	11.4	9.6	12.2	10.4	13.6	12.3	12.6	17.4	11.6	20.9	4.8	19.3	20.4	11.8	13.3	19.0	16.2	17.0	12.3	22.6	14.5	12.6	16.1	4.9	4.5	7.6	5.5	4.6	8.3	4.7	5.5	6.2	5.6	4.2	5.5	5.1	3.6	12.9	3.3	2.9	6.6	3.9	3.4	3.7	9.8	5.0	3.5	3.6	2.4	2.8	3.1	2.7	3.5	6.4	16.3	19.2	9.6	24.8	21.5	9.2	6.3	11.9	13.6	23.7	15.5	10.9	6.5	8.6	15.7	23.9	16.7	8.7	23.7	15.5	3.9	7.6	2.1	14.8	14.7	13.9	14.4	12.0	72.0	7.7	6.8	12.5	14.3	16.6	14.0	18.3	14.3	12.4	8.1	11.8	67.1	17.4	6.1	17.6	9.5	3.2	14.3	12.8	5.4	36.5	16.9	7.7	21.6	42.3	60.8	9.1	14.9	10.1	19.4	10.7	14.7	8.5	13.4	24.4	13.1	13.8	10.2	13.5	5.3	12.0	8.7	7.8	20.7	14.6	14.3	12.8
MEIOC	"C17orf104, FLJ35848"	ENSG00000180336	"Meiosis specific with coiled-coil domain"	A2RUB1	17	44656404-44690308	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"testis: 47.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 274.0;Late spermatids: 545.2;Spermatocytes: 242.4;Spermatogonia: 125.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 16.9;HMC-1: 25.4;NTERA-2: 8.7;SiHa: 9.5;SuSa: 12.0;THP-1: 12.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027266	Enhanced		Uncertain	"Cell Junctions"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Cell Junctions"		"HPA027266: AB_1848900"	"unprognostic (5.82e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.63e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.83e-4)"	"unprognostic (1.85e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.91e-3)"	"unprognostic (8.89e-3)"	0.2	0.2	0.2	0.2	0.4	0.8	0.3	1.0	0.7	0.3	0.0	0.3	0.2	0.2	0.0	0.3	0.2	0.2	0.4	0.5	0.1	0.7	0.7	0.2	0.5	0.1	0.0	0.3	0.2	0.2	0.3	0.1	0.2	0.3	0.0	1.6	0.3	0.0	2.2	0.9	0.3	0.0	0.0	0.3	0.2	47.7	0.1	0.0	0.3	0.0	0.1	0.3	0.2	0.4	0.2	7.7	1.0	1.3	0.2	0.0	0.5	1.0	0.0	0.6	2.1	0.4	0.3	0.8	1.9	0.5	0.2	0.2	16.9	0.0	0.2	0.7	6.8	0.6	0.9	0.4	0.0	0.6	25.4	0.0	0.0	0.9	0.0	1.7	0.0	1.6	0.5	0.7	0.2	1.5	0.5	1.5	8.7	0.2	0.7	0.3	0.8	0.5	0.0	0.2	1.7	2.1	9.5	0.2	0.1	12.0	1.1	12.9	0.3	0.4	0.3	1.9	0.8	0.6	1.1	0.2	0.6	0.9	1.5	0.4	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.1	0.3	0.1	0.0	0.2	0.4	1.0	0.7	0.5	0.1	0.1	0.0	0.2	0.0	0.1	0.4	0.2	0.0	1.1	0.0	0.4	0.0	1.0	0.0	1.2	2.0	0.5	0.6	0.0	0.0	0.0	0.0	2.1	0.2	0.8	0.0	3.9	0.1	274.0	0.9	0.7	0.6	0.0	0.8	0.0	0.2	0.4	0.4	0.5	1.0	0.0	0.6	0.0	1.0	0.4	0.0	0.0	0.1	0.0	1.3	0.0	545.2	4.7	0.8	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.2	0.0	3.8	0.4	0.6	0.1	1.2	0.0	2.6	19.7	1.2	0.3	242.4	125.5	0.2	0.0	0.3	0.6	0.3	0.2	0.8
MFNG		ENSG00000100060	"MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	O00587	22	37469063-37486393	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 69.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 51.4;dendritic cells: 54.6;Endothelial cells: 37.1;Hepatic stellate cells: 53.2;Kupffer cells: 45.8;monocytes: 40.6;NK-cells: 72.1;T-cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 174.6;HEL: 143.4;HL-60: 220.9;HMC-1: 266.9;HUVEC TERT2: 232.9;TIME: 134.7;U-698: 166.8;U-937: 201.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA048936, HPA056479"	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA		74000	"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA048936: AB_2680564, HPA056479: "	"unprognostic (1.21e-1)"	"unprognostic (4.17e-3)"	"prognostic unfavorable (5.12e-4)"	"prognostic favorable (1.65e-4)"	"unprognostic (6.41e-3)"	"unprognostic (1.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.91e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (2.67e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.43e-1)"	22.2	7.1	8.9	37.0	8.9	40.3	14.8	8.4	10.8	8.9	6.4	10.5	8.6	9.7	2.4	7.5	11.0	14.5	14.6	7.9	9.2	9.5	7.1	26.3	69.1	18.1	10.8	3.1	3.9	2.6	3.1	30.3	20.5	6.6	7.8	0.7	5.4	5.7	7.5	5.0	24.0	11.5	10.2	58.9	8.6	2.9	11.0	50.5	9.6	8.8	42.5	13.9	6.2	10.3	6.0	2.2	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.2	7.1	3.0	174.6	0.7	0.0	0.8	10.8	45.1	8.7	0.2	81.6	1.0	143.4	0.6	1.5	0.6	220.9	266.9	0.0	2.6	1.7	3.2	0.9	232.9	69.0	0.7	73.8	0.0	1.5	27.8	3.0	0.4	6.1	1.0	67.0	1.8	128.7	0.4	0.1	94.1	0.9	0.5	0.3	0.3	0.8	1.3	14.1	134.7	0.0	5.8	22.8	0.6	0.4	0.4	166.8	1.1	201.1	2.7	210.3	198.9	386.5	196.1	196.1	214.5	103.0	222.7	206.1	204.1	113.5	243.4	209.9	127.9	217.1	218.7	51.7	284.3	314.0	8.9	8.9	8.4	10.8	7.9	9.2	18.1	10.8	20.5	10.2	11.0	10.3	51.4	0.0	3.8	0.0	35.4	3.7	0.4	0.2	0.0	6.3	1.0	1.3	1.6	5.7	3.1	0.0	0.0	0.3	54.6	1.1	0.0	2.9	0.2	0.4	0.2	37.1	1.2	30.1	0.1	0.9	0.3	1.1	2.0	1.0	31.6	0.1	53.2	1.5	31.9	0.0	0.1	2.1	0.0	45.8	20.2	0.3	0.0	33.5	3.6	6.5	40.6	0.1	72.1	0.0	0.0	3.7	4.0	0.0	35.0	0.5	2.3	0.3	0.1	0.6	0.0	1.6	1.0	0.1	0.7	0.3	2.4	0.7	51.0	0.1	0.8	0.4
MFSD4A	"DKFZp761N1114, FLJ25004, FLJ34577, MFSD4, UNQ3064"	ENSG00000174514	"Major facilitator superfamily domain containing 4A"	Q8N468	1	205568885-205602918	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 66.7;stomach 1: 132.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.3;Collecting duct cells: 9.2;Distal tubular cells: 13.7;Endometrial ciliated cells: 9.9;Glandular and luminal cells: 40.5;Proximal tubular cells: 7.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"amygdala: 11.4;basal ganglia: 8.4;cerebral cortex: 18.4;hippocampal formation: 14.1;white matter: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.5;SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 59.8"	HPA055407	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"HPA055407: "	"unprognostic (7.15e-4)"	"prognostic favorable (7.54e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.97e-3)"	"prognostic favorable (2.27e-13)"	"unprognostic (1.58e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.75e-3)"	"unprognostic (8.78e-2)"	2.2	0.4	11.4	1.1	8.4	0.0	2.7	0.6	18.4	8.5	0.0	13.8	1.9	1.0	9.2	1.4	2.5	16.8	0.9	14.1	0.0	66.7	0.2	6.8	0.4	0.0	0.0	0.6	1.4	0.4	1.5	6.2	0.0	1.4	18.2	14.0	17.1	0.6	0.3	5.1	1.4	0.8	0.0	0.6	132.6	0.5	0.0	0.6	0.4	0.7	1.3	0.7	0.8	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	8.4	0.6	18.4	14.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	11.3	6.4	2.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.8	2.9	0.0	0.0	6.2	9.2	0.0	0.5	0.7	0.0	13.7	1.4	0.0	9.9	6.0	2.5	0.0	0.0	0.0	6.2	0.1	0.5	0.0	40.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	7.7	2.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.8	0.2	0.0	0.0
MFSD6L	FLJ35773	ENSG00000185156	"Major facilitator superfamily domain containing 6 like"	Q8IWD5	17	8797110-8799365	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"pancreas: 9.4;testis: 25.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 125.7;Ionocytes: 28.5;Late spermatids: 46.1;Spermatocytes: 45.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 8.3"	"Not detected"	"Not detected"							HPA023164	Uncertain					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA023164: AB_2142777"	"prognostic favorable (1.84e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.07e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.25e-1)"	0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.1	1.8	0.0	2.7	2.3	0.1	1.3	0.6	2.0	0.7	0.2	0.0	0.0	1.6	0.0	0.3	0.0	0.1	0.1	0.0	9.4	4.1	4.9	0.4	0.1	0.4	3.1	0.0	6.8	2.1	0.0	0.3	1.5	0.0	0.0	0.2	4.0	25.5	0.2	0.2	3.4	0.0	0.2	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	1.7	0.8	0.2	4.3	1.1	1.8	0.0	2.9	0.0	1.7	0.0	7.2	125.7	1.2	0.1	0.1	1.2	0.0	0.0	7.6	0.3	0.0	3.6	2.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.9	28.5	0.6	0.0	46.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.7	1.2	0.1	0.8	0.2	0.0	0.8	0.0	0.0	0.0	0.2	45.0	0.3	0.6	0.0	1.5	0.0	0.0	4.5	1.0
MIDEAS	"C14orf117, C14orf43, ELMSAN1, LSR68"	ENSG00000156030	"Mitotic deacetylase associated SANT domain protein"	Q6PJG2	14	73715122-73790285	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 59.4;Cardiomyocytes: 21.0;Cytotrophoblasts: 41.3;dendritic cells: 15.8;Extravillous trophoblasts: 32.5;Hofbauer cells: 25.8;Syncytiotrophoblasts: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HMC-1: 61.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003111	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA003111: AB_1078329"	"unprognostic (1.54e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.69e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.36e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.96e-1)"	9.0	5.0	4.1	9.3	4.2	14.5	6.6	5.1	5.2	6.4	0.4	7.1	7.7	7.3	1.3	9.3	6.7	9.2	6.7	2.6	4.0	3.0	4.7	6.9	9.3	5.3	2.3	11.3	5.9	9.7	2.6	8.8	1.6	5.7	3.9	2.9	7.8	5.8	10.1	11.8	8.8	6.5	0.4	13.7	7.5	5.4	5.5	5.8	6.2	5.9	5.6	5.7	6.2	7.9	12.8	14.1	5.0	9.4	4.6	7.8	9.6	5.1	8.7	7.0	6.3	12.5	14.8	18.5	5.6	7.0	7.3	19.3	8.3	14.5	2.8	24.6	5.1	29.7	12.8	4.5	7.4	5.2	61.9	10.4	8.8	6.1	7.6	6.1	11.2	6.4	15.5	16.7	3.4	29.7	12.0	8.3	1.6	6.4	11.7	13.8	27.0	4.9	10.4	13.5	6.4	5.3	19.3	26.4	10.3	2.8	20.3	10.8	22.6	14.3	16.3	10.8	5.6	13.0	6.7	20.4	11.7	6.3	17.0	0.6	0.5	0.2	0.3	0.2	0.4	0.4	0.1	0.3	0.6	0.7	0.2	0.2	0.8	0.5	0.3	1.2	0.4	0.4	4.1	4.2	5.1	5.2	2.6	4.0	5.3	2.3	1.6	0.4	5.5	7.9	59.4	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	41.3	15.8	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	32.5	9.4	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	29.4	3.6	0.0	0.0	0.0
MMP25	"MMP20, MMPL1, MT6-MMP"	ENSG00000008516	"Matrix metallopeptidase 25"	Q9NPA2	16	3046062-3060726	"Enzymes, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.1;lymphoid tissue: 81.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 6.7;Langerhans cells: 5.8;monocytes: 15.0"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 7.1"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"basophil: 18.3;neutrophil: 20.3"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 20.3"	"Cell line enriched"	"Detected in some"	15	"HMC-1: 102.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB025177, HPA055640"	Uncertain		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA		120000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"		"CAB025177: , HPA055640: "	"unprognostic (4.51e-3)"	"unprognostic (9.28e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.26e-1)"	"prognostic favorable (1.09e-5)"	"unprognostic (1.36e-1)"	"unprognostic (7.39e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.02e-1)"	5.8	0.4	0.5	15.1	0.4	33.1	1.4	0.3	1.6	0.7	0.6	1.7	1.1	0.5	0.1	1.3	6.2	1.1	2.4	0.3	0.3	1.4	2.9	14.4	2.6	0.6	0.5	0.4	1.2	0.2	0.8	1.0	0.6	1.0	1.4	0.0	1.2	0.1	0.5	0.7	3.5	0.9	0.3	81.8	1.9	0.4	0.7	1.4	1.2	3.5	1.9	2.2	0.9	0.3	0.0	0.0	1.2	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.7	0.1	0.0	6.7	0.5	0.0	0.0	0.0	0.0	0.2	102.2	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.7	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.3	7.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	1.1	0.1	18.3	0.2	4.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	20.3	0.5	0.0	0.4	0.2	0.0	0.5	0.4	0.3	1.6	0.3	0.3	0.6	0.5	0.6	0.3	0.7	0.3	1.0	3.2	6.7	0.0	0.7	0.4	0.4	0.2	0.0	0.8	2.0	1.3	1.0	0.0	0.8	1.8	0.0	0.0	1.8	0.2	0.0	0.4	0.0	1.2	1.2	1.0	0.0	2.7	1.6	0.6	0.2	0.6	1.1	3.8	1.3	0.2	0.0	0.3	0.1	0.0	1.9	0.2	0.0	3.5	5.8	0.0	0.0	3.3	0.0	1.0	15.0	0.3	3.1	1.5	0.5	1.3	0.0	0.7	0.8	0.4	1.2	0.2	0.1	0.0	0.0	0.7	0.9	0.1	0.2	0.6	0.3	0.0	4.0	0.1	0.3	0.3
MOB1A	"C2orf6, FLJ10788, FLJ11595, Mats1, MOB1, Mob4B, MOBK1B, MOBKL1B"	ENSG00000114978	"MOB kinase activator 1A"	Q9H8S9	2	74152528-74178898	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 350.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047088, HPA071690"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA047088: AB_2679927, HPA071690: AB_2686432"	"unprognostic (5.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (3.34e-4)"	"unprognostic (9.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.11e-3)"	36.6	24.7	12.6	64.2	11.8	90.5	31.4	12.9	13.5	36.4	18.6	41.0	42.3	35.0	25.5	40.2	33.2	35.5	25.3	11.4	15.6	48.1	30.7	38.9	91.9	15.8	13.6	31.9	16.0	28.6	9.1	35.8	16.7	30.3	42.7	10.2	19.5	29.4	13.2	38.9	41.7	40.5	15.8	61.1	34.2	19.8	12.8	56.1	33.6	19.4	93.1	46.6	26.0	17.9	78.2	43.9	53.9	58.5	86.9	94.0	63.5	61.3	82.0	78.1	76.6	60.2	55.4	159.0	51.3	77.4	58.2	63.7	69.6	70.2	117.7	113.0	41.5	143.7	28.0	64.3	69.1	126.1	222.1	80.2	67.1	62.6	52.5	58.6	83.3	60.4	62.5	57.2	76.8	42.1	159.4	106.9	50.3	66.4	35.6	108.2	185.2	85.2	67.3	96.1	27.3	35.6	87.1	63.6	56.4	40.4	51.0	59.1	79.6	100.9	53.0	71.4	98.7	42.2	40.5	119.5	68.0	105.3	55.3	103.7	65.3	91.5	37.3	106.1	40.3	57.8	33.3	40.3	60.5	46.1	30.2	36.4	65.6	56.4	126.0	42.1	37.2	79.7	12.6	11.8	12.9	13.5	11.4	15.6	15.8	13.6	16.7	15.8	12.8	17.9	82.6	51.3	58.0	3.9	173.0	136.9	96.5	107.4	60.9	13.3	66.8	45.1	40.0	35.8	79.5	82.8	6.2	63.8	170.1	114.1	92.0	60.9	11.1	88.3	91.3	73.1	37.7	48.8	7.4	52.6	101.9	67.2	55.0	102.2	110.4	58.5	61.1	43.0	169.5	26.9	7.9	67.4	65.1	196.6	246.9	11.8	62.4	226.1	67.6	14.0	350.8	25.2	117.4	6.0	10.1	83.4	85.7	68.4	106.4	127.8	80.4	170.2	116.6	14.5	72.3	60.6	75.3	99.5	44.6	86.6	132.0	66.4	124.4	79.3	74.0	155.3
MOB3A	"MOB-LAK, MOB1C, MOBKL2A, moblak"	ENSG00000172081	"MOB kinase activator 3A"	Q96BX8	19	2071036-2096673	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 74.4;Langerhans cells: 91.3;monocytes: 81.1;NK-cells: 77.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057744			Uncertain	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Intermediate filaments, Cytosol"		"HPA057744: "	"unprognostic (2.05e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.33e-6)"	"unprognostic (3.40e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.12e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.16e-2)"	"unprognostic (7.74e-3)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (5.90e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.18e-1)"	24.8	15.3	19.8	49.7	19.3	53.7	20.9	19.5	45.6	25.4	21.9	36.0	12.9	32.3	9.4	22.4	27.4	17.5	14.8	19.7	19.4	15.8	9.7	25.1	73.3	26.8	21.3	20.4	13.6	8.7	12.2	15.8	22.8	25.9	15.0	6.7	17.1	20.1	14.0	21.1	31.7	28.6	20.2	60.4	20.4	8.8	24.8	34.9	16.0	14.4	65.7	27.1	22.9	21.2	45.6	18.4	21.5	20.6	49.7	54.7	16.7	28.1	17.7	18.7	14.9	7.4	16.1	116.4	10.1	48.8	15.2	18.9	12.0	62.2	15.0	41.2	6.2	25.3	12.3	10.1	49.2	40.0	125.7	32.4	40.4	51.5	21.7	21.6	35.5	22.1	13.4	113.4	27.6	18.1	20.9	40.6	6.6	5.5	13.1	12.6	6.4	91.2	23.5	11.3	13.7	18.3	14.3	14.9	15.9	15.9	16.0	64.3	60.8	22.6	12.4	42.5	16.9	22.1	86.8	90.4	61.0	26.7	27.7	80.8	87.0	100.7	62.3	83.8	52.9	43.6	45.8	51.9	58.7	39.1	34.1	44.1	274.5	54.2	96.3	33.4	60.3	85.6	19.8	19.3	19.5	45.6	19.7	19.4	26.8	21.3	22.8	20.2	24.8	21.2	8.6	3.2	4.5	8.8	50.6	15.0	10.9	11.7	8.6	3.7	9.4	7.4	3.7	4.3	9.7	11.0	20.9	11.1	50.8	18.9	3.9	10.8	1.6	6.1	12.7	11.7	14.9	11.8	6.5	9.5	53.5	12.0	8.2	9.6	27.9	8.1	18.5	4.7	33.3	1.7	5.8	12.2	14.2	74.4	91.3	4.8	18.3	50.1	16.0	6.5	81.1	6.9	77.2	4.0	6.0	10.1	12.6	17.0	38.0	11.9	16.0	9.0	10.1	6.6	6.6	10.5	11.2	9.4	6.6	7.2	15.9	27.5	37.3	7.7	9.5	10.8
MORC3	"KIAA0136, NXP2, ZCW5, ZCWCC3"	ENSG00000159256	"MORC family CW-type zinc finger 3"	Q14149	21	36320189-36386148	"Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018406, HPA034848"	Approved		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Mitochondria	"HPA018406: AB_1858988, HPA034848: AB_2674359"	"unprognostic (4.01e-3)"	"unprognostic (4.86e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.13e-1)"	11.2	7.5	6.3	17.3	7.9	34.5	13.9	13.6	7.7	14.6	4.7	10.9	10.9	17.3	9.4	17.7	12.0	12.6	11.6	6.4	6.6	9.4	14.1	12.9	20.3	7.2	6.2	23.8	11.1	10.4	6.5	17.2	8.0	13.6	11.6	7.7	11.5	11.8	17.7	14.9	11.0	13.9	8.6	18.6	13.0	10.8	7.2	19.4	11.7	15.8	20.0	15.4	13.8	11.8	19.7	7.8	19.1	12.8	16.5	16.3	25.1	17.9	30.0	20.3	17.5	12.8	12.9	9.4	7.0	19.9	21.0	9.8	12.9	16.9	18.8	18.7	10.3	37.2	8.2	7.2	11.4	23.4	34.7	12.0	21.3	18.3	26.5	22.2	14.5	14.6	31.0	24.3	14.9	5.8	14.1	9.8	14.2	24.9	7.9	16.4	7.5	17.8	6.6	20.1	7.1	17.4	22.2	12.3	22.8	14.3	14.9	16.3	23.3	17.7	4.9	14.3	15.2	10.9	9.8	8.9	12.7	32.3	13.2	32.5	8.9	19.5	9.1	10.9	9.0	11.3	9.9	8.6	8.8	12.6	12.6	9.1	13.5	9.9	13.6	5.7	13.4	7.9	6.3	7.9	13.6	7.7	6.4	6.6	7.2	6.2	8.0	8.6	7.2	11.8	29.0	28.9	24.1	44.4	49.6	68.3	65.7	33.1	36.5	19.4	19.6	17.4	20.4	14.3	28.9	22.0	8.4	16.1	44.3	14.7	3.9	17.8	51.7	20.9	30.1	24.1	11.4	63.3	36.4	12.5	19.7	31.0	19.4	28.0	47.5	22.4	16.8	16.5	17.5	16.8	37.1	17.1	18.3	26.8	56.8	18.3	18.6	35.8	24.9	52.5	41.4	12.2	40.2	41.7	55.3	23.3	14.5	26.7	17.1	42.0	9.5	7.1	33.5	12.2	13.1	44.8	41.5	33.5	31.4	45.8	81.7	25.2	44.6	16.7	11.1	68.1
MPHOSPH8	"HSMPP8, mpp8"	ENSG00000196199	"M-phase phosphoprotein 8"	Q99549	13	19633659-19673441	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039701, HPA040035"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA039701: AB_10805484, HPA040035: AB_10794207"	"unprognostic (4.22e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.81e-3)"	"unprognostic (4.90e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.52e-3)"	"unprognostic (3.40e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.86e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.02e-1)"	29.0	32.5	32.4	30.0	31.9	27.9	28.7	36.5	48.7	38.6	31.1	39.7	22.5	36.1	31.6	23.3	34.0	23.4	36.1	31.6	40.2	22.9	21.1	28.7	39.2	31.8	35.7	51.4	28.2	26.3	31.6	25.4	31.5	31.2	24.4	36.9	32.3	31.2	23.4	33.6	33.3	26.6	26.8	39.9	28.3	21.5	33.6	23.2	32.9	18.5	26.4	32.3	31.7	36.5	26.0	16.4	23.9	39.0	30.3	38.2	42.2	38.2	27.5	23.6	20.1	25.1	44.5	40.8	29.7	23.1	36.6	42.2	44.4	26.7	30.2	51.1	22.7	65.7	27.8	30.8	27.0	47.8	51.4	22.8	33.8	18.6	26.1	35.8	31.6	32.5	32.5	25.5	22.2	25.1	36.8	39.9	23.4	48.0	18.1	29.3	55.2	32.6	40.7	19.8	32.7	20.0	35.7	32.3	35.3	39.8	19.7	39.1	37.3	18.1	16.4	34.8	19.6	17.2	19.2	40.1	13.8	43.4	28.7	133.6	23.4	42.5	31.5	18.2	28.1	64.3	35.6	31.1	11.4	54.1	42.5	34.8	69.2	30.4	27.8	35.8	30.9	9.9	32.4	31.9	36.5	48.7	31.6	40.2	31.8	35.7	31.5	26.8	33.6	36.5	117.3	93.0	110.6	42.1	129.7	69.0	102.1	99.0	97.3	201.0	74.8	95.0	94.4	110.1	92.2	103.0	83.4	151.1	132.0	95.1	49.0	57.6	84.3	82.3	129.2	109.0	58.8	78.9	94.7	54.6	83.7	118.8	62.7	118.8	144.2	101.0	133.2	81.3	72.9	210.3	89.4	113.2	67.1	74.5	55.5	37.9	179.3	71.4	67.6	51.5	99.8	114.9	166.9	56.3	78.7	48.2	99.7	157.2	118.5	80.8	100.5	61.6	66.6	219.0	177.5	111.5	118.5	211.0	203.7	57.9	74.0	58.7	142.7	105.3	86.8	65.3
MPP1	"DXS552E, PEMP"	ENSG00000130830	"Membrane palmitoylated protein 1"	Q00013	X	154778684-154821007	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 116.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 410.9;Erythroid cells: 393.8;Hofbauer cells: 291.9;Macrophages: 155.9;Syncytiotrophoblasts: 454.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 215.7;neutrophil: 202.1"	"Group enriched"	"Detected in all"	8	"dendritic cells: 57.7;granulocytes: 215.7;monocytes: 98.8"	"Cell line enhanced"	"Detected in many"		"HEL: 218.0;REH: 136.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076675	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		NA	NA		650000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Centriolar satellite"	"HPA076675: "	"unprognostic (2.15e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.83e-3)"	"unprognostic (7.14e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.79e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.70e-3)"	"prognostic favorable (4.60e-6)"	"unprognostic (6.69e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.68e-2)"	"unprognostic (6.67e-3)"	24.1	27.2	21.0	27.1	22.0	116.8	16.5	26.2	29.7	11.6	18.6	17.2	59.4	13.4	5.3	10.5	15.7	24.3	26.0	22.5	25.2	42.9	37.5	28.3	24.9	28.3	21.9	10.6	34.6	30.7	9.7	86.5	30.7	15.5	17.6	10.6	23.7	18.1	29.2	10.2	47.3	19.7	22.5	40.9	11.8	7.1	27.3	72.8	14.0	27.2	12.5	21.3	10.0	28.2	41.4	8.3	18.7	18.7	19.0	20.1	59.5	15.3	23.3	25.3	30.8	23.7	3.7	32.8	29.3	17.1	67.9	4.6	21.6	6.9	19.9	34.9	38.0	218.0	5.7	25.3	28.6	44.4	121.4	19.4	9.0	28.2	7.0	25.9	58.5	42.1	96.1	5.3	28.7	0.2	102.6	60.3	1.9	3.8	28.2	136.0	4.8	15.5	14.8	3.3	4.7	7.5	12.7	1.2	13.3	18.5	3.2	25.8	26.6	23.2	12.5	51.8	41.7	36.6	52.9	12.5	32.7	61.7	11.1	49.7	95.6	215.7	5.1	76.6	6.0	7.8	5.9	5.7	57.7	2.7	15.4	7.9	202.1	10.1	98.8	15.5	3.5	79.1	21.0	22.0	26.2	29.7	22.5	25.2	28.3	21.9	30.7	22.5	27.3	28.2	18.3	3.2	11.2	8.1	6.3	8.7	4.8	0.2	8.0	10.2	7.1	5.1	17.0	41.5	6.2	7.3	4.2	410.9	6.9	16.3	21.5	11.7	0.6	3.5	5.7	18.9	11.5	393.8	16.1	2.8	27.0	11.4	1.1	6.4	90.6	9.6	11.7	10.6	291.9	16.8	17.1	4.4	0.0	104.7	30.2	2.4	8.7	155.9	10.6	15.9	52.5	15.4	9.2	6.0	5.9	3.7	4.1	13.2	8.1	3.1	57.4	66.3	2.2	8.2	0.0	8.6	10.3	0.7	6.8	6.4	6.0	454.4	9.9	14.5	5.8	1.2
MPV17L	"FLJ39599, MLPH1, MLPH2, MPV17L1"	ENSG00000156968	"MPV17 mitochondrial inner membrane protein like"	Q2QL34	16	15395754-15413271	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 14.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 29.5;SK-BR-3: 8.2"					"Low region specificity"	"Detected in all"			HPA041180	Approved		Supported	Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA041180: AB_10794266"	"unprognostic (9.65e-2)"	"unprognostic (8.74e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.35e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.38e-3)"	"unprognostic (8.41e-2)"	"unprognostic (8.99e-3)"	"unprognostic (8.70e-2)"	"unprognostic (6.36e-3)"	"prognostic favorable (1.48e-11)"	"unprognostic (2.84e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.61e-3)"	"unprognostic (3.87e-2)"	1.8	2.5	1.2	1.8	0.1	4.4	6.4	1.9	2.2	2.8	0.0	2.3	3.4	2.0	0.3	1.0	1.8	2.4	1.6	0.1	0.0	3.3	9.1	0.9	2.3	0.1	0.0	2.1	14.1	2.4	3.2	0.6	0.3	2.0	1.0	4.4	7.1	1.8	8.0	4.5	2.3	0.8	0.0	1.8	1.8	1.0	0.5	0.2	2.2	2.4	0.6	1.9	1.3	0.4	1.0	1.9	0.8	0.8	0.2	0.1	1.2	0.5	0.0	0.0	0.0	1.9	3.4	1.5	1.3	0.6	0.5	1.5	3.0	0.0	0.0	1.2	0.8	5.9	4.6	3.9	0.3	3.6	29.5	0.3	0.4	0.1	0.2	0.5	0.0	1.6	2.3	3.3	0.1	1.9	1.4	2.3	1.7	0.3	0.1	2.0	0.6	1.6	0.5	0.8	4.8	1.6	2.7	8.2	0.2	0.9	1.8	2.6	2.6	1.3	0.8	1.1	1.1	1.4	0.6	1.7	0.7	1.7	0.5	1.7	1.2	0.2	0.8	0.9	0.6	0.8	0.5	0.8	0.4	1.2	0.4	0.8	1.8	1.1	0.4	0.7	0.4	0.6	1.2	0.1	1.9	2.2	0.1	0.0	0.1	0.0	0.3	0.0	0.5	0.4	2.5	6.4	8.8	3.9	2.0	7.9	14.4	8.2	0.0	12.8	11.4	6.0	6.0	14.3	13.1	0.0	10.4	0.5	4.1	2.7	15.6	7.5	4.6	5.4	9.2	6.6	1.2	2.1	5.6	12.9	0.5	8.1	2.0	10.7	6.3	7.6	4.2	29.1	1.0	8.4	5.9	8.7	2.0	13.6	20.6	0.8	7.2	6.0	21.4	2.8	0.7	6.2	0.0	7.5	3.2	5.9	15.3	14.3	1.4	9.6	9.3	19.9	21.0	16.6	0.0	23.5	6.7	9.0	2.0	0.6	11.5	0.5	9.9	4.4	12.1	10.1
MPZL3		ENSG00000160588	"Myelin protein zero like 3"	Q6UWV2	11	118226690-118252365	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 33.3;skin 1: 30.4"	"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 43.8;Suprabasal keratinocytes: 63.9;T-cells: 44.3;Urothelial cells: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	6	"basophil: 44.3;eosinophil: 99.4;MAIT T-cell: 28.9;neutrophil: 87.8"	"Group enriched"	"Detected in all"	8	"granulocytes: 99.4;T-cells: 28.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 26.3;HMC-1: 29.0;MCF7: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029116			Approved	"Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"		"HPA029116: AB_10610142"	"unprognostic (2.54e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.52e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.86e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (4.86e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.90e-1)"	"prognostic favorable (3.64e-4)"	"unprognostic (1.20e-1)"	3.3	0.5	0.7	4.7	1.0	7.3	8.2	2.8	0.7	11.5	1.7	5.6	5.4	1.5	4.9	33.3	5.4	7.6	1.6	0.7	0.8	3.1	7.5	7.9	4.8	1.0	0.7	0.5	7.2	6.7	3.8	0.8	0.9	5.6	6.1	1.3	11.7	2.7	1.7	30.4	5.3	1.5	0.7	6.0	6.8	1.1	0.8	2.8	6.1	0.9	12.6	4.4	16.8	0.7	5.0	0.6	0.0	0.7	0.0	0.0	0.7	0.6	0.1	0.1	0.1	16.7	26.3	4.9	12.5	0.0	1.9	6.8	1.2	5.6	0.1	0.3	2.0	3.0	1.4	8.1	0.2	4.1	29.0	0.3	13.6	0.0	5.4	0.0	8.8	3.3	3.8	2.7	0.1	17.1	1.9	2.2	2.4	16.5	1.2	0.0	0.0	7.4	10.0	6.2	3.4	0.3	6.6	8.6	0.5	1.3	15.4	2.2	4.3	0.1	1.3	0.1	0.1	0.4	5.1	3.1	0.1	0.1	0.3	44.3	6.0	99.4	7.0	3.7	28.9	1.7	11.3	9.6	8.1	1.9	8.4	6.9	87.8	8.2	2.6	1.1	8.4	5.3	0.7	1.0	2.8	0.7	0.7	0.8	1.0	0.7	0.9	0.7	0.8	0.7	2.4	16.0	26.9	0.0	4.9	35.6	21.7	11.8	9.6	0.3	28.2	14.7	1.7	5.7	15.9	9.2	2.1	0.6	9.6	19.6	0.0	10.5	7.4	32.7	4.1	4.9	12.0	0.4	2.2	8.8	0.7	1.6	18.3	34.0	1.3	0.1	2.2	8.2	1.3	0.0	2.3	5.1	14.2	5.1	18.7	7.7	0.0	5.5	10.6	1.9	3.8	0.3	4.1	0.5	0.3	16.7	9.1	0.4	6.6	30.6	9.3	1.1	43.8	1.7	0.0	0.4	2.3	1.7	0.8	14.3	63.9	1.6	44.3	0.2	8.1	46.4
MRTFA	"BSAC, KIAA1438, MAL, MKL, MKL1, MRTF-A"	ENSG00000196588	"Myocardin related transcription factor A"	Q969V6	22	40410281-40636719	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Actin-binding	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 4.5;Cardiomyocytes: 8.7;Cytotrophoblasts: 8.9;Extravillous trophoblasts: 8.7;Fibroblasts: 4.3;Hofbauer cells: 12.7;Syncytiotrophoblasts: 7.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 189.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 93.1;granulocytes: 189.4;monocytes: 58.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030782	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA030782: AB_10600930"	"unprognostic (7.90e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.74e-2)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (9.05e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.98e-1)"	21.1	15.4	15.8	27.3	18.0	80.7	19.9	10.9	22.8	25.5	12.3	20.8	11.7	33.1	7.3	16.6	22.6	11.7	21.3	20.2	10.0	14.6	12.3	24.5	27.5	9.3	8.7	20.9	16.1	8.9	13.8	18.3	7.9	19.4	8.8	11.1	18.2	15.2	19.1	24.4	18.6	16.3	6.7	29.7	19.1	35.9	9.5	21.7	22.1	8.0	22.8	22.0	19.6	15.3	26.5	33.9	14.5	17.5	21.6	15.9	27.8	25.6	16.6	23.1	22.8	19.1	7.9	27.2	10.2	27.0	20.3	35.5	12.7	31.9	13.8	32.0	29.2	46.3	39.9	24.7	17.8	53.5	79.8	15.5	36.7	22.4	15.1	17.5	18.3	15.0	12.9	12.3	11.5	25.3	20.7	57.4	11.7	14.2	12.1	35.4	17.5	16.4	16.9	22.1	8.7	8.7	43.7	19.4	13.8	18.3	16.0	59.0	27.8	14.7	38.7	21.4	20.9	16.1	16.5	39.1	12.1	25.6	26.5	49.0	53.5	189.4	18.5	43.7	16.9	13.0	15.8	13.6	64.3	18.6	21.1	18.1	57.2	16.8	58.8	93.1	22.0	34.2	15.8	18.0	10.9	22.8	20.2	10.0	9.3	8.7	7.9	6.7	9.5	15.3	4.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	8.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	8.7	4.3	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	7.8	0.6	0.0	0.0	0.0
MS4A4E		ENSG00000214787	"Membrane spanning 4-domains A4E"	Q96PG1	11	60200270-60243137	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.4;Erythroid cells: 1.3;Kupffer cells: 3.4;Macrophages: 5.4;Microglial cells: 1.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 17.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 17.8"	"Cell line enhanced"	"Detected in many"		"HMC-1: 8.1"									HPA040075	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA040075: AB_10793915"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.05e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.16e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.97e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.05e-2)"	5.9	4.0	5.4	3.5	5.1	7.7	3.7	8.1	6.7	1.1	6.5	2.8	3.3	1.8	2.8	1.6	1.5	3.0	1.3	6.0	4.7	1.8	5.5	2.9	2.8	5.4	4.1	1.6	1.5	1.3	0.0	1.8	4.6	2.0	2.7	4.5	1.7	1.2	4.4	4.2	4.5	2.9	2.6	4.7	2.7	2.9	5.3	1.1	1.2	0.8	1.9	1.5	0.0	5.8	4.2	1.7	0.9	2.2	0.7	0.4	3.2	1.7	0.2	0.2	0.3	1.2	1.8	1.3	1.7	0.1	1.2	3.4	0.3	0.2	0.3	5.0	1.1	2.3	3.5	2.0	0.6	1.3	8.1	0.5	1.5	0.5	0.7	0.9	0.2	1.8	2.4	4.2	0.2	1.6	1.9	2.6	1.8	2.0	1.3	1.6	1.7	1.8	0.5	2.1	1.3	2.2	4.9	1.8	2.4	2.0	2.4	2.4	1.1	1.7	7.8	4.8	1.6	5.6	4.7	1.9	0.9	2.8	1.5	17.8	1.4	0.2	0.4	1.6	0.3	0.5	0.3	0.2	2.5	0.7	0.3	0.4	2.7	0.9	1.4	1.4	0.2	0.3	5.4	5.1	8.1	6.7	6.0	4.7	5.4	4.1	4.6	2.6	5.3	5.8	0.1	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	5.4	0.0	1.9	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MSRA		ENSG00000175806	"Methionine sulfoxide reductase A"	Q9UJ68	8	10054292-10428891	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 86.0;liver: 64.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 625.8;Inhibitory neurons: 318.6;Oligodendrocyte precursor cells: 268.9;Proximal tubular cells: 666.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 28.4"	"Immune cell enhanced"	"Detected in some"		"eosinophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 12.3"	"Low region specificity"	"Detected in all"							"HPA023804, HPA075766"	Approved		Supported	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	No	No		55000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"	"Plasma membrane, Actin filaments"	"HPA023804: AB_1853826, HPA075766: "	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.00e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.43e-3)"	"unprognostic (4.02e-1)"	"unprognostic (6.36e-3)"	"unprognostic (3.07e-1)"	17.0	20.4	2.2	1.1	3.0	13.5	16.1	28.4	5.4	9.1	0.0	13.9	1.1	10.7	0.1	11.6	7.4	0.4	29.0	3.8	0.0	86.0	64.0	12.2	0.6	0.0	0.4	6.4	14.5	0.7	9.2	0.8	1.8	9.2	0.6	0.6	10.5	1.0	14.5	9.5	20.1	0.8	0.0	18.6	14.2	15.2	0.3	1.5	9.6	1.3	0.6	11.6	8.2	2.8	0.1	0.9	1.3	4.3	1.2	1.4	0.5	2.5	0.2	0.3	1.7	0.6	2.1	0.0	0.6	2.5	5.8	2.3	0.4	0.1	1.3	0.2	0.0	0.3	1.5	2.2	4.3	0.8	12.3	0.4	3.2	0.3	0.0	1.4	0.6	0.3	0.4	0.2	4.9	0.1	0.0	0.3	0.6	3.3	0.8	1.6	1.3	2.0	1.1	1.1	2.5	1.5	4.6	0.2	0.5	0.4	2.3	2.8	2.6	1.7	2.0	0.4	1.2	0.2	0.1	0.7	4.8	0.8	3.1	0.5	1.9	5.6	0.4	1.2	0.3	0.6	0.4	0.3	1.2	0.1	0.3	0.2	2.2	0.7	0.9	0.2	0.3	0.2	2.2	3.0	28.4	5.4	3.8	0.0	0.0	0.4	1.8	0.0	0.3	2.8	44.1	0.0	7.4	152.8	21.4	16.4	29.3	10.8	14.2	10.1	21.2	21.8	21.6	25.8	7.2	25.8	31.3	7.7	12.4	26.4	92.0	32.3	80.6	13.6	8.7	30.3	9.6	3.4	625.8	47.1	4.6	13.1	14.8	11.8	80.7	13.7	19.6	97.2	47.0	16.8	318.6	20.8	4.1	33.6	48.3	167.9	9.3	38.0	30.2	85.3	22.3	14.6	11.3	268.9	60.7	51.1	37.8	9.8	16.2	33.8	195.5	666.1	5.6	6.2	13.1	11.3	16.9	39.3	26.5	20.1	14.1	8.3	18.0	14.1	24.5	31.1
MTA2	"MTA1-L1, MTA1L1"	ENSG00000149480	"Metastasis associated 1 family member 2"	O94776	11	62593214-62601865	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005315, HPA006214, CAB017522, HPA072727"	Supported		Enhanced	Nucleoplasm		NA	NA		10000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB005315: AB_2146965, CAB017522: AB_831564, HPA006214: AB_1079421, HPA072727: "	"unprognostic (5.97e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (4.82e-5)"	"unprognostic (3.32e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.38e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-3)"	"unprognostic (3.16e-3)"	"unprognostic (9.84e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.50e-2)"	41.6	34.4	44.4	46.2	46.7	60.7	35.7	45.7	45.3	40.2	38.2	40.0	31.0	37.2	28.7	79.3	33.4	32.6	29.7	44.3	44.1	31.9	30.3	37.8	70.1	49.0	46.1	37.8	23.0	30.2	31.8	39.1	49.4	37.0	47.4	119.8	37.3	36.7	21.2	74.7	40.1	43.8	46.1	60.7	33.9	30.4	45.8	90.2	26.8	24.1	91.8	51.7	47.2	52.7	97.1	83.4	129.8	171.1	57.0	53.2	88.8	80.0	112.3	157.5	114.7	79.7	82.7	137.0	84.0	106.3	84.3	127.2	177.2	222.1	132.8	136.4	87.9	146.4	91.2	81.0	88.3	167.2	180.0	59.6	122.6	111.3	164.1	74.8	148.3	140.4	164.2	106.1	114.6	189.0	213.9	212.1	112.3	91.7	95.1	201.5	92.4	160.6	112.1	143.4	102.9	94.2	83.5	118.2	67.6	102.4	138.9	113.2	104.5	87.9	80.4	100.4	94.0	78.3	109.4	191.8	64.4	120.4	86.9	7.3	7.2	9.9	18.6	12.6	15.6	13.9	15.2	13.5	11.8	10.0	14.0	14.3	3.1	12.1	16.4	13.8	13.5	6.7	44.4	46.7	45.7	45.3	44.3	44.1	49.0	46.1	49.4	46.1	45.8	52.7	22.9	3.2	3.9	2.3	16.9	13.4	4.2	4.2	34.1	0.0	11.3	7.9	3.7	1.5	4.9	1.8	0.0	15.3	16.5	12.1	5.9	5.1	0.8	5.2	10.0	12.0	12.0	20.8	1.5	9.5	8.3	8.6	15.3	9.5	10.8	7.5	13.2	8.2	8.9	0.0	1.6	11.9	4.1	12.8	7.6	0.7	5.0	8.9	1.8	2.8	8.9	0.0	9.2	2.0	2.7	9.7	8.2	4.1	24.1	4.2	6.6	2.7	0.9	0.0	0.0	8.2	11.7	5.9	5.2	32.5	11.2	18.9	18.1	13.6	12.2	4.5
MTMR3	"FYVE-DSP1, KIAA0371, ZFYVE10"	ENSG00000100330	"Myotubularin related protein 3"	Q13615	22	29883169-30030868	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 81.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.3;Inhibitory neurons: 78.3;Microglial cells: 90.9;Oligodendrocyte precursor cells: 96.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034515, HPA034516, HPA061399"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA034515: AB_10669726, HPA034516: AB_10669727, HPA061399: "	"unprognostic (4.39e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.42e-1)"	"unprognostic (4.39e-1)"	"unprognostic (8.33e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.96e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.38e-2)"	17.8	18.4	18.5	13.0	19.4	81.6	17.0	21.2	18.6	18.9	17.0	15.5	11.1	16.0	12.8	22.4	16.4	12.5	13.9	20.8	19.3	11.7	10.8	20.7	11.5	19.2	19.8	20.4	16.5	18.3	17.0	15.0	17.3	16.0	12.7	21.2	17.2	11.3	36.7	25.5	14.5	14.8	18.6	21.7	15.7	26.2	21.6	16.2	17.2	30.0	13.9	15.1	19.4	16.6	13.4	11.7	17.0	18.3	16.7	12.1	12.8	12.2	17.4	15.7	18.2	10.0	7.9	10.2	7.6	22.1	12.4	16.0	18.5	14.3	16.6	21.0	15.4	18.6	10.6	10.1	15.3	15.9	45.0	12.8	22.9	14.9	26.9	14.7	15.3	10.7	11.6	17.5	10.3	16.2	10.7	11.1	6.5	13.7	7.5	12.5	23.3	10.4	14.1	24.3	19.2	13.1	22.1	19.7	11.7	14.1	11.2	15.3	16.8	25.3	16.7	5.5	8.3	14.7	11.1	9.3	11.0	7.5	11.8	8.3	7.4	11.2	3.2	4.9	4.0	2.3	2.5	3.4	4.1	2.4	3.1	2.7	17.8	4.1	5.4	1.5	2.9	4.3	18.5	19.4	21.2	18.6	20.8	19.3	19.2	19.8	17.3	18.6	21.6	16.6	15.9	3.2	14.8	111.3	13.3	16.7	9.8	11.5	14.8	0.0	13.7	11.0	4.2	10.0	17.7	12.9	0.0	13.6	10.4	21.5	1.9	9.5	14.0	16.8	14.9	10.6	12.5	21.0	61.2	8.8	7.0	12.6	31.6	24.5	7.6	14.7	13.9	10.1	10.9	0.0	78.3	9.2	46.8	20.6	11.7	16.7	13.7	20.8	14.2	90.9	22.3	0.0	12.3	96.5	73.2	12.3	11.1	11.3	13.0	14.6	12.2	7.3	16.4	0.0	6.6	15.3	11.0	26.8	28.0	18.1	13.8	13.7	13.0	8.9	11.5	21.2
MTMR6		ENSG00000139505	"Myotubularin related protein 6"	Q9Y217	13	25246222-25287488	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"				"unprognostic (8.68e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.91e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.30e-1)"	13.4	19.0	9.6	14.2	10.6	31.9	12.5	10.6	14.2	10.7	6.1	10.9	8.5	12.2	7.7	10.8	8.7	12.8	15.6	11.0	11.8	14.8	13.4	13.0	15.0	11.1	9.6	9.3	12.8	16.3	6.1	12.2	11.0	12.9	12.1	21.9	16.1	13.3	11.8	7.7	8.8	15.8	10.4	14.2	10.9	18.6	10.4	16.7	15.3	14.9	14.4	14.3	6.5	14.0	12.3	12.6	20.3	17.3	21.2	22.1	9.9	38.0	42.6	36.9	28.9	8.4	21.4	18.8	11.0	35.7	18.7	14.9	13.1	22.5	42.6	22.7	8.6	23.1	8.4	6.9	25.5	48.5	40.8	15.9	25.9	26.8	35.8	21.1	30.4	24.8	10.9	20.9	37.5	8.7	27.8	13.1	6.1	23.6	9.4	11.8	28.5	25.9	26.7	14.2	10.7	15.2	12.4	21.8	20.2	19.2	8.4	30.2	39.4	22.6	11.6	25.2	22.5	11.3	14.0	24.6	11.4	18.6	37.6	22.9	9.8	8.0	5.8	14.0	7.4	6.5	6.1	6.2	7.9	4.2	6.2	6.4	18.9	6.0	13.0	4.7	8.9	8.9	9.6	10.6	10.6	14.2	11.0	11.8	11.1	9.6	11.0	10.4	10.4	14.0	24.5	16.0	32.1	20.5	44.3	11.0	8.0	8.7	8.0	0.0	16.7	10.4	29.5	8.6	11.9	16.5	0.0	5.8	21.8	14.5	13.7	13.1	64.0	19.0	18.9	20.7	16.7	6.1	29.4	15.0	6.9	16.7	14.8	10.5	19.0	10.6	27.1	23.1	16.3	0.0	63.9	16.0	12.2	40.5	27.7	23.4	12.5	36.4	19.6	26.2	28.1	0.0	5.2	33.2	51.6	22.3	10.0	19.9	28.3	10.2	7.3	31.3	26.6	0.0	0.0	20.4	17.7	62.1	20.4	10.3	11.9	8.2	26.3	17.5	12.3	11.9
MYO15B	MYO15BP	ENSG00000266714	"Myosin XVB"	Q96JP2	17	75588058-75626849	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 179.2"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 275.4;Paneth cells: 294.2;Proximal enterocytes: 127.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A549: 46.4;HEL: 17.7;HMC-1: 24.9;THP-1: 37.7"	"Not detected"	"Not detected"							"HPA022857, HPA023105"			Approved	Cytosol		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA022857: AB_1848813, HPA023105: AB_1859526"	"prognostic favorable (9.34e-4)"	"unprognostic (7.55e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.59e-4)"	"unprognostic (7.29e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-1)"	"prognostic favorable (6.90e-5)"	40.0	17.3	34.7	17.3	39.2	57.0	38.1	33.7	45.1	74.7	29.6	53.6	179.2	46.1	7.5	18.6	65.6	25.8	44.4	32.0	34.0	76.0	29.8	55.1	19.2	39.9	36.8	87.1	20.5	4.7	28.9	15.0	40.1	56.5	21.5	9.9	23.6	14.0	13.2	15.9	149.0	9.8	35.5	108.2	25.7	20.9	36.7	17.7	65.8	8.0	7.2	29.0	44.0	46.1	0.6	46.4	0.3	1.2	0.3	0.1	0.7	0.0	0.0	0.0	0.0	5.8	13.6	0.1	1.5	0.0	0.6	0.5	0.0	0.0	0.0	0.6	2.8	17.7	9.5	11.6	1.3	0.0	24.9	0.8	0.8	0.0	0.1	0.8	0.3	7.3	1.2	5.1	0.0	5.0	0.4	7.8	0.7	12.3	11.2	12.7	0.3	2.1	0.3	1.0	1.3	3.2	0.3	0.5	1.5	1.4	3.5	37.7	0.1	0.3	1.2	0.2	0.0	1.7	0.2	0.2	0.7	8.9	0.6	1.3	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.3	0.0	0.4	0.2	0.0	0.1	34.7	39.2	33.7	45.1	32.0	34.0	39.9	36.8	40.1	35.5	36.7	46.1	13.7	0.0	3.3	44.7	8.4	2.4	2.4	2.0	8.0	4.5	4.0	2.7	7.5	11.5	2.4	9.2	16.7	0.1	11.9	275.4	1.9	1.6	0.7	11.6	8.9	14.6	31.7	9.2	1.1	1.5	0.1	7.1	52.0	8.1	14.0	13.6	21.0	2.1	5.5	1.7	1.4	40.3	12.2	10.0	12.6	2.7	5.6	17.5	3.6	42.2	6.9	4.9	12.3	32.6	46.6	8.8	294.2	4.9	1.4	1.9	127.5	14.4	8.0	13.5	6.6	7.1	8.4	3.3	6.8	2.2	3.0	0.1	6.2	4.7	20.1	1.8
NAA80	"FUS2, NAT6"	ENSG00000243477	"N-alpha-acetyltransferase 80, NatH catalytic subunit"	Q93015	3	50296402-50299416	"Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 65.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 6.5;Exocrine glandular cells: 8.8;monocytes: 9.3;Pancreatic endocrine cells: 6.5;Proximal tubular cells: 7.5;Theca cells: 6.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"eosinophil: 56.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 56.3"	"Cell line enhanced"	"Detected in all"		"HMC-1: 60.5"	"Low region specificity"	"Detected in all"							HPA039576	Approved					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA039576: AB_10794750"	"prognostic favorable (3.62e-4)"	"unprognostic (1.02e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.78e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.38e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.16e-2)"	"unprognostic (2.55e-1)"	13.4	12.2	8.2	7.6	9.2	32.4	13.9	10.9	15.2	16.8	3.1	12.3	6.4	13.3	7.0	15.4	15.4	6.3	17.2	8.8	6.5	19.3	14.6	15.5	10.3	11.6	8.0	17.5	15.1	9.0	14.3	5.8	11.9	19.1	7.7	3.8	13.8	10.6	18.0	22.5	13.4	6.8	5.3	16.5	17.7	65.5	7.3	8.2	14.4	7.2	9.7	13.1	15.9	8.9	8.0	6.2	9.0	9.5	10.7	12.3	6.0	7.4	14.6	11.5	9.9	5.4	15.0	24.6	5.5	12.9	9.4	9.9	5.3	24.2	4.7	15.6	9.0	49.2	37.7	12.3	9.4	8.3	60.5	14.8	16.8	19.3	13.3	17.0	14.1	13.2	4.4	22.7	10.5	8.3	9.9	37.7	5.0	3.6	19.9	6.4	3.2	29.9	19.4	3.9	6.3	8.9	8.4	17.5	3.5	5.5	7.6	23.4	11.7	9.2	9.2	11.4	7.3	15.4	8.9	6.1	15.9	15.5	8.8	13.7	3.1	56.3	7.1	4.2	10.3	10.4	9.7	8.6	5.2	7.5	7.6	6.4	0.9	9.8	2.7	2.6	9.4	5.5	8.2	9.2	10.9	15.2	8.8	6.5	11.6	8.0	11.9	5.3	7.3	8.9	6.5	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	3.8	4.1	0.0	0.0	0.0	3.7	0.0	5.4	4.5	0.0	3.9	4.8	0.0	3.1	3.4	2.1	0.0	0.0	0.0	8.8	5.1	2.1	0.0	3.2	0.0	3.6	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	6.5	0.0	0.0	2.4	0.0	0.0	7.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	5.1	2.1	6.4	0.0	0.0
NAGA	D22S674	ENSG00000198951	Alpha-N-acetylgalactosaminidase	P17050	22	42058334-42070842	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 65.0;Hofbauer cells: 91.6;Kupffer cells: 64.4;monocytes: 65.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 202.5;intermediate monocyte: 249.1;myeloid DC: 195.2;non-classical monocyte: 257.9;plasmacytoid DC: 119.8"	"Group enriched"	"Detected in all"	6	"dendritic cells: 195.2;monocytes: 257.9"	"Cell line enhanced"	"Detected in all"		"HMC-1: 190.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000649	Enhanced				"Intracellular and membrane"	NA	NA		2200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA000649: AB_1079448"	"unprognostic (3.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.92e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.53e-1)"	21.4	12.7	9.3	32.3	10.4	20.1	13.4	10.3	10.1	20.6	17.0	26.1	20.4	17.2	12.4	17.2	20.0	22.1	16.0	8.9	11.5	14.9	31.9	27.1	20.8	13.9	10.8	17.0	11.4	39.2	11.7	42.8	12.6	18.2	26.7	7.7	17.3	18.6	7.7	13.4	24.2	28.3	12.2	20.3	16.6	9.0	12.0	13.9	15.1	12.3	19.0	24.8	13.7	14.4	27.8	14.0	21.7	38.9	37.0	41.9	15.9	22.4	45.7	37.9	39.2	31.4	39.9	13.5	13.5	49.1	22.9	19.2	16.7	27.4	22.3	31.0	21.2	33.5	20.1	21.5	21.5	28.1	190.4	28.9	23.8	34.0	14.4	19.5	63.4	11.6	12.4	56.0	30.2	32.3	10.4	11.5	5.8	25.3	18.5	23.0	11.0	24.2	29.4	32.7	6.7	7.7	29.8	27.0	29.3	19.1	40.4	50.9	34.4	26.6	31.8	17.1	20.7	30.9	33.3	10.9	28.3	52.7	33.4	36.5	202.5	25.1	13.6	249.1	13.8	10.5	14.1	12.7	195.2	6.9	9.2	8.4	9.9	18.8	257.9	119.8	18.3	121.0	9.3	10.4	10.3	10.1	8.9	11.5	13.9	10.8	12.6	12.2	12.0	14.4	6.5	9.6	6.7	4.6	8.2	3.3	9.4	10.9	5.7	2.8	6.7	6.2	4.2	4.3	11.3	7.3	8.4	46.1	11.0	27.3	3.9	15.4	15.8	5.6	8.8	11.2	6.0	12.4	1.1	8.1	65.0	13.8	6.1	10.2	9.5	3.2	9.3	33.6	91.6	0.0	2.0	15.0	6.1	64.4	36.3	17.9	7.2	52.5	19.6	12.2	65.8	5.9	6.2	0.5	2.0	13.0	23.9	6.8	22.2	6.0	40.0	9.8	15.7	6.4	19.7	6.1	10.0	10.7	5.2	7.1	3.4	58.3	6.9	6.5	15.4	10.0
NCF1	"NCF1A, NOXO2, p47phox, SH3PXD1A"	ENSG00000158517	"Neutrophil cytosolic factor 1"	P14598	7	74773962-74789376	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 86.4;lymphoid tissue: 97.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 293.0;dendritic cells: 157.3;Kupffer cells: 119.9;Macrophages: 153.4;monocytes: 329.9;Plasma cells: 205.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 1165.0;classical monocyte: 673.5;eosinophil: 1467.3;neutrophil: 2128.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 2128.0;monocytes: 673.5"	"Group enriched"	"Detected in some"	5	"Daudi: 96.2;HMC-1: 130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004524, HPA047836, HPA052095"	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"CAB004524: AB_627987, HPA047836: AB_2680173, HPA052095: AB_2681721"	"unprognostic (4.93e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.55e-3)"	"unprognostic (7.60e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.23e-3)"	"unprognostic (9.99e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-3)"	"unprognostic (3.16e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.09e-1)"	7.5	3.8	1.9	38.7	2.2	86.4	2.7	4.6	2.9	1.7	0.9	7.2	7.6	1.3	0.5	3.3	3.2	5.5	3.0	2.8	2.0	2.9	5.0	17.7	56.8	5.0	3.4	1.1	1.5	0.7	1.2	5.0	4.5	2.1	4.5	1.6	4.2	1.4	1.5	1.8	26.6	4.0	2.4	97.5	6.6	0.8	2.3	7.5	2.6	4.8	37.5	7.6	1.8	6.6	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.1	96.2	0.1	0.0	0.0	0.4	0.0	0.4	0.0	0.5	0.6	2.9	1.4	0.9	0.0	0.8	130.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.9	0.0	0.0	0.1	16.8	0.3	0.0	0.0	1.6	0.0	3.4	0.2	0.4	0.0	0.1	0.0	0.1	0.1	0.1	0.0	20.6	0.2	0.1	0.3	0.2	0.0	0.6	0.3	16.5	0.2	8.1	0.2	1165.0	673.5	1467.3	4.2	242.3	9.8	257.0	10.0	6.7	77.7	276.6	15.4	9.4	2128.0	10.7	60.2	280.9	11.1	514.1	1.9	2.2	4.6	2.9	2.8	2.0	5.0	3.4	4.5	2.4	2.3	6.6	5.0	0.0	2.8	0.0	293.0	3.1	1.1	29.6	5.2	0.2	3.1	3.2	0.6	4.3	10.9	3.7	0.0	0.6	157.3	0.0	0.0	1.3	8.7	0.8	1.0	3.6	0.0	6.1	0.0	0.6	12.2	1.5	10.2	2.5	14.5	0.1	3.9	3.6	39.3	3.3	0.1	0.3	2.0	119.9	23.4	6.4	0.0	153.4	10.6	1.0	329.9	0.3	10.3	0.0	0.1	1.2	4.2	0.4	205.7	1.0	0.4	1.9	17.6	0.5	0.0	1.4	1.5	0.2	0.7	5.0	1.7	4.5	63.6	0.1	0.3	2.2
NCF4	"p40phox, SH3PXD4"	ENSG00000100365	"Neutrophil cytosolic factor 4"	Q15080	22	36860988-36878017	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 180.2;lymphoid tissue: 162.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 70.9;granulocytes: 74.1;Hofbauer cells: 198.4;Kupffer cells: 85.3;Langerhans cells: 55.8;Macrophages: 85.7;Plasma cells: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 657.3;eosinophil: 750.1;neutrophil: 1235.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 1235.8"	"Cell line enhanced"	"Detected in some"		"HEL: 78.3;HMC-1: 396.0;NB-4: 148.7;REH: 76.5;RPMI-8226: 144.0;THP-1: 137.9;U-937: 76.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB010146, HPA036156, HPA057975"	Enhanced		Enhanced	Cytosol		NA	NA		7800	"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"CAB010146: AB_627989, HPA036156: AB_2674974, HPA057975: AB_2683568"	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.78e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (7.06e-8)"	"unprognostic (3.60e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-1)"	29.5	14.4	4.8	43.1	5.0	180.2	12.7	4.9	7.5	4.6	6.4	19.2	11.7	4.5	1.0	7.2	13.9	13.0	9.4	4.9	5.4	8.9	10.1	45.1	39.8	6.8	5.9	3.3	4.1	1.4	5.3	24.3	6.4	7.4	11.8	0.1	10.7	4.5	3.6	4.9	42.6	10.5	5.8	162.3	9.3	1.8	8.6	12.9	8.1	7.1	33.5	18.7	7.2	7.1	1.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.6	0.0	78.3	0.0	0.0	0.0	12.8	396.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	26.8	0.0	0.8	0.0	148.7	0.0	0.0	0.0	76.5	0.0	144.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	137.9	0.0	0.0	0.2	0.1	0.2	0.5	0.1	23.7	0.1	76.8	0.1	657.3	184.6	750.1	2.3	92.5	9.8	108.2	32.0	6.9	86.1	85.9	1.9	2.1	1235.8	4.4	62.0	100.7	96.3	106.3	4.8	5.0	4.9	7.5	4.9	5.4	6.8	5.9	6.4	5.8	8.6	7.1	1.5	3.2	18.7	0.0	70.9	2.8	2.2	1.3	0.6	0.0	3.1	2.5	2.1	0.0	5.8	1.8	0.0	3.2	21.1	1.3	0.0	0.6	0.2	0.2	0.1	3.6	0.0	28.8	0.0	3.1	16.0	1.8	2.0	0.4	74.1	0.0	1.4	0.7	198.4	0.0	0.0	0.5	2.0	85.3	55.8	1.0	0.6	85.7	14.2	3.7	38.5	0.0	3.1	0.0	0.1	0.9	22.5	0.0	68.2	0.3	0.2	0.2	0.9	0.3	0.0	0.5	1.6	0.0	0.4	0.5	2.3	13.0	17.5	0.7	1.7	4.3
NDST2	"HSST2, NST2"	ENSG00000166507	"N-deacetylase and N-sulfotransferase 2"	P52849	10	73801911-73811798	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 13.7;granulocytes: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 110.2"									HPA051515	Approved		Approved	Cytosol		NA	NA		130000	"Cluster 32: T-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA051515: AB_2681517"	"unprognostic (8.84e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.43e-3)"	"unprognostic (5.69e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (4.08e-7)"	"unprognostic (3.71e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.93e-2)"	"unprognostic (9.06e-2)"	14.9	16.7	11.6	19.6	11.6	53.6	13.3	15.7	14.2	15.7	10.6	13.6	10.7	15.7	11.6	16.8	15.0	15.1	11.4	11.6	11.7	14.4	10.9	17.0	24.6	12.6	11.4	15.8	14.1	18.4	15.8	12.5	11.2	15.6	12.1	14.9	17.7	14.2	8.9	18.8	17.4	15.8	10.4	35.3	13.6	13.6	12.5	31.9	13.3	8.5	23.9	15.3	15.4	11.5	10.0	7.9	16.7	26.2	20.9	23.0	9.1	12.3	24.5	13.4	13.3	4.6	12.4	9.5	7.1	21.8	13.6	11.6	8.1	11.8	9.6	23.4	8.5	9.3	7.0	7.3	36.7	11.8	110.2	22.9	14.5	21.4	22.4	41.1	17.5	17.9	9.2	33.8	16.6	8.1	12.7	13.4	4.5	6.4	36.4	8.5	8.2	5.9	11.5	7.2	5.5	9.0	9.9	23.5	7.5	11.3	18.6	18.6	29.5	6.3	7.8	9.1	8.4	17.4	8.0	11.8	7.2	17.0	5.5	0.7	2.7	1.1	2.7	1.9	3.1	1.2	2.3	2.3	2.0	1.3	2.6	3.4	2.8	1.1	1.7	3.4	1.6	1.8	11.6	11.6	15.7	14.2	11.6	11.7	12.6	11.4	11.2	10.4	12.5	11.5	1.5	0.0	3.0	13.7	5.4	1.3	0.8	0.6	1.2	0.7	4.1	2.3	1.8	0.0	1.8	0.0	0.0	1.4	3.6	4.7	0.0	5.4	7.5	0.8	1.2	1.1	2.4	7.8	7.5	9.6	1.5	1.9	4.6	0.7	14.5	0.3	1.4	4.2	5.2	1.7	7.6	2.6	2.0	8.5	3.1	10.4	0.0	10.8	1.8	2.8	5.4	0.8	0.0	5.0	5.0	7.0	3.2	0.0	10.6	1.3	2.4	7.4	2.7	0.8	0.0	1.4	1.5	2.3	1.7	4.7	1.6	6.2	5.3	0.3	2.2	1.9
NEK6	SID6-1512	ENSG00000119408	"NIMA related kinase 6"	Q9HC98	9	124257606-124353307	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 121.0;Hofbauer cells: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 250.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045993, HPA056828"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Cytosol"	"Centriolar satellite"	"CAB045993: AB_2150651, HPA056828: AB_2683250"	"unprognostic (6.27e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.53e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (5.27e-2)"	"unprognostic (4.77e-3)"	18.0	6.1	33.5	32.6	34.3	19.6	14.7	28.1	32.4	26.1	26.5	22.3	17.5	12.2	3.4	8.5	11.2	25.4	7.4	31.8	37.0	17.2	68.2	24.3	27.4	49.8	41.2	9.0	16.7	1.9	6.1	30.2	33.9	19.6	22.5	11.3	20.6	16.7	8.2	5.4	25.8	18.7	34.4	16.6	27.1	7.8	44.2	10.2	7.3	3.1	31.7	24.3	6.4	30.4	31.8	50.0	47.8	18.8	88.3	113.9	59.3	38.8	61.1	58.4	48.4	47.7	57.0	38.2	61.0	74.6	133.2	5.9	24.7	111.7	39.4	43.7	21.8	104.4	42.1	85.4	105.2	19.4	250.0	152.8	17.8	55.4	56.9	152.3	64.3	17.6	19.5	1.7	105.6	32.6	0.9	20.8	12.2	163.7	45.5	40.6	35.6	19.6	62.6	11.4	21.4	7.5	12.6	23.6	54.5	48.3	51.4	76.4	127.5	42.2	42.8	29.5	26.7	8.4	11.4	21.6	53.5	42.3	57.5	28.1	47.6	76.4	9.2	32.1	5.9	52.5	5.5	7.8	29.0	30.2	0.9	3.8	58.8	23.3	41.4	26.9	7.6	21.6	33.5	34.3	28.1	32.4	31.8	37.0	49.8	41.2	33.9	34.4	44.2	30.4	8.4	9.6	4.7	37.9	24.5	2.4	13.8	18.9	4.6	1.0	9.4	6.5	3.3	18.6	8.8	3.7	0.0	47.1	11.3	8.5	1.9	41.3	18.2	9.4	17.7	8.4	6.0	4.0	8.3	23.3	121.0	11.1	19.4	22.2	22.2	1.1	5.0	43.5	112.0	0.0	5.3	18.2	18.3	10.4	22.5	20.0	5.0	31.2	7.2	12.2	57.7	34.6	8.2	15.1	2.4	30.6	11.9	3.8	5.5	17.1	17.2	38.0	3.3	2.1	0.0	4.9	6.4	1.3	17.1	2.4	1.1	36.1	4.5	2.1	18.7	10.2
NFATC3	"NFAT4, NFATX"	ENSG00000072736	"Nuclear factor of activated T cells 3"	Q12968	16	68084751-68229259	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 102.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 105.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050665			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA050665: AB_2681210"	"unprognostic (1.19e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.28e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.93e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.30e-1)"	10.5	6.5	11.3	12.0	13.2	23.0	11.3	15.0	12.3	11.4	13.0	9.2	11.8	10.0	9.1	10.7	10.6	8.4	7.2	10.2	11.2	11.0	19.8	17.6	23.4	13.1	12.4	11.7	11.6	23.1	5.1	11.2	12.5	10.3	10.2	10.4	10.6	9.8	28.6	22.6	11.7	11.4	11.6	17.6	9.1	27.2	12.2	102.0	14.0	22.2	22.8	9.4	6.9	14.6	12.8	15.5	24.6	26.3	20.9	13.6	21.4	8.3	10.7	23.6	19.9	21.4	11.0	43.0	12.4	14.1	7.7	18.7	29.0	14.4	22.1	8.6	18.9	44.0	15.2	48.3	13.6	37.1	105.0	10.2	17.4	23.5	12.6	12.1	20.0	35.4	54.5	12.7	17.3	25.5	60.5	51.0	15.0	19.4	7.7	34.3	23.0	44.7	9.9	14.4	17.7	18.5	62.6	15.0	8.1	14.3	20.7	28.4	11.9	12.0	12.5	14.2	12.5	16.2	30.7	77.7	9.3	34.9	16.6	17.7	3.5	7.7	20.4	5.3	19.3	7.3	11.6	20.5	4.1	8.2	11.6	18.3	4.7	20.4	11.2	4.4	8.5	15.0	11.3	13.2	15.0	12.3	10.2	11.2	13.1	12.4	12.5	11.6	12.2	14.6	26.4	35.3	49.5	50.3	41.8	78.4	41.7	39.4	33.0	28.8	64.0	36.4	1.5	78.6	32.5	58.8	33.3	53.1	64.9	20.8	23.5	27.2	155.3	33.8	17.0	27.2	26.0	34.0	46.2	21.9	16.0	19.7	7.1	37.4	49.4	24.3	37.1	117.0	23.7	37.0	53.8	37.3	34.6	51.0	28.9	99.9	21.8	29.5	23.2	91.8	40.6	9.1	129.8	45.8	73.5	33.1	33.1	26.7	28.6	75.3	57.6	53.5	31.3	27.3	19.7	27.9	18.0	68.6	61.7	25.9	143.2	85.0	59.4	19.7	39.1	58.1
NFILZ	LINC01862	ENSG00000268480	"NFIL3 like basic leucine zipper"	A0A5F9ZHS7	19	8630635-8677708	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	20	"NK-cell: 17.5"	"Lineage enriched"	"Detected in single"	20	"NK-cells: 17.5"	"Group enriched"	"Detected in some"	81	"HMC-1: 9.4;NB-4: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 48: NK-cells - Unknown function"		"Cluster 3: HMC-1 - Innate immune response"																						0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.1	0.0	0.0	0.1	0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	17.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NFKBID	"IkappaBNS, IkBNS, TA-NFKBH"	ENSG00000167604	"NFKB inhibitor delta"	Q8NI38	19	35887653-35902303	"Predicted intracellular proteins, Transcription factors"	"Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 152.7;granulocytes: 90.3;Langerhans cells: 418.5;Macrophages: 89.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA054778			Uncertain	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol	"Nuclear bodies, Plasma membrane"	"HPA054778: "	"prognostic favorable (6.01e-4)"	"unprognostic (9.60e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.51e-2)"	"prognostic favorable (5.43e-4)"	"unprognostic (4.21e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.83e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.47e-3)"	"unprognostic (5.64e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.71e-2)"	"prognostic favorable (8.34e-6)"	4.0	1.8	0.7	4.4	0.6	15.9	2.5	2.7	1.6	1.9	2.1	2.3	1.1	1.8	0.0	2.1	3.0	2.4	1.5	0.8	1.4	2.5	1.5	5.6	4.8	1.4	0.9	3.3	2.1	0.9	4.2	0.8	1.2	2.2	0.8	0.7	1.6	0.5	0.4	2.2	4.0	0.5	1.0	5.4	2.0	0.4	1.3	5.2	3.9	0.2	3.1	2.2	2.0	1.7	3.3	3.0	0.6	2.0	0.3	0.5	1.4	2.0	2.4	2.1	1.5	0.7	2.6	4.0	1.5	2.1	1.9	1.7	2.1	1.6	0.9	2.3	0.4	2.4	4.9	0.7	0.5	2.1	7.0	0.7	1.0	3.9	0.9	0.5	0.8	1.8	0.5	2.4	0.4	2.6	1.7	2.5	0.8	0.6	0.6	0.9	0.4	0.8	1.8	1.4	1.0	0.8	2.7	2.1	0.2	0.5	0.9	2.1	0.8	3.3	3.0	1.5	1.4	1.7	0.6	4.6	1.8	4.9	0.5	0.0	0.9	1.7	1.4	0.6	1.1	3.3	0.6	1.1	0.9	5.5	1.0	0.6	3.2	1.5	1.1	1.2	1.5	0.5	0.7	0.6	2.7	1.6	0.8	1.4	1.4	0.9	1.2	1.0	1.3	1.7	11.7	0.0	11.3	2.9	152.7	29.7	14.3	12.9	34.7	8.0	10.9	7.5	1.1	5.7	5.6	1.8	20.9	1.3	58.9	5.7	0.0	2.5	0.1	27.8	6.8	21.5	3.0	1.7	4.9	1.0	2.8	11.3	2.0	80.8	90.3	3.8	9.3	0.3	39.2	0.0	3.4	5.7	2.0	31.0	418.5	0.4	1.2	89.4	19.6	2.8	40.0	1.0	13.4	1.5	0.5	2.8	2.1	1.9	38.1	13.8	9.2	1.7	3.9	9.2	0.0	3.3	6.7	0.4	1.0	20.7	33.4	1.0	45.3	2.4	6.2	10.0
NHLRC4		ENSG00000257108	"NHL repeat containing 4"	P0CG21	16	567005-569495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 11.7;kidney: 10.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 23.9;Endometrial ciliated cells: 23.3;Erythroid cells: 11.8;Leydig cells: 8.1;Respiratory ciliated cells: 18.1;Theca cells: 12.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 3.3;HMC-1: 9.6;REH: 2.6;RPMI-8226: 4.3"	"Low region specificity"	"Detected in single"							HPA077301			Approved	Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria		"HPA077301: "	"unprognostic (7.95e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.28e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.95e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.60e-1)"	0.8	5.4	0.6	0.7	0.5	2.9	1.2	0.8	0.5	1.8	2.1	0.9	1.0	1.1	2.1	0.3	11.7	0.9	0.9	0.7	1.0	10.5	0.2	2.0	1.9	2.8	3.3	3.0	0.2	3.2	1.1	0.6	1.7	1.4	0.2	0.0	2.2	2.4	0.5	0.3	1.5	0.3	2.3	3.8	0.6	2.7	0.8	2.4	0.4	0.2	0.6	0.7	0.6	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.6	0.1	0.1	0.1	0.1	0.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.1	3.3	0.0	0.8	0.7	0.2	9.6	1.9	0.0	0.1	0.2	0.0	0.2	0.6	1.0	1.1	0.0	0.0	0.3	2.5	0.2	0.0	0.0	2.6	0.0	4.3	0.2	0.1	0.0	0.9	0.0	0.0	0.3	0.0	0.4	0.5	0.5	0.0	0.0	0.0	0.0	1.5	1.4	0.7	0.0	0.1	0.2	0.0	0.2	2.3	0.1	0.0	0.2	0.4	0.5	0.2	0.2	0.2	0.5	0.3	0.0	0.3	0.1	1.7	0.5	0.3	0.6	0.5	0.8	0.5	0.7	1.0	2.8	3.3	1.7	2.3	0.8	0.6	1.6	0.0	0.0	0.3	1.2	0.0	0.5	0.8	0.6	0.1	1.9	1.4	0.2	0.0	2.2	23.9	0.0	0.2	1.8	0.1	0.0	0.0	0.0	23.3	1.1	1.0	0.0	11.8	0.1	0.2	0.0	2.3	0.0	1.0	0.0	0.4	1.1	0.0	1.7	0.0	0.5	0.2	2.0	0.6	0.9	0.4	8.1	0.5	0.0	1.0	0.2	1.5	1.0	0.0	0.0	0.0	0.0	4.5	0.9	0.3	0.3	0.1	18.1	0.1	6.6	0.1	2.0	0.1	0.1	0.0	0.1	0.0	0.7	12.7	0.2	0.3
NLK		ENSG00000087095	"Nemo like kinase"	Q9UBE8	17	28041737-28196381	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 78.6"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 154.3;Early spermatids: 261.1;Excitatory neurons: 315.5;Late spermatids: 355.3;Oligodendrocytes: 366.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	45	"basophil: 29.9"	"Lineage enriched"	"Detected in single"	45	"granulocytes: 29.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018192, HPA056511"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA018192: AB_1854525, HPA056511: AB_2683160"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.54e-2)"	"unprognostic (5.64e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.72e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.57e-2)"	8.2	36.6	16.7	8.6	27.6	9.9	9.4	5.7	41.9	7.9	1.0	9.0	10.3	7.0	11.2	5.5	6.4	8.7	11.5	28.5	9.2	16.6	11.1	9.1	16.4	11.9	10.4	5.0	14.3	28.2	11.1	12.2	8.4	8.2	9.2	78.6	7.4	10.8	6.6	5.9	10.2	5.9	6.5	12.2	8.9	22.0	12.2	13.2	16.8	6.7	15.4	10.1	4.5	30.1	9.5	11.6	28.4	9.7	6.1	7.6	12.1	9.6	10.9	16.9	13.1	59.4	9.1	13.6	13.8	8.4	20.2	8.6	19.6	18.7	19.3	29.7	12.2	52.2	11.2	9.9	10.3	11.6	51.0	9.6	11.9	10.4	12.5	16.0	20.4	36.3	20.1	15.9	16.4	11.6	28.8	13.4	10.4	20.1	5.5	23.8	17.2	10.0	32.0	12.2	19.6	7.2	14.4	14.4	62.4	32.2	22.0	18.2	19.2	11.7	14.1	9.0	19.5	17.6	17.9	13.1	11.6	12.6	13.0	29.9	0.3	0.3	0.5	0.4	0.2	0.6	0.5	0.6	0.3	0.3	0.3	0.6	0.2	0.2	0.5	0.5	0.5	0.3	16.7	27.6	5.7	41.9	28.5	9.2	11.9	10.4	8.4	6.5	12.2	30.1	17.8	22.4	6.0	57.8	7.8	5.4	3.8	3.0	5.7	94.4	8.7	5.0	27.4	5.7	5.3	33.1	154.3	3.7	4.3	11.4	1.9	3.9	261.1	8.9	5.8	15.0	28.2	11.8	315.5	6.4	3.5	4.8	5.1	11.9	24.1	17.6	9.3	9.4	8.8	37.0	98.2	10.0	2.0	16.9	6.0	355.3	5.6	11.3	16.0	103.0	7.9	11.2	6.2	104.5	366.6	5.7	8.1	2.6	6.4	5.4	5.1	8.4	9.5	89.9	13.1	5.0	6.9	37.1	11.8	4.1	4.8	6.4	5.5	6.7	10.3	6.6
NLRP12	"CLR19.3, Monarch1, NALP12, PAN6, PYPAF7, RNO2"	ENSG00000142405	"NLR family pyrin domain containing 12"	P59046	19	53793741-53824394	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;lymphoid tissue: 4.3"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 7.4;granulocytes: 7.6;Kupffer cells: 11.2;Macrophages: 7.8;monocytes: 20.5"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 2.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basophil: 56.9;classical monocyte: 18.1;eosinophil: 23.2;neutrophil: 29.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 56.9;monocytes: 18.1"	"Group enriched"	"Detected in some"	4	"HMC-1: 4.6;THP-1: 4.1;U-87 MG: 4.3;U-937: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042981	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA042981: AB_10795712"	"unprognostic (6.92e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.66e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.81e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.48e-1)"	0.9	0.0	0.1	2.2	0.1	6.0	0.1	0.0	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.3	0.3	0.2	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.7	0.1	4.3	0.1	0.1	0.3	0.1	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.3	3.8	0.0	56.9	18.1	23.2	0.0	5.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	29.8	0.0	3.0	0.1	0.0	5.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.3	6.4	7.4	0.0	0.5	0.4	1.0	0.1	0.0	0.7	0.2	0.1	0.5	0.0	3.7	0.0	0.0	0.2	1.4	0.2	0.0	0.0	0.2	0.1	0.1	1.9	0.0	0.0	0.7	0.0	0.2	1.5	0.0	0.3	7.6	0.2	0.7	0.0	2.4	0.0	0.8	0.0	0.0	11.2	1.6	0.2	0.3	7.8	1.8	0.0	20.5	0.2	2.1	0.0	0.5	0.1	0.0	0.0	0.3	0.8	0.0	0.1	2.2	0.7	0.0	0.7	0.2	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.0	0.7
NME9	"NM23-H9, TXL-2, TXNDC6"	ENSG00000181322	"NME/NM23 family member 9"	Q86XW9	3	138261437-138329886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 14.6;fallopian tube: 17.6"	"Group enriched"	"Detected in some"	6	"Astrocytes: 27.4;Endometrial ciliated cells: 20.0;Excitatory neurons: 26.6;Inhibitory neurons: 17.9;Oligodendrocyte precursor cells: 67.8;Oligodendrocytes: 36.6;Respiratory ciliated cells: 48.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020943, HPA040000, HPA043881"	Enhanced		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Centriolar satellite"	"CAB020943: , HPA040000: AB_2676793, HPA043881: AB_2678712"	"unprognostic (2.71e-5)"	"unprognostic (1.68e-1)"	"unprognostic (5.09e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.58e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.17e-3)"	0.7	0.7	4.1	0.4	4.0	2.9	0.7	8.8	5.5	1.1	14.6	0.6	0.2	0.6	0.7	0.4	17.6	0.4	0.5	3.4	4.1	1.0	0.4	2.2	0.3	6.9	7.0	0.7	1.3	0.9	3.7	0.2	4.2	0.8	0.0	7.4	1.6	0.7	2.7	0.8	0.8	0.2	5.2	0.5	0.6	4.3	5.0	0.5	1.1	0.0	0.2	0.5	0.5	4.4	0.3	0.2	0.4	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.3	0.6	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.2	0.7	0.8	0.1	0.0	1.0	1.7	0.3	0.0	0.0	0.0	0.7	0.0	0.7	0.2	0.4	0.0	0.1	0.1	1.0	0.2	0.1	0.3	0.3	0.0	0.3	0.5	0.9	0.9	0.2	0.6	0.1	0.1	0.3	0.3	0.0	1.1	0.3	0.2	0.3	0.1	0.3	0.4	0.4	0.2	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.3	0.0	0.1	0.2	0.4	0.1	0.1	0.1	0.0	0.2	0.2	0.0	4.1	4.0	8.8	5.5	3.4	4.1	6.9	7.0	4.2	5.2	5.0	4.4	0.2	0.0	0.5	27.4	0.0	0.0	0.2	1.1	0.0	1.5	0.1	0.0	1.5	2.8	2.3	1.8	0.0	0.1	0.0	0.0	0.0	0.2	3.1	20.0	0.2	0.3	0.0	0.0	26.6	0.0	0.0	0.4	0.0	0.5	0.0	0.3	0.4	0.0	0.0	3.3	17.9	0.0	0.0	0.3	0.0	1.4	0.3	0.0	0.0	1.0	0.0	2.7	0.0	67.8	36.6	0.0	0.0	0.0	0.3	0.2	0.0	0.5	48.4	2.3	0.0	0.5	0.7	5.0	0.7	0.0	0.0	0.3	0.2	0.4	0.0	0.1
NMS		ENSG00000204640	"Neuromedin S"	Q5H8A3	2	100470482-100483280	"Predicted secreted proteins"		Neuropeptide		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	7	"brain: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"medulla oblongata: 2.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"HL-60: 8.4;HMC-1: 4.8"	"Group enriched"	"Detected in some"	4	"basal ganglia: 2.4;hypothalamus: 5.4;pons and medulla: 1.3"										"Secreted in brain"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"																					0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.9	2.7	0.1	0.2	1.7	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NOD2	"BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, PSORAS1"	ENSG00000167207	"Nucleotide binding oligomerization domain containing 2"	Q9HC29	16	50693588-50734041	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.6;esophagus: 11.7;skin 1: 14.4;vagina: 12.3"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 8.3;Kupffer cells: 9.0;Langerhans cells: 22.5;Macrophages: 15.2;monocytes: 15.6;Suprabasal keratinocytes: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"classical monocyte: 23.0;eosinophil: 6.0;intermediate monocyte: 13.1;myeloid DC: 21.3;neutrophil: 10.5;non-classical monocyte: 9.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 21.3;granulocytes: 10.5;monocytes: 23.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 11.6;T-47d: 5.8;THP-1: 7.3;U-266/70: 15.9;U-266/84: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041985, HPA054494"	Enhanced		Approved	"Golgi apparatus,Cytosol"		No	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Cytosol"		"HPA041985: AB_2677780, HPA054494: AB_2682505"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-3)"	"unprognostic (9.91e-3)"	"unprognostic (5.84e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.31e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	1.5	0.5	0.5	5.9	0.2	13.6	1.5	0.2	1.0	5.6	0.7	0.9	1.5	0.6	0.3	11.7	0.9	1.3	0.7	0.2	0.4	0.6	1.7	4.3	2.7	1.0	0.9	0.4	0.3	0.2	0.4	1.2	0.7	0.9	0.9	0.0	4.3	0.4	0.6	14.4	1.3	1.8	0.7	4.4	1.4	0.5	1.4	0.8	0.4	0.3	2.3	1.6	12.3	0.8	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	11.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.1	0.0	1.5	0.0	0.0	5.8	7.3	0.0	0.0	0.0	0.0	0.0	15.9	7.2	0.0	0.3	0.1	0.0	3.0	23.0	6.0	0.4	13.1	0.7	0.1	1.3	1.4	21.3	0.0	0.1	0.5	10.5	3.4	9.0	1.0	0.9	11.1	0.5	0.2	0.2	1.0	0.2	0.4	1.0	0.9	0.7	0.7	1.4	0.8	0.2	0.0	3.7	0.0	1.9	5.9	0.3	1.2	0.0	0.0	1.4	1.1	0.4	1.5	2.3	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	5.6	0.8	0.6	1.2	0.8	0.1	0.0	0.0	0.4	0.0	8.3	1.3	0.5	0.0	0.5	2.5	0.0	0.1	0.0	2.0	9.0	22.5	0.0	0.0	15.2	1.8	1.9	15.6	0.0	1.0	0.0	0.2	0.0	0.0	0.4	4.3	0.4	0.0	0.1	1.0	0.0	0.0	0.1	0.4	0.1	0.4	6.1	15.5	0.3	2.3	0.1	0.1	0.3
NPHS1	"CNF, NPHN"	ENSG00000161270	"NPHS1 adhesion molecule, nephrin"	O60500	19	35825372-35869287	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Myogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"kidney: 41.5;pancreas: 22.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.0;Early spermatids: 13.5;Endometrial ciliated cells: 4.5;Fibroblasts: 5.1;Glandular and luminal cells: 12.1;Late spermatids: 6.9"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.1;JURKAT: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB035555	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"CAB035555: "	"unprognostic (3.42e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.47e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.83e-5)"	"unprognostic (4.30e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	0.3	0.0	0.4	0.6	0.9	0.2	0.0	0.8	0.4	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	41.5	0.1	0.0	3.9	0.4	0.4	0.0	22.8	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.3	0.7	0.6	0.7	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.8	0.4	0.4	0.2	0.4	0.4	0.5	0.1	0.6	0.7	0.3	0.0	0.5	0.0	0.2	0.8	0.8	0.0	0.6	5.0	0.3	0.3	1.0	0.0	0.0	3.7	0.0	0.0	0.2	0.0	0.0	0.3	13.5	4.5	0.4	0.7	0.0	0.0	0.7	2.4	0.0	5.1	0.0	12.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	2.1	6.9	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.4	0.5	0.8	0.4	0.1	0.4	0.0	0.3	0.0	0.1	0.3
NPIPA7		ENSG00000214967	"Nuclear pore complex interacting protein family member A7"	E9PJI5	16	16379055-16393954	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Cardiomyocytes: 16.2;Endothelial cells: 3.8;Fibroblasts: 4.8;granulocytes: 5.7;Respiratory ciliated cells: 2.9;Smooth muscle cells: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HMC-1: 91.3;THP-1: 81.3"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA053611: AB_2682206"					"unprognostic (1.17e-2)"													16.5	24.2	32.7	9.7	32.2	12.9	10.9	38.4	44.1	16.7	30.8	20.1	9.7	11.1	24.7	23.2	14.6	16.7	9.9	32.4	32.8	28.5	28.9	14.8	16.0	31.8	31.2	17.6	36.5	26.8	84.7	9.9	32.0	23.4	22.6	28.8	16.9	9.1	9.5	35.5	18.6	11.0	30.5	28.1	18.7	26.3	32.1	14.3	28.2	4.1	12.9	13.7	13.6	32.5	7.6	16.6	19.6	7.6	11.5	9.2	12.8	15.7	6.1	17.6	9.2	17.3	11.9	19.0	12.2	16.5	10.6	22.8	13.9	16.1	13.0	5.6	4.2	19.2	59.5	26.0	10.9	6.8	91.3	16.5	61.1	9.7	20.6	21.7	9.2	31.3	11.6	23.8	19.4	32.5	15.4	39.5	13.6	27.8	5.5	22.5	13.2	11.1	29.1	32.3	25.3	13.5	12.4	28.3	12.8	23.9	20.4	81.3	7.9	16.8	7.9	7.7	13.5	4.9	19.7	15.4	9.6	21.2	7.6	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	32.2	38.4	44.1	32.4	32.8	31.8	31.2	32.0	30.5	32.1	32.5	0.0	3.2	2.6	0.3	0.2	1.7	0.0	0.5	0.0	0.0	0.0	0.0	16.2	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.6	0.0	0.0	4.8	0.0	0.0	5.7	0.1	0.0	0.0	0.1	0.0	0.5	0.5	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.5	0.0
NPIPA8	LCR16a9	ENSG00000214940	"Nuclear pore complex interacting protein family member A8"	P0DM63	16	18317942-18336736	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.2;granulocytes: 1.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 28.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 61.3;EFO-21: 58.1;HMC-1: 217.0;SCLC-21H: 53.1;THP-1: 60.6"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"HPA053611: AB_2682206"					"unprognostic (1.68e-1)"					"unprognostic (3.60e-2)"				"unprognostic (2.81e-1)"				14.3	9.6	3.7	2.5	3.9	6.9	13.3	6.5	28.6	13.1	2.4	28.7	0.2	12.6	0.5	10.1	28.7	0.1	11.3	4.0	3.4	18.4	9.6	12.4	2.5	4.0	3.2	20.7	11.0	6.3	36.4	6.3	4.6	16.9	2.1	5.0	9.8	7.5	18.9	14.6	12.9	0.4	2.7	13.1	13.9	20.8	4.3	3.1	13.7	0.1	0.1	15.8	10.8	3.6	0.0	2.3	0.3	0.5	1.5	0.7	0.7	0.0	0.0	0.1	0.2	0.4	10.5	61.3	58.1	0.5	0.0	0.1	23.6	7.1	0.1	0.1	0.1	0.1	1.9	2.0	9.7	0.1	217.0	0.3	0.0	0.0	0.0	0.1	4.3	14.4	24.4	0.2	0.0	0.1	0.0	0.2	16.4	24.8	0.0	2.5	36.2	1.7	0.3	0.2	53.1	16.8	0.0	0.4	0.6	11.2	0.0	60.6	0.0	1.1	0.1	0.2	13.8	0.0	0.1	0.2	18.6	16.5	1.3	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	3.9	6.5	28.6	4.0	3.4	4.0	3.2	4.6	2.7	4.3	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0
NPIPA9		ENSG00000233024	"Nuclear pore complex interacting protein family, member A9"		16	18358086-18379331	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"											HPA053611	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (9.10e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.66e-1)"	"unprognostic (5.77e-2)"	"unprognostic (8.31e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.30e-3)"	"unprognostic (5.87e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.25e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.90e-2)"	"unprognostic (5.38e-2)"	"unprognostic (6.45e-3)"	67.7	62.8	166.9	26.7	164.4	29.4	66.5	232.7	283.1	82.8	136.2	119.7	25.7	74.7	58.4	63.5	78.1	30.6	77.6	168.1	177.5	79.6	64.1	67.1	32.4	165.7	150.8	135.0	75.1	44.7	224.4	22.8	169.8	89.4	40.2	72.4	55.9	43.0	115.1	73.9	69.2	47.7	132.7	74.7	64.7	84.8	152.5	30.7	81.4	29.1	27.3	70.2	66.3	162.9	23.6	15.1	82.7	67.9	69.4	64.4	19.3	88.5	32.1	42.6	63.0	15.2	13.6	32.6	33.2	78.4	25.2	41.7	26.0	24.0	51.9	27.8	24.8	87.0	85.7	75.4	70.3	41.7	190.6	66.6	105.3	53.5	71.4	89.2	21.1	39.3	20.4	62.7	43.1	35.8	68.2	89.3	34.8	23.2	19.0	97.1	20.6	32.5	42.4	43.9	23.4	36.2	55.5	34.5	49.3	31.6	31.9	48.4	40.4	56.9	24.9	48.4	27.5	46.9	40.3	49.2	25.5	56.2	30.1	0.0	0.1	0.1	0.5	0.0	0.2	1.4	0.4	0.3	0.0	0.3	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	166.9	164.4	232.7	283.1	168.1	177.5	165.7	150.8	169.8	132.7	152.5	162.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPIPB7	"LOC440350, NPIPL1"	ENSG00000233232	"Nuclear pore complex interacting protein family member B7"	O75200	16	28456372-28471175	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 22.2"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 152.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA011188, HPA053611"	Approved		Approved	Nucleoplasm	"Secreted in male reproductive system"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA011188: AB_2668455, HPA053611: AB_2682206"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.94e-1)"		"unprognostic (7.43e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.03e-2)"	1.4	0.9	4.0	1.4	4.0	2.6	1.0	6.1	8.2	0.5	0.1	1.4	1.0	1.3	2.1	0.2	0.7	0.3	0.4	4.0	3.0	0.6	1.2	0.8	1.5	3.1	0.7	1.6	1.7	0.4	0.3	0.7	1.9	1.0	1.4	4.5	0.8	1.1	5.0	3.2	1.3	0.7	0.0	1.3	2.4	22.2	2.7	1.0	0.6	1.0	0.6	0.5	0.1	1.7	0.6	4.1	3.0	2.0	1.3	1.3	6.3	1.5	0.1	0.3	0.5	1.5	1.8	3.2	0.9	1.0	0.3	2.0	0.9	0.6	0.2	1.1	1.5	1.2	4.5	3.1	0.6	2.8	6.3	1.4	3.1	1.0	0.9	1.6	0.1	1.9	1.0	2.2	0.7	5.4	0.7	2.9	1.9	0.2	0.2	2.6	1.8	1.6	0.2	1.5	1.6	0.8	1.3	0.5	0.6	2.8	2.2	1.2	2.2	1.1	2.8	1.5	1.0	4.4	2.2	3.1	0.4	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.0	6.1	8.2	4.0	3.0	3.1	0.7	1.9	0.0	2.7	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	1.8	0.0	0.2	0.0	0.1	0.0	0.0	152.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0
NRIP3	C11orf14	ENSG00000175352	"Nuclear receptor interacting protein 3"	Q9NQ35	11	8980576-9004049	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 72.9;retina: 24.5;testis: 43.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 545.3;Horizontal cells: 242.3;Late spermatids: 478.6;Spermatocytes: 189.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 13.1"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 51.4;SiHa: 34.3;U-87 MG: 47.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058827, HPA072961"	Approved		Approved	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA058827: AB_2683829, HPA072961: "	"unprognostic (2.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.03e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.88e-3)"	"unprognostic (1.30e-1)"	1.1	10.2	16.7	1.6	13.4	13.8	3.9	23.2	42.1	3.4	0.0	1.5	0.5	3.2	3.1	0.8	2.2	1.6	1.2	72.9	20.8	1.4	0.2	0.8	0.8	20.5	18.4	0.5	0.4	5.4	1.5	0.8	23.6	0.7	0.6	24.5	0.6	0.9	0.3	0.6	0.6	2.3	25.1	0.5	2.5	43.5	31.6	0.9	0.9	0.2	0.6	1.3	0.7	17.2	0.0	0.9	1.9	0.3	0.7	2.7	0.1	20.3	8.0	16.2	16.9	3.1	1.8	0.1	3.0	5.9	9.6	0.2	5.5	0.5	28.0	1.7	8.5	2.2	1.2	0.2	1.4	26.5	51.4	3.7	0.3	16.7	0.1	17.1	13.3	4.4	4.2	0.2	15.0	0.0	1.3	8.6	6.6	0.1	0.0	0.0	2.8	0.0	0.3	1.2	5.4	1.7	34.3	0.9	5.3	1.4	3.5	2.5	16.6	24.7	11.8	1.4	0.1	0.1	0.0	0.0	47.9	3.1	12.3	13.1	0.1	2.0	0.1	0.3	0.2	0.1	0.5	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.1	0.3	16.7	13.4	23.2	42.1	72.9	20.8	20.5	18.4	23.6	25.1	31.6	17.2	4.0	0.0	1.3	1.0	1.7	2.2	5.7	0.5	0.0	19.6	12.1	8.9	1.6	0.0	0.4	0.0	10.4	0.4	7.4	0.6	5.9	0.4	545.3	3.7	4.1	2.5	5.3	2.7	11.5	1.1	0.5	2.5	7.1	6.6	15.8	2.4	0.0	0.0	12.1	242.3	96.3	0.5	8.2	3.1	17.2	478.6	6.8	12.8	3.6	0.0	0.6	4.4	0.0	4.5	1.6	8.2	0.1	5.7	1.2	3.5	0.1	0.0	0.1	10.6	0.0	6.0	3.6	189.8	44.0	0.9	1.0	1.0	5.5	5.6	0.2	4.2
NTRK1	"MTC, TRK, TRKA"	ENSG00000198400	"Neurotrophic receptor tyrosine kinase 1"	P04629	1	156815640-156881850	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 7.0;brain: 21.7"	"Group enriched"	"Detected in some"	10	"Bipolar cells: 22.8;granulocytes: 55.9;Horizontal cells: 57.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Group enriched"	"Detected in many"	6	"cerebral cortex: 7.6;medulla oblongata: 19.8;pons: 21.7"	"Immune cell enriched"	"Detected in single"	116	"basophil: 94.5"	"Lineage enriched"	"Detected in single"	768	"granulocytes: 94.5"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 82.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 8.4"	"Region enriched"	"Detected in single"	6	"basal ganglia: 4.1"	"CAB004606, HPA035799, HPA076570"	Approved		Approved	Vesicles,Cytosol		NA	NA		79000	"Cluster 38: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Vesicles, Cytosol"		"CAB004606: AB_628397, HPA035799: AB_2674788, HPA076570: "	"unprognostic (5.89e-3)"	"unprognostic (7.56e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-11)"	"unprognostic (2.18e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-1)"	0.8	7.0	0.7	0.4	1.8	0.7	0.2	1.8	7.6	0.7	0.7	0.8	0.5	1.0	0.0	0.1	0.5	0.4	1.0	0.3	2.8	3.0	0.0	0.5	0.1	19.8	1.5	0.1	0.2	0.0	0.7	0.2	21.7	1.4	0.0	1.9	0.5	0.3	0.4	0.1	0.3	0.6	0.2	0.1	0.5	1.6	0.4	0.3	0.2	0.2	0.0	0.3	0.5	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.0	11.9	0.0	14.0	0.0	0.0	0.0	0.0	82.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.4	1.6	0.0	0.2	0.0	2.4	0.2	0.0	1.5	2.5	0.0	0.2	0.0	0.5	1.5	18.2	0.0	0.1	0.0	0.3	0.0	0.1	0.3	0.0	1.1	0.0	0.0	3.5	0.6	0.0	0.0	0.0	0.1	94.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.7	1.8	1.8	7.6	0.3	2.8	19.8	1.5	21.7	0.2	0.4	0.6	0.1	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	4.2	0.7	0.0	0.0	4.3	0.0	0.1	55.9	0.0	0.0	0.0	0.1	57.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.5	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.9	3.2	2.7	0.0	0.1	0.0	1.0	0.1	0.0	0.0
NUDT14	UGPP	ENSG00000183828	"Nudix hydrolase 14"	O95848	14	105172938-105181323	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 176.1;Proximal enterocytes: 206.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046755, HPA058759"	Approved		Approved	Nucleoli,Microtubules		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Microtubules	Nucleoli	"HPA046755: AB_10963433, HPA058759: AB_2683809"	"unprognostic (1.05e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.05e-3)"	"unprognostic (9.17e-3)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.16e-3)"	"unprognostic (3.13e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.38e-1)"	16.5	23.9	17.4	3.5	20.1	2.1	19.3	19.9	28.4	9.0	27.5	14.5	12.5	6.4	3.5	17.5	8.9	6.4	27.5	19.9	21.5	28.8	19.5	20.1	5.9	19.0	17.4	6.4	40.4	16.0	61.1	3.2	19.1	18.6	2.9	4.7	17.2	2.9	31.6	14.1	16.3	1.8	17.9	12.5	17.6	13.9	17.2	3.6	22.1	12.7	2.1	8.4	11.3	21.1	18.1	24.2	2.1	9.4	2.8	3.3	38.1	5.0	6.5	8.0	11.5	17.5	18.7	1.3	24.4	2.6	17.8	22.7	1.1	13.6	0.7	9.5	17.7	4.0	10.4	12.2	19.9	4.8	46.7	4.7	16.7	1.9	1.4	3.4	15.9	8.8	6.4	2.9	2.8	52.5	0.6	0.0	12.6	42.7	33.5	9.4	21.9	10.8	8.8	51.2	32.8	4.8	9.0	0.2	21.7	3.9	18.8	23.1	38.3	13.2	5.8	9.5	5.1	1.4	1.0	2.2	19.4	5.5	4.9	6.2	40.5	1.2	12.6	40.8	7.5	12.8	9.6	8.0	33.5	10.2	9.4	10.8	1.3	15.2	68.6	17.0	6.0	19.2	17.4	20.1	19.9	28.4	19.9	21.5	19.0	17.4	19.1	17.9	17.2	21.1	66.1	12.8	28.5	5.2	12.4	38.9	101.7	123.4	52.9	12.1	46.8	78.5	54.5	40.0	41.2	35.0	18.8	44.7	16.1	88.2	176.1	94.1	3.1	59.3	8.0	61.6	37.3	10.1	5.9	30.8	18.2	14.7	30.5	31.0	38.8	11.9	27.1	28.0	137.0	35.3	3.0	62.6	73.2	27.4	27.1	9.8	11.5	33.9	46.2	12.2	35.6	38.3	22.6	0.5	5.8	51.2	132.4	3.8	7.7	51.9	206.9	169.1	65.7	19.1	0.0	39.0	11.4	12.4	48.5	30.4	19.0	38.2	26.8	5.2	75.4	82.2
NUTM2A	FAM22A	ENSG00000184923	"NUT family member 2A"	Q8IVF1	10	87225448-87236908	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 10.2"									HPA064635			Approved	"Nuclear bodies"		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear bodies"		"HPA064635: "	"unprognostic (1.75e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.29e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.75e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.65e-1)"	1.4	1.1	1.8	0.5	2.6	0.9	1.1	0.8	2.8	0.9	0.0	1.3	0.7	1.4	0.9	0.9	1.0	0.5	2.2	1.2	1.7	1.3	1.3	1.1	0.6	3.2	2.2	1.3	1.7	1.4	1.5	0.7	2.5	1.6	0.5	0.6	2.4	0.4	1.3	1.8	1.2	0.4	1.1	1.3	1.5	2.0	2.9	1.0	1.5	1.6	0.3	1.1	1.2	4.4	1.4	0.1	0.8	0.0	1.3	0.6	0.7	0.6	1.3	0.6	0.4	0.3	0.6	1.2	0.1	0.0	0.2	1.1	0.0	0.9	0.1	0.4	1.0	2.0	0.3	0.3	0.6	0.8	10.2	0.4	3.2	1.0	1.0	1.2	0.0	1.9	1.9	0.3	0.1	1.0	1.0	2.0	2.3	0.0	0.3	1.5	0.1	0.0	0.4	0.1	1.2	2.0	0.6	0.5	0.5	0.1	0.6	0.8	1.4	0.0	0.3	0.6	0.2	0.0	0.2	0.6	0.6	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.6	0.8	2.8	1.2	1.7	3.2	2.2	2.5	1.1	2.9	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0
NUTM2B	"bA119F19.1, FAM22B"	ENSG00000188199	"NUT family member 2B"	A6NNL0	10	79703227-79714681	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"											HPA064635			Approved	"Nuclear bodies"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nuclear bodies"		"HPA064635: "	"unprognostic (9.51e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.63e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.15e-1)"	"unprognostic (9.70e-2)"	"unprognostic (9.97e-2)"	"unprognostic (5.72e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.32e-2)"	0.6	0.7	1.6	0.7	1.3	1.4	0.6	3.1	1.9	0.6	0.0	0.8	0.2	0.8	0.5	0.6	0.9	0.2	1.5	1.7	0.9	1.6	1.1	0.8	0.7	1.6	0.9	0.9	1.4	0.7	1.8	0.3	1.5	1.1	0.2	0.8	1.0	0.3	1.0	1.1	0.9	0.1	0.3	1.3	0.9	3.4	1.8	0.7	0.9	0.1	0.7	0.5	0.8	1.8	0.7	0.8	1.7	1.0	0.4	0.4	0.7	0.3	0.5	0.4	0.4	0.1	1.5	1.7	0.2	0.4	0.6	0.7	0.1	0.8	0.3	1.1	0.6	1.3	0.2	0.5	0.7	1.2	2.9	1.1	0.4	0.2	0.3	1.5	0.0	2.4	1.9	0.8	0.3	1.4	0.3	2.3	1.6	0.0	0.8	0.4	0.2	0.2	0.5	0.2	0.7	1.8	1.0	1.3	1.7	0.8	0.4	1.4	1.0	0.2	0.3	0.2	0.6	0.3	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.3	3.1	1.9	1.7	0.9	1.6	0.9	1.5	0.3	1.8	1.8	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1
NUTM2D	FAM22D	ENSG00000214562	"NUT family member 2D"	Q5VT03	10	87357720-87370695	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.2;Cone photoreceptor cells: 4.2;Gastric mucus-secreting cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 12.4;hTCEpi: 11.7"									HPA064635			Approved	"Nuclear bodies"		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear bodies"		"HPA064635: "	"unprognostic (2.13e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.35e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.57e-1)"	"unprognostic (7.76e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.32e-1)"	3.1	3.0	5.3	1.4	7.2	2.4	3.1	4.5	8.4	2.4	0.2	3.6	2.1	3.0	3.4	2.8	3.1	2.6	5.6	4.5	4.9	4.8	4.2	3.3	2.1	8.1	7.0	3.7	4.7	4.1	4.8	2.5	7.0	4.5	2.0	2.7	3.9	2.0	3.8	4.7	3.2	1.3	3.6	3.7	4.0	4.9	7.1	2.5	4.5	2.9	1.6	3.1	3.1	10.5	3.9	2.8	6.1	0.0	1.6	2.3	1.4	1.0	5.0	2.2	2.5	1.8	1.9	3.3	0.9	1.7	1.0	1.8	0.1	2.0	1.0	2.2	2.7	4.9	0.2	2.8	3.8	3.1	12.4	3.7	11.7	2.5	1.9	3.4	2.2	4.3	5.2	0.8	0.5	3.5	2.4	5.2	3.4	0.8	0.3	3.3	0.4	0.1	2.2	0.8	2.4	3.7	1.1	2.6	1.2	2.3	4.9	2.4	5.5	1.5	1.0	1.4	1.8	4.0	2.4	0.9	0.9	1.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.2	4.5	8.4	4.5	4.9	8.1	7.0	7.0	3.6	7.1	10.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.9	0.3	0.3	1.2	0.0	0.0	0.0	4.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.1	0.0	0.0	0.2	1.1	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1
NUTM2E	FAM22E	ENSG00000228570	"NUT family member 2E"	B1AL46	10	79841358-79850878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 1.2;Exocrine glandular cells: 1.0;Pancreatic endocrine cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.0;NB-4: 1.6;U-266/84: 1.2"									HPA064635			Approved	"Nuclear bodies"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nuclear bodies"		"HPA064635: "	"unprognostic (2.82e-1)"	"unprognostic (3.95e-1)"		"unprognostic (1.90e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.35e-1)"	"unprognostic (4.09e-1)"	0.1	0.1	0.6	0.0	0.5	0.1	0.1	1.0	0.6	0.2	0.1	0.1	0.2	0.2	0.6	0.1	0.2	0.1	0.2	0.6	0.4	0.3	0.2	0.2	0.3	0.5	0.5	0.2	0.3	0.0	0.5	0.1	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.2	0.1	0.3	0.3	0.1	0.7	0.5	0.5	0.3	0.3	0.0	0.1	0.1	0.6	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.0	0.5	0.2	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.5	2.0	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.6	1.6	0.0	0.4	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.7	1.2	0.1	0.3	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	1.0	0.6	0.6	0.4	0.5	0.5	0.4	0.3	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	1.2	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0
OCSTAMP	"C20orf123, dJ257E24.3"	ENSG00000149635	"Osteoclast stimulatory transmembrane protein"	Q9BR26	20	46540946-46550654	"Predicted membrane proteins, Transporters"	Differentiation			"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Langerhans cells: 1.9;Melanocytes: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.1;HMC-1: 2.2;Karpas-707: 1.3;NB-4: 2.5;RPMI-8226: 1.2;U-266/84: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031116	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"		"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA031116: AB_10600758"	"unprognostic (2.77e-1)"		"unprognostic (3.04e-1)"		"unprognostic (8.80e-2)"	"unprognostic (5.02e-2)"		"unprognostic (2.42e-1)"	"unprognostic (2.71e-1)"					"unprognostic (2.65e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.08e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OLIG2	"BHLHB1, bHLHe19, OLIGO2, PRKCBP2, RACK17"	ENSG00000205927	"Oligodendrocyte transcription factor 2"	Q13516	21	33025935-33029196	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 87.2"	"Group enriched"	"Detected in some"	22	"Oligodendrocyte precursor cells: 124.1;Oligodendrocytes: 39.9"	"Cancer enriched"	"Detected in some"	52	"glioma: 46.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"eosinophil: 19.0"	"Lineage enriched"	"Detected in single"	190	"granulocytes: 19.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 56.2;NB-4: 41.8;THP-1: 35.9;WM-115: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003254, CAB019381"	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Plasma membrane"	"CAB019381: , HPA003254: AB_1854795"		"unprognostic (5.14e-1)"	"unprognostic (4.56e-1)"		"unprognostic (1.44e-2)"	"unprognostic (8.27e-2)"		"unprognostic (3.24e-2)"	"unprognostic (4.34e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.41e-2)"		"unprognostic (1.39e-1)"	"unprognostic (5.78e-5)"	"unprognostic (2.76e-1)"			0.0	0.0	46.4	0.0	58.3	0.0	0.0	52.7	54.4	0.0	21.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	48.1	49.8	0.0	0.0	0.0	0.0	58.0	54.6	0.0	0.0	0.0	0.1	0.0	51.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	48.0	0.0	0.1	0.0	50.9	0.0	0.0	0.2	0.0	0.0	0.0	87.2	0.0	0.0	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.5	0.0	0.0	0.0	1.1	8.2	0.0	0.0	0.0	1.7	56.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	41.8	3.6	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	35.9	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.0	1.4	0.0	11.7	2.8	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.4	58.3	52.7	54.4	48.1	49.8	58.0	54.6	51.4	48.0	50.9	87.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	124.1	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
OR14L1P	"OR5AV1, OR5AV1P"	ENSG00000198452	"Olfactory receptor family 14 subfamily L member 1 pseudogene"		1	247617143-247622372	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"brain: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Immune cell enriched"	"Detected in single"	53	"basophil: 5.2"	"Lineage enriched"	"Detected in single"	53	"granulocytes: 5.2"	"Group enriched"	"Detected in some"	9	"HEL: 2.0;HMC-1: 5.8"															NA	NA			"Cluster 46: Basophils - DNA binding"		"Cluster 3: HMC-1 - Innate immune response"																"unprognostic (3.03e-2)"						0.0	0.0	0.1	0.1	0.2	0.6	0.1	1.0	0.2	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.0		0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.1		0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.2	2.0	0.2	0.1	0.0	0.1	5.8	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.2	0.2	0.1	0.2	0.3	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.2	0.4	0.1	0.1	0.2	0.2	0.2	0.2	0.1	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OSBPL3	"KIAA0704, ORP-3, ORP3, OSBP3"	ENSG00000070882	"Oxysterol binding protein like 3"	Q9H4L5	7	24796540-24981634	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 123.1;Excitatory neurons: 176.1;Inhibitory neurons: 272.2;Microglial cells: 94.6;Plasma cells: 91.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000691, HPA048401"	Enhanced		Supported	Nucleoli,Cytosol		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoli	"HPA000691: AB_1854814, HPA048401: AB_2680386"	"unprognostic (3.57e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.11e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (2.34e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-2)"	2.6	1.2	3.6	6.8	4.2	4.1	3.9	2.8	5.9	10.2	3.8	5.9	9.3	2.2	0.8	7.6	5.1	5.0	2.6	3.9	4.4	16.0	1.2	8.6	11.3	3.8	3.7	5.2	1.9	14.1	2.0	3.9	3.5	2.2	6.0	1.3	3.7	2.5	3.3	10.3	7.6	3.7	3.1	6.8	8.5	2.8	4.5	8.3	9.8	2.0	14.4	13.3	6.5	5.1	40.2	10.7	7.8	14.4	17.3	34.5	17.5	44.5	49.3	20.4	32.1	27.0	52.0	22.2	6.2	47.8	26.9	34.6	23.6	33.4	31.4	13.5	9.8	5.3	16.4	20.4	24.5	15.3	113.8	17.0	27.2	26.7	31.8	26.0	31.0	19.0	28.4	30.1	34.9	0.0	9.4	18.7	15.3	38.1	13.7	7.5	21.6	9.1	20.4	28.2	1.6	16.1	30.3	21.5	6.7	23.0	11.1	1.5	37.1	9.1	17.9	49.4	33.7	20.7	32.8	55.6	19.5	24.7	102.0	5.8	1.9	1.5	8.5	1.7	7.3	3.3	5.3	5.6	3.3	1.6	1.8	3.5	0.4	7.7	1.2	2.3	9.5	2.5	3.6	4.2	2.8	5.9	3.9	4.4	3.8	3.7	3.5	3.1	4.5	5.1	2.2	0.0	26.1	123.1	18.3	12.1	8.0	8.8	21.6	0.3	3.8	4.4	5.5	5.7	22.2	25.8	0.0	8.4	13.2	3.8	3.9	3.5	0.3	24.6	2.3	3.6	1.8	11.1	176.1	3.9	2.1	3.1	19.4	31.9	0.0	0.4	3.6	0.5	10.8	0.0	272.2	1.7	20.3	12.7	9.3	0.3	0.6	13.2	16.0	94.6	7.8	4.8	14.4	44.2	3.6	24.4	4.5	0.0	91.7	5.2	3.3	0.5	53.1	0.2	0.0	3.4	4.6	0.5	5.0	16.5	8.0	4.0	18.5	20.3	4.5	16.5
OTULINL	"FAM105A, FLJ11127, NET20"	ENSG00000145569	"OTU deubiquitinase with linear linkage specificity like"	Q9NUU6	5	14581792-14616180	"Enzymes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 29.5;dendritic cells: 36.7;Endometrial stromal cells: 16.6;Hofbauer cells: 100.7;Macrophages: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 17.7;HMC-1: 55.6;OE19: 16.1;THP-1: 16.9;U-937: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046638	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoli, Cytosol"		"HPA046638: AB_2679731"	"unprognostic (1.47e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (3.14e-1)"	"unprognostic (8.79e-3)"	3.1	2.7	1.2	6.8	1.1	30.3	4.1	1.3	1.6	3.8	4.8	12.3	6.6	1.5	1.4	1.7	1.4	2.7	0.9	1.1	1.8	3.6	1.4	13.1	5.4	2.3	1.5	2.0	7.6	1.2	2.5	4.2	2.1	8.3	13.3	0.5	1.4	10.0	0.4	1.7	9.4	2.5	2.4	7.9	3.3	2.5	1.9	3.4	2.8	0.8	3.6	5.2	3.1	3.6	0.0	0.8	1.6	0.0	0.3	0.0	6.9	2.0	1.8	0.5	1.0	2.8	1.7	0.1	1.1	0.9	2.8	0.1	3.7	1.6	0.7	1.1	4.9	4.6	17.7	0.4	1.7	0.1	55.6	0.1	0.3	0.2	0.0	0.0	0.1	2.9	0.0	7.1	0.2	1.4	0.0	1.7	2.5	16.1	11.9	0.5	0.7	2.0	0.0	13.9	6.0	7.0	0.9	0.6	0.0	1.7	0.6	16.9	0.0	0.9	4.4	0.4	1.6	0.0	0.0	0.1	1.0	27.2	0.4	0.2	33.4	0.3	5.5	16.2	7.3	0.1	6.7	7.2	33.8	0.1	9.0	9.1	8.6	19.2	12.7	25.0	12.8	24.6	1.2	1.1	1.3	1.6	1.1	1.8	2.3	1.5	2.1	2.4	1.9	3.6	10.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	7.4	7.9	0.0	0.0	0.0	29.5	0.0	0.9	36.7	0.0	1.9	0.4	0.0	0.9	16.6	1.1	0.0	0.0	0.0	6.2	2.2	1.4	0.0	1.2	0.0	0.5	0.0	0.0	100.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	12.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	4.4	0.0	0.0	3.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.4	8.8	0.2	0.0	0.0
P2RY14	"GPR105, KIAA0001"	ENSG00000174944	"Purinergic receptor P2Y14"	Q15391	3	151212117-151278542	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 24.6;placenta: 31.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.0;dendritic cells: 54.4;Endometrial stromal cells: 35.5;Excitatory neurons: 41.2;granulocytes: 45.7;Langerhans cells: 61.3;Oligodendrocyte precursor cells: 29.1;Sertoli cells: 26.3;Smooth muscle cells: 29.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"eosinophil: 230.1;plasmacytoid DC: 98.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 98.0;granulocytes: 230.1"	"Cell line enriched"	"Detected in single"	68	"HMC-1: 67.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022646	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"CAB022646: "	"unprognostic (9.78e-2)"	"unprognostic (7.47e-4)"	"unprognostic (3.89e-2)"	"unprognostic (4.52e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.57e-5)"	"unprognostic (2.68e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.72e-5)"	"unprognostic (3.79e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.58e-2)"	7.9	0.8	2.6	10.8	3.8	0.7	7.0	3.4	7.1	5.9	24.6	11.7	6.9	8.0	0.6	20.2	1.1	5.2	5.3	3.2	1.8	2.0	1.0	7.2	9.6	1.3	2.2	1.5	0.6	2.4	0.9	31.7	1.1	0.7	9.7	0.4	1.2	1.3	2.5	1.9	12.0	4.1	1.0	5.7	11.2	0.5	3.8	4.8	2.5	6.4	6.7	9.2	1.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	67.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	10.3	0.4	230.1	1.1	0.3	19.0	3.7	0.6	2.2	13.8	17.0	0.1	0.0	8.9	11.7	0.1	98.0	1.1	2.0	2.6	3.8	3.4	7.1	3.2	1.8	1.3	2.2	1.1	1.0	3.8	3.3	5.8	3.2	0.5	31.0	13.9	2.3	0.0	0.0	0.0	2.1	0.1	0.3	1.8	0.0	0.0	0.0	0.0	0.1	54.4	0.0	0.0	0.0	0.4	1.0	35.5	5.9	0.0	0.4	41.2	0.0	0.2	3.9	0.0	0.7	45.7	0.0	0.0	0.0	0.6	0.0	16.4	0.0	0.0	0.8	61.3	0.5	0.0	22.7	3.6	5.6	1.2	0.4	1.0	29.1	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.7	0.4	26.3	1.6	29.3	0.0	0.1	0.2	1.7	0.3	4.8	1.5	0.1	0.1
PAFAH2	HSD-PLA2	ENSG00000158006	"Platelet activating factor acetylhydrolase 2"	Q99487	1	25959767-25998117	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 48.7"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018157	Approved					NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA018157: AB_1854928"	"unprognostic (9.89e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.63e-3)"	"prognostic favorable (3.28e-6)"	"unprognostic (5.19e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.62e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (8.15e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.27e-2)"	4.6	7.3	4.7	6.5	6.5	6.8	9.2	6.3	6.0	8.8	6.7	16.3	17.4	4.9	9.9	7.8	8.3	10.4	9.7	4.5	5.8	19.3	18.3	8.6	8.4	6.4	6.5	4.7	31.2	22.9	5.9	9.2	6.5	8.8	16.6	14.1	10.0	6.3	18.0	11.4	19.0	6.9	5.5	7.6	15.6	7.7	6.5	48.7	16.4	10.7	7.4	7.0	5.5	8.2	8.6	10.7	6.7	7.6	13.9	10.9	13.7	9.6	5.0	8.6	5.7	4.4	18.1	3.8	11.7	5.7	8.1	7.5	10.1	9.3	11.0	7.8	6.1	6.3	4.6	8.8	8.4	3.3	52.5	7.2	21.2	13.2	8.7	4.7	8.3	8.9	8.9	7.1	11.7	3.8	10.3	3.3	13.4	29.9	5.9	8.4	6.3	8.7	13.9	3.0	8.0	6.8	5.7	7.7	18.2	11.0	12.7	6.0	7.8	5.9	7.4	12.5	7.7	13.0	18.1	4.8	12.5	13.2	20.0	36.2	6.7	60.2	23.7	6.4	15.3	3.5	8.3	15.4	5.0	4.4	10.6	14.9	5.8	17.4	2.4	39.0	9.0	8.7	4.7	6.5	6.3	6.0	4.5	5.8	6.4	6.5	6.5	5.5	6.5	8.2	4.6	16.0	12.8	9.8	3.2	1.5	2.1	5.3	1.8	9.5	9.4	4.8	6.8	11.5	11.9	18.4	27.1	11.2	37.7	34.9	3.9	11.1	1.1	8.6	4.5	5.6	7.8	3.2	4.0	7.3	9.5	3.5	12.2	13.2	27.8	7.3	5.7	21.4	11.2	5.0	3.6	18.2	4.1	11.6	1.6	1.0	2.5	7.1	8.8	5.6	7.3	6.3	23.7	4.0	10.0	10.6	15.8	2.6	6.5	4.2	43.1	18.3	8.9	8.8	6.6	5.3	4.1	19.9	8.9	4.5	3.8	10.0	9.0	4.4	19.4	4.9
PAG1	"CBP, PAG"	ENSG00000076641	"Phosphoprotein membrane anchor with glycosphingolipid microdomains 1"	Q9NWQ8	8	80967810-81112068	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 169.6;granulocytes: 124.5;Melanocytes: 140.5;Microglial cells: 166.8;Sertoli cells: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 35.4;HMC-1: 45.5;SK-MEL-30: 36.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001632, HPA066527"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Plasma membrane"		"HPA001632: AB_1079557, HPA066527: AB_2685685"	"unprognostic (8.30e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.94e-3)"	3.9	3.1	3.4	9.0	3.5	12.3	2.0	14.8	4.0	1.8	4.3	9.2	7.6	1.9	2.2	1.6	1.8	7.1	4.7	2.8	3.7	1.7	4.7	14.9	14.5	4.5	4.5	1.2	14.9	0.9	2.0	16.0	4.9	2.6	8.7	5.0	3.7	2.1	1.3	4.3	9.0	3.0	4.9	9.1	4.4	0.7	5.2	10.4	1.8	2.1	14.0	4.8	2.6	5.6	0.1	0.1	4.8	0.2	8.9	8.5	0.1	2.0	15.5	1.0	1.9	0.3	0.1	35.4	0.2	0.5	7.6	1.5	0.1	1.8	0.9	0.9	4.5	20.8	0.3	0.0	9.1	3.4	45.5	4.1	1.2	8.9	8.2	0.9	0.0	6.2	0.2	0.1	14.8	0.3	12.6	0.3	0.4	8.1	1.4	9.5	2.4	0.1	1.6	7.6	1.0	1.7	0.0	0.3	36.1	0.8	1.2	3.5	0.3	1.1	0.6	0.0	1.2	5.7	1.6	12.3	9.7	11.7	8.5	13.1	1.4	2.0	2.5	6.4	6.1	2.0	6.2	4.4	1.9	1.6	4.9	3.8	2.3	1.7	14.6	4.1	7.2	2.7	3.4	3.5	14.8	4.0	2.8	3.7	4.5	4.5	4.9	4.9	5.2	5.6	6.2	0.0	12.4	40.8	37.0	31.5	3.9	5.2	0.6	39.7	2.2	2.2	15.4	10.0	14.0	3.7	0.0	0.8	39.0	169.6	0.0	4.0	3.5	0.6	4.4	10.9	3.6	3.8	57.5	6.5	26.2	24.3	8.2	1.1	124.5	97.0	12.5	10.3	27.1	63.9	60.0	23.2	6.1	73.6	26.2	2.1	2.5	79.1	140.5	166.8	40.8	34.9	19.6	82.4	75.3	2.0	62.1	7.9	38.4	7.7	109.3	0.4	0.8	3.2	124.9	32.3	37.1	0.2	3.0	3.8	22.6	2.3	78.1	11.8	27.4	13.7
PALM2AKAP2	PALM2-AKAP2	ENSG00000157654	"PALM2 and AKAP2 fusion"	"Q8IXS6, Q9Y2D5"	9	109498325-110172512	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 10.6;naive B-cell: 10.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA058905, HPA074153, HPA076866"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Nuclear bodies"	"HPA058905: AB_2683851, HPA074153: AB_2686669, HPA076866: "	"unprognostic (7.12e-2)"	"unprognostic (1.64e-6)"	"unprognostic (7.90e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.05e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.98e-4)"	"unprognostic (3.36e-5)"	97.0	13.5	21.8	37.3	21.1	9.9	17.5	6.9	22.7	28.5	0.0	17.4	14.8	28.8	8.5	26.5	14.7	37.4	93.8	15.7	18.5	30.8	38.2	69.1	32.2	18.1	26.6	9.3	13.1	14.0	0.1	97.9	20.3	14.9	18.1	3.3	38.0	25.1	17.0	10.1	13.3	48.5	10.5	38.4	18.5	4.6	38.8	45.4	25.6	24.3	31.7	43.0	0.4	26.3	20.6	7.7	112.5	0.1	110.8	93.0	33.4	116.0	141.3	101.6	93.4	134.6	17.9	92.1	30.6	129.6	146.2	28.9	9.5	98.8	185.4	68.9	12.5	9.2	30.4	11.0	75.9	12.4	256.2	109.8	24.7	183.3	280.4	62.5	150.9	14.5	0.3	76.2	204.7	1.2	61.9	31.1	47.2	9.1	62.6	5.5	98.2	25.3	72.4	2.8	25.2	1.5	10.3	9.5	26.4	87.8	4.1	22.2	240.0	94.0	77.9	137.5	108.8	52.5	89.1	52.5	81.4	51.3	73.9	2.9	0.1	1.3	1.0	0.2	0.2	10.6	1.2	1.4	1.2	10.3	0.7	0.8	0.5	2.2	0.0	2.4	3.9	1.4	21.8	21.1	6.9	22.7	15.7	18.5	18.1	26.6	20.3	10.5	38.8	26.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAQR5	"FLJ20190, MPRG"	ENSG00000137819	"Progestin and adipoQ receptor family member 5"	Q9NXK6	15	69298912-69407780	"Predicted membrane proteins"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 52.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 32.9;Distal tubular cells: 46.9;Early spermatids: 38.2;granulocytes: 67.2;Late spermatids: 123.0;Proximal tubular cells: 42.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"basophil: 1.1"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"A549: 38.1;CAPAN-2: 46.4;fHDF/TERT166: 33.1;HMC-1: 79.8;U-87 MG: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076729			Approved	Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA076729: AB_2686813"	"unprognostic (4.47e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.05e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.47e-14)"	"unprognostic (5.64e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.16e-4)"	"unprognostic (4.94e-2)"	0.6	16.0	3.5	2.6	2.8	1.2	1.2	2.7	3.0	1.7	12.0	19.0	2.3	1.0	0.2	12.4	0.9	2.0	0.8	3.1	2.8	52.9	1.1	9.1	0.3	3.4	3.1	0.6	5.1	11.3	0.8	1.6	4.0	0.6	16.2	1.9	1.8	3.7	0.2	4.9	8.0	0.9	2.8	0.4	7.7	2.4	4.4	0.2	0.8	0.2	2.1	3.6	2.9	2.9	11.7	38.1	0.8	0.8	1.6	4.2	0.3	3.7	22.2	4.3	9.1	2.2	46.4	0.1	5.9	33.1	3.7	0.7	10.9	0.6	7.4	0.1	1.7	6.9	5.6	0.8	2.9	0.2	79.8	2.2	1.7	19.4	20.7	5.5	0.0	0.2	0.1	0.7	18.4	1.6	0.2	0.2	2.6	6.1	3.2	0.1	0.6	2.2	16.6	0.9	3.3	0.7	6.0	2.3	3.1	2.1	1.0	2.8	0.6	13.1	4.2	1.1	0.4	0.2	0.3	0.1	33.1	0.1	3.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.5	2.8	2.7	3.0	3.1	2.8	3.4	3.1	4.0	2.8	4.4	2.9	0.1	12.8	21.0	1.0	0.5	0.9	1.3	0.4	1.2	0.7	1.3	0.8	0.7	32.9	0.9	20.2	0.0	0.0	0.0	31.1	46.9	19.0	38.2	0.7	0.1	1.9	0.0	0.0	0.5	0.4	0.0	2.8	2.0	1.5	67.2	2.2	0.0	0.0	3.7	0.0	0.7	4.8	0.0	0.3	0.7	123.0	0.9	1.8	0.0	20.6	0.0	5.9	0.0	1.0	0.5	2.6	6.9	1.2	0.0	1.4	26.8	42.3	0.8	0.1	6.6	0.1	0.6	0.5	0.5	15.1	1.8	0.1	0.4	19.6	13.7	0.8
PASD1	CT63	ENSG00000166049	"PAS domain containing repressor 1"	Q8IV76	X	151563675-151676739	"Predicted intracellular proteins"	"Biological rhythms"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	161	"testis: 16.1"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 19.3;Spermatogonia: 57.5"	"Cancer enhanced"	"Detected in some"		"melanoma: 0.7;testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 34.8;HMC-1: 55.3;U-266/84: 27.8"	"Not detected"	"Not detected"							"HPA011122, HPA011152"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA011122: AB_1854990, HPA011152: AB_1854991"										"unprognostic (3.34e-1)"					"unprognostic (1.02e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	55.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.3	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	19.3	57.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDE1B	PDES1B	ENSG00000123360	"Phosphodiesterase 1B"	Q01064	12	54549601-54579239	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 76.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.6;Inhibitory neurons: 10.2;Kupffer cells: 13.0;Macrophages: 9.4;Sertoli cells: 13.1;Smooth muscle cells: 13.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"basal ganglia: 76.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.7;HMC-1: 14.9;NB-4: 10.7;THP-1: 9.0;U-937: 7.2"	"Region enriched"	"Detected in all"	6	"basal ganglia: 999.4"	"Region enriched"	"Detected in all"	7	"basal ganglia: 228.7"	HPA018492	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA018492: AB_1855119"	"unprognostic (2.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.67e-4)"	"unprognostic (5.63e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (6.64e-4)"	"unprognostic (2.14e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.83e-2)"	9.1	1.1	8.4	4.0	76.9	4.8	4.6	0.0	13.7	2.0	0.0	7.4	1.0	2.7	1.8	1.7	2.0	2.2	1.4	6.3	0.1	0.8	1.0	2.3	1.3	0.0	0.0	8.6	0.4	6.1	0.3	0.2	0.0	1.3	1.0	0.4	1.0	1.4	0.6	1.4	3.4	4.0	0.0	4.0	3.3	0.7	2.4	0.9	2.0	1.0	0.8	8.7	1.5	4.9	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	2.1	0.0	0.0	12.7	0.6	4.3	0.0	0.0	0.0	5.5	14.9	0.7	0.0	0.0	0.0	0.0	0.0	5.5	0.0	2.3	0.0	0.0	0.5	10.7	3.5	0.0	0.0	2.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	9.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	2.5	0.0	7.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	76.9	0.0	13.7	6.3	0.1	0.0	0.0	0.0	0.0	2.4	4.9	2.3	0.0	1.1	1.6	1.8	1.0	0.2	0.0	0.6	2.7	0.2	0.6	3.6	0.0	0.6	3.7	0.0	0.1	1.4	0.0	0.0	0.0	6.3	0.1	0.0	0.8	1.8	3.6	18.6	0.0	0.0	1.5	0.0	0.0	0.0	4.4	0.0	0.3	8.5	5.0	10.2	0.0	0.0	13.0	2.5	4.9	2.1	9.4	0.0	2.8	6.7	0.1	4.1	1.0	0.9	0.0	0.0	3.0	2.6	0.4	0.0	0.0	0.0	0.2	13.1	0.6	13.7	0.8	0.6	0.2	0.4	0.3	2.8	0.4	0.1	0.1
PDE4A	DPDE2	ENSG00000065989	"Phosphodiesterase 4A"	P27815	19	10416773-10469630	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 190.8;Late spermatids: 197.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 36.5;NB-4: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017632, HPA043310, HPA076091"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"CAB017632: AB_1127109, HPA043310: AB_2678419, HPA076091: AB_2686775"	"unprognostic (1.29e-2)"	"unprognostic (3.98e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.00e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.15e-1)"	13.7	5.6	10.9	5.9	12.5	5.4	9.7	3.0	32.3	12.4	0.0	11.0	2.7	9.8	1.4	4.1	7.5	6.6	12.5	11.8	7.9	7.0	2.5	13.0	3.2	21.9	7.1	1.5	12.7	22.2	3.9	6.5	20.8	8.4	4.0	5.3	9.8	4.8	37.9	5.4	6.5	6.2	1.1	8.2	12.9	24.5	13.0	1.6	11.0	16.9	2.6	8.2	8.2	15.7	0.1	2.5	0.5	6.7	18.7	11.1	3.7	5.6	11.1	0.7	1.9	6.0	5.4	2.6	16.1	14.6	0.4	0.6	3.9	0.7	0.4	6.7	5.5	23.7	8.1	6.7	12.3	3.9	36.5	8.3	0.8	6.2	0.0	0.7	5.3	2.1	18.9	5.5	4.0	1.7	2.3	43.3	2.9	6.7	4.7	15.6	3.7	20.3	0.9	1.4	4.2	1.5	0.4	0.2	6.2	1.0	0.8	7.8	11.2	8.3	10.5	5.7	3.7	10.9	0.9	12.4	3.5	0.3	6.7	4.1	1.7	3.4	0.8	2.5	0.4	0.1	0.3	1.1	2.0	0.0	0.0	0.4	0.1	3.0	2.7	0.1	0.7	1.1	10.9	12.5	3.0	32.3	11.8	7.9	21.9	7.1	20.8	1.1	13.0	15.7	9.4	3.2	11.6	6.2	10.8	10.1	2.6	2.5	1.8	25.6	6.4	4.3	7.7	8.6	5.5	9.2	0.0	0.5	58.9	7.1	0.0	3.1	48.9	2.1	20.7	8.6	0.0	1.7	39.4	12.9	4.8	12.1	7.1	3.6	31.8	0.3	10.4	0.9	10.2	55.5	43.5	5.1	6.1	22.1	190.8	197.0	17.4	53.9	14.2	12.2	15.4	1.2	22.6	12.5	1.5	12.3	3.8	18.0	27.0	3.0	0.1	0.2	6.9	3.6	6.6	9.0	10.2	8.6	8.5	0.5	8.1	0.4	37.0	1.0	6.8	1.3
PEAK3	"C19orf35, FLJ45778"	ENSG00000188305	"PEAK family member 3"	Q6ZS72	19	2274631-2282175	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 2.3;lymphoid tissue: 4.1"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.5;Hofbauer cells: 1.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 41.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 41.0"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 12.2"					"Group enriched"	"Detected in some"	5	"basal ganglia: 6.7;cerebellum: 3.1"	HPA057806	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"HPA057806: AB_2683534"	"unprognostic (9.42e-2)"	"unprognostic (3.26e-2)"	"unprognostic (7.27e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.40e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.90e-1)"	0.5	0.4	0.5	1.3	0.9	2.3	0.3	0.5	1.6	0.2	0.1	0.4	0.2	0.2	0.0	0.2	0.5	0.2	0.7	0.4	0.5	0.3	0.2	1.1	0.4	1.4	1.0	0.1	0.2	0.0	0.2	0.1	1.0	0.3	0.2	0.0	0.2	0.0	0.3	0.3	0.8	0.1	0.9	4.1	0.3	0.1	0.8	0.1	0.2	0.0	0.3	0.3	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.4	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	10.5	4.4	11.7	1.6	5.7	0.2	0.2	0.1	0.2	1.8	0.4	0.1	0.3	41.0	4.5	1.9	0.2	0.0	1.1	0.5	0.9	0.5	1.6	0.4	0.5	1.4	1.0	1.0	0.9	0.8	0.6	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
PER2	KIAA0347	ENSG00000132326	"Period circadian regulator 2"	O15055	2	238244044-238290102	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Skeletal myocytes: 110.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053136, HPA060510"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 50: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA053136: , HPA060510: AB_2684298"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (2.47e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.22e-2)"	12.2	3.3	4.7	5.0	5.2	8.4	14.2	7.2	5.8	11.9	2.4	7.6	5.1	10.2	5.7	13.6	7.9	12.3	5.7	5.7	5.1	3.9	12.4	7.1	4.7	5.2	5.7	7.8	14.4	4.2	9.0	2.9	4.4	9.3	6.2	5.1	14.1	8.9	11.4	17.0	8.0	4.9	5.4	4.8	13.4	11.8	4.7	4.1	8.8	7.6	6.2	8.7	8.2	4.7	1.6	11.7	2.4	4.2	0.1	1.2	8.2	1.1	4.1	1.5	1.4	1.8	5.8	10.3	1.2	2.7	1.5	8.6	2.4	3.5	2.2	2.9	1.7	9.1	6.2	8.2	2.0	13.8	9.2	1.6	8.3	1.8	6.1	1.5	0.8	4.2	4.5	6.3	1.3	7.7	6.9	15.2	3.5	7.6	2.3	16.5	5.5	3.3	1.5	3.3	9.7	1.2	2.9	6.3	1.8	0.7	5.9	8.5	2.1	3.6	4.2	2.8	4.1	7.1	1.8	12.3	6.7	5.9	4.5	2.1	1.2	0.3	1.0	2.2	1.6	1.5	1.6	1.2	1.4	1.5	1.5	1.6	1.0	1.2	2.1	1.8	1.2	0.3	4.7	5.2	7.2	5.8	5.7	5.1	5.2	5.7	4.4	5.4	4.7	4.7	24.9	16.0	30.1	18.6	9.9	73.9	61.7	21.3	38.1	20.6	67.8	33.8	5.7	31.5	46.9	27.6	2.1	9.2	27.0	22.5	7.9	7.5	9.6	69.7	30.1	15.6	24.6	6.9	20.9	10.4	6.3	39.8	52.5	86.1	9.5	3.3	11.4	35.8	3.9	11.8	13.9	35.1	18.3	10.1	25.3	4.7	11.1	12.4	24.9	5.6	5.3	13.5	2.1	9.0	7.2	7.6	35.3	18.4	10.9	15.0	10.9	5.5	44.2	7.8	6.6	110.1	32.2	31.3	17.0	38.4	85.4	13.0	13.6	3.7	36.9	33.9
PGA3		ENSG00000229859	"Pepsinogen A3"	P0DJD8	11	61203307-61213098	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	613	"stomach 1: 89073.4"	"Cell type enriched"	"Detected in some"	526	"Gastric mucus-secreting cells: 3263.5"	"Cancer enriched"	"Detected in single"	498	"stomach cancer: 24.8"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.9"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.8;THP-1: 1.1"									"CAB026358, HPA046875"	Enhanced				"Secreted to digestive system"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB026358: , HPA046875: AB_2679851"										"unprognostic (6.39e-2)"				"unprognostic (1.11e-1)"				80.5	10.0	0.5	0.2	0.2	0.2	18.2	0.7	0.9	11.1	0.0	145.3	1.3	3.8	0.0	96.4	4.5	0.1	11.4	2.9	0.0	5.4	16.2	6.2	0.0	0.0	0.0	5.4	13.0	0.0	13.4	0.5	0.1	5.5	0.1	0.9	6.8	0.7	4.4	6.0	5.7	0.4	0.0	6.3	89073.4	7.3	0.0	0.1	5.0	0.5	0.1	6.2	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.7	1.3	0.4	0.1	0.2	0.7	0.1	0.1	0.1	0.6	0.4	0.2	0.3	0.0	0.0	1.3	0.5	0.2	0.7	0.9	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	6.2	0.0	0.3	3263.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.1	0.0	3.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.1
PGA4		ENSG00000229183	"Pepsinogen A4"	P0DJD7	11	61222349-61231694	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1281	"stomach 1: 66596.4"	"Cell type enriched"	"Detected in some"	8	"Exocrine glandular cells: 109.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"classical monocyte: 9.9;intermediate monocyte: 10.9;non-classical monocyte: 3.4"	"Lineage enriched"	"Detected in single"	26	"monocytes: 10.9"	"Group enriched"	"Detected in some"	6	"BJ hTERT+: 26.1;HMC-1: 9.5;THP-1: 15.7"									HPA046875	Supported				"Secreted to digestive system"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 1: Pancreatic cells - Digestion"			"HPA046875: AB_2679851"										"unprognostic (2.22e-1)"								9.6	8.3	0.1	2.1	0.1	0.0	9.0	0.1	0.2	7.5	0.1	52.0	2.5	4.6	0.0	9.1	19.1	0.3	6.2	0.1	0.1	30.3	11.7	37.9	0.0	0.1	0.1	4.1	18.8	0.0	3.5	3.8	0.1	16.2	0.4	0.3	4.5	0.7	2.5	4.1	2.9	0.8	0.1	5.2	66596.4	4.3	0.1	0.1	3.1	0.0	0.2	5.0	5.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.0	0.0	1.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	1.1	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.3	0.0	3.4	0.0	0.0	1.8	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	109.1	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PGPEP1	"Pcp, PGP, PGP-I, PGPI"	ENSG00000130517	"Pyroglutamyl-peptidase I"	Q9NXJ5	19	18340598-18369950	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 73.9;Proximal enterocytes: 88.2;Proximal tubular cells: 85.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 28.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 28.4"	"Cell line enhanced"	"Detected in many"		"HMC-1: 58.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035368, HPA055277"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA035368: AB_10601388, HPA055277: AB_2682770"	"unprognostic (9.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (6.95e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.29e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.11e-3)"	"prognostic favorable (6.80e-4)"	"unprognostic (2.79e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (4.81e-3)"	"prognostic favorable (3.71e-8)"	"unprognostic (1.12e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-3)"	10.1	27.8	30.1	6.9	30.2	13.1	10.3	27.0	36.7	14.9	38.3	23.5	22.4	11.1	12.8	5.5	12.7	7.9	25.1	31.0	30.6	40.8	48.4	14.3	6.5	35.6	28.9	16.5	34.2	13.9	24.4	5.2	36.2	20.3	15.6	4.2	20.4	12.9	27.1	4.9	30.3	6.4	36.2	23.5	23.6	3.8	30.2	8.2	14.6	14.4	6.3	15.9	8.3	35.5	8.7	13.6	11.1	11.2	13.7	10.8	13.5	10.2	15.9	6.9	10.2	9.7	18.4	13.4	16.7	16.8	12.3	2.3	4.4	2.3	3.8	15.9	4.8	14.7	15.0	27.9	19.4	8.7	58.5	10.9	4.9	5.3	1.0	24.6	10.4	22.8	27.5	19.7	5.8	13.9	8.9	7.0	11.3	6.0	4.2	0.1	4.1	12.1	7.5	13.5	3.9	6.1	1.9	1.1	18.4	7.2	5.1	17.3	16.1	7.9	5.3	10.4	4.4	24.3	12.6	8.2	21.0	24.0	7.4	28.4	5.5	8.1	4.8	5.8	2.9	1.9	3.4	4.5	3.5	5.5	4.2	3.8	3.1	4.8	6.8	2.3	4.2	3.9	30.1	30.2	27.0	36.7	31.0	30.6	35.6	28.9	36.2	36.2	30.2	35.5	7.5	9.6	15.0	10.4	12.2	2.3	10.2	9.5	8.6	4.7	14.3	9.8	20.9	37.1	13.2	31.3	10.4	18.6	21.2	73.9	7.9	20.7	0.8	15.2	8.6	10.0	38.9	10.7	11.3	45.4	26.6	9.6	27.5	14.7	35.4	7.9	13.6	72.5	24.1	5.0	7.9	21.0	8.2	29.0	5.4	1.7	7.8	19.3	16.0	8.4	13.1	8.9	24.7	3.5	4.3	44.4	36.5	20.3	25.8	9.2	88.2	85.7	12.3	7.0	6.6	10.3	9.0	2.9	4.7	1.8	1.1	18.7	15.2	9.4	33.4	16.9
PHACTR4	"FLJ13171, PPP1R124"	ENSG00000204138	"Phosphatase and actin regulator 4"	Q8IZ21	1	28369582-28500364	"Predicted intracellular proteins"	Neurogenesis	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 212.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028985	Approved		Approved	"Plasma membrane,Intermediate filaments,Cytosol"		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	"Intermediate filaments"	"HPA028985: AB_10602142"	"unprognostic (1.55e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.27e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (9.65e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.26e-2)"	7.2	6.5	6.3	8.6	8.1	11.8	10.1	8.2	6.8	13.6	10.2	12.9	9.1	13.7	7.1	33.0	13.2	8.9	8.9	5.8	8.5	14.1	16.3	12.4	7.8	9.1	6.8	13.1	11.7	15.1	4.0	10.4	7.2	11.8	14.1	5.1	11.3	8.2	11.9	16.2	10.3	13.8	5.5	12.0	10.7	8.6	8.0	11.9	12.4	18.3	12.2	9.4	14.8	9.3	26.0	17.2	37.8	27.5	9.6	10.2	5.8	18.1	18.3	38.5	40.0	16.4	28.1	24.5	15.9	21.6	24.3	17.7	26.3	17.4	33.9	18.1	14.9	51.6	28.2	26.5	14.3	31.2	56.7	9.9	16.4	24.7	42.7	14.0	52.0	19.5	26.0	16.9	24.5	8.0	22.3	7.8	28.3	14.0	11.8	23.2	35.7	18.5	20.2	22.8	20.1	26.0	41.0	16.9	20.9	14.9	22.5	11.1	33.3	18.8	34.6	13.4	35.8	12.4	19.7	20.1	18.4	26.2	20.3	1.9	2.0	2.0	3.3	2.0	2.9	1.4	2.6	3.3	2.2	2.2	1.8	2.6	1.4	2.4	3.3	2.6	1.2	1.5	6.3	8.1	8.2	6.8	5.8	8.5	9.1	6.8	7.2	5.5	8.0	9.3	65.9	70.5	49.8	60.7	38.9	38.6	23.6	24.1	46.7	34.6	37.0	35.8	38.5	40.0	53.7	23.9	20.9	17.6	36.7	59.9	17.6	32.4	6.1	125.6	58.6	56.2	49.3	32.2	65.8	36.5	17.3	29.1	35.2	212.6	48.0	38.8	42.5	63.3	22.8	23.5	82.6	57.0	24.4	33.6	32.3	8.5	19.3	40.3	17.8	92.8	33.7	19.8	51.5	117.1	148.1	48.2	33.5	29.7	30.8	24.4	40.0	45.5	63.3	39.8	39.5	45.6	31.0	47.1	39.4	62.1	54.1	15.2	35.7	15.3	50.6	30.9
PIK3CB	PIK3C1	ENSG00000051382	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"	P42338	3	138652698-138834928	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Autophagy, Cell adhesion, Endocytosis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 96.5;Inhibitory neurons: 92.4;Oligodendrocytes: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 115.2;HMC-1: 185.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031938, HPA042288, HPA064207"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles,Midbody		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nucleoli, Vesicles, Midbody"	"CAB031938: AB_2165408, HPA042288: , HPA064207: AB_2685212"	"unprognostic (4.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.99e-5)"	"unprognostic (2.15e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.59e-2)"	11.6	7.4	4.3	12.4	5.0	23.7	11.9	8.6	8.6	12.4	14.4	17.8	17.8	8.2	7.0	18.0	12.1	10.3	15.8	5.4	4.4	26.4	11.0	11.2	12.3	5.1	3.3	9.2	22.3	19.3	2.7	18.6	6.1	15.0	18.1	23.0	19.8	12.0	19.5	23.7	17.9	9.1	3.5	10.8	13.0	8.0	4.0	17.0	43.2	13.2	13.2	9.9	5.4	7.9	64.1	21.9	11.7	9.4	10.6	13.0	79.2	14.2	14.5	15.1	16.7	26.0	25.2	25.0	38.0	13.7	29.1	27.5	15.1	24.1	27.3	31.8	12.5	115.2	14.8	17.3	11.8	30.1	185.1	12.4	17.6	10.2	21.9	26.4	21.5	12.3	43.0	19.0	18.1	28.6	17.8	20.7	16.6	49.2	19.5	11.5	12.2	19.6	24.5	35.5	9.8	7.4	37.6	18.0	56.2	34.7	44.8	73.0	20.3	8.4	11.7	21.2	21.1	30.3	22.1	23.7	22.8	27.7	14.0	4.4	5.1	6.9	2.4	2.8	1.6	2.8	2.8	1.8	5.9	2.6	3.5	2.4	6.4	0.8	2.8	1.0	1.5	2.0	4.3	5.0	8.6	8.6	5.4	4.4	5.1	3.3	6.1	3.5	4.0	7.9	19.7	9.6	21.3	40.1	12.1	19.1	18.7	12.5	14.2	16.2	13.1	7.7	37.3	12.8	18.3	18.4	25.0	35.5	6.9	30.3	5.9	11.1	1.1	18.3	4.0	13.9	16.3	8.0	96.5	19.4	61.1	7.3	21.4	18.8	14.5	6.7	9.7	19.1	14.4	21.9	92.4	17.1	4.1	33.3	23.1	1.7	3.7	28.1	7.2	37.5	29.5	8.9	11.3	48.2	88.2	20.0	25.9	6.8	10.2	25.8	21.9	23.4	17.4	19.5	6.6	8.6	5.9	16.0	19.9	22.1	23.3	47.9	11.6	4.2	15.1	17.5
PIK3R6	"C17orf38, FLJ34500, HsT41028, p87PIKAP"	ENSG00000276231	"Phosphoinositide-3-kinase regulatory subunit 6"	Q5UE93	17	8802722-8867677	"Metabolic proteins, Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.5;granulocytes: 47.4;Hofbauer cells: 7.6;Late spermatids: 20.6;Microglial cells: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 21.9;eosinophil: 75.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 75.8"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 148.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA023077	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA023077: AB_1854909"	"unprognostic (4.29e-2)"	"unprognostic (8.56e-3)"	"unprognostic (9.39e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.46e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.50e-6)"	"unprognostic (3.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.98e-2)"	0.4	0.0	1.1	1.8	1.6	2.2	0.4	0.9	1.1	0.6	0.8	0.8	1.5	0.9	0.1	0.5	0.2	1.2	1.3	1.0	1.1	0.0	0.3	1.2	2.1	1.4	1.5	0.0	0.4	0.1	0.0	0.6	1.6	0.3	0.6	0.0	0.2	0.3	0.5	0.8	2.2	0.7	1.1	2.9	1.0	0.4	1.9	2.1	0.0	0.3	1.5	1.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	14.1	0.0	19.4	0.0	0.0	0.0	0.0	148.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	2.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	21.9	7.2	75.8	0.5	9.6	0.4	2.7	0.1	0.3	10.8	0.3	0.1	0.2	1.1	1.5	7.8	0.0	0.0	3.3	1.1	1.6	0.9	1.1	1.0	1.1	1.4	1.5	1.6	1.1	1.9	1.6	0.2	0.0	1.3	0.3	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.0	0.0	0.0	0.6	0.2	0.0	0.0	11.5	0.0	0.1	2.6	0.0	0.4	0.6	0.0	0.1	0.2	0.5	0.0	47.4	0.0	0.4	0.0	7.6	0.0	0.5	0.0	0.0	4.4	1.6	20.6	0.0	3.9	1.8	7.5	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.1	0.0	1.6	0.1	0.0	0.0
PILRA	FDF03	ENSG00000085514	"Paired immunoglobin like type 2 receptor alpha"	Q9UKJ1	7	100367530-100400096	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 80.8;Kupffer cells: 100.7;Langerhans cells: 65.9;Leydig cells: 52.5;Macrophages: 144.7;monocytes: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 1659.8;non-classical monocyte: 1146.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 1659.8;monocytes: 1146.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 27.9;HMC-1: 25.5;NB-4: 20.4"									HPA056132	Approved				"Secreted to blood"	NA	NA		1500000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA056132: AB_2683048"	"unprognostic (5.53e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (7.61e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.01e-3)"	"unprognostic (9.95e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.47e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.80e-2)"	14.6	9.3	7.2	38.5	7.5	26.0	8.9	13.7	9.6	10.7	7.7	7.6	4.1	8.2	4.7	3.7	14.2	9.3	5.7	6.9	9.3	12.6	9.7	30.4	9.2	12.1	9.4	9.5	5.3	3.6	15.5	11.3	11.7	11.3	5.3	3.8	5.7	4.0	5.3	5.3	8.0	9.8	9.0	31.1	5.9	10.8	9.3	5.0	9.4	2.9	3.5	17.7	6.7	15.5	0.3	0.4	0.6	0.7	27.9	1.8	0.2	0.2	1.4	0.1	0.5	0.0	0.5	0.6	1.7	0.4	0.3	0.8	0.2	0.1	0.0	1.4	1.0	0.6	1.3	0.1	0.3	1.1	25.5	2.0	0.4	0.2	0.6	0.1	0.3	2.5	0.2	1.8	0.2	0.9	2.0	20.4	0.6	0.4	0.3	0.5	0.0	0.4	1.1	0.6	0.8	0.3	0.0	6.9	0.7	0.1	0.1	6.0	0.6	1.2	1.2	0.8	0.2	2.5	2.0	0.6	0.3	2.3	0.4	316.9	584.3	18.5	2.5	863.0	2.1	2.3	0.9	1.0	288.0	1.1	1.0	1.8	1659.8	6.4	1146.1	5.4	2.2	354.1	7.2	7.5	13.7	9.6	6.9	9.3	12.1	9.4	11.7	9.0	9.3	15.5	1.0	3.2	12.4	8.8	2.7	1.8	0.3	0.9	0.0	3.6	2.1	3.0	0.6	2.8	3.9	1.8	4.2	0.6	2.1	0.6	27.4	0.2	0.7	3.9	13.1	4.1	0.0	2.7	15.9	0.4	0.6	2.8	0.5	5.8	10.1	0.8	1.8	1.8	80.8	1.7	14.8	1.3	0.0	100.7	65.9	1.9	52.5	144.7	1.8	28.1	72.3	1.4	3.1	2.0	10.3	0.3	0.1	21.4	0.4	0.5	0.1	0.7	3.1	2.4	0.0	1.0	0.7	1.6	2.6	0.2	0.9	0.8	2.0	0.4	0.9	0.3
PINLYP		ENSG00000234465	"Phospholipase A2 inhibitor and LY6/PLAUR domain containing"	A6NC86	19	43575801-43583964	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 23.5;Proximal tubular cells: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 21.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 73.1;HMC-1: 46.6;JURKAT: 37.1;REH: 29.8;THP-1: 36.6"	"Not detected"	"Not detected"							HPA061218	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles		"HPA061218: AB_2684453"	"unprognostic (6.72e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.60e-2)"	9.9	3.5	16.3	3.3	16.7	2.7	8.5	18.1	22.1	17.3	16.1	13.3	1.4	14.7	9.4	10.5	17.1	9.3	9.8	16.1	16.8	22.9	2.1	7.7	5.0	17.2	17.0	19.6	2.4	0.7	14.9	2.8	16.0	13.5	3.0	2.6	5.8	10.4	1.7	7.6	6.4	11.1	16.4	8.4	7.3	5.4	17.4	10.6	11.8	3.3	5.2	10.3	13.0	15.7	0.7	0.3	1.9	0.3	3.4	4.5	0.4	0.8	1.2	1.6	4.3	0.0	0.1	0.0	0.2	19.0	1.8	4.0	0.0	0.2	1.5	0.1	0.2	73.1	0.8	0.1	10.3	0.0	46.6	10.2	0.4	10.3	0.2	4.3	2.7	37.1	0.9	1.0	0.7	0.4	8.9	1.1	1.8	0.1	0.7	29.8	0.2	0.0	0.8	0.4	0.3	0.0	0.0	0.4	0.1	0.3	0.1	36.6	1.2	4.7	0.9	0.1	3.1	0.0	0.0	4.4	16.0	0.0	0.4	10.4	1.5	0.7	3.0	1.2	3.6	1.7	0.9	2.5	2.3	4.7	0.3	3.6	0.5	1.4	0.2	21.0	2.0	1.7	16.3	16.7	18.1	22.1	16.1	16.8	17.2	17.0	16.0	16.4	17.4	15.7	1.8	12.8	3.2	2.3	1.1	3.6	10.0	5.6	8.6	6.1	2.4	5.6	2.8	8.6	5.7	9.2	6.2	0.4	1.8	0.1	23.5	1.3	6.4	2.1	9.9	4.3	0.0	4.4	0.5	0.4	0.4	9.1	2.0	2.0	0.0	7.6	5.7	0.0	5.1	6.7	1.1	0.8	2.0	1.0	3.9	7.3	11.5	2.7	5.4	1.9	3.3	5.6	0.0	5.0	0.5	0.4	0.1	9.8	1.7	5.2	0.7	19.0	15.0	3.3	0.0	2.1	5.9	2.3	1.2	6.7	3.1	0.1	1.2	13.6	1.7	6.6
PLA2G6	"iPLA2, iPLA2beta, NBIA2, PARK14, PNPLA9"	ENSG00000184381	"Phospholipase A2 group VI"	O60733	22	38111495-38214778	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Lipid metabolism, Phospholipid metabolism"	"Calmodulin-binding, Hydrolase"	"Disease variant, Dystonia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 28.5;Spermatocytes: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 39.1;HMC-1: 25.6;U-266/70: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001171	Approved		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Centriolar satellite, Cytosol"		"HPA001171: AB_1079145"	"unprognostic (5.26e-2)"	"prognostic favorable (7.29e-4)"	"unprognostic (8.74e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.67e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.37e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.55e-4)"	20.0	22.2	14.1	4.6	16.6	12.2	19.5	15.2	20.3	24.9	12.3	11.4	9.2	17.8	10.6	10.3	26.2	13.2	9.5	14.3	13.7	24.0	13.3	10.4	8.5	17.2	15.0	24.3	16.1	6.7	17.7	4.1	19.5	24.9	2.8	8.3	15.9	9.2	10.7	17.2	12.5	3.4	15.3	17.1	13.2	42.1	15.4	11.7	51.8	4.4	4.6	13.2	14.4	25.5	0.8	1.3	2.6	6.3	8.0	5.5	9.8	0.9	1.0	0.5	1.2	3.2	2.4	5.9	6.7	1.3	0.9	3.5	2.2	2.5	0.3	9.2	11.1	39.1	3.4	3.5	3.1	2.6	25.6	13.3	3.7	2.3	4.6	6.6	0.8	11.7	8.0	13.3	0.7	3.1	8.5	3.0	3.4	2.7	1.3	6.5	1.2	6.1	2.8	5.9	7.1	1.9	1.9	3.1	6.7	3.9	4.1	2.4	0.6	2.1	4.5	0.9	0.6	20.6	2.7	4.0	4.0	3.2	2.0	1.4	0.1	0.0	1.0	0.0	0.7	0.5	1.0	1.5	0.4	0.3	0.4	1.2	0.6	3.7	0.2	1.3	1.6	0.7	14.1	16.6	15.2	20.3	14.3	13.7	17.2	15.0	19.5	15.3	15.4	25.5	5.6	3.2	2.7	19.9	4.6	3.1	3.5	4.0	4.6	9.9	7.4	6.5	2.0	4.3	5.0	12.9	4.2	3.3	11.1	11.3	0.0	2.1	28.5	9.5	4.4	3.1	11.4	7.4	6.4	1.0	2.7	3.3	11.2	8.7	0.0	10.6	3.6	3.5	1.7	15.2	5.9	8.6	2.0	1.0	0.8	18.3	5.9	2.1	1.8	4.7	2.3	4.9	8.2	4.5	25.2	1.1	12.6	3.8	4.7	2.9	21.9	1.9	7.6	7.5	6.6	2.6	3.4	44.5	7.7	4.1	3.4	4.9	6.6	6.8	8.4	2.1
PLCB2	FLJ38135	ENSG00000137841	"Phospholipase C beta 2"	Q00722	15	40278176-40307935	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.4;lymphoid tissue: 40.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 22.6;granulocytes: 26.6;Hofbauer cells: 30.3;Kupffer cells: 46.6;Macrophages: 41.7;Microglial cells: 39.4;monocytes: 20.9;NK-cells: 26.8;T-cells: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 78.6;HMC-1: 93.4;THP-1: 28.1;U-937: 53.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB009443, HPA041298, HPA068595, HPA069308"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		11000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"CAB009443: AB_632197, HPA041298: AB_2677395, HPA068595: , HPA069308: "	"unprognostic (5.52e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (7.20e-5)"	"unprognostic (9.89e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.13e-1)"	5.9	4.0	3.8	29.2	3.9	52.4	2.5	3.8	5.4	3.3	3.4	5.1	6.1	2.7	1.4	3.0	4.5	9.7	3.0	4.0	5.6	1.9	6.3	16.8	28.7	8.4	7.1	1.5	1.3	1.3	2.1	7.0	7.3	2.6	8.0	0.5	5.4	4.0	1.2	1.9	10.4	7.3	6.2	40.7	5.5	1.3	7.7	20.5	2.2	1.7	22.2	7.3	1.8	9.6	0.4	0.0	0.6	0.0	0.0	0.0	10.5	0.0	0.1	0.0	0.0	0.1	19.1	1.5	17.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	78.6	0.0	0.0	0.0	16.9	93.4	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.7	4.3	0.0	0.0	4.7	9.2	0.9	0.0	0.2	13.7	2.0	0.1	0.1	0.0	0.3	0.3	0.0	0.0	0.2	5.1	0.0	28.1	10.1	0.0	9.1	0.0	0.0	0.0	0.0	3.7	0.0	53.2	0.0	1.7	2.6	5.3	1.8	2.7	1.2	0.4	0.9	0.9	2.7	0.5	0.9	1.0	4.2	1.2	2.7	1.0	1.9	1.5	3.8	3.9	3.8	5.4	4.0	5.6	8.4	7.1	7.3	6.2	7.7	9.6	0.9	6.4	16.8	0.3	9.6	0.9	0.1	0.1	0.6	0.1	1.9	2.5	3.3	1.5	3.2	1.8	0.0	0.5	22.6	0.2	0.0	0.1	2.2	0.2	0.5	1.7	0.0	8.0	1.8	0.0	0.5	1.9	0.0	0.2	26.6	0.1	1.1	0.4	30.3	0.0	0.8	1.7	0.0	46.6	15.5	0.6	0.3	41.7	3.6	39.4	20.9	0.0	26.8	0.5	0.2	0.4	0.3	0.0	5.7	0.0	0.0	0.9	4.4	0.2	0.0	0.4	0.7	0.5	2.3	0.3	0.6	0.4	20.8	0.3	2.0	0.0
PLD3	HU-K4	ENSG00000105223	"Phospholipase D family member 3"	Q8IV08	19	40348456-40380439	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response"	"Exonuclease, Hydrolase, Nuclease"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 711.9"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 688.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 1727.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 1727.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012800, CAB020812"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA		450000	"Cluster 10: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB020812: , HPA012800: AB_1855330"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.60e-2)"	"prognostic favorable (6.44e-4)"	"unprognostic (4.34e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.42e-2)"	169.3	200.0	143.3	78.4	159.7	48.3	138.4	46.0	229.7	139.4	54.0	131.4	71.7	155.7	84.7	84.9	133.5	96.7	206.1	202.5	294.4	130.2	121.3	181.5	98.1	132.4	128.5	199.0	151.0	105.9	711.9	123.4	137.9	133.4	49.2	51.4	138.7	106.2	105.1	120.5	105.3	79.1	63.8	197.0	126.5	77.7	197.7	44.3	120.8	82.3	41.4	126.2	126.0	129.6	85.6	257.8	163.7	259.1	444.2	210.2	124.5	206.5	208.6	146.4	166.6	49.4	93.8	36.9	211.0	180.9	47.8	39.3	39.9	81.2	63.5	138.4	145.3	39.9	82.1	63.2	302.7	16.8	435.1	402.5	167.0	112.1	76.6	244.2	125.0	59.3	142.5	144.5	106.7	111.5	29.5	79.6	107.4	138.7	52.8	37.0	124.5	154.2	75.2	63.2	116.7	193.9	99.0	60.6	113.8	169.5	83.6	283.2	222.3	122.8	58.5	105.6	47.0	148.9	173.3	38.8	197.7	66.2	77.9	1727.4	256.7	378.7	75.0	129.5	62.0	34.4	59.5	67.7	235.0	28.1	60.8	61.3	25.7	102.3	64.2	34.7	64.5	208.6	143.3	159.7	46.0	229.7	202.5	294.4	132.4	128.5	137.9	63.8	197.7	129.6	66.7	32.1	69.6	59.4	27.0	35.4	93.6	263.1	39.9	101.5	45.9	61.2	22.0	45.8	90.4	57.0	33.3	158.2	27.2	42.5	21.5	52.5	8.7	32.0	49.8	53.9	72.8	18.7	99.1	58.3	107.2	158.8	38.2	31.5	60.3	134.7	88.2	43.1	688.4	121.1	113.4	41.3	126.1	280.9	59.1	15.7	151.6	261.3	92.5	50.6	54.2	94.1	35.0	53.3	70.2	54.3	42.6	143.7	85.8	57.9	78.8	37.1	35.2	47.6	19.7	73.1	59.7	24.2	67.9	32.4	33.4	195.9	28.8	114.1	41.6	68.2
PLD4	C14orf175	ENSG00000166428	"Phospholipase D family member 4"	Q96BZ4	14	104924713-104937761	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.4;brain: 16.7;lymphoid tissue: 11.3"	"Cell type enriched"	"Detected in many"	7	"dendritic cells: 284.8"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 3621.6"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 3621.6"	"Group enriched"	"Detected in some"	4	"HMC-1: 127.3;RPMI-8226: 85.5;THP-1: 191.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051512	Uncertain					NA	NA		2900000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA051512: AB_2681515"	"unprognostic (4.50e-3)"	"unprognostic (1.78e-4)"	"unprognostic (7.12e-2)"	"unprognostic (5.30e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.19e-3)"	"unprognostic (3.45e-3)"	"unprognostic (3.89e-1)"	"unprognostic (6.90e-3)"	"unprognostic (8.94e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.41e-1)"	0.4	1.0	5.1	5.7	4.7	13.4	1.5	7.0	7.1	1.0	0.4	0.8	3.8	1.0	0.2	0.6	1.8	2.4	0.5	4.5	7.3	0.8	0.5	1.8	11.3	15.7	6.8	0.5	1.1	1.2	2.1	0.8	10.3	1.7	0.5	0.5	3.5	1.8	0.3	0.6	5.1	0.5	13.9	10.4	2.8	0.6	9.4	2.8	0.6	0.0	9.4	1.9	0.4	16.7	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.0	9.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	127.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.1	10.7	0.1	0.0	0.1	30.0	0.1	85.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	191.5	0.0	0.1	0.3	0.1	0.2	0.4	0.0	0.1	0.2	1.6	0.3	4.6	43.0	699.5	1.0	188.4	1.9	222.7	0.8	1.2	545.8	198.4	1.7	0.4	9.8	25.4	297.9	3621.6	1.0	72.9	5.1	4.7	7.0	7.1	4.5	7.3	15.7	6.8	10.3	13.9	9.4	16.7	0.8	0.0	0.0	0.3	34.7	0.4	0.1	0.0	0.0	2.7	0.6	2.8	1.4	0.0	0.0	0.0	0.0	0.2	284.8	0.0	0.0	0.0	0.7	0.1	0.3	2.7	0.0	5.5	0.1	0.0	0.4	1.1	1.1	0.4	3.8	0.0	0.0	0.0	30.6	1.7	0.1	0.0	0.0	1.3	32.0	4.7	0.0	38.0	5.4	22.5	11.3	0.1	2.1	0.5	0.1	0.0	0.0	0.0	2.3	0.1	0.0	0.1	0.0	1.1	6.6	1.6	0.3	1.6	1.6	0.0	0.4	0.3	2.2	0.0	0.1	0.0
PNPLA7	"C9orf111, FLJ31318, FLJ43070, FLJ44279, NTE-R1, NTEL1, RP11-48C7.2"	ENSG00000130653	"Patatin like phospholipase domain containing 7"	Q6ZV29	9	137459952-137550402	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 56.2;Excitatory neurons: 23.6;Inhibitory neurons: 21.5;Oligodendrocytes: 21.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 9.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.0;T-reg: 1.2"	"Group enriched"	"Detected in many"	4	"B-cells: 1.0;T-cells: 1.2"	"Cell line enriched"	"Detected in some"	22	"HMC-1: 83.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009130	Uncertain		Uncertain	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol	"Centriolar satellite"	"HPA009130: AB_2268411"	"unprognostic (1.49e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.72e-3)"	"unprognostic (5.14e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (2.24e-5)"	"unprognostic (1.09e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.81e-2)"	"unprognostic (3.45e-3)"	9.6	7.0	5.2	2.2	5.3	2.1	11.3	1.9	8.6	17.6	1.2	10.8	2.2	12.3	1.0	2.7	13.0	3.7	6.9	6.6	2.6	6.3	14.0	4.7	4.4	4.6	2.6	21.5	17.9	2.0	8.9	0.6	3.6	22.5	1.4	1.3	15.9	2.7	17.3	14.3	8.4	1.6	2.2	7.0	16.3	2.6	4.2	1.4	17.3	3.4	1.4	10.5	7.6	5.9	0.1	1.0	0.2	0.3	0.8	0.5	0.4	0.8	0.8	0.2	0.2	0.1	0.5	0.6	0.8	0.4	0.4	0.3	0.1	0.0	0.0	1.6	0.9	0.8	1.0	0.3	0.5	0.4	83.7	1.2	0.1	0.3	0.0	1.4	0.1	0.1	0.1	2.3	0.1	1.6	0.2	1.6	0.0	1.2	0.9	2.0	1.3	2.8	0.1	0.3	1.6	0.4	0.1	0.6	0.3	0.2	3.7	1.2	0.6	0.0	0.1	0.4	0.1	0.8	0.2	0.2	1.2	0.8	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.1	0.1	0.2	1.0	0.3	0.2	0.0	0.0	0.0	0.1	1.2	0.2	5.2	5.3	1.9	8.6	6.6	2.6	4.6	2.6	3.6	2.2	4.2	5.9	3.0	9.6	5.9	56.2	4.8	1.5	1.1	0.9	2.2	2.5	6.5	8.3	3.9	4.3	2.6	1.8	6.2	0.2	2.1	6.6	0.0	0.7	0.5	1.7	4.8	1.2	17.3	0.8	23.6	0.0	0.3	3.6	12.2	3.8	7.0	1.2	2.5	10.2	2.6	5.0	21.5	9.2	0.0	4.5	1.0	0.6	4.4	1.2	0.0	9.4	1.3	2.5	1.0	11.6	21.0	0.6	7.1	1.9	1.6	2.5	3.8	1.0	1.6	9.6	0.0	2.3	2.1	3.1	4.0	0.9	3.3	0.0	2.3	0.6	2.0	0.7
POLB		ENSG00000070501	"DNA polymerase beta"	P06746	8	42338454-42371808	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 254.5;Late spermatids: 133.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 280.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011616, HPA049104, HPA069013"	Enhanced		Uncertain	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"CAB011616: AB_731977, HPA049104: AB_2680632, HPA069013: "	"unprognostic (1.67e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (8.49e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.77e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (5.65e-4)"	12.4	17.5	26.6	13.5	27.4	51.3	27.4	82.3	35.5	18.9	24.3	12.3	10.8	12.9	19.7	26.5	13.2	17.4	26.1	28.1	29.0	18.0	33.9	14.2	20.2	27.1	27.8	20.4	16.9	18.8	26.7	11.1	28.9	24.8	13.2	18.0	30.3	11.3	85.3	23.1	10.8	10.6	27.6	17.2	14.0	53.1	30.2	24.8	14.2	70.0	22.2	30.8	18.9	28.9	40.2	23.5	40.6	80.4	21.8	20.7	33.8	25.2	29.3	41.5	37.7	33.1	46.0	36.4	31.1	16.5	43.4	20.0	34.1	29.5	50.3	23.8	36.7	26.5	18.2	45.3	34.1	18.6	280.6	18.8	34.4	30.1	35.4	51.8	32.1	77.2	58.4	22.4	40.3	23.6	78.0	52.6	54.4	48.4	26.7	44.2	40.8	31.4	78.4	32.1	22.7	41.8	29.9	19.9	79.0	41.4	52.5	31.5	17.8	19.1	27.0	48.8	24.6	32.5	58.4	52.2	19.3	39.4	52.2	47.6	15.1	48.1	12.0	18.8	13.3	12.2	12.5	13.0	15.7	11.1	14.1	13.3	63.6	22.2	26.3	84.9	19.3	11.5	26.6	27.4	82.3	35.5	28.1	29.0	27.1	27.8	28.9	27.6	30.2	28.9	13.9	3.2	13.6	6.8	20.2	16.8	30.1	14.2	31.3	2.9	14.3	15.1	21.6	7.2	20.7	7.3	8.4	7.5	51.9	3.1	5.9	11.7	254.5	13.8	7.7	12.5	6.0	7.6	15.8	9.6	7.0	9.7	10.2	9.9	23.4	12.7	8.6	12.7	7.4	6.7	20.3	5.4	4.1	5.7	9.9	133.9	7.2	18.2	7.2	19.7	11.2	8.3	13.4	12.5	16.7	33.6	5.8	3.8	21.9	41.6	4.3	6.8	16.4	4.4	0.0	6.6	12.3	19.4	15.4	27.3	20.0	11.1	16.2	7.8	6.6	31.6
POMC	"ACTH, CLIP, LPH, MSH, NPP, POC"	ENSG00000115138	Proopiomelanocortin	P01189	2	25160853-25168903	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"		"Endorphin, Hormone"	"Cancer-related genes, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	903	"pituitary gland: 34360.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 119.8;Late spermatids: 352.6;Spermatocytes: 83.0"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 18.5"	"Group enriched"	"Detected in all"	6	"hypothalamus: 38.0;thalamus: 13.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.5;THP-1: 2.1"	"Region enriched"	"Detected in all"	7	"hypothalamus: 44.0"	"Region enriched"	"Detected in all"	5	"hypothalamus: 88.1"	"CAB002762, HPA046135, HPA063644, CAB079881"	Enhanced				"Secreted to blood"	NA	NA	380000		"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"CAB002762: , CAB079881: , HPA046135: AB_2679552, HPA063644: AB_2685071"	"unprognostic (8.02e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.30e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.70e-4)"	"unprognostic (8.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.84e-2)"	6.1	19.1	2.7	1.2	2.8	1.1	3.5	3.2	4.4	3.0	2.2	6.9	0.4	3.1	0.3	13.7	2.2	0.2	12.1	2.3	38.0	4.9	12.9	3.5	1.1	4.5	3.3	5.0	22.6	0.1	34360.0	1.2	3.7	5.0	0.0	0.2	5.8	0.3	5.7	35.7	4.8	0.1	4.0	11.1	15.5	25.7	13.1	1.2	8.4	5.2	0.4	2.5	3.7	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	12.6	8.6	11.5	13.2	9.1	16.8	8.8	11.3	15.9	17.4	11.6	12.6	3.8	18.2	8.0	27.9	10.5	9.7	2.7	2.8	3.2	4.4	2.3	38.0	4.5	3.3	3.7	4.0	13.1	3.5	22.3	0.0	2.2	1.0	16.1	4.5	2.2	6.9	2.2	2.6	6.1	6.7	2.5	2.8	2.5	0.0	0.0	0.5	24.4	0.2	15.6	7.8	119.8	0.6	4.9	11.6	0.0	28.8	0.3	17.3	6.0	5.2	4.6	0.6	7.0	9.7	15.4	2.0	34.5	6.7	0.6	0.0	6.1	10.9	7.9	352.6	4.7	17.2	17.8	1.9	8.5	11.5	15.5	0.0	0.3	10.1	1.1	13.2	17.8	4.1	0.1	3.9	0.7	7.5	13.1	4.6	3.8	83.0	27.3	1.6	5.5	0.4	14.9	12.9	0.6	3.8
PPARA	"hPPAR, NR1C1, PPAR"	ENSG00000186951	"Peroxisome proliferator activated receptor alpha"	Q07869	22	46150521-46243756	"FDA approved drug targets, Metabolic proteins, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 44.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 99.4;Hepatocytes: 144.5;Proximal enterocytes: 93.2;Rod photoreceptor cells: 148.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 10.3;plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.1;granulocytes: 10.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058901, HPA067049, CAB075701"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB075701: , HPA058901: AB_2683849, HPA067049: AB_2685770"	"unprognostic (1.96e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.94e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.95e-1)"	"unprognostic (5.52e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.39e-9)"	"unprognostic (4.84e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.18e-2)"	7.9	6.3	9.6	4.5	12.7	6.6	3.8	9.5	6.9	4.1	23.5	11.8	18.4	3.8	3.6	7.7	4.1	4.4	26.3	7.7	8.8	22.4	33.2	4.0	3.4	11.0	11.2	11.2	8.2	7.4	2.6	4.3	10.0	6.2	9.1	18.2	7.8	5.7	26.2	7.7	18.4	4.3	8.6	4.4	6.1	1.3	11.7	3.7	7.0	44.6	3.9	5.1	4.0	10.5	7.8	1.9	2.4	8.4	13.0	8.3	5.3	6.7	13.2	7.0	7.2	3.8	3.7	2.8	3.3	15.6	6.5	3.5	7.1	8.7	6.3	8.1	8.9	8.7	4.8	8.0	8.1	6.0	14.3	6.6	6.9	5.2	11.8	6.0	1.5	6.3	3.2	6.4	6.6	2.0	6.8	2.2	0.3	6.5	1.9	8.0	8.6	3.6	4.7	4.6	2.4	7.0	2.6	2.4	8.0	3.2	2.7	4.6	2.6	7.3	7.7	6.7	2.9	6.3	4.0	1.2	11.4	6.6	2.3	1.4	0.8	10.3	1.0	1.0	0.8	0.8	0.5	0.5	0.6	1.0	0.6	0.4	0.7	0.7	0.7	3.1	1.4	0.2	9.6	12.7	9.5	6.9	7.7	8.8	11.0	11.2	10.0	8.6	11.7	10.5	15.0	3.2	13.6	49.6	8.0	23.3	15.0	7.8	9.1	15.0	14.3	11.4	99.4	22.8	8.9	7.3	62.6	8.0	18.4	58.8	9.8	10.3	0.6	9.4	26.4	15.5	19.9	32.0	1.4	16.6	6.7	16.0	14.8	18.4	5.1	19.1	22.5	144.5	8.8	5.0	13.8	31.4	0.0	24.8	10.2	1.1	19.6	10.4	3.6	10.3	12.2	16.0	8.2	19.6	27.2	13.0	24.5	30.1	10.6	19.1	93.2	40.8	5.0	148.0	6.6	31.0	15.8	0.7	1.7	19.3	34.2	3.0	9.6	14.6	37.9	19.9
PPM1H	"ARHCL1, FLJ13253, KIAA1157, NERPP-2C"	ENSG00000111110	"Protein phosphatase, Mg2+/Mn2+ dependent 1H"	Q9ULR3	12	62643994-62935150	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0;parathyroid gland: 42.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 123.5;Glandular and luminal cells: 81.6;Inhibitory neurons: 162.1;Microglial cells: 89.9;Oligodendrocytes: 341.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 80.6;HMC-1: 62.7;SK-BR-3: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020694, HPA044244, HPA058777"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB020694: , HPA044244: AB_2678871, HPA058777: AB_2683816"	"unprognostic (3.41e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (2.72e-5)"	"unprognostic (3.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.14e-1)"	2.2	1.5	12.0	1.2	12.7	3.1	4.9	30.0	16.0	7.5	5.7	2.4	3.1	6.2	6.7	0.6	6.5	6.7	2.4	13.3	15.7	10.6	3.4	2.7	1.2	11.1	11.3	9.6	3.9	42.4	8.2	6.5	14.9	13.4	3.0	26.7	11.4	6.0	1.1	0.8	1.7	1.5	7.8	0.9	5.7	0.9	16.5	4.3	3.2	1.3	1.7	2.1	0.3	16.2	1.2	12.4	2.2	0.2	0.5	0.0	26.5	2.9	2.9	1.8	0.6	80.6	5.7	0.0	2.7	1.4	1.8	1.6	8.7	0.2	1.1	0.2	4.3	15.2	2.4	18.4	0.1	4.6	62.7	0.1	0.3	0.0	0.7	1.9	0.3	2.7	4.0	0.0	1.3	9.5	1.5	2.2	15.9	4.1	5.9	2.1	5.6	23.0	18.1	28.3	6.9	0.0	5.0	35.6	12.1	8.5	19.6	2.7	0.2	0.5	1.5	0.2	0.9	3.3	21.4	4.1	0.2	0.1	1.2	2.9	0.7	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.0	0.1	12.0	12.7	30.0	16.0	13.3	15.7	11.1	11.3	14.9	7.8	16.5	16.2	4.6	6.4	4.7	25.5	1.0	0.1	0.3	3.0	0.0	9.4	9.5	3.4	2.4	12.8	5.9	16.5	27.1	22.2	0.0	0.7	3.9	4.2	8.5	27.6	25.3	6.5	9.0	3.8	123.5	6.3	2.1	1.3	7.7	81.6	14.5	0.3	9.7	6.1	6.1	11.8	162.1	2.0	6.1	1.6	2.1	10.1	0.9	2.1	3.6	89.9	2.1	6.4	0.0	41.7	341.4	4.5	2.1	1.5	0.5	4.3	0.1	8.5	14.0	10.9	0.0	0.6	1.7	0.0	0.5	0.5	0.1	6.8	1.3	2.8	2.4	0.5
PPP6R1	"KIAA1115, SAP190, SAPS1"	ENSG00000105063	"Protein phosphatase 6 regulatory subunit 1"	Q9UPN7	19	55229779-55259017	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 237.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 28.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043989, HPA063681"	Approved		Enhanced	Cytosol		No	No		19000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA043989: AB_10987309, HPA063681: AB_2685087"	"unprognostic (1.15e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.82e-6)"	"unprognostic (2.22e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.63e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.20e-1)"	21.8	36.8	31.6	52.7	35.4	96.4	20.3	8.0	35.7	22.0	19.4	28.3	38.1	25.7	5.1	35.2	26.6	23.8	28.3	41.7	12.8	23.8	25.5	28.3	82.4	15.0	13.2	21.1	20.3	22.6	29.7	21.2	15.6	23.5	12.2	8.8	24.1	21.4	38.7	28.5	42.4	18.4	8.3	61.5	42.6	89.7	20.6	62.2	27.3	20.2	49.3	33.4	23.4	18.1	101.2	143.4	28.7	46.1	33.5	30.8	73.1	63.1	54.7	64.8	55.2	95.4	67.9	261.0	33.7	56.6	48.2	48.2	10.3	65.9	25.1	98.2	241.8	198.5	71.8	71.0	57.5	295.9	187.6	45.4	37.4	64.5	43.4	34.7	42.2	178.7	105.5	112.1	42.5	64.5	218.1	105.5	39.3	82.2	116.5	131.8	56.4	216.0	45.9	126.6	81.8	45.5	58.7	69.7	62.2	24.6	38.3	219.7	55.3	101.3	49.7	39.4	96.4	55.4	108.7	184.1	92.4	240.5	79.1	0.0	2.8	6.5	11.7	3.9	6.6	3.3	4.8	9.3	4.0	2.7	4.9	7.5	3.1	7.8	3.4	28.6	3.6	6.8	31.6	35.4	8.0	35.7	41.7	12.8	15.0	13.2	15.6	8.3	20.6	18.1	14.7	12.8	19.8	11.1	27.2	2.8	8.9	1.0	11.4	16.3	14.2	10.4	2.6	18.6	6.2	18.4	10.4	11.1	66.2	21.7	0.0	21.2	237.3	36.3	13.6	15.8	15.1	41.4	14.4	28.7	9.3	9.7	50.4	19.7	7.6	19.7	16.1	22.3	32.4	30.3	10.6	15.7	2.0	31.2	4.8	55.3	18.6	34.0	0.0	9.4	21.9	14.7	51.5	6.0	11.3	47.3	18.8	19.5	27.0	22.1	34.2	12.3	12.6	15.3	19.7	12.5	10.7	38.5	41.0	13.9	3.4	11.4	39.6	31.3	14.2	50.7
PRDM10	"KIAA1231, MGC131802, PFM7"	ENSG00000170325	"PR/SET domain 10"	Q9NQV6	11	129899706-130002835	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.5;Excitatory neurons: 21.3;Inhibitory neurons: 21.2;Oligodendrocytes: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026997, HPA061749"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center, Vesicles"	"HPA026997: AB_1855681, HPA061749: "	"unprognostic (4.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.32e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.87e-3)"	"unprognostic (3.33e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.88e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.51e-1)"	2.8	2.4	2.5	3.1	2.5	7.9	4.2	7.4	3.3	3.2	2.8	3.4	3.4	3.0	3.3	4.0	2.6	2.8	2.0	2.9	3.4	2.2	3.5	3.0	3.9	1.8	1.8	3.4	3.1	3.4	4.6	2.6	1.9	3.4	3.9	4.7	3.1	2.5	6.7	6.2	3.7	2.5	0.9	3.1	4.0	2.4	3.3	6.7	3.0	3.8	4.0	2.6	3.4	4.0	4.7	6.1	7.7	5.1	3.4	4.1	5.1	3.9	5.0	3.2	4.1	6.2	4.8	17.8	4.5	4.6	4.4	6.1	6.4	3.2	5.2	6.6	5.5	12.3	7.5	5.0	2.2	10.9	44.8	2.9	7.1	4.8	3.1	4.9	5.7	5.0	7.0	6.6	4.7	5.2	6.7	5.7	5.9	6.3	4.4	6.5	4.8	2.9	4.7	8.0	8.3	4.3	5.7	6.4	1.7	4.3	4.5	4.8	5.7	7.2	3.4	3.8	5.1	1.7	3.0	25.1	3.2	6.1	5.9	2.4	2.2	6.0	2.6	2.5	2.6	6.8	2.1	2.2	2.1	3.6	3.1	1.4	6.3	4.4	2.7	2.1	2.9	1.4	2.5	2.5	7.4	3.3	2.9	3.4	1.8	1.8	1.9	0.9	3.3	4.0	2.7	3.2	2.7	22.5	3.2	6.1	2.6	1.8	6.8	3.7	3.5	2.2	2.7	1.5	2.0	0.0	0.0	1.5	2.5	6.3	0.0	1.2	3.0	2.9	2.7	1.8	1.8	8.6	21.3	1.1	1.2	2.7	4.6	3.2	1.3	2.7	1.1	2.3	1.6	1.7	21.2	3.1	2.0	3.1	2.9	4.1	2.5	2.8	0.0	13.1	2.1	1.0	1.0	13.6	21.6	0.9	3.2	1.9	2.4	4.6	3.1	1.0	2.3	2.7	0.0	3.9	3.4	0.8	0.8	7.2	5.1	0.5	3.5	1.7	2.7	5.8
PRG3	"MBP2, MBPH"	ENSG00000156575	"Proteoglycan 3, pro eosinophil major basic protein 2"	Q9Y2Y8	11	57376769-57381150	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"bone marrow: 48.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	46	"HMC-1: 198.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory bulb: 3.5"	HPA064183	Enhanced				"Secreted in other tissues"	NA	NA		680000		"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"				"HPA064183: AB_2685205"																		0.0	0.0	0.0	0.0	0.0	48.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.4	198.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRKX	PKX1	ENSG00000183943	"Protein kinase X-linked"	P51817	X	3604340-3713649	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 33.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 108.3;Endometrial ciliated cells: 164.0;Glandular and luminal cells: 179.5;NK-cells: 139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 11.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015324	Supported		Supported	Nucleoplasm		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA015324: AB_1855715"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.15e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.70e-2)"	5.5	1.6	10.0	9.8	12.9	7.7	7.9	12.6	8.8	7.8	12.7	6.5	5.1	4.6	9.6	13.9	19.4	4.4	3.7	8.3	14.3	15.6	1.8	9.0	12.8	18.1	13.8	4.0	4.4	3.1	2.0	5.3	15.8	3.8	6.1	1.7	6.1	5.9	2.2	12.0	6.3	3.7	14.5	12.4	4.0	6.8	15.3	15.4	33.8	3.2	9.9	4.5	12.4	17.1	9.1	8.3	22.4	16.7	4.2	5.6	20.5	5.3	2.1	2.6	3.5	12.4	6.1	0.7	5.3	4.3	5.4	6.2	21.1	16.1	4.5	10.2	14.7	10.0	6.7	0.2	4.4	13.0	74.7	3.8	16.8	2.8	10.3	7.1	25.7	12.3	11.8	12.7	8.6	8.0	15.0	11.7	15.0	7.0	9.4	27.7	21.5	17.2	20.6	7.6	14.9	9.6	5.6	3.6	5.5	35.1	2.8	10.3	14.2	2.2	3.8	3.7	3.6	0.3	0.7	11.6	1.3	11.6	5.8	11.0	2.0	1.2	2.3	2.4	2.4	1.6	2.4	2.2	1.6	1.5	1.9	2.1	0.5	2.4	3.2	1.9	1.8	1.2	10.0	12.9	12.6	8.8	8.3	14.3	18.1	13.8	15.8	14.5	15.3	17.1	32.0	3.2	9.4	7.8	35.5	21.4	22.3	9.7	21.6	1.8	14.4	9.1	1.6	30.0	10.1	5.5	0.0	30.8	108.3	8.8	13.7	10.8	11.9	164.0	23.8	19.7	4.8	7.2	1.3	3.1	5.8	10.4	6.1	179.5	85.1	11.8	13.2	2.3	16.9	1.7	20.2	13.5	24.4	19.4	24.1	49.2	19.9	29.0	5.4	39.4	53.4	2.2	139.0	11.1	7.0	5.6	13.1	21.8	38.2	29.0	10.7	6.1	18.0	0.6	32.9	46.4	12.4	1.3	21.6	34.1	26.9	7.8	63.5	10.6	23.6	20.4
PRR5L	"FLJ14213, PROTOR-2"	ENSG00000135362	"Proline rich 5 like"	Q6MZQ0	11	36296288-36465204	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.9;intestine: 34.7;lymphoid tissue: 36.4"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 302.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 35.5;HMC-1: 55.7;hTERT-HME1: 57.9;SiHa: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070174			Approved	"Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cytokinetic bridge, Cytosol"		"HPA070174: AB_2686231"	"unprognostic (6.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (7.30e-5)"	"unprognostic (2.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (7.71e-8)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.98e-2)"	3.6	1.5	10.1	8.9	27.8	4.7	2.7	21.7	16.7	11.4	2.2	34.7	3.3	2.8	2.0	1.4	6.3	7.1	2.0	9.6	21.1	7.7	2.9	13.6	9.3	36.6	23.8	12.8	1.2	0.9	2.7	3.6	33.9	2.4	27.8	0.7	7.8	2.0	0.9	1.7	12.2	5.9	24.1	36.4	3.4	1.5	23.9	3.4	3.2	0.7	3.3	4.3	3.8	46.9	0.0	5.5	10.3	0.2	1.4	0.0	0.1	13.2	8.9	25.7	27.2	0.0	0.2	0.1	4.4	15.7	5.9	0.5	2.1	5.9	12.9	5.0	3.7	1.5	35.5	0.0	3.5	0.0	55.7	3.8	9.0	2.3	57.9	25.2	9.4	0.0	0.0	0.1	13.6	3.3	0.7	0.1	0.8	0.1	2.3	4.1	1.1	1.1	27.0	6.9	0.0	0.4	40.1	0.0	2.2	6.5	0.0	0.6	7.8	22.3	6.8	0.0	16.4	0.2	0.0	0.0	9.7	1.5	6.7	36.1	2.0	24.9	34.6	21.4	8.2	0.0	12.2	29.7	2.5	1.6	2.6	18.0	11.8	9.6	24.6	7.7	0.0	15.4	10.1	27.8	21.7	16.7	9.6	21.1	36.6	23.8	33.9	24.1	23.9	46.9	2.1	19.2	4.2	17.6	0.7	0.4	0.2	5.0	0.0	0.1	1.9	0.9	0.9	1.5	6.8	7.3	0.0	0.2	25.9	44.3	1.9	1.3	17.6	1.5	0.8	7.7	1.8	7.0	1.8	2.2	0.1	2.1	1.1	2.5	5.1	0.5	22.5	0.4	8.8	0.0	1.1	22.7	10.2	11.7	0.7	54.9	0.6	5.4	0.0	16.9	4.7	1.2	58.7	31.7	302.0	3.9	37.0	0.4	4.2	0.7	13.2	0.5	9.0	0.2	6.6	1.8	2.6	0.3	0.6	0.4	0.6	0.3	14.5	0.9	17.5	0.5
PRSS50	"CT20, TSP50"	ENSG00000283706	"Serine protease 50"	Q9UI38	3	46712117-46717869	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"pituitary gland: 17.2;testis: 52.0;thyroid gland: 16.5"	"Group enriched"	"Detected in some"	8	"Spermatocytes: 359.2;Spermatogonia: 303.6"					"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.4"									HPA040768	Supported				"Intracellular and membrane"	NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA040768: AB_2677126"																		0.5	1.2	0.9	0.0	0.9	0.1	1.9	2.3	1.5	4.5	0.7	1.6	0.0	1.5	2.9	0.4	2.3	0.1	4.1	1.1	1.2	5.4	2.7	0.7	0.0	1.2	0.9	2.2	4.6	1.4	17.2	0.1	1.0	4.5	0.0	0.2	1.9	2.1	1.2	0.4	0.5	0.2	1.2	0.3	1.0	52.0	1.1	0.2	16.5	0.0	0.0	1.7	2.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	2.3	1.5	1.1	1.2	1.2	0.9	1.0	1.2	1.1	0.9	0.0	0.0	0.0	1.6	0.0	0.1	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	3.1	0.2	0.0	1.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.1	0.1	39.5	0.2	0.0	359.2	303.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5
PSTPIP2		ENSG00000152229	"Proline-serine-threonine phosphatase interacting protein 2"	Q9H939	18	45983536-46072272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 72.4;lymphoid tissue: 63.4;skeletal muscle: 33.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 44.6;Erythroid cells: 46.7;Macrophages: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 112.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 102.0;HMC-1: 108.3"	"Low region specificity"	"Detected in all"							"HPA040923, HPA040944"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		No	No		1500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Mitochondria"	Nucleoplasm	"HPA040923: AB_10794429, HPA040944: AB_10795485"	"unprognostic (1.61e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (2.39e-7)"	"unprognostic (5.21e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.93e-1)"	4.4	4.6	0.9	11.1	0.9	72.4	8.5	0.8	1.5	4.2	1.8	4.4	3.6	2.9	1.4	5.1	4.0	5.3	2.1	0.8	1.1	3.7	10.0	11.4	6.3	1.8	1.2	3.6	3.5	3.8	2.9	12.1	1.5	8.0	5.1	2.8	5.9	2.7	33.0	8.8	4.5	4.6	1.1	63.4	6.4	1.3	1.2	3.9	2.1	5.8	4.9	9.6	4.3	1.4	2.9	0.0	3.8	0.1	0.9	6.7	20.6	15.0	7.4	5.3	4.5	11.6	4.0	0.1	0.9	5.0	0.0	36.2	20.3	28.1	6.6	0.0	3.2	102.0	4.6	0.2	5.9	6.0	108.3	5.0	34.4	5.0	16.3	4.8	10.6	0.2	24.8	0.1	23.1	3.6	0.9	0.1	2.3	0.0	0.1	0.1	7.5	4.9	11.2	37.0	0.3	2.1	2.4	10.3	0.5	28.2	32.6	12.0	7.6	0.6	8.2	0.8	0.2	0.1	0.3	0.1	1.3	0.2	0.4	77.3	25.3	112.8	10.4	35.0	3.6	0.1	6.2	7.7	25.3	0.1	7.2	8.8	13.5	2.9	36.4	0.9	4.1	20.0	0.9	0.9	0.8	1.5	0.8	1.1	1.8	1.2	1.5	1.1	1.2	1.4	1.7	12.8	11.6	0.7	2.4	13.8	19.4	44.6	15.4	0.7	11.1	17.1	3.5	2.8	24.9	0.0	0.0	26.6	21.8	0.6	3.9	9.6	2.0	4.1	2.6	3.1	1.2	46.7	1.6	3.9	3.3	4.2	11.2	11.2	43.6	20.6	7.1	17.3	14.6	0.0	1.4	4.2	6.1	42.5	5.5	7.3	2.8	58.7	7.2	2.8	37.4	10.9	25.7	2.0	0.9	17.7	0.3	2.2	3.6	39.7	0.5	4.1	13.0	0.4	6.6	3.1	7.7	1.1	1.6	7.3	10.2	8.8	17.8	7.1	2.4	21.8
PTAFR		ENSG00000169403	"Platelet activating factor receptor"	P25105	1	28147166-28193936	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.1;lymphoid tissue: 30.8"	"Cell type enhanced"	"Detected in many"		"granulocytes: 75.4;Hofbauer cells: 71.7;Kupffer cells: 93.0;Langerhans cells: 67.8;Macrophages: 64.5;monocytes: 52.8;Pancreatic endocrine cells: 89.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 256.7;eosinophil: 906.5;neutrophil: 747.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 906.5;monocytes: 256.7"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 36.6;HMC-1: 131.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027543	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA027543: AB_10610287"	"unprognostic (2.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.38e-2)"	10.4	2.4	4.3	30.8	4.7	41.1	3.4	4.7	5.6	3.4	4.1	5.5	4.1	1.7	1.2	7.2	2.6	7.2	2.0	3.8	5.1	2.7	4.1	17.8	13.5	8.9	6.6	1.3	2.0	1.6	0.6	7.3	7.7	1.5	6.7	0.5	2.3	1.5	0.7	5.4	6.3	7.9	8.1	14.4	3.8	1.3	7.2	3.6	1.9	2.6	18.0	14.4	1.9	11.8	20.1	0.2	0.1	0.4	0.2	0.0	0.5	0.0	0.0	0.7	0.2	0.2	5.7	1.3	0.1	0.1	0.3	13.5	0.5	36.6	0.8	0.4	0.6	7.7	0.2	0.9	0.1	1.9	131.3	0.0	6.0	0.4	0.4	0.0	0.2	0.1	0.5	0.4	0.0	1.3	0.2	19.3	0.6	0.5	0.2	0.3	0.1	0.1	8.7	2.1	0.3	0.1	0.1	18.1	0.2	0.4	0.4	5.4	0.1	0.2	0.7	0.0	0.2	1.2	1.1	5.6	0.1	2.4	0.6	61.7	256.7	906.5	0.6	77.9	1.2	12.5	0.4	0.4	116.1	6.7	0.5	0.7	747.1	0.7	34.1	1.3	1.2	112.4	4.3	4.7	4.7	5.6	3.8	5.1	8.9	6.6	7.7	8.1	7.2	11.8	2.1	6.4	6.7	0.0	4.1	6.5	2.0	37.9	5.2	1.5	0.8	0.5	2.2	1.5	20.9	1.8	2.1	0.6	2.9	0.4	0.0	18.1	0.4	0.5	0.2	7.3	0.0	4.0	0.9	5.1	0.5	1.3	1.1	0.5	75.4	2.0	2.9	1.0	71.7	0.0	0.7	0.0	18.3	93.0	67.8	0.2	0.6	64.5	0.0	15.0	52.8	0.2	0.0	1.5	6.6	89.8	0.6	0.0	0.5	0.6	0.3	0.2	20.2	0.9	0.0	0.6	1.0	2.3	0.7	3.2	2.8	1.5	2.0	0.0	0.4	9.4
PTGDR2	"CD294, CRTH2, DP2, GPR44"	ENSG00000183134	"Prostaglandin D2 receptor 2"	Q9Y5Y4	11	60850933-60855950	"CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.2;intestine: 8.2;stomach 1: 9.3"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 2.1;Endothelial cells: 2.2;Fibroblasts: 4.1;granulocytes: 4.5;Intestinal goblet cells: 2.0;Langerhans cells: 2.4;Smooth muscle cells: 6.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 178.1;eosinophil: 234.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 234.1"	"Cell line enhanced"	"Detected in some"		"HEL: 9.6;Hep G2: 4.8;HMC-1: 5.9;K-562: 4.0;MOLT-4: 3.1;NB-4: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA014259	Uncertain					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA014259: AB_1849304"	"unprognostic (9.77e-2)"	"unprognostic (1.35e-3)"	"unprognostic (5.45e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.30e-4)"	"unprognostic (2.61e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.99e-2)"	0.6	0.0	4.3	0.6	4.2	0.0	0.6	3.3	11.2	0.4	2.3	8.2	4.4	0.4	0.2	0.8	0.6	0.5	6.7	3.4	3.6	0.1	0.5	0.6	0.1	3.7	4.2	0.1	0.5	3.4	0.3	1.0	3.9	0.5	4.1	0.1	0.1	0.1	7.3	0.4	6.9	0.3	3.0	0.5	9.3	0.3	4.2	5.0	0.1	3.9	0.1	0.5	0.2	3.4	0.0	0.0	0.1	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	9.6	0.0	4.8	1.0	0.0	5.9	1.9	0.1	0.0	0.0	0.0	0.0	0.3	4.0	0.0	0.0	0.1	3.1	14.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	178.1	0.1	234.1	0.0	10.9	0.0	0.0	1.5	1.1	5.2	0.0	0.0	0.0	0.7	0.1	35.8	1.1	1.6	2.3	4.3	4.2	3.3	11.2	3.4	3.6	3.7	4.2	3.9	3.0	4.2	3.4	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.1	0.1	0.6	0.0	0.0	0.0	2.1	0.0	0.4	0.1	0.0	0.0	0.1	0.1	0.0	2.2	1.2	0.0	0.2	0.0	0.0	4.1	0.5	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	2.4	0.0	0.3	0.5	0.0	1.9	0.6	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.9	6.8	0.1	0.0	0.0	0.3	0.0	1.8	0.0	0.1	0.0
PTGS1	"COX1, PGHS-1, PTGHS"	ENSG00000095303	"Prostaglandin-endoperoxide synthase 1"	P23219	9	122370530-122395703	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 108.3;skin 1: 152.5;urinary bladder: 175.0"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 109.9;Glandular and luminal cells: 191.9;granulocytes: 208.0;Hepatic stellate cells: 61.8;Macrophages: 55.3;Suprabasal keratinocytes: 58.7"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 53.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 28.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 20.0;granulocytes: 28.9;monocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 113.7;ASC TERT1: 89.5;BJ: 115.2;BJ hTERT+: 156.0;HEL: 73.6;HMC-1: 298.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002834, CAB020315"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		2100000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Vesicles	"CAB020315: , HPA002834: AB_1079711"	"unprognostic (4.20e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (9.35e-4)"	12.8	2.9	3.1	10.5	3.2	9.0	6.7	4.2	4.8	5.8	5.5	108.3	10.8	6.1	2.2	67.3	43.2	9.6	12.6	7.4	5.5	9.3	3.0	11.3	4.6	6.5	5.2	2.0	1.8	2.0	4.8	2.2	6.3	21.1	24.2	0.7	4.3	6.1	2.1	152.5	17.7	16.1	6.7	8.0	20.5	0.9	7.0	2.2	3.2	4.0	11.6	175.0	15.9	11.9	0.3	0.5	0.4	0.0	113.7	89.5	0.0	115.2	156.0	1.0	1.1	0.0	0.2	4.2	5.4	19.7	0.3	7.1	0.4	10.5	0.9	0.0	0.2	73.6	0.6	0.0	32.9	5.2	298.4	46.1	1.2	5.7	0.3	0.0	42.3	0.1	0.1	0.3	2.3	0.0	0.2	6.6	1.6	0.0	0.5	0.3	1.4	8.6	14.7	0.0	0.5	0.6	0.6	9.5	0.2	0.5	0.3	8.4	1.0	0.7	0.6	1.7	0.1	0.3	0.2	0.0	0.4	31.6	0.3	28.9	12.1	23.3	0.0	13.1	0.0	2.4	0.0	0.0	20.0	3.5	0.1	0.0	5.2	2.8	10.2	1.4	0.2	21.9	3.1	3.2	4.2	4.8	7.4	5.5	6.5	5.2	6.3	6.7	7.0	11.9	0.9	0.0	6.6	0.0	5.9	9.9	2.6	7.7	0.0	0.1	1.1	1.4	1.6	4.3	2.2	42.3	0.0	0.1	0.2	0.1	0.0	0.6	0.1	109.9	10.4	24.7	1.8	18.7	0.8	0.5	0.3	10.7	2.0	191.9	208.0	0.1	61.8	0.8	26.1	0.0	0.5	0.6	4.1	15.5	20.7	0.3	1.5	55.3	3.6	16.9	11.7	0.0	7.2	1.0	0.1	0.6	0.6	0.0	0.3	2.8	0.0	0.0	0.8	0.1	0.0	1.4	3.6	0.0	0.2	18.2	58.7	0.4	3.4	0.1	1.0	0.8
PTPN18	BDP1	ENSG00000072135	"Protein tyrosine phosphatase non-receptor type 18"	Q99952	2	130356045-130375405	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 143.4;NK-cells: 148.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 63.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012174, HPA053367"	Uncertain		Approved	"Intermediate filaments"		NA	NA		270000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Intermediate filaments"		"CAB012174: AB_2173224, HPA053367: AB_2732579"	"unprognostic (3.11e-3)"	"unprognostic (2.89e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.81e-3)"	"unprognostic (3.08e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.65e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.85e-3)"	22.3	12.3	19.6	23.2	19.4	28.2	21.5	21.7	21.4	21.2	18.4	35.3	21.7	15.7	6.1	17.8	19.6	14.8	15.3	18.8	19.1	25.4	37.8	22.0	42.7	21.0	19.6	12.5	34.6	9.5	19.0	12.2	20.1	33.3	24.7	6.4	31.9	13.2	7.5	12.7	39.4	13.3	18.7	63.8	27.0	4.6	20.0	11.1	20.0	7.5	48.6	18.8	18.9	19.6	12.4	8.3	3.2	16.2	19.7	13.5	32.9	6.2	5.6	7.9	8.8	16.4	18.5	46.4	6.2	15.2	3.7	13.8	14.3	14.1	7.6	21.1	8.0	16.9	9.8	19.5	10.2	16.6	44.5	16.0	11.4	8.7	12.0	1.7	15.2	10.1	16.1	34.2	15.4	24.3	3.1	28.4	3.3	26.6	8.6	28.4	9.5	63.0	15.9	7.5	20.6	5.4	10.9	38.6	18.7	3.1	13.2	24.1	14.4	11.2	12.6	6.2	5.9	5.6	1.6	44.5	17.1	14.9	12.4	8.4	7.8	6.7	6.4	11.2	4.0	7.3	4.2	6.1	6.9	5.1	2.6	5.1	4.8	3.1	19.4	7.5	6.0	10.7	19.6	19.4	21.7	21.4	18.8	19.1	21.0	19.6	20.1	18.7	20.0	19.6	37.2	28.9	23.9	12.1	43.6	6.5	28.8	15.9	12.0	13.4	52.0	53.5	9.0	18.6	17.5	36.8	4.2	15.6	85.6	75.9	54.8	19.0	0.9	20.6	14.0	30.7	48.6	32.4	18.2	45.4	30.5	16.3	65.2	24.0	35.5	12.2	25.7	21.1	92.4	10.1	18.6	52.5	30.5	113.6	35.9	1.6	19.0	143.4	33.8	35.6	65.2	18.4	148.3	5.5	6.1	29.0	66.9	11.3	23.5	37.9	41.3	37.3	20.5	11.6	19.7	15.1	21.5	2.6	6.0	19.4	5.8	11.5	39.3	16.2	47.5	28.9
PTPN6	"HCP, HCPH, PTP-1C, SHP-1, SHP1"	ENSG00000111679	"Protein tyrosine phosphatase non-receptor type 6"	P29350	12	6946468-6961316	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 131.8;lymphoid tissue: 153.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 214.6;granulocytes: 137.3;Hofbauer cells: 191.6;Kupffer cells: 146.5;Langerhans cells: 118.2;Macrophages: 152.1;NK-cells: 154.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 170.9;HL-60: 154.3;HMC-1: 648.7;THP-1: 259.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001466, CAB004572, CAB072845"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA		6000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Nucleoli	"CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930"	"unprognostic (4.28e-3)"	"prognostic favorable (1.87e-4)"	"prognostic unfavorable (5.42e-4)"	"prognostic favorable (6.65e-4)"	"unprognostic (6.54e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.93e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.60e-2)"	"unprognostic (5.91e-2)"	"prognostic favorable (2.64e-8)"	14.4	15.6	3.7	102.5	3.9	131.8	11.0	4.3	4.2	11.1	6.0	21.9	30.4	6.2	10.2	12.8	13.9	20.3	4.9	3.6	5.2	12.2	19.3	49.7	153.5	7.0	4.6	2.9	11.9	13.7	10.0	19.8	6.3	11.7	21.3	0.7	17.0	9.0	2.0	18.8	42.0	12.3	5.9	128.0	28.0	3.1	6.3	71.3	12.6	4.5	127.3	27.0	7.5	10.6	16.4	30.8	0.2	0.1	0.1	0.0	28.5	0.0	0.0	0.0	0.0	16.5	36.0	11.9	8.4	0.0	0.0	18.3	0.3	21.6	0.0	7.3	6.5	170.9	3.4	13.9	0.0	154.3	648.7	0.1	15.4	0.0	6.5	0.0	0.0	60.0	0.3	1.3	0.0	34.5	55.4	92.2	8.3	38.0	5.1	50.4	0.2	86.5	16.7	30.2	2.7	0.0	5.2	24.9	0.2	20.9	7.7	259.8	0.4	0.0	0.2	0.1	0.2	0.4	0.2	5.5	0.4	66.3	0.5	676.7	368.3	1112.5	263.4	728.6	169.3	595.0	125.3	195.9	377.0	650.0	142.7	182.6	674.8	238.6	1117.7	98.7	146.8	789.3	3.7	3.9	4.3	4.2	3.6	5.2	7.0	4.6	6.3	5.9	6.3	10.6	10.5	6.4	13.8	0.7	214.6	9.1	8.2	18.8	29.6	0.0	8.6	10.0	2.1	11.5	15.3	5.5	0.0	25.6	77.7	16.0	15.6	15.8	50.4	12.1	1.5	7.5	24.7	22.9	0.9	15.4	18.3	3.0	25.0	11.8	137.3	10.9	8.9	11.6	191.6	0.0	0.9	13.2	18.3	146.5	118.2	10.5	0.9	152.1	14.2	3.7	99.7	0.5	154.5	2.0	0.1	12.6	16.9	0.0	53.5	3.9	22.8	14.3	17.2	0.5	6.6	1.6	4.0	0.3	1.3	14.6	8.7	18.5	86.2	24.5	15.6	7.8
PTPN7	"HEPTP, LC-PTP"	ENSG00000143851	"Protein tyrosine phosphatase non-receptor type 7"	P35236	1	202147013-202161588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.7;lymphoid tissue: 31.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 46.8;dendritic cells: 112.7;granulocytes: 140.7;NK-cells: 99.9;Plasma cells: 63.9;T-cells: 127.2;Theca cells: 54.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 9.8"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 24.9;NK-cells: 14.9;T-cells: 14.0"	"Cell line enhanced"	"Detected in some"		"HEL: 54.1;HL-60: 118.6;HMC-1: 150.8;NB-4: 51.4;THP-1: 53.7;U-937: 84.0"	"Region enriched"	"Detected in single"	9	"basal ganglia: 6.1"	"Region enriched"	"Detected in many"	8	"basal ganglia: 13.3"	"CAB009530, HPA019118"	Approved		Supported	"Microtubules,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Microtubules, Mitotic spindle"	"CAB009530: AB_2173845, HPA019118: AB_1855755"	"unprognostic (4.19e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.91e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	1.3	4.2	0.6	10.2	9.8	39.7	0.7	1.0	1.8	0.8	0.5	2.2	4.5	1.1	0.0	1.5	0.6	3.2	0.5	0.6	1.2	1.3	1.1	2.5	20.8	2.3	1.5	0.3	0.4	0.1	0.3	0.5	1.8	0.8	2.7	0.0	1.3	0.6	0.1	1.2	5.6	1.5	1.4	9.9	2.4	8.3	2.9	31.1	0.8	0.5	20.8	3.2	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.6	0.0	54.1	0.0	0.0	0.0	118.6	150.8	0.0	0.0	0.0	0.0	0.0	0.1	40.0	2.3	5.0	0.0	0.0	16.3	51.4	0.0	0.0	0.0	2.4	0.0	39.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	53.7	0.3	0.0	0.5	0.0	0.1	22.8	6.3	33.7	0.1	84.0	0.1	17.9	1.5	24.9	13.7	1.5	12.5	2.6	9.2	14.0	2.9	3.2	6.7	8.2	9.9	14.9	0.6	3.8	12.8	4.5	0.6	9.8	1.0	1.8	0.6	1.2	2.3	1.5	1.8	1.4	2.9	2.5	3.2	3.2	5.1	3.3	46.8	2.3	1.3	0.1	0.0	2.7	1.5	1.8	0.7	1.5	0.7	0.0	0.0	0.5	112.7	0.5	0.0	0.5	0.6	0.9	0.8	5.6	0.0	35.5	0.7	0.0	0.2	2.2	1.5	0.7	140.7	6.7	3.6	0.4	15.4	0.0	0.7	0.1	0.0	11.2	31.2	2.4	5.3	21.3	8.8	1.0	10.4	3.8	99.9	1.0	4.6	0.1	0.1	2.2	63.9	0.6	0.2	0.7	0.1	3.7	0.0	0.9	1.1	0.8	0.7	0.5	2.4	0.8	127.2	54.6	0.5	0.6
PYY	PYY1	ENSG00000131096	"Peptide YY"	P10082	17	43952738-44004469	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"intestine: 52.5"	"Cell type enriched"	"Detected in some"	96	"Enteroendocrine cells: 19377.2"	"Group enriched"	"Detected in many"	8	"endometrial cancer: 7.9;ovarian cancer: 15.2;testis cancer: 18.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.9"	"Region enriched"	"Detected in single"	14	"pons and medulla: 1.4"	"Low region specificity"	"Detected in single"			"HPA010973, CAB016734"	Enhanced				"Secreted to blood"	NA	NA	87100			"Cluster 9: Intestine - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"CAB016734: AB_876471, HPA010973: AB_1855194"	"unprognostic (8.17e-3)"	"unprognostic (5.41e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.48e-4)"	"unprognostic (5.26e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.20e-1)"	0.1	1.7	0.2	1.4	0.3	0.1	0.4	0.2	0.7	0.3	0.1	52.5	2.5	0.4	0.4	0.0	0.4	0.0	0.0	0.3	0.3	1.4	0.2	0.2	0.3	0.3	0.3	0.0	0.6	0.2	0.0	0.0	0.4	0.3	36.6	0.8	0.1	0.8	0.1	0.1	41.6	0.1	0.1	0.1	0.5	1.1	0.4	0.3	0.5	0.1	0.1	0.0	0.0	0.5	0.1	0.2	0.2	0.4	0.3	0.6	0.0	0.4	0.1	0.5	0.3	0.5	0.3	0.2	0.6	0.5	0.4	0.2	0.4	0.1	0.3	1.2	0.2	0.7	0.2	0.0	0.4	0.2	2.9	0.8	0.1	0.5	0.2	0.6	0.1	0.3	0.2	0.5	0.4	0.6	0.2	0.4	0.6	0.4	0.2	0.1	0.1	0.0	0.8	0.0	0.4	0.1	0.3	0.0	0.7	0.3	0.5	0.0	0.5	0.6	0.5	0.1	0.4	0.0	0.5	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.7	0.3	0.3	0.3	0.3	0.4	0.1	0.4	0.5	0.1	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	65.0	1.9	0.0	1.0	7.9	1.3	0.1	19377.2	0.0	3.5	0.0	0.1	0.0	0.0	18.9	8.9	0.1	0.0	0.0	0.0	0.0	3.3	199.9	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	35.5	0.0	0.0	0.0	20.7	0.1	0.0	0.0	0.0	0.0	0.1	2.3	4.3	0.0	0.1	0.0	1.0	0.0	36.8	0.0
RAB44	"dJ431A14.3, RASD3, RASL13"	ENSG00000255587	"RAB44, member RAS oncogene family"	Q7Z6P3	6	36697826-36733184	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	63	"bone marrow: 58.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 4.4;granulocytes: 14.5;monocytes: 2.3;Squamous epithelial cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"basophil: 10.6;eosinophil: 7.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 10.6"	"Cell line enhanced"	"Detected in some"		"HEL: 21.9;HL-60: 30.9;HMC-1: 88.9;NB-4: 76.7;THP-1: 30.1;U-937: 60.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079390			Approved	Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Vesicles		"HPA079390: "	"unprognostic (8.86e-2)"	"unprognostic (5.58e-3)"	"unprognostic (5.09e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.56e-2)"	"unprognostic (6.35e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.57e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.13e-3)"	"unprognostic (3.03e-2)"	"unprognostic (9.67e-3)"	"unprognostic (5.79e-2)"	0.5	0.0	0.0	0.6	0.1	58.9	0.4	0.0	0.1	0.4	0.0	0.4	0.6	0.3	0.2	0.5	0.5	0.8	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.2	0.1	0.1	0.5	0.9	0.4	0.0	0.5	0.7	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	30.9	88.9	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	76.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.7	0.0	10.6	0.8	7.2	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.2	4.4	0.7	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.3	0.0	1.3	0.3	0.2	0.0	0.3	0.0	0.5	14.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.3	0.0	1.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.3	0.0	0.0	2.2	0.0	0.0	0.4	0.1	0.0	0.1
RAB4B	"FLJ78649, MGC52123"	ENSG00000167578	"RAB4B, member RAS oncogene family"	P61018	19	40778216-40796942	"Enzymes, Predicted intracellular proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 80.4;Syncytiotrophoblasts: 102.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (9.11e-3)"	"unprognostic (2.67e-3)"	"unprognostic (4.23e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.73e-3)"	"unprognostic (5.74e-2)"	"unprognostic (7.93e-2)"	"unprognostic (5.32e-1)"	"unprognostic (2.46e-2)"	"prognostic favorable (2.08e-4)"	"unprognostic (7.73e-2)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (1.60e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.99e-5)"	26.1	51.2	65.0	20.7	74.3	18.1	23.6	78.8	81.6	26.4	53.6	28.8	17.5	21.5	5.3	30.4	19.3	13.7	25.0	64.8	72.3	34.8	24.9	30.9	31.8	82.4	73.5	15.0	19.0	11.0	47.8	16.4	78.8	26.4	9.4	15.3	20.2	13.9	17.0	19.6	30.2	8.8	74.3	50.7	27.0	22.5	76.3	24.3	28.7	8.1	18.0	23.1	24.0	84.0	11.8	37.5	9.1	14.9	19.7	14.3	12.6	15.0	14.1	6.5	17.5	21.1	12.5	19.3	25.6	12.8	21.2	10.6	4.0	13.6	3.2	45.7	17.1	15.4	7.2	12.7	30.4	13.7	54.6	24.3	13.6	14.2	3.5	11.2	25.5	38.3	8.6	33.6	13.8	18.8	20.8	22.1	7.0	20.7	17.8	18.4	7.4	18.9	18.9	23.0	7.9	14.1	34.4	10.5	16.3	8.9	10.6	29.4	18.8	16.2	11.6	14.5	6.3	19.9	13.0	20.1	31.3	17.5	17.3	86.5	65.7	116.9	61.3	83.9	33.8	71.6	39.7	53.4	82.9	89.2	36.2	44.5	113.6	38.9	62.5	151.2	59.6	70.0	65.0	74.3	78.8	81.6	64.8	72.3	82.4	73.5	78.8	74.3	76.3	84.0	2.6	9.6	18.8	0.0	19.8	7.8	15.0	47.0	3.4	22.2	2.0	2.2	5.6	12.8	33.6	1.8	6.2	52.8	23.3	80.4	0.0	1.1	3.2	3.0	2.2	16.5	26.3	4.4	0.0	1.0	19.1	8.7	25.0	7.3	21.5	1.4	23.9	15.2	40.9	32.0	0.0	17.7	40.7	29.0	34.8	3.3	8.7	16.6	32.0	0.0	14.6	26.3	42.2	0.0	0.0	0.7	68.2	10.5	3.0	17.6	49.9	0.8	33.8	15.0	26.3	7.7	15.7	16.6	21.6	7.7	9.9	102.7	17.2	1.4	16.5	26.2
RAB7B	"MGC16212, MGC9726"	ENSG00000276600	"RAB7B, member RAS oncogene family"	Q96AH8	1	205976740-206003461	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 52.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 13.6;Cytotrophoblasts: 29.0;Fibroblasts: 13.6;Hofbauer cells: 32.8;Squamous epithelial cells: 12.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"myeloid DC: 5.1"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 5.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 26.3;HBEC3-KT: 33.6;HL-60: 22.0;HMC-1: 89.1;hTCEpi: 38.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"				"unprognostic (4.18e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (6.99e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.23e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.13e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.82e-3)"	8.0	0.9	1.7	5.2	3.2	1.3	11.0	3.5	2.5	8.5	1.6	2.7	2.8	6.9	5.9	20.2	5.6	15.0	5.1	1.6	2.2	0.6	2.4	8.8	8.5	4.3	3.5	3.5	1.3	0.6	1.8	7.1	3.0	5.8	3.1	0.8	7.2	7.5	2.1	52.1	2.5	8.0	4.1	3.8	7.0	1.1	5.7	6.7	8.1	2.2	4.9	8.2	15.5	7.0	1.5	0.1	0.7	0.8	1.9	14.5	3.5	6.8	8.1	2.8	2.6	0.9	2.4	0.0	2.3	26.3	2.9	6.6	0.0	33.6	0.9	0.3	0.0	0.0	0.0	0.8	0.1	22.0	89.1	4.9	38.2	5.2	0.1	1.7	0.1	0.0	0.4	0.0	1.9	0.4	0.1	13.3	0.3	1.1	0.0	0.0	1.9	0.7	0.8	0.3	0.0	0.1	0.9	0.0	4.4	6.9	2.3	7.5	0.0	1.9	4.5	1.8	0.5	0.1	0.0	0.0	12.0	9.3	3.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	1.7	3.2	3.5	2.5	1.6	2.2	4.3	3.5	3.0	4.1	5.7	7.0	0.8	3.2	3.9	1.3	0.2	0.0	8.3	0.0	13.6	0.0	1.9	5.5	0.7	4.3	6.2	0.0	0.0	29.0	0.1	0.0	0.0	3.6	0.0	0.8	7.9	0.7	0.0	0.0	1.7	0.2	1.0	13.6	3.6	0.6	2.5	0.4	0.7	0.1	32.8	0.0	0.1	0.0	0.0	6.4	0.0	0.8	1.8	11.0	0.0	1.9	4.1	3.1	0.0	0.0	8.2	0.6	0.1	3.4	0.1	0.7	0.0	0.0	0.0	0.4	0.0	3.2	2.8	0.0	0.1	12.6	0.0	6.3	0.8	0.1	0.0	1.9
RAC2	EN-7	ENSG00000128340	"Rac family small GTPase 2"	P15153	22	37225270-37244448	"Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 411.9;lymphoid tissue: 387.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 329.0;dendritic cells: 381.4;granulocytes: 520.5;NK-cells: 717.9;Plasma cells: 287.8;T-cells: 419.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 522.5;HL-60: 734.5;HMC-1: 1427.9;Karpas-707: 684.5;U-87 MG: 618.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022946, HPA047820"	Enhanced					NA	Yes		3300000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB022946: , HPA047820: AB_2680167"	"prognostic favorable (1.03e-5)"	"unprognostic (2.91e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (6.74e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (5.00e-2)"	"unprognostic (8.52e-3)"	"unprognostic (2.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.50e-2)"	24.7	8.4	3.6	207.2	3.8	411.9	11.4	3.9	8.0	12.2	4.4	34.8	35.3	10.1	4.7	15.9	11.7	37.1	6.5	3.8	4.7	10.9	19.3	63.4	387.9	6.5	5.3	5.5	5.3	2.1	3.4	12.4	7.1	10.9	33.9	0.4	21.5	8.3	4.9	7.6	96.9	19.6	5.2	299.9	42.7	3.5	6.1	323.9	9.5	7.2	309.1	54.0	9.9	7.2	136.6	0.2	0.0	0.0	14.3	130.5	0.6	17.9	41.1	14.2	28.8	0.3	44.8	167.4	19.8	52.9	0.8	33.3	1.0	231.6	15.6	522.5	0.6	209.6	3.6	0.6	35.8	734.5	1427.9	96.4	32.3	25.1	84.3	0.9	239.7	159.1	50.5	684.5	1.9	0.2	218.9	291.2	2.8	13.1	87.2	72.3	0.7	193.8	22.6	0.1	2.0	0.6	0.9	23.0	2.7	0.8	9.7	391.8	258.7	0.6	23.5	1.0	2.0	307.0	171.4	176.6	618.6	316.5	35.1	1319.9	519.8	1602.2	972.1	695.5	731.5	761.7	768.6	858.9	494.0	672.8	584.3	759.8	1336.4	972.2	879.5	728.7	1163.4	1566.2	3.6	3.8	3.9	8.0	3.8	4.7	6.5	5.3	7.1	5.2	6.1	7.2	4.4	16.0	47.7	0.0	329.0	5.4	2.2	26.0	16.5	0.0	8.6	9.5	1.1	2.8	12.6	1.8	0.0	0.8	381.4	3.4	0.0	13.6	0.2	1.1	0.8	5.6	4.2	109.7	0.4	2.2	1.5	9.2	33.6	1.0	520.5	0.3	13.6	3.4	150.8	0.0	0.1	6.3	0.0	129.9	63.9	0.9	0.3	147.9	30.2	3.7	125.9	0.0	717.9	0.5	0.0	18.2	18.1	0.0	287.8	0.5	0.6	1.5	4.4	0.0	13.1	2.4	4.5	0.0	1.0	5.1	4.0	2.9	419.6	3.7	11.2	3.6
RANBP10	KIAA1464	ENSG00000141084	"RAN binding protein 10"	Q6VN20	16	67723070-67806652	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"				"unprognostic (2.64e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.51e-2)"	"unprognostic (8.00e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.77e-3)"	"unprognostic (7.46e-3)"	"prognostic favorable (7.52e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.16e-1)"	9.6	23.0	8.6	7.9	8.3	44.2	10.1	13.1	9.7	16.5	8.4	11.0	7.2	12.9	6.8	14.1	14.4	7.8	10.6	8.6	8.2	12.4	31.2	10.4	9.6	7.9	8.7	15.2	13.1	12.0	11.8	9.1	8.3	12.1	8.1	8.2	9.8	8.1	25.1	15.0	10.6	10.0	6.7	16.6	9.4	10.7	8.3	10.2	10.6	13.3	10.0	9.7	14.0	8.0	9.8	13.4	13.1	13.0	15.6	8.7	20.2	8.9	15.3	16.7	16.5	14.0	8.5	16.4	12.5	9.5	6.4	14.7	13.4	11.9	13.6	8.9	10.5	6.9	10.9	12.2	12.1	14.1	37.5	9.2	13.5	15.0	16.4	12.7	15.3	21.5	18.8	5.0	8.7	14.2	13.3	14.6	10.4	10.8	7.2	22.8	8.3	13.6	9.2	11.6	8.8	9.8	42.6	8.0	15.8	8.4	16.5	13.3	13.4	9.4	9.4	11.6	9.6	11.2	14.8	26.3	8.5	14.8	15.1	0.0	0.6	0.9	0.6	0.7	1.0	0.4	0.6	0.6	0.9	0.5	0.5	0.8	0.3	0.6	0.6	0.7	1.0	0.5	8.6	8.3	13.1	9.7	8.6	8.2	7.9	8.7	8.3	6.7	8.3	8.0	9.2	12.8	8.9	16.0	7.8	4.5	3.2	5.4	4.6	5.4	8.8	6.7	7.7	5.7	4.7	1.8	16.7	5.6	6.2	7.4	3.9	6.5	4.1	21.6	10.8	8.0	4.9	67.1	29.4	4.9	4.2	5.0	6.6	9.1	0.0	9.6	7.5	22.2	5.8	10.1	24.3	6.3	2.0	7.5	2.3	5.1	4.4	5.4	0.0	13.1	6.7	3.6	9.2	15.1	14.4	6.2	6.3	3.8	6.1	5.4	5.4	3.4	16.7	9.2	0.0	6.2	5.9	4.8	5.0	6.4	5.5	8.5	5.6	8.8	6.5	3.7
RAPGEF2	"DKFZP586O1422, KIAA0313, PDZ-GEF1, PDZGEF1, RA-GEF"	ENSG00000109756	"Rap guanine nucleotide exchange factor 2"	Q9Y4G8	4	159103013-159360174	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, GTPase activation, Guanine-nucleotide releasing factor"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 456.2;Inhibitory neurons: 264.1;Microglial cells: 238.9;Oligodendrocyte precursor cells: 199.0;Oligodendrocytes: 236.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.9;NK-cells: 3.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 104.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068798			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA068798: "	"unprognostic (4.88e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.67e-2)"	"unprognostic (7.79e-3)"	"unprognostic (8.16e-2)"	"unprognostic (4.71e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.76e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-1)"	22.7	9.4	8.7	13.4	19.8	87.5	24.1	4.1	32.1	16.7	0.0	21.8	15.9	16.1	9.8	13.8	14.0	20.1	23.2	27.4	0.3	22.7	30.5	26.6	11.9	0.0	0.7	13.5	19.5	23.5	15.3	38.5	0.3	12.2	20.8	35.1	25.3	12.6	21.7	17.5	17.0	19.7	0.6	29.7	19.3	9.8	6.0	17.5	39.5	31.4	11.5	14.8	11.8	18.6	8.9	11.9	55.4	17.2	21.4	23.9	84.9	17.0	21.3	15.2	10.9	36.7	19.4	50.7	6.1	17.0	22.0	8.0	19.1	21.8	18.0	8.6	13.2	79.0	25.3	21.4	15.5	9.7	104.5	14.1	12.1	36.5	12.9	32.0	44.1	20.7	17.6	46.0	19.0	15.6	24.1	1.5	23.7	10.4	11.8	19.7	14.0	2.0	13.6	20.2	15.7	21.0	24.9	12.1	20.0	26.5	6.0	6.3	47.0	23.9	25.2	30.7	14.2	51.0	32.9	0.8	28.3	4.1	14.8	2.2	1.0	0.7	0.5	0.5	0.6	0.2	0.4	0.3	0.5	0.2	0.6	0.3	5.9	3.3	0.6	1.0	1.0	0.3	8.7	19.8	4.1	32.1	27.4	0.3	0.0	0.7	0.3	0.6	6.0	18.6	66.7	57.7	30.1	110.7	12.9	20.4	11.2	7.5	9.6	19.7	23.5	11.9	39.0	11.5	13.8	7.3	41.7	11.1	20.2	24.8	0.0	9.2	5.3	43.5	19.5	49.2	14.4	38.9	456.2	12.6	9.6	16.9	7.7	59.2	51.8	22.9	32.2	30.5	10.8	33.7	264.1	12.0	2.0	24.6	20.1	5.3	7.8	29.5	33.8	238.9	15.6	30.2	2.1	199.0	236.2	22.1	17.7	8.6	40.5	17.6	7.1	8.7	18.7	22.4	52.6	28.1	37.2	3.5	8.9	10.7	20.0	5.9	12.9	7.2	7.9	15.1
RASGRP4		ENSG00000171777	"RAS guanyl releasing protein 4"	Q8TDF6	19	38409051-38426305	"Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 20.8;lymphoid tissue: 8.9"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 18.1;granulocytes: 26.6;Hofbauer cells: 15.1;Kupffer cells: 32.9;Langerhans cells: 11.6;Macrophages: 19.1;monocytes: 25.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 39.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 25.7;HMC-1: 24.0;U-937: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041929			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041929: AB_10961405"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.23e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.66e-2)"	3.2	0.8	0.3	6.7	0.3	20.8	0.7	0.3	0.9	1.1	0.4	1.2	1.2	0.5	0.1	1.0	1.0	1.9	0.6	0.2	0.3	0.3	0.7	3.3	1.1	0.9	0.4	0.4	1.1	0.3	0.2	2.3	0.6	0.5	0.8	0.0	0.4	0.5	0.8	0.5	1.8	2.0	0.7	8.9	0.9	0.2	1.1	1.1	0.2	1.4	0.7	2.5	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	25.7	0.0	0.0	0.0	0.1	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	12.5	13.5	20.1	0.0	15.4	0.0	0.1	0.3	0.0	9.4	0.1	0.0	0.0	39.4	0.0	17.9	0.7	1.4	4.4	0.3	0.3	0.3	0.9	0.2	0.3	0.9	0.4	0.6	0.7	1.1	1.0	0.2	0.0	0.6	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.3	18.1	0.0	1.3	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.8	0.7	0.0	0.2	0.4	0.0	0.0	26.6	0.0	1.4	0.0	15.1	0.0	0.4	0.0	0.0	32.9	11.6	0.0	0.0	19.1	1.8	0.0	25.7	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.7	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.3	1.5	0.0	0.0	0.1
RAX	RX	ENSG00000134438	"Retina and anterior neural fold homeobox"	Q9Y2V3	18	59267035-59274086	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"pituitary gland: 6.6;retina: 16.0"	"Cell type enriched"	"Detected in some"	5	"Muller glia cells: 493.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"white matter: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.8;SH-SY5Y: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 5: Muller glia cells - Visual perception"					"unprognostic (4.14e-2)"				"unprognostic (1.79e-1)"		"unprognostic (3.76e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.22e-1)"				"unprognostic (1.33e-1)"	"unprognostic (3.46e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	6.6	0.0	0.0	0.1	0.0	16.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.9	0.0	0.0	1.3	0.0	0.0	0.0	83.4	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	493.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	20.7	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RELL2	"C5orf16, FLJ90583"	ENSG00000164620	"RELT like 2"	Q8NC24	5	141636950-141641064	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.2;parathyroid gland: 16.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 28.5;Horizontal cells: 65.6;Inhibitory neurons: 28.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 31.7;JURKAT: 32.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077928			Uncertain	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"HPA077928: "	"unprognostic (3.27e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.95e-3)"	"unprognostic (1.91e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.76e-4)"	"unprognostic (4.17e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.85e-2)"	"unprognostic (8.74e-3)"	"unprognostic (4.31e-2)"	"unprognostic (6.58e-2)"	1.0	5.9	14.4	1.3	12.8	1.0	1.3	18.8	38.2	1.6	5.4	1.4	1.5	2.1	0.6	3.5	0.8	1.0	1.0	13.4	19.3	3.7	1.9	3.3	2.5	34.1	18.9	0.8	1.4	16.1	15.7	2.3	31.4	2.1	0.7	3.6	2.7	0.5	0.3	2.7	2.8	0.8	10.6	5.8	1.1	6.0	28.5	4.8	2.8	0.0	2.5	1.5	1.8	17.6	1.6	4.3	4.3	7.7	3.2	1.1	2.0	3.6	6.7	11.4	16.9	16.6	1.6	0.2	1.7	5.4	24.9	7.0	4.1	15.1	2.9	4.7	2.5	10.3	10.0	7.8	5.2	3.5	31.7	2.2	9.3	10.6	7.7	2.5	3.1	32.9	3.4	5.3	2.6	2.1	5.8	1.6	4.8	5.7	2.3	0.4	1.0	6.7	3.6	3.9	7.0	7.6	3.3	15.1	2.7	0.6	5.4	8.4	3.8	8.8	4.1	7.1	6.6	3.2	9.0	23.4	4.5	14.5	5.6	0.0	0.8	0.0	1.6	2.0	0.6	1.4	1.7	1.6	1.3	0.8	1.5	0.8	0.6	0.0	1.4	4.5	3.2	1.2	14.4	12.8	18.8	38.2	13.4	19.3	34.1	18.9	31.4	10.6	28.5	17.6	1.1	0.0	0.6	4.2	6.0	4.6	1.5	2.6	2.8	10.5	2.3	2.4	0.3	1.5	2.0	1.8	12.5	0.2	10.0	4.2	1.9	3.3	1.8	0.3	0.8	2.0	1.2	0.0	28.5	2.5	4.1	0.8	0.5	0.2	0.0	0.4	0.4	0.2	4.2	65.6	28.8	2.4	4.1	4.4	3.5	4.7	0.6	5.1	7.2	4.7	2.3	6.6	5.2	2.5	2.8	2.1	5.0	1.5	1.7	2.7	1.2	5.6	1.9	8.6	0.0	0.3	1.3	17.8	7.5	3.6	4.3	6.2	5.5	0.9	0.9	2.2
REN		ENSG00000143839	Renin	P00797	1	204154819-204190324	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"kidney: 162.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 6.8;Late spermatids: 28.4;Paneth cells: 5.6;Smooth muscle cells: 10.7;Urothelial cells: 7.0"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 39.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.0;BJ: 2.0;HMC-1: 2.6;SK-BR-3: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA005131	Approved				"Secreted to blood"	NA	NA	692000	10000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 33: Fibroblasts - ECM organization"			"HPA005131: AB_1079174"	"unprognostic (4.45e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.58e-2)"		"unprognostic (2.89e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (6.45e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.49e-2)"	1.0	1.4	0.3	0.2	0.9	0.0	0.1	0.0	0.2	4.3	3.2	0.4	0.3	9.6	0.3	0.2	2.3	0.1	1.8	0.2	0.0	162.2	0.7	0.7	0.0	0.3	0.4	16.3	0.0	0.0	0.6	15.2	0.1	0.3	0.2	0.1	0.8	0.8	0.0	0.1	0.1	1.5	0.0	0.1	0.0	0.9	0.2	0.5	0.0	0.0	0.5	5.2	0.3	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.2	0.2	0.0	0.3	0.4	0.1	0.0	0.2	0.0	0.0	0.0	1.5	1.0	0.0	0.0	0.8	0.7	0.0	0.7	0.1	0.0	0.2	0.0	0.3	1.8	0.0	0.3	0.0	0.0	0.0	1.2	6.8	0.2	0.5	0.4	0.0	0.0	0.3	1.1	0.2	2.8	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	28.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	5.6	0.4	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	10.7	0.3	0.2	0.0	0.0	1.1	0.1	1.3	0.0	7.0
RENBP	"RBP, RNBP"	ENSG00000102032	"Renin binding protein"	P51606	X	153935269-153944687	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 43.0;lymphoid tissue: 67.0"	"Cell type enhanced"	"Detected in many"		"granulocytes: 127.7;Hofbauer cells: 183.4;Kupffer cells: 70.7;Proximal tubular cells: 204.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 57.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"granulocytes: 2.7;monocytes: 1.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 35.5;HMC-1: 121.4;SK-MEL-30: 86.4;U-266/84: 74.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000428, HPA000522"	Enhanced					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA000428: AB_1079799, HPA000522: AB_1079798"	"unprognostic (3.08e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.12e-2)"	"unprognostic (3.29e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (3.08e-5)"	"unprognostic (2.39e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.25e-2)"	"unprognostic (8.51e-2)"	22.2	19.2	14.6	13.5	18.2	10.9	11.1	16.0	20.6	5.0	12.3	13.8	8.4	3.9	2.5	2.9	5.6	6.2	11.5	14.6	18.8	43.0	5.3	24.6	16.5	18.4	19.8	1.7	1.8	2.1	6.0	10.3	18.0	3.8	4.2	2.2	5.8	2.0	2.2	9.7	13.9	4.7	15.2	67.0	5.9	1.2	19.4	6.2	5.4	0.1	6.3	6.2	4.5	19.6	0.0	0.0	3.3	0.1	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	35.5	0.0	0.1	0.0	7.1	0.0	0.0	0.0	1.5	28.2	0.0	2.3	20.4	0.0	121.4	0.8	0.0	0.0	0.0	0.0	0.0	1.0	8.2	10.3	0.0	0.6	7.5	0.3	0.4	0.3	0.0	13.6	0.0	0.1	0.0	0.0	0.1	2.0	0.0	0.0	86.4	3.0	0.3	9.9	1.3	0.0	0.8	0.0	0.1	12.5	74.8	5.0	2.5	13.3	9.8	1.7	0.9	2.7	0.1	0.7	0.1	0.4	0.0	0.0	0.1	0.2	0.4	0.2	2.0	0.1	1.6	0.3	0.0	0.5	14.6	18.2	16.0	20.6	14.6	18.8	18.4	19.8	18.0	15.2	19.4	19.6	1.9	0.0	2.2	7.2	8.0	4.7	1.3	0.3	0.6	2.4	0.4	0.6	1.0	2.8	0.4	9.2	0.0	1.3	2.6	0.4	37.2	1.4	0.1	0.1	0.5	10.7	1.8	3.0	0.2	0.4	6.0	4.5	0.0	0.3	127.7	1.3	52.1	0.8	183.4	15.2	1.7	1.0	0.0	70.7	13.3	0.4	0.3	49.2	28.4	6.5	40.7	10.7	8.2	0.5	6.2	0.5	5.3	0.4	4.0	1.4	12.3	204.2	0.2	0.8	13.1	2.2	4.9	0.1	1.4	0.4	2.0	2.9	7.5	0.7	0.7	0.6
REV1	REV1L	ENSG00000135945	"REV1 DNA directed polymerase"	Q9UBZ9	2	99400475-99490035	"Predicted intracellular proteins"	"DNA damage, DNA repair, DNA synthesis"	"DNA-binding, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044534, HPA051036"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA044534: AB_2678975, HPA051036: AB_2681319"	"unprognostic (3.05e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.56e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.33e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.36e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-3)"	9.8	11.6	7.0	6.1	7.6	7.0	11.2	13.1	9.6	11.9	9.4	9.3	6.1	14.2	17.3	10.5	11.4	7.9	12.4	7.2	8.7	9.0	10.0	11.2	10.0	7.0	7.4	12.1	6.9	8.8	10.4	7.3	6.8	11.2	9.2	12.2	9.4	12.0	15.7	10.3	9.0	10.1	6.9	9.4	8.2	9.6	8.5	9.7	10.3	23.7	10.0	10.5	11.5	8.5	7.9	2.0	12.4	4.7	9.5	9.3	13.0	8.6	10.8	9.9	11.3	4.6	7.5	15.9	6.7	9.2	10.4	10.9	9.3	11.5	15.3	7.0	5.8	8.1	7.7	10.5	10.6	10.6	16.5	9.1	13.7	8.9	13.0	11.1	12.9	8.1	9.4	5.3	11.1	5.2	11.2	19.0	8.9	5.1	5.2	17.4	8.8	7.0	12.3	13.4	8.0	8.5	7.6	6.4	11.2	13.3	6.6	15.2	9.1	11.7	9.7	4.9	5.7	7.2	7.8	12.8	4.8	13.4	9.2	0.0	0.2	0.0	0.3	0.2	0.2	0.1	0.5	0.4	0.3	0.4	0.9	0.7	0.1	0.3	0.1	0.1	0.3	0.1	7.0	7.6	13.1	9.6	7.2	8.7	7.0	7.4	6.8	6.9	8.5	8.5	45.3	70.5	61.9	59.4	27.7	48.3	57.5	37.8	58.6	84.2	21.7	20.4	52.5	20.0	38.6	22.0	39.6	32.9	17.5	24.1	5.9	18.4	29.2	41.6	32.8	31.6	17.5	35.7	71.3	18.1	20.0	33.8	31.6	30.0	25.3	32.4	23.6	18.0	19.1	82.4	78.2	16.3	26.4	17.6	28.3	21.6	27.1	20.6	19.6	53.4	27.3	36.7	14.4	60.3	77.0	16.4	25.6	46.3	23.3	51.0	30.0	12.5	33.7	57.2	26.3	51.2	28.8	52.1	53.8	36.3	35.5	35.2	26.8	39.7	19.3	63.5
RFLNB	"Cfm1, FAM101B, MGC45871, RefilinB"	ENSG00000183688	"Refilin B"	Q8N5W9	17	439978-445939	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 101.3;Endothelial cells: 51.1;Hofbauer cells: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 201.5"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 201.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 95.5;HMC-1: 222.1;NB-4: 74.8;U-937: 64.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030879, HPA060388"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Actin filaments"	"Plasma membrane, Cytosol"	"HPA030879: AB_2673643, HPA060388: AB_2732649"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (3.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.03e-3)"	19.8	5.9	2.4	7.4	2.5	77.9	15.6	2.3	2.8	8.7	10.1	13.7	3.2	10.1	3.5	3.1	7.1	4.6	12.8	3.3	2.2	8.6	3.5	13.3	5.4	2.5	2.4	5.7	3.5	3.9	4.3	10.4	2.2	9.5	1.9	1.5	4.1	2.8	7.9	6.3	9.6	6.1	2.7	10.5	8.6	3.7	2.4	16.7	8.2	3.9	4.8	11.8	5.4	2.1	30.5	8.0	4.0	18.9	13.0	9.4	20.8	48.8	21.4	15.8	7.7	0.5	1.1	0.0	1.2	95.5	7.0	3.0	11.2	1.1	14.5	0.2	6.5	1.3	1.5	2.2	19.0	11.4	222.1	5.2	0.3	5.0	1.9	6.1	16.0	4.8	4.7	0.3	18.1	0.4	0.6	74.8	8.6	0.8	0.3	3.2	8.6	0.0	2.9	0.1	0.3	43.6	19.8	0.0	17.6	14.9	0.4	34.7	3.2	12.4	11.0	7.5	0.1	7.1	7.7	0.0	0.2	64.1	19.5	201.5	6.9	80.7	6.1	5.4	6.2	0.1	6.1	5.2	2.1	0.1	9.7	8.7	35.5	2.2	7.3	9.1	4.3	3.8	2.4	2.5	2.3	2.8	3.3	2.2	2.5	2.4	2.2	2.7	2.4	2.1	101.3	0.0	4.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	3.1	7.4	0.0	0.0	1.8	1.8	0.0	0.8	16.5	0.0	0.0	1.1	0.0	2.3	1.9	51.1	0.0	0.0	0.0	0.9	1.2	9.2	0.0	6.0	1.3	12.5	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	1.9	0.0	0.0	5.9	0.0	0.0	0.5	1.5	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.5	10.7	4.2	0.0	0.0
RGS10		ENSG00000148908	"Regulator of G protein signaling 10"	O43665	10	119499817-119542719	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 222.9"	"Cell type enhanced"	"Detected in many"		"granulocytes: 291.2;Hofbauer cells: 528.1;Kupffer cells: 297.2;Langerhans cells: 358.3;Macrophages: 529.3;monocytes: 294.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 474.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004559, HPA021305, HPA058485"	Enhanced	Supported	Supported	"Nucleoplasm,Plasma membrane"		NA	NA		840000	"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Plasma membrane"		"CAB004559: AB_628216, HPA021305: AB_1856225, HPA058485: AB_2683732"	"unprognostic (1.64e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (7.98e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (5.21e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.35e-2)"	"unprognostic (9.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.20e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.20e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.92e-3)"	25.1	20.6	20.0	59.3	20.2	74.5	40.7	22.3	30.4	63.9	22.3	114.3	34.2	38.5	15.8	51.5	28.5	38.3	13.4	20.7	24.5	18.8	11.4	28.1	119.0	28.6	24.5	22.5	7.0	6.9	13.8	45.6	28.9	43.2	49.7	2.6	41.0	20.3	31.5	22.9	58.3	42.8	26.1	48.7	30.0	4.9	26.1	222.9	33.0	11.6	96.5	50.3	45.8	37.2	165.2	31.2	2.4	294.7	41.4	262.6	25.9	74.9	118.1	45.3	73.5	9.8	38.7	66.8	38.1	60.9	45.7	35.4	44.3	48.2	123.8	32.0	42.8	183.1	8.9	24.2	63.1	40.0	474.0	100.7	63.1	88.3	84.4	159.4	88.2	65.4	47.6	58.5	55.0	79.2	221.9	134.8	13.5	21.2	71.1	43.8	0.3	26.1	24.7	40.4	10.8	9.3	14.4	192.6	285.3	36.3	35.1	71.7	108.3	25.4	21.9	36.1	67.8	2.7	46.0	27.0	7.6	166.5	11.4	184.8	116.0	1.4	77.9	151.4	82.9	36.0	169.6	134.9	224.3	21.7	397.5	303.3	52.5	44.3	130.4	133.2	202.3	372.5	20.0	20.2	22.3	30.4	20.7	24.5	28.6	24.5	28.9	26.1	26.1	37.2	10.4	0.0	13.1	2.6	60.3	36.8	25.7	104.5	27.9	0.2	68.9	96.6	1.1	1.5	39.7	1.8	0.0	14.0	70.1	7.1	60.7	0.8	2.1	89.8	25.1	12.7	18.7	156.6	0.2	6.4	34.8	68.6	11.2	53.6	291.2	101.2	13.2	1.5	528.1	0.0	1.8	85.7	32.6	297.2	358.3	5.1	50.1	529.3	94.3	67.5	294.5	1.8	50.4	0.5	0.2	9.9	10.0	9.4	32.1	88.8	3.3	5.2	24.6	0.8	13.1	14.4	31.8	0.3	9.3	39.6	28.1	10.1	164.7	3.5	19.3	41.4
RGS19	"GAIP, RGSGAIP"	ENSG00000171700	"Regulator of G protein signaling 19"	P49795	20	64073181-64079988	"Predicted intracellular proteins"	Autophagy	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 57.2;lymphoid tissue: 77.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 97.8;dendritic cells: 82.0;Hofbauer cells: 135.0;Kupffer cells: 104.6;Macrophages: 101.6;monocytes: 86.3;NK-cells: 140.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 154.2;NB-4: 128.1;THP-1: 107.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056384, HPA069984"	Enhanced		Supported	"Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Cell Junctions"	"Nucleoli fibrillar center"	"HPA056384: AB_2732602, HPA069984: AB_2732145"	"unprognostic (3.98e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.26e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.94e-2)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.25e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (2.06e-9)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.66e-3)"	12.5	8.8	7.1	28.5	6.8	57.2	9.0	7.3	7.8	5.9	6.3	6.7	7.5	5.1	2.0	8.1	6.9	6.0	6.4	6.7	7.3	7.6	5.9	19.6	35.2	12.3	8.8	2.3	7.0	2.7	4.3	7.2	10.0	7.3	2.2	0.3	8.5	2.5	2.5	8.4	21.1	4.3	11.4	77.5	8.2	1.8	11.8	13.9	6.8	2.2	17.3	8.3	6.9	12.2	16.1	24.1	6.8	12.2	3.0	4.9	11.5	10.0	6.9	20.2	8.4	36.0	21.8	28.1	27.0	6.2	21.6	15.4	7.0	12.8	4.8	14.0	13.2	40.3	12.3	14.8	4.0	83.0	154.2	3.3	7.7	8.6	3.0	4.0	13.3	18.4	15.5	14.5	6.2	28.6	61.6	128.1	7.0	13.8	30.3	51.1	4.0	20.4	5.7	7.8	12.9	12.1	10.3	6.3	13.6	3.4	8.3	107.3	14.0	18.9	9.5	3.3	9.8	9.1	7.6	34.7	10.5	62.6	12.8	289.5	273.2	760.9	96.6	396.0	99.2	125.7	91.1	92.6	228.8	125.7	62.4	64.9	606.5	75.1	458.3	130.8	107.1	204.7	7.1	6.8	7.3	7.8	6.7	7.3	12.3	8.8	10.0	11.4	11.8	12.2	19.0	3.2	4.1	2.0	97.8	9.7	6.4	8.0	4.0	0.1	10.4	13.3	3.9	2.8	5.7	1.8	0.0	3.0	82.0	0.5	0.0	12.0	0.5	2.8	8.3	17.2	0.0	14.7	1.4	14.3	8.1	6.5	4.6	2.2	48.8	4.5	15.0	0.8	135.0	0.0	1.0	0.5	4.1	104.6	50.0	1.1	4.4	101.6	5.4	17.8	86.3	0.3	140.1	2.5	0.2	16.9	3.8	1.2	25.0	14.5	0.1	2.4	3.3	0.2	13.1	2.4	8.8	0.3	7.0	5.2	8.9	1.8	57.1	3.7	0.9	8.8
RHEX	"C1orf186, FLJ16052"	ENSG00000263961	"Regulator of hemoglobinization and erythroid cell expansion"	Q6ZWK4	1	206053173-206102449	"Predicted membrane proteins"	"Differentiation, Erythrocyte maturation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 24.4"	"Group enriched"	"Detected in some"	14	"Endometrial ciliated cells: 202.9;Glandular and luminal cells: 337.5;granulocytes: 334.3"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 42.8;ovarian cancer: 41.1;renal cancer: 27.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	152	"basophil: 1312.1"	"Lineage enriched"	"Detected in single"	1544	"granulocytes: 1312.1"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 1562.9"					"Low region specificity"	"Detected in all"			HPA037859			Supported	"Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA037859: AB_10697084"	"unprognostic (9.26e-3)"	"unprognostic (1.91e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.27e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.04e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.80e-3)"	4.1	0.4	0.0	2.9	0.0	1.3	4.7	0.0	0.0	24.4	0.0	7.5	3.3	12.8	16.3	7.7	5.3	16.3	0.9	0.0	0.0	14.3	0.9	10.7	4.1	0.0	0.0	0.2	1.4	0.3	0.4	0.6	0.0	2.8	7.4	0.0	2.8	20.0	1.0	4.5	6.7	7.3	0.0	3.0	6.4	1.0	0.1	3.1	2.0	2.5	4.6	7.7	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	13.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	143.8	0.0	0.9	0.0	75.2	1562.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	5.9	330.8	0.0	0.0	0.0	0.1	0.2	0.7	20.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.6	0.9	1.1	0.8	1312.1	0.0	8.6	0.0	0.1	0.1	0.5	0.2	0.0	0.6	0.2	0.1	0.2	0.5	0.0	0.2	0.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	20.2	0.0	2.3	0.7	0.0	1.9	3.6	0.0	202.9	17.6	1.3	0.0	0.0	0.0	0.2	0.2	0.4	0.0	337.5	334.3	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0
RHOG	"ARHG, MGC125835, MGC125836"	ENSG00000177105	"Ras homolog family member G"	P84095	11	3826978-3840959	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 273.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 365.2;Langerhans cells: 356.6;monocytes: 391.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 625.4"	"Low region specificity"	"Detected in all"							HPA039871	Enhanced					NA	NA		86000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"			"HPA039871: AB_10673428"	"unprognostic (2.39e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.21e-2)"	"unprognostic (4.27e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (9.49e-8)"	"unprognostic (9.38e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	61.2	39.5	62.6	82.5	90.0	273.1	45.7	84.0	70.5	46.2	56.0	50.1	44.7	46.7	19.5	82.6	44.6	34.4	47.0	60.4	71.2	35.6	39.3	87.5	85.2	91.1	83.6	38.0	30.5	18.3	25.4	43.5	91.7	36.8	28.3	4.3	39.1	28.4	53.0	50.1	64.2	39.2	76.5	168.4	42.2	15.3	81.7	68.0	29.0	27.0	67.3	56.5	48.6	107.2	74.1	99.0	19.8	34.1	74.8	84.1	21.4	48.1	59.6	73.7	77.8	61.0	78.7	74.9	24.9	89.2	74.9	85.3	31.2	68.0	47.6	66.6	75.3	170.3	44.7	57.9	75.3	150.0	625.4	82.0	61.1	46.1	44.4	42.6	85.8	99.5	101.3	80.8	61.0	86.5	126.5	206.8	31.5	53.4	78.8	63.7	21.4	44.4	53.1	50.9	10.6	26.7	34.0	77.7	39.4	22.5	41.0	111.6	67.2	88.8	44.5	95.3	57.2	44.8	66.4	42.5	81.0	135.8	50.6	441.3	351.1	739.9	114.8	468.1	101.8	79.8	125.6	128.7	310.8	78.1	87.4	101.6	981.2	97.9	561.9	77.2	206.6	346.7	62.6	90.0	84.0	70.5	60.4	71.2	91.1	83.6	91.7	76.5	81.7	107.2	38.4	19.2	21.5	2.9	109.0	68.7	62.4	35.3	22.8	0.9	24.0	26.3	6.6	20.0	26.9	20.2	0.0	100.4	105.2	99.1	15.6	67.2	1.6	10.2	20.6	58.5	16.2	71.9	1.9	56.6	82.1	38.2	22.4	19.1	200.0	62.8	43.5	19.5	247.7	3.3	1.9	26.7	14.2	365.2	356.6	3.6	38.5	250.6	53.4	8.4	391.7	18.0	166.9	3.0	45.9	86.6	143.6	36.1	45.1	70.4	135.4	24.8	9.7	3.0	19.7	21.6	34.0	10.2	23.9	45.1	59.5	124.2	124.8	11.2	28.9	95.7
RIN3	FLJ22439	ENSG00000100599	"Ras and Rab interactor 3"	Q8TB24	14	92513781-92688994	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 46.3"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 125.1;Macrophages: 78.7;Microglial cells: 100.2;monocytes: 109.8;NK-cells: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 35.7;classical monocyte: 43.4;eosinophil: 54.1;intermediate monocyte: 40.4;myeloid DC: 41.6;neutrophil: 40.2;NK-cell: 21.5;non-classical monocyte: 50.8"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"HMC-1: 108.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA079218	Approved					NA	NA		7400	"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA079218: "	"unprognostic (1.06e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.18e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.07e-3)"	"unprognostic (5.69e-3)"	"unprognostic (5.13e-2)"	"unprognostic (5.90e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-1)"	10.5	13.6	4.3	9.6	3.6	46.3	8.1	4.1	5.3	7.3	2.8	19.1	6.6	15.4	1.6	6.7	8.7	8.1	8.6	4.4	6.6	4.5	12.4	16.3	6.1	9.6	5.9	6.7	2.2	5.4	2.7	6.4	7.0	7.0	4.8	0.2	5.1	5.1	3.2	5.3	9.7	10.2	7.5	22.8	6.4	5.2	9.1	10.9	5.0	2.9	5.3	10.6	8.6	8.6	10.3	19.8	4.4	1.7	1.7	14.3	15.0	12.9	14.0	12.0	8.0	7.5	17.5	0.0	12.1	19.1	8.2	22.0	3.1	0.1	5.5	10.6	3.9	21.4	1.5	8.1	8.7	6.9	108.1	8.1	7.7	11.5	4.8	4.7	7.1	2.6	3.1	0.5	5.0	6.5	3.3	16.3	2.7	1.1	6.0	2.7	2.1	0.2	4.9	6.9	1.0	0.0	6.2	2.1	9.5	4.3	0.1	2.5	12.5	13.8	10.8	20.1	10.9	3.1	0.0	0.2	13.5	0.3	18.1	35.7	43.4	54.1	10.1	40.4	3.4	7.8	4.7	4.9	41.6	8.5	6.8	7.7	40.2	21.5	50.8	1.8	3.0	24.5	4.3	3.6	4.1	5.3	4.4	6.6	9.6	5.9	7.0	7.5	9.1	8.6	19.2	0.0	8.9	18.3	28.2	3.8	2.0	3.4	0.6	2.2	3.7	5.5	4.7	1.5	2.2	0.0	0.0	5.1	44.0	9.2	0.0	1.6	10.2	2.2	3.5	15.4	0.0	12.6	6.9	1.4	3.1	4.2	1.1	2.6	51.4	5.4	8.2	14.9	49.3	0.0	5.2	7.3	4.1	125.1	50.8	6.6	5.3	78.7	12.4	100.2	109.8	0.0	114.4	20.6	0.9	10.1	3.8	18.8	9.7	3.8	9.5	6.2	2.5	0.3	13.1	10.1	4.6	19.1	4.0	1.1	2.7	12.7	32.5	1.9	8.9	3.6
RNASEK	MGC71993	ENSG00000219200	"Ribonuclease K"	Q6P5S7	17	7012417-7014532	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 246.4;Macrophages: 174.7;Plasma cells: 253.2;Squamous epithelial cells: 250.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA044708	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"			"HPA044708: AB_10962051"	"unprognostic (7.59e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.63e-2)"	"unprognostic (5.92e-2)"	"unprognostic (9.73e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.50e-3)"	"prognostic favorable (1.92e-4)"	"unprognostic (2.93e-3)"	"unprognostic (1.72e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.33e-3)"	309.4	592.6	276.9	173.8	296.6	292.9	278.5	285.0	391.0	252.6	339.9	271.8	161.1	254.5	135.1	241.5	239.4	173.3	325.9	298.9	381.3	515.3	280.2	347.4	217.8	307.5	307.5	265.2	233.9	287.8	505.1	158.7	323.9	255.0	118.2	81.6	246.4	161.1	321.9	297.0	229.1	144.9	275.9	396.8	275.2	180.2	300.6	159.6	256.0	226.6	166.8	231.1	225.3	288.4	223.4	353.3	160.9	276.4	406.6	363.4	142.8	224.5	389.5	283.9	320.6	149.6	205.6	157.2	221.3	435.5	343.2	328.5	199.1	274.7	153.6	319.2	520.8	157.0	264.7	252.9	466.1	99.9	748.3	462.4	321.7	338.5	194.0	316.1	344.6	168.0	138.1	327.7	348.4	206.0	137.0	327.4	111.7	178.2	314.0	160.7	92.3	180.9	374.2	192.4	82.1	291.9	191.0	135.6	421.5	157.8	176.0	177.3	322.5	304.6	132.8	383.9	289.3	267.6	278.0	68.6	475.7	225.3	253.2	993.4	1136.6	1378.0	373.6	1031.0	369.9	593.4	413.9	381.0	848.3	542.0	329.5	321.0	2175.1	420.9	1007.1	1070.5	451.1	1052.7	276.9	296.6	285.0	391.0	298.9	381.3	307.5	307.5	323.9	275.9	300.6	288.4	21.3	57.7	65.7	0.0	109.7	20.5	9.2	16.3	246.4	16.3	21.6	14.9	0.8	8.6	47.9	5.5	41.7	5.3	31.5	21.0	3.9	21.4	5.8	45.4	32.4	37.9	13.2	62.0	0.0	5.5	3.4	58.9	110.1	38.6	54.2	14.4	20.0	16.2	14.2	11.8	0.0	15.9	8.2	62.3	47.0	6.2	9.0	174.7	21.4	0.0	42.4	7.6	28.8	0.0	0.0	12.1	10.8	6.4	253.2	12.1	20.4	6.7	58.8	31.5	26.3	11.4	35.6	3.6	1.2	250.2	21.7	11.8	98.0	15.9	15.1	13.8
RNF115	"CL469780, ZNF364"	ENSG00000265491	"Ring finger protein 115"	Q9Y4L5	1	145738868-145824095	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 6.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019130	Approved		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli, Mitochondria"		"HPA019130: AB_1859220"	"unprognostic (3.44e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	8.9	5.0	7.7	4.6	7.3	7.5	7.5	16.1	9.0	7.1	6.1	9.0	3.4	12.2	4.1	5.7	7.9	4.7	24.9	7.7	6.8	5.6	5.1	5.9	5.0	6.3	6.8	5.5	5.3	6.8	5.3	3.5	6.6	7.3	3.7	13.9	5.9	5.2	32.1	6.1	5.5	11.1	5.7	5.0	5.8	3.9	7.5	5.0	6.1	25.3	4.7	7.9	5.6	7.1	11.0	4.5	5.4	3.9	9.6	12.5	4.2	8.1	15.1	5.9	7.1	4.9	3.8	7.7	9.0	11.7	5.7	7.5	6.0	5.5	6.3	7.7	3.9	6.1	5.9	4.6	6.1	9.7	13.7	7.3	4.8	6.0	7.1	6.7	7.7	5.9	6.1	12.2	10.8	8.3	7.1	6.0	6.8	7.0	9.4	6.7	5.4	6.4	11.6	3.6	5.3	7.4	6.6	8.0	6.3	6.6	8.9	9.1	9.4	8.4	6.6	5.1	8.7	10.2	10.3	8.0	4.2	6.4	5.4	6.4	1.0	1.6	1.4	0.8	1.2	1.5	1.0	1.4	0.8	1.2	1.0	1.4	0.7	1.6	0.8	1.1	1.0	0.7	7.7	7.3	16.1	9.0	7.7	6.8	6.3	6.8	6.6	5.7	7.5	7.1	168.4	16.0	29.2	61.7	43.5	20.6	32.6	24.4	23.9	101.3	35.9	29.1	152.5	38.6	27.0	18.4	114.7	26.8	155.6	13.2	33.2	44.8	68.5	52.9	45.4	72.3	27.1	60.6	91.2	80.3	28.7	60.8	28.1	55.8	31.7	39.1	71.7	33.1	37.2	82.4	77.6	23.5	28.5	41.5	36.2	25.3	39.4	38.9	39.2	84.3	71.0	64.4	90.6	81.4	83.9	52.4	18.8	80.9	90.5	76.0	22.5	46.6	29.6	111.1	59.2	60.2	53.5	76.5	63.7	23.7	18.0	19.8	75.7	65.2	23.6	40.2
RNF125	FLJ20456	ENSG00000101695	"Ring finger protein 125"	Q96EQ8	18	32018825-32073219	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 169.6;Early spermatids: 90.7;NK-cells: 160.6;Oligodendrocytes: 64.3;T-cells: 114.8"	"Cancer enhanced"	"Detected in all"		"testis cancer: 8.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 51.5;SK-MEL-30: 13.2;U-937: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041514	Uncertain		Supported	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"	Nucleoli	"HPA041514: AB_10795596"	"unprognostic (2.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.93e-1)"	"unprognostic (5.03e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.30e-3)"	"unprognostic (6.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.07e-3)"	10.2	1.3	2.0	5.2	3.7	18.4	6.3	2.7	2.7	3.9	1.6	5.0	10.5	2.9	0.5	2.5	3.4	3.3	2.6	1.9	2.3	1.0	12.5	4.7	7.0	3.6	3.2	1.4	3.1	1.7	0.3	3.7	3.4	1.8	6.4	0.3	2.2	1.4	2.3	4.9	11.3	3.3	2.6	5.9	3.4	1.0	3.8	5.3	1.4	2.9	4.0	3.0	1.7	6.2	1.2	0.1	0.2	0.4	0.5	0.8	1.0	0.1	0.0	0.0	0.0	0.1	2.5	0.1	1.2	0.1	0.4	0.9	1.6	1.2	0.2	6.6	2.6	0.3	0.4	0.3	0.1	8.9	51.5	1.6	2.4	0.0	2.8	0.3	0.4	2.7	0.1	1.9	0.1	2.0	2.3	8.2	4.2	8.9	1.5	9.2	0.6	0.2	0.5	0.5	0.9	0.3	0.2	0.1	13.2	1.6	1.3	4.2	0.2	0.1	0.7	0.1	0.1	5.9	0.2	0.1	0.6	11.5	6.9	13.3	4.5	4.5	15.0	2.5	9.9	2.5	12.0	12.8	4.2	2.3	9.5	12.3	1.9	15.5	2.8	4.3	13.7	6.9	2.0	3.7	2.7	2.7	1.9	2.3	3.6	3.2	3.4	2.6	3.8	6.2	62.2	3.2	5.8	3.3	16.3	9.8	3.1	1.0	14.2	0.8	5.3	3.7	2.1	4.3	3.8	12.9	0.0	0.4	169.6	24.6	1.9	1.0	90.7	4.9	2.1	28.4	1.2	15.8	2.7	1.8	0.1	5.3	8.6	13.4	18.9	0.2	12.5	25.1	10.5	0.0	3.0	8.3	0.0	19.2	12.6	17.4	2.8	18.4	1.8	30.9	23.8	0.7	160.6	3.5	64.3	1.1	4.5	0.0	49.9	2.7	41.4	4.5	1.7	0.9	0.0	3.2	3.2	0.5	1.8	5.8	6.8	0.8	114.8	0.2	14.7	2.4
RNF144A	"hUIP4, KIAA0161, RNF144, UBCE7IP4"	ENSG00000151692	"Ring finger protein 144A"	P50876	2	6917412-7068286	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 73.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 176.6;Inhibitory neurons: 101.7;Oligodendrocyte precursor cells: 194.5;Oligodendrocytes: 330.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 6.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 6.1;T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"HEL: 39.7;HMC-1: 127.9;SH-SY5Y: 39.0;SK-MEL-30: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049939	Approved		Supported	Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA049939: AB_2680960"	"unprognostic (1.78e-1)"	"unprognostic (2.53e-3)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (6.00e-4)"	"unprognostic (6.57e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (7.04e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.03e-2)"	"unprognostic (5.64e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (7.32e-5)"	"unprognostic (1.30e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.82e-3)"	9.7	28.5	21.1	4.1	46.1	13.9	10.1	59.2	36.7	24.2	1.2	5.7	2.6	26.3	7.7	4.3	7.8	7.1	8.1	17.5	24.0	7.3	1.3	5.4	6.0	30.1	27.0	19.3	30.7	38.1	12.9	5.9	33.4	9.1	5.3	23.0	4.6	6.4	9.6	5.4	3.8	11.6	21.5	23.0	2.6	4.7	30.3	7.5	3.4	10.1	5.6	4.4	7.5	73.6	0.8	5.8	30.1	6.2	6.6	13.6	23.0	0.2	0.0	1.1	2.8	0.1	0.7	2.9	3.3	0.3	8.7	0.7	10.0	0.0	0.0	1.6	2.6	39.7	0.3	11.8	0.3	0.7	127.9	21.7	0.1	2.2	0.0	0.0	0.0	9.9	17.3	0.6	0.0	4.9	20.6	1.7	11.0	0.7	13.6	15.9	21.8	2.6	1.0	10.2	9.9	39.0	0.5	4.0	39.8	3.9	1.7	2.6	0.1	3.9	10.0	10.7	4.5	10.4	3.5	0.1	14.7	8.7	14.3	1.3	0.0	6.1	1.2	0.0	1.8	0.0	1.3	0.9	0.1	0.1	2.4	1.7	0.3	0.5	0.0	0.0	0.6	0.4	21.1	46.1	59.2	36.7	17.5	24.0	30.1	27.0	33.4	21.5	30.3	73.6	27.8	3.2	4.2	34.3	2.4	2.4	0.7	0.0	1.8	4.6	2.5	2.5	11.5	2.8	1.9	0.0	75.0	2.4	5.3	15.4	1.9	3.3	5.5	6.1	15.4	13.9	25.4	18.5	176.6	5.8	3.1	10.4	2.6	10.7	8.9	31.5	23.2	1.1	4.9	10.1	101.7	2.7	0.0	1.0	1.7	14.2	4.4	1.7	24.9	17.8	1.2	7.6	10.3	194.5	330.3	3.0	11.1	10.5	3.1	3.0	2.0	0.3	1.5	39.8	0.0	16.1	5.2	1.8	6.6	5.2	1.6	1.1	9.8	19.1	2.7	1.7
RPS6KA5	"MSK1, RLPK"	ENSG00000100784	"Ribosomal protein S6 kinase A5"	O75582	14	90847861-91060641	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 162.0;Oligodendrocytes: 156.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001274, HPA001780, CAB025458"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB025458: , HPA001274: AB_1079417, HPA001780: AB_2666432"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-3)"	"unprognostic (4.27e-4)"	"unprognostic (1.98e-3)"	"unprognostic (4.79e-2)"	"unprognostic (4.20e-4)"	"unprognostic (3.70e-2)"	"unprognostic (5.80e-4)"	"unprognostic (6.70e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.38e-4)"	"unprognostic (5.73e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.75e-1)"	2.6	0.9	2.4	2.9	7.8	3.3	7.5	14.7	3.7	3.1	1.0	6.6	3.7	4.9	0.3	5.3	4.1	2.8	2.6	1.6	3.0	1.9	1.7	2.8	3.4	4.1	3.8	4.6	1.5	3.0	2.6	3.4	4.1	3.1	5.1	3.0	4.9	4.3	9.0	3.7	4.9	3.9	2.9	3.1	5.4	2.4	4.5	5.0	4.0	9.9	3.5	5.4	4.1	8.0	1.3	2.1	2.7	1.4	0.0	0.5	9.4	0.9	1.3	2.9	4.1	1.2	2.7	6.7	2.8	2.8	1.8	4.7	2.2	1.8	5.1	1.0	3.5	7.5	1.8	0.4	0.0	7.1	31.8	0.8	4.3	1.7	1.3	0.7	3.2	5.1	0.7	7.1	2.9	3.1	2.0	2.2	0.9	4.6	3.4	3.3	11.2	3.2	3.2	2.9	10.4	3.2	2.7	14.8	8.1	1.8	3.0	1.9	0.6	0.8	1.5	0.6	3.4	2.8	3.5	5.9	1.7	5.0	10.6	16.9	3.0	9.0	3.7	2.5	6.1	4.5	4.6	3.5	2.7	5.8	5.5	3.0	19.8	10.4	3.5	1.2	7.9	2.6	2.4	7.8	14.7	3.7	1.6	3.0	4.1	3.8	4.1	2.9	4.5	8.0	13.2	19.2	26.5	80.3	53.7	40.4	45.2	20.4	53.5	32.9	41.4	42.9	20.7	14.3	22.7	7.3	16.7	43.7	21.0	36.7	0.0	11.1	9.1	96.2	19.0	21.4	16.3	22.5	65.4	5.1	6.5	21.8	13.3	162.0	92.2	32.5	20.3	6.5	7.1	26.9	32.5	17.3	4.1	17.6	13.4	3.1	14.0	21.8	19.6	53.4	21.2	10.5	23.7	36.7	156.1	3.5	13.0	11.7	26.0	29.3	41.9	3.7	31.3	32.1	13.1	51.9	22.3	21.2	23.7	35.5	46.3	111.8	48.6	7.2	20.8	52.7
RPS6KC1	"humS6PKh1, RSKL1"	ENSG00000136643	"Ribosomal protein S6 kinase C1"	Q96S38	1	213051233-213274774	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 86.2;Excitatory neurons: 273.2;Inhibitory neurons: 151.2;Microglial cells: 101.2;Oligodendrocyte precursor cells: 116.6;Oligodendrocytes: 137.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 16.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026531, HPA031565"	Approved		Supported	Endosomes,Lysosomes		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endosomes, Lysosomes"		"HPA026531: AB_10601497, HPA031565: AB_2673935"	"unprognostic (3.90e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.34e-1)"	"unprognostic (4.18e-1)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (8.10e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.44e-2)"	8.3	8.8	9.7	7.1	11.5	4.9	7.2	8.2	13.9	8.8	4.3	7.8	6.2	9.4	5.2	6.7	7.6	7.7	6.4	12.9	8.8	6.4	7.4	7.1	5.2	8.6	8.8	9.2	9.2	10.2	4.5	8.4	8.6	11.5	6.5	9.3	6.8	11.3	10.0	4.3	6.0	12.6	8.6	7.9	8.6	19.3	9.9	5.4	6.9	11.6	5.4	8.1	4.6	13.2	11.0	9.3	15.0	16.3	15.0	21.6	13.2	14.1	20.7	21.5	24.6	7.7	11.9	6.9	9.3	21.4	14.1	8.9	18.3	11.6	16.2	14.7	6.7	18.7	10.9	10.5	13.6	11.9	21.4	14.3	9.8	18.8	10.2	17.9	18.2	6.7	24.6	10.5	22.3	6.3	5.0	3.9	21.8	9.8	10.4	5.9	14.1	6.8	9.7	10.9	8.7	22.6	15.3	11.9	20.6	25.5	17.1	4.9	17.0	14.6	13.3	16.9	9.3	6.1	12.6	5.2	6.2	4.5	15.2	16.8	4.5	3.5	2.5	6.4	2.1	2.4	2.0	2.2	8.5	1.6	1.3	3.0	0.5	3.8	6.7	1.0	1.6	2.2	9.7	11.5	8.2	13.9	12.9	8.8	8.6	8.8	8.6	8.6	9.9	13.2	10.1	9.6	5.8	86.2	8.8	2.9	2.7	4.5	7.4	17.4	6.6	5.6	9.6	7.2	4.3	0.0	14.6	3.5	7.7	4.8	0.0	5.2	33.6	7.4	12.1	9.9	3.6	12.4	273.2	8.0	4.0	10.1	15.3	9.9	7.6	16.6	7.9	9.3	7.1	20.2	151.2	3.3	6.1	11.4	7.7	45.2	11.1	15.1	7.2	101.2	13.1	5.6	10.3	116.6	137.6	6.6	2.1	7.5	8.1	5.4	4.4	5.7	4.7	20.0	13.1	13.7	9.1	19.6	19.6	9.1	4.4	3.8	10.4	6.1	4.3	3.2
RRN3	"DKFZp566E104, TIF-IA"	ENSG00000085721	"RRN3 homolog, RNA polymerase I transcription factor"	Q9NYV6	16	15060033-15094311	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049837	Supported		Supported	"Nucleoli rim"		NA	No			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoli rim"		"HPA049837: AB_2680906"	"unprognostic (1.83e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.74e-3)"	"unprognostic (3.67e-2)"	"unprognostic (4.50e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.27e-1)"	21.9	17.1	8.5	11.2	8.2	28.1	20.1	10.8	13.5	15.3	7.5	16.1	7.0	16.6	11.1	13.3	16.0	12.0	16.3	8.3	9.0	15.2	31.1	12.7	15.6	8.2	10.5	20.7	20.0	20.7	15.5	12.2	9.0	16.9	18.2	23.9	13.0	13.3	41.4	15.6	14.7	13.5	8.1	16.2	15.1	13.7	9.0	19.0	16.4	39.1	18.1	18.2	14.0	10.2	17.3	8.5	25.6	22.8	20.2	24.2	7.6	19.4	19.9	28.5	29.9	5.6	31.6	39.2	28.9	27.8	27.7	18.0	40.5	26.3	46.9	20.4	21.9	95.6	17.3	52.4	44.5	17.9	103.4	19.9	41.4	38.2	41.0	25.2	20.9	13.6	18.6	32.0	44.9	26.3	17.0	44.1	25.5	23.3	4.6	61.7	26.4	41.0	26.6	18.4	42.3	33.8	30.5	38.2	24.7	16.4	43.3	25.4	19.4	34.5	14.2	19.8	26.8	27.7	32.8	56.1	20.4	30.2	43.7	8.4	3.4	3.9	3.8	2.3	5.3	4.7	2.8	3.4	3.6	2.2	4.1	3.0	0.4	6.8	2.7	1.8	3.1	4.6	8.5	8.2	10.8	13.5	8.3	9.0	8.2	10.5	9.0	8.1	9.0	10.2	31.6	9.6	13.7	13.1	28.1	17.8	10.3	8.6	28.5	14.4	16.5	12.8	22.3	8.6	10.2	16.5	20.9	11.7	21.4	14.3	5.9	10.1	18.1	9.6	22.3	20.2	7.2	22.5	13.7	8.0	10.9	19.9	20.9	15.0	10.1	22.4	15.4	18.2	15.1	11.8	16.4	17.0	12.2	14.1	15.0	7.7	14.6	21.2	16.0	14.0	15.9	19.0	18.6	13.6	12.7	11.0	13.7	18.0	23.2	12.2	12.8	15.1	5.9	18.9	0.0	14.9	19.1	15.5	21.3	27.9	21.9	6.7	27.6	19.4	14.9	11.0
SAMD14	FLJ36890	ENSG00000167100	"Sterile alpha motif domain containing 14"	Q8IZD0	17	50110040-50130160	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4"	"Cell type enriched"	"Detected in many"	4	"Bipolar cells: 56.1"	"Cancer enhanced"	"Detected in some"		"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.7;HEL: 8.6;HMC-1: 28.0;SH-SY5Y: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051916	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA051916: AB_2681662"	"unprognostic (2.33e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.84e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (7.48e-4)"	0.9	1.4	14.9	0.8	14.0	0.3	0.5	19.4	15.4	1.6	0.0	1.0	0.2	3.1	0.8	0.5	0.5	0.3	1.2	15.3	11.0	3.1	0.8	6.0	0.3	9.4	8.8	1.3	0.2	0.7	3.4	0.7	8.5	3.0	0.1	1.3	0.1	0.7	1.4	0.3	0.9	0.4	6.0	1.7	1.1	2.1	11.2	0.1	0.9	0.5	0.5	1.8	1.1	10.1	0.0	0.2	4.2	0.0	1.1	0.3	0.0	3.0	1.1	0.1	0.0	0.6	0.0	0.1	4.1	1.3	0.0	0.1	0.3	0.0	0.1	12.7	0.1	8.6	0.3	0.0	0.7	0.0	28.0	0.4	0.0	0.0	0.0	0.6	0.7	0.0	0.3	0.3	0.0	0.0	0.1	0.7	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.4	12.9	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.6	1.6	0.3	0.1	0.2	0.0	0.1	2.2	0.1	1.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	14.0	19.4	15.4	15.3	11.0	9.4	8.8	8.5	6.0	11.2	10.1	0.6	0.0	0.5	6.2	0.0	0.4	0.1	0.2	0.6	56.1	0.2	0.3	1.1	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.2	3.1	0.0	1.4	6.1	12.7	2.7	8.3	0.4	0.2	2.3	0.5	0.1	2.5	0.1	8.2	0.3	0.1	11.8	7.2	0.3	0.0	0.6	1.0	2.2	1.5	5.7	0.0	1.0	2.0	2.2	0.0	2.5	0.4	0.2	0.1	3.4	0.2	0.0	0.3	1.1	0.0	4.6	0.0	0.1	2.8	1.5	1.1	0.2	0.1	0.4	0.2	0.7	0.1	0.1
SCART1	CD163c-alpha	ENSG00000214279	"Scavenger receptor family member expressed on T cells 1"	Q4G0T1	10	133453928-133523558	"Predicted membrane proteins"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.0"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 7.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HMC-1: 3.7;NB-4: 3.6;THP-1: 1.1;U-266/84: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043101	Supported					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA043101: AB_10797026"	"unprognostic (4.32e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.42e-2)"	"unprognostic (8.20e-4)"	"unprognostic (1.29e-3)"	"unprognostic (4.28e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.24e-5)"	"unprognostic (8.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.94e-1)"	0.0	0.1	0.2	0.0	0.4	0.2	0.1	0.8	1.0	0.1	0.7	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.7	0.4	0.1	0.1	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.1	3.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	3.6	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.2	0.2	4.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.8	1.0	0.7	0.4	0.2	0.4	0.2	0.2	0.4	0.3	0.8	0.0	1.5	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.6	7.4	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.2	0.0	0.9	0.8	0.5	0.0	0.0	1.3	0.2	0.0	0.4	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	1.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.1	0.0
SCUBE1		ENSG00000159307	"Signal peptide, CUB domain and EGF like domain containing 1"	Q8IWY4	22	43197280-43343372	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 26.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Extravillous trophoblasts: 13.3;Granulosa cells: 37.2;Peritubular cells: 45.5;Theca cells: 14.3"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"midbrain: 10.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HMC-1: 49.8;THP-1: 20.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003190	Approved				"Secreted to blood"	NA	NA	2170000	190000		"Cluster 72: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA003190: AB_1079882"	"unprognostic (5.29e-2)"	"unprognostic (7.15e-6)"	"unprognostic (6.03e-3)"	"unprognostic (8.33e-2)"	"unprognostic (3.65e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.87e-3)"	1.8	6.1	0.8	0.8	1.1	0.1	1.2	0.1	1.4	0.9	4.1	3.8	5.9	1.1	0.1	3.6	1.2	0.8	0.2	0.6	3.8	3.5	5.1	6.8	0.0	1.7	10.2	26.4	0.1	9.1	3.8	2.6	7.0	1.9	2.0	0.4	3.6	0.5	9.6	0.6	7.7	0.5	0.3	5.7	7.0	7.1	1.2	0.1	3.1	1.9	0.0	3.3	0.7	0.4	0.0	0.0	2.2	7.8	0.0	0.0	4.9	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.1	0.1	0.3	0.1	0.7	0.0	0.0	0.1	0.7	0.0	0.1	0.7	0.2	0.2	49.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.1	0.1	0.2	0.8	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	1.2	0.0	0.1	0.0	0.3	0.1	20.4	0.0	0.3	0.2	0.6	0.0	2.1	4.3	0.0	0.5	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	1.1	0.1	1.4	0.6	3.8	1.7	10.2	7.0	0.3	1.2	0.4	0.2	9.6	1.7	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.9	0.1	1.4	0.0	0.6	0.0	0.0	0.2	0.2	0.0	1.9	0.1	3.0	1.3	1.2	1.3	0.0	0.0	0.4	0.0	13.3	2.6	0.5	3.4	1.3	37.2	0.4	1.9	0.8	0.0	0.3	0.2	0.0	0.0	0.4	4.6	7.8	0.2	0.0	0.0	0.1	4.1	0.0	0.0	0.3	0.1	0.0	45.5	0.4	0.0	0.0	0.4	0.7	0.2	0.0	0.4	1.2	3.8	2.0	0.0	0.1	0.4	2.8	14.3	0.0	0.1
SCYL2	"CVAK104, KIAA1360"	ENSG00000136021	"SCY1 like pseudokinase 2"	Q6P3W7	12	100267140-100341715	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021050	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"			"HPA021050: AB_1846175"	"unprognostic (7.01e-3)"	"unprognostic (3.04e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.01e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.27e-2)"	"unprognostic (8.19e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.93e-2)"	"unprognostic (4.44e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.18e-1)"	13.4	13.4	6.2	16.4	7.3	21.5	16.8	9.9	8.2	14.0	7.6	22.9	20.2	14.5	20.9	22.1	10.9	16.2	14.9	7.6	8.6	21.2	28.7	17.2	15.0	5.6	5.4	8.8	17.9	20.9	12.9	21.0	6.3	17.0	26.9	16.7	15.7	15.9	15.6	13.7	17.0	17.4	6.3	14.7	16.4	14.6	7.5	19.0	15.6	19.1	19.8	21.5	11.5	7.2	37.7	29.0	45.8	37.7	28.8	31.1	43.2	38.0	42.8	34.8	29.6	28.1	19.4	23.4	17.7	46.9	23.7	32.1	36.4	27.8	40.6	36.5	24.2	76.0	18.5	20.3	25.7	36.2	72.8	23.1	42.5	39.5	44.9	41.3	44.4	26.0	40.8	19.7	37.4	29.2	29.2	31.7	28.6	21.7	32.6	23.4	33.6	22.7	31.6	61.1	28.3	25.3	43.0	44.2	36.2	48.2	64.9	27.8	41.7	29.7	17.2	27.8	24.8	22.6	32.1	28.3	14.6	24.6	34.4	12.3	5.2	10.0	4.0	6.5	5.1	3.3	4.2	3.8	6.6	2.3	4.5	4.9	6.7	8.6	5.7	2.0	6.2	4.0	6.2	7.3	9.9	8.2	7.6	8.6	5.6	5.4	6.3	6.3	7.5	7.2	24.4	16.0	35.2	37.9	20.4	35.9	21.3	17.4	33.0	16.8	29.6	17.1	30.1	7.2	26.8	20.2	27.1	31.3	22.7	44.1	5.9	16.8	8.5	24.4	19.1	24.8	21.7	28.6	50.3	21.7	22.2	20.2	37.8	31.2	27.9	15.1	16.4	37.1	25.1	15.2	54.1	30.6	12.2	34.6	47.4	4.7	13.4	29.2	16.0	44.0	27.5	10.9	17.5	64.3	47.2	24.0	32.1	15.4	22.2	36.8	16.2	26.3	18.3	16.2	0.0	13.1	20.9	24.9	12.0	36.8	34.7	59.4	22.6	19.2	33.6	52.8
SDS	SDH	ENSG00000135094	"Serine dehydratase"	P20132	12	113392445-113426301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Gluconeogenesis	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	34	"liver: 1024.6"	"Cell type enhanced"	"Detected in some"		"Hepatocytes: 364.6;Hofbauer cells: 199.4;Langerhans cells: 111.9;Macrophages: 93.7;monocytes: 97.6"	"Cancer enriched"	"Detected in all"	31	"liver cancer: 165.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"myeloid DC: 11.6"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 11.6"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.7;SK-BR-3: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA039230	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	Mitochondria	"HPA039230: AB_10674281"	"unprognostic (1.31e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (6.37e-3)"	"unprognostic (6.94e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.35e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.99e-2)"	3.2	10.0	13.5	4.3	18.8	1.5	1.9	13.2	13.0	1.1	8.7	3.3	1.9	0.9	0.3	0.3	0.6	4.1	1.2	13.4	15.2	0.5	1024.6	6.3	0.8	30.0	27.7	0.5	1.0	0.8	1.1	2.9	16.1	1.1	2.3	3.0	2.7	0.1	0.8	0.2	2.0	0.5	10.5	1.7	2.9	0.4	19.1	0.4	1.0	0.0	0.3	3.8	0.3	11.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.0	0.1	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.5	1.0	0.2	0.0	0.3	0.5	0.2	0.0	0.2	0.3	0.0	0.2	0.1	0.0	0.3	0.2	0.1	0.2	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.5	0.1	0.1	1.1	0.0	0.4	13.5	18.8	13.2	13.0	13.4	15.2	30.0	27.7	16.1	10.5	19.1	11.4	0.2	0.0	0.6	15.0	5.1	2.4	0.4	0.0	0.0	0.2	0.4	1.5	0.5	17.2	0.0	0.0	0.0	0.8	0.3	0.1	0.0	2.8	0.0	0.1	0.2	1.3	0.0	29.5	0.1	0.4	1.3	0.6	0.0	0.1	0.0	0.1	18.9	364.6	199.4	0.0	0.1	0.0	0.0	45.1	111.9	0.0	0.0	93.7	1.8	0.0	97.6	1.9	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.5	0.0	0.3	0.6	0.0	0.0	0.4	3.1	2.5	2.4	0.8	0.0	0.1
SEMA6B	"SEM-SEMA-Y, SEMA-VIB, SEMAN, semaZ"	ENSG00000167680	"Semaphorin 6B"	Q9H3T3	19	4542593-4581776	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 72.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 43.6;Alveolar cells type 1: 28.9;Alveolar cells type 2: 44.6;Endothelial cells: 40.1;Excitatory neurons: 30.6;granulocytes: 29.7;Hepatic stellate cells: 37.5;Inhibitory neurons: 30.3;Macrophages: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 124.5;HMC-1: 198.1;HUVEC TERT2: 83.8;TIME: 107.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025157, HPA055778, HPA058523"	Enhanced					NA	NA		1100000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"			"CAB025157: , HPA055778: AB_2682916, HPA058523: AB_2683741"	"unprognostic (4.03e-1)"	"unprognostic (9.69e-3)"	"unprognostic (6.38e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.34e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.21e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (3.29e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (9.55e-2)"	25.6	19.7	44.0	11.0	30.7	7.8	17.1	0.6	72.3	8.7	0.0	6.6	4.0	10.6	0.4	3.6	8.8	5.8	20.2	65.2	12.4	13.3	2.9	10.7	1.2	13.5	11.0	3.3	4.1	9.2	7.2	8.9	1.8	7.0	1.0	1.4	3.9	1.3	6.0	4.6	7.3	6.9	0.5	31.9	6.1	1.9	30.2	0.7	9.1	4.3	0.7	10.0	6.7	17.4	7.2	25.0	2.3	21.4	0.1	1.2	0.2	0.0	0.7	2.4	0.6	0.2	2.0	0.0	23.7	0.0	3.8	4.4	6.5	0.0	0.9	0.1	1.0	0.0	0.4	124.5	0.4	0.0	198.1	7.5	0.1	0.2	0.2	24.9	83.8	0.1	1.6	0.3	0.7	6.5	0.0	0.0	26.8	1.7	0.3	0.4	46.8	0.6	1.7	0.1	17.7	1.7	0.1	1.7	11.5	1.8	2.7	1.1	107.8	3.1	34.7	0.5	18.6	1.3	0.0	0.4	0.8	1.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	30.7	0.6	72.3	65.2	12.4	13.5	11.0	1.8	0.5	30.2	17.4	43.6	28.9	44.6	2.6	2.3	4.7	1.5	0.5	0.0	9.0	2.1	1.9	1.9	1.5	19.3	1.8	4.2	0.6	2.3	0.2	0.0	1.1	1.1	1.1	2.5	40.1	0.0	8.4	30.6	0.2	0.6	8.2	0.0	2.0	29.7	0.5	37.5	6.0	3.3	18.5	30.3	0.1	0.0	6.1	18.1	0.4	0.6	35.2	7.2	7.5	1.4	2.0	1.0	19.1	1.4	0.2	0.1	0.7	1.1	1.2	0.0	0.4	17.7	4.1	0.0	8.8	1.8	2.0	2.2	0.0	5.1	0.3	5.4	1.6	0.1	0.9
SEMA7A	"CD108, H-Sema-L, SEMAL"	ENSG00000138623	"Semaphorin 7A (John Milton Hagen blood group)"	O75326	15	74409289-74433958	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Differentiation, Inflammatory response, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 60.1;retina: 34.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 68.8;Extravillous trophoblasts: 58.8;Granulosa cells: 65.1;Pancreatic endocrine cells: 91.0;Rod photoreceptor cells: 58.3;Syncytiotrophoblasts: 166.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 1.8;eosinophil: 3.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 275.8;hTEC/SVTERT24-B: 108.7;U-251 MG: 166.3;U-87 MG: 92.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008210, HPA042273"	Uncertain		Uncertain	Vesicles		NA	NA		38000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"HPA008210: , HPA042273: AB_10806234"	"unprognostic (2.00e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.02e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (2.45e-11)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.57e-2)"	2.0	2.5	4.6	7.0	11.0	9.9	1.9	19.1	14.4	2.2	0.9	2.4	1.5	2.9	0.9	4.8	1.4	1.8	2.3	5.1	8.2	2.8	1.6	8.1	13.2	19.9	11.6	7.8	0.9	1.9	2.7	16.3	22.9	1.8	0.9	34.6	2.2	1.2	2.0	8.5	10.8	1.1	10.6	60.1	3.5	29.5	17.2	9.4	1.3	0.3	12.9	8.2	2.5	20.2	16.7	0.2	4.8	1.4	6.0	20.1	39.7	75.2	30.1	15.5	23.8	6.5	26.6	0.1	4.3	34.2	12.6	4.9	1.5	4.8	16.0	1.3	0.9	30.0	0.1	8.3	1.3	0.9	275.8	14.3	0.2	108.7	6.0	39.0	0.2	2.0	17.5	10.1	51.2	1.4	4.3	9.9	5.2	0.4	11.3	0.6	3.3	4.4	6.5	7.1	0.3	0.5	0.5	13.4	6.1	4.1	1.0	6.0	3.0	28.8	19.2	14.1	166.3	1.8	1.3	0.3	92.4	3.4	1.5	1.8	0.0	3.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	4.6	11.0	19.1	14.4	5.1	8.2	19.9	11.6	22.9	10.6	17.2	20.2	1.8	3.2	0.0	1.0	22.6	0.4	1.6	3.1	0.6	13.7	1.2	1.3	1.4	0.0	4.0	1.8	68.8	25.6	5.2	0.6	0.0	19.8	0.5	4.6	1.5	5.3	0.0	21.7	12.4	13.9	58.8	1.8	1.5	10.6	8.2	65.1	0.7	0.7	7.2	1.7	5.9	0.0	0.0	0.3	12.0	2.5	3.7	4.8	8.8	0.0	28.6	6.8	1.0	4.0	16.3	91.0	0.1	1.9	6.4	3.3	0.1	0.1	2.0	58.3	0.0	0.2	9.0	0.9	0.8	0.2	1.4	166.4	5.7	22.0	0.0	24.4
SEPHS2	"SPS2, SPS2b"	ENSG00000179918	"Selenophosphate synthetase 2"	Q99611	16	30443631-30445874	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 402.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 385.4;Proximal tubular cells: 384.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 477.5"	"Low region specificity"	"Detected in all"							HPA047931	Approved		Approved	Nucleoplasm		No	No		29000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA047931: AB_2680216"	"unprognostic (5.33e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.69e-3)"	"unprognostic (2.38e-1)"	"unprognostic (9.86e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.49e-1)"	"prognostic favorable (4.35e-8)"	"unprognostic (2.24e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.62e-2)"	27.5	30.6	16.8	33.7	17.5	26.0	33.8	18.5	19.9	24.8	21.2	75.5	136.0	19.9	23.9	20.4	20.5	34.0	27.8	18.5	20.5	158.5	402.6	28.8	44.8	18.5	18.9	14.9	35.2	48.9	20.4	25.1	19.5	28.7	65.9	19.7	33.6	23.2	41.7	21.1	105.8	25.9	18.6	29.8	62.5	11.5	20.2	43.5	37.7	32.3	41.9	27.7	14.2	19.8	77.6	68.9	23.8	83.1	71.7	45.7	62.5	52.3	64.5	50.5	62.2	42.9	57.7	110.8	79.0	56.0	45.7	42.1	44.5	47.9	51.0	71.2	137.5	110.8	35.9	204.0	90.5	62.0	477.5	58.4	100.5	47.6	87.7	31.6	47.0	80.1	91.1	69.7	45.4	114.5	93.9	127.8	59.3	58.0	51.4	90.2	41.8	85.3	62.6	68.9	50.5	43.1	44.8	129.3	179.7	47.8	113.7	204.2	39.6	52.2	37.1	50.9	32.0	59.6	103.4	57.6	45.3	114.3	59.7	8.7	19.4	30.2	14.8	16.1	22.2	17.8	20.9	21.4	21.6	20.2	25.0	17.2	17.6	31.9	20.5	15.4	22.8	14.8	16.8	17.5	18.5	19.9	18.5	20.5	18.5	18.9	19.5	18.6	20.2	19.8	76.2	44.8	40.3	3.9	34.3	37.5	1.4	47.6	58.6	0.5	66.2	52.7	49.4	1.5	39.4	64.4	0.0	1.3	41.5	108.9	385.4	112.2	0.1	34.2	25.1	32.4	35.5	20.8	6.7	82.7	1.1	30.4	68.8	59.2	31.0	20.5	0.7	9.1	1.4	0.0	8.6	31.0	63.1	2.9	34.9	0.1	0.0	42.5	44.4	5.6	37.1	0.2	1.0	5.5	4.6	57.4	42.4	0.0	30.6	1.6	11.1	384.9	27.2	1.1	0.0	2.0	49.4	0.8	0.8	45.4	42.6	1.2	35.7	52.6	46.0	0.9
SERTM2	LINC00890	ENSG00000260802	"Serine rich and transmembrane domain containing 2"	A0A1B0GWG4	X	111511662-111522399	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 27.3;epididymis: 41.9;seminal vesicle: 75.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 4.6;granulocytes: 1.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.9;renal cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 16.9"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.8"	"Low region specificity"	"Detected in many"									NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"				"unprognostic (9.56e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.65e-1)"		"unprognostic (3.79e-2)"	"unprognostic (5.74e-2)"		"unprognostic (1.93e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.77e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.26e-1)"	"unprognostic (9.57e-3)"	0.0	0.1	0.0	0.8	0.0	0.0	0.3	0.0	0.0	13.1	0.0	1.8	0.1	27.3	41.9	0.0	4.2	0.2	0.0	0.0	0.8	0.2	5.4	0.2	0.1	0.3	0.3	0.8	0.0	0.0	1.0	0.3	0.4	9.8	0.1	0.3	0.0	75.8	0.0	0.0	0.4	4.8	0.1	0.4	2.1	0.0	0.8	0.0	0.0	0.0	0.3	0.7	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.7	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.3	0.4	0.1	0.8	0.1	0.1	3.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
SHISA7		ENSG00000187902	"Shisa family member 7"	A6NL88	19	55428740-55443277	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 25.9"	"Group enriched"	"Detected in some"	6	"Erythroid cells: 13.5;Excitatory neurons: 19.4;Inhibitory neurons: 16.1;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 16.1"	"Cancer enriched"	"Detected in single"	9	"glioma: 2.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 2.9;HMC-1: 2.8;THP-1: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058935	Uncertain		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA058935: AB_2683857"	"unprognostic (3.98e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"		"unprognostic (3.08e-1)"	"unprognostic (4.40e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.87e-7)"	"unprognostic (7.53e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.29e-4)"	"unprognostic (4.04e-1)"	0.0	0.4	20.2	0.0	19.7	1.1	0.0	0.5	20.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	10.4	0.0	0.0	0.0	0.0	5.1	4.9	0.0	0.0	0.0	4.9	0.0	3.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	1.3	9.6	0.1	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	19.7	0.5	20.2	25.9	10.4	5.1	4.9	3.6	4.6	9.6	12.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	13.5	19.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	16.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	23.1	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SIGLEC12	"S2V, Siglec-12, Siglec-L1, Siglec-XII, SIGLECL1, SLG"	ENSG00000254521	"Sialic acid binding Ig like lectin 12"	Q96PQ1	19	51491227-51501800	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 6.1;lymphoid tissue: 14.9"	"Group enriched"	"Detected in some"	8	"granulocytes: 2.5;Hofbauer cells: 2.2;Kupffer cells: 3.8;Macrophages: 4.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HMC-1: 146.9;U-937: 81.3"															NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"				"unprognostic (1.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.13e-2)"	"unprognostic (9.58e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.79e-2)"	"unprognostic (9.21e-5)"	"unprognostic (2.45e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.57e-1)"	1.8	0.6	0.0	4.7	0.0	1.4	0.1	0.0	0.0	0.1	0.1	0.7	6.1	0.1	0.0	0.2	0.1	1.3	0.1	0.0	0.0	0.1	0.7	2.2	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	1.9	0.0	0.2	0.0	0.0	0.0	4.9	2.5	0.0	14.9	0.3	0.0	0.0	0.8	0.0	0.0	0.6	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	146.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.9	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	81.3	0.0	0.0	0.4	0.8	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	4.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SIGLEC14		ENSG00000254415	"Sialic acid binding Ig like lectin 14"	Q08ET2	19	51642553-51646801	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 28.3;lymphoid tissue: 40.3"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 18.5;Kupffer cells: 41.5;Macrophages: 13.5;monocytes: 24.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 109.1;intermediate monocyte: 125.1;myeloid DC: 65.4;neutrophil: 200.1;non-classical monocyte: 93.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 65.4;granulocytes: 200.1;monocytes: 125.1"	"Group enriched"	"Detected in some"	11	"HMC-1: 98.7;U-937: 24.7"									"HPA014377, HPA014428"	Uncertain		Uncertain	"Vesicles,Plasma membrane"		NA	NA		24000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	"Plasma membrane"	"HPA014377: AB_2189277, HPA014428: "	"unprognostic (3.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.28e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.28e-3)"	"unprognostic (8.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.89e-1)"	3.4	2.4	1.4	25.2	1.5	28.3	1.0	1.6	3.2	1.8	1.3	1.8	0.7	0.9	0.3	1.1	2.3	2.6	1.3	1.4	2.4	0.7	3.5	7.3	13.3	4.7	3.0	0.4	1.1	0.4	0.5	2.5	3.9	0.9	1.6	0.1	1.1	0.9	0.4	0.3	6.1	2.5	2.7	40.3	1.6	2.4	3.9	1.9	0.6	0.0	14.2	4.1	0.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	1.6	98.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.0	16.6	109.1	1.8	0.3	125.1	0.1	19.3	0.2	0.3	65.4	18.2	0.1	0.1	200.1	0.7	93.3	12.0	0.2	40.3	1.4	1.5	1.6	3.2	1.4	2.4	4.7	3.0	3.9	2.7	3.9	4.1	0.0	0.0	1.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.4	18.5	0.0	0.0	0.0	0.0	41.5	6.0	0.8	0.3	13.5	0.0	1.0	24.1	0.0	2.1	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0
SIGLEC5	"CD170, CD33L2, OB-BP2, SIGLEC-5"	ENSG00000105501	"Sialic acid binding Ig like lectin 5"	O15389	19	51611927-51645545	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 14.7;lymphoid tissue: 12.4"	"Cell type enhanced"	"Detected in some"		"granulocytes: 8.2;Hofbauer cells: 5.6;Kupffer cells: 10.4;Macrophages: 4.4;monocytes: 3.0"	"Cancer enriched"	"Detected in single"	5	"urothelial cancer: 1.7"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"neutrophil: 152.5;non-classical monocyte: 49.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 152.5;monocytes: 49.3"	"Group enriched"	"Detected in some"	5	"HMC-1: 59.2;U-937: 25.6"									"HPA009085, CAB024900"	Supported					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB024900: , HPA009085: AB_1079965"	"unprognostic (1.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.28e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.71e-4)"	"unprognostic (4.37e-2)"	"unprognostic (3.55e-3)"	"unprognostic (4.02e-1)"	"unprognostic (1.95e-1)"	1.4	0.4	0.3	6.6	0.6	14.7	0.2	0.3	1.2	0.2	0.0	0.7	0.1	0.3	0.0	0.3	0.7	0.7	0.4	0.3	0.3	0.3	1.5	3.4	3.1	0.4	0.3	0.1	0.2	0.3	0.1	0.8	0.5	0.3	0.7	0.2	0.3	0.1	0.0	0.0	2.0	0.9	0.4	12.4	0.6	0.8	0.4	0.7	0.2	0.4	2.2	1.5	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	59.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	15.5	22.2	0.5	0.0	24.2	0.0	2.5	0.0	0.0	15.6	2.0	0.0	0.0	152.5	0.7	49.3	5.0	0.0	8.4	0.3	0.6	0.3	1.2	0.3	0.3	0.4	0.3	0.5	0.4	0.4	0.6	0.0	0.0	0.0	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	8.2	0.0	0.0	0.0	5.6	0.0	0.2	0.0	0.0	10.4	1.2	0.5	0.3	4.4	0.0	1.0	3.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0
SIGLEC6	"CD327, CD33L, CD33L1, OB-BP1, SIGLEC-6"	ENSG00000105492	"Sialic acid binding Ig like lectin 6"	O43699	19	51517819-51531856	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	24	"placenta: 106.7"	"Group enriched"	"Detected in some"	13	"Cytotrophoblasts: 76.0;granulocytes: 55.0;Syncytiotrophoblasts: 188.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 4.9;memory B-cell: 7.2;naive B-cell: 4.5;plasmacytoid DC: 11.0"	"Group enriched"	"Detected in many"	13	"B-cells: 7.2;dendritic cells: 11.0;granulocytes: 4.9"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 500.7"									"HPA008945, HPA009084, HPA018198"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Cytosol"		"HPA008945: , HPA009084: AB_1079967, HPA018198: AB_1856868"	"unprognostic (1.97e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-3)"	"unprognostic (9.31e-3)"		"unprognostic (8.46e-4)"	"unprognostic (2.91e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.57e-3)"	0.6	0.1	0.2	3.0	0.3	0.5	0.7	0.4	0.3	1.6	0.1	2.2	2.2	1.5	1.0	2.5	0.3	2.5	0.4	0.2	0.0	0.1	0.1	4.3	3.8	0.1	0.1	0.1	0.3	0.1	0.0	106.7	0.2	1.0	3.1	0.4	0.5	0.7	0.5	0.5	3.3	1.3	0.0	1.7	2.6	0.3	0.2	0.7	0.0	0.6	4.2	1.8	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	15.8	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	73.1	0.0	0.0	0.0	1.2	500.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.3	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	19.1	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.9	0.2	4.9	0.1	0.0	0.0	0.0	0.0	7.2	0.0	0.0	1.6	4.5	0.0	0.0	0.2	0.6	0.0	11.0	0.0	0.4	0.2	0.3	0.4	0.3	0.2	0.0	0.1	0.1	0.2	0.0	0.2	0.5	0.0	0.0	1.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	76.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	5.2	0.7	0.0	0.0	55.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	188.7	0.5	0.0	0.0	0.0
SIGLEC8	"MGC59785, SAF2, SIGLEC-8, SIGLEC8L"	ENSG00000105366	"Sialic acid binding Ig like lectin 8"	Q9NYZ4	19	51450847-51458456	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.9;lymphoid tissue: 6.8"	"Cell type enhanced"	"Detected in some"		"granulocytes: 44.9;Kupffer cells: 17.7;Microglial cells: 11.2"	"Group enriched"	"Detected in many"	4	"glioma: 7.2;renal cancer: 2.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	38	"eosinophil: 290.2"	"Lineage enriched"	"Detected in single"	719	"granulocytes: 290.2"	"Cell line enriched"	"Detected in some"	44	"HMC-1: 147.5"									HPA012556	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Cytosol		"HPA012556: AB_1856869"	"unprognostic (1.27e-1)"	"unprognostic (1.88e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.19e-1)"	"unprognostic (8.62e-3)"	"unprognostic (7.18e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.28e-3)"	"unprognostic (3.29e-1)"	0.3	4.0	4.9	1.6	5.2	0.5	1.4	5.3	6.1	0.9	1.7	1.8	1.8	0.6	0.7	0.7	0.7	1.4	0.2	4.5	6.2	0.1	0.8	2.5	6.8	13.3	6.6	0.2	0.5	1.0	0.4	0.1	10.1	0.6	1.6	0.7	0.6	0.5	0.1	0.5	2.8	0.9	7.3	6.3	1.4	0.3	11.6	2.1	0.4	0.2	2.5	1.0	0.3	14.9	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	2.3	0.1	0.1	0.0	0.0	147.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.3	0.0	0.0	0.2	3.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	1.1	0.1	7.6	0.4	290.2	0.2	0.3	0.1	0.2	0.2	0.1	0.1	0.3	0.1	0.2	2.5	0.3	0.4	0.2	0.1	0.2	4.9	5.2	5.3	6.1	4.5	6.2	13.3	6.6	10.1	7.3	11.6	14.9	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	44.9	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	2.5	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SLC11A1	"LSH, NRAMP, NRAMP1"	ENSG00000018280	"Solute carrier family 11 member 1"	P49279	2	218382029-218396894	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 78.6;lymphoid tissue: 46.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 108.0;Kupffer cells: 166.8;Macrophages: 209.4;monocytes: 101.2"	"Cancer enhanced"	"Detected in many"		"glioma: 7.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 6.1;intermediate monocyte: 4.5;myeloid DC: 1.9;neutrophil: 4.1;non-classical monocyte: 6.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 1.9;granulocytes: 4.1;monocytes: 6.1"	"Cell line enhanced"	"Detected in some"		"HEL: 1.2;HMC-1: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA029590, HPA050378, HPA068540"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Mitochondria	Nucleoli	"HPA029590: AB_10794613, HPA050378: , HPA068540: "	"unprognostic (2.64e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (2.58e-8)"	"unprognostic (9.55e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.08e-2)"	14.1	8.5	3.5	7.1	4.3	6.7	4.9	3.9	11.1	2.7	4.7	3.5	0.2	2.2	0.1	1.6	7.4	1.0	8.0	3.3	5.0	3.4	5.1	78.6	0.2	7.4	5.2	1.7	3.2	0.3	3.1	2.7	6.9	3.2	0.0	0.6	3.2	0.1	1.7	1.5	2.2	1.9	5.2	46.6	3.0	0.9	17.3	0.3	2.7	1.3	0.0	7.2	2.4	7.4	0.1	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.2	0.2	0.2	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.2	0.0	0.4	0.0	0.9	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	6.1	0.6	0.3	4.5	0.2	0.1	0.2	0.1	1.9	0.2	0.3	0.2	4.1	0.2	6.0	0.2	0.2	2.0	3.5	4.3	3.9	11.1	3.3	5.0	7.4	5.2	6.9	5.2	17.3	7.4	1.5	22.4	38.5	1.6	4.1	0.9	4.3	1.9	1.2	3.1	4.5	4.6	8.6	2.8	13.8	9.2	0.0	1.8	3.1	1.8	9.8	1.3	1.8	6.1	2.3	17.0	1.2	1.7	1.3	2.1	7.8	5.8	2.0	2.8	25.3	0.9	6.8	7.3	108.0	1.7	0.9	4.0	6.1	166.8	6.3	0.5	2.1	209.4	1.8	4.7	101.2	12.9	10.3	0.5	1.4	0.4	1.6	0.7	5.6	3.9	2.5	11.7	11.0	3.3	19.7	2.9	4.2	0.8	1.8	2.1	1.0	8.1	6.7	3.3	2.9	3.3
SLC17A7	"BNPI, VGLUT1"	ENSG00000104888	"Solute carrier family 17 member 7"	Q9P2U7	19	49429401-49442360	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	63	"brain: 405.4;retina: 315.8"	"Group enriched"	"Detected in some"	13	"Bipolar cells: 362.7;Cone photoreceptor cells: 369.1;Excitatory neurons: 107.8;Rod photoreceptor cells: 358.0"	"Cancer enriched"	"Detected in some"	6	"glioma: 7.5"	"Group enriched"	"Detected in many"	7	"amygdala: 176.7;basal ganglia: 243.4;cerebral cortex: 289.7;hippocampal formation: 405.4;white matter: 169.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 20.8;K-562: 7.0;REH: 4.0;SCLC-21H: 4.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 201.2;cerebellum: 204.6;cerebral cortex: 339.5;hippocampal formation: 471.2"	"CAB037183, HPA050458, HPA063679"	Enhanced	Supported				NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB037183: AB_261840, HPA050458: AB_2681134, HPA063679: AB_2685086"	"unprognostic (1.79e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.12e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.70e-3)"	"unprognostic (8.32e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.26e-12)"	"unprognostic (8.36e-4)"	"unprognostic (4.27e-1)"	"unprognostic (1.35e-2)"	"unprognostic (6.17e-3)"	5.7	1.4	176.7	0.2	243.4	0.0	3.0	32.2	289.7	2.0	0.0	1.5	0.4	1.2	0.6	1.1	2.2	0.9	2.8	405.4	0.0	1.0	0.3	0.6	1.0	31.7	0.8	0.6	0.6	0.6	1.6	0.1	37.8	0.5	0.5	315.8	1.2	0.3	1.7	2.2	1.5	0.6	0.0	0.1	0.9	2.3	0.0	0.3	2.3	2.5	0.6	1.6	1.8	169.9	0.0	0.3	0.2	0.4	1.6	0.3	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.3	0.5	1.2	0.1	1.9	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.1	0.3	0.0	0.3	0.0	0.3	7.0	1.0	0.0	0.2	0.0	0.1	0.0	0.3	0.3	4.0	0.1	0.1	0.0	0.0	4.9	0.4	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.3	2.3	0.9	0.0	0.4	0.3	0.3	0.6	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	176.7	243.4	32.2	289.7	405.4	0.0	31.7	0.8	37.8	0.0	0.0	169.9	1.9	0.0	0.0	9.4	0.0	1.3	0.2	0.0	0.0	362.7	0.5	0.8	3.2	0.0	0.0	0.0	369.1	0.1	0.0	0.2	0.0	0.0	5.6	0.0	0.0	1.7	0.0	0.0	107.8	0.0	0.1	5.5	0.0	0.1	0.0	0.1	0.0	0.0	0.3	11.8	3.4	0.0	0.0	0.0	1.3	0.5	6.5	0.3	1.8	11.2	0.0	22.6	0.0	6.0	8.0	0.1	0.0	0.4	0.0	0.1	0.1	0.0	0.0	358.0	6.6	0.4	4.3	3.5	4.4	0.6	0.6	0.0	0.1	0.0	0.3	0.1
SLC18A2	"SVAT, SVMT, VMAT2"	ENSG00000165646	"Solute carrier family 18 member A2"	Q05940	10	117241093-117279430	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Disease variant, Dystonia, FDA approved drug targets, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.1;cervix: 30.0"	"Cell type enriched"	"Detected in many"	5	"granulocytes: 636.0"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	11	"hypothalamus: 20.8;midbrain: 81.1;pons: 70.5"	"Immune cell enriched"	"Detected in some"	15	"basophil: 59.5"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 59.5"	"Cell line enriched"	"Detected in some"	19	"HMC-1: 351.0"	"Region enhanced"	"Detected in many"		"midbrain: 62.7"	"Region enriched"	"Detected in all"	4	"midbrain: 111.6"	HPA073224	Enhanced		Approved	Vesicles,Centrosome		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Vesicles, Centrosome"		"HPA073224: AB_2732222"	"unprognostic (1.49e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.06e-3)"	"unprognostic (7.94e-5)"	"unprognostic (2.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	1.1	14.6	0.1	0.9	1.1	2.4	1.8	0.1	0.3	30.0	0.2	2.3	1.5	2.6	1.6	2.5	0.5	3.6	0.7	0.2	20.8	0.9	2.8	7.4	0.6	3.8	81.1	10.4	3.4	0.2	0.2	0.1	70.5	9.2	3.5	0.4	0.8	1.3	0.8	6.3	2.1	2.3	0.0	0.3	4.4	0.9	5.0	6.1	0.0	0.5	0.9	2.9	7.9	0.2	0.2	1.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.3	0.6	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.7	18.6	0.1	0.2	0.0	1.0	351.0	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.0	0.7	0.0	0.1	1.0	0.3	0.2	0.3	0.6	0.2	0.4	0.2	0.0	0.2	3.4	0.7	0.3	0.1	0.0	0.2	0.0	0.1	0.3	0.1	2.5	0.3	0.8	0.5	0.4	0.2	0.4	1.9	0.3	59.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	3.8	0.0	2.0	0.1	1.1	0.1	0.3	0.2	20.8	3.8	81.1	70.5	0.0	5.0	0.2	0.0	9.6	16.2	1.0	0.2	1.9	0.0	0.0	0.0	2.1	0.2	0.0	0.3	0.0	2.5	0.0	4.2	0.0	5.7	0.4	0.0	0.0	0.0	13.1	16.1	0.7	8.9	4.2	1.1	0.0	0.0	3.4	4.1	112.4	636.0	2.4	9.7	0.3	0.8	0.0	1.7	0.0	0.0	1.0	3.6	0.2	0.6	3.5	1.8	0.0	0.1	0.4	0.0	0.5	0.6	0.1	0.1	4.9	1.9	3.8	0.0	0.1	0.7	0.8	0.0	0.4	1.3	0.2	2.1	0.0	2.7	0.0	5.6	9.8	0.1	0.1
SLC24A3		ENSG00000185052	"Solute carrier family 24 member 3"	Q9HC58	20	19212642-19722926	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.7"	"Group enriched"	"Detected in many"	9	"Astrocytes: 134.5;Inhibitory neurons: 327.0;Oligodendrocyte precursor cells: 375.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	39	"basophil: 5.8;eosinophil: 1.8"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 5.8"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043400, HPA045497"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Cytosol	"HPA043400: AB_2678462, HPA045497: AB_2679349"	"unprognostic (8.74e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (7.36e-3)"	10.4	3.1	16.2	4.0	11.7	1.4	4.9	13.3	56.1	17.8	2.7	10.8	3.8	28.3	24.3	20.6	20.0	13.0	1.1	81.7	18.6	1.1	0.7	5.5	1.0	13.6	19.2	14.6	0.7	7.5	1.2	3.0	9.1	10.9	5.4	7.3	4.7	17.5	40.9	7.0	5.0	29.1	10.3	2.4	3.8	1.5	34.8	1.9	3.0	16.9	2.7	8.6	8.9	5.4	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.8	13.3	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	18.2	0.0	0.0	0.7	0.0	75.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	8.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	9.0	0.0	0.6	17.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.2	11.7	13.3	56.1	81.7	18.6	13.6	19.2	9.1	10.3	34.8	5.4	0.2	3.2	1.1	134.5	0.1	1.1	1.1	0.4	0.0	19.1	5.0	2.3	0.4	0.0	1.3	1.8	0.0	8.5	0.1	0.3	0.0	0.1	17.0	1.2	29.8	0.4	7.7	3.4	11.8	0.0	0.3	1.9	0.0	1.6	26.6	0.1	0.4	0.0	0.6	1.7	327.0	4.1	0.0	0.0	0.7	18.3	3.7	1.1	0.0	12.2	0.0	3.1	0.0	375.5	2.4	0.2	2.8	4.1	0.4	0.8	0.4	0.0	0.0	2.2	0.0	2.7	3.0	0.5	0.8	2.9	4.1	3.4	0.4	0.1	0.7	3.8
SLC25A41	"APC4, FLJ40442, MGC34725"	ENSG00000181240	"Solute carrier family 25 member 41"	Q8N5S1	19	6426037-6433779	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 6.3;choroid plexus: 4.3;testis: 2.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 92.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 3.0;U-937: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043591	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA043591: AB_10964585"	"unprognostic (1.87e-3)"	"unprognostic (2.52e-3)"	"unprognostic (6.81e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.29e-4)"	"unprognostic (4.43e-3)"	"unprognostic (2.81e-2)"	"unprognostic (9.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-1)"	0.1	0.1	4.7	0.0	5.3	0.0	0.0	4.6	6.3	0.2	4.3	0.6	0.0	0.1	0.0	0.3	0.2	0.0	0.3	4.8	4.7	0.2	0.3	0.0	0.0	4.6	4.6	0.3	0.1	0.0	0.2	0.0	4.9	0.4	0.0	0.3	0.1	0.1	0.3	0.2	0.2	0.1	4.4	0.1	0.2	2.1	4.5	0.0	0.2	0.0	0.0	0.3	0.2	4.4	0.1	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.0	0.2	0.6	0.0	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	5.3	4.6	6.3	4.8	4.7	4.6	4.6	4.9	4.4	4.5	4.4	0.0	0.0	0.0	2.0	0.1	0.0	0.1	0.3	0.0	1.0	0.2	0.3	0.5	0.0	0.0	0.0	2.1	0.4	0.1	0.4	0.0	0.3	92.2	0.1	0.1	0.0	0.0	0.0	5.0	0.0	0.1	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.1	3.3	4.5	0.4	0.0	0.0	0.0	20.6	0.9	0.1	0.0	0.0	0.0	1.1	0.0	1.0	1.6	0.6	0.2	0.0	0.0	0.2	0.2	0.2	0.1	1.2	0.0	0.1	0.1	0.3	0.6	0.0	0.3	0.5	0.0	0.0	0.4	0.1
SLC28A3	CNT3	ENSG00000197506	"Solute carrier family 28 member 3"	Q9HAS3	9	84275457-84340758	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 22.4;salivary gland: 12.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 10.7;Breast glandular cells: 9.5;Cholangiocytes: 8.6;Ductal cells: 24.9;Endometrial ciliated cells: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 58.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023311, HPA024729"	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA023311: AB_1857067, HPA024729: AB_1857069"	"prognostic favorable (3.37e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.82e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-7)"	"unprognostic (1.03e-1)"	"unprognostic (9.87e-2)"	"unprognostic (8.75e-2)"	"unprognostic (4.03e-2)"	5.2	0.0	0.1	0.3	0.0	9.4	8.9	0.1	0.0	1.0	22.4	0.7	1.0	0.5	0.5	4.2	2.3	7.3	0.4	0.8	0.1	0.1	0.3	1.1	0.1	0.9	1.0	0.0	8.2	0.1	1.2	0.3	0.4	0.1	2.5	0.0	12.0	2.8	0.0	10.0	1.9	0.1	0.4	0.3	0.8	0.4	0.3	0.5	0.1	0.0	1.3	0.3	1.5	0.1	0.7	0.0	0.0	0.0	0.0	0.1	6.2	0.7	1.5	0.8	0.7	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	0.0	0.0	0.0	0.4	0.2	58.1	0.1	0.5	0.4	0.4	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	1.0	0.1	0.0	0.5	0.1	9.3	0.0	0.1	6.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.1	0.9	1.0	0.4	0.4	0.3	0.1	0.0	0.0	0.5	1.6	0.1	0.3	0.0	10.7	0.0	0.0	9.5	3.8	0.8	8.6	4.2	1.8	0.0	0.2	0.3	0.7	0.0	24.9	1.4	9.2	0.8	0.2	3.0	0.0	0.4	3.1	0.1	0.5	2.0	6.7	1.3	1.5	0.0	0.0	2.1	0.0	0.4	5.4	2.0	1.2	0.0	2.5	0.0	0.7	0.0	0.0	1.5	0.4	0.0	0.0	0.1	4.5	0.3	0.0	0.4	0.1	1.0	0.0	4.2	0.0	0.0	0.0	0.4	0.6	0.3	3.4	0.9	0.1	0.1	0.0	4.8	0.2
SLC2A6	"GLUT6, GLUT9, HSA011372"	ENSG00000160326	"Solute carrier family 2 member 6"	Q9UGQ3	9	133471094-133479127	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.9;lymphoid tissue: 13.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 52.1;granulocytes: 47.4;monocytes: 60.4;Paneth cells: 39.8;Rod photoreceptor cells: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 73.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 33.1;HMC-1: 67.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042272, CAB046014"	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"CAB046014: AB_2270444, HPA042272: AB_2677924"	"unprognostic (2.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.87e-3)"	"unprognostic (1.71e-3)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (1.02e-11)"	"unprognostic (7.24e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.36e-2)"	"unprognostic (6.28e-3)"	4.0	3.8	5.9	4.6	5.7	4.3	2.9	6.6	9.2	1.3	2.5	2.4	0.9	2.5	0.7	1.1	1.5	0.8	4.7	5.7	7.4	3.9	3.5	8.4	4.1	11.9	7.1	0.9	2.7	0.5	2.3	0.7	11.9	1.9	0.4	0.6	1.5	0.4	1.1	1.0	6.7	0.9	4.7	13.3	2.5	1.6	8.1	0.5	1.8	0.3	2.3	4.5	1.4	6.1	5.7	9.6	3.2	9.4	1.8	2.7	2.8	5.2	8.5	4.9	5.2	4.3	7.5	4.5	14.0	4.8	23.3	8.3	2.0	5.7	1.1	33.1	1.9	5.5	6.8	5.2	6.3	0.1	67.8	3.7	0.9	7.2	0.8	0.3	5.0	5.3	0.8	4.3	3.4	12.4	2.9	5.3	4.8	2.2	12.0	2.3	5.8	23.3	6.8	14.5	4.0	5.5	8.2	3.9	2.6	1.7	14.9	2.4	13.9	12.3	5.0	14.0	4.2	2.4	2.0	6.3	3.2	1.3	2.8	46.3	18.2	1.8	1.6	36.9	1.1	9.3	0.3	1.1	16.3	8.8	0.5	1.3	0.9	1.2	73.2	17.3	0.2	9.3	5.9	5.7	6.6	9.2	5.7	7.4	11.9	7.1	11.9	4.7	8.1	6.1	6.2	3.2	4.1	9.1	24.6	0.4	1.2	17.3	0.6	25.9	1.1	0.1	1.8	5.7	6.2	3.7	52.1	0.4	31.3	2.8	0.0	36.0	6.0	1.2	1.1	9.6	3.6	0.4	21.7	8.9	0.7	2.6	5.1	1.9	47.4	1.2	2.5	0.6	4.5	23.5	15.6	2.4	2.0	15.6	10.3	2.4	0.9	30.6	3.6	1.9	60.4	5.6	4.1	3.5	6.9	21.5	39.8	0.0	10.8	1.0	1.9	0.3	3.3	46.0	32.9	3.8	7.6	2.2	6.8	0.2	0.4	0.3	5.5	5.2	2.3	0.6
SLC39A11	C17orf26	ENSG00000133195	"Solute carrier family 39 member 11"	Q8N1S5	17	72645949-73092712	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 205.3;Excitatory neurons: 107.7;Oligodendrocytes: 360.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 217.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021455			Approved	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA021455: AB_2670710"	"unprognostic (2.29e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.45e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.96e-3)"	"unprognostic (3.85e-2)"	12.6	7.8	14.0	10.8	27.8	21.2	17.4	22.5	17.2	14.9	9.5	24.0	20.3	5.5	15.7	15.5	9.1	11.0	4.9	14.1	17.9	13.4	39.4	10.9	8.8	25.7	23.7	3.4	29.3	4.7	2.9	8.7	24.0	7.7	24.1	2.3	30.3	8.0	4.5	14.2	22.8	7.3	16.9	7.9	48.2	6.8	23.9	5.5	36.1	3.5	12.4	12.5	9.3	35.3	20.5	36.8	4.3	17.2	30.7	24.8	24.4	21.6	19.0	9.7	13.0	13.7	90.7	25.4	21.5	22.1	15.4	17.2	6.2	10.9	14.8	27.6	12.8	23.8	9.9	16.3	18.3	25.4	217.5	21.2	20.3	20.1	11.6	10.6	10.1	13.1	12.6	31.0	12.4	28.9	16.3	55.1	3.5	62.4	15.6	10.9	16.3	21.5	16.0	20.9	10.2	13.8	11.6	84.7	12.7	16.8	58.4	34.9	8.5	19.0	17.7	16.3	13.4	24.9	12.2	17.9	30.8	50.6	11.1	19.3	39.9	26.0	16.7	40.4	10.9	16.7	12.5	12.5	37.9	9.8	8.8	12.1	6.6	22.6	33.1	26.8	17.1	18.1	14.0	27.8	22.5	17.2	14.1	17.9	25.7	23.7	24.0	16.9	23.9	35.3	4.9	0.0	6.3	205.3	7.6	4.5	5.3	5.6	10.2	2.6	13.7	5.5	2.3	4.3	8.6	3.7	0.0	5.6	6.9	15.8	0.0	9.4	18.5	5.6	3.6	4.0	8.4	9.9	107.7	14.1	17.4	4.7	29.0	9.5	29.9	7.9	3.6	30.1	26.3	5.0	32.1	79.0	10.2	21.0	5.6	66.7	4.1	14.4	10.6	64.6	19.6	4.1	8.2	22.6	360.3	9.1	20.5	3.4	15.1	6.0	24.8	11.5	7.8	1.6	13.1	2.6	7.1	2.0	2.9	10.3	4.4	4.9	5.4	4.4	18.3	7.5
SLC45A3	"IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein"	ENSG00000158715	"Solute carrier family 45 member 3"	Q96JT2	1	205657851-205680509	"Cancer-related genes, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"prostate: 306.4"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 19.9;granulocytes: 119.2;Oligodendrocytes: 47.1;Prostatic glandular cells: 67.2"	"Cancer enriched"	"Detected in all"	49	"prostate cancer: 539.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	382	"basophil: 40.5"	"Lineage enriched"	"Detected in single"	382	"granulocytes: 40.5"	"Cell line enriched"	"Detected in many"	29	"HMC-1: 834.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA019073, HPA019075"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 35: Glandular cells - Unknown function"	Vesicles	Nucleoplasm	"HPA019073: AB_1857177, HPA019075: AB_1857179"	"unprognostic (1.80e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (4.04e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (7.33e-5)"	1.4	3.6	6.7	3.2	19.5	0.8	1.6	17.6	13.4	3.7	1.9	4.8	4.6	1.7	0.5	1.6	2.1	3.8	1.5	8.0	10.3	2.1	11.2	3.4	2.7	25.1	17.3	2.7	0.8	0.3	4.7	0.5	21.8	306.4	3.2	0.1	2.8	0.6	5.6	1.5	4.8	1.0	12.6	12.4	16.8	1.4	16.6	0.5	1.0	2.3	0.8	2.8	1.1	44.7	9.7	3.0	2.8	2.7	0.0	0.1	2.2	1.3	0.3	3.3	2.7	7.1	18.0	2.7	4.6	0.3	3.0	3.5	1.6	3.3	0.5	3.9	2.9	29.0	0.6	2.0	1.9	5.0	834.2	0.3	1.1	2.3	0.0	2.2	9.4	4.5	4.9	1.7	1.4	2.3	0.8	8.5	12.2	16.7	10.7	1.0	4.1	1.5	3.7	13.7	1.2	2.9	1.5	20.6	3.9	2.3	4.7	1.4	9.6	1.4	9.5	3.5	7.1	0.4	0.6	0.4	1.8	1.5	7.1	40.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.7	19.5	17.6	13.4	8.0	10.3	25.1	17.3	21.8	12.6	16.6	44.7	0.2	0.0	3.2	1.0	4.0	0.0	1.0	0.6	0.0	0.4	1.5	1.8	2.0	2.8	1.0	1.8	0.0	0.5	0.1	5.7	0.0	1.7	0.2	1.9	0.2	1.7	0.0	3.4	0.2	0.5	0.1	0.7	19.9	0.2	119.2	0.2	0.7	6.6	1.9	0.0	0.3	6.9	2.0	1.0	0.3	0.4	1.8	2.0	0.0	0.0	0.6	0.1	0.0	2.0	47.1	3.9	8.0	1.5	0.3	67.2	0.9	1.8	3.2	0.1	6.6	0.1	0.8	0.0	2.6	0.4	0.1	0.0	0.9	0.2	6.7	0.9
SLC52A1	"FLJ10060, GPCR42, GPR172B, hRFT1, PAR2, RFVT1"	ENSG00000132517	"Solute carrier family 52 member 1"	Q9NWF4	17	5032600-5052009	"Disease related genes, Metabolic proteins, Predicted membrane proteins"	Transport	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"intestine: 35.8;placenta: 18.4;skin 1: 11.1"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 820.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.4;BEWO: 1.9;EFO-21: 1.8;HMC-1: 4.6;SK-BR-3: 2.6;T-47d: 1.6"															NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"				"unprognostic (8.81e-3)"	"prognostic favorable (9.54e-4)"	"unprognostic (9.34e-2)"	"unprognostic (7.30e-4)"	"unprognostic (6.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.82e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.19e-2)"	"unprognostic (5.17e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.60e-2)"	0.1	0.1	0.1	0.1	0.1	0.5	0.5	0.5	0.3	0.6	0.0	1.0	35.8	0.2	0.3	1.0	0.9	0.3	0.1	0.1	0.0	0.1	0.1	0.4	0.2	0.1	0.0	0.1	0.3	0.6	0.1	18.4	0.1	1.0	0.4	0.2	0.4	0.6	0.3	11.1	23.5	0.1	0.0	0.3	0.3	0.5	0.0	0.6	0.3	0.0	0.2	1.1	0.7	0.4	0.1	2.4	0.0	0.1	0.1	0.1	1.9	0.0	0.0	0.3	0.3	0.0	0.1	0.1	1.8	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	4.6	0.0	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.5	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.4	2.6	0.0	0.0	1.6	0.7	0.3	0.1	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.7	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.2	0.1	0.7	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.5	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.0	1.1	1.6	2.0	0.6	0.0	0.2	0.5	0.7	0.0	0.9	0.0	0.0	185.7	0.1	4.1	0.0	0.0	0.2	1.7	0.1	0.6	1.2	0.0	0.0	0.0	15.3	1.2	0.0	0.5	0.0	0.3	2.2	0.0	15.7	0.0	0.1	6.6	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.3	76.4	0.1	7.7	0.0	0.0	0.2	0.1	2.0	2.1	2.3	1.7	820.1	0.3	0.1	2.6	1.5
SMYD3	"KMT3E, ZMYND1, ZNFN3A1"	ENSG00000185420	"SET and MYND domain containing 3"	Q9H7B4	1	245749342-246507312	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 406.1;Excitatory neurons: 725.6;Inhibitory neurons: 788.3;Microglial cells: 277.3;Oligodendrocyte precursor cells: 372.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 402.2;K-562: 162.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012229, HPA045821, HPA054352"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB012229: , HPA045821: AB_2679461, HPA054352: AB_2682458"	"unprognostic (7.00e-3)"	"unprognostic (7.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.32e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.78e-5)"	"unprognostic (9.03e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.58e-1)"	7.9	12.1	9.5	5.0	9.6	9.7	11.1	16.4	9.6	9.1	5.8	7.5	5.0	7.1	22.1	6.4	10.3	8.2	6.7	10.4	10.2	9.4	6.0	9.8	7.7	7.0	10.3	8.2	7.8	9.5	9.2	5.3	9.8	6.8	8.8	7.0	6.6	5.4	11.6	8.0	6.0	6.7	4.4	5.7	7.3	8.7	11.6	10.8	16.0	9.8	7.7	10.1	5.9	6.8	20.8	12.6	17.8	15.4	19.9	27.1	17.3	28.7	21.4	33.4	74.4	16.2	23.7	33.5	22.6	27.0	20.8	13.2	16.3	32.1	111.3	17.7	16.4	20.0	17.9	19.5	37.3	20.1	402.2	73.5	7.6	44.3	28.5	25.3	23.1	23.5	162.0	11.5	33.0	7.0	38.8	38.8	15.9	29.1	19.5	35.5	21.3	48.9	24.5	29.3	41.9	19.8	13.5	2.0	26.4	19.3	16.5	33.8	17.6	15.9	11.0	11.4	34.8	57.0	16.7	17.3	30.5	27.3	18.8	13.1	4.6	11.5	12.9	4.1	13.7	14.2	13.7	16.4	8.0	15.8	15.1	16.1	3.2	27.5	4.6	5.0	16.2	12.1	9.5	9.6	16.4	9.6	10.4	10.2	7.0	10.3	9.8	4.4	11.6	6.8	14.2	6.4	30.7	406.1	16.2	12.2	14.7	26.5	13.1	7.7	8.7	9.3	9.1	4.3	18.9	12.9	22.9	8.1	15.8	5.1	15.6	22.3	54.8	24.9	14.3	12.7	25.1	6.3	725.6	31.1	42.6	15.9	9.2	13.6	110.9	25.7	12.5	4.9	12.3	10.1	788.3	7.9	26.4	4.1	10.2	110.9	11.1	6.0	12.4	277.3	3.7	7.6	16.5	372.4	136.5	24.0	3.7	17.3	19.9	4.8	4.0	19.3	36.9	13.2	0.0	12.1	20.7	19.6	27.5	12.0	11.5	7.3	18.3	46.3	8.8	10.0
SNX20	"SLIC-1, SLIC1"	ENSG00000167208	"Sorting nexin 20"	Q7Z614	16	50666300-50681353	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.0;lymphoid tissue: 33.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 15.3;Cardiomyocytes: 16.4;dendritic cells: 23.7;Hofbauer cells: 17.6;Kupffer cells: 17.2;Langerhans cells: 25.2;Macrophages: 19.3;monocytes: 26.1;NK-cells: 24.7;T-cells: 21.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 29.7;HMC-1: 78.5;NB-4: 48.0;RPMI-8226: 20.6;THP-1: 21.3;U-266/70: 25.7;U-937: 28.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA043649	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA043649: AB_10965697"	"unprognostic (1.53e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (5.58e-2)"	"unprognostic (5.06e-3)"	"unprognostic (9.03e-2)"	"prognostic favorable (6.56e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (6.00e-6)"	"unprognostic (3.24e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.54e-1)"	2.3	1.0	1.5	20.0	1.5	18.0	1.1	1.8	1.7	1.1	1.5	2.7	2.9	1.0	0.6	1.6	1.0	4.0	0.8	1.3	1.8	0.8	2.2	7.7	27.8	3.4	2.1	0.6	0.5	0.4	0.5	2.7	2.5	1.1	3.6	0.3	1.9	0.7	0.8	2.4	6.1	2.7	2.1	19.2	3.7	0.5	2.6	33.2	0.9	1.1	27.0	6.1	0.7	2.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	29.7	0.0	5.2	0.0	0.0	0.0	7.4	78.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.0	0.0	48.0	0.0	0.0	0.0	2.4	0.2	20.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.2	0.0	0.0	0.1	0.0	25.7	14.3	6.5	0.0	28.4	0.0	306.6	66.9	208.0	41.6	118.3	52.2	22.6	73.8	50.9	123.4	22.6	56.1	38.9	62.3	51.3	147.5	34.3	137.5	81.8	1.5	1.5	1.8	1.7	1.3	1.8	3.4	2.1	2.5	2.1	2.6	2.9	0.2	0.0	0.0	0.3	15.3	0.8	0.0	0.0	0.0	0.2	0.3	0.6	16.4	2.8	1.3	0.0	0.0	0.1	23.7	0.0	0.0	0.0	0.1	0.3	0.1	1.5	0.0	6.5	0.0	0.0	0.2	0.5	0.5	0.1	5.1	0.0	1.1	0.4	17.6	1.7	0.0	0.0	0.0	17.2	25.2	0.0	0.0	19.3	0.0	0.0	26.1	0.1	24.7	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.1	0.0	0.1	13.1	0.5	0.5	0.2	0.1	0.0	0.6	0.4	21.3	0.1	0.2	0.0
SORBS1	"CAP, FLJ12406, KIAA1296, ponsin, SH3D5, sh3p12"	ENSG00000095637	"Sorbin and SH3 domain containing 1"	Q9BX66	10	95311771-95561414	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 800.2;Cardiomyocytes: 612.3;Excitatory neurons: 401.1;Inhibitory neurons: 295.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 6.1"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 6.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 28.0;Hep G2: 19.5;HMC-1: 48.3;SK-MEL-30: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027559, CAB032850, HPA043084"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Centrosome"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites"	"Plasma membrane, Centrosome"	"CAB032850: AB_2286335, HPA027559: AB_10600812, HPA043084: AB_2678307"	"prognostic favorable (2.84e-4)"	"unprognostic (3.53e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.01e-3)"	370.8	21.6	128.5	53.3	153.3	4.7	78.3	101.7	144.1	46.0	42.6	312.8	25.6	169.4	32.1	155.5	99.2	81.3	351.6	127.0	165.4	17.6	49.3	34.4	3.1	164.0	161.5	19.0	22.0	26.4	11.5	30.3	126.7	140.6	67.0	39.0	24.5	217.4	190.5	24.5	62.7	151.0	138.9	8.1	143.1	14.4	127.0	3.7	14.8	155.9	1.5	235.3	47.1	139.9	1.6	1.2	12.4	3.1	4.2	0.2	2.4	0.4	0.1	0.4	0.1	28.0	10.9	0.0	2.2	0.2	4.2	0.6	2.4	0.6	0.4	3.2	4.5	7.2	0.4	19.5	1.5	0.0	48.3	0.9	0.4	0.5	0.3	0.2	4.9	1.9	11.7	2.3	1.3	0.8	0.1	0.8	5.7	6.2	2.6	1.0	4.0	0.4	15.1	18.3	4.9	3.7	1.8	0.6	45.2	8.9	2.1	0.4	0.3	0.1	4.0	0.1	2.4	1.8	0.5	0.2	4.8	0.5	11.7	6.1	0.1	1.2	0.4	0.6	0.5	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.3	0.1	128.5	153.3	101.7	144.1	127.0	165.4	164.0	161.5	126.7	138.9	127.0	139.9	42.2	22.4	20.9	800.2	0.8	11.6	8.7	0.0	5.2	7.5	6.5	19.3	612.3	12.8	1.3	1.8	2.1	20.2	1.0	4.0	3.9	7.2	70.4	1.4	15.8	25.7	6.0	16.0	401.1	3.1	2.4	21.4	8.6	1.6	16.4	8.2	30.4	50.5	3.1	6.7	295.1	10.9	0.0	3.8	12.0	48.6	7.5	1.1	14.2	163.9	0.7	22.1	1.0	155.3	22.6	2.3	2.8	76.8	1.1	4.7	1.2	6.1	0.1	5.5	0.0	11.8	51.6	3.4	3.7	1.9	12.5	29.6	1.6	0.1	5.1	5.9
SOS1	"GF1, GINGF, HGF"	ENSG00000115904	"SOS Ras/Rac guanine nucleotide exchange factor 1"	Q07889	2	38981549-39124345	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 226.6;Inhibitory neurons: 224.0;Microglial cells: 161.1;Oligodendrocyte precursor cells: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HMC-1: 134.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005396	Uncertain		Approved	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB005396: AB_2270724"	"unprognostic (6.68e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-3)"	"unprognostic (4.02e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.96e-3)"	"unprognostic (7.61e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.33e-2)"	17.5	8.4	8.2	14.8	10.2	10.8	9.8	14.1	10.3	13.1	6.8	11.0	14.7	14.3	10.3	12.3	11.2	13.5	9.5	9.7	10.8	11.0	11.9	11.0	16.9	9.5	10.2	20.1	9.1	17.1	0.1	17.0	9.5	13.4	12.9	13.2	9.0	12.2	13.7	9.4	15.6	13.8	6.7	12.5	11.5	10.3	8.7	15.4	15.1	16.4	17.8	13.5	0.1	10.6	24.8	15.1	22.8	16.2	29.1	35.0	23.8	15.3	18.7	12.0	11.4	16.3	14.6	35.8	10.3	20.1	18.5	14.4	26.9	13.9	22.1	36.3	11.9	55.5	12.8	22.0	11.8	17.9	134.9	21.6	20.5	16.3	15.8	19.5	18.9	8.1	23.9	16.4	15.4	13.5	19.4	15.8	14.3	30.4	10.4	21.5	20.5	10.5	12.1	19.8	22.0	22.0	18.3	32.3	18.2	18.5	10.4	9.3	21.5	19.8	16.0	15.7	15.4	19.3	20.9	18.4	15.8	17.3	12.0	0.0	0.5	1.4	1.3	0.7	1.9	1.6	1.3	1.4	0.4	1.0	1.5	1.4	0.6	2.7	0.9	0.6	0.9	0.4	8.2	10.2	14.1	10.3	9.7	10.8	9.5	10.2	9.5	6.7	8.7	10.6	72.3	16.0	31.2	120.5	20.9	20.8	15.5	10.9	19.9	19.0	18.4	16.9	33.9	18.6	17.8	9.2	10.4	10.2	27.6	19.5	1.9	11.0	64.9	30.0	36.6	43.2	12.0	12.8	226.6	11.9	8.4	22.9	21.4	34.0	3.8	30.0	12.8	18.6	10.3	8.4	224.0	16.9	26.4	19.1	13.2	11.4	22.7	19.9	7.2	161.1	19.6	15.1	26.8	173.4	125.2	14.2	14.6	21.8	37.5	25.3	28.0	12.8	20.4	11.2	6.6	27.1	22.7	11.3	7.0	17.1	25.3	10.4	33.2	18.4	17.0	28.4
SPI1	"OF, PU.1, SFPI1, SPI-1, SPI-A"	ENSG00000066336	"Spi-1 proto-oncogene"	P17947	11	47354860-47378547	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"bone marrow: 335.1;lung: 101.0;lymphoid tissue: 172.7"	"Group enriched"	"Detected in many"	6	"Hofbauer cells: 432.9;Kupffer cells: 411.9;Langerhans cells: 537.6;Macrophages: 453.3;monocytes: 357.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 179.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 179.7"	"Cell line enhanced"	"Detected in some"		"HEL: 90.1;HL-60: 159.7;HMC-1: 282.2;NB-4: 267.8;THP-1: 206.7;U-698: 85.3;U-937: 117.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004079, HPA044653"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"CAB004079: AB_10692379, HPA044653: AB_2679036"	"unprognostic (4.45e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.92e-2)"	36.5	19.7	12.0	107.3	13.1	335.1	17.7	14.3	19.4	7.9	15.8	15.6	21.5	7.3	2.1	9.1	19.1	21.3	13.5	11.7	16.4	10.6	15.6	101.0	65.0	31.2	20.9	5.2	7.8	3.1	7.6	28.0	24.7	10.3	10.2	1.0	14.6	6.1	5.0	13.8	29.3	21.9	19.8	172.7	17.0	3.7	26.2	15.7	8.8	8.3	32.0	29.9	7.6	30.3	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.2	0.1	0.0	0.0	72.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	90.1	0.0	0.0	0.0	159.7	282.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.7	0.0	0.0	0.2	267.8	0.2	0.0	0.0	48.7	0.2	47.5	0.0	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	206.7	0.3	0.0	0.5	0.5	0.1	0.1	0.3	85.3	0.3	117.5	0.1	14.1	19.2	179.7	0.0	27.4	0.0	3.9	0.0	0.0	16.4	2.4	0.0	0.0	83.8	0.0	34.7	0.9	0.0	7.3	12.0	13.1	14.3	19.4	11.7	16.4	31.2	20.9	24.7	19.8	26.2	30.3	2.1	3.2	1.1	10.4	72.6	10.5	0.5	0.0	1.2	1.3	2.1	5.0	2.9	4.3	0.6	5.5	0.0	2.3	6.3	0.5	19.6	0.1	7.5	0.1	0.3	5.5	4.2	39.7	3.1	0.4	3.1	2.6	1.1	0.3	33.7	0.2	7.9	3.2	432.9	0.0	3.3	0.3	0.0	411.9	537.6	27.5	1.8	453.3	10.6	36.5	357.5	7.0	8.2	3.5	1.5	0.0	0.1	0.0	21.8	0.4	0.2	2.3	0.7	1.7	13.1	1.5	1.4	5.1	9.3	0.8	9.9	4.2	4.8	1.1	0.4	0.5
SSX2B	CT5.2b	ENSG00000268447	"SSX family member 2B"	Q16385	X	52751132-52790305	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 29.9"	"Cell type enriched"	"Detected in single"	9	"Spermatogonia: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.7;PC-3: 2.5;T-47d: 1.0;U-2197: 1.5"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	29.9	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.5	0.0	0.2	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.2	0.7	0.9	0.2	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX7		ENSG00000187754	"SSX family member 7"	Q7RTT5	X	52644061-52654900	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.3;RT4: 1.7"									"HPA045683, HPA071685"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "																"unprognostic (1.29e-1)"		0.0	0.0	0.4	0.1	0.5	0.2	0.0	1.2	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.6	0.2	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.7	0.4	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	1.2	0.7	0.2	0.1	0.6	0.2	0.7	0.2	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ST8SIA6	SIAT8F	ENSG00000148488	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6"	P61647	10	17315421-17454595	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.5;lung: 5.9"	"Cell type enriched"	"Detected in some"	5	"Microglial cells: 137.7"	"Cancer enhanced"	"Detected in some"		"breast cancer: 5.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"HMC-1: 208.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011635, HPA072708"	Uncertain		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"HPA011635: AB_2194921, HPA072708: "	"unprognostic (4.86e-3)"	"unprognostic (7.01e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.23e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.26e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.07e-3)"	0.7	0.3	5.8	0.4	4.1	1.8	5.2	3.2	3.6	0.3	2.4	0.6	0.3	0.4	4.6	0.5	0.3	0.5	3.4	2.9	3.3	0.8	1.0	5.9	0.2	5.4	10.5	0.4	0.2	0.0	0.3	1.1	4.6	1.5	0.4	0.4	0.6	0.2	0.2	1.0	0.4	0.3	3.6	0.6	0.3	0.3	8.0	0.3	0.4	0.8	0.4	0.2	0.4	4.3	0.2	0.2	0.1	1.7	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.6	0.6	0.0	0.1	0.3	0.3	0.5	0.1	0.0	0.0	0.4	0.2	25.9	0.4	0.5	0.0	0.0	208.0	0.1	0.0	0.2	0.1	1.8	0.0	0.3	4.6	0.4	2.5	1.9	1.1	0.4	2.1	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	9.3	0.2	1.1	0.0	3.6	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.1	0.4	0.1	1.7	0.5	0.5	0.5	0.1	0.2	0.1	0.3	0.3	0.2	0.3	0.3	0.4	1.0	0.7	0.3	0.2	0.8	0.2	5.8	4.1	3.2	3.6	2.9	3.3	5.4	10.5	4.6	3.6	8.0	4.3	0.6	0.0	0.0	2.6	0.1	0.6	0.1	0.2	0.0	0.0	10.0	3.9	0.8	0.0	0.2	0.0	0.0	0.0	5.5	1.2	0.0	0.0	0.5	0.1	0.0	10.9	0.0	25.5	3.0	0.0	0.0	0.3	0.0	0.8	10.2	2.8	26.7	0.0	0.1	0.0	4.4	0.0	0.0	0.9	0.0	0.6	0.0	0.2	8.8	137.7	0.2	0.0	8.2	1.5	1.1	0.1	0.1	0.0	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.8	0.3	0.0	0.0	0.0	2.4	0.1	0.0	0.1
STAG3		ENSG00000066923	"Stromal antigen 3"	Q9UJ98	7	100177563-100221488	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Chromosome partition, Meiosis"		"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	66	"testis: 54.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 56.5;Spermatocytes: 152.6;Spermatogonia: 60.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 41.7;HMC-1: 54.4;U-698: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA049106, HPA058330"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA049106: AB_2680634, HPA058330: AB_2683681"	"unprognostic (6.56e-4)"	"prognostic favorable (8.45e-4)"	"unprognostic (1.25e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.31e-4)"	"unprognostic (4.26e-4)"	"unprognostic (7.48e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.07e-4)"	0.2	0.2	0.1	0.1	0.1	0.8	0.3	0.2	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.0	0.3	0.1	0.3	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.2	0.1	54.7	0.3	0.6	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.2	0.0	41.7	1.1	0.0	0.1	0.2	0.0	0.0	1.2	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	54.4	0.0	0.1	0.8	0.2	0.0	0.3	1.4	0.2	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	13.1	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.3	0.3	1.9	0.0	2.7	2.9	56.5	6.8	10.9	1.8	1.2	7.4	1.9	1.8	2.2	10.0	1.7	7.3	2.1	2.0	12.1	1.7	13.7	0.3	29.8	26.1	2.9	4.2	1.2	8.4	6.5	0.2	3.3	4.1	0.5	7.8	1.3	4.9	4.2	29.4	2.2	20.2	6.1	5.7	0.0	2.2	8.6	23.5	4.7	4.6	5.4	5.6	4.2	2.7	13.4	5.0	5.1	0.2	0.5	1.9	2.1	8.2	1.1	6.9	15.1	7.0	0.0	8.0	5.4	152.6	60.0	0.4	8.5	2.9	10.8	2.6	2.0	11.7
STARD5	MGC10327	ENSG00000172345	"StAR related lipid transfer domain containing 5"	Q9NSY2	15	81309053-81324183	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 28.0;Plasma cells: 31.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 5.8;RPMI-8226: 6.2;U-266/70: 7.1;U-937: 6.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040662	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	Cytosol	"HPA040662: AB_10959593"	"unprognostic (5.35e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.08e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.84e-3)"	"unprognostic (7.55e-3)"	1.0	0.6	0.6	6.0	0.8	4.3	0.7	3.4	1.3	7.2	1.9	2.8	2.2	4.6	5.0	3.4	1.8	1.3	0.8	0.6	0.7	0.7	5.1	1.1	7.7	0.9	1.0	1.2	0.6	0.6	0.4	1.6	1.2	3.6	3.7	0.4	1.6	2.1	0.6	7.9	4.2	1.8	0.9	6.2	2.1	0.7	0.7	0.5	0.8	0.3	1.5	2.5	5.5	1.4	0.3	0.0	0.0	0.9	2.3	2.3	0.1	0.3	0.3	0.8	1.2	0.1	0.1	4.8	0.0	1.5	0.2	4.0	1.1	1.0	0.6	0.1	0.4	1.8	0.3	0.4	0.5	2.8	5.8	2.0	2.0	0.3	0.6	1.5	0.1	1.9	0.6	1.3	0.5	0.1	0.5	4.0	0.3	0.2	0.0	0.1	0.7	6.2	0.3	1.4	0.3	0.1	0.1	0.5	0.6	0.3	0.6	0.6	0.2	1.3	0.6	1.3	0.1	7.1	1.5	1.8	0.9	6.8	0.4	5.0	1.8	2.3	3.0	2.4	2.5	1.0	2.7	3.2	2.6	0.7	3.9	3.9	1.3	2.6	2.3	1.4	3.6	3.7	0.6	0.8	3.4	1.3	0.6	0.7	0.9	1.0	1.2	0.9	0.7	1.4	3.8	0.0	1.1	0.0	11.4	13.3	12.0	28.0	10.8	1.8	2.7	4.2	0.3	0.0	4.9	0.0	6.2	2.5	4.2	22.1	3.9	1.3	15.2	2.5	14.4	2.5	11.4	2.5	2.2	1.4	4.0	8.5	15.8	2.3	10.2	1.0	3.6	25.4	5.2	1.7	2.0	24.3	2.0	7.9	10.9	1.5	5.0	8.0	1.8	1.9	0.7	1.2	2.1	0.0	0.4	1.8	14.4	9.8	31.5	3.3	23.9	0.7	4.0	0.9	0.0	3.8	2.8	0.9	0.7	19.6	16.3	4.9	4.2	6.3	19.9	9.6
STK11IP	"KIAA1898, LIP1, LKB1IP, STK11IP1"	ENSG00000144589	"Serine/threonine kinase 11 interacting protein"	Q8N1F8	2	219597857-219616451	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 15.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036837, HPA036838, HPA053192"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA036837: AB_10969754, HPA036838: AB_10672100, HPA053192: AB_2682075"	"unprognostic (3.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.22e-3)"	"unprognostic (8.36e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.87e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.80e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	7.6	10.0	12.0	9.5	12.4	19.5	7.1	11.3	13.8	9.2	12.6	9.8	9.2	9.2	15.0	9.6	10.4	9.5	8.0	12.4	10.6	11.2	5.9	9.3	14.0	12.0	11.9	24.5	9.5	7.5	21.5	8.2	12.3	9.9	7.8	12.3	8.1	6.5	5.8	18.4	10.0	8.3	10.0	15.1	8.6	31.2	12.0	19.5	11.1	4.3	11.1	9.0	8.3	11.8	10.1	15.4	16.1	11.0	5.6	9.9	16.5	8.7	7.6	13.9	11.7	14.3	16.7	5.8	8.7	8.4	12.6	24.4	7.7	18.7	10.3	8.7	11.7	15.1	17.2	11.6	7.4	15.9	38.2	9.6	16.5	11.7	5.9	14.2	8.6	9.7	11.4	8.5	7.9	19.7	9.3	19.6	16.2	4.8	8.4	17.5	5.9	4.5	13.8	15.8	10.6	16.8	5.7	13.8	12.0	12.9	8.8	15.3	6.5	15.0	12.6	14.5	8.6	9.4	4.5	10.8	11.4	8.7	9.5	1.5	4.3	5.3	2.6	5.8	2.1	1.7	1.2	2.1	7.7	1.2	1.0	1.0	1.4	3.7	6.5	15.1	2.1	2.6	12.0	12.4	11.3	13.8	12.4	10.6	12.0	11.9	12.3	10.0	12.0	11.8	3.5	6.4	6.7	12.4	3.9	2.3	2.1	6.3	1.2	7.8	5.1	5.5	3.6	1.5	7.8	7.3	18.8	10.0	10.3	14.6	1.9	5.0	14.0	11.9	4.0	4.6	13.1	6.9	10.7	6.5	5.6	5.3	17.3	5.8	12.7	29.7	4.2	3.3	8.4	11.8	8.0	8.8	6.1	8.6	5.7	30.9	25.4	8.9	3.6	8.4	7.0	4.9	4.1	8.5	7.4	4.2	3.3	14.7	2.8	1.7	5.4	2.7	19.9	12.6	13.1	3.2	4.9	18.5	13.8	3.5	2.7	16.1	4.5	5.4	8.8	2.8
STK17B	DRAK2	ENSG00000081320	"Serine/threonine kinase 17b"	O94768	2	196133583-196176503	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 376.2;lymphoid tissue: 113.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 229.3;dendritic cells: 267.7;granulocytes: 195.1;Langerhans cells: 201.3;Macrophages: 198.9;Plasma cells: 191.8;T-cells: 342.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 122.3;HMC-1: 118.9;Karpas-707: 111.6;U-698: 132.1"	"Region enriched"	"Detected in all"	5	"cerebellum: 63.4"	"Low region specificity"	"Detected in all"			HPA034858	Enhanced		Uncertain	"Plasma membrane,Cytosol"		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA034858: AB_10670981"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.63e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.72e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.80e-2)"	28.2	8.9	2.1	67.0	2.9	376.2	21.5	3.7	5.3	24.2	3.3	19.1	27.8	5.4	1.8	11.9	5.8	20.4	4.6	4.1	3.3	6.5	8.5	23.6	113.3	3.1	2.0	2.2	12.7	2.1	3.0	16.7	3.2	10.5	17.5	0.4	17.0	5.7	2.4	11.2	40.1	16.8	2.2	56.9	20.1	9.5	4.0	60.9	7.2	3.5	111.1	24.4	5.2	2.9	11.0	7.5	11.2	4.2	47.7	18.1	12.4	25.7	38.4	27.7	28.5	22.8	3.9	122.3	23.1	14.8	7.3	7.4	4.7	11.1	33.4	21.8	12.7	11.6	9.1	2.2	14.2	47.0	118.9	23.1	10.9	34.3	17.7	39.2	11.5	28.5	9.1	111.6	69.4	5.9	61.6	106.0	6.3	19.9	17.2	10.1	67.5	37.4	16.3	25.6	4.2	4.2	6.6	6.4	5.4	17.2	4.3	24.3	14.0	26.8	13.1	19.3	14.7	45.5	78.9	132.1	20.2	15.9	12.1	165.1	74.3	163.1	43.7	81.3	55.4	49.2	77.0	52.8	53.0	58.6	98.6	82.4	236.7	40.8	113.1	37.7	73.8	89.3	2.1	2.9	3.7	5.3	4.1	3.3	3.1	2.0	3.2	2.2	4.0	2.9	23.3	89.8	74.0	48.3	229.3	59.9	27.1	15.1	10.8	0.9	28.9	15.2	2.6	12.8	42.5	11.0	0.0	7.9	267.7	54.0	3.9	6.6	6.8	15.3	14.1	11.3	3.0	68.8	3.4	2.8	24.0	27.2	38.2	26.5	195.1	47.4	5.3	2.4	26.1	0.0	3.1	13.9	18.3	151.1	201.3	3.6	5.6	198.9	58.7	11.2	158.0	0.6	118.4	17.6	0.7	10.9	41.6	4.5	191.8	34.3	80.7	2.5	26.9	0.3	6.6	49.7	19.7	41.1	26.3	16.4	63.4	5.1	342.5	22.6	13.2	53.8
STX3	STX3A	ENSG00000166900	"Syntaxin 3"	Q13277	11	59713456-59805882	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"retina: 313.2"	"Cell type enhanced"	"Detected in all"		"Bipolar cells: 373.0;Cone photoreceptor cells: 394.0;Rod photoreceptor cells: 400.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 42.5;eosinophil: 74.1;neutrophil: 60.7"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 74.1"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 167.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002191, HPA069176"	Approved		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles	"Nuclear membrane"	"HPA002191: AB_1080165, HPA069176: AB_2686098"	"unprognostic (2.24e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.36e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (1.64e-1)"	"unprognostic (3.00e-1)"	"unprognostic (7.71e-3)"	"unprognostic (2.07e-2)"	"unprognostic (5.55e-2)"	"prognostic favorable (1.14e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.17e-2)"	16.4	24.1	10.1	23.7	11.8	59.2	20.1	18.3	14.6	21.1	11.8	51.0	59.5	29.7	36.7	21.4	15.1	39.1	16.4	10.8	11.2	58.6	15.4	40.7	9.7	11.7	11.9	18.7	24.0	34.1	19.4	50.3	13.4	20.2	56.3	313.2	21.6	24.6	10.9	26.2	44.1	26.4	9.7	23.4	47.5	22.1	12.4	7.4	27.8	17.9	13.8	28.3	18.3	13.1	40.1	23.8	0.9	11.0	20.5	11.5	33.1	21.1	37.7	49.4	61.0	109.4	38.2	11.2	38.9	16.1	85.6	44.0	63.5	22.0	59.4	9.6	12.0	12.7	16.4	34.0	51.1	41.7	116.4	21.0	46.6	38.3	46.2	30.5	39.7	16.6	110.5	23.0	21.5	23.8	0.4	28.9	60.1	63.1	18.2	14.5	40.8	18.6	92.7	94.5	27.0	41.4	9.0	48.0	167.2	79.9	52.1	29.0	54.0	20.8	44.0	28.6	19.3	25.8	49.4	22.8	27.8	27.0	29.0	42.5	6.3	74.1	2.4	1.9	2.5	1.0	3.3	1.6	7.1	3.1	3.0	0.9	60.7	0.5	1.2	1.0	0.0	2.7	10.1	11.8	18.3	14.6	10.8	11.2	11.7	11.9	13.4	9.7	12.4	13.1	17.0	67.3	30.6	2.6	9.5	50.7	69.5	12.8	30.1	373.0	43.5	15.2	10.2	31.5	18.9	11.0	394.0	10.1	5.9	124.6	17.6	40.2	4.8	37.8	9.6	30.2	26.3	4.4	40.4	25.6	15.9	12.8	29.6	68.5	58.2	14.9	20.7	5.6	16.0	72.3	33.0	36.5	18.3	18.9	49.7	7.5	3.7	26.4	37.4	24.4	28.7	48.4	11.3	3.5	25.3	48.9	64.1	7.5	5.8	87.2	34.0	69.5	13.3	400.3	6.6	10.0	15.9	4.6	20.6	29.4	60.1	40.5	17.9	5.6	26.5	87.7
STXBP5	"LLGL3, tomosyn"	ENSG00000164506	"Syntaxin binding protein 5"	Q5T5C0	6	147204425-147390476	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 115.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 325.8;Excitatory neurons: 441.9;Inhibitory neurons: 300.1;Oligodendrocyte precursor cells: 206.1;Oligodendrocytes: 150.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 3.8;eosinophil: 9.2;neutrophil: 3.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 9.2"	"Cell line enhanced"	"Detected in many"		"HEL: 210.2;HMC-1: 219.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039991, HPA049727, CAB079016"	Enhanced	Supported	Enhanced	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB079016: , HPA039991: AB_10673368, HPA049727: AB_2680863"	"prognostic unfavorable (4.48e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.28e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.56e-4)"	"unprognostic (6.01e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavorable (2.74e-7)"	"unprognostic (8.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.35e-3)"	7.0	9.1	7.2	9.5	12.7	34.3	7.8	24.2	13.2	9.5	0.0	14.2	8.0	8.3	7.7	13.7	5.9	9.5	5.9	9.5	6.5	3.6	3.9	6.6	7.8	0.6	0.5	5.5	15.5	115.8	7.7	6.3	0.5	11.4	16.3	20.1	5.5	14.5	7.7	15.4	11.2	10.9	0.0	8.3	8.0	22.2	0.6	9.4	6.3	8.1	9.6	8.5	9.9	8.5	10.8	9.4	4.9	16.5	23.4	48.8	5.4	24.5	36.1	17.8	19.9	8.0	7.0	7.8	5.6	48.8	30.5	12.7	14.1	21.5	21.6	17.1	11.0	210.2	27.2	9.0	26.8	72.7	219.6	35.6	15.0	35.6	72.0	42.1	23.2	12.2	57.8	9.6	35.4	15.7	11.6	18.8	4.0	8.9	21.4	1.7	25.4	3.0	9.7	18.4	10.6	7.6	18.9	13.3	8.2	8.7	3.9	28.0	26.9	25.4	9.2	12.6	22.5	7.9	0.1	9.1	14.0	26.2	18.5	3.8	0.3	9.2	0.9	0.4	0.9	0.3	0.5	1.1	0.4	0.9	0.8	1.3	3.1	0.4	0.5	0.3	0.2	0.3	7.2	12.7	24.2	13.2	9.5	6.5	0.6	0.5	0.5	0.0	0.6	8.5	12.1	16.0	8.8	325.8	5.7	3.6	2.6	1.9	3.4	38.8	6.7	7.7	14.1	11.5	6.7	16.5	31.3	5.2	9.5	18.7	0.0	4.8	39.0	10.1	10.5	10.8	41.1	10.1	441.9	12.9	4.6	10.1	14.3	20.5	44.2	5.1	8.9	4.5	4.7	33.7	300.1	30.3	0.0	7.8	3.1	42.8	7.8	7.8	10.6	97.4	8.5	5.4	6.2	206.1	150.4	11.7	21.4	7.2	5.8	10.4	29.3	1.9	2.2	29.0	13.1	12.7	5.6	13.1	11.5	11.0	6.7	3.8	9.3	5.4	19.3	3.6
SUN2	UNC84B	ENSG00000100242	"Sad1 and UNC84 domain containing 2"	Q9UH99	22	38734725-38794143	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 201.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001209	Supported		Supported	"Nuclear membrane"		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear membrane"		"HPA001209: AB_1080465"	"unprognostic (9.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.15e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.33e-2)"	137.8	35.1	123.6	73.6	219.0	160.4	111.7	149.1	155.3	95.4	41.4	107.8	47.6	128.2	22.2	84.0	125.3	41.1	86.7	118.3	133.1	52.8	121.9	107.0	104.0	187.1	182.2	112.9	78.0	18.2	40.3	28.7	170.7	78.2	25.2	12.3	74.9	52.1	145.4	90.3	93.1	46.1	107.2	97.2	94.3	34.6	163.3	74.3	53.1	63.8	60.0	121.7	89.0	257.7	89.8	41.0	40.0	44.7	118.8	29.5	52.0	60.2	69.4	69.7	58.9	36.8	98.7	28.1	71.9	85.9	43.1	65.4	13.4	44.7	28.4	98.0	54.7	18.4	44.7	33.7	71.9	62.3	184.0	25.0	37.3	33.6	31.2	46.9	56.2	55.3	23.5	154.3	38.5	28.7	35.0	53.9	3.9	63.0	26.2	57.6	55.8	85.7	17.4	43.1	35.3	13.2	67.0	73.7	35.1	18.5	49.5	115.3	95.2	50.6	43.3	44.9	79.5	113.1	38.2	30.4	93.8	74.2	86.6	29.0	13.7	18.6	42.3	15.6	27.5	10.8	27.0	34.9	10.7	10.1	27.6	33.6	13.9	24.8	26.9	6.7	19.9	24.8	123.6	219.0	149.1	155.3	118.3	133.1	187.1	182.2	170.7	107.2	163.3	257.7	55.5	22.4	22.9	20.2	57.0	18.1	28.4	15.1	24.5	9.9	36.5	39.0	6.2	40.0	17.8	33.1	8.4	16.9	141.8	65.6	3.9	34.9	1.8	11.6	15.8	37.4	18.6	31.8	12.5	47.6	65.9	34.0	42.8	32.9	25.4	41.5	52.1	109.6	25.0	21.9	7.7	30.1	8.2	42.4	21.4	4.4	61.2	41.8	17.8	16.9	25.5	21.4	201.8	7.1	132.9	60.0	41.8	65.5	44.7	22.0	42.2	18.9	5.7	13.0	52.6	100.7	37.0	3.8	1.1	32.1	17.2	14.8	133.4	10.9	21.4	21.4
SUSD6	KIAA0247	ENSG00000100647	"Sushi domain containing 6"	Q92537	14	69611596-69715144	"Predicted membrane proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030464	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Intermediate filaments"	"HPA030464: AB_10601128"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.10e-2)"	"unprognostic (6.70e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.10e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.34e-1)"	25.3	19.3	12.0	32.9	12.4	67.2	22.2	26.7	11.6	16.2	13.1	20.9	25.4	13.0	43.1	31.8	21.0	27.5	15.6	13.5	12.8	22.2	12.2	37.1	30.4	24.5	14.5	13.5	22.1	16.6	14.4	17.0	15.3	17.8	19.0	15.6	29.7	16.7	12.3	27.3	32.8	19.7	18.2	33.6	20.9	10.7	14.2	21.7	22.4	11.5	36.2	21.7	18.1	15.5	19.4	4.9	7.0	6.4	14.0	10.2	12.8	10.7	22.6	6.0	5.8	5.9	16.7	22.6	11.8	13.5	4.8	26.4	4.0	22.1	5.6	38.9	3.0	18.4	4.1	9.8	22.6	3.0	45.6	16.6	21.5	10.1	18.7	6.5	12.4	6.9	5.7	19.6	8.4	9.5	4.5	8.1	1.4	11.3	5.0	7.7	6.2	9.1	11.5	9.8	3.0	4.7	8.8	25.4	4.0	5.1	10.4	8.3	19.4	13.8	8.1	8.8	4.4	13.5	3.2	15.7	8.9	10.3	7.4	16.3	11.6	12.3	5.5	10.2	5.5	5.3	4.8	3.4	7.6	5.0	4.6	3.4	33.0	4.1	13.7	4.3	4.6	8.8	12.0	12.4	26.7	11.6	13.5	12.8	24.5	14.5	15.3	18.2	14.2	15.5	45.6	12.8	30.0	22.2	24.6	0.0	36.0	0.0	23.3	16.7	44.2	21.5	14.0	21.5	11.2	18.4	20.9	4.3	32.9	44.3	7.9	26.7	1.0	34.7	13.3	32.8	7.3	13.9	34.6	24.6	1.7	13.1	18.8	28.4	8.8	9.7	17.9	15.9	23.5	15.2	21.1	21.9	0.0	67.4	0.0	5.1	5.3	44.3	0.0	107.7	31.6	4.3	16.5	22.1	28.4	38.7	20.4	6.8	15.1	43.0	74.1	15.2	10.9	23.7	26.3	18.3	19.0	8.4	15.4	19.7	0.0	9.2	21.2	7.6	8.5	54.6
SVOPL	MGC46715	ENSG00000157703	"SVOP like"	Q8N434	7	138594285-138701362	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 4.1;salivary gland: 4.0"	"Cell type enriched"	"Detected in some"	8	"granulocytes: 76.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	14	"eosinophil: 2.1"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 8.8;MOLT-4: 2.0;NTERA-2: 1.9;RT4: 2.0;T-47d: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018035	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"HPA018035: AB_2197028"	"unprognostic (6.70e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.59e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.03e-3)"	"unprognostic (2.22e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.51e-2)"	0.0	2.0	0.6	0.1	0.5	0.2	0.9	0.2	0.4	0.5	2.5	0.9	0.1	0.2	0.8	0.1	1.8	0.0	0.2	0.5	0.6	2.7	0.0	0.2	0.1	0.8	0.8	0.5	0.5	4.1	0.9	0.6	0.5	0.4	0.3	3.2	4.0	0.8	0.0	0.3	0.2	0.0	0.6	0.1	0.1	0.9	0.7	0.5	0.7	0.0	0.0	0.4	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.6	0.2	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	2.0	1.1	1.9	0.0	0.0	0.5	0.0	0.1	0.0	2.0	0.1	0.6	0.0	0.4	0.0	0.3	5.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.2	0.4	0.5	0.6	0.8	0.8	0.5	0.6	0.7	0.7	0.0	0.0	1.9	0.7	0.0	0.1	1.9	2.0	0.0	0.6	1.2	1.4	2.1	0.0	3.1	1.8	0.0	3.7	0.4	0.4	0.0	0.0	0.7	8.2	0.1	0.1	0.0	5.5	1.1	0.0	0.8	0.3	0.0	0.9	76.0	1.2	0.0	0.1	0.1	0.0	1.8	0.1	4.1	0.0	0.2	0.5	0.6	0.1	0.0	0.0	0.1	0.5	0.0	1.0	1.5	0.1	0.0	0.4	0.1	0.2	0.1	0.0	5.6	8.6	0.0	0.0	0.3	2.2	0.7	0.0	0.1	1.9	0.7	0.3	0.5	0.5
SYCP2L	"C6orf177, dJ62D2.1, NO145"	ENSG00000153157	"Synaptonemal complex protein 2 like"	Q5T4T6	6	10886831-10979320	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"parathyroid gland: 68.7"	"Group enriched"	"Detected in many"	4	"Astrocytes: 21.5;dendritic cells: 9.5;Early spermatids: 17.1;Excitatory neurons: 28.5;granulocytes: 10.8;Inhibitory neurons: 23.1;Microglial cells: 13.1;Oligodendrocyte precursor cells: 14.1;Oligodendrocytes: 12.4;Spermatogonia: 8.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.4"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"basophil: 1.7;eosinophil: 3.4;plasmacytoid DC: 4.2"	"Group enriched"	"Detected in many"	17	"dendritic cells: 4.2;granulocytes: 3.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 13.4;HMC-1: 38.7;K-562: 10.7;NB-4: 15.3;SuSa: 8.1;THP-1: 11.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA034679			Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA034679: AB_10669729"	"unprognostic (3.25e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.72e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.57e-3)"	"unprognostic (4.23e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.74e-2)"	0.6	0.3	0.6	0.6	0.9	0.7	0.5	0.8	1.4	0.5	0.0	0.3	0.1	0.4	2.6	0.2	0.4	0.5	1.2	0.8	0.2	1.1	0.1	1.7	0.5	0.2	0.1	0.8	1.7	68.7	0.4	1.1	0.2	0.6	0.2	0.7	0.3	0.2	0.2	0.5	0.3	0.2	0.0	0.6	0.3	3.2	0.3	0.1	1.2	0.9	0.3	0.3	0.3	1.2	0.0	1.0	1.9	0.1	0.1	0.0	5.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.5	0.2	0.2	0.1	6.4	0.0	0.0	0.0	0.0	13.4	38.7	0.0	1.0	0.0	0.0	0.3	0.0	0.4	10.7	0.1	0.0	0.1	3.4	15.3	0.7	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.7	3.5	0.0	3.5	0.0	8.1	0.1	11.4	0.0	0.0	0.7	0.0	0.2	0.3	0.0	0.1	0.1	0.1	1.1	1.7	0.0	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.6	0.9	0.8	1.4	0.8	0.2	0.2	0.1	0.2	0.0	0.3	1.2	1.1	0.0	1.3	21.5	0.3	0.1	0.0	0.2	0.0	2.1	0.3	0.0	0.4	0.0	0.1	0.0	0.0	2.9	9.5	0.0	0.0	0.2	17.1	0.1	0.4	1.4	0.0	2.1	28.5	0.2	2.0	2.9	0.0	0.4	10.8	1.5	0.0	0.0	0.5	3.3	23.1	0.0	0.0	0.0	0.5	3.2	1.2	1.0	0.0	13.1	1.0	0.6	0.0	14.1	12.4	0.6	0.0	1.5	0.0	0.5	0.0	0.0	0.7	0.1	0.0	0.6	0.3	3.1	8.7	0.0	0.0	1.4	0.6	0.1	0.0	0.1
SYK		ENSG00000165025	"Spleen associated tyrosine kinase"	P43405	9	90801787-90898549	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 73.8;parathyroid gland: 87.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 91.3;Hofbauer cells: 73.1;Kupffer cells: 96.7;Macrophages: 95.2;Microglial cells: 114.3;monocytes: 92.5;Plasma cells: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"classical monocyte: 77.3;eosinophil: 83.5;intermediate monocyte: 64.0;memory B-cell: 74.5;myeloid DC: 85.1;naive B-cell: 58.4;neutrophil: 112.1;NK-cell: 30.0;non-classical monocyte: 60.2;plasmacytoid DC: 63.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 125.8;HEL: 72.8;HL-60: 101.6;HMC-1: 64.1;REH: 84.4;THP-1: 76.8;U-698: 58.8;U-937: 70.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001384, CAB007773"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		No	NA		290000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"	Vesicles	"CAB007773: AB_562232, HPA001384: AB_1080144"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.20e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.77e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.06e-2)"	7.4	4.6	4.1	42.5	4.1	50.9	6.8	4.5	4.9	7.7	4.2	20.1	30.8	4.1	16.1	17.5	17.0	12.9	2.9	3.8	5.0	11.2	4.5	20.6	61.8	7.1	5.8	1.7	9.1	87.6	2.4	12.0	7.0	3.8	20.5	0.7	8.4	4.2	1.0	9.9	36.3	9.3	6.6	40.3	19.1	6.9	7.1	49.7	25.6	2.4	73.8	17.5	8.3	9.8	22.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	14.3	125.8	3.5	0.0	4.2	19.1	2.7	10.2	0.0	0.0	17.0	72.8	0.0	0.0	0.0	101.6	64.1	0.0	14.0	0.0	1.4	0.0	0.0	15.5	2.0	9.9	0.0	15.4	0.1	44.4	0.7	47.0	0.0	84.4	0.1	34.6	2.6	18.6	6.4	5.7	0.1	8.7	0.1	0.3	7.9	76.8	0.2	0.0	0.4	0.1	0.1	0.2	0.0	58.8	0.0	70.3	0.0	5.3	77.3	83.5	0.3	64.0	0.3	74.5	0.2	0.2	85.1	58.4	0.2	0.1	112.1	30.0	60.2	63.2	0.1	44.6	4.1	4.1	4.5	4.9	3.8	5.0	7.1	5.8	7.0	6.6	7.1	9.8	0.5	12.8	20.2	0.0	91.3	3.4	3.7	8.7	12.0	1.4	6.3	2.8	1.6	14.3	12.8	14.7	0.0	1.3	70.4	16.5	15.6	15.0	7.1	10.7	1.0	2.1	10.3	37.9	0.4	12.5	2.6	2.1	22.4	12.6	43.6	0.0	3.3	1.0	73.1	0.0	0.7	24.4	0.0	96.7	28.8	6.2	0.6	95.2	12.4	114.3	92.5	0.0	62.8	1.5	0.5	18.2	25.1	0.0	83.1	2.5	31.4	0.4	10.4	0.2	6.6	0.7	2.3	0.8	0.7	30.4	5.7	1.4	8.3	0.0	31.1	8.0
SYTL4		ENSG00000102362	"Synaptotagmin like 4"	Q96C24	X	100674491-100732123	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 68.3"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 58.1;Leydig cells: 72.7;Sertoli cells: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 29.5;HMC-1: 60.0;RT4: 40.8;TIME: 34.9"	"Region enriched"	"Detected in many"	5	"hypothalamus: 30.1"	"Low region specificity"	"Detected in all"			"HPA001475, HPA001589, HPA075138"	Approved		Approved	Vesicles		NA	Yes		3300000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA001475: AB_1080172, HPA001589: AB_1080174, HPA075138: "	"unprognostic (7.82e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.60e-2)"	6.9	4.1	6.9	2.2	13.2	2.3	6.0	4.5	5.1	21.7	14.1	9.8	2.1	43.1	3.1	3.9	17.8	4.0	3.2	5.2	13.1	5.6	10.5	4.7	0.7	8.4	9.3	68.3	8.3	1.2	18.8	3.6	7.4	12.7	9.7	1.3	6.1	7.2	2.3	2.0	4.9	32.7	6.1	3.3	7.4	6.8	18.0	0.6	8.8	4.9	1.7	6.1	10.2	7.9	0.3	6.0	1.6	0.0	8.5	4.8	0.1	7.7	4.9	8.0	14.3	0.7	7.6	0.0	2.0	5.4	6.9	6.8	29.5	2.3	8.4	0.0	2.6	0.1	10.8	0.4	2.1	0.0	60.0	1.7	0.5	7.3	0.4	3.1	20.5	0.0	3.0	0.0	3.8	2.0	0.1	0.0	1.2	21.2	0.0	0.0	2.4	0.0	7.0	40.8	14.5	0.6	3.1	11.5	1.7	3.0	7.1	0.6	34.9	4.2	8.8	20.9	1.9	0.1	0.0	0.1	5.2	0.0	4.8	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.1	0.0	0.0	0.0	0.8	6.9	13.2	4.5	5.1	5.2	13.1	8.4	9.3	7.4	6.1	18.0	7.9	15.6	28.9	1.7	41.8	0.5	0.1	7.7	3.1	1.2	0.2	19.0	6.6	3.8	18.6	8.0	3.7	0.0	0.4	0.7	29.1	3.9	8.9	1.6	4.3	25.8	13.5	0.0	5.0	0.5	2.3	0.4	20.0	26.5	6.2	3.8	58.1	11.4	38.6	1.3	0.0	1.0	26.9	8.2	1.6	1.9	3.8	72.7	7.2	3.6	8.4	0.5	5.4	0.0	10.6	0.2	7.2	27.1	41.8	0.5	11.9	5.8	2.6	8.1	0.6	52.6	38.1	11.8	2.6	4.4	2.6	0.9	0.0	0.9	18.0	9.6	13.8
TAGAP	"ARHGAP47, FLJ32631, IDDM21"	ENSG00000164691	"T cell activation RhoGTPase activating protein"	Q8N103	6	159034468-159045152	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 146.6;lymphoid tissue: 47.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 249.5;dendritic cells: 152.3;Macrophages: 91.1;NK-cells: 86.5;Plasma cells: 272.1;T-cells: 223.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 30.1;HMC-1: 42.5;Karpas-707: 43.8;U-266/84: 20.6;U-698: 39.6;U-937: 33.4"					"Low region specificity"	"Detected in all"			"HPA031000, HPA039982"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA031000: AB_10610560, HPA039982: "	"unprognostic (9.86e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.35e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.24e-2)"	"unprognostic (7.39e-2)"	5.0	2.8	1.0	28.9	1.1	146.6	3.9	1.3	2.1	3.4	3.0	5.9	4.4	9.5	2.3	4.1	2.0	6.9	1.6	1.2	3.4	1.3	4.1	8.4	39.6	2.7	2.0	2.2	0.9	0.7	0.8	3.4	2.1	2.8	8.2	1.5	3.0	1.8	0.7	1.2	10.2	26.0	2.2	22.8	7.2	1.6	2.2	24.3	1.6	2.3	47.6	10.0	1.2	4.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	30.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	6.2	0.0	0.0	0.0	15.6	42.5	0.3	0.0	0.0	0.0	0.0	0.0	9.0	0.1	43.8	0.0	0.0	4.0	8.2	12.0	0.0	0.0	1.4	0.0	1.4	0.0	0.0	0.3	0.2	0.0	0.1	0.1	1.2	0.0	6.9	0.2	0.0	0.0	0.0	0.0	4.7	20.6	39.6	0.0	33.4	0.0	163.6	27.8	88.4	54.8	20.4	62.6	45.9	73.9	64.6	27.9	46.6	56.9	40.8	169.7	45.6	27.6	9.3	57.5	60.9	1.0	1.1	1.3	2.1	1.2	3.4	2.7	2.0	2.1	2.2	2.2	4.2	5.2	3.2	6.6	0.0	249.5	2.8	0.3	0.2	3.4	0.3	4.4	6.0	0.6	0.0	1.4	0.0	0.0	0.7	152.3	0.2	0.0	0.1	0.3	0.5	0.4	5.2	0.0	8.8	1.2	0.0	0.6	4.3	16.8	0.5	19.0	1.8	1.4	0.8	24.9	0.0	1.0	0.0	0.0	21.9	60.2	1.1	1.2	91.1	28.4	20.6	21.5	0.4	86.5	1.5	0.0	0.0	0.0	22.6	272.1	0.3	0.0	0.3	1.2	0.2	0.0	0.8	2.0	0.1	0.1	2.0	2.7	0.8	223.6	4.6	0.4	0.3
TAOK3	"DPK, JIK, MAP3K18"	ENSG00000135090	"TAO kinase 3"	Q9H2K8	12	118149801-118372907	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 400.6;Rod photoreceptor cells: 323.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 123.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017160	Approved		Uncertain	Mitochondria		NA	NA		520000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA017160: AB_1851994"	"unprognostic (3.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.80e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.38e-2)"	"unprognostic (2.76e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.14e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.44e-1)"	15.4	18.2	33.9	24.9	35.7	41.9	17.1	36.8	38.5	12.7	27.9	23.8	27.1	16.8	12.7	18.2	10.5	19.5	18.5	33.0	38.1	16.2	18.4	23.2	33.8	34.2	35.3	19.3	11.7	15.5	18.7	14.3	33.5	29.0	24.6	48.3	15.2	16.0	21.8	20.3	28.8	17.7	33.6	26.0	25.2	10.7	41.2	31.6	21.1	13.0	33.0	20.6	13.3	42.6	25.7	17.2	12.7	11.1	30.6	37.0	14.5	26.2	29.8	14.9	19.3	8.9	38.5	77.4	8.4	34.9	21.5	22.5	11.2	23.5	23.3	28.3	9.2	91.7	9.0	11.7	35.6	95.2	123.5	25.3	27.7	46.9	68.4	31.3	48.3	45.5	54.3	9.0	27.8	18.2	50.0	62.0	4.7	11.7	9.2	29.1	17.2	8.3	14.1	43.8	2.3	12.5	24.1	10.9	33.6	5.5	22.0	70.0	75.9	25.5	4.5	24.2	22.6	8.7	8.9	60.6	35.8	64.1	35.2	122.3	39.4	91.5	60.9	53.8	58.1	47.9	46.0	53.4	52.4	44.9	40.3	52.9	86.2	86.9	95.4	48.8	46.6	46.0	33.9	35.7	36.8	38.5	33.0	38.1	34.2	35.3	33.5	33.6	41.2	42.6	43.2	35.3	98.9	203.4	110.7	35.2	46.7	30.4	38.1	69.9	52.3	39.6	57.6	52.9	36.7	46.0	212.7	36.1	138.5	116.3	70.5	40.3	18.6	17.5	30.6	36.2	25.1	65.2	117.0	59.1	93.5	37.8	75.4	39.2	167.6	31.6	29.6	57.7	78.5	40.4	156.2	80.7	22.4	104.3	103.0	10.3	38.8	160.5	35.6	133.0	156.9	48.4	217.3	400.6	202.2	91.0	111.7	47.8	84.9	44.4	105.2	37.4	20.7	323.8	46.0	29.9	55.2	101.4	53.3	48.3	31.4	43.8	103.5	66.4	69.3	53.7
TBC1D14	KIAA1322	ENSG00000132405	"TBC1 domain family member 14"	Q9P2M4	4	6909242-7033118	"Plasma proteins, Predicted intracellular proteins"	Autophagy	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 197.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036930, HPA067398"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA036930: AB_10670155, HPA067398: AB_2685833"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (5.28e-10)"	"unprognostic (1.56e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.13e-3)"	"unprognostic (4.12e-2)"	26.3	42.1	42.7	31.5	41.9	15.9	27.6	38.7	43.9	19.4	50.2	26.4	22.8	20.9	22.9	34.0	23.5	17.0	30.4	42.9	44.9	44.5	27.4	24.4	29.8	49.3	45.6	28.7	19.5	41.9	27.1	23.8	44.8	24.5	26.3	18.5	31.7	20.2	51.6	49.5	26.0	22.9	45.7	34.9	58.5	30.0	48.7	40.1	19.2	41.3	26.9	19.8	22.2	44.2	34.5	36.8	40.4	45.5	32.8	27.4	24.5	27.0	29.3	24.7	21.1	38.3	69.8	54.9	15.6	32.5	62.8	24.5	68.4	61.7	30.0	15.5	22.2	91.8	23.8	40.4	22.7	42.0	197.9	21.3	85.8	23.4	38.3	31.5	23.5	51.2	88.6	19.3	30.2	22.3	64.9	42.5	54.9	41.1	40.8	80.2	53.2	59.9	36.8	23.9	61.6	44.0	22.4	24.1	84.3	31.2	33.3	39.4	23.7	27.2	20.5	24.0	40.3	36.7	91.6	55.7	25.4	53.2	26.6	2.6	13.2	5.6	8.6	8.2	13.1	8.1	9.3	9.3	10.7	8.3	6.9	6.6	40.6	8.6	3.9	11.5	11.9	10.8	42.7	41.9	38.7	43.9	42.9	44.9	49.3	45.6	44.8	45.7	48.7	44.2	8.4	6.4	17.7	22.5	15.5	9.1	7.0	15.8	15.9	10.2	21.1	16.3	4.6	10.0	14.8	14.7	14.6	12.5	16.3	17.7	19.6	11.5	68.0	12.3	10.3	7.8	6.6	7.2	25.6	10.2	7.1	9.5	14.8	11.9	7.6	18.9	8.2	24.4	26.0	25.2	25.1	15.7	10.2	33.6	8.7	41.0	7.2	27.8	19.6	27.2	24.4	13.4	16.5	51.8	27.0	11.8	14.2	8.6	15.4	12.9	12.8	19.8	10.7	6.6	0.0	12.7	7.1	17.7	18.0	19.8	11.9	16.4	16.3	12.5	19.9	10.1
TBL1X	"EBI, TBL1"	ENSG00000101849	"Transducin beta like 1 X-linked"	O60907	X	9463295-9741037	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator	"Congenital hypothyroidism, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 103.8;Oligodendrocytes: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 18.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"CAB005363, HPA067703"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	Nucleoli	"CAB005363: AB_2240272, HPA067703: AB_2685892"	"prognostic unfavorable (8.50e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.66e-1)"	"prognostic favorable (4.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.53e-1)"	9.3	9.1	20.0	8.7	21.3	7.2	9.7	17.4	16.7	18.1	14.2	9.4	2.8	38.4	35.3	10.2	16.6	7.1	7.3	16.7	21.1	16.6	13.6	5.8	9.0	23.8	20.2	18.0	9.2	23.9	18.7	20.7	19.7	25.4	5.3	16.5	7.3	43.2	4.6	7.5	5.0	26.6	18.6	8.4	8.1	9.7	26.7	18.4	12.0	5.2	10.2	13.5	12.7	20.0	0.1	29.6	18.5	49.2	16.8	17.4	18.4	11.3	25.0	21.3	22.2	22.4	20.2	31.6	0.8	22.7	9.1	6.7	40.7	8.9	30.9	13.0	19.6	20.0	35.6	26.5	23.7	7.2	68.6	15.6	10.1	22.3	11.8	11.7	19.9	17.2	35.8	53.5	12.5	25.6	17.8	27.2	36.7	14.2	31.5	39.3	14.5	39.3	28.9	16.9	23.4	10.6	27.2	6.8	16.9	48.2	13.3	15.6	29.1	7.5	18.3	0.8	4.6	32.6	27.8	25.1	27.2	17.4	7.1	6.3	4.7	5.7	2.2	2.9	1.8	2.2	1.7	2.0	3.5	3.6	3.1	2.9	18.7	0.3	2.0	0.3	2.9	2.1	20.0	21.3	17.4	16.7	16.7	21.1	23.8	20.2	19.7	18.6	26.7	20.0	12.6	0.0	4.5	103.8	17.3	6.5	13.2	3.8	9.1	11.8	19.1	18.0	10.1	20.0	6.8	31.3	22.9	78.1	20.4	7.9	13.7	10.7	1.0	34.4	80.7	10.3	22.8	3.8	12.5	7.8	6.0	13.1	9.7	51.1	11.4	32.5	11.4	64.3	11.3	6.7	17.1	5.4	2.0	33.0	22.8	3.2	14.3	19.7	5.4	61.8	37.5	46.6	19.6	46.3	109.7	7.5	7.9	28.6	9.5	24.1	0.2	21.8	10.0	24.5	0.0	9.4	27.9	1.4	18.0	16.5	12.4	45.0	18.8	22.3	4.9	23.7
TBRG1	"FLJ14621, NIAM, TB-5"	ENSG00000154144	"Transforming growth factor beta regulator 1"	Q3YBR2	11	124622836-124635926	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 21.6;HMC-1: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055645, HPA068022"			Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA055645: AB_2682873, HPA068022: AB_2685942"	"unprognostic (1.64e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.21e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.83e-1)"	"unprognostic (7.13e-3)"	5.5	7.2	6.4	5.5	9.5	4.0	4.3	5.3	9.8	3.8	5.9	5.9	6.2	3.9	4.0	5.0	4.1	3.1	4.3	6.9	6.6	6.2	8.1	6.0	6.4	5.6	5.2	2.7	8.1	2.3	4.1	3.8	5.3	5.1	5.4	1.8	5.6	3.0	10.1	5.1	8.4	2.5	5.1	8.3	6.8	3.4	6.0	3.9	5.7	3.9	6.1	4.3	4.0	7.2	3.7	3.1	2.7	1.5	4.6	3.1	2.7	3.7	2.5	2.0	1.8	6.0	2.7	4.4	4.5	3.7	4.0	4.5	3.5	4.8	3.8	4.5	2.7	21.6	1.8	3.9	3.2	6.7	20.9	3.2	8.1	3.7	2.8	2.3	3.6	3.6	7.4	4.8	5.1	1.7	3.0	6.6	2.9	8.6	2.1	2.7	3.6	3.2	3.3	3.6	2.2	2.3	2.1	3.5	2.5	2.5	5.6	3.3	5.5	4.5	1.8	1.5	3.2	3.8	6.2	5.1	2.5	7.8	3.2	30.5	24.3	35.1	25.6	22.9	19.1	34.0	25.9	22.1	14.8	30.6	27.4	22.1	33.1	14.6	21.7	23.9	27.5	13.1	6.4	9.5	5.3	9.8	6.9	6.6	5.6	5.2	5.3	5.1	6.0	7.2	37.9	44.8	56.5	37.9	67.2	46.1	52.0	37.5	67.2	19.2	34.8	30.6	24.0	40.0	39.5	23.9	12.5	32.9	58.0	46.4	52.8	38.8	61.3	25.1	31.1	42.7	28.3	43.3	113.8	47.4	28.8	45.9	39.3	25.9	72.1	23.6	31.8	69.7	36.2	30.3	53.6	46.7	30.5	45.8	66.8	11.5	37.9	55.9	33.8	41.2	53.6	33.5	64.9	33.7	50.1	58.5	43.2	33.4	62.1	88.7	61.9	90.4	33.9	19.5	26.3	39.3	83.3	52.0	24.7	42.5	48.2	48.3	65.7	27.7	33.4	68.6
TCF15	"bHLHa40, EC2, PARAXIS"	ENSG00000125878	"Transcription factor 15"	Q12870	20	603797-610398	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 27.8;skeletal muscle: 13.2;tongue: 9.1"	"Cell type enriched"	"Detected in some"	6	"Adipocytes: 260.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 10.6;HMC-1: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA050998, HPA060221"	Approved		Supported	"Nuclear speckles"		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles"		"HPA050998: AB_2681302, HPA060221: AB_2684225"	"unprognostic (2.12e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.52e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.21e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.11e-1)"	"unprognostic (6.99e-2)"	7.0	0.6	1.3	0.1	1.2	0.0	4.6	1.2	1.4	0.2	0.9	1.6	0.1	0.8	0.0	0.3	0.4	0.1	27.8	1.1	1.2	1.5	0.2	0.6	0.1	1.3	1.3	0.2	0.3	0.1	0.4	3.3	1.4	0.3	0.0	0.0	0.6	0.0	13.2	0.2	0.5	0.2	1.3	0.0	0.6	2.0	1.3	0.0	0.5	9.1	0.0	0.9	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.9	10.6	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	1.5	0.0	1.3	0.0	3.0	0.0	1.4	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	1.2	1.4	1.1	1.2	1.3	1.3	1.4	1.3	1.3	1.2	260.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.6	0.5	0.6	1.0	15.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.7	0.2	0.2	41.2	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.6	0.0	0.1	7.1	0.0	0.1	1.7	0.5	0.0	0.0	0.0	0.4	0.2	0.0	0.5	0.0	2.8	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	13.1	3.7	23.3	2.3	0.6	0.0	0.0	0.0	0.2	0.5	0.0	0.0
TDRD9	"C14orf75, DKFZp434N0820, FLJ36164, NET54"	ENSG00000156414	"Tudor domain containing 9"	Q8NDG6	14	103928456-104052667	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"parathyroid gland: 30.6;testis: 40.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 43.2;Spermatocytes: 63.2;Spermatogonia: 38.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"classical monocyte: 1.6"	"Lineage enriched"	"Detected in single"	6	"monocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 24.4;HeLa: 21.5;HMC-1: 94.2;RPTEC TERT1: 25.5;SK-MEL-30: 13.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"				"unprognostic (3.71e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.13e-4)"	"unprognostic (1.60e-2)"	"unprognostic (4.57e-3)"	"unprognostic (8.97e-2)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (2.41e-2)"	0.4	0.5	0.9	0.6	0.8	1.7	0.5	1.3	0.9	0.4	1.2	0.3	0.1	0.4	0.4	0.2	0.9	0.9	0.6	0.8	0.8	2.1	0.3	1.0	0.5	1.7	1.0	0.2	0.5	30.6	1.0	0.5	2.0	0.3	0.2	3.5	0.3	0.5	0.1	0.1	0.3	0.5	1.1	3.0	0.8	40.7	1.1	0.3	5.4	0.5	0.5	0.4	0.2	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	21.5	0.0	0.0	0.0	94.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	25.5	0.0	8.7	0.0	0.0	0.6	13.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.8	1.3	0.9	0.8	0.8	1.7	1.0	2.0	1.1	1.1	1.3	0.9	6.4	2.0	2.3	0.0	0.0	0.1	0.1	0.0	4.3	1.0	0.4	12.4	0.0	0.7	0.0	4.2	0.0	0.5	0.0	1.9	0.6	13.1	43.2	1.5	0.9	0.0	1.3	9.1	0.0	0.0	0.7	0.0	3.7	0.0	0.3	0.4	0.1	1.9	6.7	4.6	0.0	2.0	1.8	0.0	7.3	0.9	1.5	0.0	2.8	2.9	0.6	0.0	1.0	4.6	0.5	0.0	2.2	0.3	0.5	0.0	2.5	0.2	2.3	6.6	0.9	0.8	63.2	38.6	0.0	0.0	0.0	0.3	11.7	0.0	0.1
TESPA1	"ITPRID3, KIAA0748"	ENSG00000135426	"Thymocyte expressed, positive selection associated 1"	A2RU30	12	54948015-54984762	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 81.3;lymphoid tissue: 75.2"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 202.7;granulocytes: 120.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HEL: 247.1;HMC-1: 187.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058823, HPA079222"	Approved		Supported	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA058823: AB_2683828, HPA079222: "	"unprognostic (1.98e-5)"	"unprognostic (3.70e-4)"	"unprognostic (3.87e-4)"	"unprognostic (1.13e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.55e-4)"	"unprognostic (2.29e-3)"	"unprognostic (5.34e-4)"	"unprognostic (3.83e-4)"	"unprognostic (1.35e-2)"	"unprognostic (3.97e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-1)"	1.3	0.5	19.6	13.9	37.6	14.5	1.7	12.0	81.3	1.9	11.9	3.7	3.0	2.3	4.8	1.9	1.3	4.8	1.0	36.6	13.2	0.8	0.9	5.8	36.4	11.6	12.2	6.9	0.9	0.7	0.6	0.5	12.1	1.5	4.8	1.0	1.4	1.1	1.4	1.0	7.5	2.1	11.4	13.5	3.9	0.9	16.1	75.2	1.1	0.6	36.4	4.0	1.1	44.2	0.2	0.4	0.6	0.4	0.7	0.7	3.2	0.0	0.7	0.2	0.3	0.0	0.4	17.5	0.2	0.7	0.6	0.4	0.7	0.4	0.3	20.0	0.6	247.1	0.8	0.3	0.6	13.6	187.7	0.5	0.4	0.4	0.7	0.5	0.0	41.5	1.0	16.3	0.4	0.4	39.1	1.5	0.5	0.2	0.2	9.3	0.3	2.7	0.6	0.9	0.5	0.2	0.6	0.1	0.5	0.7	0.2	3.6	0.3	0.4	0.4	0.2	0.2	11.1	0.4	12.0	1.7	4.0	0.4	43.1	1.4	1.6	38.3	1.3	43.5	17.9	126.0	57.5	16.0	15.0	175.8	98.8	3.1	57.2	1.5	5.6	92.6	64.5	19.6	37.6	12.0	81.3	36.6	13.2	11.6	12.2	12.1	11.4	16.1	44.2	0.7	0.0	4.3	10.1	9.9	0.5	0.0	0.0	0.0	0.0	0.2	0.3	1.5	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.0	32.4	202.7	0.0	0.0	1.3	0.0	0.1	120.1	0.0	0.4	0.5	0.1	0.0	2.5	0.0	0.0	1.3	1.6	0.0	0.9	4.6	1.8	2.8	3.3	0.0	25.7	7.1	5.1	0.0	0.0	1.2	3.4	0.0	0.0	0.3	0.0	0.0	0.0	0.3	1.0	0.0	0.2	0.0	0.3	0.0	37.0	0.8	0.1	0.0
TGOLN2	"TGN38, TGN46, TGN48, TGN51, TTGN2"	ENSG00000152291	"Trans-golgi network protein 2"	O43493	2	85318020-85328296	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011489, HPA012609, HPA012723"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA		12000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"CAB011489: AB_443302, HPA012609: AB_1857976, HPA012723: AB_1857975"	"unprognostic (3.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.50e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.37e-2)"	70.0	67.5	37.5	82.6	42.1	129.9	58.3	38.5	44.0	63.5	32.2	85.8	110.6	62.0	60.9	41.1	65.1	75.7	63.5	39.6	45.3	120.8	136.5	86.8	73.9	45.5	43.4	61.3	56.0	67.1	26.9	76.6	44.9	66.9	102.3	31.8	59.8	62.5	34.7	40.1	111.9	74.0	40.4	83.2	74.8	37.1	45.1	65.2	91.3	46.2	66.1	61.4	41.0	50.0	46.5	116.4	51.8	68.6	124.0	129.0	120.7	144.1	172.2	98.5	78.5	100.6	142.2	60.6	108.3	207.1	132.9	76.4	37.8	71.9	161.8	96.5	36.7	87.2	41.3	113.3	67.1	173.0	189.5	96.2	45.2	125.5	76.1	152.1	144.4	49.5	50.9	94.1	147.1	43.9	54.0	86.3	46.0	109.3	47.5	55.4	193.1	45.6	104.8	73.2	47.4	40.5	127.2	95.5	83.6	61.7	50.7	77.0	155.7	205.5	73.9	158.6	173.5	58.7	81.9	58.1	152.3	131.1	137.3	62.6	78.0	68.5	32.4	73.3	25.0	25.0	23.8	22.4	41.5	24.4	24.3	23.6	96.3	25.1	103.5	15.9	20.9	75.6	37.5	42.1	38.5	44.0	39.6	45.3	45.5	43.4	44.9	40.4	45.1	50.0	104.4	102.5	96.4	22.5	89.7	38.2	57.1	72.5	43.9	53.3	89.2	56.4	64.3	150.2	84.2	180.3	39.6	59.4	116.9	216.1	9.8	92.7	6.0	86.3	89.5	91.7	89.5	39.5	29.5	93.2	80.9	87.5	64.7	105.7	158.8	70.5	86.7	245.0	113.0	208.6	37.9	99.0	52.9	187.1	85.3	7.8	49.4	145.6	60.5	33.7	126.9	47.8	95.8	25.1	50.6	101.6	121.8	69.2	74.0	62.8	211.2	82.8	111.4	36.5	65.7	85.0	65.8	36.1	37.1	32.6	34.9	44.6	91.1	61.9	100.3	70.8
THUMPD1	"FLJ20274, Tan1"	ENSG00000066654	"THUMP domain containing 1"	Q9NXG2	16	20702816-20742084	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027851	Approved		Approved	Cytosol		NA	NA		9300000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA027851: AB_10670036"	"unprognostic (1.67e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (2.99e-4)"	"unprognostic (1.48e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.45e-1)"	"prognostic favorable (8.52e-8)"	"unprognostic (1.98e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.25e-2)"	16.0	16.4	10.9	14.4	11.4	21.2	38.3	12.4	14.2	23.0	12.3	23.0	13.3	25.3	28.3	15.2	21.8	15.6	11.4	11.3	12.8	22.8	17.0	16.6	21.0	10.6	10.9	23.5	18.9	30.5	13.8	17.6	10.4	33.4	18.5	20.6	19.6	22.8	17.1	15.7	17.6	24.4	11.2	18.3	23.3	16.4	12.9	20.7	20.2	20.3	20.7	20.0	19.2	12.0	22.4	22.8	41.9	23.7	35.7	31.3	25.2	22.0	22.8	20.7	20.4	17.6	23.2	53.9	42.0	25.0	19.5	21.3	27.7	29.6	32.5	32.0	16.0	49.0	20.5	43.3	23.6	79.2	100.2	25.5	40.0	22.5	25.3	23.8	24.1	24.0	95.7	41.5	23.9	25.3	38.7	32.3	35.3	20.5	14.2	51.6	38.0	43.8	24.4	17.9	31.8	21.7	18.2	32.1	23.4	25.5	22.4	28.4	23.1	28.9	17.1	19.8	21.9	42.6	43.2	38.5	21.9	22.7	24.6	13.3	6.4	19.3	15.3	7.4	19.5	10.7	15.6	15.0	6.4	9.7	19.7	17.7	2.9	14.3	8.3	5.5	12.4	9.4	10.9	11.4	12.4	14.2	11.3	12.8	10.6	10.9	10.4	11.2	12.9	12.0	55.6	41.7	48.5	16.3	66.6	48.4	37.5	27.1	57.5	37.0	62.7	48.8	30.3	42.9	38.2	31.3	20.9	61.0	81.6	35.6	39.2	29.8	5.9	66.2	64.3	47.9	36.5	23.5	25.6	34.4	35.3	45.5	26.5	97.0	72.1	42.7	42.1	45.2	30.0	35.3	24.7	38.3	26.4	34.8	35.2	8.9	41.0	34.3	33.8	20.6	45.5	45.1	55.6	21.1	32.6	27.5	33.8	67.7	41.3	52.0	32.2	49.7	39.8	37.0	46.0	50.9	50.7	44.1	66.3	46.6	55.4	73.1	72.5	25.5	44.9	35.6
TIMM8A	"DDP, DFN1, MTS"	ENSG00000126953	"Translocase of inner mitochondrial membrane 8A"	O60220	X	101345661-101348742	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone	"Deafness, Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 102.2;Hepatocytes: 68.3;Suprabasal keratinocytes: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 217.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003628	Supported		Supported	Mitochondria		NA	NA		59000	"Cluster 30: Non-specific - Translation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 28: Keratinocytes - Keratinization"	Mitochondria		"HPA003628: AB_1080284"	"prognostic unfavorable (7.89e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (8.87e-5)"	"unprognostic (2.06e-1)"	"unprognostic (9.28e-3)"	"unprognostic (5.14e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.86e-3)"	"unprognostic (6.41e-2)"	"unprognostic (8.57e-3)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.86e-2)"	5.1	5.6	4.3	6.5	4.4	6.9	7.6	5.1	5.2	4.4	4.8	7.2	6.6	4.2	4.7	7.0	5.6	3.6	10.9	4.5	5.3	9.2	25.3	3.1	8.2	4.5	5.5	5.9	5.2	6.7	1.9	6.3	4.5	6.5	7.5	5.0	6.0	3.7	10.0	6.5	6.3	4.8	5.0	4.5	4.2	3.2	5.2	6.8	6.5	14.0	8.7	6.5	3.1	4.3	31.5	30.0	17.1	33.8	13.3	15.0	20.3	23.5	11.4	20.0	40.6	26.4	21.3	38.0	29.7	17.8	36.5	27.7	46.2	24.5	33.3	17.7	29.9	62.8	44.7	46.5	12.7	39.9	217.8	15.0	21.5	30.0	18.8	9.6	19.7	15.9	51.0	40.8	26.8	50.7	18.3	39.1	55.3	46.4	49.3	30.2	31.1	44.9	18.3	21.1	22.7	20.9	28.6	22.8	22.5	18.8	19.1	19.3	14.2	27.5	31.5	40.6	26.1	18.7	50.8	45.9	14.6	53.8	22.2	1.2	3.8	0.2	4.9	5.8	7.0	12.1	6.8	7.2	4.6	11.9	10.3	8.4	0.4	5.2	3.1	11.7	3.8	4.3	4.3	4.4	5.1	5.2	4.5	5.3	4.5	5.5	4.5	5.0	5.2	4.3	7.0	3.2	4.4	1.3	10.7	102.2	39.6	27.6	31.9	7.6	11.2	16.8	25.8	5.7	14.1	11.0	6.2	38.4	8.7	7.5	39.2	13.5	0.7	9.0	10.8	10.2	8.4	27.4	2.8	10.9	47.6	13.0	7.1	7.3	16.5	9.3	5.3	68.3	21.1	3.3	2.8	8.6	22.4	7.2	13.9	0.5	6.5	7.5	14.2	1.9	5.0	5.4	3.1	1.0	0.7	15.4	6.7	2.6	13.8	36.2	8.0	39.9	9.1	8.5	0.0	9.6	16.7	2.9	10.9	27.7	88.5	36.7	6.9	12.4	18.0	27.8
TLDC2	"C20orf118, dJ132F21.2"	ENSG00000101342	"TBC/LysM-associated domain containing 2"	A0PJX2	20	36876121-36894235	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 10.2;granulocytes: 15.2;Intestinal goblet cells: 4.9;Paneth cells: 11.5;Proximal enterocytes: 20.4;Undifferentiated cells: 7.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 9.4"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"basophil: 4.6"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.6"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 34.7"	"Region enriched"	"Detected in many"	4	"cerebellum: 5.7"	"Low region specificity"	"Detected in all"			HPA047468	Enhanced					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA047468: AB_2680059"	"unprognostic (9.06e-3)"	"unprognostic (3.35e-4)"	"unprognostic (4.60e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.82e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (9.97e-5)"	"unprognostic (7.25e-2)"	"unprognostic (6.20e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.87e-2)"	10.0	2.6	0.6	4.7	0.9	1.6	6.5	0.1	0.8	6.3	2.7	11.7	18.2	2.7	0.4	3.2	8.0	2.7	7.0	0.4	1.0	5.9	2.3	11.1	2.8	1.5	1.0	5.1	4.3	0.0	2.8	0.2	1.4	3.8	12.3	1.3	4.1	0.2	2.0	4.7	17.1	0.7	0.9	7.9	3.6	3.0	1.7	0.0	4.1	0.0	0.1	5.5	5.6	2.1	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	1.6	0.5	0.4	0.2	0.7	0.3	0.4	0.0	0.0	0.0	0.1	0.3	1.3	0.6	4.0	0.0	0.4	34.7	0.1	0.2	0.1	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.1	0.0	1.2	0.0	6.2	1.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.6	0.3	0.2	0.1	0.0	0.0	0.2	0.1	4.6	0.5	0.0	0.2	0.6	0.2	0.1	0.2	0.1	0.8	0.6	0.5	0.1	0.0	0.8	0.7	0.4	0.4	0.5	0.6	0.9	0.1	0.8	0.4	1.0	1.5	1.0	1.4	0.9	1.7	2.1	0.1	0.0	1.7	0.0	0.0	0.0	0.1	0.1	1.2	0.0	0.0	0.0	0.7	2.8	0.0	0.0	0.0	0.0	0.4	10.2	0.0	0.5	0.3	0.3	0.1	0.1	3.6	0.8	0.3	0.0	0.0	0.5	1.1	0.3	15.2	0.3	0.0	0.0	0.3	0.0	0.3	4.9	0.0	0.0	0.5	0.4	0.0	0.3	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.5	11.5	0.0	0.1	0.0	20.4	0.2	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.4	0.1	7.3	0.0
TMC8	"EVER2, EVIN2"	ENSG00000167895	"Transmembrane channel like 8"	Q8IU68	17	78130770-78142968	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 91.8;intestine: 54.6;lymphoid tissue: 117.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 44.9;dendritic cells: 52.3;granulocytes: 41.2;Langerhans cells: 44.6;NK-cells: 85.5;T-cells: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 46.3;HL-60: 63.0;HMC-1: 119.9;Karpas-707: 103.9;RPMI-8226: 66.6;U-266/70: 49.3;U-937: 51.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047387, HPA054429"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"HPA047387: , HPA054429: AB_2682485"	"unprognostic (8.54e-3)"	"prognostic favorable (8.45e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.59e-1)"	"prognostic favorable (4.19e-5)"	"unprognostic (6.38e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.27e-1)"	"prognostic unfavorable (1.96e-7)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	7.8	3.0	3.6	56.0	4.4	91.8	3.7	3.7	5.1	3.7	3.5	8.2	10.3	2.5	0.7	4.8	4.0	7.4	2.7	3.6	4.8	5.2	7.1	18.4	100.5	5.8	4.7	1.3	2.0	0.5	2.2	3.9	5.6	4.9	4.5	0.1	5.8	1.3	1.8	3.6	54.6	2.4	5.0	117.0	10.4	1.2	7.8	60.1	6.4	0.9	46.7	6.4	5.0	7.2	0.5	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.3	46.3	2.0	0.0	0.1	3.4	0.0	0.1	0.0	0.0	0.1	16.4	0.1	0.8	0.0	63.0	119.9	0.0	0.0	0.0	0.0	0.0	0.0	22.1	4.0	103.9	0.0	1.3	20.9	2.8	0.2	3.5	0.5	1.4	0.3	66.6	0.0	0.2	0.0	0.1	0.0	2.2	0.6	0.1	6.9	12.7	0.1	0.0	0.1	0.1	0.0	49.3	2.0	4.6	0.1	51.9	0.1	2.6	2.0	6.6	13.4	3.4	9.7	5.5	10.8	13.3	2.3	4.8	9.4	8.6	3.3	7.5	7.9	2.1	6.5	5.5	3.6	4.4	3.7	5.1	3.6	4.8	5.8	4.7	5.6	5.0	7.8	7.2	3.6	3.2	10.2	1.0	44.9	5.4	10.4	4.9	4.6	0.2	1.2	1.5	1.9	1.5	6.5	0.0	0.0	0.4	52.3	3.7	0.0	1.0	0.7	1.0	0.6	3.2	1.2	17.1	0.4	1.3	1.4	2.3	2.0	1.8	41.2	0.1	5.7	0.5	30.5	0.0	0.4	1.4	14.2	28.2	44.6	0.5	0.0	22.0	7.2	24.4	30.2	0.2	85.5	1.0	2.7	0.6	3.6	0.4	20.2	2.9	0.9	0.4	2.1	0.2	0.0	0.3	2.0	0.4	0.6	8.4	4.5	0.5	68.6	2.7	7.0	10.7
TMED8	FAM15B	ENSG00000100580	"Transmembrane p24 trafficking protein family member 8"	Q6PL24	14	77335029-77377094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 62.7;Cone photoreceptor cells: 108.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Daudi: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001205	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	Vesicles	"HPA001205: AB_2204460"	"unprognostic (1.07e-1)"	"unprognostic (4.70e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.23e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.77e-1)"	5.5	8.3	8.2	8.6	9.6	7.7	5.7	4.7	8.4	5.9	4.1	4.4	3.3	6.7	5.1	3.6	5.4	4.1	3.4	7.5	16.6	10.4	3.4	4.6	17.5	7.9	10.5	7.3	5.6	11.1	9.2	4.4	11.2	5.9	4.8	24.2	4.4	5.9	2.3	4.9	5.5	5.6	6.9	8.0	6.2	6.8	12.8	9.8	10.9	2.4	19.5	4.7	3.5	5.9	14.7	12.0	13.9	12.4	8.5	7.6	11.8	9.2	6.0	9.4	10.1	7.5	8.1	58.7	7.5	7.5	7.7	10.0	10.4	10.5	14.6	18.6	6.3	19.6	9.5	7.9	5.9	9.6	51.8	8.0	7.4	12.3	11.0	9.5	13.5	47.7	10.1	15.4	9.5	14.4	15.2	14.2	6.9	10.7	12.0	12.2	12.7	4.7	9.9	9.0	17.2	10.4	15.9	9.4	11.8	10.6	15.2	15.9	9.7	9.7	6.2	17.5	10.7	12.3	25.2	28.9	11.1	17.7	14.3	2.3	0.7	2.2	0.3	0.9	0.4	2.1	0.5	0.4	0.6	2.1	0.3	0.5	1.0	0.5	0.8	1.0	0.7	0.5	8.2	9.6	4.7	8.4	7.5	16.6	7.9	10.5	11.2	6.9	12.8	5.9	6.6	3.2	7.8	62.7	33.9	6.6	4.9	7.7	2.8	33.4	12.5	8.3	16.8	8.6	5.3	22.0	108.4	10.5	7.9	6.5	5.9	6.4	4.8	9.8	15.5	10.4	44.3	15.4	44.7	4.7	10.0	8.4	7.1	9.0	0.0	9.1	8.9	9.8	7.8	28.6	40.7	6.3	10.2	24.8	7.7	6.9	14.6	19.8	5.4	21.5	16.8	14.9	6.2	39.7	24.2	6.8	3.3	14.3	19.9	7.5	3.2	22.2	20.9	39.3	13.1	7.1	8.4	6.8	15.7	8.2	8.9	4.1	10.3	19.8	6.7	4.3
TMEM106A	MGC20235	ENSG00000184988	"Transmembrane protein 106A"	Q96A25	17	43211835-43220041	"Predicted membrane proteins, Transporters"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 21.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 45.6;Hofbauer cells: 45.3;Kupffer cells: 44.8;Langerhans cells: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 26.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 26.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 16.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (9.71e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (4.95e-3)"	"unprognostic (8.62e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (6.08e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.30e-2)"	4.9	2.4	1.7	10.2	2.1	3.3	4.1	1.2	2.9	3.8	2.4	3.6	4.0	3.6	1.7	1.5	3.3	3.6	2.1	1.6	2.5	21.9	3.5	5.2	6.9	6.2	3.0	7.8	3.1	2.4	1.6	10.1	3.8	2.5	5.3	0.8	2.8	3.1	1.1	1.3	3.4	8.8	2.8	9.7	4.8	3.3	6.1	4.0	5.3	1.5	6.1	4.8	2.4	4.1	3.1	0.9	0.4	0.2	3.8	4.1	2.3	7.8	5.0	6.7	10.5	2.3	6.4	4.5	1.5	12.1	2.6	1.3	0.8	1.0	7.8	7.1	0.0	3.2	2.7	10.7	2.2	0.1	16.8	2.6	0.2	12.5	0.3	2.4	6.0	5.3	0.1	3.2	8.5	1.3	5.5	2.1	0.3	0.0	0.0	4.0	1.3	2.7	2.9	0.2	0.6	0.0	1.5	3.7	1.8	1.6	5.5	4.5	6.8	3.3	0.4	3.3	1.6	5.0	0.5	1.4	2.8	5.4	6.7	26.7	5.1	5.7	1.5	5.6	0.7	1.9	1.0	1.5	4.2	3.2	0.7	1.3	1.4	2.1	2.0	6.0	2.9	2.2	1.7	2.1	1.2	2.9	1.6	2.5	6.2	3.0	3.8	2.8	6.1	4.1	4.5	3.2	4.5	1.3	13.6	2.4	11.0	2.4	0.6	4.3	6.5	4.2	1.2	0.0	3.9	7.3	2.1	5.0	22.7	3.9	3.9	2.0	5.9	2.6	7.1	6.5	3.0	2.5	1.0	4.0	8.3	6.6	10.7	3.9	8.2	45.6	5.0	1.7	45.3	0.0	1.0	4.5	0.0	44.8	35.6	2.7	14.0	25.2	0.0	17.8	16.5	1.2	14.4	3.5	4.0	5.5	3.4	7.2	5.4	10.9	2.1	17.8	6.0	3.7	13.1	4.0	4.6	7.4	3.6	0.5	1.7	5.2	7.3	3.2	2.9	13.1
TMEM154	FLJ32028	ENSG00000170006	"Transmembrane protein 154"	Q6P9G4	4	152618628-152680012	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 58.3;skin 1: 58.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 108.6;Basal keratinocytes: 74.2;Glandular and luminal cells: 75.0;granulocytes: 101.2;monocytes: 82.1;Squamous epithelial cells: 119.2;Suprabasal keratinocytes: 194.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 6.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"basophil: 403.7;eosinophil: 305.7;neutrophil: 477.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 477.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 63.0;HMC-1: 71.1;Karpas-707: 55.6;U-266/70: 69.7;U-937: 56.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019184, HPA055411"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Nuclear membrane"	Nucleoplasm	"HPA019184: AB_2670088, HPA055411: "	"unprognostic (1.09e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.00e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	3.1	0.5	0.3	17.2	0.7	18.6	4.3	0.6	1.7	5.7	0.5	3.1	2.6	1.6	0.7	58.3	1.4	5.1	0.8	0.4	0.7	0.6	5.9	5.1	14.3	0.8	0.6	0.2	1.0	0.3	0.8	3.8	1.1	2.0	2.6	0.2	6.9	2.3	0.4	58.5	3.6	1.8	0.7	12.4	5.9	0.2	1.0	6.2	3.6	1.9	26.4	11.6	7.9	1.0	32.1	0.1	0.3	0.1	0.5	8.7	14.1	8.0	29.1	8.5	16.2	0.4	4.2	32.5	3.3	7.6	9.3	22.8	0.0	63.0	15.5	0.1	0.1	1.8	0.5	0.0	8.9	25.7	71.1	8.3	29.7	27.1	23.4	0.0	21.4	19.7	0.1	55.6	0.7	2.3	10.1	8.0	1.6	0.1	7.8	1.2	0.1	0.2	47.5	19.4	0.1	1.2	2.2	6.2	1.0	8.4	1.0	17.8	8.6	1.2	5.1	0.7	11.1	69.7	26.0	18.1	11.7	56.6	6.6	403.7	37.8	305.7	4.9	38.2	9.2	51.6	10.9	7.9	19.6	45.1	10.7	7.4	477.5	0.8	43.7	2.5	22.5	17.2	0.3	0.7	0.6	1.7	0.4	0.7	0.8	0.6	1.1	0.7	1.0	1.0	6.5	12.8	19.3	0.0	108.6	74.2	9.0	23.6	20.5	0.1	8.8	4.8	1.7	0.0	20.9	22.0	2.1	25.0	9.8	0.9	0.0	6.4	0.1	31.9	13.4	6.7	1.2	6.6	0.5	3.7	14.5	5.2	8.2	75.0	101.2	0.1	0.7	4.6	4.5	3.3	0.3	0.7	14.2	9.8	15.7	0.2	0.6	28.2	5.4	15.9	82.1	0.1	5.2	3.5	0.1	21.5	7.1	0.0	45.7	5.4	0.0	0.3	60.5	0.7	0.0	3.0	3.6	0.1	0.5	119.2	194.4	25.9	28.6	0.5	2.6	27.2
TMEM161B	MGC33214	ENSG00000164180	"Transmembrane protein 161B"	Q8NDZ6	5	88189633-88269476	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 59.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 82.1;HMC-1: 85.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044562	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"			"HPA044562: AB_10794291"	"unprognostic (2.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.62e-3)"	"unprognostic (9.35e-2)"	4.6	5.8	5.0	5.8	4.7	6.2	16.0	7.3	6.3	6.5	3.0	9.7	12.4	6.4	14.2	7.8	7.1	5.6	4.8	4.3	3.8	9.7	11.9	10.1	9.1	3.1	3.1	11.2	14.0	23.0	4.8	8.1	3.2	12.3	11.3	18.2	14.1	8.9	6.4	15.6	11.5	5.8	3.0	6.4	22.9	12.5	4.0	8.6	20.9	7.0	9.5	7.4	6.0	5.6	11.8	8.0	8.7	9.5	5.4	10.3	18.6	10.3	15.4	14.6	21.2	8.9	30.2	18.2	5.2	7.7	26.6	12.3	10.2	13.3	18.4	16.4	10.7	82.1	10.3	5.9	14.0	15.9	85.2	9.2	19.1	12.4	18.3	10.4	6.5	11.9	40.5	16.0	12.7	5.5	11.6	13.9	5.6	8.7	14.3	9.7	10.1	19.9	13.0	16.4	11.1	9.3	5.9	16.3	24.5	7.7	9.8	14.5	5.4	9.5	8.7	13.7	18.9	19.6	33.3	14.9	23.3	15.7	13.4	1.5	1.4	1.0	2.9	2.8	2.9	2.2	2.4	2.1	0.8	2.1	2.4	1.9	0.8	2.9	1.1	2.6	2.1	1.2	5.0	4.7	7.3	6.3	4.3	3.8	3.1	3.1	3.2	3.0	4.0	5.6	9.8	28.9	16.4	37.2	19.2	7.8	8.0	12.0	5.7	15.8	13.6	9.7	16.3	11.5	15.0	9.2	16.7	9.3	17.9	14.7	3.9	8.8	3.6	10.2	11.4	7.7	14.3	10.3	43.4	9.7	4.1	9.8	12.2	14.0	16.5	14.4	15.0	23.1	5.3	6.7	46.3	13.7	6.1	11.8	5.5	3.1	10.5	8.2	0.0	28.1	7.1	15.6	22.6	59.3	55.0	11.3	6.6	12.8	13.1	9.4	11.3	6.4	9.4	22.2	6.6	8.9	8.9	35.8	12.6	9.3	7.1	15.1	15.8	11.3	14.3	7.5
TMEM164	"FLJ22679, RP13-360B22.2"	ENSG00000157600	"Transmembrane protein 164"	Q5U3C3	X	110002631-110182734	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.5;Distal enterocytes: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 59.7"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 59.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038784	Approved		Approved	"Vesicles,Cell Junctions"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles	"Cell Junctions"	"HPA038784: AB_10670790"	"unprognostic (2.14e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.65e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (8.17e-6)"	"unprognostic (9.85e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.66e-2)"	"prognostic favorable (3.14e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.81e-2)"	"unprognostic (4.19e-3)"	16.9	10.3	11.4	9.6	11.8	19.0	12.3	6.8	9.7	5.5	14.3	18.8	21.5	5.3	6.0	13.8	8.1	5.1	22.7	9.0	12.1	11.1	2.0	17.9	6.7	13.5	13.0	13.8	25.4	8.3	9.6	5.2	11.2	8.9	21.2	3.6	9.8	14.4	27.5	20.3	19.2	6.9	8.2	8.4	14.0	1.9	12.3	12.6	13.8	19.3	8.0	5.8	6.8	8.6	10.8	24.3	19.5	12.8	23.7	17.3	11.9	5.3	12.4	11.0	7.1	19.1	16.6	8.6	35.2	8.3	27.1	15.6	17.1	27.9	10.8	23.9	11.7	58.5	13.0	8.1	13.9	26.1	80.1	24.0	48.4	19.9	27.2	30.2	21.8	15.2	18.4	10.2	19.7	21.6	27.4	33.1	17.5	36.9	17.3	12.4	15.1	7.2	17.5	11.3	18.2	20.3	34.0	33.1	15.9	18.1	9.6	25.7	49.0	9.3	6.8	11.0	7.7	5.9	7.9	6.9	24.3	32.0	25.3	59.7	3.3	14.2	0.6	2.9	1.6	0.2	0.7	0.6	2.7	0.6	0.4	0.5	16.3	2.3	1.8	0.5	1.0	1.8	11.4	11.8	6.8	9.7	9.0	12.1	13.5	13.0	11.2	8.2	12.3	8.6	2.9	3.2	36.1	84.5	3.7	4.8	3.7	4.7	4.6	1.2	11.7	9.1	21.3	11.5	6.9	16.5	2.1	2.7	3.5	53.0	3.9	4.6	0.5	6.7	3.8	6.0	27.6	14.5	22.9	11.4	6.3	3.1	7.7	10.7	3.8	4.3	6.4	1.7	13.6	0.0	31.4	12.7	10.2	25.1	9.4	1.3	1.8	12.5	1.8	24.4	28.1	1.0	4.1	34.2	7.6	13.5	15.0	1.5	1.6	9.0	31.9	3.3	5.4	1.3	0.0	6.4	4.1	0.2	0.3	10.4	8.0	2.7	5.2	3.8	21.2	12.3
TNFSF10	"Apo-2L, CD253, TL2, TRAIL"	ENSG00000121858	"TNF superfamily member 10"	P50591	3	172505508-172523475	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 732.8;Exocrine glandular cells: 424.6;Proximal tubular cells: 556.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 265.4;classical monocyte: 133.4;intermediate monocyte: 203.5;neutrophil: 257.1;non-classical monocyte: 213.2"	"Group enriched"	"Detected in all"	5	"granulocytes: 265.4;monocytes: 213.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 73.1;CAPAN-2: 53.7;HaCaT: 51.5;HMC-1: 244.5;RPTEC TERT1: 122.1"	"Low region specificity"	"Detected in all"							HPA054938	Uncertain				"Secreted to blood"	NA	NA	67400	18000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA054938: AB_2682643"	"unprognostic (9.16e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.27e-2)"	51.0	49.9	9.5	55.4	9.8	14.8	84.5	9.8	17.0	37.3	17.3	76.8	100.3	47.1	19.6	66.4	39.1	45.3	31.7	9.0	9.9	145.1	209.0	177.2	54.7	12.0	10.2	27.1	22.2	77.7	10.4	167.9	11.0	86.7	91.4	1.4	127.9	42.7	20.7	54.6	95.2	26.3	11.0	70.9	47.3	4.8	10.3	34.2	29.3	61.7	46.8	70.3	62.4	10.6	12.4	0.6	0.1	0.2	8.2	6.6	73.1	0.0	0.5	3.7	5.9	0.3	53.7	7.9	34.7	0.0	3.2	51.5	0.3	6.3	0.7	19.6	0.2	0.2	1.5	1.1	0.4	14.7	244.5	8.2	8.0	1.3	0.2	0.0	25.6	1.6	0.3	8.7	0.0	0.1	1.9	19.4	0.3	0.2	0.5	2.9	0.2	3.5	122.1	4.6	0.3	0.5	27.2	1.0	0.6	0.4	15.3	8.0	1.1	0.1	0.2	0.1	0.7	9.3	1.1	9.5	0.6	8.0	0.2	265.4	133.4	14.7	10.9	203.5	15.0	16.7	30.4	16.8	49.1	18.2	21.6	8.5	257.1	49.3	213.2	2.9	36.8	73.6	9.5	9.8	9.8	17.0	9.0	9.9	12.0	10.2	11.0	11.0	10.3	10.6	326.5	70.5	114.4	0.0	26.2	22.0	169.5	398.4	69.4	0.3	146.5	97.3	7.9	84.4	281.1	66.2	0.0	6.6	20.7	294.2	45.0	732.8	4.5	60.5	18.2	247.5	48.3	9.7	0.1	424.6	189.4	69.2	44.9	121.0	257.0	2.4	186.7	75.2	23.5	1.7	0.1	111.3	175.0	79.8	23.7	3.8	18.3	70.5	7.2	52.5	160.3	18.7	52.5	0.0	0.1	244.0	216.4	4.9	23.2	82.7	317.0	556.7	114.5	1.5	0.0	6.5	22.3	0.1	0.3	103.1	25.6	10.9	51.8	19.7	74.3	170.1
TNFSF9	"4-1BB-L, 4-1BBL"	ENSG00000125657	"TNF superfamily member 9"	P41273	19	6531026-6535924	"Plasma proteins, Predicted intracellular proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 9.8;esophagus: 9.8;vagina: 9.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 57.5;dendritic cells: 51.6;Gastric mucus-secreting cells: 23.0;Macrophages: 22.5;T-cells: 31.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 85.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA059857			Approved	"Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus"		"HPA059857: AB_2684144"	"unprognostic (2.21e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.41e-3)"	"unprognostic (4.88e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.07e-3)"	1.8	0.6	3.5	1.0	3.0	3.7	0.8	3.7	7.6	9.8	2.3	1.2	0.3	0.3	0.3	9.8	1.1	1.0	0.6	3.9	3.3	0.9	0.4	4.9	1.1	3.6	2.9	0.5	0.3	0.5	0.3	0.9	3.4	0.3	1.8	0.3	1.5	0.1	0.7	1.4	1.2	0.4	3.1	2.2	0.6	3.3	3.1	0.5	0.4	0.3	0.7	0.7	9.5	6.3	10.7	13.4	0.2	4.8	2.5	6.0	0.4	1.5	4.8	3.6	17.1	0.3	18.0	11.3	6.8	3.0	0.0	19.2	5.4	2.3	0.9	0.0	2.6	1.8	18.4	4.4	0.4	0.3	85.8	1.0	10.1	20.1	5.5	2.6	0.6	1.6	10.9	0.2	1.3	1.5	0.9	1.8	1.8	0.7	9.5	1.2	0.0	2.8	22.9	0.4	0.0	0.0	29.8	1.7	5.0	0.6	1.2	16.4	6.2	0.0	9.6	26.0	0.0	26.9	10.2	20.9	10.2	5.9	5.9	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	3.5	3.0	3.7	7.6	3.9	3.3	3.6	2.9	3.4	3.1	3.1	6.3	11.3	0.0	4.5	0.0	57.5	2.7	0.3	4.3	6.2	0.2	4.0	3.8	8.1	0.0	1.6	0.0	0.0	0.1	51.6	4.3	0.0	0.3	0.1	5.7	3.9	6.8	14.2	0.0	2.2	0.2	0.0	12.6	23.0	9.2	8.9	0.6	1.8	0.0	4.5	0.0	2.5	3.4	2.0	1.9	15.9	0.0	0.0	22.5	3.6	0.0	1.6	0.8	0.0	1.5	2.9	0.8	4.9	0.0	17.2	0.9	0.2	0.1	0.9	0.2	0.0	2.5	7.5	0.1	0.4	12.7	1.3	0.1	31.5	0.9	5.7	0.3
TNIK	KIAA0551	ENSG00000154310	"TRAF2 and NCK interacting kinase"	Q9UKE5	3	171058414-171460408	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1074.4;Excitatory neurons: 248.4;Inhibitory neurons: 360.8;Oligodendrocyte precursor cells: 374.5;Oligodendrocytes: 205.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 65.2;HMC-1: 71.3;WM-115: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012128, HPA012297"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		160000	"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA012128: AB_1858226, HPA012297: AB_1858225"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.97e-2)"	1.4	4.4	25.7	6.2	33.7	4.4	2.1	4.1	17.5	1.3	0.0	8.2	21.0	3.4	0.9	4.1	2.8	5.1	9.4	20.8	15.7	3.8	3.1	8.9	6.7	25.5	18.7	1.5	3.7	0.5	8.4	1.9	6.3	3.5	6.7	19.4	1.9	4.6	23.2	1.0	21.3	4.3	19.0	4.5	7.0	7.7	20.1	7.0	6.3	23.6	5.3	4.8	2.1	10.7	0.9	1.2	43.4	4.7	0.8	0.1	10.4	9.3	2.5	7.3	4.8	41.5	16.9	0.0	3.4	9.0	6.9	14.1	6.3	2.6	7.3	0.3	9.8	65.2	3.7	0.0	19.0	13.0	71.3	6.1	5.9	4.3	0.9	15.7	43.6	10.5	23.3	0.1	1.1	1.1	4.1	13.5	18.2	30.6	17.9	0.0	11.8	16.6	12.0	0.1	2.1	2.3	5.8	0.4	9.6	4.1	20.4	2.9	0.5	0.0	7.9	20.5	7.1	0.1	0.0	0.1	1.8	13.8	52.1	4.6	0.1	10.5	3.5	0.0	4.4	0.0	4.2	3.2	0.0	0.2	5.8	3.1	0.1	2.4	0.1	0.0	5.3	1.0	25.7	33.7	4.1	17.5	20.8	15.7	25.5	18.7	6.3	19.0	20.1	10.7	0.7	6.4	50.4	1074.4	4.9	2.5	1.6	1.3	9.1	19.2	8.4	6.5	28.6	21.5	7.1	9.2	14.6	6.3	32.5	19.6	5.9	12.1	48.6	1.1	2.5	1.6	13.2	13.5	248.4	7.7	1.3	9.1	21.4	0.3	83.5	0.4	2.5	8.1	2.9	0.0	360.8	10.3	0.0	6.5	1.9	38.0	2.5	10.4	1.8	57.1	1.6	65.0	51.5	374.5	205.5	7.1	21.6	6.4	11.7	0.7	56.2	17.3	1.8	28.7	0.0	12.4	6.2	3.1	1.0	10.3	1.6	2.5	47.4	9.9	16.6	3.2
TNNT1	"ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS"	ENSG00000105048	"Troponin T1, slow skeletal type"	P13805	19	55132698-55149206	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	29	"skeletal muscle: 21567.3;tongue: 13372.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 61.2;Basal squamous epithelial cells: 47.8;Cardiomyocytes: 51.5;Skeletal myocytes: 192.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"eosinophil: 211.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 211.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 829.4;RH-30: 638.8"	"Region enriched"	"Detected in many"	5	"thalamus: 125.0"	"Region enhanced"	"Detected in all"		"thalamus: 23.1"	"CAB015168, HPA058448"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		79000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Golgi apparatus, Cytosol"		"CAB015168: AB_2206426, HPA058448: AB_2683720"	"unprognostic (1.88e-1)"	"unprognostic (7.23e-2)"	"prognostic unfavorable (4.66e-4)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (3.47e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.91e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-2)"	5.7	1.2	42.1	0.4	45.7	3.3	5.0	44.3	55.4	1.9	36.4	2.7	1.0	1.1	1.0	593.5	8.4	1.0	256.7	43.9	38.9	1.3	2.5	8.3	0.4	36.7	41.4	1.5	2.5	2.3	8.5	6.0	38.5	200.4	0.6	0.6	171.2	0.4	21567.3	48.5	2.0	0.4	35.6	1.9	1.9	10.6	40.8	3.4	3.8	13372.6	2.0	1.7	5.8	40.8	178.4	102.3	1.0	22.4	0.0	1.7	33.3	8.0	30.1	11.1	32.7	37.9	115.8	2.6	66.5	3.2	88.8	88.5	24.0	76.0	9.4	11.8	192.2	33.6	11.8	6.7	3.7	2.7	829.4	36.6	121.3	3.4	127.0	125.7	0.5	35.1	171.7	158.6	10.3	168.0	3.4	0.3	21.4	45.0	202.1	113.9	638.8	21.2	26.5	5.8	6.6	49.3	10.7	1.3	57.9	8.5	106.3	102.7	2.9	163.6	238.9	6.5	12.4	1.2	7.0	8.8	171.8	26.4	50.9	2.4	39.4	211.5	0.3	21.7	0.3	0.2	0.3	0.3	37.4	0.4	0.3	0.4	1.9	0.6	10.2	0.9	0.1	12.2	42.1	45.7	44.3	55.4	43.9	38.9	36.7	41.4	38.5	35.6	40.8	40.8	0.0	0.0	0.0	0.7	0.3	61.2	0.6	25.1	47.8	4.5	0.5	5.3	51.5	0.0	2.8	0.0	0.0	2.2	0.0	0.5	0.0	2.1	2.1	9.7	0.3	2.6	2.4	2.7	0.4	0.0	18.0	18.8	0.0	3.4	0.0	22.1	1.4	0.0	12.9	0.0	0.7	0.3	0.0	13.2	3.8	10.7	0.3	8.9	3.6	0.0	25.8	0.7	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.7	0.0	192.0	3.5	4.3	34.1	2.5	30.4	3.6	1.6	1.2	0.8	0.2
TOGARAM2	"Crescerin-2, FAM179A, FLJ43249, LOC165186"	ENSG00000189350	"TOG array regulator of axonemal microtubules 2"	Q6ZUX3	2	28956611-29052230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 34.9;choroid plexus: 25.2;fallopian tube: 20.1"	"Group enriched"	"Detected in some"	4	"dendritic cells: 20.1;Endometrial ciliated cells: 65.4;Respiratory ciliated cells: 30.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.3;JURKAT: 1.2;NB-4: 1.3"	"Low region specificity"	"Detected in many"							"HPA037561, HPA037562, HPA075216"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Plasma membrane"		"HPA037561: AB_10670384, HPA037562: AB_2675545, HPA075216: "	"unprognostic (8.35e-5)"	"unprognostic (2.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.53e-3)"	"unprognostic (3.93e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.92e-2)"	"unprognostic (3.94e-11)"	"unprognostic (3.75e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.81e-3)"	0.1	1.2	4.5	0.6	11.5	1.9	0.2	10.6	2.3	0.5	25.2	0.3	0.5	0.6	0.1	0.4	20.1	0.3	2.8	4.5	7.6	0.1	0.2	2.8	0.8	19.2	34.9	0.5	0.3	0.0	1.1	0.3	17.3	0.2	0.2	0.2	0.2	0.1	1.2	0.3	0.4	0.5	12.5	2.0	1.0	1.3	10.6	0.2	0.1	3.0	0.7	0.2	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.7	0.0	0.6	0.1	0.2	0.6	2.3	0.1	0.0	0.0	0.0	0.2	0.1	1.2	0.0	0.3	0.3	0.0	0.3	1.3	1.0	0.4	0.1	0.0	0.3	0.6	0.3	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.0	1.6	0.0	0.7	0.0	0.1	1.1	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.6	0.5	4.5	11.5	10.6	2.3	4.5	7.6	19.2	34.9	17.3	12.5	10.6	5.3	0.3	0.0	3.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.6	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	65.4	1.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.9	0.0	0.0	0.2	30.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	3.6	0.5	0.0	0.0
TP53RK	"BUD32, C20orf64, dJ101A2.2, Nori-2p, prpk, TPRKB"	ENSG00000172315	"TP53 regulating kinase"	Q96S44	20	46684365-46689444	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 214.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 212.4;SK-MEL-30: 90.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004688, HPA015837"	Approved					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"CAB004688: AB_426116, HPA015837: AB_1855776"	"unprognostic (9.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (9.76e-2)"	"prognostic unfavorable (6.70e-5)"	"unprognostic (4.41e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (6.27e-5)"	"unprognostic (9.16e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.74e-2)"	6.5	7.7	6.0	7.3	5.3	6.3	8.9	4.7	6.1	6.9	2.6	6.5	4.8	7.0	4.6	8.8	6.3	5.7	5.1	5.0	6.1	6.8	7.0	5.7	11.2	5.1	5.3	6.2	5.4	7.4	6.2	6.0	5.0	7.9	6.0	6.4	7.1	6.1	6.7	9.6	5.9	6.8	4.8	7.0	7.0	12.1	6.9	13.2	8.0	5.3	11.9	10.6	6.8	6.5	12.7	8.7	17.9	15.9	18.5	15.1	16.6	17.7	16.3	22.7	16.4	24.7	8.0	32.2	26.1	14.6	20.3	19.6	23.1	20.3	19.6	7.9	12.0	31.0	8.4	22.4	24.3	20.2	212.4	20.3	24.2	15.8	15.4	10.6	15.3	12.7	21.5	13.1	19.6	19.1	31.0	35.5	14.6	18.1	29.8	17.9	16.2	19.1	15.2	14.1	21.6	11.5	21.3	42.1	90.7	9.3	15.4	21.8	15.7	26.3	15.5	17.5	19.8	14.5	19.6	24.7	15.2	15.2	12.6	36.6	16.1	28.4	16.9	15.8	19.5	19.9	18.2	19.4	16.7	19.3	19.9	17.1	2.7	22.5	14.6	25.4	25.5	17.4	6.0	5.3	4.7	6.1	5.0	6.1	5.1	5.3	5.0	4.8	6.9	6.5	12.6	9.6	13.1	5.2	14.3	50.7	54.8	45.9	39.9	9.4	22.8	21.2	7.0	18.6	27.7	9.2	12.5	42.6	23.9	10.4	27.4	28.9	214.7	13.3	25.6	17.5	13.1	16.2	5.0	23.8	73.6	29.1	23.4	14.2	22.9	14.6	11.0	12.2	25.8	15.2	4.7	16.5	32.6	14.4	28.5	49.9	22.1	13.1	37.4	4.7	17.9	8.1	21.6	6.0	6.0	34.7	4.9	16.1	8.4	62.6	15.5	31.1	18.0	10.4	6.6	8.8	26.1	87.6	15.6	35.2	61.8	88.7	19.4	26.8	13.1	59.9
TP53TG3D		ENSG00000205456	"TP53 target 3D"	Q9ULZ0	16	32252719-32255922	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"epididymis: 3.4;testis: 2.2"	"Group enriched"	"Detected in some"	6	"Early spermatids: 77.5;Late spermatids: 21.1;Spermatocytes: 32.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.2;HEL: 1.1;HMC-1: 1.4;RH-30: 1.1;SCLC-21H: 1.2;U-2 OS: 1.2"									"HPA047832, HPA060916"			Approved	"Centriolar satellite"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Centriolar satellite"		"HPA047832: , HPA060916: "	"unprognostic (1.65e-2)"				"unprognostic (1.92e-1)"	"unprognostic (5.60e-2)"		"unprognostic (1.57e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.98e-3)"	"unprognostic (1.47e-2)"		"unprognostic (2.06e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-1)"		0.1	0.8	0.1	0.1	0.2	0.0	0.2	0.8	0.3	0.3	0.0	0.2	0.0	0.4	3.4	0.7	0.2	0.0	0.3	0.1	0.3	0.5	0.0	0.1	0.1	0.3	0.2	0.2	0.1	0.0	0.5	0.4	0.4	0.3	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.1	2.2	0.4	0.0	0.2	0.0	0.0	0.2	0.4	0.4	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	1.2	0.3	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.1	1.2	0.2	0.0	0.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.8	0.3	0.1	0.3	0.3	0.2	0.4	0.1	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.1	0.5	0.8	0.3	0.0	0.1	0.0	2.1	0.1	0.5	0.0	0.0	0.0	77.5	0.1	1.0	0.1	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.6	21.1	1.2	0.1	5.4	0.0	0.0	0.4	0.0	0.0	0.4	0.1	0.0	1.2	0.1	0.2	0.0	0.0	0.2	0.1	6.6	0.6	0.3	32.5	6.6	0.0	0.1	0.0	0.1	0.4	0.0	0.0
TPBGL		ENSG00000261594	"Trophoblast glycoprotein like"	P0DKB5	11	75240774-75243704	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 10.7;testis: 4.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 16.9;Melanocytes: 3.6;Muller glia cells: 10.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 5.1"	"Region enhanced"	"Detected in many"		"medulla oblongata: 10.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.4;HMC-1: 1.8;SCLC-21H: 1.8"	"Low region specificity"	"Detected in many"													NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 5: Muller glia cells - Visual perception"				"unprognostic (1.55e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.93e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.49e-14)"	"unprognostic (3.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.62e-2)"	0.3	1.6	2.0	0.4	3.7	0.0	0.2	0.0	4.0	0.4	0.0	0.3	0.1	0.9	0.0	0.1	0.3	0.3	0.2	1.1	0.6	0.2	0.1	0.2	0.2	10.7	0.3	0.1	0.1	0.0	0.3	0.0	0.7	0.1	0.1	1.4	0.1	0.1	0.0	0.2	0.2	0.6	0.8	0.2	0.1	4.4	0.3	0.1	0.1	0.0	0.2	0.2	0.2	0.8	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.7	0.0	4.0	1.1	0.6	10.7	0.3	0.7	0.8	0.3	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	16.9	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.5	0.0	0.0	0.8	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.2	1.7	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	3.6	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.2	0.0	0.8	0.1	0.0	0.0	0.1	0.1	0.0	0.0
TPP1	"CLN2, LPIC, SCAR7, TPP-1"	ENSG00000166340	"Tripeptidyl peptidase 1"	O14773	11	6612768-6619448	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant, Epilepsy, Neurodegeneration, Neuronal ceroid lipofuscinosis, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 261.6;Kupffer cells: 376.5;Macrophages: 219.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037709, HPA044868"	Enhanced				"Intracellular and membrane"	NA	NA		9500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA037709: AB_10672913, HPA044868: AB_2679122"	"unprognostic (8.27e-3)"	"unprognostic (5.85e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.34e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (4.31e-4)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (3.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-2)"	74.7	145.9	71.0	74.6	81.0	111.7	44.3	80.3	81.4	53.8	120.1	59.1	59.9	74.0	43.1	39.5	47.1	65.1	56.3	70.6	78.4	71.6	92.7	81.5	77.7	85.2	82.6	49.7	36.2	54.2	63.6	94.2	81.0	38.9	59.7	48.5	42.5	57.5	31.4	39.5	73.3	92.0	74.7	135.0	48.4	20.0	83.3	47.4	45.7	39.0	60.9	68.4	42.8	90.4	26.1	48.1	25.9	50.5	309.9	160.1	21.8	50.9	220.7	36.9	62.0	20.1	122.5	37.4	32.6	136.6	220.2	85.8	48.3	68.7	57.9	37.3	27.6	32.2	23.8	54.9	210.9	45.8	182.6	231.8	104.5	45.9	102.6	240.4	158.8	32.9	59.8	124.6	110.4	30.2	16.6	52.4	18.0	61.5	57.1	36.1	21.6	77.0	62.8	38.2	4.5	20.4	52.6	44.6	91.0	76.5	30.8	79.7	188.0	119.7	33.1	101.1	19.8	92.3	95.3	14.0	139.8	101.7	64.5	67.0	167.1	38.2	39.9	171.2	30.0	35.1	31.4	41.0	185.9	37.0	20.1	27.2	27.5	29.1	125.1	93.1	60.3	138.8	71.0	81.0	80.3	81.4	70.6	78.4	85.2	82.6	81.0	74.7	83.3	90.4	32.0	25.6	37.3	31.6	53.0	23.7	28.4	29.8	13.1	24.8	21.1	23.9	41.8	50.1	26.8	16.5	12.5	35.4	71.0	55.2	5.9	42.2	11.8	13.3	30.2	40.7	16.7	37.5	12.5	13.4	45.3	40.3	16.3	24.8	62.2	25.6	75.7	81.0	261.6	15.2	12.4	31.3	26.4	376.5	126.5	11.2	27.1	219.8	90.7	15.9	156.0	37.9	49.4	8.0	21.9	17.4	44.1	26.4	26.4	23.5	99.7	51.6	14.5	23.8	6.6	19.0	20.3	0.8	1.1	27.6	20.0	88.0	42.2	24.6	32.5	26.5
TPSAB1	"TPS1, TPS2, TPSB1"	ENSG00000172236	"Tryptase alpha/beta 1"	Q15661	16	1240379-1242554	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	13	"granulocytes: 5873.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	893	"basophil: 89.3"	"Lineage enriched"	"Detected in single"	893	"granulocytes: 89.3"	"Cell line enriched"	"Detected in some"	166	"HMC-1: 3813.2"									"CAB016369, CAB022175, HPA049153, HPA049554"	Supported				"Secreted to blood"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"CAB016369: AB_628406, CAB022175: , HPA049153: AB_2680656, HPA049554: AB_2680815"	"unprognostic (2.06e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.64e-2)"	"unprognostic (9.31e-3)"	"prognostic favorable (9.62e-6)"	"unprognostic (1.02e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.36e-2)"	96.6	2.9	0.3	23.6	0.5	2.4	47.2	0.3	0.9	53.7	0.9	83.0	71.6	73.3	6.0	64.3	26.6	129.7	14.7	0.4	0.4	13.9	12.2	128.5	21.3	0.4	0.3	3.2	18.9	2.3	3.5	1.2	0.6	65.9	34.6	0.0	60.2	22.5	10.1	122.7	148.7	17.9	0.4	5.9	104.0	8.9	0.4	14.2	4.7	13.0	13.2	113.5	52.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	1.3	3813.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.3	2.1	6.1	0.5	0.4	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.1	1.1	0.0	0.0	2.8	22.9	2.0	89.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.5	0.3	0.9	0.4	0.4	0.4	0.3	0.6	0.4	0.4	0.3	0.0	25.6	135.5	0.0	2.9	18.6	5.1	0.0	1.2	0.0	0.9	0.1	0.3	0.0	8.1	0.0	0.0	0.0	0.2	0.9	0.0	1.2	0.3	0.0	0.0	4.1	0.0	3.8	0.0	0.0	0.2	7.6	0.5	0.0	5873.9	0.0	0.0	0.3	5.2	0.0	0.0	0.0	0.0	0.3	25.6	0.2	0.0	7.7	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	11.7	4.0	0.4	0.1	5.1	0.0	0.0	0.3	3.2	0.0	0.1	0.1	9.9	0.3	440.9	0.0	0.5	5.6
TPSB2		ENSG00000197253	"Tryptase beta 2"	P20231	16	1227272-1230184	"Enzymes, Metabolic proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	25	"granulocytes: 8966.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	50	"basophil: 5.0"	"Lineage enriched"	"Detected in single"	50	"granulocytes: 5.0"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 297.5"									"HPA049153, HPA049554"	Supported				"Secreted to blood"	NA	NA		16000000	"Cluster 10: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"HPA049153: AB_2680656, HPA049554: AB_2680815"	"unprognostic (9.05e-2)"	"unprognostic (8.46e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.27e-2)"	"unprognostic (4.97e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.17e-2)"	95.1	2.5	0.3	20.2	0.6	4.3	47.8	0.3	0.9	53.2	1.0	77.8	35.5	71.8	9.8	64.6	30.4	103.9	15.0	0.5	0.5	15.5	12.2	127.8	26.2	0.5	0.4	3.5	18.9	1.5	3.9	1.3	0.5	67.0	19.8	0.0	64.5	13.3	10.0	122.5	146.1	22.0	0.5	5.2	102.1	9.9	0.5	4.9	4.7	10.4	9.9	118.6	53.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.2	0.4	297.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	4.7	0.3	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.7	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.3	0.9	0.5	0.5	0.5	0.4	0.5	0.5	0.5	0.3	0.1	38.5	275.3	0.0	2.8	0.0	4.4	0.0	0.0	0.0	1.5	0.0	1.5	0.0	16.7	0.0	0.0	0.1	0.6	0.7	0.0	2.4	0.6	0.0	0.0	3.2	0.0	18.9	0.0	0.0	0.2	6.0	2.0	0.0	8966.1	0.0	0.0	0.0	3.8	0.0	0.1	0.7	0.0	0.0	0.0	1.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	25.8	5.4	0.7	0.1	3.6	0.0	0.0	0.4	1.1	0.0	0.7	0.0	0.0	0.1	345.1	0.0	1.0	6.1
TPSD1		ENSG00000095917	"Tryptase delta 1"	Q9BZJ3	16	1256059-1259008	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 21.2"	"Cell type enriched"	"Detected in some"	19	"granulocytes: 202.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	29	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	49	"HEL: 28.2;HMC-1: 40.4"									"CAB002215, CAB032871, HPA040182, HPA049554"	Supported				"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"CAB002215: AB_563870, CAB032871: AB_2206475, HPA040182: AB_2676875, HPA049554: AB_2680815"	"unprognostic (5.99e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.15e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.30e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.50e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.89e-1)"	"unprognostic (7.46e-3)"	8.0	0.5	1.2	1.9	1.3	1.6	4.5	1.3	2.7	5.1	1.0	7.8	3.8	8.5	1.9	8.1	3.2	13.8	1.1	1.4	1.1	1.2	0.7	17.8	5.4	1.4	1.3	0.3	1.5	0.1	0.4	0.1	1.5	5.5	0.8	0.1	4.8	1.2	1.4	9.5	13.4	5.4	1.1	0.4	21.2	1.3	1.4	1.2	0.3	1.0	2.3	13.3	5.0	1.2	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.2	40.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	1.3	2.7	1.4	1.1	1.4	1.3	1.5	1.1	1.4	1.2	0.0	3.2	7.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	10.5	0.0	0.0	0.0	0.2	0.0	0.0	202.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1
TPSG1	"PRSS31, TMT"	ENSG00000116176	"Tryptase gamma 1"	Q9NRR2	16	1221651-1225257	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 14.7"	"Cell type enriched"	"Detected in some"	6	"Intestinal goblet cells: 278.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 5.2"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HMC-1: 23.2;MCF7: 7.9"	"Not detected"	"Not detected"							HPA060458	Enhanced					NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA060458: AB_2684283"	"unprognostic (1.86e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (1.76e-8)"	"unprognostic (2.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (8.65e-4)"	"unprognostic (5.70e-2)"	0.7	1.0	0.4	1.4	1.6	0.0	3.2	0.0	0.4	0.7	0.0	14.7	14.1	1.3	0.1	0.8	0.7	1.0	0.3	0.2	0.4	1.2	0.4	0.8	0.0	0.1	0.1	2.1	0.2	0.0	3.1	0.0	0.3	1.1	9.0	0.1	0.3	0.2	0.2	1.2	9.3	0.3	0.1	0.0	1.1	1.6	0.5	0.0	0.1	0.0	0.0	1.8	0.8	0.0	0.0	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.7	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.4	0.2	0.4	0.1	0.1	0.3	0.1	0.5	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.2	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.9	0.0	0.0	0.4	0.0	0.0	0.0	278.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.3	0.1	5.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	4.7	0.0
TPST2	TANGO13B	ENSG00000128294	"Tyrosylprotein sulfotransferase 2"	O60704	22	26521996-26596717	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 398.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 171.0;NK-cells: 263.7;Plasma cells: 183.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 158.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021054	Enhanced				"Intracellular and membrane"	NA	NA		88000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA021054: AB_1858221"	"unprognostic (2.24e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.08e-5)"	"unprognostic (8.88e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavorable (2.34e-6)"	"unprognostic (9.68e-2)"	"unprognostic (9.21e-3)"	"unprognostic (5.62e-2)"	"unprognostic (2.01e-1)"	24.4	31.0	24.4	15.2	20.8	23.1	21.8	19.1	29.9	17.4	26.9	11.5	13.6	18.0	111.6	18.7	17.0	12.2	27.5	23.4	22.9	24.9	74.9	45.7	19.1	22.0	24.2	9.2	398.8	5.3	9.9	41.8	20.8	16.0	8.8	3.3	10.9	17.8	38.5	18.4	13.4	12.1	23.1	36.4	11.7	20.6	34.2	10.7	38.8	22.6	17.0	17.1	17.3	20.7	12.8	9.1	11.7	6.0	24.4	18.7	16.4	27.9	49.9	22.2	20.3	6.2	6.5	21.4	7.3	50.4	11.6	19.5	8.8	19.2	12.7	8.8	16.9	51.8	5.6	13.1	10.2	6.0	158.7	20.1	30.3	22.5	7.7	22.5	41.6	9.6	52.6	65.2	17.2	14.3	24.3	40.7	15.4	10.0	9.1	22.5	15.8	60.2	6.7	14.3	8.8	6.1	12.9	11.2	16.0	17.0	5.2	24.7	33.2	27.3	61.2	22.5	27.3	20.9	31.5	20.6	20.7	23.1	25.3	490.4	77.0	111.9	249.2	86.3	70.5	23.6	57.0	187.2	48.3	25.6	27.8	163.6	163.0	354.9	94.3	115.3	71.9	240.7	24.4	20.8	19.1	29.9	23.4	22.9	22.0	24.2	20.8	23.1	34.2	20.7	37.3	16.0	12.6	13.7	30.8	38.1	82.5	29.9	14.2	9.0	10.8	13.1	15.5	47.1	14.4	22.0	6.2	171.0	120.8	6.7	27.4	12.9	15.2	31.1	14.8	66.1	0.0	64.6	23.4	65.1	49.8	10.7	5.1	39.5	53.7	13.9	113.6	79.3	123.9	6.7	20.3	9.3	12.2	55.9	48.6	4.5	5.3	70.1	28.4	47.8	32.4	1.9	263.7	5.0	1.9	53.1	8.7	4.1	183.7	36.4	16.5	7.6	18.6	5.3	6.6	9.9	15.3	2.9	13.2	15.1	35.9	143.0	64.4	42.0	11.8	83.7
TRIM24	"hTIF1, RNF82, TIF1, Tif1a"	ENSG00000122779	"Tripartite motif containing 24"	O15164	7	138460259-138589996	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"AF22: 146.5;HMC-1: 196.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043495, HPA061717"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA043495: AB_10962915, HPA061717: AB_2684592"	"unprognostic (2.40e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.94e-4)"	"prognostic favorable (6.57e-4)"	"unprognostic (4.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.54e-2)"	"unprognostic (6.34e-2)"	7.5	25.7	6.0	6.9	6.8	10.6	9.1	5.8	7.0	6.4	5.2	8.1	10.0	8.8	8.4	9.0	5.7	5.3	10.4	6.0	7.1	8.0	23.1	11.4	8.0	6.8	6.4	30.0	10.8	14.2	3.8	12.3	6.3	11.7	9.2	12.2	8.3	5.2	13.9	8.6	9.7	7.6	6.2	7.2	11.6	27.3	8.2	17.3	9.1	16.4	7.8	7.5	6.1	9.0	15.0	18.1	146.5	42.7	9.6	8.9	11.4	13.7	14.4	10.5	10.2	28.7	13.6	28.7	13.2	13.2	21.5	7.9	71.9	11.4	15.4	22.1	17.7	63.1	13.1	88.9	13.1	49.8	196.8	7.9	11.8	8.8	13.9	7.3	25.0	15.4	72.6	17.1	12.7	29.2	85.2	44.8	56.3	77.6	16.0	66.5	17.3	24.2	23.6	43.9	30.3	68.8	25.5	22.6	7.5	50.6	15.5	32.3	10.7	12.1	9.9	21.4	19.1	15.6	18.2	47.8	20.1	32.1	18.0	0.3	0.6	1.0	0.5	0.6	0.1	0.2	0.4	0.3	0.5	0.3	0.4	0.5	0.9	0.6	0.3	0.3	0.7	0.2	6.0	6.8	5.8	7.0	6.0	7.1	6.8	6.4	6.3	6.2	8.2	9.0	29.0	51.3	46.9	26.1	9.5	13.9	13.4	13.8	10.8	13.6	14.7	14.4	39.7	20.0	18.8	7.3	16.7	28.4	14.9	12.2	5.9	7.1	70.4	16.7	22.9	18.9	10.1	31.3	27.9	12.4	15.2	16.0	20.4	25.2	40.4	85.2	14.3	31.9	10.3	40.4	46.6	10.9	14.2	9.5	14.9	38.7	14.0	13.8	14.2	21.5	12.2	23.3	9.2	64.3	67.1	9.5	9.5	16.1	13.7	12.2	6.8	10.6	14.5	22.4	13.1	21.5	17.6	72.8	14.7	22.2	11.8	22.2	15.8	34.6	19.4	12.8
TRPV2	"VRL, VRL-1, VRL1"	ENSG00000187688	"Transient receptor potential cation channel subfamily V member 2"	Q9Y5S1	17	16415571-16437003	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 50.0;Hofbauer cells: 50.6;monocytes: 39.4;NK-cells: 49.4"	"Cancer enriched"	"Detected in all"	8	"melanoma: 59.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 78.8;fHDF/TERT166: 108.4;HMC-1: 89.0;SK-MEL-30: 94.7;TIME: 84.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA044993	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"HPA044993: AB_10960889"	"unprognostic (1.57e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.16e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.40e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.19e-6)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (5.53e-4)"	"unprognostic (8.07e-2)"	"unprognostic (1.23e-1)"	17.1	20.5	6.2	18.3	8.0	22.8	10.4	5.7	7.6	7.9	3.9	7.0	6.6	7.6	1.8	5.3	7.3	8.5	11.2	6.1	9.8	4.7	4.0	30.2	24.6	10.6	15.4	7.8	6.3	8.9	1.6	20.1	17.2	6.0	6.2	1.0	4.5	2.6	3.9	6.5	10.7	11.8	7.1	23.7	5.9	2.0	7.3	15.7	6.2	5.5	16.2	10.7	7.2	8.0	0.3	1.6	0.0	0.0	25.6	78.8	4.9	8.3	9.4	9.1	8.9	0.3	0.3	9.6	2.2	108.4	7.8	0.2	0.2	0.0	5.1	43.0	0.7	10.7	0.0	26.1	30.0	14.8	89.0	35.2	0.0	54.0	0.7	4.1	3.8	12.9	37.2	26.0	43.4	0.5	19.1	20.5	0.1	0.1	0.2	11.3	0.3	4.3	40.6	1.1	1.2	0.1	0.0	0.0	94.7	41.0	0.0	12.7	84.9	0.2	0.3	0.3	1.1	0.1	0.3	5.1	8.2	21.6	12.6	60.8	26.6	35.8	63.4	52.8	55.5	19.2	46.0	59.3	58.7	20.3	25.7	44.8	6.8	63.2	49.4	51.3	49.9	43.1	6.2	8.0	5.7	7.6	6.1	9.8	10.6	15.4	17.2	7.1	7.3	8.0	15.8	0.0	5.3	1.0	11.1	2.8	0.1	0.0	0.0	0.6	0.5	0.4	1.1	1.5	0.6	0.0	0.0	2.2	29.3	0.0	0.0	0.2	0.3	0.4	0.1	12.3	0.0	6.7	3.3	3.6	2.3	11.0	1.1	0.1	50.0	16.7	8.9	0.4	50.6	0.0	2.6	0.0	0.0	19.5	18.2	0.0	1.8	28.7	28.4	4.7	39.4	0.3	49.4	0.5	0.5	4.7	0.1	4.5	15.1	0.0	0.0	0.1	0.8	0.6	26.3	7.9	23.6	1.3	5.9	0.4	1.7	16.1	26.8	2.8	0.0	0.1
TYROBP	"DAP12, KARAP, PLO-SL, PLOSL"	ENSG00000011600	"Transmembrane immune signaling adaptor TYROBP"	O43914	19	35904401-35908295	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 596.8;lymphoid tissue: 423.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 3777.1;Kupffer cells: 3698.1;Langerhans cells: 1990.8;Macrophages: 2837.1;monocytes: 3371.2;NK-cells: 1772.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 6415.4"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"HMC-1: 678.1;THP-1: 390.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009493, HPA041899"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB009493: AB_638987, HPA041899: AB_10795266"	"unprognostic (7.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.39e-2)"	126.3	76.1	55.8	234.3	54.3	596.8	59.1	58.6	116.8	44.3	61.4	62.0	70.6	25.9	15.0	28.1	43.7	105.0	39.7	53.0	66.4	34.4	85.5	261.5	161.0	81.7	64.0	18.3	24.7	22.0	27.0	124.7	74.8	31.7	49.8	3.9	38.3	26.7	10.6	21.5	78.8	68.0	74.1	423.3	43.1	15.0	74.0	52.5	21.9	31.6	36.6	131.7	21.5	114.4	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	56.7	0.0	0.0	0.5	33.2	678.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	49.1	0.3	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.3	0.5	0.0	0.0	0.2	0.9	0.0	390.6	0.0	0.0	0.3	0.8	0.1	0.4	0.1	1.0	0.1	10.8	0.1	974.2	4983.5	2573.9	468.0	3367.8	246.5	22.4	9.5	64.2	1912.0	8.4	11.7	51.2	6415.4	1664.1	3413.8	1653.1	9.5	5260.2	55.8	54.3	58.6	116.8	53.0	66.4	81.7	64.0	74.8	74.1	74.0	114.4	24.5	57.7	168.4	0.0	50.9	55.2	2.0	0.0	1.2	0.1	11.5	43.3	6.8	34.3	43.4	20.2	0.0	19.8	987.6	1.7	1.9	2.1	3.9	1.3	1.4	47.1	0.0	87.8	0.1	5.8	28.0	24.9	5.6	1.5	753.7	0.3	73.2	25.0	3777.1	0.0	0.1	0.2	0.0	3698.1	1990.8	11.6	9.3	2837.1	56.9	18.7	3371.2	0.6	1772.4	0.0	0.1	1.3	2.3	1.2	19.4	1.5	0.5	8.9	20.5	1.8	78.9	5.3	10.0	0.9	3.0	4.9	44.6	38.9	236.5	0.1	0.5	1.8
UBA7	"D8, UBA1B, UBE1L, UBE2"	ENSG00000182179	"Ubiquitin like modifier activating enzyme 7"	P41226	3	49805209-49813953	"Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 52.5;granulocytes: 83.0;Proximal enterocytes: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 56.7;HEL: 55.7;HMC-1: 103.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB015444, HPA058182"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		370000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Vesicles"	Cytosol	"CAB015444: AB_793598, HPA058182: AB_2683631"	"prognostic favorable (1.55e-4)"	"unprognostic (7.07e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.61e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (9.11e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.48e-4)"	21.6	21.4	10.1	32.7	10.6	40.2	20.7	10.4	12.1	25.6	10.4	29.0	43.4	22.5	15.6	18.7	23.8	27.7	17.9	9.8	10.5	25.6	23.0	35.4	51.2	13.7	11.1	32.8	17.2	2.9	14.1	19.4	12.1	34.8	26.1	1.2	42.3	22.4	9.1	20.5	48.6	20.6	12.3	65.6	27.5	5.8	12.2	39.8	31.8	10.3	33.6	23.1	23.3	13.8	11.6	0.1	0.9	0.3	30.2	31.7	3.5	6.1	27.0	42.7	56.7	0.0	23.9	0.4	4.8	22.4	18.3	6.2	0.1	10.9	3.7	29.9	0.1	55.7	0.6	3.5	22.3	5.3	103.7	49.0	0.7	16.9	1.0	29.6	21.7	2.0	0.1	3.4	10.0	0.3	11.6	13.7	0.1	0.0	1.2	14.6	1.0	1.9	8.8	22.3	0.0	0.9	7.4	10.7	3.8	0.6	1.1	36.8	9.7	8.3	1.1	3.7	2.4	0.1	0.2	0.3	23.2	19.8	2.0	20.7	22.5	38.5	16.4	32.9	14.3	17.1	15.0	14.5	21.3	18.1	13.4	12.4	6.8	17.1	27.6	7.6	15.9	22.0	10.1	10.6	10.4	12.1	9.8	10.5	13.7	11.1	12.1	12.3	12.2	13.8	17.3	32.1	20.3	11.4	28.0	3.8	6.3	10.5	6.8	0.2	9.2	9.1	6.9	17.2	16.6	12.9	0.0	5.2	15.5	28.7	0.0	9.5	6.9	5.8	3.0	13.5	9.5	8.0	0.2	7.8	3.5	11.8	52.5	6.5	83.0	13.2	16.1	7.6	21.6	0.0	0.1	21.7	8.2	20.1	6.4	34.1	11.1	32.5	0.0	15.0	16.8	2.4	19.6	1.0	0.1	5.2	21.7	11.3	14.1	4.4	51.8	5.6	12.8	1.2	6.6	5.8	8.1	0.9	0.3	7.3	4.7	2.9	17.7	6.9	20.2	6.6
UBASH3B	"KIAA1959, STS-1, TULA-2, TULA2"	ENSG00000154127	"Ubiquitin associated and SH3 domain containing B"	Q8TF42	11	122655722-122814473	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.0;lymphoid tissue: 15.6;placenta: 13.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 54.9;Inhibitory neurons: 166.3;Langerhans cells: 51.2;Syncytiotrophoblasts: 47.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 122.2;HMC-1: 88.9;hTEC/SVTERT24-B: 72.9;REH: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038605, HPA038606, HPA038607"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		23000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA038605: AB_10669648, HPA038606: , HPA038607: AB_2676112"	"unprognostic (4.94e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.09e-2)"	"unprognostic (4.67e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.20e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.53e-1)"	3.4	0.7	1.1	4.8	1.5	6.7	1.1	15.0	1.9	3.0	0.1	1.2	1.3	1.0	0.2	1.1	0.5	1.9	0.9	1.2	5.5	1.7	1.3	4.6	5.7	10.3	7.1	0.2	0.6	0.4	0.3	13.8	10.2	0.7	1.4	1.9	0.7	0.7	1.1	3.4	1.7	1.9	1.2	15.6	1.4	1.2	2.8	15.1	2.3	0.3	3.2	4.4	0.5	1.4	13.1	31.5	5.6	7.5	2.4	4.4	29.1	45.6	25.1	18.1	13.9	12.5	6.8	5.3	3.5	24.3	17.2	6.4	0.1	16.3	28.7	0.2	0.9	122.2	1.0	10.8	6.7	15.0	88.9	3.9	1.0	72.9	26.9	19.7	12.4	5.3	0.1	0.1	17.8	0.5	18.5	9.6	2.5	13.3	7.4	73.3	3.3	0.7	28.6	10.9	12.7	0.2	12.1	0.9	10.1	11.7	0.2	4.0	32.3	23.4	12.6	13.9	19.1	1.0	0.0	15.1	12.4	20.6	43.4	0.0	1.3	9.9	1.8	6.3	1.9	0.3	2.3	1.7	1.7	1.1	2.6	1.4	2.7	6.4	11.1	0.2	4.7	1.8	1.1	1.5	15.0	1.9	1.2	5.5	10.3	7.1	10.2	1.2	2.8	1.4	2.2	0.0	4.7	9.1	4.6	7.1	4.2	3.4	2.8	1.8	1.2	1.3	1.1	0.0	2.0	3.7	0.0	32.5	10.0	0.6	0.0	8.4	2.4	0.6	4.0	4.5	0.0	1.7	24.8	9.7	54.9	4.9	2.0	1.5	12.7	11.5	5.0	0.6	35.7	11.8	166.3	0.5	4.1	26.0	51.2	3.9	0.0	26.5	1.8	30.0	9.1	0.2	17.5	26.2	2.7	26.3	0.3	0.4	11.4	4.7	0.2	0.6	2.5	1.1	0.0	3.8	3.4	0.1	0.8	2.4	6.0	47.6	16.8	0.1	0.4	3.1
UQCRC2	"QCR2, UQCR2"	ENSG00000140740	"Ubiquinol-cytochrome c reductase core protein 2"	P22695	16	21953288-21983660	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 722.2;tongue: 933.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 556.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007998, HPA019146"	Enhanced		Enhanced	Mitochondria		NA	NA		180000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA007998: AB_1858648, HPA019146: AB_1858649"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (6.58e-9)"	"unprognostic (2.33e-1)"	"unprognostic (9.78e-3)"	"unprognostic (4.67e-3)"	"unprognostic (7.36e-2)"	158.8	117.7	69.0	103.1	71.2	127.7	108.4	75.5	90.0	90.8	113.9	259.8	292.5	98.2	72.7	157.4	109.7	99.5	559.4	72.4	73.7	240.0	245.1	75.4	120.0	74.1	69.5	114.5	89.7	257.2	39.8	96.5	72.7	95.6	262.8	142.3	133.8	104.3	722.2	85.4	233.6	121.2	65.8	80.9	153.2	55.8	76.5	131.3	107.9	933.2	149.3	153.6	59.8	73.3	173.9	193.1	116.5	66.4	154.3	186.8	169.1	163.8	160.6	177.5	174.5	347.9	177.7	338.9	144.3	170.4	129.8	324.6	222.3	212.7	193.7	151.4	178.4	185.9	166.1	494.3	164.6	249.1	501.2	232.3	229.4	130.3	186.2	169.4	248.1	224.1	217.9	159.1	177.2	230.6	288.6	175.0	124.6	261.1	148.8	310.9	263.6	390.0	285.8	214.6	154.4	114.9	237.2	318.6	190.3	151.6	354.4	264.1	179.3	103.3	98.1	104.0	148.0	126.3	87.2	302.7	188.7	239.8	126.4	80.1	128.7	71.4	80.0	147.8	103.3	96.0	98.3	89.3	153.9	77.9	106.8	97.6	45.9	101.8	148.1	67.6	134.8	157.3	69.0	71.2	75.5	90.0	72.4	73.7	74.1	69.5	72.7	65.8	76.5	73.3	105.5	64.1	52.5	81.9	81.1	90.6	190.8	444.0	74.6	109.1	91.7	79.6	556.2	84.4	194.9	71.7	87.6	238.3	82.6	233.4	455.9	124.5	88.0	72.0	55.7	91.3	113.8	92.4	65.0	109.6	157.6	89.0	144.3	65.8	92.6	99.6	84.3	122.3	195.5	69.0	74.0	224.4	238.0	145.1	100.6	89.9	68.3	104.6	131.6	27.2	162.1	108.0	91.6	60.3	50.7	97.2	214.0	97.0	72.9	114.4	378.0	306.9	110.2	152.6	78.9	94.1	109.5	68.9	56.7	132.0	88.4	278.3	91.3	170.2	358.7	204.3
VAPA	"hVAP-33, VAP-A"	ENSG00000101558	"VAMP associated protein A"	Q9P0L0	18	9914016-9960021	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009174	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA		580000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA009174: AB_1080549"	"unprognostic (4.03e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.36e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.99e-2)"	"unprognostic (8.11e-2)"	"prognostic favorable (5.72e-7)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.77e-2)"	33.1	67.1	21.5	24.2	26.8	97.1	29.5	30.7	28.1	30.2	21.5	38.6	31.2	32.9	24.8	47.5	29.3	31.9	37.5	23.2	24.9	32.6	36.6	33.9	25.7	34.9	26.3	39.1	40.9	36.2	17.7	29.8	34.5	24.5	35.4	20.1	32.6	22.0	69.7	32.3	30.6	27.4	27.8	26.7	38.9	29.1	25.5	30.0	35.2	38.4	26.3	36.5	32.2	30.7	58.1	34.4	40.7	26.7	46.9	50.5	56.8	69.9	57.9	62.3	67.9	46.6	55.9	56.5	63.6	61.5	53.9	39.7	39.8	66.7	70.7	35.6	49.8	92.4	33.8	72.3	110.8	126.3	169.7	47.8	66.3	59.0	69.6	48.7	64.0	45.4	94.6	57.3	55.2	31.2	97.4	72.9	26.2	197.6	54.3	50.4	55.2	77.5	60.9	57.3	57.2	31.2	81.1	48.7	53.2	37.2	45.7	64.2	68.9	100.7	75.3	105.6	86.3	101.9	89.2	66.6	57.0	53.5	70.8	131.3	143.3	251.0	69.8	127.9	82.9	100.0	72.1	75.4	118.1	94.4	78.1	72.1	226.2	90.8	109.5	84.6	98.9	183.9	21.5	26.8	30.7	28.1	23.2	24.9	34.9	26.3	34.5	27.8	25.5	30.7	173.6	128.2	178.8	63.0	160.0	673.4	358.4	356.5	278.3	113.9	248.2	179.3	218.3	167.3	229.4	207.8	62.6	296.9	148.0	427.2	457.8	291.8	10.5	235.9	182.2	232.4	144.6	188.1	91.4	361.3	321.6	221.4	156.0	255.8	225.2	220.2	211.3	141.1	287.8	136.3	93.2	180.6	390.6	288.2	459.8	21.7	182.0	285.9	279.3	63.7	350.4	124.3	108.1	102.1	150.4	310.2	262.7	216.3	146.6	335.4	255.9	390.4	265.5	79.5	190.7	204.8	371.4	231.3	201.4	267.3	622.5	452.6	190.2	253.6	201.0	390.8
VCPIP1	"DUBA3, FLJ23132, KIAA1850, VCIP135"	ENSG00000175073	"Valosin containing protein interacting protein 1"	Q96JH7	8	66628487-66667231	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 20.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023932	Uncertain		Approved	"Plasma membrane,Centrosome"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"	Centrosome	"HPA023932: AB_2671373"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.23e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.96e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.28e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.58e-3)"	4.6	3.6	3.2	6.0	3.6	20.2	4.8	4.1	5.1	3.7	1.8	4.4	3.8	3.0	4.5	3.5	2.9	3.7	2.9	4.1	4.7	4.4	7.0	4.1	8.6	4.0	3.6	3.9	4.0	5.6	1.6	4.4	4.4	3.6	4.1	4.5	4.2	3.1	5.3	3.3	3.6	3.3	3.4	8.8	4.5	5.7	5.0	5.3	4.2	5.3	7.7	4.1	2.4	4.3	8.5	7.6	3.8	5.1	11.5	8.1	3.7	6.7	6.7	5.0	5.8	4.5	7.8	11.5	1.9	9.0	6.2	7.4	6.2	5.6	7.2	8.6	4.5	12.8	7.5	5.6	6.9	4.3	13.2	8.7	8.1	5.5	9.9	6.1	5.5	6.1	8.8	10.8	7.5	4.1	9.4	7.4	7.3	7.1	5.2	5.9	6.0	5.8	7.3	6.6	2.2	4.3	5.2	7.8	6.0	4.8	8.0	7.0	11.1	6.6	4.9	5.9	4.5	9.5	5.0	11.9	6.6	6.0	5.1	10.0	2.7	5.9	3.4	4.3	2.8	1.7	2.1	2.5	2.9	2.2	1.7	2.2	9.7	2.4	8.3	1.1	2.8	1.7	3.2	3.6	4.1	5.1	4.1	4.7	4.0	3.6	4.4	3.4	5.0	4.3	18.6	19.2	15.2	9.8	18.5	17.0	9.3	10.3	12.5	11.0	12.6	9.4	20.3	11.5	12.8	7.3	22.9	10.4	38.9	18.4	3.9	10.2	7.5	16.7	17.1	14.2	6.0	23.4	17.6	13.6	5.5	15.0	15.3	16.4	19.0	12.4	17.2	22.9	14.9	11.8	18.1	15.5	8.2	47.3	20.4	5.2	8.1	25.6	10.6	14.0	28.6	11.9	39.1	13.6	21.1	13.0	16.6	15.8	21.8	14.2	14.7	12.8	18.6	12.1	6.6	21.7	20.2	32.9	16.6	16.3	20.6	9.9	28.6	11.8	13.2	16.9
VSIR	"B7-H5, B7H5, C10orf54, Dies1, GI24, PD-1H, SISP1, VISTA"	ENSG00000107738	"V-set immunoregulatory receptor"	Q9H7M9	10	71747556-71773520	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 90.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 217.1;Cytotrophoblasts: 324.4;Extravillous trophoblasts: 293.4;Syncytiotrophoblasts: 677.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1006.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 63.1;HaCaT: 48.0;HMC-1: 78.6;U-937: 71.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007968			Approved	Nucleoplasm		NA	NA		320000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"HPA007968: AB_1845518"	"unprognostic (1.19e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.57e-3)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (2.37e-3)"	"unprognostic (3.29e-1)"	40.8	8.0	32.9	31.6	33.6	81.4	28.6	31.4	38.3	18.7	25.0	18.9	21.2	23.8	3.5	23.7	24.5	12.7	28.2	29.9	33.6	8.3	4.8	34.7	25.7	39.3	34.4	17.6	6.3	2.8	5.5	23.6	33.4	15.5	8.3	0.7	12.2	9.7	7.6	15.3	25.3	15.9	33.0	90.3	14.5	3.6	36.7	10.7	12.3	12.9	20.6	19.6	20.7	30.4	8.2	15.7	0.0	0.2	8.1	6.7	7.4	2.9	18.8	3.7	6.1	6.5	63.1	0.5	3.9	27.1	0.0	48.0	0.0	1.8	1.0	0.3	0.1	10.7	3.1	0.6	11.2	1.8	78.6	5.6	1.8	0.5	0.3	5.3	1.3	1.4	0.2	5.9	2.3	0.3	1.9	13.5	0.0	12.3	3.1	0.1	0.8	3.8	0.0	3.8	0.0	0.3	4.1	3.0	3.0	0.9	0.2	23.0	4.2	0.0	0.0	12.7	0.0	4.4	2.3	0.1	0.4	71.5	0.2	237.3	400.9	768.1	75.4	371.8	99.5	15.0	75.2	71.7	220.3	16.8	68.6	69.2	1006.0	56.8	435.5	58.0	82.9	472.3	32.9	33.6	31.4	38.3	29.9	33.6	39.3	34.4	33.4	33.0	36.7	30.4	217.1	28.9	6.8	0.0	15.6	0.0	0.0	0.0	0.0	0.0	10.5	15.5	0.0	0.0	6.2	11.0	0.0	324.4	51.6	0.0	0.0	41.3	0.0	1.9	8.1	33.0	0.0	0.0	0.0	10.6	293.4	32.5	0.0	1.7	31.5	0.3	0.0	0.0	71.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.5	0.0	0.0	67.7	0.0	0.0	0.0	0.0	59.8	0.0	0.0	12.6	0.0	0.0	14.5	3.6	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	677.7	34.7	5.1	0.0	0.0
VSTM1	UNQ3033	ENSG00000189068	"V-set and transmembrane domain containing 1"	Q6UX27	19	54040825-54063953	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"bone marrow: 43.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.4;Late spermatids: 20.3;Macrophages: 4.5;monocytes: 12.4;NK-cells: 3.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	16	"eosinophil: 129.2"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 129.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.0;hTERT-HME1: 1.0;U-2 OS: 1.0"					"Low region specificity"	"Detected in all"			HPA059365			Approved	Vesicles	"Secreted to blood"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"HPA059365: "	"unprognostic (5.13e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.30e-1)"		"unprognostic (1.09e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.31e-5)"	"unprognostic (3.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.74e-2)"	"unprognostic (4.67e-2)"	0.2	0.1	0.0	0.2	0.0	43.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.0	0.1	0.2	1.0	0.0	0.0	0.0	0.0	1.4	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.0	3.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	7.4	129.2	0.0	6.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	8.1	0.0	0.0	4.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	3.4	0.2	0.1	0.1	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	2.1	0.0	0.4	0.0	0.0	2.5	0.0	20.3	0.0	4.5	0.0	0.0	12.4	0.0	3.1	0.5	0.6	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0
WAS	"IMD2, THC, WASP, WASPA"	ENSG00000015285	"WASP actin nucleation promoting factor"	P42768	X	48676596-48691427	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 58.4;lymphoid tissue: 83.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 83.2;dendritic cells: 91.7;Hofbauer cells: 111.5;Kupffer cells: 110.7;Macrophages: 118.1;monocytes: 88.2;NK-cells: 84.5;Plasma cells: 57.8;T-cells: 99.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 37.4"	"Group enriched"	"Detected in all"	4	"granulocytes: 37.4;monocytes: 9.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 76.5;HEL: 67.6;HMC-1: 157.0;MOLT-4: 70.8;NB-4: 75.7;RPMI-8226: 94.0;THP-1: 68.8;U-266/70: 83.1;U-937: 87.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002022, CAB004290"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		600000	"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Cytosol	"CAB004290: AB_628445, HPA002022: AB_1080581"	"unprognostic (1.43e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.36e-2)"	"prognostic favorable (4.95e-4)"	"unprognostic (9.89e-2)"	"prognostic favorable (3.78e-4)"	"unprognostic (5.12e-3)"	"unprognostic (7.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavorable (5.58e-6)"	"unprognostic (2.24e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.71e-1)"	10.2	5.2	6.3	52.2	5.8	58.4	4.4	5.9	8.1	3.3	6.3	6.4	8.0	2.8	3.0	3.5	5.6	6.9	3.5	6.0	8.0	4.4	7.2	19.1	54.2	11.1	8.2	1.8	2.4	1.4	2.9	9.0	8.6	4.2	5.0	0.4	4.9	2.8	1.4	2.8	23.0	6.1	8.0	83.0	7.0	1.9	8.6	42.0	3.5	3.4	36.2	10.3	3.0	10.8	0.8	0.2	0.4	1.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.6	0.9	76.5	0.3	0.0	0.3	2.0	0.3	0.2	0.0	44.2	0.4	67.6	0.9	0.0	0.8	34.9	157.0	0.3	0.1	0.1	0.0	0.0	0.0	40.3	0.7	45.7	0.0	7.6	70.8	75.7	0.4	1.1	0.4	61.1	0.3	94.0	0.1	0.0	0.5	0.9	1.0	0.7	0.5	0.2	0.4	68.8	0.5	0.1	0.4	1.2	0.1	83.1	43.6	53.7	0.5	87.4	0.2	3.3	7.6	37.4	4.6	8.4	3.4	3.0	3.5	3.9	5.7	3.3	3.1	3.5	29.2	3.6	9.5	3.1	5.4	4.0	6.3	5.8	5.9	8.1	6.0	8.0	11.1	8.2	8.6	8.0	8.6	10.8	1.5	3.2	14.3	0.7	83.2	2.4	0.2	0.2	2.2	0.2	1.1	1.8	1.1	0.0	0.1	0.0	0.0	0.9	91.7	0.3	1.9	0.4	0.6	0.4	0.4	2.6	1.2	14.1	0.3	0.4	1.1	1.5	5.6	0.3	48.1	0.2	3.9	1.6	111.5	0.0	0.3	0.2	0.0	110.7	54.5	1.1	0.0	118.1	3.6	4.7	88.2	0.2	84.5	0.5	0.0	0.1	0.1	0.0	57.8	0.2	0.1	1.8	1.6	0.2	0.0	1.0	1.3	1.3	1.1	0.8	1.4	1.4	99.3	0.4	0.1	0.2
Z83844.2		ENSG00000285304	"Novel protein"		22	37639693-37666932	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"bone marrow: 8.8"	"Not detected"	"Not detected"							"Region enhanced"	"Detected in single"		"cerebral cortex: 1.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 33.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA000757	Approved		Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"		"Cluster 3: HMC-1 - Innate immune response"		Cytosol		"HPA000757: AB_1079951"																		1.0	0.2	0.1	7.3	0.0	8.8	1.0	0.1	1.4	3.1	0.0	5.9	5.6	1.3	0.0	4.0	1.6	1.3	0.5	0.2	0.1	0.0	0.9	3.4	7.4	0.0	0.0	1.0	0.7	2.6		3.7	0.2	0.9	5.0	0.1	2.1	2.3	0.2	1.7	8.1	2.3	0.1	3.9	1.4	0.7	0.2	6.5	0.5	0.0	6.6	4.2		0.4	14.7	2.1	7.7	5.0	2.3	6.5	8.3	4.1	12.9	15.3	15.8	9.8	3.5	8.4	1.4	4.5	5.1	12.2	9.2	22.3	4.7	10.2	7.0	21.3	0.0	10.7	4.2	33.2	25.5	7.8	9.4	17.7	1.6	6.5	0.9	6.1	5.9	7.5	0.7	13.4	1.2	1.9	7.9	23.9	1.6	12.6	4.9	7.7	1.6	4.5	4.4	7.2	1.1	4.9	8.0	5.4	6.4	14.5	1.5	2.0	7.5	1.2	0.0	12.3	4.7	8.8	5.2	21.5	14.8	0.0	0.6	0.0	0.4	0.3	0.3	0.3	0.2	0.5	0.9	0.2	0.6	0.4	0.0	0.5	0.6	0.4	0.6	0.3	0.1	0.0	0.1	1.4	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZBTB48	"HKR3, TZAP, ZNF855"	ENSG00000204859	"Zinc finger and BTB domain containing 48"	P10074	1	6579994-6589280	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030417	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA030417: AB_10603145"	"unprognostic (6.66e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (7.15e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.15e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.70e-1)"	"prognostic favorable (5.19e-6)"	"unprognostic (7.73e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.91e-3)"	10.1	10.9	6.7	13.3	7.3	14.2	10.8	6.9	8.6	15.4	9.3	10.7	11.8	11.0	11.9	11.9	13.1	11.2	8.5	7.2	7.2	11.5	21.2	11.1	14.1	7.1	7.7	16.5	11.6	13.3	11.9	10.5	7.2	15.5	12.4	6.9	11.5	10.0	10.2	14.1	11.5	10.6	6.5	16.0	12.4	25.5	7.8	16.9	14.2	14.2	15.0	12.0	13.0	8.5	6.5	7.2	12.1	17.8	13.0	10.1	6.1	6.3	7.5	12.2	12.8	8.1	14.8	20.8	11.1	5.7	8.1	12.4	18.3	12.8	9.3	21.6	16.5	17.0	24.1	7.9	15.1	28.0	45.2	10.0	9.5	11.9	18.9	16.1	8.9	16.0	17.5	13.2	9.0	12.0	14.0	20.0	9.2	12.7	12.9	15.5	11.3	23.4	10.6	5.3	23.4	10.7	9.7	22.3	15.1	12.1	12.7	22.2	9.9	8.3	5.3	9.1	8.3	14.7	13.8	33.2	7.7	22.0	5.1	20.0	10.5	42.3	8.3	6.5	8.5	9.1	6.5	8.1	11.5	10.5	8.7	7.8	14.6	10.6	10.7	7.7	5.9	8.4	6.7	7.3	6.9	8.6	7.2	7.2	7.1	7.7	7.2	6.5	7.8	8.5	7.7	3.2	12.3	10.4	13.0	4.7	9.3	13.3	3.4	8.0	7.8	8.0	5.8	11.5	10.0	11.0	6.2	6.1	12.5	15.1	11.7	4.7	61.8	10.1	7.1	6.1	15.5	3.4	7.5	3.6	5.1	6.8	23.4	6.5	26.6	10.1	7.1	15.1	10.8	10.1	6.6	15.5	14.2	7.6	5.4	19.1	8.7	11.2	5.4	4.7	9.2	11.1	9.2	4.0	5.5	3.1	14.6	5.7	6.6	5.6	22.6	12.6	18.3	7.8	19.7	10.5	8.2	34.5	14.8	5.3	5.5	5.1	9.9	13.6	10.0	6.5
ZBTB9	"MGC23166, ZNF919"	ENSG00000213588	"Zinc finger and BTB domain containing 9"	Q96C00	6	33453970-33457544	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 4.5;Ionocytes: 6.1;Respiratory ciliated cells: 4.3;Suprabasal keratinocytes: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 11.6;BEWO: 11.3;GAMG: 16.5;HMC-1: 14.2;U-698: 12.0"	"Low region specificity"	"Detected in all"							"HPA036767, HPA058171"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA036767: AB_10696787, HPA058171: "	"unprognostic (1.79e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.85e-4)"	"unprognostic (4.20e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.95e-1)"	2.8	3.9	0.9	1.5	1.0	1.7	2.3	0.8	1.6	2.5	8.6	2.4	2.3	2.6	1.7	3.8	2.5	0.6	3.0	1.9	0.7	4.4	3.2	2.4	1.9	1.2	0.9	3.0	2.9	0.6	10.0	0.5	0.6	2.4	1.4	1.9	2.9	0.1	1.8	3.8	2.7	0.8	0.2	3.5	2.7	7.4	0.4	0.2	2.2	1.0	3.3	2.5	2.2	0.9	1.0	0.3	11.6	2.9	2.1	0.1	11.3	0.6	0.2	0.2	0.1	3.0	0.8	2.7	1.8	0.3	16.5	1.2	4.8	2.4	1.3	3.1	2.0	9.0	2.3	0.0	0.0	2.3	14.2	0.5	0.9	3.3	2.6	0.6	0.1	1.5	3.2	1.8	2.6	1.6	0.6	0.9	4.3	0.5	0.7	5.6	3.0	2.7	2.2	2.3	1.8	1.1	3.3	0.3	1.1	1.1	1.6	0.4	1.9	0.9	1.3	1.3	1.2	0.7	3.5	12.0	0.9	2.9	0.3	5.2	1.1	0.4	2.8	0.8	1.2	0.4	1.2	2.6	1.5	0.8	2.5	1.9	0.8	1.3	1.7	0.3	2.2	0.6	0.9	1.0	0.8	1.6	1.9	0.7	1.2	0.9	0.6	0.2	0.4	0.9	0.1	0.0	0.0	1.3	2.1	4.5	0.0	1.9	1.8	0.0	0.2	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.5	0.0	1.5	0.3	0.4	0.1	0.6	1.8	1.3	1.2	1.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.7	6.1	0.0	1.2	1.1	0.0	0.2	1.8	1.0	0.0	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.6	0.0	0.2	0.1	4.3	0.0	0.0	0.0	0.7	0.1	0.1	0.8	3.7	0.0	0.7	0.1	1.0	0.0
ZNF200		ENSG00000010539	"Zinc finger protein 200"	P98182	16	3222325-3236221	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 17.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 51.8;Spermatocytes: 39.0;Spermatogonia: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018981, HPA059310"	Uncertain		Approved	Mitochondria		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Mitochondria		"HPA018981: AB_1859021, HPA059310: AB_2683974"	"unprognostic (1.74e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.21e-2)"	"unprognostic (8.78e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.23e-3)"	3.7	3.0	2.2	5.8	2.3	2.4	4.4	3.1	3.3	3.5	2.2	3.4	4.1	3.8	3.7	3.3	4.3	3.5	3.4	2.4	2.5	3.5	3.9	4.0	7.0	2.5	2.3	4.4	2.2	4.7	2.4	6.3	2.3	3.4	3.6	4.0	2.8	3.4	2.1	3.2	3.2	3.9	2.4	6.1	3.3	17.6	2.4	5.2	3.3	3.6	6.6	4.2	2.9	2.4	7.1	7.3	16.1	11.6	5.9	6.1	19.2	9.1	11.2	12.2	11.2	11.2	5.9	13.6	6.8	7.4	7.2	5.3	13.2	9.8	14.6	12.7	12.2	11.3	9.6	9.5	7.8	19.9	26.0	6.2	8.3	9.0	8.1	7.0	10.8	9.7	12.8	10.3	11.1	6.5	14.0	10.8	25.3	8.8	6.9	16.9	22.0	16.0	7.6	4.0	9.1	13.3	8.6	6.5	7.5	11.0	9.3	21.9	7.4	12.4	11.4	4.5	8.0	25.8	27.1	11.9	3.0	12.3	9.8	32.4	5.3	18.4	10.6	6.8	10.3	7.2	9.4	12.5	6.6	6.9	9.6	10.9	22.1	11.6	6.6	4.2	12.1	7.2	2.2	2.3	3.1	3.3	2.4	2.5	2.5	2.3	2.3	2.4	2.4	2.4	10.7	3.2	3.7	4.2	6.4	3.2	4.5	4.2	1.2	5.4	5.2	5.8	3.9	5.7	5.1	3.7	12.5	7.5	7.4	3.3	3.9	5.0	51.8	3.6	3.2	8.1	6.7	9.1	5.2	4.0	6.7	5.0	0.5	3.1	5.1	5.7	10.4	3.8	7.1	0.0	4.1	3.8	4.1	6.6	5.4	22.6	5.6	6.6	7.2	1.9	6.3	6.7	13.4	5.0	3.4	3.6	6.3	3.0	5.7	4.6	3.7	2.8	3.5	8.1	6.6	7.4	4.5	39.0	44.9	4.3	3.1	5.9	8.5	6.1	3.5	4.0
ZNF490	KIAA1198	ENSG00000188033	"Zinc finger protein 490"	Q9ULM2	19	12576100-12640098	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 10.2;Gastric mucus-secreting cells: 13.7;Inhibitory neurons: 9.3;Oligodendrocytes: 10.0;Plasma cells: 14.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA005576	Uncertain					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"			"HPA005576: AB_10602689"	"unprognostic (1.81e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.77e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.59e-2)"	"unprognostic (5.79e-2)"	0.7	1.0	2.0	1.3	1.9	1.7	1.4	2.1	2.4	1.3	0.3	1.2	1.2	1.0	2.0	0.8	1.5	1.1	0.9	1.6	2.1	1.3	1.8	1.3	2.0	1.0	0.8	1.8	1.5	1.9	0.5	1.1	1.0	1.4	1.3	2.1	1.1	1.3	0.9	1.8	0.9	0.9	0.2	2.4	1.2	1.4	1.7	2.2	2.3	1.0	2.4	1.0	0.5	2.2	0.7	0.6	1.2	3.3	3.5	2.3	1.0	0.9	1.6	1.2	1.5	1.1	1.0	1.2	2.0	1.2	0.8	0.9	1.7	1.4	1.6	1.6	1.0	1.5	1.4	1.4	1.9	2.9	3.6	1.8	1.6	1.0	2.2	1.7	1.1	1.4	1.1	1.4	1.6	1.5	2.0	2.2	1.8	0.6	1.8	1.5	1.8	2.1	1.4	1.8	2.2	1.5	1.9	1.2	1.5	1.8	1.7	1.7	1.6	3.0	0.8	2.2	1.0	4.3	3.3	1.5	1.6	1.9	2.0	5.0	1.5	2.3	2.7	2.1	2.5	2.2	1.7	2.6	1.3	2.8	1.5	2.6	1.4	3.8	2.6	3.8	2.3	1.0	2.0	1.9	2.1	2.4	1.6	2.1	1.0	0.8	1.0	0.2	1.7	2.2	1.7	0.0	1.1	7.2	7.4	0.5	0.3	1.2	2.8	1.4	1.8	1.8	1.2	1.5	1.7	0.0	0.0	0.3	2.7	0.9	1.9	0.2	3.9	1.6	3.0	1.5	0.0	3.8	10.2	0.2	0.2	2.4	13.7	2.3	5.7	1.5	0.0	1.0	0.4	0.0	9.3	0.1	0.0	1.6	1.8	1.6	0.6	2.4	3.6	6.5	0.3	0.5	1.0	4.0	10.0	0.2	0.1	0.0	14.8	0.3	0.9	0.3	0.8	0.8	6.6	0.8	2.2	0.9	1.0	4.9	0.3	0.8	6.0	1.1	0.5	0.2
ZNF619	FLJ90764	ENSG00000177873	"Zinc finger protein 619"	Q8N2I2	3	40477113-40491053	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA045094	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Intermediate filaments"	"HPA045094: AB_10959900"	"unprognostic (7.16e-2)"	"unprognostic (5.94e-1)"	"unprognostic (8.38e-3)"	"unprognostic (5.42e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.99e-2)"	"unprognostic (6.15e-3)"	"unprognostic (8.28e-6)"	"unprognostic (1.94e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.38e-2)"	1.7	1.6	2.3	2.0	3.5	3.1	2.9	3.0	2.8	2.0	2.5	2.0	2.3	2.0	2.1	1.4	2.5	1.3	1.8	2.2	2.6	2.2	2.4	2.0	2.4	3.0	3.0	2.6	2.5	3.1	1.2	2.0	3.0	2.1	2.6	4.1	2.7	2.2	2.5	2.4	2.0	2.3	2.2	2.9	2.4	1.1	3.0	1.5	3.0	2.2	2.9	1.7	1.5	4.6	1.9	2.5	2.9	2.8	4.5	4.3	1.3	2.7	3.1	4.5	3.9	0.9	2.6	0.2	1.4	2.2	2.2	2.1	3.2	5.0	4.8	3.6	1.1	6.1	2.2	1.4	4.6	4.2	5.0	3.4	3.9	4.7	6.6	3.9	3.8	0.2	3.9	2.9	2.9	2.3	0.1	2.1	1.6	2.2	2.8	1.2	3.0	3.3	2.1	4.2	2.1	2.2	2.4	4.1	2.0	2.9	3.4	2.7	3.6	3.3	2.7	2.0	2.8	1.6	2.2	0.2	2.1	2.6	3.7	0.8	0.7	1.1	0.7	0.9	0.7	0.7	0.6	0.8	1.0	0.8	0.6	0.9	0.8	1.3	1.0	0.6	1.2	0.7	2.3	3.5	3.0	2.8	2.2	2.6	3.0	3.0	3.0	2.2	3.0	4.6	1.5	0.0	1.1	1.0	2.3	0.3	0.8	0.6	1.2	3.6	1.0	1.0	1.3	0.0	0.3	3.7	2.1	1.4	1.0	0.7	0.0	1.4	0.1	1.4	1.6	1.6	0.0	2.1	0.5	1.5	0.9	1.2	1.5	1.1	0.0	2.4	1.8	0.9	1.1	0.0	1.0	1.3	0.0	1.6	0.4	0.0	1.2	1.2	0.0	2.8	1.6	2.5	2.1	1.0	2.3	0.6	0.2	0.4	1.7	0.5	1.6	1.3	1.0	3.6	0.0	2.0	1.1	1.2	1.4	1.7	0.1	0.4	1.5	2.5	0.8	0.6
ZNF648	FLJ46813	ENSG00000179930	"Zinc finger protein 648"	Q5T619	1	182054570-182061712	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.7;Early spermatids: 1.2;Melanocytes: 1.8;Spermatogonia: 1.3;Theca cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	78	"HMC-1: 36.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053897	Uncertain					NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA053897: AB_2682297"	"unprognostic (3.52e-4)"	"unprognostic (1.44e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.30e-1)"		"unprognostic (4.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-2)"	"unprognostic (8.16e-6)"	"unprognostic (4.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.83e-1)"	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.4	0.0	0.0	0.4	0.4	0.4	0.1	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.8	0.4	0.4	0.5	0.1	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	2.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0
ZNF768	FLJ23436	ENSG00000169957	"Zinc finger protein 768"	Q9H5H4	16	30524004-30526821	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024630, HPA066512"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA024630: AB_1859446, HPA066512: AB_2685683"	"unprognostic (2.33e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (9.30e-6)"	"unprognostic (4.49e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.13e-1)"	"prognostic favorable (6.46e-4)"	22.3	23.2	31.4	9.9	32.9	13.3	22.6	30.6	35.0	28.7	28.3	42.6	29.8	30.8	9.9	22.8	27.5	10.1	49.3	27.8	27.7	34.8	38.5	19.0	7.3	32.3	31.9	28.9	25.7	30.2	27.2	11.3	30.3	30.3	17.0	13.7	25.6	21.1	93.8	28.2	31.1	13.4	28.5	22.1	30.9	39.3	33.0	6.0	23.7	53.1	7.4	34.9	23.0	29.9	27.1	33.3	37.0	36.1	17.6	20.3	29.1	20.2	22.5	32.7	28.4	21.3	36.8	17.1	30.1	14.2	26.3	35.4	24.8	24.1	19.4	38.5	52.6	40.0	24.0	30.0	44.1	26.8	121.3	17.9	52.5	25.1	32.4	30.2	21.9	6.7	47.4	28.0	17.1	74.9	10.0	64.7	34.8	22.0	27.1	50.7	24.7	42.5	23.9	14.0	43.6	48.4	11.5	59.9	77.3	15.9	59.3	66.5	14.9	34.2	25.9	19.4	22.8	41.3	32.4	21.1	28.5	41.4	35.2	0.0	0.4	1.0	0.0	0.6	0.1	1.1	0.1	0.0	0.6	0.4	0.1	0.0	0.5	0.6	0.1	0.5	0.0	0.2	31.4	32.9	30.6	35.0	27.8	27.7	32.3	31.9	30.3	28.5	33.0	29.9	9.7	9.6	1.9	8.8	4.1	5.5	6.7	9.5	6.8	13.3	15.4	12.6	7.6	14.3	5.5	16.5	2.1	7.2	2.0	50.4	11.7	12.2	18.4	10.9	9.9	9.2	18.0	3.8	2.6	16.2	8.0	6.5	10.7	13.3	3.8	15.5	14.6	17.9	12.7	21.9	3.4	29.1	8.2	8.1	7.7	7.4	10.8	6.1	5.4	4.7	6.8	16.5	0.0	4.0	4.5	11.6	38.2	13.2	2.2	7.9	38.9	17.0	7.4	12.7	6.6	11.8	10.5	15.2	5.1	10.0	5.7	3.6	2.1	14.1	31.3	5.3
ZNRF1	"DKFZp434E229, FLJ14846, nin283"	ENSG00000186187	"Zinc and ring finger 1"	Q8ND25	16	74999024-75110994	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.4;T-reg: 2.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.4;T-cells: 2.4"	"Cell line enhanced"	"Detected in all"		"HMC-1: 176.9;MOLT-4: 134.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027470	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"HPA027470: AB_10603108"	"unprognostic (2.78e-2)"	"prognostic favorable (9.90e-4)"	"unprognostic (4.45e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.44e-2)"	18.7	16.5	21.1	9.6	22.3	6.7	17.8	9.1	22.8	25.3	19.0	30.6	9.6	22.5	9.5	65.9	18.0	7.5	21.0	23.4	24.5	14.7	17.6	24.1	7.7	19.6	22.5	17.4	11.5	11.8	13.4	11.2	18.6	13.7	12.1	7.4	16.9	7.0	81.2	25.0	15.3	11.4	13.4	4.5	21.0	37.4	30.7	53.2	29.3	30.6	13.3	22.5	26.4	17.5	10.9	15.7	26.7	27.5	27.7	21.4	91.2	13.0	18.3	17.5	17.1	25.4	33.2	2.9	9.9	28.3	16.8	25.5	13.0	17.8	13.9	26.7	7.5	56.7	4.8	47.0	22.0	27.5	176.9	19.5	14.7	18.4	14.9	30.8	29.0	68.3	27.8	8.8	13.7	104.5	134.6	100.6	37.1	31.4	16.7	59.0	10.0	17.4	25.1	30.5	35.4	37.7	20.7	27.0	8.3	21.7	71.6	25.8	19.9	12.0	21.0	21.5	7.9	50.5	55.1	31.6	15.8	30.2	12.6	2.4	0.5	0.4	0.0	0.5	0.5	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.5	0.0	2.4	0.1	21.1	22.3	9.1	22.8	23.4	24.5	19.6	22.5	18.6	13.4	30.7	17.5	34.8	9.6	14.4	16.6	1.8	15.9	16.0	11.2	4.6	12.6	24.3	22.4	16.4	18.6	14.0	3.7	52.1	6.4	2.3	25.5	0.0	8.9	25.9	30.7	15.1	30.2	19.8	30.5	45.2	12.7	10.1	15.1	18.3	28.0	36.8	23.7	12.8	14.4	10.4	3.3	42.4	14.0	14.2	7.3	10.9	16.3	6.8	7.3	14.2	33.7	7.6	15.0	0.0	33.7	29.5	20.0	12.1	4.1	1.8	17.2	9.6	6.2	15.1	6.5	0.0	12.4	14.7	13.6	18.7	21.0	19.6	4.5	13.3	16.7	12.7	29.6
ZPR1	ZNF259	ENSG00000109917	"ZPR1 zinc finger"	O75312	11	116773799-116788039	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 228.5;Late spermatids: 418.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022596, HPA030979"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"CAB022596: , HPA030979: AB_2673684"	"unprognostic (2.12e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (8.01e-4)"	"prognostic unfavorable (5.87e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.42e-2)"	"unprognostic (4.96e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.71e-2)"	"unprognostic (6.66e-2)"	21.2	12.3	12.2	14.3	12.7	35.2	16.5	10.9	13.4	13.4	8.3	13.9	10.6	14.0	13.0	16.5	13.5	11.6	14.3	13.7	13.6	16.3	24.5	14.4	15.6	12.4	12.2	15.2	21.1	9.6	11.8	12.8	12.6	13.3	12.6	5.6	12.3	12.3	28.4	15.3	14.2	15.6	13.6	14.1	16.1	27.3	14.0	13.9	14.1	14.3	18.7	20.3	13.6	14.2	23.3	33.3	19.4	36.9	29.0	30.1	25.7	39.0	30.6	34.4	36.6	84.0	41.1	53.2	67.4	39.1	61.9	31.0	53.9	35.7	48.5	34.7	26.5	112.6	18.1	45.6	57.4	51.4	45.2	28.7	49.3	65.6	105.6	23.0	38.7	33.8	54.4	35.3	50.7	28.9	42.3	64.0	35.5	63.9	49.7	32.9	29.6	58.9	33.1	40.0	25.3	43.7	32.0	42.2	28.1	33.1	28.5	34.9	33.3	44.3	22.0	26.2	55.6	24.6	19.8	64.3	24.2	89.9	43.5	12.7	20.7	16.5	15.9	22.2	18.5	28.1	21.6	20.5	22.5	22.6	21.2	19.3	3.0	24.5	18.5	16.2	23.7	20.3	12.2	12.7	10.9	13.4	13.7	13.6	12.4	12.2	12.6	13.6	14.0	14.2	23.8	9.6	15.9	0.7	37.0	0.0	66.3	0.0	32.5	8.8	21.6	20.1	11.7	20.0	9.9	20.2	0.0	34.5	36.3	13.6	45.0	45.8	228.5	18.9	20.1	22.0	23.4	14.7	1.1	40.2	58.0	21.3	18.8	24.2	28.0	29.9	13.9	19.9	36.3	5.0	1.4	19.2	0.0	19.5	0.0	418.8	19.0	25.1	0.0	1.9	36.6	7.9	26.8	1.0	2.4	62.5	20.3	12.4	29.4	83.1	42.5	28.8	2.9	6.2	6.6	29.3	23.3	75.2	33.2	30.4	0.0	45.8	34.3	27.1	25.4	84.2